Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,anterograde trans-synaptic signaling (GO:0098916),0.572898522490114,2.623171756420188,0.0,0.0,0.0,84/224,15.12%,KCND2;NRXN1;GRM5;GRIA3;KCNQ3;NLGN1;GRIK2;ASIC2;SYT1;SYT5;DLG2;GLRA3;GABRG3;CHRM2;GABRB1;HTR2C;RIT2;AMPH;DLGAP1;GRIN2B;SNAP25;GRIA4;HCRTR1;GABRB3;HTR3A;GAD2;CACNA1B;PCDHB5;PNOC;CDK5;GLRA1;GRIN2A;GABRB2;APBA2;GABRA2;PLP1;CACNA1A;GABBR2;GRIA1;CAMK4;SYN1;CHRM3;MTNR1B;CACNB3;SNCG;CNP;SLC1A2;NPTX2;RAPSN;GRM1;NPY;GRIK1;HOMER1;CACNB4;SLC12A5;CACNA1E;HTR4;GRIA2;GRM7;SLC6A2;SLC6A5;SYN2;GABRA3;GABRA1;MINK1;KIF5A;PENK;CBLN1;MBP;DTNA;HTR1D;PRKAR1B;DLG4;SLC12A4;NLGN2;UTS2;SLC1A3;PTCHD1;NOVA1;GABRE;KCNC4;SCN2B;GRM4;HTR1F
prerank,chemical synaptic transmission (GO:0007268),0.5606570263981289,2.618979411855272,0.0,0.0,0.0,103/284,15.12%,KCND2;NRXN1;GRID2;GRM5;GRIA3;KCNQ3;NLGN1;GRIK5;GRIK2;GRID1;ASIC2;SYT1;SYT5;DLG2;GLRA3;GABRG3;CHRM2;GABRB1;HTR2C;RIT2;AMPH;ERC2;DLGAP1;GRIN2B;CDH8;SNAP25;GRIA4;HCRTR1;GABRB3;SNPH;DLGAP2;RIMS1;PTPRN2;HTR3A;GAD2;CACNA1B;PCDHB5;PNOC;CDK5;GLRA1;GRIN2A;GABRB2;APBA2;GABRA2;PLP1;CACNA1A;GABBR2;GRIA1;CAMK4;SYN1;CHRM3;MTNR1B;CACNB3;SNCG;CNP;SLC1A2;NPTX2;RAPSN;GRM1;NPY;GRIK1;HOMER1;CACNB4;STXBP2;SLC12A5;CACNA1E;HTR4;GRIA2;GRM7;TSPOAP1;SLC6A2;SLC6A5;SYN2;GABRA3;GABRA1;MINK1;PDLIM4;KIF5A;PENK;RAB3A;LIN7C;SLC17A6;CBLN1;MBP;NAAA;DTNA;HTR1D;PRKAR1B;DLG4;SLC12A4;NLGN2;UTS2;PPFIA3;SLC1A3;PTCHD1;NOVA1;GABRE;KCNC4;SCN2B;APOE;GRM4;UNC13A;HTR1F
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.5570208186605012,2.4714459335568977,0.0,0.0,0.0,59/159,11.59%,KIRREL3;PTPRD;GRID2;CDH18;LRRC4C;IL1RAPL1;TENM4;ROBO2;NLGN1;UNC5D;L1CAM;LRFN5;CNTN6;CNTN4;DSCAML1;CDH8;TENM1;PCDHGB4;CDH20;CDH9;CDH10;DSCAM;ADGRL3;ROBO1;IGSF11;TENM3;PCDHB5;CD177;NTNG1;MMP24;CLDN18;PTPRT;IGSF21;CEACAM5;DCHS1;CDH19;TENM2;CXADR;CLDN14;CDH12;NECTIN3;MYPN;CLDN11;SDK1;VSTM2L;CDH7;SLITRK1;EMB;CNTN2;CDH17;PTPRS;CDH24;CDHR3;MAG;LRFN4;LRRC4B;CBLN1;CELSR2;CDH2
prerank,neurotransmitter secretion (GO:0007269),0.6918631913683515,2.4203100240065045,0.0,0.0,0.0,22/44,18.01%,NRXN1;SYT1;PCLO;RIMS2;SNAP25;SNPH;RIMS1;PTPRN2;GAD2;CDK5;SYN1;STXBP2;SYN2;RAB3A;LIN7C;NAAA;PPFIA3;GRM4;UNC13A;SNAPIN;GAD1;SLC32A1
prerank,signal release from synapse (GO:0099643),0.683545260902052,2.3926176112853534,0.0,0.0,0.0,21/43,18.01%,NRXN1;SYT1;PCLO;SNAP25;SNPH;RIMS1;PTPRN2;GAD2;CDK5;SYN1;STXBP2;SYN2;RAB3A;LIN7C;NAAA;PPFIA3;GRM4;UNC13A;SNAPIN;GAD1;SLC32A1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.5571120423786323,2.309267810441294,0.0,0.00010927816802827865,0.001,43/107,15.07%,GRID2;GRM5;LRRC4C;NRG3;NLGN1;GRIK5;GRIK2;GRID1;SYT1;DGKI;DLGAP1;ATP1A2;RIMS2;CNTNAP4;DLGAP2;RIMS1;TMEM108;GRM8;PSMC5;CACNA1B;CDK5;CLN3;NPTXR;CACNA1A;SYN1;SLC8A2;NPTX2;GRM1;GRIK1;HOMER1;GRM7;MCTP2;CLSTN2;CDH2;SLC8A3;DLG4;DLGAP3;BDNF;NLGN2;CACNG5;BEGAIN;GRM4;UNC13A
prerank,glutamate receptor signaling pathway (GO:0007215),0.6800744588668166,2.2916652405008047,0.0,0.000187334002334192,0.002,15/37,8.89%,GRID2;GRM5;GRIA3;GRIK2;GRIN2B;GRIA4;GRM8;GRIN2A;CLN3;GRM1;GRIK1;HOMER1;TRPM1;GRIA2;GRM7
prerank,regulation of endothelial cell migration (GO:0010594),-0.5942648359507602,-2.2889156917346525,0.0,0.0,0.0,47/85,22.67%,FOXP1;TEK;DAB2IP;PTPRM;SP100;NRP2;ACVRL1;BMPER;ETS1;RAC1;RHOJ;BMPR2;THBS1;KDR;ANXA3;PRKD2;ABL1;SLIT2;PTK2;FGF1;BMP4;PRKD1;FLT4;SCARB1;ADAMTS9;RRAS;BCAR1;PIK3CD;AKT1;EDN1;BCAS3;RIN2;FGF2;CEACAM1;PRCP;PIK3CB;ROCK2;SMOC2;ANGPT1;SASH1;EPHA2;ITGB3;NF1;NR2F2;DLL4;PTK2B;PTN
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.6159119932175331,2.2866104242147043,0.0,0.000163917252042418,0.002,29/57,14.09%,GRIA3;NLGN1;DLG2;LRRC7;DLGAP1;GRIN2B;GRIA4;DLGAP2;OPRM1;LYNX1;GRIN2A;SHANK1;NPTXR;GRIA1;CACNG8;NPTX2;CAMK2B;NETO1;CACNG3;GRIA2;MINK1;CACNG2;CACNG4;PRRT1;DLG4;DLGAP3;NLGN2;CACNG5;BEGAIN
prerank,neuron cell-cell adhesion (GO:0007158),0.8427426539178339,2.2678139941410755,0.0,0.00014570422403770486,0.002,7/14,4.93%,NRXN3;NRXN1;NLGN1;NCAM2;CNTN4;ASTN2;ASTN1
prerank,neurotransmitter transport (GO:0006836),0.589443854361966,2.257071502283395,0.0,0.0001967007024509016,0.003,35/73,18.01%,NRXN1;SYT1;ATP1A2;SNAP25;PPFIA2;SNPH;RIMS1;PTPRN2;SLC22A1;GAD2;SLC6A15;GABRA2;SYN1;SLC1A2;STXBP2;SLC29A4;TSPOAP1;SLC6A2;SYN2;SLC28A2;RAB3A;LIN7C;SLC17A6;NAAA;GLS2;GLS;PPFIA3;SLC1A3;GRM4;UNC13A;SNAPIN;SLC6A4;GAD1;PPFIA4;SLC32A1
prerank,establishment of endothelial barrier (GO:0061028),-0.7162941065953115,-2.2532938631209314,0.0,0.0,0.0,15/29,11.03%,TJP1;RAPGEF2;PECAM1;F11R;RAB1A;ICAM1;MSN;AFDN;PDE2A;ROBO4;RAP1A;EZR;TJP2;RAP1B;RAPGEF1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.6050267615033985,-2.2485145210918884,0.0,0.0,0.0,31/67,15.36%,FLT1;DAB2IP;WASF2;NRP2;DOCK1;ABI1;RAC1;CLEC14A;ELMO1;CRK;PAK2;KDR;PRKD2;NCK1;PXN;PIK3R1;PTK2;MAPKAPK2;ROCK1;PRKD1;SHB;FLT4;BCAR1;VEGFC;NCK2;RHOA;NCF2;PIK3CB;ELMO2;NCKAP1;ROCK2
prerank,regulation of cell junction assembly (GO:1901888),-0.7421945166083277,-2.233416846777433,0.0,0.0,0.0,16/27,15.36%,TJP1;PRKCH;RAPGEF2;CLDN5;CBFB;F11R;PDLIM5;RAP1A;MEF2C;SETD5;RAP1B;ROCK1;OCLN;RAPGEF1;FLOT1;ROCK2
prerank,presynapse assembly (GO:0099054),0.8192855093564932,2.2308642573385855,0.0,0.0002980313673498509,0.005,5/16,0.55%,PTPRD;IL1RAPL1;NLGN1;PCLO;LRRTM3
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.5684843123170591,-2.224467103716288,0.0,0.0,0.0,35/84,16.14%,FOXP1;TEK;NRP2;NOS3;ETS1;RAC1;BMPR2;THBS1;TMSB4X;KDR;ANXA3;PLCG1;PRKD2;SP1;ABL1;FGF1;BMP4;PRKD1;AKT3;FLT4;SCARB1;RRAS;BCAR1;PIK3CD;AKT1;EDN1;BCAS3;RIN2;FGF2;CD40;PIK3CB;ROCK2;SMOC2;LGMN;ANGPT1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6414116966751737,2.2048813259745756,0.0,0.0004917517561272539,0.009,13/37,6.66%,PTPRD;GRID2;IL1RAPL1;TENM4;NLGN1;TENM1;TENM3;IGSF21;CEACAM5;DCHS1;TENM2;CXADR;NECTIN3
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6162991533960045,2.1618930214573364,0.0,0.0018661348694059895,0.032,24/46,15.07%,NRXN1;GRM5;NLGN1;SYT1;DGKI;ATP1A2;GRM8;CDK5;CLN3;CACNG8;GRM1;ATAD1;GRIK1;HOMER1;CACNG3;GRM7;CACNG2;CACNG4;CDH2;CCL2;NLGN2;CACNG5;GRM4;UNC13A
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.6418696793006855,2.158576732460316,0.0,0.0017796730221748239,0.033,15/35,10.12%,CDH18;NLGN1;CDH8;PCDHGB4;CDH20;CDH9;CDH10;PCDHB5;DCHS1;CDH19;CDH12;CDH7;CDH17;CDH24;CDHR3
prerank,regulation of synapse assembly (GO:0051963),0.6068319103003136,2.130419207570774,0.0,0.0027538098343126223,0.057,19/46,13.33%,PTPRD;NRXN1;GRID2;IL1RAPL1;ROBO2;NLGN1;LRFN5;IL1RAPL2;MUSK;EPHB1;SYNDIG1;MDGA1;SLITRK1;SLIT1;LRFN4;LRRC4B;CLSTN2;BDNF;NLGN2
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.8088985859774765,-2.1239031860555135,0.0,0.0036049059862676446,0.015,9/14,11.47%,GHR;LYN;PTPN1;PXN;PIK3R1;PTK2;STAT6;SOCS2;JAK2
prerank,positive regulation of nervous system development (GO:0051962),0.608050399149925,2.1231580367143397,0.0,0.0028275725977317105,0.061,14/42,13.33%,PTPRD;NRXN1;GRID2;IL1RAPL1;NLGN1;OPRM1;MME;EPHB1;SYNDIG1;GPER1;LRRC4B;CLSTN2;BDNF;NLGN2
prerank,neuropeptide signaling pathway (GO:0007218),0.5627915648607069,2.122034563211753,0.0,0.002892657388983847,0.066,16/58,11.23%,GLRA3;HCRTR1;OPRM1;SORCS1;SORCS3;NXPH3;PNOC;GLRA1;GPR37;CPE;NXPH4;NPY;KISS1R;SORL1;PENK;NMUR2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.5336314349734238,-2.1203238586656643,0.0,0.0032716793824950053,0.016,29/87,12.22%,CLDN5;PARD3;ENG;ITGB1;ACVRL1;FERMT2;ZMIZ1;USP9X;GCNT2;F11R;ID1;SMURF1;TGFBR3;ADAM9;TGFBR2;CBL;PXN;ITGB5;TGFB2;PTK2;PTPRK;CDH5;JUN;SMAD1;SMAD2;SMAD4;SMAD7;USP15;RHOA
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.5394534475190498,-2.118903698790611,0.0,0.0028627194596831293,0.016,42/92,17.07%,FOXP1;TEK;RREB1;NRP2;DOCK1;ETS1;RAC1;PRKCE;BMPR2;THBS1;KDR;ANXA3;MTOR;PLCG1;PRKD2;ADAM9;ABL1;TGFB2;FGF1;BMP4;PPM1F;PRKD1;FLT4;PLCG2;SCARB1;RRAS;BCAR1;PIK3CD;FGF7;AKT1;EDN1;BCAS3;RIN2;FGF2;PIK3CB;MAP4K4;ROCK2;SMOC2;ANGPT1;RAB11A;CTSH;HDAC6
prerank,regulation of cation channel activity (GO:2001257),0.5242916666075093,2.1151016863149095,0.0,0.00298693659277295,0.073,39/89,17.85%,GRIA3;FGF14;NLGN1;DLG2;LRRC7;ANK3;GRIN2B;GRIA4;FGF12;OPRM1;GRIN2A;SHANK1;HPCA;GRIA1;CALM2;CACNB3;CACNG8;CAMK2B;HOMER1;NETO1;CACNG3;CACNB4;GRIA2;STAC;MINK1;CACNG2;CACNG4;PRRT1;HRC;DLG4;NLGN2;CACNG5;KCNS2;SHISA9;SELENON;NEFL;EPO;CACNB1;CNIH2
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.7651813288215723,-2.099237640664154,0.0,0.004382434728403803,0.028,9/17,12.19%,PBX1;CREBBP;MAML2;KAT2B;NOTCH3;PLXND1;MAML1;NOTCH4;NOTCH1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.49946896072478,-2.09516987206827,0.0,0.004580351135493007,0.033,40/128,12.22%,CLDN5;PARD3;ENG;ITGB1;ACVRL1;FERMT2;ZMIZ1;USP9X;BMPR2;SMURF2;GCNT2;BMP5;F11R;RNF111;ID1;SMURF1;TGFBR3;ADAM9;TGFBR2;BMP6;CBL;PXN;ITGB5;PDCD4;HIVEP1;TGFB2;PTK2;BMP4;PTPRK;CDH5;JUN;SMAD1;SMAD2;ACVR2A;SMAD4;RGMB;SMAD7;USP15;HFE;RHOA
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.5052518186412359,-2.0894409393247795,0.0,0.004163955577720915,0.033,35/112,12.80%,CLDN5;PARD3;ENG;ITGB1;ACVRL1;FERMT2;ZMIZ1;USP9X;LIMS1;GCNT2;F11R;ID1;NR3C1;SMURF1;TGFBR3;PDE3A;ADAM9;TGFBR2;CBL;PXN;ITGB5;PDE2A;TGFB2;PTK2;PTPRK;MEF2C;CDH5;JUN;SMAD1;SMAD2;SMAD4;SMAD7;USP15;RHOA;WWOX
prerank,calcium ion transport into cytosol (GO:0060402),0.7021397409988692,2.0856169074063557,0.0,0.004762227533021827,0.12,10/21,11.91%,GRIN2B;MS4A1;ATP2B4;CACNA2D1;GRIN2A;CACNB3;RYR2;TRPM1;ADRA1A;SLC8A1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.6283450187876212,2.083820532823964,0.0,0.00455689960677922,0.121,10/33,4.29%,GRID2;LRRC4C;NRG3;NLGN1;GRIK5;GRIK2;GRID1;PSMC5;CACNA1B;CACNA1A
prerank,Notch signaling pathway (GO:0007219),-0.5668574170861025,-2.082418009367315,0.0,0.004771199099471883,0.042,27/59,17.95%,PBX1;ZNF423;CREBBP;MAML2;GMDS;KAT2B;DTX3L;NOTCH3;HES1;JAG2;PSEN2;SORBS2;PLXND1;MAML1;NOTCH2;ADAM10;MIB1;NOTCH4;PSEN1;GALNT11;NOTCH1;DTX3;JAG1;NLE1;APH1A;HEY1;HEY2
prerank,positive regulation of synapse assembly (GO:0051965),0.6502871258973304,2.0542148029139087,0.0,0.007243581423588756,0.195,11/27,13.33%,PTPRD;NRXN1;GRID2;IL1RAPL1;NLGN1;EPHB1;SYNDIG1;LRRC4B;CLSTN2;BDNF;NLGN2
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.6347327146009909,-2.044857219069721,0.0,0.008416884565222193,0.077,16/33,14.15%,TJP1;SEMA6A;KLF4;BMPER;RHOJ;KLF2;THBS1;JAK1;FGF1;SMAD1;CEMIP2;ADAMTS9;FGF2;S100A1;CEACAM1;PIK3CB
prerank,regulation of cation transmembrane transport (GO:1904062),0.636836854301847,2.0425598279719646,0.0,0.008166059465385914,0.229,12/29,8.20%,KCNIP4;DPP10;KCNIP1;FGF12;DPP6;ATP2B4;KCNN2;CD63;WNK3;CACNA1D;HOMER1;SCN5A
prerank,protein localization to cell-cell junction (GO:0150105),-0.7777904109748767,-2.041770027859641,0.0,0.00808831847339043,0.08,11/15,16.15%,TJP1;MPP7;F11R;JAK1;PAK2;CGNL1;LSR;CDH5;TJP2;ACTB;ARHGEF18
prerank,sprouting angiogenesis (GO:0002040),-0.5701817794163464,-2.0387310116855093,0.0,0.007888382511126845,0.084,29/51,24.90%,TEK;ENG;ACVRL1;RSPO3;ADGRA2;BMPER;PARVA;THBS1;KDR;RNF213;OTULIN;SLIT2;BMP4;FLT4;RAMP2;AKT1;VEGFC;NAXE;FGF2;JMJD6;ANGPT1;PIK3R3;SEMA3E;PTK2B;RECK;ESM1;E2F7;SEMA5A;EGR3
prerank,regulation of DNA binding (GO:0051101),-0.5902335031190176,-2.0364522235536295,0.0,0.007554398574163814,0.086,21/44,20.11%,LEF1;SP100;SMO;HES1;NFKBIA;ZBTB7A;NGF;JUN;HJURP;DOT1L;JAK2;MAPK8;FOXC1;ILRUN;IGF1;SKI;SUMO1;TFAP4;CEBPG;TXN;PPARG
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5697149703739193,-2.028881178868557,0.0,0.008008130253231239,0.098,30/48,30.81%,JCAD;NOS3;ETS1;RHOJ;THBS1;TMSB4X;KDR;PLCG1;PRKD2;SP1;PIK3C2A;PRKD1;AKT3;AKT1;MAP3K3;FGF2;CD40;ANGPT1;ANXA1;GATA2;HDAC7;MAP2K3;HMGB1;ADAM17;HMOX1;ANGPT4;FGF18;FOXC2;MAPK14;TGFB1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.6006198740376166,-2.028289704346861,0.0,0.007845971852464873,0.101,22/39,23.60%,TJP1;DAB2IP;RAPGEF2;SNCAIP;TIE1;MSN;IRGM;RAP1A;EZR;RAP1B;ROCK1;SPTY2D1;HJURP;RAPGEF1;NOTCH1;HCFC1;ROCK2;NCLN;CCL19;PTPN11;HSP90AA1;GFAP
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.6662382366849017,-2.0212158244416134,0.0,0.008705345725352207,0.115,21/26,29.65%,ANKRD17;KMT2E;DDX3X;EGFR;PLCB1;CCND3;CDK10;AKT1;RGCC;RPTOR;UBE2E2;LSM11;ANXA1;LSM10;CCND1;MTBP;TFDP1;ADAM17;FGF10;RDX;CCND2
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.7624493639187986,-2.0198735017478673,0.0018484288354898336,0.008397310415070513,0.116,7/14,11.79%,NOS3;ACE;ECE1;ENPEP;EDN1;EDN3;AGTR1
prerank,axon development (GO:0061564),0.5188387988471059,2.014816843928473,0.0,0.011288909879790874,0.314,30/78,10.41%,CTNNA2;L1CAM;DCC;ANK3;CNTN4;DSCAML1;SHTN1;CDK5;NTNG2;NTNG1;PLPPR4;PLP1;NRCAM;ATL1;PAX2;PAK3;MAP1S;FGFR2;SLITRK1;MAPT;POU4F1;RTN4;NEFH;S100A6;GRM7;SPTBN4;SLITRK4;MAP1B;CCK;RAB3A
prerank,potassium ion transport (GO:0006813),0.47649449682118833,2.0124696880414503,0.0,0.011228331764905631,0.32,20/120,5.25%,KCND2;KCNC2;KCNQ3;HCN1;SLC24A4;SLC24A2;KCNMA1;ATP1A2;KCNA6;KCNH8;KCNQ5;KCNH7;KCNA5;KCNJ3;KCNH4;SLC9A7;KCNH5;KCNN2;KCNA2;SLC9A9
prerank,receptor clustering (GO:0043113),0.6409433814564741,2.011680779896567,0.0022471910112359553,0.010910332295943341,0.323,6/27,3.18%,NRXN1;MAGI2;NLGN1;DLG2;LRRC7;MUSK
prerank,negative regulation of DNA binding (GO:0043392),-0.6411592218311183,-2.0081794096868584,0.0,0.010542078010261684,0.145,13/28,17.95%,LEF1;SP100;SMO;NFKBIA;JUN;SIN3A;JAK2;ILRUN;MAD2L2;SUMO1;TFAP4;HEY1;HEY2
prerank,endothelial cell proliferation (GO:0001935),-0.7146236720594312,-2.0056988456346554,0.001876172607879925,0.010409888944302288,0.148,8/17,7.35%,TEK;ACVRL1;BMPER;CD34;BMPR2;DLG1;BMP4;ERN1
prerank,regulation of potassium ion transport (GO:0043266),0.6264806079737696,1.9994746297636226,0.002197802197802198,0.012609019387878308,0.364,10/31,9.30%,KCNIP4;DPP10;KCNIP1;ANK3;DPP6;KCNA5;KCNN2;CD63;CACNA1D;ADRA2A
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.5018238679837697,-1.996174677947221,0.0,0.011948742092590453,0.173,34/100,14.48%,FLT1;TEK;DAB2IP;IGF1R;GAB1;ROR1;INSR;LYN;PDGFD;KDR;EGFR;PIP4K2A;CBL;PIK3R1;TGFB2;NEDD4;PTK2;PIP4K2B;STAMBP;PIP5K1B;MAPK1;HAX1;IER3;WNT16;PIK3CD;JAK2;MAZ;FGF2;CEACAM1;PTPN13;MYOC;HGF;PIK3CB;PIK3IP1
prerank,maintenance of blood-brain barrier (GO:0035633),-0.6312426500344369,-1.9918046405112504,0.0,0.012299091011971965,0.187,13/30,9.39%,TJP1;PECAM1;CLDN5;ITGB1;JAM2;ESAM;F11R;LSR;SLC12A2;CDH5;TJP2;MFSD2A;OCLN
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.5906060097886644,-1.987877288550433,0.0,0.012468733646619854,0.196,17/42,14.75%,UTRN;TEK;FERMT2;RAC1;LIMS1;GSK3B;CCL25;KDR;PTPRJ;ABL1;ROCK1;PPM1F;RRAS;RIN2;MYOC;CDK6;MAP4K4
prerank,positive regulation of synaptic transmission (GO:0050806),0.5110757666429019,1.985717750327837,0.0,0.014594706441110106,0.414,25/72,13.44%,NRXN1;NLGN1;GRIK2;SYT1;MPP2;SLC24A2;GRIN2B;RIMS2;RIMS1;ADCY8;GRIN2A;CACNG8;SLC8A2;CACNG3;GPER1;CACNG2;PRKCZ;ADRA1A;CACNG4;CLSTN2;SLC8A3;DLG4;CCL2;NLGN2;CACNG5
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.5284980472648212,-1.9844281812585791,0.0,0.012772132973970885,0.208,37/66,28.04%,RB1;DCUN1D3;KLF4;PKD2;ANKRD17;KMT2E;DDX3X;EGFR;DLG1;PLCB1;CCND3;PSME2;FAM107A;AKT1;RGCC;RPTOR;CDC73;UBE2E2;LSM11;CDK6;ANXA1;LSM10;CDK2AP2;PSME1;CCND1;PTEN;CDKN2C;FHL1;E2F7;TFDP1;INO80;ADAM17;APC;FGF10;KIF14;CDKN2B;RDX
prerank,synapse assembly (GO:0007416),0.515748799337996,1.9837183770882105,0.0,0.014541801931191653,0.423,19/67,9.50%,KIRREL3;NRXN1;GRID2;NLGN1;LRRTM3;GABRB3;DSCAM;ADGRL3;DNER;PCDHB5;CDK5;GABRB2;GABRA2;NRCAM;GPM6A;SDK1;SLITRK1;POU4F1;GABRA1
prerank,synaptic vesicle exocytosis (GO:0016079),0.5693441310436939,1.9834707578925124,0.0,0.014085579037576056,0.425,10/40,6.17%,SYT1;PCLO;SYT5;RIMS2;SNAP25;SNPH;RIMS1;CDK5;STX2;PRRT2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.6337013399262794,-1.9831768289731928,0.0017482517482517483,0.012487582828247397,0.211,10/29,11.47%,GHR;PKD2;IL15;IFNAR1;NMI;STAT6;STAMBP;SOCS2;STAT2;JAK2
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.6164262920269609,-1.9805195823476267,0.0,0.012405117658626896,0.219,17/32,21.75%,JCAD;KLF4;RHOJ;THBS1;KDR;MEOX2;PIK3C2A;AKT3;STARD13;MAP3K3;NOTCH1;RHOA;FGF2;ANXA1;GATA2;DLL4;HDAC7
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5974563003166308,-1.967908727007711,0.0,0.015048471642472236,0.266,15/38,15.15%,SP100;NOS3;GSK3B;THBS1;BMP5;DDX3X;TNFSF10;ICAM1;FAS;ARHGEF2;CASP8;CFLAR;GPX1;TNFAIP3;FEM1B
prerank,secondary palate development (GO:0062009),-0.7358864603154042,-1.959044189170336,0.0,0.01666738885415511,0.304,7/14,13.26%,LEF1;TGFBR3;TGFBR2;TGFB2;SMAD2;SMAD4;WNT11
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.7024673188328098,-1.951195075288154,0.0,0.018428115231508606,0.336,11/19,14.75%,TEK;FERMT2;RAC1;LIMS1;KDR;PTPRJ;ABL1;ROCK1;PPM1F;MYOC;MAP4K4
prerank,neuronal action potential (GO:0019228),0.6527462263402897,1.9498635527965502,0.0,0.022096045575317944,0.581,8/22,9.96%,ANK3;SCN8A;SCN1A;SCN3A;KCNA2;SCN2A;SCN5A;GPER1
prerank,regulation of NMDA receptor activity (GO:2000310),0.5902178776875494,1.9440446674399567,0.0,0.02301186712543881,0.609,11/32,8.83%,GRIA3;NLGN1;DLG2;LRRC7;GRIN2B;GRIA4;OPRM1;GRIN2A;GRIA1;CAMK2B;GRIA2
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.6622956376660181,-1.9428609905493204,0.0,0.02067519609771149,0.377,10/23,12.29%,ENG;SMURF2;ITGA3;TGFBR3;NREP;SMAD2;SMAD4;LATS2;SMAD7;LTBP4
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.64070807900349,-1.934821949903324,0.0,0.02270897995627425,0.41,11/24,13.14%,SEC31A;SEC24B;ACE;SEC24A;ABCB9;SEC24D;TAP2;SEC13;BCAP31;HFE;PDIA3
prerank,blood vessel morphogenesis (GO:0048514),-0.5372732539889482,-1.9324162077634515,0.0,0.022976598016280284,0.423,20/54,12.04%,FLT1;ENG;CAV1;LRP5;ID1;TBX1;KDR;SOX17;TGFBR3;TGFBR2;HES1;RASIP1;COL4A1;FLT4;RAMP2;LAMA1;CUL7;SMAD7;ADM;RASA1
prerank,protein localization to synapse (GO:0035418),0.7481919906582856,1.9233849406350605,0.0,0.029402657085108728,0.705,6/12,13.33%,NRXN1;NLGN1;PCLO;SHANK1;DLG4;NLGN2
prerank,synaptic membrane adhesion (GO:0099560),0.7167572019162378,1.9210506064522357,0.0,0.029306417789402003,0.715,8/14,10.44%,PTPRD;LRRC4C;LRFN5;NTNG1;SLITRK1;PTPRS;LRFN4;LRRC4B
prerank,synapse organization (GO:0050808),0.45023267225929015,1.9178254618364854,0.0,0.029562958515414916,0.726,38/125,11.77%,KIRREL3;PTPRD;NRXN1;GRM5;LRRC4C;NLGN1;L1CAM;LRFN5;ANK3;ARHGAP39;CTNND2;PPFIA2;WNT7B;DSCAM;ADGRL3;DNER;PCDHB5;CDK5;MUSK;NTNG1;NRCAM;CACNB3;SNCG;PAK3;SLC8A2;GPM6A;SDK1;CACNB4;SLITRK1;CNTN2;MAPT;POU4F1;PTPRS;LRFN4;LRRC4B;CBLN1;CDH2;SLC8A3
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.7065520286730949,1.917197260128988,0.0,0.029018036961566337,0.727,6/15,8.89%,GRM5;GRM8;GRM1;HOMER1;TRPM1;GRM7
prerank,central nervous system neuron differentiation (GO:0021953),0.5856175684300335,1.917156982148635,0.0,0.028248406435310035,0.728,14/33,10.91%,GRID2;MDGA2;SPOCK1;CHD5;LHX1;TOX;MDGA1;MAP2;PROX1;NPY;NTRK2;MAPT;FAIM2;CBLN1
prerank,tight junction assembly (GO:0120192),-0.5366426458871388,-1.9072964923101825,0.0,0.034025465577948055,0.559,14/49,9.78%,PECAM1;CLDN5;PARD3;ESAM;MPP7;F11R;PAK2;LSR;AFDN;DLG1;PARD6G;CDH5;OCLN;RAMP2
prerank,regulation of gastrulation (GO:0010470),0.7070080744021108,1.905856710422588,0.0,0.03133034612010757,0.776,5/14,6.40%,TENM4;LHX1;OSR1;PHLDB1;PHLDB2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.5989063733344793,-1.905713148545839,0.0,0.03396386914512947,0.568,11/30,12.29%,ENG;XIAP;SMURF2;ITGA3;TGFBR3;NREP;SMAD2;SMAD4;LATS2;SMAD7;LTBP4
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.5647390575968567,-1.8939741903046814,0.0017211703958691911,0.039166816391340356,0.633,21/39,24.43%,TEK;THBS1;KDR;ICAM1;PLCG1;GAS6;PDCD4;CDH5;RAMP2;RGCC;ANO6;ITGA4;ECSCR;CD40;TNFAIP3;ANGPT1;GATA2;MAPK7;NFE2L2;SERPINE1;SEMA5A
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.4547291531583731,-1.8930620276726766,0.0,0.038705306378873656,0.639,48/122,21.67%,SORBS1;INSR;KLF4;THBS1;STN1;EIF3E;METTL14;DDX3X;KDR;MTOR;PRKD2;NIBAN1;EGFR;PLD1;EIF3C;NFKB1;IRS1;TGFB2;UPF3B;SAMD4A;ABCB10;LDB1;NAMPT;RPL26;AKT1;ZCCHC4;RGCC;EEF2;JAK2;FGF2;DNA2;CTC1;LARP4B;HGF;RPS4X;SMOC2;RPL5;METTL5;IGF1;NLRC5;CCL19;NOD2;SOX4;PRKDC;FGFR4;IGF2;RBM3;PDGFRB
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.7756073365076633,-1.8929613287245697,0.001851851851851852,0.03774548620915534,0.64,6/11,7.60%,TJP1;RAPGEF2;F11R;RAB1A;AFDN;TJP2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.7439724835298849,-1.8921377149657228,0.0034904013961605585,0.037342584951866604,0.646,4/12,7.28%,IGF1R;INSR;IRGM;BNIP3
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.49562109238746865,-1.8894472142144494,0.0,0.0375489490104779,0.657,23/72,14.15%,FLT1;TEK;IGF1R;GAB1;ROR1;INSR;LYN;PDGFD;KDR;CBL;PIK3R1;TGFB2;NEDD4;PTK2;HAX1;WNT16;PIK3CD;JAK2;MAZ;FGF2;MYOC;HGF;PIK3CB
prerank,sodium ion export across plasma membrane (GO:0036376),0.7230724459469045,1.887427882845894,0.0,0.03816683805450827,0.843,5/13,8.71%,ATP1A2;ATP12A;SLC4A4;ATP1B1;ATP4A
prerank,bicellular tight junction assembly (GO:0070830),-0.5343548140143299,-1.885353004763286,0.0,0.03853311272716339,0.673,13/46,9.78%,PECAM1;CLDN5;PARD3;ESAM;MPP7;F11R;PAK2;AFDN;DLG1;PARD6G;CDH5;OCLN;RAMP2
prerank,sodium ion transmembrane transport (GO:0035725),0.4701223482174462,1.8850782170428984,0.0,0.03854997527520661,0.852,22/84,9.20%,ASIC2;HCN1;SLC24A4;SLC24A2;ATP1A2;SCN8A;SCN1B;SCN1A;ATP12A;SLC6A15;SLC9A7;SLC4A4;SCN3A;ATP1B1;SLC6A11;SLC9A9;SCN2A;SLC8A2;SCN5A;ATP4A;SLC6A2;SLC6A5
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.579384644723308,-1.8823443100935233,0.0017857142857142857,0.039146024239387914,0.684,21/34,25.51%,FLT1;DAB2IP;SEMA6A;GAB1;KDR;PRKD2;ERN1;MAPKAPK2;PRKD1;FLT4;RAMP2;VEGFC;NOTCH1;FOXC1;ANXA1;DLL4;MAP2K3;RELA;EGR3;PIK3CA;MT1G
prerank,sensory perception of chemical stimulus (GO:0007606),0.6932260357406157,1.8775994234023012,0.004329004329004329,0.04101209646101298,0.877,6/15,16.20%,SLC24A4;GNAL;BBS4;UBR3;ADCY3;MKKS
prerank,epithelial to mesenchymal transition (GO:0001837),-0.5408778664035017,-1.8770346549886527,0.0,0.04114797768817265,0.7,22/47,20.86%,LEF1;ENG;LIMS1;GSK3B;LOXL3;TGFBR3;TGFB2;ROCK1;HNRNPAB;TASOR;CUL7;NOTCH4;NOTCH1;FOXF2;HGF;ROCK2;BMP7;CTNNB1;HEY1;HEY2;AKNA;TRIM28
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.7501070490162736,-1.8740433808636492,0.0,0.04204309962023519,0.719,3/11,1.78%,MECOM;ETV6;CD34
prerank,synaptic vesicle cycle (GO:0099504),0.5721952263615933,1.8737691392868774,0.0,0.04210674386611576,0.89,8/30,10.73%,NLGN1;PCLO;SNAP25;RIMS1;CDK5;SYNDIG1;RAB3A;SLC17A6
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.5784796319541698,-1.873603922982128,0.0,0.04143336957106597,0.72,23/33,29.65%,ANKRD17;KMT2E;DDX3X;EGFR;PLCB1;CCND3;STXBP4;PLCG2;AKT1;RGCC;RPTOR;CDC73;UBE2E2;LSM11;ANXA1;LSM10;CCND1;TFDP1;CRNN;ADAM17;FGF10;RDX;CCND2
prerank,contractile actin filament bundle assembly (GO:0030038),-0.7020235462315396,-1.8724739932767056,0.0,0.04042265903719234,0.729,9/15,12.22%,SORBS1;ITGB1;FAM171A1;ITGB5;CUL3;PDLIM1;TNFAIP1;PHACTR1;RHOA
prerank,stress fiber assembly (GO:0043149),-0.7020235462315396,-1.8724739932767056,0.0,0.04042265903719234,0.729,9/15,12.22%,SORBS1;ITGB1;FAM171A1;ITGB5;CUL3;PDLIM1;TNFAIP1;PHACTR1;RHOA
prerank,positive regulation of glucose import (GO:0046326),-0.6349097748575672,-1.8716462654361996,0.0017605633802816902,0.04003912387148649,0.732,9/21,16.38%,SORBS1;INSR;PIK3R1;IRS1;RHOQ;OCLN;AKT1;CREBL2;IGF1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.589585121213575,-1.871623374080026,0.0017793594306049821,0.03926378778925395,0.733,15/30,23.22%,NOS3;GSK3B;BMP5;DDX3X;TNFSF10;ICAM1;FAS;ARHGEF2;CASP8;CFLAR;GPX1;TNFAIP3;BRCA1;SERPINE1;RIPK1
prerank,regulation of focal adhesion assembly (GO:0051893),-0.5268206963370538,-1.8698949411370356,0.0,0.03954170234072122,0.741,24/54,16.67%,TEK;ACVRL1;FERMT2;RAC1;LIMS1;CORO1C;THBS1;KDR;PTPRJ;ABL1;MACF1;PTK2;ROCK1;PPM1F;LDB1;FAM107A;BCAS3;RHOA;LIMCH1;DUSP3;MYOC;MAP4K4;ROCK2;SLK
prerank,mesenchymal cell differentiation (GO:0048762),-0.5281040041143773,-1.8692072234207537,0.0,0.039074897240290236,0.742,24/51,20.86%,LEF1;ENG;LIMS1;GSK3B;FBXL17;LOXL3;TGFBR3;LRP6;TGFB2;MEF2C;ROCK1;HNRNPAB;CUL7;NOTCH4;NOTCH1;FOXF2;HGF;FOXC1;ROCK2;BMP7;CTNNB1;HEY2;AKNA;TRIM28
prerank,regulation of angiogenesis (GO:0045765),-0.425736496426827,-1.8687333419192882,0.0,0.038553689327053296,0.746,66/192,20.79%,FLT1;TEK;DAB2IP;PTPRM;SEMA6A;CLDN5;SP100;ITGB1;GAB1;COL4A2;NOS3;TIE1;ADGRA2;KLF4;BMPER;ETS1;CD34;RHOJ;THBS1;KDR;ANXA3;PLCG1;PRKD2;SP1;TGFB2;FGF1;ISM1;CDH5;PLXND1;ROCK1;HSPG2;PRKD1;CEMIP2;RRAS;PIK3CD;RAMP2;VEGFC;PIK3R6;RGCC;STAB1;NAXE;FGF2;MTDH;CEACAM1;ECSCR;CD40;MECP2;AGO2;TNFAIP3;FOXC1;ROCK2;SMOC2;FOXO4;NPR1;HIPK1;GTF2I;CTSH;CTNNB1;SASH1;SEMA3E;GATA2;EPHA2;PPARG;F3;BRCA1;NF1
prerank,apical junction assembly (GO:0043297),-0.52166426208029,-1.8674850296162664,0.0,0.038358084612050494,0.747,17/53,14.01%,CTNNA1;PECAM1;CLDN5;PARD3;ESAM;MPP7;F11R;PAK2;AFDN;DLG1;PARD6G;CDH5;OCLN;RAMP2;RHOA;RHOC;PKN2
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.6891690914118264,-1.8583345331121182,0.0018726591760299626,0.042958141710154114,0.799,6/15,5.93%,IGF1R;DYRK1A;KDR;EGFR;BMX;ABL1
prerank,sodium ion transport (GO:0006814),0.4578032636982613,1.8576102058639983,0.0,0.05001817862322926,0.93,27/85,15.60%,ASIC2;HCN1;SLC24A4;SLC24A2;ATP1A2;SCN8A;SLC5A12;SCN1B;SCN1A;CATSPER4;SLC6A15;SLC4A4;SCN3A;ATP1B1;SLC6A11;SCN2A;SLC8A2;SCN5A;SLC6A2;SLC6A5;SLC8A3;SLC8A1;SGK1;SCN2B;ASIC1;SLC4A11;SLC6A4
prerank,regulation of epithelial cell migration (GO:0010632),-0.520571836045185,-1.8571145868517709,0.0,0.0430543918738058,0.806,16/51,9.00%,PTPRG;DAB2IP;RREB1;DOCK1;BMPER;RHOJ;PRKCE;BMPR2;CORO1C;MCC;PLCG1;TGFB2;MACF1;PTK2;PPM1F;PLCG2
prerank,sensory perception of smell (GO:0007608),0.7551709211857555,1.8551912056267672,0.0,0.050196799416152564,0.933,5/11,16.20%,SLC24A4;BBS4;UBR3;ADCY3;MKKS
prerank,endothelial cell development (GO:0001885),-0.609893033971634,-1.847336601452532,0.001834862385321101,0.047566901899296285,0.844,11/25,11.76%,RAPGEF2;PECAM1;ICAM1;MSN;PDE2A;ROBO4;RAP1A;EZR;RAP1B;RAPGEF1;COL15A1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.7036796574213393,-1.8465034876396544,0.0,0.04727326004304325,0.844,9/15,15.65%,THBS1;TMSB4X;PRKD2;FGF1;PRKD1;NOTCH1;FGF2;SMOC2;LGMN
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.6245014309557245,-1.8454848264681587,0.0,0.04716209008155935,0.844,13/24,14.75%,TEK;FERMT2;RAC1;LIMS1;KDR;PTPRJ;PIK3R1;ABL1;ROCK1;PPM1F;DUSP3;MYOC;MAP4K4
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.5731489693712276,-1.84242862254448,0.0018181818181818182,0.048560204167958275,0.85,10/33,9.23%,PTPRG;DAB2IP;PTPRM;SP100;ACVRL1;CORO1C;THBS1;MCC;SLIT2;ADAMTS9
prerank,calcium ion import into cytosol (GO:1902656),0.6844720683957949,1.8419889146251984,0.0,0.05665576293320665,0.952,7/15,11.91%,SLC24A2;MS4A1;ATP2B4;CACNA2D1;SLC8A2;SLC8A3;SLC8A1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.6353008366393318,-1.8415696311415235,0.0035460992907801418,0.04818128926679802,0.856,8/21,17.13%,DAB2IP;CD2AP;CGNL1;SLIT2;TGFB2;STAMBP;SPRY4;ARHGAP12
prerank,positive regulation of protein modification process (GO:0031401),-0.4123844432776445,-1.839410050967281,0.0,0.04879961917653392,0.864,59/203,13.69%,TEK;PECAM1;ENG;TRABD2B;PPP2R5A;DYRK1A;INSR;DAB2;RAC1;FAM20A;LYN;RAB3GAP1;DVL3;APP;ATG7;RALBP1;LIMK2;RAMP1;TBX1;LRRK2;ATG10;DDX3X;ALG10B;KDR;NIBAN1;SLCO3A1;EGFR;ACE;TFRC;GAS6;ABL1;FAS;IL34;CCND3;PTK2;IRGM;PRKCD;FGF1;SPPL3;BMP4;CDH5;NOS1AP;FLT4;ACVR2A;ASPSCR1;FGF7;AKT1;VEGFC;AXIN2;RAB3GAP2;ILK;FGF2;LIMCH1;CSNK1D;KAT5;FLOT1;CHP1;CD40;HGF
prerank,potassium ion transmembrane transport (GO:0071805),0.4254995376499395,1.839276809167313,0.0,0.057159767089991625,0.953,34/135,15.23%,KCND2;KCNC2;KCNQ3;HCN1;SLC24A4;SLC24A2;ATP1A2;KCNA6;KCNH8;KCNQ5;KCNH7;KCNA5;KCNJ3;ATP12A;KCNH4;SLC9A7;KCNH5;KCNN2;KCNA2;ATP1B1;SLC9A9;SLC12A5;ATP4A;KCNJ6;KCNN3;KCND1;SLC12A4;SLC1A3;KCNS2;KCNC4;KCNK12;KCNK10;KCNA4;KCNK9
prerank,BMP signaling pathway (GO:0030509),-0.49888308326398345,-1.8376962408254172,0.0,0.04919636404788786,0.875,20/62,11.78%,ENG;ACVRL1;USP9X;BMPR2;BMP5;SMURF1;TGFBR3;BMP6;PDCD4;HIVEP1;TGFB2;BMP4;SMAD1;SMAD2;ACVR2A;SMAD4;RGMB;SMAD7;USP15;HFE
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.46937714241472256,-1.8315473723659434,0.0,0.051886790206756725,0.889,52/91,31.94%,RPS21;RPL37;RPL31;RPL9;RPS14;RPSA;RPL3;RPLP1;SRPRA;RPL26;RPS11;SRP9;RPL13;RPL38;RPL27;RPS16;RPS4X;RPL10;RPL7A;RPL5;SRP14;SIL1;RPS27;RPL27A;RPS3;RPL36A;RPL35A;RPL37A;RPL32;RPS7;RPS15;RPS8;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS23;RPS17;RPS2;RPL39;RPS26;RPS15A;SEC61A1;RPL15;RPL34;RPLP2;RPL18;RPL19;RPS13;RPL8;SEC63
prerank,positive regulation of cell communication (GO:0010647),0.5827766751896177,1.8305369106218778,0.0,0.06200348229430594,0.968,9/28,12.35%,GRIK2;SYT1;ANK3;RIMS2;RIMS1;CARTPT;HOMER1;CLSTN2;DLG4
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.4721413313922814,1.8299282532182484,0.0,0.06089351533320465,0.969,30/75,12.34%,CTNNA2;DCC;ANK3;CNTN4;DSCAML1;SHTN1;CDK5;NTNG2;NTNG1;PLPPR4;NRCAM;ATL1;DCDC2;PAX2;PAK3;MAP2;MAP1S;FGFR2;SLITRK1;POU4F1;NEFH;S100A6;MINK1;SPTBN4;SLITRK4;MAP1B;CCK;RAB3A;CELSR2;LLGL1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.56477074102257,-1.8274918061516776,0.0017241379310344827,0.05404422856878715,0.9,17/33,24.43%,TEK;CAST;KDR;ICAM1;PPARA;GAS6;CDH5;YAP1;RAMP2;TNFAIP3;ANGPT1;GATA2;TCF7L2;MAPK7;NFE2L2;SERPINE1;SEMA5A
prerank,regulation of presynapse assembly (GO:1905606),0.6429195210704534,1.827189952768874,0.002150537634408602,0.059973642747274895,0.97,8/18,10.44%,PTPRD;IL1RAPL1;LRFN5;IL1RAPL2;MDGA1;SLITRK1;LRFN4;LRRC4B
prerank,regulation of presynapse organization (GO:0099174),0.6429195210704534,1.827189952768874,0.002150537634408602,0.059973642747274895,0.97,8/18,10.44%,PTPRD;IL1RAPL1;LRFN5;IL1RAPL2;MDGA1;SLITRK1;LRFN4;LRRC4B
prerank,positive regulation of cell motility (GO:2000147),-0.4154643473515593,-1.8267843100040715,0.0,0.0535145402025614,0.902,76/205,22.76%,FLT1;TJP1;LEF1;IGF1R;ITGA6;SEMA6A;PECAM1;SEMA3C;ITGB1;PODXL;FERMT2;INSR;CAV1;DAB2;CBLL1;NTN1;PDGFD;SEMA7A;THBS1;GCNT2;ATM;SPOCK2;SYNE2;KDR;SMO;EGFR;ADAM9;PTK2;FGF1;CDH5;PPM1F;FAM107A;MYLK;BCAR1;PIK3CD;ADAM10;EDN1;MAZ;TWIST2;NOTCH1;SEMA3G;SEMA6B;SEMA4C;ACTN4;NEDD9;WNT11;MYOC;RHOC;HGF;NUMB;MAP4K4;ROCK2;VSIR;CAVIN1;SEMA5B;PIK3R3;IGF1;RIPOR1;CTSH;SEMA4A;SEMA3E;CCL19;WASHC1;CXCL12;F3;FERMT3;LAMB1;SEMA4G;SH3RF2;ROR2;PDGFRB;SPAG9;LAMC2;PTK2B;CCN1;MIEN1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.7401376993476244,1.8266358547960486,0.0,0.059102004396414234,0.972,7/10,18.60%,GABRG3;GABRB2;GABRA2;GABRA3;GABRA1;GABRE;GABRA5
prerank,neuron projection morphogenesis (GO:0048812),0.4272111608709397,1.8230817747817596,0.0,0.06006442365036681,0.977,48/137,13.10%,CNTNAP2;NLGN1;CTNNA2;DCC;ANK3;CNTN4;DSCAML1;CTNND2;DOCK10;EPB41L3;SHTN1;CDK5;EPHB1;NTNG2;NTNG1;PLPPR4;SHANK1;NBL1;NRCAM;TNIK;ATL1;DCDC2;IMPACT;PAX2;PAK3;MAP2;MAP1S;GPM6A;PAK1;FGFR2;SLITRK1;NYAP2;POU4F1;NEFH;S100A6;MINK1;SPTBN4;CPNE1;SLITRK4;MAP1B;CCK;RAB3A;SRGAP2;CELSR2;LLGL1;DLG4;SGK1;BDNF
prerank,artery morphogenesis (GO:0048844),-0.5820890140714703,-1.8225466389658382,0.0,0.05577318111502057,0.916,21/30,28.96%,ENG;PKD2;BMPR2;TBX1;HES1;TGFB2;BMP4;TBX2;ADAMTS9;SMAD7;NOTCH1;JAG1;HEY2;NF1;PDGFRB;FOXF1;GJA5;LRP1;STRA6;TGFBR1;LRP2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.7684515775139549,-1.8220091397986176,0.0017211703958691911,0.05528977779976241,0.916,5/10,11.47%,GHR;LYN;PTPN1;STAT6;JAK2
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6433308832574614,-1.816282910832168,0.007079646017699115,0.058526708953521765,0.93,10/19,19.29%,TJP1;PRKCH;CLDN5;CBFB;F11R;ROCK1;OCLN;ROCK2;IKBKB;EPHA2
prerank,regulation of glucose import (GO:0046324),-0.5640167188819076,-1.815336448468406,0.0051813471502590676,0.05838130098096643,0.931,11/30,16.38%,SORBS1;INSR;PIK3R1;IRS1;RHOQ;GRB10;GSK3A;OCLN;AKT1;CREBL2;IGF1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.37347964142431117,-1.8149415159251594,0.0,0.057845749082047836,0.931,159/476,22.69%,MECOM;LEF1;RREB1;SMARCA2;FLI1;ZBTB16;NFIB;SP100;ZNF423;ACVRL1;FOXO1;AFAP1L2;CREBBP;NSD1;DYRK1A;ZMIZ1;KAT6B;ELF1;KLF4;ETS1;LRP5;ESR1;MLLT3;ZFHX3;KLF2;DVL3;RXRA;TRIM56;NFATC1;PRDM16;RNF111;BICRA;TEAD1;KMT2E;ARID1B;TBX1;DTX3L;MITF;MAP3K5;KAT6A;SOX17;EGFR;CD38;NAA16;SP1;FZD4;CRLF3;CTCF;HDAC1;NFKB1;HES1;PPARA;SIX1;SMARCC1;RYBP;TASP1;FOXO3;DNM2;LRP6;PLCB1;NSD3;MED1;BMP4;CREB3L2;MEF2C;JUN;SMAD2;ZFP90;ACTA2;SETD3;MDFIC;HNRNPAB;YAP1;CDH1;PPARD;PHF5A;IRF1;GLI3;PICALM;SMAD4;SP3;FGF7;TAL1;AKT1;GLIS2;NAA15;ELF2;TP53;NOTCH4;ETS2;MED13;KDM3A;RGMB;ILK;SMARCC2;PSEN1;MAZ;ARHGEF11;MED17;YAF2;NOTCH1;FOXF2;FGF2;RPS6KA1;HDAC4;KAT5;WNT11;RHOG;FBXW11;XPC;SMARCD3;ZIC3;ATF4;NR1D2;HCFC1;TCF3;FOXC1;MRPL12;TADA3;JMJD6;TRIM16;MAD2L2;CREBL2;PCBD2;BMP7;IGF1;SIX4;RARA;CTNNB1;GPATCH3;TFAP4;HEY1;HEY2;WBP2;ZIC1;CITED2;RNF10;EDRF1;IKBKB;SOX4;NCOA6;RNF4;TCF4;TBL1X;PPARG;BRCA1;NR2F2;TRIM28;FOXL2;BLM;CAND2;CREB1;MAP2K3;ELF4;NOS1;ATAD2;RELA;MYOCD;KCNH2
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.6318202942498266,-1.813464874332074,0.0018484288354898336,0.05797890461247128,0.932,12/19,26.17%,CBFB;ELF1;KLF4;IFIH1;LIFR;IRAK1;IRAK2;MAVS;MAPK7;TAF9;DHX9;PARP9
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.6961636028528905,-1.811092497121733,0.0018281535648994515,0.058997292974291585,0.939,10/14,22.63%,SEC31A;SEC24B;RAB1A;SEC24A;SEC24D;SEC13;SEC23B;TBC1D20;SEC24C;SAR1A
prerank,hemopoiesis (GO:0030097),-0.46379943811328683,-1.80918940352548,0.0,0.05943796499774522,0.944,29/87,14.85%,MECOM;FLT1;TEK;KITLG;ETV6;ZBTB16;SNRK;CD34;CDK13;KDR;KAT6A;TGFBR3;TGFBR2;TET2;TGFB2;BMP4;NOTCH2;FLT4;RRAS;TAL1;TP53;FUT10;NOTCH4;PRRC2C;ZFPM1;ASH2L;MKNK2;ATF4;JAG1
prerank,receptor signaling pathway via STAT (GO:0097696),-0.6041855779612236,-1.807350393141897,0.0017064846416382253,0.0600025998749584,0.948,9/25,11.47%,GHR;PKD2;IFNAR1;NMI;STAT6;STAMBP;SOCS2;STAT2;JAK2
prerank,positive regulation of vasculogenesis (GO:2001214),-0.7686561494915124,-1.8056967411945646,0.0,0.06073652748380348,0.952,7/10,12.66%,RAPGEF2;CD34;KDR;RAP1A;RRAS;RIN2;CEACAM1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.4903888070181881,-1.8049338469343092,0.0,0.060393879510198194,0.952,21/67,13.67%,UTRN;RREB1;DOCK1;RSU1;FERMT2;RAC1;LIMS2;LIMS1;GSK3B;VIT;CRK;CCL25;ABL1;PPM1F;FBLN2;FLNA;ILK;JAK2;NEDD9;MYOC;CDK6
prerank,regulation of sodium ion transport (GO:0002028),0.5456051718214141,1.804750747616253,0.0021691973969631237,0.07127878659967607,0.992,13/34,9.74%,NKAIN2;ANK3;FGF12;SCN1B;ATP2B4;NKAIN3;PKP2;NKAIN4;GPD1L;WNK2;WNK3;SCN5A;SPTBN4
prerank,Ras protein signal transduction (GO:0007265),-0.427778989007457,-1.8045730532788846,0.0,0.05984796408876013,0.952,63/137,20.86%,RREB1;RAPGEF2;GNB1;RB1;EPS8;BRAP;RAC1;ARHGEF3;NTN1;ELMO1;PLEKHG5;PLD1;EPS8L2;ARHGAP5;GNA12;SHOC2;PHACTR4;RAP1A;ARHGDIA;JUN;PLCE1;PLK2;RAP1B;ROCK1;RASGRP2;PRKD1;RRAS;RASSF1;TP53;GRAP;RAPGEF1;ARHGAP1;AGTR1;ARHGEF11;GDI1;RHOA;FGF2;RTKN;TAX1BP3;RHOG;CDC42EP3;KSR1;GRB2;NCKAP1;ROCK2;RERG;IGF1;DNMT1;RIPOR1;DBNL;ARHGAP29;ADGRG1;RAP2A;CFL1;WASF1;RRAS2;RAP2C;KRAS;NRAS;RGL2;CDC42EP1;NF1;TRIM28
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.4798188957344797,-1.8025164254266337,0.0017793594306049821,0.060475451876850356,0.954,28/72,17.77%,AKAP13;BCR;HEG1;EPS8;RAC1;ARHGEF3;NET1;ARHGEF28;STARD8;ITGA3;RALBP1;F11R;SCAI;EPS8L2;RASIP1;ABL1;CUL3;ARHGDIA;PRAG1;ARHGEF2;RAF1;STARD13;TNFAIP1;MYOC;ARHGEF18;KCTD10;ARHGAP35;ADGRG1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.5286625025128597,-1.8022164230453812,0.0018484288354898336,0.05995806868336332,0.954,16/43,16.77%,FOXP1;THBS1;LDLRAP1;MMP2;IL6R;BMP4;ERN1;JUN;AKT1;EDN1;FGF2;P2RY6;IGFBP5;HTR1B;IGF1;DNMT1
prerank,cellular response to mechanical stimulus (GO:0071260),-0.525513459713141,-1.802111928761088,0.0,0.05928067621862349,0.954,21/46,23.27%,PIEZO2;F11R;NFKB1;PDE2A;FAS;BNIP3;IRF1;CASP8;CRADD;CD40;MAPK8;TNFRSF1A;MAP2K4;CASP8AP2;MAP3K14;CHEK1;PIEZO1;CASP2;LTBR;GADD45A;CASP1
prerank,mesoderm formation (GO:0001707),-0.6447304845747467,-1.8009457855839626,0.0036968576709796672,0.059473190726099925,0.955,8/17,20.64%,ITGB1;BMPR2;ITGA3;ITGB4;SMAD2;KDM6B;ITGA2;ITGB3
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.48015331154176205,1.7989403405392324,0.002136752136752137,0.07468441136453415,0.994,20/59,8.83%,KIRREL3;ROBO2;L1CAM;CNTN6;CNTN4;DSCAML1;DSCAM;ROBO1;IGSF11;TENM3;PTPRT;IGSF21;CEACAM5;NECTIN3;MYPN;SDK1;VSTM2L;EMB;CNTN2;CDH17
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.5207042483778216,-1.7983168090230923,0.0,0.060519498938843355,0.955,24/47,27.56%,RREB1;ZBTB16;LRP5;SOX13;TRPM4;SIX1;NAPEPLD;PPARD;AKT1;LPL;TMEM64;CREBL2;BMP7;CARM1;CMKLR1;PPARG;AAMDC;CREB1;SYAP1;PIM1;BMP2;ZFP36L1;FRZB;HNRNPU
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.5026404221793035,-1.7979940113270372,0.0017574692442882249,0.06019284197238496,0.956,32/54,30.81%,ACVRL1;NOS3;ETS1;THBS1;TMSB4X;KDR;PLCG1;PRKD2;SP1;MEF2C;PRKD1;AKT3;AKT1;RGCC;FGF2;PRCP;CD40;MECP2;ANGPT1;GATA2;EPHA2;PPARG;NF1;MAP2K3;GADD45A;HMGB1;ADAM17;ANGPT4;FGF18;JUP;MAPK14;TGFB1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.6447886145814129,-1.7954099236832775,0.005025125628140704,0.06156530790942071,0.959,8/18,12.19%,ENG;ACVRL1;NOS3;TGFBR2;TGFB2;BMP4;TBX2;NOTCH1
prerank,membrane depolarization (GO:0051899),0.5466115781326112,1.7953783290988796,0.0,0.07620330917171965,0.995,13/32,10.99%,SCN8A;SCN1B;CACNA1B;SCN1A;SCN3A;CACNA1A;SCN2A;CACNB3;CACNB4;CACNA1E;SCN5A;CACNG2;CACNG4
prerank,regulation of mononuclear cell migration (GO:0071675),-0.5952645946125119,-1.794288723481922,0.0036968576709796672,0.061722302768982,0.963,9/23,11.10%,LYN;THBS1;BMP5;MSN;IL34;SLIT2;PTK2;MAPK1;STK10
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.5839783631301378,-1.7939831447192656,0.0017452006980802793,0.06129071394907788,0.963,16/27,24.82%,ACVRL1;BMPR2;ATM;PRKD2;PARP4;DACH1;HMBOX1;RGCC;FGF2;HGF;SMOC2;TERF2;FGFR4;PDGFRB;SMG6;PINX1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.48413451252535866,1.788448189111675,0.002136752136752137,0.08015851656241589,0.996,20/57,15.12%,CHRM2;GNAI2;OPRM1;GRM8;ADCY8;GNAI1;GNAL;CHRM3;GPR37;GNAT3;MTNR1A;HTR4;ADCY7;GRM7;ADRA2A;HTR1D;GABBR1;ADCY3;GRM4;HTR1F
prerank,positive regulation of angiogenesis (GO:0045766),-0.4446758078426533,-1.7883298453259577,0.0,0.0652208458718717,0.968,32/108,14.23%,FLT1;TJP1;TEK;ITGB1;GAB1;NOS3;TIE1;KLF4;BMPER;ETS1;CD34;THBS1;JAK1;KDR;ANXA3;PLCG1;PRKD2;SP1;FGF1;CDH5;SMAD1;PRKD1;RRAS;PIK3CD;RAMP2;VEGFC;PIK3R6;FGF2;MTDH;S100A1;CD40;AGO2
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.5944096356214897,1.7881584479132309,0.0,0.07892615685842426,0.996,10/21,18.81%,GCK;PGLS;H6PD;TKT;RPIA;HK1;PGD;PGM2;PGM2L1;HK3
prerank,actomyosin structure organization (GO:0031032),-0.46526956379558665,-1.7873085492110448,0.0018050541516245488,0.06528858812670588,0.968,24/75,12.82%,TJP1;FRMD6;PGM5;SORBS1;ITGB1;MYH9;FAM171A1;F11R;ITGB5;TMOD3;CUL3;CDC42BPA;MYO18A;EPB41L2;ROCK1;PDLIM1;CSRP2;EPB41L5;TNFAIP1;PHACTR1;FRMD5;RHOA;LMOD1;TPM1
prerank,regulation of autophagosome assembly (GO:2000785),-0.5535331789160838,-1.7838277360695654,0.0,0.0672491677516674,0.974,16/33,23.45%,RAB3GAP1;MTMR3;LRRK2;PIP4K2A;PIP4K2B;RAB5A;TBC1D14;SCFD1;CHMP4B;CHMP4A;RAB3GAP2;PHF23;IFT20;TBC1D12;SEC22B;RALB
prerank,regulation of tube diameter (GO:0035296),-0.7007180702978266,-1.7836652606817747,0.0,0.06589786582314064,0.975,10/13,26.88%,NOS3;ACE;ROCK1;SCPEP1;AGTR1;ROCK2;NPR1;GCLC;ACE2;ADCY6
prerank,vascular process in circulatory system (GO:0003018),-0.7007180702978266,-1.7836652606817747,0.0,0.06589786582314064,0.975,10/13,26.88%,NOS3;ACE;ROCK1;SCPEP1;AGTR1;ROCK2;NPR1;GCLC;ACE2;ADCY6
prerank,receptor internalization (GO:0031623),-0.518152923458402,-1.7835641208185902,0.0017730496453900709,0.06524401005127285,0.975,18/44,14.62%,ITGB1;CALCRL;CAV1;DNM3;RAMP1;LDLRAP1;TFRC;DNM2;NEDD4;RAB5A;PICALM;RAMP2;ADM;CEACAM1;LMBRD1;ACKR3;SAG;GRB2
prerank,inorganic cation transmembrane transport (GO:0098662),0.3780543534389653,1.7829536032289492,0.0,0.08185509933570852,0.998,65/268,15.68%,TRPM3;KCND2;KCNC2;KCNQ3;ASIC2;HCN1;SLC24A4;SLC24A2;ATP1A2;KCNA6;KCNH8;KCNQ5;SCN8A;KCNH7;SCN1B;RYR3;KCNA5;SCN1A;ATP12A;ATP2B4;SLC6A15;KCNH4;SLC9A7;KCNH5;SLC4A4;KCNN2;SCN3A;CACNA1A;KCNA2;ATP1B1;SLC46A1;SLC6A11;SLC9A9;SCN2A;CACNA1D;SLC8A2;UCP3;TMCO1;SLC36A2;TRPM1;ATP6V0C;SCN5A;ATP4A;SLC6A2;SLC6A5;SLC39A2;KCNN3;P2RX3;SLC8A3;SLC8A1;KCND1;SLC1A3;CACNA2D4;SLC39A7;KCNS2;KCNC4;KCNK12;SCN2B;ASIC1;KCNK10;KCNA4;KCNK9;SLC4A11;SLC6A4;ATP6V0D1
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.5151567978969143,-1.782819220920401,0.0,0.06525376130086226,0.975,23/44,27.32%,TNRC6B;ZC3HAV1;METTL14;GIGYF2;FTO;PUM1;ROCK1;POLR2G;CELF1;AGO2;RC3H1;BTG2;ROCK2;MOV10;TNRC6A;TOB1;METTL16;RBM24;CNOT8;ZFP36L1;NANOS1;CNOT1;PABPC1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.5761010972984375,1.7811318900441158,0.006896551724137931,0.08193601674506522,0.998,13/26,13.33%,NRXN1;NLGN1;RIMS2;RIMS1;TMEM108;SHANK1;SLC8A2;MTMR2;PRKCZ;CBLN1;SLC8A3;DLG4;NLGN2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.7201686079746701,-1.7798428644086164,0.0,0.06700437640605705,0.978,5/12,13.05%,FOXP1;DAB2;HDAC1;ZBTB7A;PIAS2
prerank,embryonic limb morphogenesis (GO:0030326),-0.5341311000064907,-1.7786828236088987,0.0036968576709796672,0.06720764064839423,0.979,11/34,9.10%,MBNL1;MAP3K20;CREBBP;NIPBL;HDAC1;RARG;LRP6;TGFB2;ECE1;TBX2;GLI3
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.5358032122014403,-1.778340293291481,0.0017857142857142857,0.06673776224910773,0.979,17/34,22.06%,FLT1;TEK;DAB2IP;PIK3R1;IRS1;AMBRA1;PTK2;PRKD1;FGF2;PIK3IP1;TNFAIP8L3;PIK3R3;CCL19;WASHC1;NOD2;PDGFRB;PTK2B
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.6307190909142532,1.7781729261590296,0.004454342984409799,0.0829032339143348,0.999,8/18,10.73%,GRID2;GRIK5;GRIK2;GRID1;CDH8;GRIK1;GRIA2;SLC17A6
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.5842395575456709,-1.7771810377053388,0.0018083182640144665,0.06697854735830053,0.979,10/25,12.19%,ZNF423;ENG;ACVRL1;BMPR2;BMP4;CDH5;SMAD2;ACVR2A;SMAD4;NOTCH1
prerank,neuromuscular process controlling balance (GO:0050885),0.6963216764262012,1.7767891765999253,0.008849557522123894,0.08261429502937866,0.999,4/12,3.86%,NRXN1;PCDH15;SHANK1;CLN3
prerank,blood vessel diameter maintenance (GO:0097746),-0.5461162927846928,-1.7731986239248014,0.0,0.06970770078258717,0.983,17/34,26.88%,NOS3;EDNRA;KLF2;ACE;ECE1;ROCK1;SCPEP1;EDN1;EDN3;AGTR1;ROCK2;NPR1;KCNMB2;GCLC;NOS1;ACE2;ADCY6
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.46128209053184394,-1.7731490088848854,0.0017211703958691911,0.06906151656515568,0.983,29/74,23.22%,ITGA6;NOS3;EYA4;MCL1;GSK3B;THBS1;BMP5;DDX3X;TNFSF10;ICAM1;FAS;BMP4;BIRC6;ARHGEF2;SH3RF1;CASP8;CFLAR;AKT1;GPX1;TNFAIP3;IGF1;ZMYND11;TCF7L2;BRCA1;TERT;MAPK7;RELA;SERPINE1;RIPK1
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.4573038858444744,-1.7717710750755034,0.0,0.06951148945448409,0.984,29/86,16.38%,DAB2IP;AKAP13;BCR;EPS8;LYN;ARHGEF28;STARD8;EPS8L2;SHOC2;TGFB2;STAMBP;ARHGDIA;NGF;PLCE1;DENND3;NOTCH2;ARHGEF2;RAF1;ARHGAP17;STARD13;GABARAP;RAPGEF1;JAK2;NOTCH1;SPRY4;GRB2;DENND4C;ARHGEF18;IGF1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5484627162716329,-1.7689318986413636,0.0,0.07129980144465695,0.986,12/34,13.32%,RREB1;DOCK1;FERMT2;RAC1;LIMS2;LIMS1;CRK;ABL1;FLNA;ILK;NEDD9;MYOC
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7183386193195063,-1.7671801726682097,0.00718132854578097,0.07186753750350139,0.987,6/11,13.83%,RSPO3;DAB2;MLLT3;NKD1;CSNK1D;PLEKHA4
prerank,endothelial tube morphogenesis (GO:0061154),-0.7380999607248336,-1.764657659413624,0.0,0.0733785953811086,0.989,6/10,17.12%,ACVRL1;PRKD2;BMP4;STARD13;RHOA;CTNNB1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.7329535939976436,-1.7631188122575303,0.0035149384885764497,0.07407324468589618,0.99,7/11,9.84%,IGF1R;GHR;GIGYF2;PIK3R1;IRS1;PLCB1;AKT1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.6839390257727581,-1.7623498090604852,0.005309734513274336,0.07407061545368801,0.99,8/14,13.55%,THBS1;PLCG1;PDCD4;RGCC;ANO6;ITGA4;ECSCR;CD40
prerank,lipid modification (GO:0030258),0.5169244378825876,1.761340329390272,0.0045351473922902496,0.09447008053775814,0.999,15/37,16.65%,DGKK;DGKI;DGKQ;PLPPR4;PLPPR1;PLPP2;PLA2G7;SGPP1;PLPP4;PLPPR5;ALOX12;MBOAT7;ALOX5;CYP1A1;MBOAT2
prerank,regulation of Notch signaling pathway (GO:0008593),-0.46321397393145514,-1.7612365308337106,0.0017574692442882249,0.07425828878804212,0.992,32/76,21.16%,CREBBP;NOS3;ZMIZ1;MAML2;KAT2B;EGFR;IL6ST;NOTCH3;JAG2;ZBTB7A;TGFB2;PRAG1;AAK1;MAML1;TSPAN14;ARRDC1;YAP1;AKT1;NOTCH4;MFNG;GALNT11;TSPAN5;NOTCH1;TCIM;JAG1;CCN3;HEY1;NOD2;GATA2;RITA1;WWP2;DLL4
prerank,regulation of defense response (GO:0031347),-0.4552892858790474,-1.7595748765006323,0.0,0.07497261992355324,0.994,31/76,25.01%,FOXP1;IL1R1;XIAP;CASP12;SEMA7A;TMSB4X;BIRC3;SAMHD1;IRF1;CELF1;CASP8;AREL1;JAK2;AGTR1;MGLL;USP18;NR1D2;N4BP1;ANXA1;ZMPSTE24;ERAP1;NOD2;DAGLB;TKFC;BCL6;AKNA;RELA;CASP1;SHPK;ACE2;BRD4
prerank,regulation of interleukin-8 production (GO:0032677),-0.4673785124750799,-1.7592595170135141,0.0,0.07458828683945035,0.994,39/69,37.61%,AFAP1L2;KLF4;NOD1;TMSB4X;RAB1A;PRKD2;LBP;ANXA4;ANXA1;MAVS;HYAL2;NOD2;PTPRC;F3;RELA;SERPINE1;RIPK1;ARRB1;HSPA1B;HMGB1;F2R;LGALS9;CACTIN;DDIT3;STAT3;TLR6;TLR1;C5AR2;NOS2;TLR5;CD14;PARK7;CD74;TLR2;CD33;TLR8;MAPKBP1;SYK;CRP
prerank,positive regulation of cell migration (GO:0030335),-0.3878719948131381,-1.7582521137072056,0.0,0.07478926879317623,0.994,89/253,22.06%,FLT1;TJP1;LEF1;DAB2IP;IGF1R;RREB1;ITGA6;RAPGEF2;SEMA6A;PECAM1;SEMA3C;DOCK1;ITGB1;GAB1;PODXL;FERMT2;INSR;CAV1;DAB2;PRKCE;BMPR2;CBLL1;SMURF2;PDGFD;SEMA7A;THBS1;GCNT2;ATM;SYNE2;KDR;MTOR;PLCG1;SMO;EGFR;ADAM9;NIPBL;TGFB2;PTK2;FGF1;CDH5;PPM1F;ARHGEF2;PLCG2;FAM107A;MYLK;BCAR1;PIK3CD;ADAM10;EDN1;MAZ;TWIST2;NOTCH1;SEMA3G;SEMA6B;SEMA4C;ACTN4;NEDD9;WNT11;MYOC;RHOC;HGF;AGO2;NUMB;MAP4K4;ROCK2;VSIR;SEMA5B;PIK3R3;IGF1;RAB11A;RIPOR1;CTSH;HDAC6;SEMA4A;SEMA3E;WASHC1;PTPRC;CXCL12;F3;FERMT3;LAMB1;SEMA4G;SH3RF2;ROR2;PDGFRB;SPAG9;LAMC2;SYDE1;PTK2B
prerank,positive regulation of lipid transport (GO:0032370),0.679556961256742,1.7570335655018328,0.009153318077803204,0.09659485033260942,0.999,5/12,14.63%,ABCA12;PRELID1;TRIAP1;SPP1;APOE
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.6187245068972907,-1.7524764010255447,0.0,0.07926208233717254,0.994,10/19,16.00%,TJP1;BMP6;AFDN;PPM1F;DENND6A;NOTCH4;RGCC;NOTCH1;FLOT1;MAD2L2
prerank,I-kappaB phosphorylation (GO:0007252),-0.7270114433972893,-1.7523343093600832,0.003527336860670194,0.0787020651455743,0.994,2/10,1.49%,DAB2IP;ERC1
prerank,regulation of vasculogenesis (GO:2001212),-0.6770794742253174,-1.7510605100509928,0.0,0.07925538751901494,0.995,9/14,17.95%,RAPGEF2;CD34;KDR;RAP1A;RRAS;RIN2;CEACAM1;HEY1;HEY2
prerank,response to laminar fluid shear stress (GO:0034616),-0.7335773590341201,-1.7503846253766948,0.005263157894736842,0.0791963247014093,0.995,6/10,22.38%,KLF4;KLF2;SMAD7;SMAD6;MAPK7;NFE2L2
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.5734730724419679,-1.7492733586935223,0.0017857142857142857,0.07943700761555506,0.995,14/26,27.14%,DAB2IP;IQGAP1;PLCG1;EGFR;PTPN12;MED1;DUSP3;ZPR1;FOXC1;DUSP22;PTPN11;SYAP1;ZFP36L1;SNAI2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.6204550485133038,-1.7480131461515698,0.001763668430335097,0.07999162076424929,0.996,15/20,30.39%,ENG;ACVRL1;TGFBR3;PDCD4;TGFB2;BMP4;NOTCH1;HEY1;HEY2;TBX3;HAS2;BMP2;SNAI2;TGFBR1;SPRY1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.539262894079778,-1.7463032478860172,0.0,0.08074336937567801,0.996,11/35,11.85%,TJP1;TEK;ESAM;BAIAP2L1;F11R;ABL1;ARHGDIA;NOTCH2;HAX1;BCAS3;ABI3
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.6767067118455121,-1.7454509394007156,0.0054249547920434,0.08090012845951985,0.996,6/14,12.22%,KLF4;THBS1;MEOX2;STARD13;NOTCH1;RHOA
prerank,endocardial cushion development (GO:0003197),-0.6090106990692221,-1.7451970853039882,0.0033783783783783786,0.08049828127714018,0.996,8/21,12.19%,ENG;ACVRL1;NOS3;BMPR2;TGFB2;BMP4;TBX2;NOTCH1
prerank,dendrite self-avoidance (GO:0070593),0.6392678707759424,1.744834990675844,0.009111617312072893,0.106145527211468,0.999,8/16,8.42%,CNTN6;CNTN4;DSCAML1;DSCAM;MYPN;VSTM2L;EMB;CNTN2
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.41336902850618074,-1.7442571892487586,0.0,0.08053784079908538,0.996,57/132,27.44%,ZBTB20;FOXO1;INSR;DAPK1;SH3BP4;GSK3B;PTPN1;APP;ZC3HAV1;DTX3L;LRRK2;MSN;VGLL4;ADAM9;PPARA;TNFRSF1B;IRS1;FOXO3;IRGM;PRKCD;BNIP3;EZR;PIK3C2A;SNX9;PLK2;ROCK1;PRKD1;GSK3A;PRKAA1;PFKFB3;PSEN1;TRIM14;MTDH;KAT5;PIK3CB;RC3H1;IGF1;MOV10;ARNT;RNF152;DAGLB;ORMDL3;AMER1;HSP90AA1;ATF6;PFKFB4;TRIM68;HMGB1;PNPLA2;PLEKHF1;CNOT8;TPCN1;DXO;VPS35;CNOT1;TRIM6;PFKFB2
prerank,regulation of catecholamine secretion (GO:0050433),0.5337573334712142,1.742481176707392,0.009237875288683603,0.10680233453388797,0.999,10/29,16.94%,SYT1;SYT5;SYT12;SYT11;KCNA2;CHGA;SYT4;FGF20;SYT3;SYT9
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.6598880367498998,-1.7414098783124028,0.007220216606498195,0.08249048360409238,0.996,8/15,12.53%,TJP1;KLF4;BMPER;JAK1;FGF1;SMAD1;FGF2;S100A1
prerank,cellular response to BMP stimulus (GO:0071773),-0.46786794389251246,-1.7405692419308967,0.0,0.08263821128790207,0.996,20/66,11.78%,ENG;ACVRL1;USP9X;BMPR2;BMP5;SMURF1;TGFBR3;BMP6;PDCD4;HIVEP1;TGFB2;BMP4;SMAD1;SMAD2;ACVR2A;SMAD4;RGMB;SMAD7;USP15;HFE
prerank,protein targeting to ER (GO:0045047),-0.43849790356279805,-1.7403932414048278,0.0,0.0820801406055488,0.996,54/99,31.12%,RPS21;RPL37;RPL31;RPL9;RPS14;RPSA;RPL3;RPLP1;SRPRA;RPL26;CHMP4B;CHMP4A;RPS11;SRP9;RPL13;RPL38;SGTA;RPL27;RPS16;RPS4X;RPL10;RPL7A;RPL5;SRP14;RPS27;RPL27A;RPS3;RPL36A;RPL35A;RPL37A;RPL32;RPS7;RPS15;RPS8;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS23;RPS17;ZFAND2A;RPS2;RPL39;RPS26;RPS15A;SEC61A1;RPL15;RPL34;RPLP2;RPL18;RPL19;RPS13;RPL8
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",-0.478954192161856,-1.7394030839268029,0.0017985611510791368,0.08241348638055519,0.996,26/59,23.73%,LEF1;CBFB;TNRC6B;MED15;MED26;MITF;NFKB1;MED1;JUN;TP53;MED13;MED17;MECP2;CCNC;MOV10;CTNNB1;PPM1D;TNRC6A;CCND1;MED10;TCF7L2;PTEN;TRIM28;MED27;RELA;MED20
prerank,nervous system development (GO:0007399),0.35623299542167863,1.7375657744677135,0.0,0.1097993408296443,1.0,102/429,13.66%,LSAMP;KIRREL3;RBFOX1;NRXN1;ROBO2;NLGN1;NRG1;L1CAM;NAV3;ASIC2;ERBB4;MYT1L;CHRM2;CNTN6;IL1RAPL2;CNTN4;DSCAML1;ADAM23;TENM1;ADAM22;SCN8A;FGF12;SH3GL2;DSCAM;ADGRL3;APC2;MOBP;CYP46A1;ROBO1;NPAS1;SPOCK1;GPM6B;DNER;PCDHB5;KALRN;CDK5;ZEB2;LHX1;VLDLR;EPHB1;APBA2;TYRO3;SRRM4;NBL1;NRCAM;GFRA1;NELL1;DCHS1;PCDHA4;CHRM3;LIMK1;SCN2A;ATXN10;DPYSL5;EFNB3;NFASC;PTPRZ1;CYP51A1;MAP1S;PROX1;HPCAL4;TMOD2;PCDHA5;GSN;GPM6A;GRIK1;SCRG1;SDK1;MSI1;SLITRK1;AHI1;LRCH4;NCAN;ACVR1B;POU4F1;FGF5;KLK6;NRSN1;VEGFA;DCX;DPF1;POU3F3;SDHA;HAPLN2;RBFOX3;MOG;CBLN1;MBP;ALDH1A2;NMUR2;ARNT2;CDH2;DLG4;ESS2;FZD9;GDF11;FKTN;BDNF;RPS6KA6;NLGN2;SCD5;CAPG
prerank,calcium-ion regulated exocytosis (GO:0017156),0.5478798632342083,1.737245315477827,0.004618937644341801,0.10843374582078741,1.0,6/27,3.42%,SYT1;SYT5;RIMS2;RIMS1;SYT12;SYT11
prerank,negative regulation of angiogenesis (GO:0016525),-0.45486504296247576,-1.7363149777739222,0.0,0.08473649600662063,0.996,27/84,17.12%,TEK;DAB2IP;PTPRM;SEMA6A;CLDN5;COL4A2;KLF4;KLF2;THBS1;SLC12A2;TGFB2;ISM1;ROCK1;HSPG2;ADAMTS9;RGCC;STAB1;NAXE;ECSCR;MECP2;PIK3CB;FOXC1;ROCK2;FOXO4;NPR1;GTF2I;CTNNB1
prerank,regulation of dopamine secretion (GO:0014059),0.5534767852788038,1.7362383469523779,0.00683371298405467,0.10787223100081036,1.0,10/25,19.27%,SYT1;SYT5;SYT12;SYT11;KCNA2;SYT4;FGF20;SYT3;SYT9;SYT17
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.6134690952266337,-1.7360898477133464,0.008880994671403197,0.08432652630622156,0.996,5/19,5.38%,KLF4;SLCO1C1;KLF2;APP;NFKB1
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.648683439892539,-1.7335495387912425,0.005291005291005291,0.08606692170826866,0.997,9/15,24.96%,GSK3B;YWHAE;EMD;GAS6;TP53;TPR;XPO4;TCF7L2;RAPGEF3
prerank,negative regulation of binding (GO:0051100),-0.44487723258127376,-1.7326583755259124,0.0017421602787456446,0.08648792367605175,0.997,29/81,19.98%,LEF1;SP100;CAV1;DAB2;BTAF1;GSK3B;LRRK2;SMO;NFKBIA;PRKCD;JUN;ROCK1;NES;WAPL;AKT1;JAK2;ZFPM1;ARHGAP28;ACTB;MAPK8;ILRUN;CTSZ;MITD1;PEX14;SUMO1;TFAP4;PLN;TFIP11;CTNNBIP1
prerank,axonogenesis (GO:0007409),0.37447017381392683,1.7320121637907702,0.0,0.11050915445047957,1.0,61/237,10.41%,NRXN3;NRXN1;ROBO2;UNC5D;CTNNA2;L1CAM;DAB1;DCC;ANK3;NCAM1;CNTN6;CNTN4;DSCAML1;EPHA6;ENAH;DSCAM;SCN1B;ROBO1;SHTN1;CDK5;VLDLR;EPHB1;NTNG2;NTNG1;PLPPR4;NRCAM;TNR;DOK5;UNC5C;ATL1;GFRA1;SEMA6D;EPHA5;EFNA3;EFNB3;SEMA3B;DOK6;PAX2;PAK3;GPC1;MAP1S;MYPN;SHC3;FGFR2;VSTM2L;SLITRK1;EMB;CNTN2;POU4F1;NEFH;S100A6;SHC1;SPTBN2;SPTBN4;SLITRK4;SLIT3;SLIT1;KIF5A;MAP1B;CCK;RAB3A
prerank,positive regulation of vascular permeability (GO:0043117),-0.6922235160351881,-1.7316852597084407,0.005272407732864675,0.08673472843567076,0.997,9/12,18.49%,TJP1;PDE3A;BMP6;PDE2A;TJP2;OCLN;FGFBP3;ANGPT1;TRPV4
prerank,myeloid cell development (GO:0061515),-0.6291992490883371,-1.731640587037488,0.0035335689045936395,0.08614583481754157,0.997,6/18,8.14%,FOXP1;ALAS1;ANXA2;APP;MED1;ABCB10
prerank,cardiac muscle cell contraction (GO:0086003),0.5909744242997743,1.7311013260678856,0.008791208791208791,0.10986731989069198,1.0,8/19,8.20%,FGF12;SCN1B;SCN1A;CACNA2D1;PKP2;CACNA1D;GSN;SCN5A
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.5895298417625837,1.7300996972127407,0.0045662100456621,0.10941242406328482,1.0,8/21,12.82%,ATP1A2;AKAP6;CALM2;RYR2;SLC8A1;SRI;HRC;CASQ1
prerank,cytoplasmic translation (GO:0002181),-0.44533567962942305,-1.729143321824493,0.0,0.08775121397196632,0.997,51/91,31.12%,RPS21;RPL37;RPL31;RPL9;RPS14;RPSA;RPL3;RPLP1;RPL26;RPS11;RPL13;RPL38;DRG1;RPL27;RWDD1;RPS16;RPS4X;GSPT1;RPL10;RPL7A;RPL5;RPS27;RPL27A;RPS3;RPL36A;RPL35A;RPL37A;RPL32;RPS7;RPS15;RPS8;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS23;RPS17;EIF3I;RPS2;RPL39;RPS26;RPS15A;RPL15;RPL34;RPL22L1;RPL18;RPL19;RPS13;EIF4A2;RPL8
prerank,regulation of monooxygenase activity (GO:0032768),-0.5821448278324727,-1.7277871480247469,0.008960573476702509,0.08860936024534348,0.997,9/23,9.84%,NOS3;CAV1;NOSTRIN;EGFR;DNM2;CYGB;WASL;NOS1AP;AKT1
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.645102475563694,-1.7275960055800308,0.00718132854578097,0.08811531810573536,0.997,10/17,21.48%,CLDN5;F11R;CDH5;ROCK1;PPP1R12A;ROCK2;TNFRSF1A;IKBKB;VCL;S1PR3
prerank,receptor metabolic process (GO:0043112),-0.48603696042334393,-1.7244148140065365,0.0037313432835820895,0.09079995420547186,0.998,31/53,30.86%,ITGB1;CALCRL;CAV1;DNM3;RAMP1;LDLRAP1;SMURF1;TFRC;DNM2;NEDD4;PICALM;RAMP2;ADM;ACKR3;REP15;GRB2;LGMN;AP2M1;SNX25;KIF16B;ARFGEF2;BECN1;GRK3;LRP1;FCER1G;GRK4;PHETA2;CD9;RAB31;TGFB1;LILRB1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.47853569585955646,-1.7226945390165593,0.005199306759098787,0.09168241943637032,0.999,15/56,11.78%,RBPMS;ENG;ACVRL1;BMPER;DAB2;BMPR2;BMP5;BMP6;LDLRAD4;TGFB2;BMP4;ACVR2A;SMAD4;SMAD7;HFE
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.4607281026204556,-1.721911000803881,0.0,0.09179412855689825,0.999,27/70,16.68%,WASF2;DOCK1;MYO10;ABI1;RAC1;LYN;PRKCE;ELMO1;CRK;PLCG1;YES1;NCK1;PIK3R1;ABL1;PTK2;PRKCD;WASL;MAPK1;PLD2;PLCG2;ACTB;PIK3CB;GRB2;ELMO2;NCKAP1;ARPC4;FYN
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.4433403008422945,-1.721331814029516,0.0,0.09166274474313864,0.999,51/87,32.78%,RPS21;RPL37;RPL31;RPL9;RPS14;RPSA;RPL3;RPLP1;RPL26;RPS11;SRP9;RPL13;RPL38;RPL27;RPS16;RPS4X;RPL10;RPL7A;RPL5;SRP14;RPS27;RPL27A;RPS3;RPL36A;RPL35A;RPL37A;RPL32;RPS7;RPS15;RPS8;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS23;RPS17;RPS2;RPL39;RPS26;RPS15A;SEC61A1;RPL15;RPL34;RPLP2;RPL18;RPL19;RPS13;RPL8;SEC63;RPL41
prerank,cell-substrate junction assembly (GO:0007044),-0.5222750438486026,-1.7197215093244913,0.007380073800738007,0.09268572859321901,0.999,9/33,8.83%,ITGA6;SORBS1;THSD1;BCR;FERMT2;ITGB4;LAMA3;PTPRK;DST
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.4486104668171241,-1.7186119233874355,0.0,0.09320886413414328,0.999,29/76,18.97%,NFAT5;NR3C2;NOD1;UACA;LIMS1;TMSB4X;APP;DDX3X;EGFR;NFKBIA;DLG1;NMI;PDCD4;RASSF2;EZR;PPM1B;ILK;RHOA;IRAK1;ACTN4;TCIM;IFI35;CCN3;C1QTNF3;BMP7;SASH1;RPS3;CCL19;NOD2
prerank,cellular response to growth factor stimulus (GO:0071363),-0.4001967465781797,-1.718345627791178,0.0,0.09281572648172637,0.999,65/151,24.99%,FLT1;DAB2IP;RAPGEF2;SEMA6A;ACVRL1;KLF4;BMPR2;LIMS1;IQGAP1;TBX1;NR3C1;KDR;PLCG1;PRKD2;EGFR;EMD;PTPN12;PDE3A;TGFBR2;BMP6;DSTYK;PDE2A;MED1;BMP4;RAP1A;ERN1;MEF2C;MAPKAPK2;PRKD1;FLT4;ACVR2A;SMAD4;MTSS2;BCAR1;RAMP2;AKT1;RAPGEF1;EHD1;SMAD7;NOTCH1;WWOX;DUSP3;ZPR1;HGF;HAS1;FOXC1;LGMN;BMP7;ANXA1;CTNNB1;HYAL2;DUSP22;SMAD9;DLL4;PTPN11;MAP2K3;MAPK7;NOS1;RELA;SYAP1;HAS2;ADAMTS7;ACVR2B;EGR3;BMP2
prerank,calcium ion import across plasma membrane (GO:0098703),0.6484821103585775,1.7161596045370153,0.006772009029345372,0.12173280092524812,1.0,6/14,11.91%,SLC24A2;ATP2B4;CACNA2D1;SLC8A2;SLC8A3;SLC8A1
prerank,regulation of GTPase activity (GO:0043087),-0.39662596056859084,-1.7159334274753584,0.0,0.09449455691663274,0.999,49/177,13.86%,DAB2IP;DOCK9;CHN2;PRKG1;ITGA6;RAPGEF2;RSU1;ITGB1;FGD5;FERMT2;FGD6;RAB3GAP1;LIMS1;SH3BP4;NET1;GSK3B;DVL3;RALBP1;F11R;LRCH1;PKP4;CRK;CCL25;LRRK2;AFDN;RASIP1;CHN1;PTK2;RAP1A;SNX9;PLXND1;TGM2;USP6NL;AGRN;RASGRP2;EPHA4;TBC1D30;PLXNA4;PICALM;RASA4;RAB3GAP2;RAPGEF1;ARAP1;BCAS3;ARFGEF1;WNT11;CD40;LARS1;GPR137B
prerank,neuron differentiation (GO:0030182),0.388552877012208,1.7151440801538826,0.0,0.12110752971733982,1.0,28/165,9.25%,PTPRD;IL1RAPL1;TENM4;PHOX2A;MYT1L;TENM1;ATP8A2;SNPH;WNT7B;IRX4;NIF3L1;SPOCK1;TENM3;ATP2B2;FUT9;CDK5;LHX1;ITM2C;TENM2;EPHA5;RUNX2;NTRK2;IRX3;ADNP2;INSM1;ACSL3;LMX1B;VEGFA
prerank,regulation of actin filament-based movement (GO:1903115),0.7129607706679468,1.714207214916932,0.006382978723404255,0.12045448039128041,1.0,5/10,12.08%,PDE4B;PDPN;STC1;SCN5A;SRI
prerank,myelination in peripheral nervous system (GO:0022011),-0.6723349334351916,-1.713594116845205,0.013582342954159592,0.09616766184907363,1.0,9/13,20.79%,PARD3;ADGRG6;CNTNAP1;DICER1;MYOC;ARHGEF10;SKI;SOD1;NF1
prerank,limb development (GO:0060173),-0.5404502204870313,-1.7124958153356242,0.0055248618784530384,0.0966429177034286,1.0,8/28,12.31%,MAP3K20;KAT2B;SMOC1;ZNRF3;KREMEN1;GLI3;PCSK5;COMP
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.5699215553072754,-1.7115978764370376,0.007142857142857143,0.09679349284206383,1.0,13/24,24.43%,TEK;KDR;ICAM1;GAS6;CDH5;RAMP2;TNFAIP3;ANGPT1;GATA2;MAPK7;NFE2L2;SERPINE1;SEMA5A
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.488086244764637,-1.7109828324246976,0.003616636528028933,0.09669630174929683,1.0,24/46,26.65%,UBR5;GSK3B;YWHAE;EMD;GAS6;PIK3R1;NEDD4;PRKCD;CDH1;TP53;FLNA;PSEN1;ZPR1;TPR;XPO4;MAVS;ZIC1;HYAL2;TCF7L2;TRIM28;KHDRBS1;DHX9;RAPGEF3;RAN
prerank,clathrin coat assembly (GO:0048268),-0.6348807934029116,-1.709614363738973,0.008802816901408451,0.09753289556399874,1.0,6/15,9.18%,HIP1;FCHO2;EPS15;AP2S1;PIK3C2A;PICALM
prerank,regulation of cardiac muscle contraction (GO:0055117),0.5120006368698554,1.707917510104163,0.004415011037527594,0.1256935209445266,1.0,11/34,12.08%,PDE4B;STC1;ATP1B1;CHGA;CALM2;RNF207;RYR2;SCN5A;ADRA1A;SLC8A1;SRI
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5926782530480775,-1.7071744726433424,0.005484460694698354,0.09950059836286396,1.0,6/21,3.24%,FOXP1;PRKCH;CBFB;ELF1;LYN;SLC39A10
prerank,chloride transmembrane transport (GO:1902476),0.4743268297143287,1.7067728136146714,0.006818181818181818,0.12522403830696507,1.0,15/48,14.23%,GLRA3;GABRG3;GABRB1;GABRB3;ANO3;GLRA1;GABRB2;GABRA2;ANO4;SLC12A5;GABRA3;GABRA1;SLC12A4;SLC1A3;GABRE
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.5468950041153431,-1.7064778773879854,0.0037174721189591076,0.09946445690250393,1.0,12/27,22.06%,FLT1;TEK;IRS1;AMBRA1;PTK2;PRKD1;FGF2;TNFAIP8L3;CCL19;NOD2;PDGFRB;PTK2B
prerank,pharyngeal system development (GO:0060037),-0.6359384814866317,-1.7062826390474193,0.007312614259597806,0.09895915232891211,1.0,8/15,16.91%,BMPR2;BMP5;TBX1;HES1;TGFB2;BMP4;BMP7;SIX4
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.7260291784267572,-1.7049716155501005,0.0111731843575419,0.09955478014311375,1.0,8/10,23.46%,RXRA;TBX1;RARG;ACTN4;RARA;PPARG;RARB;RXRG
prerank,clathrin-dependent endocytosis (GO:0072583),-0.5684297948780055,-1.7042673612105683,0.00718132854578097,0.09956112769864858,1.0,12/26,13.61%,FCHO2;FNBP1L;AP2B1;AP2A2;AP2S1;ITSN1;GPR107;PICALM;GAK;FCHSD2;ITSN2;LMBRD1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.45515342770048994,-1.703940468223014,0.0018050541516245488,0.09924931179375107,1.0,27/71,16.68%,WASF2;DOCK1;MYO10;ABI1;RAC1;LYN;PRKCE;ELMO1;CRK;PLCG1;YES1;NCK1;PIK3R1;ABL1;PTK2;PRKCD;WASL;MAPK1;PLD2;PLCG2;ACTB;PIK3CB;GRB2;ELMO2;NCKAP1;ARPC4;FYN
prerank,heart morphogenesis (GO:0003007),-0.47750674631610257,-1.7034007166627099,0.0017825311942959,0.09914115148392817,1.0,17/50,17.95%,ENG;ACVRL1;NOS3;INSR;TBX1;SOX17;TGFBR3;NIPBL;HES1;TGFB2;PTK2;TBX2;ZFPM1;NOTCH1;FLRT2;HEY1;HEY2
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.6707839920850267,-1.70261250596574,0.0070052539404553416,0.09945574850119916,1.0,6/13,11.47%,RBPMS;DAB2;BMP6;BMP4;SMAD4;JAK2
prerank,sulfur compound transport (GO:0072348),-0.5515446506666912,-1.7025817598389352,0.0036101083032490976,0.09883872405460806,1.0,8/27,10.75%,ABCG2;SLC6A6;SLC26A7;SLC13A4;SLC5A6;SLC19A2;LRRC8D;SLC25A11
prerank,regulation of regulated secretory pathway (GO:1903305),0.49697048225055895,1.7019531403516144,0.002173913043478261,0.12870955174846493,1.0,14/34,17.38%,SYT1;SYT5;RIMS2;RIMS1;RAB15;SYT12;SYT11;SYN1;RAB3A;SYT4;SYT3;SNAPIN;SYT9;RIMS3
prerank,epithelial tube morphogenesis (GO:0060562),-0.5236512182357999,-1.7010903289957655,0.005291005291005291,0.09955902120897994,1.0,11/32,7.35%,ACVRL1;PODXL;PKD2;PRKD2;SOX17;HES1;RASIP1;COL4A1;SLIT2;BMP4;MEF2C
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.34657700411084014,-1.699506279300585,0.0,0.10075637945432513,1.0,168/572,21.31%,FOXP1;KLF12;DAB2IP;KLF7;RREB1;FOXP2;SMARCA2;ETV6;ZBTB16;NFIB;SP100;MEF2A;CREBBP;NSD1;RB1;CBFB;ZEB1;KLF4;CAV1;USP9X;DAB2;ESR1;NEDD4L;MIER1;CUX1;ZFHX3;NRIP1;PRDM5;SMURF2;KLF2;IRF2;RXRA;PRDM16;WWC2;NFATC4;ID1;MITF;NR3C1;THRB;SOX13;NFIX;ZHX2;ZNF148;CTCF;NIPBL;BMP6;HDAC1;NFKB1;HES1;PPARA;RARG;RPS14;DLG1;ZBTB7A;FOXO3;PDE2A;HIVEP1;NEDD4;MED1;SPEN;GTF2IRD1;BMP4;MAX;MEF2C;EZR;SKIL;JUN;ZBTB4;SMAD2;ZFP90;PHF21A;TBX2;SUV39H1;DACH1;YAP1;LDB1;PRDM2;PPARD;GLI3;ZNF25;USP2;SMAD4;CTBP2;UBE2D3;GLIS2;TP53;FRK;KLF10;EDN1;HMBOX1;PER3;NOTCH4;ETS2;DICER1;NFIC;SIN3A;FNIP2;PSEN1;MAZ;SMAD7;ZFPM1;PRDM6;CHD3;NOTCH1;MTDH;CDC73;RTF1;HDAC4;SFPQ;LRRFIP1;WWOX;KAT5;ZHX1;MECP2;ATF4;MZF1;RPL10;KMT5A;NR1D2;HCFC1;TCF3;FOXC1;PHF6;BCOR;NR2C1;DR1;TPR;MIER2;MAD2L2;TAF7;TRPS1;HIC1;SKI;ORC2;SUMO1;RARA;ZNF692;ARID5B;TAF3;IGBP1;HDAC10;HEY1;HEY2;MIER3;VPS72;ELK4;KDM1B;CITED2;NCOA5;RNF2;CCND1;DUSP22;LIN37;ATRX;RITA1;TCF7L2;TBL1X;PPARG;WWP2;PRDM1;BCL6;RARB;NR2F2;IGF2;GLIS1;DLL4;MDM2;NKAP
prerank,cell differentiation in hindbrain (GO:0021533),0.6736676921353324,1.6984597178747678,0.02335456475583864,0.13069101217387177,1.0,6/11,13.24%,GRID2;LHX1;PROX1;FAIM2;CBLN1;KNDC1
prerank,protein-containing complex assembly (GO:0065003),-0.3751957851074314,-1.6977387965800483,0.0,0.1017855807887335,1.0,95/259,23.81%,LEF1;FBXL7;SLC2A1;PARD3;MNAT1;SEC31A;CREBBP;SEC24B;FERMT2;CSNK1A1;CD2AP;CTSC;GSK3B;TRAPPC3;TRAPPC9;RANBP9;TEAD1;SH3PXD2B;LRRK2;MITF;RAB1A;HDAC1;HES1;RBX1;AFDN;SEC24A;TRRAP;FAS;KPNA3;CUL3;SEC16B;SNX9;WASL;SEC24D;KLHL12;SEC13;YAP1;SCFD1;AFG3L2;PICALM;DET1;OCLN;CASP8;ADAM10;SAMM50;TP53;AXIN2;HFE;ANO6;CDC73;PPP6R3;CDC123;CSNK1D;KAT5;ASH2L;CD40;TCF7L1;CTSZ;TBC1D20;PEX14;TUBGCP4;TNFRSF1A;F5;TFG;CTNNB1;TFAP4;DBNL;FANCC;DNAJB12;IKBKG;VAMP3;WASF1;MDN1;MAGI1;TCF7L2;AP2M1;CXCL12;FERMT3;TERT;MDM2;BLM;CAND2;VAMP2;PTK2B;PREB;SEC24C;AMER1;SEC22B;PPIH;TSPAN33;BET1;RIPK1;NDUFAF1;CD247;RBBP5
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.38801746016880173,-1.6975267238426976,0.0,0.10136947621318207,1.0,58/186,16.35%,NXN;DAB2IP;TRABD2B;CSNK1A1;CAV1;DAB2;MLLT3;FZD6;GSK3B;DVL3;MCC;NFATC1;PSMA2;IGFBP4;ZNRF3;SOX13;SOX17;EMD;KREMEN1;VGLL4;RNF213;FZD4;LIMD1;HDAC1;FRMD8;RBX1;STK3;RNF43;CUL3;LRP6;NKD1;PSME2;KLHL12;CTNND1;GRB10;PSMB4;GLI3;GSK3A;LATS2;UBAC2;AXIN2;HMGXB4;WWOX;DKK2;TMEM64;NOTUM;TAX1BP3;WNT11;APCDD1;PSMC2;LMBR1L;TMEM170B;PSMB2;FUZ;RUVBL2;PSMB1;MAD2L2;HIC1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.427518054296955,-1.6974112841373454,0.0,0.10083929296733823,1.0,34/95,20.88%,ENG;CREBBP;CAV1;DAB2;SMURF2;IL17RD;THBS1;ITGA3;PRDM16;RNF111;SPRED2;SMURF1;TGFBR3;TGFBR2;NREP;PPARA;LDLRAD4;ZBTB7A;ASPN;SKIL;SMAD2;SMAD4;LATS2;SMAD7;LTBP4;SMAD6;SKI;GIPC1;CITED2;PMEPA1;HTRA3;DAND5;SNX25;STRAP
prerank,action potential (GO:0001508),0.4804632978041412,1.6972261311113723,0.0,0.13026798230263342,1.0,12/44,12.08%,KCND2;ANK3;SCN8A;SCN1A;AKAP6;CLN3;SCN3A;KCNA2;SCN2A;SCN5A;GPER1;SRI
prerank,regulation of protein import into nucleus (GO:0042306),-0.5115474707160622,-1.6950895757889954,0.00539568345323741,0.10260745193795928,1.0,17/36,20.86%,UBR5;PIK3R1;PRKCD;BMP4;MDFIC;CDH1;FLNA;PSEN1;CHP1;UFM1;ZPR1;RAB23;TPR;MAVS;ZIC1;HYAL2;TRIM28
prerank,regulation of developmental growth (GO:0048638),-0.5457737161713947,-1.6920256928820638,0.007104795737122558,0.10535907147228857,1.0,15/29,18.07%,GHR;INSR;GSK3B;APP;NIPBL;SIX1;ABL1;DNM2;PLCB1;MFSD2A;LATS2;SIN3A;IGF1;SIX4;SOD1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),-0.3515847712398388,-1.691213061840458,0.0,0.1055010667132302,1.0,135/417,21.81%,FOXP1;MECOM;LEF1;DAB2IP;FOXP2;SMARCA2;ZBTB16;ATP8B1;WWP1;ZNF423;FOXO1;ZHX3;RB1;ZEB1;KAT6B;KLF4;CBFA2T3;BTAF1;FOXN3;PRDM5;SMURF2;LIMS1;RBFOX2;SPINDOC;PRDM16;RPS6KA5;UIMC1;ID1;NR3C1;SOX13;KAT6A;RCOR1;LOXL3;PSPC1;CD38;ZHX2;CDKN1B;VGLL4;ZNF148;ELK3;CTCF;NIPBL;LIMD1;HDAC1;HES1;GAS6;ZBTB7A;PDCD4;PLCB1;SPEN;BMP4;PTPRK;MIDEAS;JUN;ZBTB4;SMAD2;PBXIP1;TBX2;SUV39H1;PPM1F;DACH1;MDFIC;NAB1;SMARCE1;LDB1;PPARD;IRF1;GLI3;SMAD4;CTBP2;SP3;GLIS2;TP53;EHMT1;KLF10;HMBOX1;SMARCC2;SIN3A;SOX7;SCMH1;TWIST2;YAF2;NOTCH1;HDAC4;SFPQ;PA2G4;KAT5;WNT11;CIC;FBXW11;ZHX1;MECP2;KMT5A;SAMD1;NR1D2;DAP;BCOR;PHC1;PEX14;TAF7;BMP7;SUMO1;SIX4;RARA;ARID5B;HDAC6;ZBTB14;CTNNB1;TFAP4;HDAC10;PATZ1;HEY1;ZMYND11;HEY2;CITED2;BAP1;PIAS4;SCML4;TCF7L2;NONO;TIMELESS;PPARG;WWP2;BCL6;BRCA1;NR2F2;TRIM28;FOXL2;MDM2;NKAP;NACC1;CBFA2T2;GCLC;PHC3;TSHZ3
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.5730104741274489,-1.6909524278376178,0.007312614259597806,0.10514481527665434,1.0,8/22,14.94%,DAB2IP;MFHAS1;LYN;WDFY1;LBP;FLOT1;TNFAIP3;IFI35
prerank,mesenchyme morphogenesis (GO:0072132),-0.6233284143376928,-1.689721056735376,0.008880994671403197,0.10573362755872073,1.0,7/17,12.19%,ENG;ACVRL1;NOS3;TGFB2;SMAD2;TBX2;NOTCH1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.5777893789794953,-1.6877797104765269,0.008680555555555556,0.10732706986330084,1.0,10/22,16.38%,MEF2A;IL6ST;ROCK1;SMAD4;LMCD1;EDN1;PDE9A;NOTCH1;ROCK2;IGF1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.6083972521078879,1.6872269795296704,0.013303769401330377,0.14010567755585102,1.0,8/18,13.33%,NRXN1;NLGN1;RIMS2;RIMS1;SHANK1;PRKCZ;DLG4;NLGN2
prerank,monocarboxylic acid transport (GO:0015718),-0.4784033728153053,-1.6870007513374254,0.0018552875695732839,0.1074614982803208,1.0,15/51,12.66%,ABCC4;ABCG2;ATP8B1;SLCO2A1;SLCO1C1;RXRA;SLCO3A1;SLC16A12;SLC5A6;SLC16A9;SLC16A1;SLCO2B1;SLC16A6;SLC27A4;CEACAM1
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.6068634911073919,-1.6839678040099553,0.005802707930367505,0.11002536590020241,1.0,8/18,19.79%,ABL1;RFK;EDN1;EDN3;AGTR1;SIRT3;NOD2;POR
prerank,positive regulation of neuron migration (GO:2001224),-0.6944952323288993,-1.6829057228612165,0.00931098696461825,0.11050360612551997,1.0,5/11,8.57%,DAB2IP;RAPGEF2;SEMA6A;NIPBL;ARHGEF2
prerank,collagen fibril organization (GO:0030199),-0.42838431206528127,-1.6804785443362087,0.005172413793103448,0.11267514108635167,1.0,26/88,11.76%,TLL1;COL8A1;ITGA6;COL12A1;COL4A2;COL25A1;PLOD1;PLOD2;ADAMTS2;COL4A6;P3H2;COL5A1;ITGB4;LOXL3;LAMA3;COL4A5;COL4A1;TGFB2;COL8A2;COL5A2;COLGALT2;LOXL1;DST;P4HA1;COL6A3;COL15A1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.4910336244524116,-1.6797205811917073,0.0018726591760299626,0.11304300650023597,1.0,14/43,12.27%,NFIB;KLF4;ETS1;TEAD1;NFATC4;NR3C1;PPARA;FOXO3;TGFB2;BMP4;JUN;PPARD;TP53;FGF2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.6493928183873043,-1.6796172882022933,0.008865248226950355,0.11250413504475638,1.0,5/13,8.91%,NFIB;NFATC4;PPARA;BMP4;PPARD
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.41876060481953203,-1.6786459686100523,0.0017793594306049821,0.11293492619882886,1.0,38/101,22.46%,KLF4;THBS1;ATG7;EIF3E;METTL14;ATG10;DDX3X;MTOR;NIBAN1;MSN;PLD1;VGLL4;EIF3C;NFKBIA;UPF3B;SAMD4A;EZR;ASPH;ASPSCR1;CASP8;RPL26;AKT1;ZCCHC4;PERP;EEF2;AGTR1;FBXW11;LARP4B;RPS4X;RPL5;METTL5;SOX4;PRKDC;FGFR4;RBM3;OGT;AMER1;HSP90AA1
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.47623379979610186,-1.6782121747535492,0.003669724770642202,0.11276847894567874,1.0,27/49,36.92%,AFAP1L2;NOD1;RAB1A;PRKD2;LBP;MAVS;HYAL2;NOD2;F3;RELA;SERPINE1;RIPK1;HSPA1B;HMGB1;F2R;LGALS9;DDIT3;STAT3;TLR1;NOS2;TLR5;CD14;PARK7;CD74;TLR2;TLR8;SYK
prerank,response to lipid (GO:0033993),-0.4176235720761304,-1.678207055594732,0.0,0.11214589883330102,1.0,33/105,17.12%,FOXP1;FOXO1;PELI1;NOS3;SRR;ESR1;ACER2;ASXL1;RXRA;IFNAR1;HNRNPA0;PPARA;RARG;STRN3;GGT5;FOXO3;ALPL;GCH1;LBP;RBP4;MAPKAPK2;PPARD;SOCS2;JAK2;IRAK1;RPS6KA3;TRIM16;SMAD6;TAB2;RARA;ANXA1;CTSH;CTNNB1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5950795195146135,-1.67811867279738,0.00558659217877095,0.11162437165900808,1.0,10/18,21.75%,JCAD;RHOJ;KDR;PIK3C2A;AKT3;MAP3K3;FGF2;ANXA1;GATA2;HDAC7
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.557543711274542,-1.6780828701280335,0.014134275618374558,0.11103685497482813,1.0,8/24,9.84%,SORBS1;INSR;GSK3B;PPP1R3B;IRS1;PPP1R3C;GSK3A;AKT1
prerank,regulation of protein export from nucleus (GO:0046825),-0.5651984027917076,-1.6780526438922443,0.008710801393728223,0.11045593960170638,1.0,10/23,19.87%,SP100;PTPN14;GSK3B;YWHAE;EMD;GAS6;TP53;TPR;XPO4;TCF7L2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.5108318210511373,-1.6740801900896127,0.006968641114982578,0.1143381880284614,1.0,14/35,18.86%,UBR5;ZMIZ1;NR3C2;ESR1;RBFOX2;NR3C1;NEDD4;MED1;YAP1;KDM3A;NCOA4;TADA3;WBP2;PMEPA1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.5947254809119631,-1.6736474356851392,0.008771929824561403,0.11409174024381578,1.0,11/18,26.25%,FLT1;PLCG1;SP1;MEF2C;AKT3;FGF2;ITGA4;PPARG;IGF2;HMGB1;ADAM17
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.6943039372939216,1.6725670318272619,0.021321961620469083,0.15651638811270283,1.0,7/10,14.09%,DLGAP1;DLGAP2;NPTXR;NPTX2;DLGAP3;CACNG5;BEGAIN
prerank,regulation of chromatin organization (GO:1902275),-0.6366222111015205,-1.6708685147738385,0.01718213058419244,0.11685659496076697,1.0,9/14,27.56%,MLLT3;TLK2;TLK1;METTL4;SETD5;HPF1;IGF2;ALKBH4;HNRNPU
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.474854155520247,-1.6704568576875078,0.0017271157167530224,0.11667591643983258,1.0,16/44,14.71%,CAST;XIAP;KLF4;THBS1;DDX3X;YWHAE;GAS6;NGF;DNAJB6;RAF1;SH3RF1;AKT1;RPS6KA1;HGF;RPS6KA3;GPX1
prerank,positive regulation of sodium ion transport (GO:0010765),0.6469539662990231,1.670245478688957,0.008849557522123894,0.15764387572968347,1.0,6/12,8.20%,ANK3;SCN1B;PKP2;GPD1L;WNK3;SCN5A
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.4337443994145908,-1.6699051863394863,0.0,0.11665712158839886,1.0,24/80,14.71%,XIAP;KLF4;DAPK1;NOD1;UACA;THBS1;MAP3K5;DDX3X;TNFSF10;YWHAE;GAS6;NGF;DNAJB6;PPM1F;RAF1;ARL6IP5;SH3RF1;AKT1;BCAP31;SOX7;RPS6KA1;HGF;RPS6KA3;GPX1
prerank,positive regulation of GTPase activity (GO:0043547),-0.38169809116996883,-1.6695716730701244,0.0,0.11636193977668526,1.0,76/188,25.65%,DOCK9;ITGA6;TBC1D4;RAPGEF2;RSU1;ITGB1;BCR;FERMT2;RALGAPA1;RAB3GAP1;LIMS1;NET1;CORO1C;GSK3B;DVL3;RALBP1;F11R;PKP4;CCL25;TBC1D1;AFDN;TBC1D2B;ARHGEF15;RAP1A;TBC1D8B;SNX9;TGM2;USP6NL;SIPA1L3;AGRN;RASGRP2;TBC1D30;TBC1D14;PICALM;MTSS2;TBC1D22B;RAPGEF1;ARAP1;TBC1D22A;BCAS3;SLC27A4;TAX1BP3;WNT11;ARHGEF10;RHOG;CD40;LARS1;MAP4K4;TBC1D20;ARHGAP22;ABR;ALS2;ARHGAP29;CCL19;TBC1D8;NDEL1;EPHA2;TBC1D17;TBC1D25;ARHGAP42;NF1;ARHGEF5;ASAP3;SYDE1;SNX13;TBC1D12;EVI5;ARHGAP11A;PIP5K1A;SNX18;ADRB1;PLXNB1;RAPGEF3;FZD10;SIPA1;SIPA1L1
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.5744837450424467,-1.667158236674697,0.018083182640144666,0.11849767276958637,1.0,11/21,26.50%,CSNK1A1;CAV1;GSK3B;DVL3;LRP6;CTNNB1;AMER1;PPP1CA;FZD5;FZD1;APC
prerank,regulation of cellular component size (GO:0032535),-0.521059887441957,-1.6660947791457736,0.005128205128205128,0.11914658912487637,1.0,19/30,28.89%,RIN3;EPS8;RAC1;MTOR;MSN;RARG;EZR;PICALM;RPTOR;LARS1;PEX11A;AP2M1;PTEN;VAV2;MTPN;PPP1CA;RAB22A;RDX;PEX11B
prerank,regulation of ion transport (GO:0043269),0.4341660955151637,1.6648854498971264,0.0,0.16270186558824978,1.0,13/76,4.61%,NKAIN2;SYT1;SYT5;ANK3;CA2;KCNA5;STC1;KCNJ3;NKAIN3;SYT12;SYT11;NKAIN4;KCNA2
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.47851103129509637,-1.6631180470752902,0.005535055350553505,0.12212228539953057,1.0,15/45,11.38%,GAB1;IQGAP1;RPS6KA5;PLCG1;EGFR;SLC30A10;CBL;PIK3R1;PTK2;PIK3C2A;PLCE1;BCAR1;AKT1;NCK2;BRAF
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.4404786205449011,-1.6626854870361885,0.0,0.12191936422267513,1.0,24/75,18.35%,TEK;DAB2IP;PTPRM;SEMA6A;CLDN5;COL4A2;KLF4;THBS1;TGFB2;ISM1;ROCK1;HSPG2;RGCC;STAB1;NAXE;ECSCR;MECP2;FOXC1;ROCK2;FOXO4;NPR1;GTF2I;CTNNB1;SEMA3E
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.4878252439053917,-1.661589377913306,0.007168458781362007,0.12252641242961233,1.0,12/45,11.78%,RBPMS;ENG;ACVRL1;DAB2;BMPR2;BMP5;BMP6;TGFB2;BMP4;ACVR2A;SMAD4;HFE
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.32953629176019816,-1.6606761884846992,0.0,0.12293957090133935,1.0,241/807,21.82%,FOXP1;MECOM;KLF12;LEF1;DAB2IP;KLF7;RREB1;FOXP2;SMARCA2;ETV6;ZBTB16;ATP8B1;SP100;WWP1;ZNF423;FOXO1;MEF2A;ZHX3;CREBBP;NSD1;RB1;CBFB;ZEB1;KAT6B;KLF4;CAV1;USP9X;CBFA2T3;DAB2;ESR1;NEDD4L;BTAF1;MIER1;CUX1;FOXN3;ZFHX3;NRIP1;PRDM5;SMURF2;LIMS1;RBFOX2;KLF2;IRF2;RXRA;SPINDOC;PRDM16;RPS6KA5;UIMC1;WWC2;ID1;MITF;NR3C1;THRB;KDM2A;SOX13;NFIX;KAT6A;RCOR1;LOXL3;PSPC1;CD38;ZHX2;CDKN1B;VGLL4;ZNF148;ELK3;CTCF;NIPBL;LIMD1;BMP6;HDAC1;NFKB1;HES1;PPARA;RARG;GAS6;RPS14;DLG1;ZBTB7A;FOXO3;PDE2A;PDCD4;HIVEP1;PLCB1;MED1;SPEN;GTF2IRD1;BMP4;MAX;PTPRK;MEF2C;EZR;MIDEAS;SKIL;JUN;ZBTB4;SMAD2;ZFP90;PHF21A;PBXIP1;TBX2;SUV39H1;PPM1F;DACH1;MDFIC;NAB1;SMARCE1;YAP1;LDB1;PRDM2;PPARD;IRF1;GLI3;ZNF25;USP2;SMAD4;CTBP2;SP3;UBE2D3;GLIS2;TP53;FLNA;EHMT1;FRK;KLF10;EDN1;HMBOX1;PER3;NOTCH4;ETS2;DICER1;NFIC;SMARCC2;SIN3A;FNIP2;PSEN1;SOX7;MAZ;SMAD7;ZFPM1;PRDM6;SCMH1;CHD3;TWIST2;YAF2;NOTCH1;MTDH;CDC73;RTF1;HDAC4;SFPQ;PA2G4;LRRFIP1;WWOX;KAT5;WNT11;CIC;FBXW11;ZHX1;MECP2;ATF4;MZF1;RPL10;KMT5A;SAMD1;NR1D2;HCFC1;TCF3;FOXC1;PHF6;DAP;BCOR;NR2C1;NAB2;PHC1;DR1;PEX14;TPR;MIER2;MAD2L2;TAF7;TRPS1;BMP7;HIC1;SKI;ORC2;SUMO1;SIX4;RARA;ZNF692;ARID5B;HDAC6;ZBTB14;CTNNB1;TAF3;IGBP1;TFAP4;HDAC10;PATZ1;HEY1;ZMYND11;HEY2;MIER3;VPS72;ELK4;KDM1B;CITED2;NCOA5;RNF2;BAP1;CCND1;DUSP22;LIN37;PIAS4;RITA1;SCML4;TCF7L2;NONO;TIMELESS;TBL1X;PPARG;WWP2;PRDM1;BCL6;RARB;BRCA1;NR2F2;TRIM28;IGF2;FOXL2;GLIS1;DLL4;MDM2;NKAP;NACC1;CBFA2T2;HSF4;GCLC;PHC3;TSHZ3;CREB1
prerank,RNA destabilization (GO:0050779),-0.5920346574550716,-1.6594875695745075,0.021660649819494584,0.12387465054628848,1.0,10/18,26.53%,METTL14;GIGYF2;FTO;PUM1;ROCK1;CELF1;ROCK2;METTL16;RBM24;DXO
prerank,positive regulation of protein metabolic process (GO:0051247),-0.4131728351973882,-1.6586720989457036,0.0,0.12405117658626896,1.0,40/110,23.54%,DAB2IP;WWP1;FOXO1;KLF4;NEDD4L;SMURF2;KLF2;GSK3B;APP;ATG7;RANBP9;RAB7A;RAB1A;SMURF1;TIPARP;CDKN1B;NFKBIA;NEDD4;NKD1;PLK2;ABCB10;LDB1;GSK3A;AKT1;AREL1;PSEN1;AGTR1;MAPK8;TNFAIP3;ROCK2;PAEP;OAZ2;GPC3;WWP2;HUWE1;MAPK7;HACE1;SEC22B;MTPN;FZR1
prerank,regulation of T cell cytokine production (GO:0002724),-0.6167781529979979,-1.658331617555766,0.01841620626151013,0.12382374118878117,1.0,7/15,24.76%,TRPM4;TNFRSF1B;CD55;SMAD7;HFE;FZD5;MAP3K7
prerank,regulation of hydrolase activity (GO:0051336),-0.438729381241035,-1.6565167623794868,0.0,0.12536284644179385,1.0,28/71,22.47%,DAB2IP;CHN2;PRKG1;FGD5;FGD6;CAV1;RAB3GAP1;RALBP1;CRK;RASIP1;CHN1;PTK2;PLXND1;EPHA4;PLXNA4;RAB3GAP2;PAFAH1B1;FBXW11;GPR137B;ARHGAP12;CDK5RAP3;SOD1;WRN;NF1;ARHGEF5;VAV2;NOS1;EPHB3
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.49745116438444953,-1.656349517682153,0.008976660682226212,0.12487002853428088,1.0,17/39,15.43%,CREBBP;NOS3;ZMIZ1;MAML2;KAT2B;IL6ST;JAG2;TGFB2;AAK1;MAML1;TSPAN14;YAP1;NOTCH4;TSPAN5;NOTCH1;JAG1;CCN3
prerank,Wnt signaling pathway (GO:0016055),-0.4159499874833489,-1.6561844868539304,0.0,0.12438223938092617,1.0,38/92,26.77%,LEF1;NXN;FERMT2;CSNK1A1;LRP5;FZD6;GSK3B;DVL3;LRRK2;DDX3X;CSNK1G3;FZD4;RBX1;RARG;LRP6;KLHL12;PLCG2;WNT16;VPS26A;CSNK1G1;WNT11;TCF7L1;USP34;CTNNB1;TCF7L2;PTEN;AMER1;FZD7;SFRP4;FZD5;PLPP3;FZD10;WNT2B;WNT5B;FZD1;APC;VPS35;FRZB
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),-0.39251527340281145,-1.6550383399526516,0.0018115942028985507,0.12494567550373338,1.0,47/140,17.60%,CHN2;ARHGAP31;AKAP13;BCR;CD2AP;RAC1;RHOJ;ARHGEF3;NET1;STARD8;RALBP1;MCF2L;ARHGAP10;CGNL1;ARAP3;PLEKHG5;ARHGAP5;RASGRF2;CHN1;ARHGEF12;SLIT2;RHOQ;ARHGDIA;PLCE1;TGM2;ITSN1;ARHGEF2;ARHGAP17;SOS2;STARD13;ARAP1;ARHGAP1;ARHGEF11;RHOA;ARHGAP28;FAM13A;RHOC;RHOG;TRIO;ARHGAP22;ABR;ARHGEF18;DEPDC7;PREX1;ARHGAP12;ARHGAP29;ARHGAP35
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.6418554213225744,-1.654917160977946,0.005272407732864675,0.12384977923734652,1.0,4/14,12.52%,ABCG2;SLCO2B1;BLVRA;HMOX2
prerank,heme catabolic process (GO:0042167),-0.6418554213225744,-1.654917160977946,0.005272407732864675,0.12384977923734652,1.0,4/14,12.52%,ABCG2;SLCO2B1;BLVRA;HMOX2
prerank,circulatory system development (GO:0072359),-0.40580221305298125,-1.6530100417407942,0.0,0.12556523710050135,1.0,45/118,19.09%,NXN;TEK;ACVRL1;MEF2A;AKAP13;HEG1;PKD2;KAT2B;MICAL2;SH3PXD2B;TBX1;SOX17;CDKN1B;PDLIM5;TGFBR2;TGFB2;SMYD4;RBP4;MTHFD1;ECE1;MEF2C;WDR11;CDH5;PLCE1;HSPG2;PDLIM1;KDM6A;FLT4;PCSK5;CASP8;RAMP2;KDM6B;NOTCH4;ZFPM1;NOTCH1;PDLIM3;RBM20;FOXC1;BCOR;TAB2;HEY1;HEY2;CITED2;SOX4;NCOA6
prerank,regulation of transferase activity (GO:0051338),-0.5932143982230633,-1.652329591227844,0.008787346221441126,0.12575076790727485,1.0,11/17,29.78%,ATM;PARP4;LDB1;FEM1A;HMBOX1;FEM1B;NLRC5;SMG6;PINX1;BAG5;EMP2
prerank,peptidyl-serine phosphorylation (GO:0018105),-0.3816437499660574,-1.6516543448116063,0.0,0.12594705900071257,1.0,50/153,16.81%,PRKCH;DYRK1A;CSNK1A1;PRKCE;TLK2;GSK3B;ATM;MARK1;RPS6KA5;PAK2;LRRK2;NEK6;MTOR;PRKD2;TLK1;CSNK1G3;TGFBR2;RICTOR;GAS6;MAST4;MAST2;PRKCD;ERN1;MAPKAPK2;PLK2;MAPK1;ROCK1;PRKD1;AKT3;LATS2;CLSPN;AKT1;STK32C;IKBKE;STK38;RPS6KA1;CSNK1G1;CSNK1D;ULK2;MKNK2;MAPK8;PKN2;RPS6KA3;MARK2;PKN3;ROCK2;MAPK12;SRPK2;MARK3;HIPK1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.3277039885496395,-1.6513065354448684,0.0,0.12567761489998056,1.0,278/834,25.06%,LEF1;PBX1;DAB2IP;KLF7;NFIA;RREB1;SMARCA2;ITGA6;NFIB;ENG;ERG;ACVRL1;FOXO1;MEF2A;CREBBP;MLLT10;MRTFB;SENP1;NFAT5;ZMIZ1;KAT6B;ELF1;KLF4;ETS1;PKD2;DAB2;LRP5;ESR1;BMPR2;TCF12;ASXL1;ZFHX3;NRIP1;MAML2;KLF2;IRF2;CDK13;DVL3;RXRA;APP;KAT2B;NFATC1;BMP5;ATM;RPS6KA5;FOSL2;RNF111;LMO2;TEAD1;MICAL2;ZSCAN21;TBX1;MITF;NR3C1;THRB;DDX3X;KANSL3;NFIX;KAT6A;PRKD2;PLAGL1;SOX17;CDK12;EGFR;NOTCH3;RTRAF;SP1;CRLF3;ELK3;BMP6;HDAC1;NFKB1;HES1;PPARA;MEOX2;RARG;SIX1;UBP1;TET2;NCK1;NFKBIA;PIK3R1;ABL1;FOXO3;LMO7;HIVEP1;LRP6;TGFB2;RHOQ;MED1;AATF;STAT6;PRPF6;E2F4;FGF1;GABPB2;BMP4;MAX;MEF2C;JUN;WASL;SMAD1;SMAD2;PLXND1;AGRN;MAML1;SETD3;PRKD1;ARHGEF2;ATAD2B;YAP1;LDB1;PRDM2;PPARD;IRF1;GLI3;ACVR2A;HAX1;SMAD4;AKIRIN2;NAMPT;CTBP2;SP3;TAL1;GLIS2;TP53;KDM6B;BCLAF3;KLF10;EDN1;DOT1L;NOTCH4;MED13;NCK2;POGZ;HELZ2;NFIC;PPP1R12A;RGCC;SIN3A;SMAD7;ZFPM1;BCAS3;MED17;NOTCH1;FOXF2;FOXJ3;FGF2;CDC73;RPS6KA1;HDAC4;SFPQ;TCEA1;GABPB1;WWOX;KAT5;EIF5A;CREBRF;CD40;HGF;PLSCR1;SMARCD3;ZIC3;ATF4;MZF1;AGO2;GRHL1;RPS6KA3;NR1D2;HCFC1;JAG1;TCF3;FOXC1;MYBL2;ZNF462;JMJD6;KMT2C;DR1;RUVBL2;ETV1;TNFRSF1A;FOXO4;TAF7;IGF1;SKI;CCNC;GCN1;RARA;CTNNB1;NLRC5;ARNT;CEBPG;MAVS;HEY1;HEY2;THAP3;NRF1;WBP2;ELK4;KDM1B;IKBKG;HLF;EPAS1;ZNF507;CITED2;RNF10;IKBKB;HYAL2;NOD2;GATA2;SOX4;NCOA6;RNF4;PRKDC;ATRX;SMAD9;MED10;TCF4;TCF7L2;SS18;TBL1X;PPARG;RARB;LPIN2;CKAP2;BRCA1;AKNA;NR2F2;IGF2;GLIS1;OGT;PCGF5;TERT;PBX2;CAPRIN2;TET3;CREB1;ELF4;MAPK7;NOS1;NFE2L2;GABPA;CCN1;ATAD2;RELA;MYOCD;YY1;SERPINE1;GLMP;TBX3;USP16;ATF6;RIPK1;RXRG;CRTC1;RFXANK;PCBP1;SUPT4H1;CEBPA;FZD5;ARRB1;SSBP4;THRAP3;ATF5;CCNK;E2F7;E2F3;TAF9;SMARCB1;TFDP1;HMGB1;GPS2;DHX9;INO80;BMP2;BRD4;IRF7;APBB1
prerank,aorta morphogenesis (GO:0035909),-0.5977130564045525,-1.6509456450230628,0.018867924528301886,0.12545447043905478,1.0,11/17,21.67%,ENG;ACVRL1;TBX1;TBX2;ADAMTS9;MYLK;JAG1;HEY1;HEY2;DLL4;PDGFRB
prerank,plasma membrane tubulation (GO:0097320),-0.6592201899459658,-1.6507712296146642,0.022263450834879406,0.12509696136449466,1.0,6/13,10.04%,CAVIN2;FNBP1L;EHD2;SNX9;BIN3;CHMP4A
prerank,regulation of BMP signaling pathway (GO:0030510),-0.427239154230043,-1.6502136623935075,0.0017452006980802793,0.12522467539390605,1.0,20/73,12.19%,ZNF423;ENG;ACVRL1;XIAP;BMPER;CRIM1;BMPR2;SMURF2;ITGA3;SMURF1;BMP4;SKIL;CDH5;SMAD1;SMAD2;ACVR2A;SMAD4;UBE2D3;SMAD7;NOTCH1
prerank,regulation of inflammatory response (GO:0050727),-0.37517349511385023,-1.6493530982864089,0.0,0.12573838322434305,1.0,66/190,25.01%,FOXP1;TEK;IL1R1;XIAP;RB1;KLF4;ETS1;MFHAS1;CASP12;CD200;SEMA7A;TMSB4X;APP;IL15;BIRC3;PPARA;TNFRSF1B;NFKBIA;OTULIN;NMI;PDE2A;PDCD4;PRKCD;NAPEPLD;CDH5;PPARD;CELF1;FEM1A;AREL1;JAK2;AGTR1;MGLL;USP18;LPL;IL17RA;NR1D2;TNFAIP3;IFI35;CCN3;C1QTNF3;IL16;TNFRSF1A;ANXA1;VAMP3;HYAL2;NOD2;DAGLB;PPARG;BCL6;AKNA;LPCAT3;VAMP2;GPR4;MAPK7;RELA;SERPINE1;RIPK1;CASP1;CEBPA;PTGIS;SHPK;ACE2;DDT;GPS2;DHX9;BRD4
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4531334142885246,1.6485066297359128,0.008368200836820083,0.18342932975541906,1.0,16/53,17.27%,CHRM2;HTR2C;OPRM1;CNR1;CHRM3;MTNR1B;MTNR1A;NPY;HTR4;ADRB3;TSHR;HTR1D;CCL2;HTR1F;HRH1;HRH2
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.5969862059940609,-1.6477700623586862,0.005366726296958855,0.12706681909401207,1.0,10/18,15.01%,CTNNA1;MFHAS1;GSK3B;MDFIC;LATS2;SIN3A;CHP1;UFM1;RAB23;ILRUN
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.6318669083210993,1.6477109342565692,0.017937219730941704,0.18253356852437833,1.0,4/12,1.29%,SYT1;SYT5;RIMS2;RIMS1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.49642622051356894,-1.6474095563246323,0.019434628975265017,0.1268484537616531,1.0,13/35,17.60%,DAB2IP;HEG1;ITGA3;SCAI;RASIP1;CUL3;TGFB2;STAMBP;TNFAIP1;MYOC;SPRY4;KCTD10;ARHGAP35
prerank,myeloid cell differentiation (GO:0030099),-0.4657869484258862,-1.647289659074451,0.003527336860670194,0.12641405614029314,1.0,12/47,11.57%,ZBTB16;SNRK;MFHAS1;LYN;KMT2E;KAT6A;TET2;RPS14;ACIN1;TAL1;JAK2;ZFPM1
prerank,positive regulation of vasculature development (GO:1904018),-0.41809985674609357,-1.6461158649964076,0.0,0.12733448516088183,1.0,39/94,25.22%,FLT1;TEK;ITGB1;GAB1;NOS3;TIE1;ETS1;CD34;THBS1;KDR;ANXA3;PLCG1;PRKD2;SP1;FGF1;CDH5;PRKD1;RRAS;PIK3CD;RAMP2;VEGFC;PIK3R6;FGF2;MTDH;CD40;AGO2;SMOC2;HIPK1;CTSH;SASH1;GATA2;F3;BRCA1;SERPINE1;CYP1B1;PTGIS;SEMA5A;RAPGEF3;TNFSF12
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.45909742002501186,-1.6457129648128916,0.0054446460980036296,0.1271299503447961,1.0,17/50,14.71%,XIAP;KLF4;THBS1;PAK2;DDX3X;YWHAE;GAS6;NGF;DNAJB6;RAF1;CAAP1;SH3RF1;AKT1;RPS6KA1;HGF;RPS6KA3;GPX1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.39204041588630817,-1.6450873804498334,0.0,0.12727378931135824,1.0,48/136,24.19%,DAB2IP;SP100;RB1;KLF4;PKD2;ESR1;CD200;FZD6;TMSB4X;ID1;SIK1;TAX1BP1;HES1;GAS6;NFKBIA;OTULIN;ANXA4;GLIS2;FLNA;NFKBIL1;SMAD7;IRAK1;HDAC4;CHP1;TNFAIP3;DAP;PEX14;MAD2L2;MTURN;BMP7;SUMO1;IRAK2;TAF3;NLRC5;CDK5RAP3;CEBPG;CMKLR1;RNF2;USP7;TCF7L2;CTNNBIP1;WWP2;KEAP1;SFRP4;PIM1;CYP1B1;ARRB1;PTGIS
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5460886488449315,-1.644844522768653,0.01282051282051282,0.1269822683694959,1.0,11/24,9.29%,SEMA3C;NRP2;ENG;BMPR2;PARVA;TBX1;TGFBR2;TGFB2;BMP4;TBX2;SMAD4
prerank,heart trabecula morphogenesis (GO:0061384),-0.5813105358256947,-1.6440357684828568,0.017889087656529516,0.12727340035019133,1.0,11/18,17.91%,TEK;ENG;ADGRG6;BMP5;TGFBR3;TGFB2;RBP4;S1PR1;NOTCH1;BMP7;HEY1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.6624211124418263,-1.6437129867565297,0.006779661016949152,0.12704348416964145,1.0,6/13,7.18%,ABHD2;NR3C2;ESR1;NR3C1;MED1;BMP4
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.4335628297301203,-1.6428875976136215,0.0,0.12747823142330897,1.0,31/75,26.25%,TEK;JCAD;NRP2;BMPR2;KDR;PLCG1;PRKD2;SP1;BMP4;PRKD1;AKT3;FLT4;PIK3CD;AKT1;VEGFC;AGTR1;FGF2;ITGA4;ARNT;GATA2;NRAS;F3;ITGB3;IGF2;SEMA5A;HMGB1;EGR3;BMP2;THBS4;TNFSF12;ADAM17
prerank,Rho protein signal transduction (GO:0007266),-0.4615144356279069,-1.642462455564761,0.0018484288354898336,0.12733702991104284,1.0,24/53,18.29%,EPS8;RHOJ;ARHGEF3;NTN1;PLEKHG5;EPS8L2;ARHGAP5;GNA12;PHACTR4;ARHGDIA;ROCK1;ARHGAP1;AGTR1;ARHGEF11;RHOA;RTKN;TAX1BP3;RHOG;CDC42EP3;ROCK2;RIPOR1;ARHGAP29;ADGRG1;CFL1
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.6199125293216275,-1.642078011719918,0.014652014652014652,0.1271622598346917,1.0,7/15,11.65%,PRKCE;LDLRAP1;PPARA;IRS1;PPARD;AKT1;ADM
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.33603117119013637,-1.6417656031035706,0.0,0.12695437894740216,1.0,153/497,21.81%,FOXP1;MECOM;LEF1;DAB2IP;FOXP2;SMARCA2;ZBTB16;ATP8B1;WWP1;ZNF423;ACVRL1;FOXO1;ZHX3;RB1;ZEB1;KAT6B;KLF4;CBFA2T3;DAPK1;BTAF1;FOXN3;BMPR2;PRDM5;SMURF2;LIMS1;RBFOX2;GSK3B;SPINDOC;PRDM16;RPS6KA5;RNF139;UIMC1;ID1;NR3C1;DDX3X;SOX13;KAT6A;RCOR1;LOXL3;GIGYF2;PSPC1;CD38;ZHX2;CDKN1B;VGLL4;ZNF148;ELK3;CTCF;NIPBL;LIMD1;HDAC1;LARP1;HES1;GAS6;ZBTB7A;PDCD4;PLCB1;SPEN;BMP4;PTPRK;SAMD4A;MIDEAS;JUN;ZBTB4;SMAD2;PBXIP1;TBX2;SUV39H1;PPM1F;DACH1;MDFIC;NAB1;SMARCE1;LDB1;PPARD;IRF1;GLI3;GSK3A;SMAD4;CTBP2;SP3;WAPL;GLIS2;TP53;EHMT1;KLF10;HMBOX1;SMARCC2;SIN3A;SOX7;SCMH1;TWIST2;YAF2;PDS5A;NOTCH1;HDAC4;SFPQ;PA2G4;KAT5;WNT11;CIC;FBXW11;ZHX1;MECP2;KMT5A;SAMD1;NR1D2;IGFBP5;DAP;SYNCRIP;BCOR;BTG2;PHC1;PEX14;TAF7;BMP7;SUMO1;SIX4;RARA;ARID5B;HDAC6;ZBTB14;CTNNB1;TFAP4;HDAC10;PATZ1;HEY1;ZMYND11;HEY2;RPS3;CITED2;BAP1;PIAS4;SCML4;TCF7L2;NONO;TIMELESS;CAPRIN1;PPARG;WWP2;BCL6;BRCA1;TOB1;NR2F2;TRIM28;FOXL2;MDM2;NKAP;NACC1;CBFA2T2;GCLC;PHC3;TSHZ3
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.6758344367526551,-1.640787169993359,0.0196078431372549,0.12743347459041945,1.0,3/11,2.75%,CD34;CD200;THBS1
prerank,positive regulation of protein catabolic process (GO:0045732),-0.4300893112896309,-1.6401171592110517,0.0,0.12754719034083695,1.0,22/84,10.67%,DAB2IP;WWP1;FOXO1;NEDD4L;SMURF2;GSK3B;ATG7;RAB7A;SMURF1;TIPARP;CDKN1B;MSN;VGLL4;ADAM9;TNFRSF1B;NEDD4;NKD1;EZR;SNX9;PLK2;GSK3A;AREL1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.4017492795946093,-1.6387124219234754,0.0016778523489932886,0.12857846685285304,1.0,58/110,31.12%,RPS21;EIF3E;RPL37;RPL31;RPL9;RPS14;UPF3B;RPSA;UPF2;RPL3;RPLP1;RPL26;RPS11;HELZ2;RPL13;RPL38;RPL27;RPS16;RPS4X;GSPT1;RPL10;RPL7A;RPL5;RPS27;RPL27A;RPS3;CTIF;RPL36A;RPL35A;PPP2CA;DCP1A;RNPS1;RPL37A;RPL32;RPS7;RPS15;RPS8;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS23;SMG6;RPS17;RPS2;RPL39;RPS26;RPS15A;RPL15;RPL34;PABPC1;SMG1;RPLP2;RPL18;RPL19;RPS13;RPL8
prerank,negative regulation of MAPK cascade (GO:0043409),-0.4228938425473294,-1.6381486082992167,0.0054446460980036296,0.1286974157093261,1.0,31/87,20.79%,DAB2IP;SEMA6A;FOXO1;CAV1;LYN;PTPN1;RANBP9;SPRED2;PTPRJ;DLG1;PPEF2;PRKCD;BMP4;EZR;SMAD4;PEBP1;STK38;TIMP3;CNKSR3;DUSP3;SPRY4;PIK3CB;ABCA7;BMP7;IGBP1;CDK5RAP3;HYAL2;PTPRC;UCHL1;PTEN;NF1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.49441494204008285,-1.63778715725386,0.009345794392523364,0.12854387902719386,1.0,17/37,20.17%,PRKG1;LDLRAP1;MMP2;CDKN1B;PDCD4;ERN1;MEF2C;JUN;FGF2;TPM1;P2RY6;IGFBP5;HTR1B;IGF1;DNMT1;PPARG;PTEN
prerank,long-term memory (GO:0007616),0.564729236622783,1.6364261513502982,0.02320185614849188,0.1967546987221626,1.0,8/19,14.63%,RASGRF1;SHANK1;CAMK4;SLC2A4;CPEB3;SGK1;LDLR;APOE
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.5359165652789984,-1.6363405906141841,0.012433392539964476,0.12966402083662112,1.0,10/26,16.38%,SORBS1;INSR;PIK3R1;IRS1;RHOQ;OCLN;AKT1;BRAF;CREBL2;IGF1
prerank,purine-containing compound salvage (GO:0043101),-0.655728016654384,-1.6362069793489915,0.008865248226950355,0.12926096168225618,1.0,9/12,31.66%,ADK;AMPD2;HPRT1;AMPD3;ADA;PNP;GMPR2;APRT;DCK
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.4358558020398478,-1.634829397880618,0.0071174377224199285,0.1303513915375014,1.0,16/66,13.67%,DAB2IP;PTPRM;NFIB;CAV1;THBS1;MCC;TGFBR3;TGFB2;MED1;AQP11;PTPRK;RGCC;CDC73;CEACAM1;KLF9;CDK6
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.31237457556465154,-1.6347772202103992,0.0,0.129821063357508,1.0,522/1668,25.06%,FOXP1;MECOM;KLF12;LEF1;PBX1;DAB2IP;KLF7;NFIA;RREB1;FOXP2;SMARCA2;FLI1;ETV6;BAZ2B;ITGA6;ZBTB16;NFIB;SP100;TEF;ENG;ERG;MNAT1;ZBTB20;ACVRL1;FOXO1;MEF2A;ZHX3;CREBBP;MLLT10;NSD1;MRTFB;RB1;CBFB;SENP1;ZEB1;NFAT5;ZMIZ1;KAT6B;ELF1;KLF4;ETS1;CAV1;USP9X;CHD1;PKD2;DAB2;LRP5;NR3C2;DACH2;PKNOX2;ESR1;NEDD4L;VGLL3;MIER1;CUX1;BMPR2;TCF12;ASXL1;HIVEP2;ZFHX3;TEAD4;TNRC6B;NRIP1;PRDM5;MED15;SMURF2;ZNF260;MED26;MAML2;KLF2;CHD2;IRF2;CDK13;DVL3;RXRA;PRRX1;APP;KLF3;TRAK1;KAT2B;NFATC1;BMP5;ATM;TBX15;PRDM16;DEK;RPS6KA5;FOSL2;RNF111;LMO2;TEAD1;CRK;WWC2;NFATC4;ZSCAN21;ARID1B;ID1;TBX1;MITF;NR3C1;THRB;DDX3X;KDM2A;ZBTB37;KANSL3;SOX13;NFIX;KAT6A;PBX3;PRKD2;PLAGL1;RCOR1;SOX17;CDK12;EGFR;MKX;ZHX2;ZBTB46;RTRAF;SP1;ZNF148;CRLF3;ELK3;CTCF;NIPBL;MGA;BMP6;HDAC1;NFKB1;HES1;LHX6;PPARA;MEOX2;RARG;SIX1;UBP1;TET2;SMARCC1;NCK1;NFKBIA;PIK3R1;RPS14;DLG1;PHF20;ABL1;ZBTB7A;FOXO3;ZIC4;PDE2A;LMO7;IKZF2;HIVEP1;HOXB6;LRP6;BBX;RHOQ;FUS;MED1;AATF;STAT6;NFYC;PRPF6;E2F4;BAZ1A;FGF1;SPEN;BRD2;GTF2IRD1;GABPB2;BMP4;CREB3L2;MAX;MEF2C;EZR;MIDEAS;SKIL;ZNF182;JUN;ZBTB4;WASL;SMAD1;SMAD2;ZFP90;TSHZ2;SRCAP;AGRN;PHF21A;TBX2;SUV39H1;MAML1;SETD3;DACH1;PRKD1;ARHGEF2;BACH2;ANXA4;ATAD2B;SMARCE1;ZBTB39;YAP1;NOP2;LDB1;PRDM2;PPARD;EBF1;IRF1;GLI3;ZNF25;ACVR2A;USP2;HAX1;SMAD4;AKIRIN2;RBBP8;ZIC5;HSF5;NAMPT;CTBP2;HOXC6;SP3;PHF20L1;UBE2D3;TAL1;GLIS2;ELF2;TP53;ZBTB40;FRK;KDM6B;BCLAF3;KLF10;EDN1;HMBOX1;DOT1L;MAMLD1;PER3;NOTCH4;ETS2;MED13;NCK2;KDM3A;POGZ;DICER1;HELZ2;STAT2;NFIC;PPP1R12A;RGCC;SMARCC2;SIN3A;PRRX2;GMEB1;FNIP2;PSEN1;JMJD1C;ZBTB7C;MAZ;SMAD7;ZFPM1;PRDM6;BCAS3;CHD3;TWIST2;HR;MED17;ZSCAN25;NOTCH1;FOXF2;FOXJ3;FGF2;MTDH;CDC73;SP140;RTF1;RPS6KA1;HDAC4;SFPQ;ZNF394;TCEA1;GABPB1;LRRFIP1;WWOX;TIAL1;KAT5;PROX2;PIAS2;ZBTB6;KLF9;EIF5A;CREBRF;CIC;CD40;HGF;ZHX1;PLSCR1;TFCP2L1;SMARCD3;DBX2;MECP2;ZIC3;ATF4;KDM7A;PGBD1;MZF1;ARID3B;AGO2;RPL10;KMT5A;GRHL1;ZBTB25;RPS6KA3;NR1D2;HCFC1;ZBTB34;HIF3A;JAG1;TCF3;TCF7L1;FOXC1;MYBL2;PHF6;MED29;ZKSCAN1;BCOR;TADA3;ZNF32;NR2C1;ZNF462;JMJD6;KMT2C;SMAD6;DR1;RUVBL2;TPR;BRWD3;ETV1;MIER2;TNFRSF1A;FOXO4;MAD2L2;CC2D1B;ZFP1;TAF7;TRPS1;HIC1;IGF1;SKI;CCNC;MOV10;ORC2;ZNF235;SUMO1;KDM5B;SIX4;RARA;MAMSTR;ZNF692;HOXA2;ARID5B;ZNF691;ZBTB14;CTNNB1;FOXQ1;ZBTB8A;TAF3;IGBP1;TFAP4;ZXDB;ZNF250;HDAC10;ZNF83;NLRC5;ARNT;PATZ1;CEBPG;MAVS;HEY1;ZFP28;HEY2;TSHZ1;THAP3;ZSCAN12;NRF1;WBP2;MIER3;VPS72;ELK4;KDM1B;HOXB9;ZIC1;IKBKG;ZBTB12;HLF;EPAS1;ZNF507;CITED2;RNF10;NCOA5;IKBKB;HYAL2;PCGF3;NOD2;GATA2;RNF2;PPM1D;SOX4;ZFX;NCOA6;TNRC6A;CCND1;DUSP22;LIN37;RNF4;PRKDC;ATRX;SMAD9;PIAS4;RITA1;MED10;TCF4;TCF7L2;SS18;TBL1X;PPARG;WWP2;PRDM1;PTEN;BCL6;RARB;ELOC;LPIN2;CKAP2;BRCA1;ZSCAN26;BAZ1B;AKNA;NR2F2;TRIM28;IGF2;FOXL2;GLIS1;MED27;OGT;DLL4;PCGF5;MDM2;NKAP;NACC1;TOX4;PBX2;HSF4;CAPRIN2;TET3;TSHZ3;CREB1;ZSCAN18;ELF4;MAPK7;NOS1;AASS;NFE2L2;GADD45A;GABPA;MCPH1;CCN1;ATAD2;RELA;MYOCD;YY1;SERPINE1;KDM3B;GLMP;TBX3;SUDS3;USP16;ATF6;RIPK1;MSX1;ZKSCAN8;RXRG;CRTC1;RFXANK;PCBP1;AEBP2;MED20;SUPT4H1;CEBPA;FZD5;ARRB1;BEND3;SSBP4;ZNF697;THRAP3;TRIB3;KLF16;ATF5;ZFP3;ACVR2B;CCNK;E2F7;ZFHX4;GMEB2;CNOT2;ARID3A;E2F3;TAF9;SMARCB1;ZNF276;TFDP1;TLE6;ZKSCAN4;HMGB1;RBAK;GPS2;EGR3;SP110;DHX9;INO80;BMP2;BRD4;IRF7;APBB1
prerank,Rap protein signal transduction (GO:0032486),-0.692799646823927,-1.634199095347045,0.009074410163339383,0.12992597478179257,1.0,9/10,27.59%,RAPGEF2;RAP1A;PLK2;RAP1B;RAPGEF1;RAP2A;RAP2C;RAPGEF3;RAP2B
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.38653955428575193,-1.6334069981591366,0.0,0.1303053717694728,1.0,59/138,28.94%,MNAT1;CREBBP;NR3C2;ESR1;TEAD4;MED26;MAML2;RXRA;KAT2B;TEAD1;NR3C1;THRB;NOTCH3;HDAC1;PPARA;RARG;MED1;MAML1;POLR2G;NOTCH2;YAP1;PPARD;GTF2E1;GTF2E2;ERCC2;TAF11;NOTCH4;MAZ;MED17;NOTCH1;TAF8;ERCC3;NR1D2;NR2C1;DR1;TAF7;RARA;TAF3;HDAC10;TBL1X;PPARG;RARB;MED27;HDAC7;TAF4B;TAF13;RXRG;POLR2C;E2F3;TAF9;TAF15;POLR2L;POLR2H;HDAC5;GTF2H3;MAML3;E2F2;CCNH;RORC
prerank,neuron projection organization (GO:0106027),-0.6115177208858493,-1.633178465486382,0.02146690518783542,0.12999049684457703,1.0,6/15,15.65%,INSR;GSK3B;APP;PSEN1;DCTN1;LGMN
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.4354573261119393,-1.6331238320441208,0.0019157088122605363,0.12948720371476594,1.0,19/67,12.16%,FLT1;TEK;IGF1R;GHR;DYRK1A;INSR;ABI1;LYN;IL15;KDR;EGFR;BMX;ABL1;PTK2;EPHA4;FLT4;JAK2;ABI3;PKDCC
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.5718231229404179,1.6325818110852932,0.02301255230125523,0.20054322780110526,1.0,9/18,13.44%,NRXN1;NLGN1;CACNG8;CACNG3;CACNG2;CACNG4;CCL2;NLGN2;CACNG5
prerank,membrane depolarization during action potential (GO:0086010),0.5229882852990992,1.6317406866882371,0.009389671361502348,0.19955700767039936,1.0,12/26,17.93%,ATP1A2;SCN8A;SCN1B;SCN1A;SCN3A;SCN2A;CACNA1D;SCN5A;SLC8A1;SCN2B;CACNA1G;CACNA1I
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.37590645377486576,-1.630361066578591,0.0,0.13242456304004296,1.0,77/168,27.32%,PAN3;TUT7;TENT4B;ATM;CNOT4;RPS21;EIF3E;RPL37;RPL31;RPL9;RPS14;UPF3B;XRN1;RPSA;SAMD4A;UPF2;POLR2G;RPL3;RPLP1;RPL26;RPS11;HELZ2;XRN2;TUT4;RPL13;RPL38;RPL27;RPS16;RPS4X;TENT2;PARN;GSPT1;RPL10;PDE12;RPL7A;RC3H1;RPL5;EXOSC8;RPS27;RPL27A;RPS3;CTIF;RPL36A;RPL35A;PPP2CA;EXOSC5;PELO;DCP1A;RNPS1;RPL37A;RPL32;DIS3L2;RPS7;RPS15;RPS8;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS23;THRAP3;SMG6;CNOT2;RPS17;EXOSC7;RPS2;CNOT8;ZFP36L1;RPL39;RPS26;RPS15A;DXO;RPL15;RPL34;CNOT1;PABPC1
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.5015368759346231,-1.630233321364904,0.015873015873015872,0.13203972044019321,1.0,15/35,18.35%,SEMA6A;SEMA3C;NRP2;RAC1;SEMA7A;ARHGDIA;PLXND1;PLXNA4;FLNA;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E
prerank,DNA double-strand break processing (GO:0000729),-0.5800491389452114,-1.6298785506880271,0.0166358595194085,0.13193308967488804,1.0,9/18,21.31%,ATM;MRE11;RBBP8;DNA2;KAT5;UBE2V2;SMARCAD1;BRCA1;BLM
prerank,phosphorylation (GO:0016310),-0.3400800913007513,-1.6297576880247011,0.0,0.13155893685699913,1.0,106/385,15.37%,GRK5;PRKCH;PRKG1;SNRK;MAP3K20;ERG;ACVRL1;BCR;DYRK1A;INSR;CSNK1A1;NEK7;DAPK1;FAM20A;LYN;PRKCE;BMPR2;TLK2;GSK3B;CDK13;PRKACB;APP;ATM;JAK1;MARK1;RPS6KA5;LIMK2;PAK2;PANK2;SIK1;LRRK2;MAP3K5;MAP4K3;NEK6;MTOR;CDK17;PRKD2;MERTK;CDK12;TLK1;TGFBR2;LIMD1;GAS6;STK3;STK24;BMX;ABL1;MAST2;TGFB2;PRKCD;BRD2;CDK10;ERN1;MAPKAPK2;PRAG1;CDC42BPA;AAK1;PLK2;MAPK1;ROCK1;MAML1;BIRC6;PRKD1;AKT3;YWHAZ;PXK;GSK3A;ACVR2A;LATS2;PIK3CD;ADAM10;AKT1;DGKA;SIK3;FRK;DGKZ;TAOK3;PRKAA1;WNK4;STK10;ILK;FNIP2;IKBKE;BRAF;JAK2;STK38;IRAK1;CSNK1D;CLK3;WNT11;CSK;CDK6;PNKP;MKNK2;AGK;MAPK8;PKN2;PIK3CB;GK5;MAP4K4;MARK2;LIPE;GMFB;PKN3;ROCK2;NUAK1
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.4791169129284728,-1.6294107410112704,0.012477718360071301,0.1313536505020993,1.0,14/39,16.00%,PODXL;KLF4;BMP6;PPARA;PTK2;FXYD5;PPM1F;CDH1;AKT1;NOTCH4;RGCC;NOTCH1;JAG1;MAD2L2
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.6328208349429254,-1.6286280664853015,0.02197802197802198,0.1317196979840812,1.0,7/15,16.38%,MEF2A;IL6ST;ROCK1;EDN1;PDE9A;ROCK2;IGF1
prerank,protein K48-linked ubiquitination (GO:0070936),-0.4585128267759757,-1.6277035881751383,0.0051635111876075735,0.13226824170202606,1.0,36/54,37.74%,PELI1;UBR5;NEDD4L;ZNRF1;UBE2K;DTX3L;RBX1;CUL3;RNF115;UBE2D3;UBE2E2;TNFAIP3;KLHL3;RNF152;RNF4;UBE2R2;RNF216;HACE1;RNF146;FBXO38;ARIH2;RNF34;RNF187;CDC34;UBE2H;TRIM32;UBE2A;IFI27;UBE2T;TOPORS;UBE2G2;UBE2C;ITCH;UBE3A;KBTBD7;RNF5
prerank,neuron development (GO:0048666),0.37171730032805345,1.626874280027332,0.0022371364653243847,0.20430795310250652,1.0,32/141,9.80%,CNTNAP2;TENM4;NLGN1;L1CAM;RASGRF1;MYT1L;PPP1R9A;CNTN4;BLK;TENM1;ATP8A2;SH3GL2;TMEM108;GPM6B;TENM3;CDK5;SRRM4;PLP1;TENM2;EPHA5;ATXN10;MAP2;NPY;GPM6A;NTRK2;INSM1;MAPT;POU4F1;ARL3;DCX;ZFYVE27;STMN2
prerank,renal filtration (GO:0097205),-0.6939252953714307,-1.6262255894982378,0.010309278350515464,0.13338768071618987,1.0,5/10,10.92%,CD34;XPNPEP3;ITGA3;TBC1D8B;MCAM
prerank,regulation of peptide hormone secretion (GO:0090276),0.43484324078278097,1.626146755328525,0.002398081534772182,0.2031616206550005,1.0,20/67,18.04%,KCNC2;HTR2C;SNAP25;GIP;GCK;KCNA5;CACNA1A;MTNR1B;CACNA1D;ADRA2C;CACNA1E;GIPR;ADRA2A;EIPR1;CCL5;ALOX5;SLC8B1;GLP1R;ABCC8;KCNG2
prerank,positive regulation of phosphorylation (GO:0042327),-0.3583992350618851,-1.6257919379184553,0.0,0.13345687927382288,1.0,85/240,23.45%,FLT1;TEK;IGF1R;ITGA6;PECAM1;ENG;ZBTB20;TIE1;ROR1;INSR;DAB2;RAC1;FAM20A;LYN;THBS1;DVL3;APP;RALBP1;LIMK2;TBX1;LRRK2;KDR;NIBAN1;MERTK;SLCO3A1;EGFR;TFRC;GAS6;ABL1;DSTYK;FAS;LMO4;IL34;CCND3;PTK2;IRGM;FGF1;BMP4;MRE11;EPHA4;FLT4;ACVR2A;FGF7;AKT1;VEGFC;AXIN2;PRKAA1;ILK;PFKFB3;PSEN1;FGF2;LIMCH1;CSNK1D;FLOT1;CD40;HGF;PTGES3;MIF;ROCK2;ANGPT1;PELI2;PIK3R3;IGF1;ARNT;MAVS;RAP2A;AKTIP;CCND1;BRAT1;EPHA2;KRAS;FGFR4;ITGB3;IGF2;P2RY1;ROR2;PDGFRB;EPHB6;CCN1;HSP90AA1;EPHB3;PFKFB4;RIPK1;FZD7;RALB
prerank,presynapse organization (GO:0099172),0.6762545844465238,1.6247469854634349,0.02178649237472767,0.20298055450692667,1.0,2/10,0.55%,NLGN1;LRRTM3
prerank,lipid phosphorylation (GO:0046834),0.6552705229789065,1.624486072396971,0.036637931034482756,0.20105261542820363,1.0,3/10,1.83%,DGKK;DGKI;DGKQ
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.4995211633048712,-1.624366241958394,0.013816925734024179,0.13469311038015272,1.0,19/33,30.81%,ACVRL1;KLF4;THBS1;MEOX2;MEF2C;STARD13;RGCC;NOTCH1;RHOA;FGF2;MECP2;PPARG;DLL4;GADD45A;HMGB1;HDAC5;ANGPT4;JUP;TGFB1
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.5907303589336276,-1.6236838567264689,0.018315018315018316,0.1351005436811115,1.0,5/16,10.04%,CREBBP;KAT2B;NAA16;NAA80;NAA15
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.5614171060772251,-1.6231029604758243,0.019230769230769232,0.13517748305769045,1.0,9/22,21.82%,SORBS1;ZBTB20;MTOR;PPARA;PPARD;AKT1;CREBL2;PPARG;CREB1
prerank,protein phosphorylation (GO:0006468),-0.33397512490468917,-1.6230314416163967,0.0,0.13475210985110073,1.0,134/479,17.01%,FLT1;GRK5;TEK;PRKCH;DAB2IP;IGF1R;PRKG1;SNRK;MAP3K20;ERG;ACVRL1;BCR;DYRK1A;ERC1;INSR;ABI1;CSNK1A1;NEK7;DAPK1;FAM20A;LYN;PRKCE;BMPR2;TLK2;GSK3B;CDK13;PRKACB;APP;ATM;JAK1;MARK1;RPS6KA5;LIMK2;PAK2;SIK1;LRRK2;MAP3K5;MAP4K3;NEK6;KDR;MTOR;CDK17;PRKD2;MERTK;CDK12;EGFR;TLK1;CSNK1G3;TGFBR3;TGFBR2;RICTOR;GAS6;STK3;STK24;BMX;ABL1;MAST4;MAST2;TGFB2;PTK2;PRKCD;BRD2;BMP4;CDK10;ERN1;MAPKAPK2;PRAG1;CDC42BPA;SMAD2;AAK1;PLK2;MAPK1;ROCK1;MAML1;BIRC6;EPHA4;PRKD1;AKT3;YWHAZ;FLT4;PXK;GSK3A;ACVR2A;LATS2;CLSPN;PIK3CD;ADAM10;AKT1;MAP3K3;SIK3;FRK;TAOK3;PRKAA1;WNK4;STK10;ILK;STK32C;FNIP2;IKBKE;BRAF;JAK2;SMAD7;USP15;ABI3;STK38;PKDCC;IRAK1;RPS6KA1;CSNK1G1;CSNK1D;CLK3;WNT11;CSK;ULK2;CDK6;MKNK2;MAPK8;PKN2;RPS6KA3;MAP4K4;MARK2;LIPE;GMFB;PKN3;ROCK2;NUAK1;MAPK12;SRPK2;SLK;FYN;MARK3;HIPK1;RARA;CDC42BPB
prerank,muscle tissue development (GO:0060537),-0.6384122666172672,-1.6226490263508246,0.01757469244288225,0.13471651287286168,1.0,5/13,8.49%,PGM5;ENG;SMO;BMP4;CSRP2
prerank,cilium movement (GO:0003341),0.4640255045524444,1.6207040147191805,0.014388489208633094,0.20467563310461748,1.0,18/47,18.48%,TEKT1;TTC29;ADCY10;CFAP54;CCDC63;ODAD2;DNAAF5;DNAAF1;ROPN1L;DNAI4;CFAP70;GAS8;SPAG17;ODAD1;CABYR;DNAAF2;CAMSAP3;ODAD3
prerank,presynaptic endocytosis (GO:0140238),0.5330121941054312,1.6204856204762155,0.015086206896551725,0.20277797863415167,1.0,6/24,6.00%,NLGN1;SYT1;SYT5;AMPH;CDK5;SNCG
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.46581423048251025,-1.6190007030876412,0.006993006993006993,0.1388418937946318,1.0,16/47,14.08%,RREB1;DOCK1;FERMT2;RAC1;LIMS2;LIMS1;CORO1C;CRK;ABL1;PTK2;FLNA;ILK;ACTN4;NEDD9;MYOC;SPRY4
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.4807347367961552,-1.6187342508621996,0.011131725417439703,0.13863175664553856,1.0,11/38,11.47%,INSR;KLF4;CAV1;PKD2;CD34;RAC1;KLF2;NOS1AP;AKT1;EDN1;JAK2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.442415352707788,-1.618390716692125,0.008741258741258742,0.13853017545346627,1.0,25/60,23.73%,LEF1;CBFB;TNRC6B;MED15;MED26;NFKB1;MED1;TP53;MED13;MED17;MECP2;CCNC;MOV10;CTNNB1;HEY2;PPM1D;TNRC6A;CCND1;MED10;TCF7L2;PTEN;TRIM28;MED27;RELA;MED20
prerank,small GTPase mediated signal transduction (GO:0007264),-0.3980271649206575,-1.6179560439407579,0.0,0.13855612874896622,1.0,42/103,21.36%,RAPGEF5;RREB1;ARHGAP31;RAPGEF2;GNB1;BCR;RB1;BRAP;RAC1;NTN1;RALBP1;PLD1;SHOC2;JUN;PLCE1;PLK2;RASGRP2;PRKD1;PLD2;RRAS;RASSF1;TP53;GRAP;ARHGAP1;RIN2;FGF2;CHP1;KSR1;GRB2;RERG;ABR;ARHGEF18;IGF1;DNMT1;RGL1;RRAS2;KRAS;NRAS;RGL2;NF1;TRIM28;NUCB2
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.5100660498644777,-1.6172688932836727,0.0037174721189591076,0.13877878269543242,1.0,13/29,22.06%,FLT1;TEK;IRS1;AMBRA1;PTK2;PRKD1;DGKZ;FGF2;TNFAIP8L3;CCL19;NOD2;PDGFRB;PTK2B
prerank,regulation of cell migration (GO:0030334),-0.34215090918586083,-1.6170523273156425,0.0,0.13847163868664902,1.0,140/382,22.81%,FLT1;TJP1;LEF1;IGF1R;ITGA6;SEMA6A;PECAM1;CLDN5;SEMA3C;ENG;ITGB1;ACVRL1;PODXL;FERMT2;INSR;CAV1;DAB2;RAC1;CBLL1;CORO1C;PDGFD;SEMA7A;THBS1;TMSB4X;GCNT2;ATM;MITF;ARID2;SYNE2;KDR;PTPRJ;SCAI;SMO;EGFR;ACE;ADAM9;LDLRAD4;GNA12;AFDN;TCAF1;STK24;FOXO3;LMO4;SLIT2;ROBO4;MACF1;PTK2;FGF1;NKD1;PTPRK;CDH5;PLXND1;ROCK1;PPM1F;EPHA4;DACH1;PLXNA4;LDB1;CDH1;FAM107A;MYLK;BCAR1;PIK3CD;ADAM10;FGF7;AKT1;FLNA;EDN1;ZMYND8;LMNA;MAZ;SMAD7;PHACTR1;FRMD5;TWIST2;ABI3;NOTCH1;RHOA;FGF2;SEMA3G;LIMCH1;SEMA6B;CEACAM1;SEMA4C;TPM1;ACTN4;DUSP3;NEDD9;WNT11;MYOC;RHOC;HGF;NUMB;MAP4K4;JAG1;IGFBP5;MIF;TBCCD1;ROCK2;FUZ;VSIR;SEMA5B;PIK3R3;IGF1;SLK;RIPOR1;ANXA1;CTSH;TMSB10;ADARB1;SEMA4A;RAP2A;SASH1;SEMA3E;WASHC1;CITED2;DUSP22;RAP2C;CXCL12;PTEN;F3;FERMT3;SPATA13;NF1;LAMB1;SEMA4G;VCL;AMOTL2;SH3RF2;ROR2;PDGFRB;SPAG9;LAMC2;PTK2B;HACE1;SERPINE2;CCN1;RECK;MIEN1;SERPINE1
prerank,embryonic organ development (GO:0048568),-0.4411025758481894,-1.6163153414270512,0.003656307129798903,0.13882310954620866,1.0,27/61,21.46%,PBX1;KITLG;TEAD4;TEAD1;KDR;PBX3;SOX17;TGFBR2;TGFB2;RBP4;TBX2;NES;GLI3;PCSK5;MFSD2A;TAL1;ZFPM1;PKDCC;ATF4;RPL10;ERCC3;TBC1D23;HEY1;HEY2;COL13A1;RARB;PBX2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.5594694048544179,-1.6160124120485948,0.01348747591522158,0.13873274871719288,1.0,10/21,16.77%,LDLRAP1;MMP2;ERN1;JUN;FGF2;P2RY6;IGFBP5;HTR1B;IGF1;DNMT1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.3401400115395474,-1.6157393593801141,0.0,0.13855860384810065,1.0,112/390,17.16%,PTPRG;FLT1;TEK;IGF1R;RAPGEF2;GHR;SORBS1;WASF2;NRP2;DOCK1;FOXO1;GAB1;COL4A2;TIE1;ROR1;INSR;ABI1;ANKS1A;RAC1;LYN;RBFOX2;ARHGEF28;COL4A6;PDGFD;GSK3B;ELMO1;CRK;PAK2;NFATC4;SPRED2;KDR;PRKD2;MERTK;PTPRJ;MMP2;EGFR;GIGYF2;YES1;AP2B1;CEP57;AP2A2;CBL;NCK1;PXN;PIK3R1;IRS1;PSEN2;SHOC2;CHN1;PLCB1;DDIT4;RHOQ;PTK2;AP2S1;FGF1;PIK3C2A;MAPKAPK2;NGF;WASL;ITSN1;HNRNPM;MAPK1;ROCK1;EPHA4;POLR2G;PRKD1;GRB10;SHB;FLT4;GSK3A;ZNF106;NAMPT;GRB14;BCAR1;FGF7;AKT1;MPZL1;VEGFC;SOCS2;FRK;NCK2;RAPGEF1;PSEN1;JAK2;HNRNPF;RASA1;RHOA;FGF2;ACTB;TIAL1;ATP6V1E1;NEDD9;HGF;NCF2;PIK3CB;GRB2;ELMO2;NCKAP1;HNRNPA1;FOXC1;FLRT2;ROCK2;FOXO4;ANGPTL1;ANGPT1;PIK3R3;ARPC4;IGF1;FYN;UBASH3B;PLAT;APH1A
prerank,inhibitory synapse assembly (GO:1904862),0.6301985719024756,1.6145855566027936,0.031042128603104215,0.20982105781650962,1.0,4/11,9.50%,GABRB3;GABRB2;GABRA2;GABRA1
prerank,cell junction assembly (GO:0034329),0.3957188006275677,1.6133164012979775,0.0,0.2097243594868613,1.0,29/100,10.12%,KIRREL3;NRXN1;CDH18;NLGN1;CDH8;CTNND2;CDH20;CDH9;CDH10;DSCAM;ADGRL3;DNER;PCDHB5;CDK5;NRCAM;PKP2;DCHS1;CDH19;FLNC;FLCN;CDH12;FSCN1;GPM6A;SDK1;CDH7;SLITRK1;POU4F1;CDH24;CDHR3
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6510223252026521,1.6129592127195072,0.031026252983293555,0.20820222963587792,1.0,4/12,6.37%,ANK3;ATP1B1;WNK2;WNK3
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.6550724089981657,-1.6126326204592933,0.024305555555555556,0.1419007831783788,1.0,4/12,7.35%,DAB2IP;PTPN1;PIK3R1;ERN1
prerank,generation of neurons (GO:0048699),0.35862977186168155,1.6119134907687647,0.0,0.20761725346321108,1.0,44/190,14.86%,PTPRD;IL1RAPL1;TAFA1;MYT1L;SNPH;WNT7B;IRX4;ADGRL3;NIF3L1;SPOCK1;DNER;ATP2B2;ASTN2;FUT9;CDK5;LHX1;CDKL5;NRCAM;ITM2C;ASTN1;MDGA1;DCDC2;RUNX2;GPM6A;NTRK2;IRX3;ADNP2;INSM1;MAPT;ACSL3;LMX1B;DCX;MAP1B;CCK;AUTS2;HMGB2;WNT6;FZD3;NRBP2;TUBGCP2;BRSK2;RNF112;WNT4;RACGAP1
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.5418341949131642,-1.6113547162958735,0.01391304347826087,0.14283515319597273,1.0,8/24,8.07%,PECAM1;ITGB1;F11R;ICAM1;NT5E;MSN;EZR;ROCK1
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.4139560139872447,-1.6099552516060263,0.0034071550255536627,0.14409144091192716,1.0,31/88,25.22%,TEK;PTPRM;NRP2;ACVRL1;TIE1;CAV1;BMPR2;THBS1;KDR;PRKD2;BMP4;PRKD1;AKT3;FLT4;PIK3CD;AKT1;VEGFC;RGCC;FGF2;ANGPT1;ARNT;NRAS;F3;ITGB3;NF1;NR2F2;SEMA5A;EGR3;BMP2;THBS4;TNFSF12
prerank,establishment of epithelial cell polarity (GO:0090162),-0.5832363794219997,-1.6092324990796425,0.025594149908592323,0.1444719087320086,1.0,10/19,18.14%,CYTH3;PARD3;MSN;CYTH1;EZR;MYO18A;SIPA1L3;RHOA;GOLPH3;RAP2A
prerank,positive regulation of hydrolase activity (GO:0051345),-0.38546101813759887,-1.6088441548922472,0.0,0.14444485365665527,1.0,55/137,25.12%,DOCK9;ITGA6;RAPGEF2;RSU1;ITGB1;FERMT2;RAB3GAP1;CD200;LIMS1;NET1;GSK3B;DVL3;RALBP1;F11R;PKP4;CCL25;AFDN;RAP1A;SNX9;TGM2;USP6NL;AGRN;RASGRP2;TBC1D30;PICALM;RAPGEF1;ARAP1;BCAS3;RHOA;MTCL1;WNT11;RHOC;CD40;LARS1;MAPK8;MAP4K4;MAPK12;TBC1D20;CTSH;ALS2;WRN;RPS3;CCL19;NDEL1;NF1;ASAP3;SNX13;EVI5;ARHGAP11A;SNX18;ADRB1;PLXNB1;RAPGEF3;BMP2;FZD10
prerank,response to histamine (GO:0034776),0.671506802793554,1.6088222141062682,0.047619047619047616,0.2102891081202139,1.0,3/10,3.54%,GABRB1;GABRB3;GABRB2
prerank,regulation of response to biotic stimulus (GO:0002831),-0.5156589972363993,-1.6086078650877598,0.012589928057553957,0.1441751959941178,1.0,11/28,19.26%,FOXP1;XIAP;BIRC3;SAMHD1;CD55;IRF1;CASP8;N4BP1;ZMPSTE24;ERAP1;TKFC
prerank,positive regulation of cell differentiation (GO:0045597),-0.3538282628220734,-1.6081954467747512,0.0,0.1441930143055604,1.0,68/237,16.38%,LEF1;PRKCH;KITLG;CTNNA1;SLC6A6;RAPGEF2;ZBTB16;ACVRL1;MEF2A;ZHX3;ZEB1;FERMT2;BOC;CD34;DAB2;LRP5;BMPR2;GCNT2;KDR;MTOR;IL6ST;TRPM4;TGFBR2;BMP6;IL6R;NFKB1;ABL1;PLCB1;TGFB2;BLOC1S5;BMP4;RAP1A;MEF2C;CDON;NGF;SMAD2;MMD;BNIP2;PRKD1;ARHGEF2;YAP1;PPARD;ACVR2A;SMAD4;RRAS;AKT1;AXIN2;RGCC;SIN3A;EDN3;AGTR1;RIN2;PKDCC;RHOA;RPS6KA1;PA2G4;CEACAM1;LPL;TMEM64;HGF;RPS6KA3;SMYD1;TCF3;FOXC1;MAPK12;CREBL2;BMP7;IGF1
prerank,regulation of secretion (GO:0051046),0.6155975443943823,1.6080448740481799,0.02050113895216401,0.2093438553458097,1.0,7/13,15.40%,NRG1;POFUT2;ACSL3;OAS2;GPLD1;SGK1;MYO6
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.3134134690523099,-1.6072230452966758,0.0,0.1447938441863972,1.0,352/1082,25.06%,MECOM;LEF1;PBX1;DAB2IP;KLF7;NFIA;RREB1;SMARCA2;FLI1;ITGA6;ZBTB16;NFIB;SP100;ZNF423;ENG;ERG;ACVRL1;FOXO1;MEF2A;AFAP1L2;CREBBP;MLLT10;NSD1;MRTFB;SENP1;NFAT5;DYRK1A;ZMIZ1;KAT6B;ELF1;KLF4;ETS1;PKD2;DAB2;LRP5;ESR1;BMPR2;TCF12;ASXL1;MLLT3;ZFHX3;NRIP1;MAML2;KLF2;IRF2;DVL3;RXRA;APP;TRIM56;KAT2B;NFATC1;BMP5;ATM;PRDM16;RPS6KA5;FOSL2;RNF111;LMO2;BICRA;TEAD1;KMT2E;ZSCAN21;ARID1B;TBX1;DTX3L;MITF;NR3C1;THRB;MAP3K5;DDX3X;KANSL3;NFIX;MTOR;KAT6A;PRKD2;PLAGL1;SOX17;EGFR;CD38;NAA16;RTRAF;SP1;FZD4;CRLF3;ELK3;CTCF;BMP6;HDAC1;NFKB1;HES1;PPARA;MEOX2;RARG;SIX1;UBP1;TET2;SMARCC1;RYBP;NCK1;TASP1;NFKBIA;PIK3R1;WDR75;ABL1;FOXO3;DNM2;LMO7;HIVEP1;LRP6;PLCB1;RHOQ;NSD3;MED1;AATF;STAT6;PRPF6;E2F4;FGF1;GABPB2;BMP4;CREB3L2;MAX;MEF2C;JUN;WASL;SMAD1;SMAD2;ZFP90;ACTA2;AGRN;MAML1;SETD3;PRKD1;MDFIC;ARHGEF2;ATAD2B;HNRNPAB;YAP1;LDB1;PRDM2;CDH1;PPARD;PHF5A;IRF1;GLI3;ACVR2A;PICALM;DDX39B;HAX1;SMAD4;AKIRIN2;NAMPT;CTBP2;SP3;FGF7;TAL1;AKT1;GLIS2;NAA15;ELF2;TP53;KDM6B;BCLAF3;KLF10;EDN1;DOT1L;NOTCH4;ETS2;MED13;NCK2;KDM3A;POGZ;HELZ2;RGMB;NFIC;PPP1R12A;RGCC;ILK;SMARCC2;SIN3A;PSEN1;MAZ;SMAD7;ZFPM1;BCAS3;RPTOR;ICE1;ARHGEF11;MED17;YAF2;NOTCH1;FOXF2;FOXJ3;FGF2;RPS6KA1;HDAC4;SFPQ;TCEA1;GABPB1;WWOX;KAT5;EIF5A;WNT11;CREBRF;ZPR1;RHOG;FBXW11;CD40;HGF;XPC;PLSCR1;SMARCD3;ZIC3;ATF4;MZF1;AGO2;GRHL1;RPS6KA3;NR1D2;HCFC1;JAG1;TCF3;FOXC1;MYBL2;MRPL12;TADA3;ZNF462;JMJD6;TRIM16;KMT2C;DR1;RUVBL2;ETV1;TNFRSF1A;FOXO4;MAD2L2;CREBL2;PCBD2;TAF7;THOC1;BMP7;IGF1;SKI;CCNC;SIX4;RARA;CTNNB1;GPATCH3;TFAP4;NLRC5;ARNT;CEBPG;MAVS;HEY1;HEY2;THAP3;NRF1;WBP2;ELK4;KDM1B;ZIC1;IKBKG;HLF;EPAS1;ZNF507;CITED2;RNF10;EDRF1;IKBKB;HYAL2;NOD2;GATA2;SOX4;NCOA6;RNF4;PRKDC;ATRX;ELOF1;MED10;TCF4;TCF7L2;SS18;TBL1X;PPARG;RARB;LPIN2;CKAP2;BRCA1;AKNA;NR2F2;TRIM28;IGF2;FOXL2;GLIS1;OGT;PCGF5;BLM;PBX2;CAND2;CAPRIN2;TET3;CREB1;CHEK1;MAP2K3;ELF4;MAPK7;NOS1;UBTF;NFE2L2;GABPA;CCN1;ATAD2;RELA;MYOCD;KCNH2;YY1;SERPINE1;GLMP;TBX3;USP16;ATF6;RIPK1;EIF2AK3;FZD7;RXRG;CRTC1;RFXANK;PCBP1;SUPT4H1;CEBPA;FZD5;ARRB1;SSBP4;THRAP3;ATF5;SERTAD2;CCNK;E2F7;E2F3;TAF9;SMARCB1;TFDP1;TAF15;HMGB1;GPS2;FANK1;DHX9;INO80;BMP2;BRD4;IRF7;APBB1
prerank,extracellular matrix organization (GO:0030198),-0.3470313494877225,-1.6069826335850792,0.0,0.14453072351336058,1.0,82/276,15.88%,VWF;TLL1;COL8A1;ITGA6;ELN;SH3PXD2A;PECAM1;ADAMTSL3;COL12A1;ITGB1;JAM2;BSG;COL4A2;COL25A1;PLOD1;PLOD2;ADAMTS2;COL4A6;THBS1;ITGA3;APP;F11R;VIT;SPOCK2;SH3PXD2B;ITGA1;SMOC1;KDR;P3H2;COL5A1;ICAM1;ITGB4;HTRA1;MMP2;LOXL3;LAMA3;LAMA4;GAS6;ITGB5;COL4A5;COL4A1;TGFB2;COL8A2;COL5A2;SLC39A8;AGRN;HSPG2;COLGALT2;LOXL1;DST;CDH1;ADAMTS9;CAPN2;ADAM10;ADAMTS4;LAMA1;ADAMTS10;BGN;FBLN5;ADAMTS5;P4HA1;ADAMTS20;COL6A3;ADAMTS17;COL15A1;LAMA5;FGF2;COMP;THSD4;LAMC3;LCP1;NID1;FLOT1;ITGA4;COL26A1;ICAM2;HAS1;FLRT2;EXOC8;SMOC2;ITGA2;COL6A2
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.33020622067644656,-1.6066926570361564,0.0,0.144374810645072,1.0,141/509,18.97%,FLT1;HIP1;TEK;VWF;DAB2IP;IGF1R;KITLG;JCAD;RAPGEF2;ENG;ITGB1;PELI1;GAB1;AKAP13;FERMT2;NFAT5;ROR1;INSR;CAV1;RAC1;TAB3;NR3C2;MFHAS1;ESR1;LYN;MIER1;ANKRD17;NOD1;LIMS1;TRAF5;PDGFD;THBS1;IQGAP1;GCNT2;TRIM25;APP;ADRA1B;TBX1;DDX3X;PLEKHG5;RPL37;NEK6;KDR;TNFSF10;PRKD2;PTPRJ;EGFR;BIRC3;TFRC;RICTOR;CBL;GAS6;PIK3R1;IRS1;NMI;PDCD4;TGFB2;NEDD4;PTK2;FGF1;PUM1;PLK2;TGM2;SEC13;ROCK1;MIOS;PRKD1;NOS1AP;FLT4;PLCG2;HAX1;ALPK1;WNT16;CASP8;PIK3CD;CFLAR;FGF7;MAP3K3;TP53;FLNA;THEM4;BCAP31;DDX60;ILK;IKBKE;TRIM14;JAK2;MAZ;ADGRV1;USP15;RPTOR;RHOA;FGF2;IRAK1;MTDH;ACTN4;TCIM;WNT11;MYOC;RHOC;RHOG;CD40;LARS1;HGF;KSR1;PIK3CB;GRB2;IFI35;BBC3;IAPP;CGAS;TNFRSF19;MIF;ROCK2;GAB2;TNFRSF1A;TNFAIP8L3;ANGPT1;PELI2;BCL2L11;IGF1;TAB2;TFG;TRIM13;MIB2;FYN;GSDME;VAPA;GOLPH3;CDK5RAP3;MAVS;SASH1;RPS3;IKBKG;CCL19;LURAP1;MAP3K14;EDAR;SIAH1;IKBKB;NOD2
prerank,canonical Wnt signaling pathway (GO:0060070),-0.4238287898220595,-1.6062930780528526,0.0017513134851138354,0.14431060527181672,1.0,30/68,26.77%,LEF1;CSNK1A1;CAV1;LRP5;FZD6;GSK3B;DVL3;LRRK2;FZD4;RARG;LRP6;RAB5A;WNT16;WNT11;TCF7L1;CTNNB1;TCF7L2;PTEN;AMER1;FZD7;SFRP4;PPP1CA;FZD5;PLPP3;FZD10;WNT2B;WNT5B;FZD1;APC;FRZB
prerank,positive regulation by host of viral transcription (GO:0043923),-0.6047149450873488,-1.6056066622080811,0.02142857142857143,0.1446883929896563,1.0,5/15,9.48%,LEF1;CHD1;SP1;JUN;TAF11
prerank,regulation of nervous system process (GO:0031644),0.5711142704657376,1.6055190558349304,0.0368763557483731,0.2111254206306344,1.0,11/18,14.09%,HTR2C;DLGAP1;DLGAP2;TMEM108;NPTXR;SLC8A2;NPTX2;SLC8A3;DLGAP3;CACNG5;BEGAIN
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.5312976815047439,-1.6044442850275231,0.018518518518518517,0.14550324450761193,1.0,5/26,5.93%,FOXP1;DAB2;HDAC1;STRN3;ZBTB7A
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.5150706354439717,-1.6041228000589804,0.011049723756906077,0.14539787477946164,1.0,14/29,26.46%,LEF1;CREBBP;HDAC1;TRRAP;AXIN2;CDC73;KAT5;ASH2L;TCF7L1;CTNNB1;TCF7L2;TERT;RBBP5;LEO1
prerank,homologous chromosome segregation (GO:0045143),0.541397095889972,1.6039401945367848,0.017897091722595078,0.21157984469570246,1.0,4/20,3.69%,SYCP1;MAJIN;ZCWPW1;FMN2
prerank,embryonic hemopoiesis (GO:0035162),-0.6388888701451969,-1.6034478555308622,0.03169014084507042,0.1457439937465246,1.0,6/12,14.04%,KITLG;KDR;TGFBR2;TAL1;ZFPM1;ATF4
prerank,positive regulation of cartilage development (GO:0061036),-0.5790160703621774,-1.6034093645003156,0.030357142857142857,0.14523155847098335,1.0,5/17,12.16%,ZBTB16;ACVRL1;BMPR2;BMP4;PKDCC
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.3401863147012869,-1.603120682547766,0.0,0.14503047108812261,1.0,117/348,22.46%,TEK;RBPMS;RAPGEF2;GHR;PECAM1;ENG;ACVRL1;INSR;CAV1;DAB2;RAC1;FAM20A;LYN;BMPR2;PDGFD;IQGAP1;DVL3;UBE2K;APP;RALBP1;BMP5;RPS6KA5;LIMK2;PAK2;TBX1;LRRK2;IL15;DDX3X;KDR;PRKD2;NIBAN1;PTPRJ;SLCO3A1;EGFR;TFRC;BMP6;IL6R;GAS6;MRNIP;ABL1;FAS;IL34;CCND3;TGFB2;PTK2;IRGM;RASSF2;FGF1;BMP4;RAP1A;SNX9;NGF;MRE11;MAPK1;MMD;PRKD1;ARHGEF2;RAF1;FLT4;PLCG2;ACVR2A;HAX1;SMAD4;CSPG4;FGF7;AKT1;VEGFC;TP53;AXIN2;ILK;FNIP2;BRAF;JAK2;HFE;RPTOR;FGF2;LIMCH1;CSNK1D;MTCP1;FLOT1;CD40;HGF;MIF;ROCK2;MAD2L2;CREBL2;ANGPT1;PELI2;PIK3R3;BMP7;IGF1;TAB2;HDAC6;ALS2;MAVS;CACUL1;RAP2A;CCL19;CENPE;AKTIP;CCND1;BRAT1;PTPRC;RAP2C;TXN;KRAS;ITGB3;IGF2;PTPN11;P2RY1;CAPRIN2;MAP2K3;NOS1;PTK2B;TTK;CCN1;HSP90AA1
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.555518969221555,-1.6029118223312788,0.019748653500897665,0.14478905997141875,1.0,11/21,17.95%,NOS3;SRGN;TRPM4;GAS6;ASPN;ROCK1;NOTCH1;BCOR;ROCK2;HEY1;HEY2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.4912863737368605,-1.6028885872099747,0.012773722627737226,0.14429031400264689,1.0,19/33,32.81%,RB1;DCUN1D3;KLF4;PKD2;DLG1;FAM107A;CDC73;CDK6;CDK2AP2;PTEN;CDKN2C;FHL1;E2F7;PLK3;APC;CDKN2B;JADE1;WEE1;CDK4
prerank,integrin-mediated signaling pathway (GO:0007229),-0.42280910264224103,-1.6027700549537807,0.005415162454873646,0.14391042849015773,1.0,22/73,13.20%,DOCK1;ITGB1;FERMT2;MYH9;DAB2;ITGBL1;SEMA7A;ITGB4;ADAM9;LAMA3;ITGB5;ABL1;CUL3;PTK2;PRKD1;DST;BCAR1;ADAM10;ILK;LAMA5;CEACAM1;NEDD9
prerank,endothelial cell differentiation (GO:0045446),-0.6297408441279202,-1.6024608653924395,0.02142857142857143,0.1437675396519566,1.0,6/12,14.85%,ACVRL1;TIE1;BMPR2;KDR;KDM6B;JAG1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.4240303333646678,-1.6015892013453792,0.00865051903114187,0.14433048901769333,1.0,29/75,22.61%,DAB2IP;RB1;HEG1;LRP5;LYN;PTPN1;PTPRJ;CDKN1B;RASIP1;ABL1;LRP6;PRKCD;BMP4;LATS2;AKT1;STK38;SPRY4;PIK3CB;PKIG;BMP7;TFAP4;CDK5RAP3;HYAL2;UCHL1;PTEN;NF1;NR2F2;GADD45A;MYOCD
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.5192944518225124,-1.5996249478701718,0.013582342954159592,0.14636693552845834,1.0,15/27,32.99%,TNRC6B;EGFR;LIMD1;BMP4;PUM1;TP53;AGO2;WTIP;RIPK1;AJUBA;DHX9;FXR1;TGFB1;STAT3;PUM2
prerank,membrane assembly (GO:0071709),0.4861715107071871,1.5989102837632894,0.00477326968973747,0.2172385699126869,1.0,6/34,3.52%,PTPRD;NRXN1;IL1RAPL1;NLGN1;ANK3;STX2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.3709749815491997,-1.598640592463395,0.0,0.14719830821742114,1.0,46/161,16.00%,DAB2IP;CSNK1A1;CAV1;DAB2;MLLT3;FZD6;GSK3B;DVL3;MCC;PSMA2;IGFBP4;ZNRF3;SOX13;SOX17;EMD;KREMEN1;FZD4;LIMD1;HDAC1;FRMD8;RBX1;STK3;CUL3;LRP6;NKD1;PSME2;KLHL12;CTNND1;PSMB4;GLI3;GSK3A;LATS2;UBAC2;AXIN2;DKK2;TMEM64;NOTUM;WNT11;PSMC2;LMBR1L;TMEM170B;PSMB2;FUZ;RUVBL2;PSMB1;MAD2L2
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.6367203059691763,-1.5985821532933504,0.025454545454545455,0.1467604995598407,1.0,5/12,9.09%,GMDS;CSGALNACT1;GFPT2;FUT8;SLC35A3
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.4376729613336804,-1.5982919010385201,0.01415929203539823,0.14662808466547206,1.0,25/64,22.06%,UTRN;ACER2;CORO1C;GSK3B;THBS1;CCL25;MACF1;PTK2;ROCK1;LDB1;RASA1;RHOA;LIMCH1;DUSP3;MYOC;CDK6;PIK3CB;MAP4K4;JAG1;ROCK2;SLK;SEMA3E;NF1;VCL;PTK2B
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.5309785556483655,-1.5964708876083107,0.019400352733686066,0.14858716630157429,1.0,9/23,17.56%,ZBTB20;INSR;APP;NFKB1;PRKAA1;PFKFB3;PSEN1;IGF1;ARNT
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.42800596399219276,-1.5962043425881611,0.012567324955116697,0.14838653199315277,1.0,32/65,30.81%,CAV1;SMURF2;IL17RD;PRDM16;SPRED2;SMURF1;TGFBR2;PPARA;LDLRAD4;ZBTB7A;ASPN;SKIL;SMAD2;SMAD7;SMAD6;SKI;NRROS;PMEPA1;HTRA3;DAND5;SNX25;STRAP;MTMR4;FBN1;ADAM17;EMILIN1;TGFBR1;ADAMTSL2;BAMBI;LTBP1;SPRY1;TGFB1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.48047399208841257,-1.5947762234503937,0.00865051903114187,0.1497453393156354,1.0,14/39,12.27%,ENG;TIE1;PKD2;LRP5;KDR;TGFBR2;SIX1;RASIP1;COL4A1;LRP6;SLIT2;BMP4;NOTCH4;FGF2
prerank,copper ion homeostasis (GO:0055070),-0.5687651052246332,-1.5943611027484457,0.02608695652173913,0.1497555946718154,1.0,4/17,4.50%,XIAP;APP;ATOX1;SLC31A1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.5219445584004838,-1.594251815078318,0.011363636363636364,0.14934019425218054,1.0,7/26,10.40%,INSR;KLF4;PKD2;KLF2;NOS1AP;AKT1;EDN1
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5657897857041705,-1.593454204672395,0.031135531135531136,0.14987750060063249,1.0,8/18,17.28%,ANKRD17;RNF125;BIRC3;PUM1;SEC14L1;DDX60;USP15;GPATCH3
prerank,macrophage activation (GO:0042116),-0.48701482072412694,-1.5914715194105966,0.021164021164021163,0.15217208477346772,1.0,9/34,14.94%,FOXP1;APP;DYSF;NMI;LBP;CD93;PLCG2;JAK2;IFI35
prerank,atrial septum morphogenesis (GO:0060413),-0.670188127415498,-1.5912355860569416,0.02737226277372263,0.1518798808510507,1.0,6/10,19.06%,BMPR2;TGFB2;NOTCH2;ZFPM1;HEY2;SOX4
prerank,vascular transport (GO:0010232),-0.415036628236322,-1.5909455106175057,0.0034542314335060447,0.15178206344849154,1.0,25/81,11.66%,ABCC4;ABCG2;SLC6A6;SLC2A1;INSR;SLCO1C1;SLC7A1;SLC7A5;SLCO3A1;SLC16A12;SLC12A2;ABCC9;TFRC;SLC5A6;SLC38A5;SLC22A5;SLC16A1;SLC44A1;SLC1A5;ATP2A3;SLCO2B1;SLC13A3;MFSD2A;SLC2A13;SLC27A4
prerank,regulation of exocytosis (GO:0017157),0.4567662273893651,1.5904296384566567,0.01366742596810934,0.22872026663627493,1.0,8/46,5.60%,IL1RAPL1;STXBP5L;SYT1;RIMS2;CADPS;RAB15;RAB3C;RAB27B
prerank,negative regulation of vascular permeability (GO:0043116),-0.6279800225012926,-1.5899044471385175,0.024778761061946902,0.15264351310748767,1.0,9/12,16.14%,CLDN5;FERMT2;PTPRJ;PDE3A;PDE2A;SLIT2;RAMP2;CEACAM1;ANGPT1
prerank,translation (GO:0006412),-0.3601992443456868,-1.5896211354194232,0.0,0.1524569093818961,1.0,95/208,30.55%,YARS1;WARS2;RRBP1;RPS21;RPL37;RPL31;RPL9;RPS14;FARS2;RPSA;PTCD3;RPL3;RPLP1;MRPL32;MRPL47;RPL26;RPS11;EEF2;RPL13;MRPS18A;RPL38;DRG1;RPL27;RWDD1;RPS16;LARS1;RPS4X;MRPL2;GSPT1;AGO2;RPL10;MRPS24;RPL7A;AIMP2;HARS2;N6AMT1;DARS2;RPL5;MRPL24;RPS27;RPL27A;MRPL57;RPS3;NDUFA7;RPL36A;RPL35A;FARSA;MRPS14;RPL37A;IARS2;ABCE1;MRPS21;MRPL35;GFM2;RPL32;WARS1;RPS7;RPS15;MRPL34;RPS8;RPL28;RPL22;RPL13A;MRPL13;MRPL9;RPL36;RPL30;RPS23;MRPS2;SRBD1;NOA1;RPS17;MRPS28;RPS2;MRPL43;TUFM;EEF1B2;RPL39;MRPL11;RPS26;TNIP1;RPS15A;TRMT112;RPL15;RPL34;EEF1G;RPL22L1;GATB;RPLP2;RPL18;MRPS17;RPL19;EEF1D;RPS13;COPS5
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5850528224563842,-1.5894936103728505,0.012797074954296161,0.15209847034017124,1.0,5/17,8.91%,CAV1;ADIPOR2;PANK2;PPARA;PPARD
prerank,positive regulation of axon extension (GO:0045773),0.5275947771562803,1.5886179101030862,0.03296703296703297,0.22945893482060942,1.0,9/22,9.71%,L1CAM;DSCAM;SHTN1;CDKL5;LIMK1;MEGF8;MAPT;VEGFA;ZFYVE27
prerank,receptor catabolic process (GO:0032801),-0.531701751290721,-1.5881212472192203,0.02146690518783542,0.15354527379913988,1.0,13/24,23.00%,ZNRF3;SMURF1;AP2B1;AP2A2;RNF43;NEDD4;AP2S1;MYLIP;LGMN;AP2M1;SNX25;KIF16B;BECN1
prerank,sodium-independent organic anion transport (GO:0043252),-0.6675076435327552,-1.5871313568031733,0.023214285714285715,0.15440631896507115,1.0,7/10,29.04%,SLCO2A1;SLCO1C1;SLCO3A1;SLCO2B1;SLCO4A1;SLCO1B1;SLC16A2
prerank,response to ethanol (GO:0045471),0.6049261451367882,1.5866748857778603,0.03902439024390244,0.230564445606179,1.0,5/14,13.88%,GRIN2B;GLRA1;GRIN2A;ADCY7;GRIN3A
prerank,sensory perception (GO:0007600),0.44089115929004125,1.5861678682727736,0.013729977116704805,0.22930477171564068,1.0,15/45,18.12%,PCDH15;OPRM1;MME;PNOC;GNAL;KCNA2;TTC8;BBS4;PENK;CCL2;WHRN;NTSR2;CLRN1;RETREG1;TRPV2
prerank,transport across blood-brain barrier (GO:0150104),-0.4115159282778453,-1.5854970678119822,0.0017211703958691911,0.15606693997114265,1.0,25/83,11.66%,ABCC4;ABCG2;SLC6A6;SLC2A1;INSR;SLCO1C1;SLC7A1;SLC7A5;SLCO3A1;SLC16A12;SLC12A2;ABCC9;TFRC;SLC5A6;SLC38A5;SLC22A5;SLC16A1;SLC44A1;SLC1A5;ATP2A3;SLCO2B1;SLC13A3;MFSD2A;SLC2A13;SLC27A4
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.5151757765194057,-1.5848220098533055,0.014625228519195612,0.15646544375690924,1.0,12/27,26.67%,FBXL12;FBXL17;SIK1;FBXL3;USP2;TP53;PER3;RBM4B;CRTC1;PPP1CA;FBXL22;CRY2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.5227596972148324,-1.5844630359913154,0.01338432122370937,0.15643575696221612,1.0,7/25,10.40%,INSR;KLF4;PKD2;KLF2;NOS1AP;AKT1;EDN1
prerank,regulation of intracellular signal transduction (GO:1902531),-0.3305763126019133,-1.5832141491485825,0.0,0.15768706997107915,1.0,137/420,22.02%,SGMS1;TEK;VWF;DAB2IP;CHN2;ARHGAP31;MOB3B;AKAP13;PPP1R13B;XIAP;BCR;RAC1;RHOJ;ARHGEF3;LYN;NET1;TRAF5;STARD8;TMSB4X;RALBP1;ATM;MCF2L;ARHGAP10;CRK;PAK2;WWC2;LRRK2;ARAP3;PLEKHG5;MTOR;KAT6A;PRKD2;EGFR;BIRC3;PIP4K2A;TOP3A;RICTOR;HDAC1;ARHGAP5;RASGRF2;GNA12;NFKBIA;DLG1;PHF20;STK3;PDE2A;CHN1;ARHGEF12;DDIT4;PAK1IP1;RHOQ;PIP4K2B;RASSF2;FGF1;PIP5K1B;EZR;ARHGDIA;MRE11;ITSN1;MAPK1;ARHGEF2;NOP2;PLCG2;USP2;IER3;RRAS;RBBP8;TAF11;ARHGAP17;SOS2;STARD13;AKT1;TP53;EHMT1;TAOK3;PRKAA1;ARAP1;ARHGAP1;CHD3;TTI1;ARHGEF11;RHOA;ARHGAP28;CEACAM1;RPA3;DNA2;KAT5;PTPN13;RPA1;FAM13A;MYOC;RHOC;RHOG;KMT5A;TRIO;ZFAND6;MAP4K4;NUAK1;RPL5;ARHGAP22;CASTOR1;ABR;ARHGEF18;DEPDC7;TAF7;PREX1;HIPK1;ARHGAP12;TAF3;ARHGAP29;ARHGAP35;CMKLR1;WRN;IKBKG;RPA2;PRKAB1;ITFG2;ARHGAP26;VRK2;USP7;BOP1;FAM13B;TMEM127;PRDM1;PTEN;BRCA1;ARHGEF5;RRS1;MDM2;BLM;NRK;VAV2;ARHGEF1;RFC4;TAF4B;CHEK1;SYDE1
prerank,amino acid import (GO:0043090),-0.5449798036223231,-1.5831410709484894,0.03304347826086956,0.1572392782292399,1.0,5/21,2.55%,SLC47A1;SLC6A6;SLC7A1;SLC7A5;SH3BP4
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.42070024415157803,-1.5831306028635537,0.005434782608695652,0.15673125730556553,1.0,27/73,16.68%,WASF2;DOCK1;MYO10;ABI1;RAC1;LYN;PRKCE;ELMO1;CRK;PLCG1;YES1;NCK1;PIK3R1;ABL1;PTK2;PRKCD;WASL;MAPK1;PLD2;PLCG2;ACTB;PIK3CB;GRB2;ELMO2;NCKAP1;ARPC4;FYN
prerank,regulation of leukocyte activation (GO:0002694),-0.6073598188463072,-1.5826946960229624,0.014209591474245116,0.1567976638709611,1.0,7/14,15.33%,MFHAS1;LYN;CD200;MYO18A;PLSCR1;GPR137B;MIF
prerank,cellular response to cadmium ion (GO:0071276),-0.525618428507969,-1.582336349959483,0.012704174228675136,0.1567464462047552,1.0,14/24,25.53%,EGFR;JUN;MAPK1;AKT1;MAPK8;SUMO1;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.5802906983888311,-1.5818091073920795,0.02394106813996317,0.15695002834407004,1.0,5/16,12.29%,ST3GAL4;NFAT5;ETS1;RHOA;IRAK1
prerank,cellular component maintenance (GO:0043954),-0.6345643553250971,-1.580789807493379,0.027985074626865673,0.15779675557652065,1.0,3/12,2.92%,IGF1R;INSR;ITGA3
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.47779560932690424,-1.5803106731508136,0.026041666666666668,0.1578795480515799,1.0,18/36,24.97%,DAB2IP;PTPRM;SP100;ACVRL1;THBS1;SLIT2;MEF2C;ADAMTS9;RGCC;NOTCH1;FGF2;MECP2;PPARG;NR2F2;DLL4;GADD45A;HMGB1;ADGRB1
prerank,positive regulation of catabolic process (GO:0009896),-0.429039053169708,-1.5801119853308898,0.00338409475465313,0.15761480661502136,1.0,28/65,26.50%,DAB2IP;WWP1;FOXO1;NEDD4L;SMURF2;GSK3B;ATG7;RAB7A;SMURF1;TIPARP;CDKN1B;NEDD4;NKD1;PLK2;GSK3A;AREL1;TNFAIP3;VSIR;OAZ2;GPC3;WWP2;HUWE1;HACE1;SEC22B;FZR1;TNFSF12;DTL;APC
prerank,Notch signaling involved in heart development (GO:0061314),-0.6540281887705028,-1.579008641096114,0.032758620689655175,0.15841410395165628,1.0,8/11,27.14%,NOTCH2;GALNT11;NOTCH1;JAG1;HEY1;HEY2;DLL4;SNAI2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.5901140992367658,-1.5774908127512701,0.018835616438356163,0.15998805341635566,1.0,10/15,28.84%,TMSB4X;KDR;PRKD2;PRKD1;FGF2;SMOC2;LGMN;SEMA5A;MET;FGF18
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.5214814596867632,-1.5772627175643985,0.025225225225225224,0.15974363235762365,1.0,11/26,18.97%,TAB3;NOD1;IFIH1;ALPK1;CASP8;IRAK1;TNFAIP3;TAB2;IRAK2;IKBKG;NOD2
prerank,regulation of glycolytic process (GO:0006110),-0.4190361954626255,-1.5768200617678516,0.005454545454545455,0.15982701393641155,1.0,20/68,17.86%,ZBTB20;INSR;CBFA2T3;APP;NUP42;RAE1;RANBP2;PPARA;ZBTB7A;NUP98;SEC13;PRKAA1;PFKFB3;PSEN1;NUP153;HDAC4;TPR;IGF1;ARNT;NUP214
prerank,response to gamma radiation (GO:0010332),-0.5331145405507758,-1.5762176517785402,0.012411347517730497,0.1600521349031786,1.0,13/24,21.28%,MAP3K20;DCUN1D3;TLK2;ATM;YAP1;RPL26;TP53;PRKAA1;TRIM13;FANCD2;WRN;LIG4;MDM2
prerank,long-term synaptic potentiation (GO:0060291),0.5224059014315325,1.5748868137556646,0.05066079295154185,0.2465683135582361,1.0,7/21,11.77%,MPP2;SLC24A2;GRIN2B;GRIN2A;SLC8A2;PRKCZ;SLC8A3
prerank,insulin receptor signaling pathway (GO:0008286),-0.4116864966397113,-1.5726302016901252,0.01232394366197183,0.16432374376219339,1.0,21/69,16.18%,IGF1R;SORBS1;FOXO1;GAB1;INSR;GSK3B;PIK3R1;IRS1;RHOQ;PIK3C2A;GRB10;GSK3A;ZNF106;NAMPT;GRB14;BCAR1;AKT1;ATP6V1E1;GRB2;FOXO4;PIK3R3
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.6529005734040485,-1.572293332363409,0.04634581105169341,0.1643110089875269,1.0,7/10,21.16%,BMP5;PHACTR4;LRP6;NOTCH1;BMP7;ARHGAP12;DLL4
prerank,actin filament organization (GO:0007015),-0.3661134121985516,-1.5713599201303232,0.003590664272890485,0.16505530454324924,1.0,44/151,17.13%,HIP1;SHROOM4;MYO1D;EPS8;ABI1;BAIAP2L1;CD2AP;RAC1;SHROOM3;TPM3;RHOBTB1;CORO1C;PLS3;SVIL;ELMO1;RND3;CGNL1;DLG1;TMOD3;WASL;MYO1F;BIN3;ARHGEF2;SHROOM1;ARHGAP17;BCAR1;NEBL;FLNA;SHROOM2;FAT1;RHOA;ACTN1;LCP1;LMOD1;TPM1;NEDD9;RHOC;RHOG;ELMO2;HIP1R;MAD2L2;ARPC4;CORO7;ARHGAP12
prerank,regulation of cell cycle (GO:0051726),-0.3415127393113959,-1.5710007359879126,0.0,0.16507245136746967,1.0,96/271,26.54%,MECOM;GRK5;APBB2;DAB2IP;TTC28;MAP3K20;PPP1R13B;XIAP;AFAP1L2;RB1;DCUN1D3;NEK7;PKD2;ANKRD17;THBS1;IQGAP1;FBXL12;LIN52;KAT2B;ATM;FBXL17;SIK1;NEK6;PLAGL1;FBXL3;BIRC3;CDKN1B;CRLF3;ABL1;PDCD4;PHACTR4;LRP6;TGFB2;RNF40;CDC14A;BMP4;PTPRK;CDK10;ERN1;PUM1;JUN;UHRF2;NOTCH2;IRF1;RASSF1;ADAM10;TP53;RGCC;NOTCH1;SON;CDC123;CDK6;TBRG1;NUDT6;RNF167;HCFC1;MYBL2;MIF;MAPK12;FOXO4;BMP7;SRPK2;RARA;TFAP4;ADARB1;CDK5RAP3;RAD23A;CITED2;BAP1;CCND1;PTPRC;LIN37;BOP1;TCF7L2;CDK11B;BRCA1;PES1;MDM2;CDKN2C;CHEK1;CDC25A;GADD45A;TBX3;MAEA;BMP2;APBB1;FBXL22;SIPA1;MLF1;DTL;RPS15A;NUPR2;CDKN3;APC;GAS2L1;FGF10
prerank,microtubule-based transport (GO:0099111),0.5958525956499957,1.5704225216381058,0.04357298474945534,0.252286863921286,1.0,8/12,21.01%,ADCY10;ROPN1L;DYNC1I1;HTT;SPAG17;CABYR;DNAAF2;DYNC1I2
prerank,granulocyte differentiation (GO:0030851),-0.5730570499084523,-1.5700083565567657,0.019891500904159132,0.16586568542365313,1.0,7/18,16.92%,LEF1;CBFA2T3;RXRA;DEK;TAL1;LBR;RARA
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.41749790479469023,-1.5699377287550746,0.007104795737122558,0.16544544187685947,1.0,29/64,28.74%,MNAT1;MLLT3;CDK13;SETD2;CDK12;IWS1;EAF1;POLR2G;ERCC2;CDC73;RTF1;TCEA1;MLLT1;ERCC3;NELFB;ELOF1;ADRM1;ELOC;TCEA2;SUPT4H1;POLR2C;CCNK;POLR1E;POLR2L;POLR2H;LEO1;GTF2H3;CCNH;ELP2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.4434560434311872,-1.5695582710715577,0.008818342151675485,0.1654810887666831,1.0,32/56,31.34%,RB1;ANKRD17;KMT2E;DDX3X;EGFR;CUL3;PLCB1;CCND3;AKT1;RGCC;CDC16;RPTOR;NSMCE2;UBE2E2;LSM11;MECP2;RAB11A;ANXA1;LSM10;CCND1;CDC25A;TFDP1;BRD4;ANAPC7;DTL;ADAM17;FGF10;RDX;ANAPC11;CCND2;STOX1;ANAPC5
prerank,regulation of vasculature development (GO:1901342),-0.5103861016475398,-1.5689110318172406,0.018281535648994516,0.16590098401453385,1.0,13/26,29.78%,SP100;ADGRA2;BMPER;ETS1;PLXND1;FGF2;CTNNB1;EPHA2;NF1;WARS1;TSPAN12;HMOX1;EMP2
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.33926409404445734,-1.5684589393238118,0.001579778830963665,0.16600611823280514,1.0,123/306,27.65%,MEF2A;ST3GAL4;EXT1;ALAS1;RBMS1;RRBP1;ATM;RPS21;THRB;RPL37;RPL31;TOP3A;RPL9;RPS14;RPSA;MRE11;POLR2G;MCM9;ST3GAL2;RPL3;RPLP1;MRPL32;RBBP8;CLSPN;RPL26;MCM4;PWP1;RPS11;TAF1B;ORC5;EEF2;POLD3;RPL13;MRPS18A;RPA3;DNA2;KAT5;RPL38;REV1;DRG1;RPA1;RPL27;RPS16;TBRG1;RPS4X;GSPT1;AGO2;RPL10;B4GALT5;RPL7A;GAL3ST2;HARS2;RPL5;TOP1MT;CREBL2;ORC2;MRPL24;RPS27;POLE2;PTMS;RPL27A;GOLPH3;WRN;RPS3;LARGE1;ORC4;RPA2;RPL36A;RPL35A;MRPS14;TIMELESS;RNPS1;RPL37A;BRCA1;MRPS21;MRPL35;TERT;RPL32;BLM;WARS1;RFC4;CHEK1;PTMA;RPS7;RPS15;MCM3;TOP1;MRPL34;RPS8;RPL28;RPL22;RPL13A;MRPL13;MRPL9;RPL36;RPL30;MED20;RPS23;POLR2C;SRBD1;RPS17;POLR2L;POLA2;RPS2;MRPL43;MLF1;POLR2H;TUFM;MCM7;EEF1B2;RPL39;MRPL11;RPS26;TNIP1;RPS15A;MMS19;RPL15;RPL34;MCM5;EEF1G;MCM10;POLL;EXO1
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.4214557243970504,-1.5682072208375282,0.010810810810810811,0.16583880560319153,1.0,31/66,29.47%,UBR5;FERMT2;LIMK2;DTX3L;TFRC;PIK3R1;PRKCD;TCP1;YAP1;CDH1;AKT1;FLNA;PSEN1;ZPR1;TPR;CDK5RAP3;MAVS;ZIC1;HYAL2;ORMDL3;TRIM28;TERT;EIF2AK3;PINX1;CCT5;CCT2;PARP9;RAN;NMD3;JUP;LARP7
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.620156712295079,-1.5670239715839436,0.02333931777378815,0.16702338378422846,1.0,7/13,15.78%,SP100;MDFIC;NUP153;CHP1;UFM1;RAB23;TPR
prerank,photoperiodism (GO:0009648),-0.5059878036691433,-1.566717802722463,0.014732965009208104,0.1669909897740083,1.0,12/28,26.67%,FBXL12;FBXL17;SIK1;FBXL3;USP2;TP53;PER3;RBM4B;CRTC1;PPP1CA;FBXL22;CRY2
prerank,erythrocyte development (GO:0048821),-0.6700884476203077,-1.5666315619993976,0.02040816326530612,0.16667779136290037,1.0,4/10,8.14%,ALAS1;ZBTB7A;MED1;ABCB10
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5805642635355585,1.565816675553468,0.0378619153674833,0.25877872230696597,1.0,7/15,15.55%,MELTF;PDPN;DDR2;FSCN1;CST3;DDR1;CLASP2
prerank,negative regulation of apoptotic process (GO:0043066),-0.3272284184467604,-1.565782131793225,0.0,0.1671369039893286,1.0,117/444,17.30%,TJP1;LEF1;GRK5;TEK;PRKCH;IGF1R;ITGB1;FOXO1;XIAP;RB1;ERC1;KLF4;CAV1;MCL1;DAB2;TNFAIP8;GSK3B;THBS1;ARHGAP10;PAK2;NFATC4;TBX1;DDX3X;KDR;YWHAE;MERTK;EGFR;IL6ST;BIRC3;TFRC;CD38;NAA16;TAX1BP1;RNF213;SLC30A10;HDAC1;NFKB1;SIX1;CBL;GAS6;NFKBIA;PIK3R1;DSTYK;PSEN2;FAS;PTK2;MED1;AATF;PRKCD;BMP4;BNIP3;MEF2C;ARHGDIA;NGF;RNF144B;MYO18A;PLK2;MRE11;DNAJB6;MAPK1;BIRC6;NOTCH2;BNIP2;ANXA4;RAF1;YAP1;YWHAZ;FLT4;SH3RF1;HAX1;ADAM10;CFLAR;AKT1;NAA15;SOCS2;TP53;FLNA;PRKAA1;AREL1;PSEN1;BRAF;MAZ;RASA1;NOTCH1;SON;IRAK1;COMP;MTDH;RPS6KA1;SFPQ;PA2G4;CAT;TCIM;WNT11;UFM1;BABAM2;HGF;MAPK8;RPL10;RPS6KA3;ZFAND6;GPX1;MAP4K4;MIF;PRDM9;SMAD6;LGMN;ANGPT1;IGF1;SIX4;ANXA1;CTSH;CTNNB1;FOXQ1;IGBP1;API5;PPIF
prerank,T-helper cell differentiation (GO:0042093),-0.5911852140483305,-1.5637235845578032,0.03473491773308958,0.16954048702489233,1.0,2/14,0.16%,FOXP1;LEF1
prerank,cellular response to reactive oxygen species (GO:0034614),-0.4271717820045184,-1.5619808456649962,0.014035087719298246,0.17146925784922698,1.0,26/59,24.02%,PKD2;NET1;MAP3K5;EGFR;PXN;ABL1;PRKCD;PTPRK;JUN;MAPK1;ANKZF1;AKT1;TPM1;MAPK8;TNFAIP3;AGAP3;ANXA1;HDAC6;PPIF;RPS3;ERCC6L2;MAPK7;NFE2L2;RELA;RIPK1;CYP1B1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.29912688401426507,-1.5617894456576844,0.0,0.17122339556165359,1.0,512/1646,25.19%,FOXP1;MECOM;KLF12;LEF1;PBX1;APBB2;DAB2IP;KLF7;NFIA;RREB1;FOXP2;SMARCA2;FLI1;ETV6;BAZ2B;ZBTB16;ATP8B1;NFIB;SP100;WWP1;ZNF423;TEF;ENG;ERG;MNAT1;ZBTB20;ACVRL1;FOXO1;MEF2A;ZHX3;AFAP1L2;CREBBP;NSD1;RB1;BNC2;CBFB;ZEB1;NFAT5;DYRK1A;ZMIZ1;KAT6B;ELF1;ERC1;INSR;KLF4;ETS1;CHD1;CBFA2T3;LRP5;NR3C2;DACH2;PKNOX2;ESR1;VGLL3;BTAF1;CUX1;FOXN3;TCF12;HIVEP2;MLLT3;ZFHX3;TEAD4;PRDM5;SMURF2;ZNF260;LIMS1;RBFOX2;MED26;KLF2;CHD2;IRF2;ZNF326;DVL3;RXRA;PRRX1;KLF3;TRIM56;TRAK1;NFATC1;TBX15;SPINDOC;PRDM16;DEK;RPS6KA5;FOSL2;RNF111;BICRA;TEAD1;CRK;UIMC1;WWC2;KMT2E;NFATC4;ZSCAN21;ARID1B;ID1;TBX1;DTX3L;MITF;NR3C1;MAP3K5;KDM2A;ZBTB37;SOX13;NFIX;KAT6A;CDK17;PBX3;PLAGL1;RCOR1;SOX17;EGFR;LOXL3;MKX;PSPC1;CD38;ZHX2;CDKN1B;NAA16;ZBTB46;VGLL4;SP1;FZD4;ZNF148;CRLF3;VSX1;ELK3;METTL4;CTCF;NIPBL;LIMD1;MGA;HDAC1;NFKB1;HES1;LHX6;PPARA;MEOX2;SIX1;UBP1;SMARCC1;RYBP;GAS6;TASP1;PHF20;ABL1;ZBTB7A;FOXO3;ZIC4;DNM2;TRRAP;IKZF2;PDCD4;HIVEP1;HOXB6;LRP6;PLCB1;BBX;NSD3;FUS;MED1;AATF;STAT6;NFYC;E2F4;BAZ1A;SPEN;BRD2;GTF2IRD1;BMP4;CREB3L2;MAX;PTPRK;MEF2C;SETD5;MIDEAS;SLC39A8;ZNF182;JUN;ZBTB4;SMAD1;SMAD2;ZFP90;ASCC1;ACTA2;TSHZ2;SRCAP;PBXIP1;TBX2;SUV39H1;PPM1F;SETD3;DACH1;MDFIC;BACH2;ANXA4;HNRNPAB;NAB1;SMARCE1;ZBTB39;YAP1;NOP2;LDB1;PRDM2;CDH1;PPARD;PHF5A;EBF1;IRF1;GLI3;ZNF25;PICALM;SMAD4;RBBP8;ZIC5;GPBP1;SPTY2D1;HSF5;CTBP2;HOXC6;SP3;USP13;PHF20L1;FGF7;TAL1;AKT1;GLIS2;NAA15;ELF2;TP53;ZBTB40;EHMT1;KLF10;HMBOX1;MAMLD1;NOTCH4;ETS2;MED13;KDM3A;HMG20A;RGMB;STAT2;NFIC;ILK;SMARCC2;SIN3A;PRRX2;GMEB1;PSEN1;SOX7;JMJD1C;ZBTB7C;MAZ;SMAD7;SCMH1;CHD3;TWIST2;HR;ARHGEF11;MED17;YAF2;ZSCAN25;NOTCH1;FOXF2;FOXJ3;FGF2;MTDH;SP140;RPS6KA1;HDAC4;SFPQ;PA2G4;ZNF394;OGG1;LRRFIP1;TIAL1;KAT5;PROX2;PIAS2;ZBTB6;TCIM;KLF9;WNT11;CREBRF;RHOG;CIC;FBXW11;TAF5L;XPC;ZHX1;TFCP2L1;SMARCD3;DBX2;MECP2;ZIC3;ATF4;KDM7A;PGBD1;MZF1;ARID3B;GPBP1L1;KMT5A;SAMD1;GRHL1;ZBTB25;RPS6KA3;NR1D2;HCFC1;ZBTB34;HIF3A;TCF3;TCF7L1;POLR3F;FOXC1;MYBL2;PHF6;DAP;MRPL12;MED29;ZKSCAN1;BCOR;TADA3;ZNF32;NR2C1;JMJD6;TRIM16;NAB2;SMAD6;PHC1;RUVBL2;PEX14;BRWD3;UBE2L3;ETV1;FOXO4;MAD2L2;CC2D1B;CREBL2;PCBD2;ZFP1;TAF7;THOC1;TRPS1;BMP7;HIC1;IGF1;CCNC;ZNF235;SUMO1;KDM5B;SIX4;RARA;MAMSTR;ZNF692;HOXA2;ARID5B;HDAC6;ZNF691;ZBTB14;CTNNB1;FOXQ1;HINT1;ZBTB8A;GPATCH3;TFAP4;ZXDB;ZNF250;HDAC10;ZNF83;ARNT;PATZ1;CEBPG;HEY1;ZMYND11;ZFP28;HEY2;TSHZ1;CARM1;ZSCAN12;NRF1;WBP2;ELK4;HOXB9;WTIP;ZIC1;ZBTB12;HLF;EPAS1;CITED2;RNF10;EDRF1;IKBKB;PCGF3;GATA2;BAP1;SOX4;ZFX;NCOA6;PPP2CA;RNF4;UTP4;ATRX;SMAD9;PIAS4;SCML4;TCF4;TCF7L2;NONO;TIMELESS;TBL1X;CDK11B;PPARG;WWP2;PRDM1;BCL6;ELOC;BRCA1;ZSCAN26;BAZ1B;NR2F2;TRIM28;IGF2;FOXL2;GLIS1;MED27;OGT;SRSF10;PCGF5;MDM2;BLM;NKAP;NACC1;TOX4;PBX2;CDK14;CBFA2T2;HSF4;CAND2;GCLC;PHC3;TSHZ3;CREB1;ZSCAN18;MAP2K3;ELF4;NOS1;NFE2L2;GABPA;ATAD2;RELA;MYOCD;KCNH2;YY1;TULP3;ZNHIT3;KDM3B;TBX3;SUDS3;USP16;ATF6;MSX1;ZKSCAN8;TCEA2;FZD7;RXRG;RFXANK;MYCBP;RBM15;AJUBA;AEBP2;MED20;SUPT4H1;CEBPA;ARRB1;ZNF697;THRAP3;CDK18;TRIB3;KLF16;ATF5;ZFP3;ACVR2B;CCNK;E2F7;ZFHX4;GMEB2;CNOT2;ARID3A;E2F3;SMARCB1;ZNF276;MBTD1;TFDP1;TAF15;ZKSCAN4;HMGB1;RBAK;GCFC2;KHDRBS1;SETDB2;EGR3;FANK1;SP110;DHX9;BMP2;BRD4;IRF7;APBB1;POLR2L;HIC2;EID2B;FOXF1
prerank,positive regulation of blood coagulation (GO:0030194),-0.5754573370466359,-1.5614796041915255,0.029616724738675958,0.17112508576788618,1.0,9/17,26.84%,ST3GAL4;THBS1;ENPP4;ANO6;F3;SERPINE1;HPSE;DMTN;F2R
prerank,aortic valve development (GO:0003176),-0.48014880632864926,-1.5594065930953458,0.02702702702702703,0.17346853593381106,1.0,17/34,17.95%,ELN;RB1;NOS3;TIE1;BMPR2;NFATC1;TNFRSF1B;SLIT2;BMP4;ROCK1;NOTCH1;JAG1;ROCK2;SMAD6;TNFRSF1A;HEY1;HEY2
prerank,negative regulation of programmed cell death (GO:0043069),-0.3326974093211303,-1.5589428480063854,0.0,0.17367355761080636,1.0,96/355,17.30%,MECOM;TJP1;LEF1;GRK5;TEK;IGF1R;FOXO1;XIAP;ERC1;MCL1;DAB2;TNFAIP8;GSK3B;THBS1;ARHGAP10;PAK2;RAB7A;DDX3X;KDR;EGFR;IL6ST;BIRC3;TFRC;CD38;NAA16;TAX1BP1;HDAC1;NFKB1;CBL;GAS6;NFKBIA;PIK3R1;DSTYK;PSEN2;FAS;PTK2;MED1;AATF;BMP4;BNIP3;ARHGDIA;NGF;RNF144B;MYO18A;PLK2;MRE11;BIRC6;NOTCH2;BNIP2;ANXA4;RAF1;YWHAZ;FLT4;SH3RF1;HAX1;ADAM10;CFLAR;AKT1;NAA15;SOCS2;TP53;FLNA;PRKAA1;AREL1;PSEN1;BRAF;RASA1;SON;IRAK1;COMP;TM7SF3;MTDH;RPS6KA1;PA2G4;CAT;TCIM;WNT11;UFM1;BABAM2;HGF;MAPK8;RPL10;RPS6KA3;ZFAND6;MAP4K4;MIF;PRDM9;SMAD6;ANGPT1;IGF1;SIX4;ANXA1;CTSH;CTNNB1;API5;PPIF
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.3591604081731637,-1.5569392339472803,0.0,0.17603343839177257,1.0,54/166,21.67%,SORBS1;INSR;KLF4;PKD2;KLF2;THBS1;STN1;EIF3E;METTL14;DDX3X;MTOR;PRKD2;NIBAN1;EGFR;PLD1;SP1;EIF3C;ELOVL5;IRS1;UPF3B;SAMD4A;ABCB10;NOS1AP;LDB1;SCARB1;MFSD2A;RPL26;AKT1;ZCCHC4;EDN1;RGCC;EEF2;FGF2;STARD4;DNA2;CHP1;CTC1;LARP4B;HGF;RPS4X;SMOC2;RPL5;METTL5;IGF1;ARNT;GIPC1;CCL19;STAR;SOX4;PRKDC;FGFR4;IGF2;RBM3;PDGFRB
prerank,positive regulation of TORC1 signaling (GO:1904263),0.5576721693808975,1.5567448509738364,0.05228758169934641,0.2732411182136903,1.0,6/16,8.51%,GPR137C;PIP4P1;RRAGA;FLCN;KLHL22;SEH1L
prerank,cardiac muscle cell action potential (GO:0086001),0.47743082374098333,1.554806512382826,0.030373831775700934,0.27445359573502226,1.0,9/30,8.20%,ATP1A2;FGF12;SCN1B;SCN1A;CACNA2D1;PKP2;ATP1B1;CACNA1D;SCN5A
prerank,positive regulation of gene expression (GO:0010628),-0.3233154748912789,-1.554404382671885,0.0,0.17905147092179297,1.0,134/442,21.16%,LEF1;CLDN5;UBR5;NOS3;DYRK1A;KLF4;ETS1;CD34;TNRC6B;LIMS1;MED26;GSK3B;THBS1;TENT4B;APP;KAT2B;ATM;DEK;EIF3E;METTL14;MITF;IL15;DDX3X;MTOR;NIBAN1;SMO;EGFR;TFRC;MSN;PLD1;SP1;CTCF;EIF3C;BMP6;AFDN;GAS6;PIK3R1;PDE2A;UPF3B;MED1;SEC16B;FGF1;BMP4;ERN1;MEF2C;SAMD4A;EZR;CDH5;NGF;SMAD1;ACTA2;MAPK1;ROCK1;PPM1F;RAB27A;NOS1AP;YAP1;PLCG2;CELF1;GSK3A;SF3B1;OCLN;WNT16;PIK3CD;TENT4A;RPL26;FGF7;RAMP2;AKT1;MYOM1;TP53;ZCCHC4;PRKAA1;TAF1B;RGCC;PSEN1;BRAF;EEF2;MAZ;HFE;NOTCH1;FGF2;ACTB;FLOT1;WNT11;ZPR1;LARP4B;TAF1C;PLSCR1;MAPK8;RPS4X;ATF4;PIK3CB;AGO2;RBM20;FAM98A;HCFC1;AGPAT1;MIF;ROCK2;TADA3;C1QTNF3;RPL5;VSIR;TERF2;ANGPT1;PIK3R3;METTL5;BMP7;IGF1;MOV10;SRPK2;DNMT1;CTSH;FUBP1;HEY1;HEY2;SOD1;RPS3;WBP2;LURAP1;CITED2;GATA2;SOX4;TNRC6A;PRKAB1;PRKDC;KRAS;F3;FGFR4;BRCA1;BAZ1B;RBM3;DLL4
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4715944210827867,-1.5542276642827018,0.01967799642218247,0.1787722862580691,1.0,17/36,22.46%,NOS3;CAV1;NOSTRIN;EGFR;DNM2;GCH1;CYGB;WASL;NOS1AP;SCARB1;AKT1;S100A1;PIK3CB;TERF2;TERT;GLA;HSP90AA1
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.36559393720618155,-1.5541919553068968,0.0035398230088495575,0.1782833344215717,1.0,50/150,23.17%,HIP1;TEK;IGF1R;KITLG;ENG;ITGB1;GAB1;FERMT2;INSR;RAC1;MFHAS1;ESR1;THBS1;GCNT2;PTPRJ;EGFR;RICTOR;GAS6;PIK3R1;IRS1;PTK2;FGF1;HAX1;PIK3CD;FGF7;THEM4;MAZ;FGF2;MTDH;MYOC;RHOG;HGF;PIK3CB;GRB2;IAPP;GAB2;TNFAIP8L3;ANGPT1;FYN;CCL19;TXN;TCF7L2;F3;FGFR4;IGF2;PTPN11;PDGFRB;HSP90AA1;HPSE;FRS2
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.40300055075900687,-1.5539867309151256,0.014336917562724014,0.17803065988916975,1.0,24/78,14.87%,SPTBN1;PRKCH;SORBS1;ITGB1;PPP2R5A;DAB2;PRKCE;ITGA3;PTPN9;LDLRAP1;EGFR;PIK3R1;DLG1;STX3;RHOQ;PPFIA1;STX8;PICALM;AKT1;ABI3;ACTB;RHOG;NUMB;STAC3
prerank,vasoconstriction (GO:0042310),-0.6437531995115091,-1.5534324111832072,0.024299065420560748,0.17831617731760757,1.0,5/11,11.69%,EDNRA;PIK3C2A;ACTA2;EDN1;EDN3
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.41764408755262805,-1.553396793766836,0.007326007326007326,0.17782539702502262,1.0,22/63,23.22%,ITGA6;SP100;CAV1;THBS1;PAK2;TNFSF10;FAS;BMP4;BIRC6;SH3RF1;CASP8;CFLAR;WWOX;FEM1B;IGF1;ZMYND11;HYAL2;TCF7L2;G0S2;LTBR;RELA;RIPK1
prerank,cytoskeleton organization (GO:0007010),-0.3800288689413548,-1.5532815811739507,0.0016863406408094434,0.17747554749988625,1.0,38/114,18.40%,SEMA6A;FGD5;FGD6;RAC1;PDZD8;RHOBTB1;RANBP9;MARK1;ARHGAP10;RND3;MICAL2;ARAP3;DIAPH1;LIMD1;ZMYM6;CNTNAP1;MAST4;MAST2;PLCE1;PPP2R3C;SIPA1L3;PLD2;DST;LRCH3;CECR2;RHOA;ZMYM4;TPM1;NEDD9;RHOC;RHOG;TNFAIP3;BRWD3;FMNL2;CDC42BPB;CAPZB;CFL1;WTIP
prerank,spinal cord development (GO:0021510),-0.6191946857619689,-1.5531833169705267,0.03502626970227671,0.17708682131303008,1.0,6/12,20.79%,PKD2;VIT;LOXL3;ZPR1;SOX4;NF1
prerank,regulation of humoral immune response (GO:0002920),0.4352517896204797,1.552967424399317,0.02320185614849188,0.27522292036679274,1.0,11/44,13.37%,VTN;CPB2;PHB2;C9;CD81;SUSD4;C3AR1;CPN1;SERPING1;CLU;GATA6
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.4079599823045831,-1.5508894619317575,0.0036036036036036037,0.18004251948770983,1.0,32/72,25.98%,CBFB;ELF1;PTPN1;JAK1;BIRC3;TAX1BP1;GAS6;OTULIN;LIFR;CASP8;CFLAR;JAK2;IRAK1;USP18;TNFAIP3;AGPAT1;TNFRSF1A;SUMO1;HIPK1;IRAK2;IKBKG;IKBKB;IFNGR2;PTPRC;VRK2;ABCE1;PTPN11;IFNAR2;RIPK1;IL7;PTPN2;TRIM44
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.5702672516978967,1.5505216128096133,0.042986425339366516,0.27744663092602684,1.0,5/15,13.33%,NLGN1;CNTNAP4;CLN3;ADRA1A;NLGN2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6381631645483514,-1.5494699757743087,0.03314917127071823,0.18150159178944472,1.0,5/11,14.15%,SEMA6A;KLF2;THBS1;ADAMTS9;PIK3CB
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.48482199514743773,-1.5493530278742824,0.032667876588021776,0.18118202168730752,1.0,10/29,15.88%,TUT7;PUM1;SMAD1;SMAD2;ZC3H7B;SNIP1;DICER1;TUT4;AGO2;PUS10
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.49823437692944894,-1.5485958654257594,0.014336917562724014,0.18183508614241628,1.0,10/29,16.11%,SORBS1;ZBTB20;MTOR;PPARA;ELOVL5;SCARB1;MFSD2A;AKT1;CHP1;CREBL2
prerank,positive regulation of binding (GO:0051099),-0.40068521884692165,-1.5483344302479682,0.005208333333333333,0.181648395455859,1.0,46/84,30.00%,RAPGEF2;CLDN5;CAV1;GSK3B;APP;DTX3L;LRRK2;HES1;STK3;SPPL3;BMP4;NGF;DPH3;HMBOX1;PSEN1;HFE;FLOT1;FOXC1;HIP1R;IGF1;SKI;MARK3;RARA;CEBPG;AKTIP;CLN5;TXN;TCF7L2;PPARG;TERT;CAPRIN2;RALB;TRIB3;HMGB1;DHX9;BMP2;LRP1;PARP9;RAN;NMD3;MET;STMN1;PLAUR;KDM4D;MED25;BAMBI
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.43721036084813214,-1.547924351163078,0.012237762237762238,0.18172236018402332,1.0,19/50,18.97%,NFAT5;NR3C2;NOD1;LIMS1;APP;DDX3X;EGFR;NMI;PDCD4;ILK;RHOA;IRAK1;ACTN4;TCIM;IFI35;SASH1;RPS3;CCL19;NOD2
prerank,embryonic digit morphogenesis (GO:0042733),-0.5454635629014046,-1.5466332942946937,0.03656307129798903,0.1830682208054098,1.0,6/18,9.10%,MAP3K20;CREBBP;HDAC1;ECE1;TBX2;GLI3
prerank,erythrocyte differentiation (GO:0030218),-0.44688798230299287,-1.5452352801006677,0.007352941176470588,0.18464267875007645,1.0,15/44,18.25%,ALAS1;MFHAS1;LYN;KMT2E;TGFBR3;RPS14;MED1;ACIN1;ABCB10;TAL1;JAK2;ZFPM1;CDK5RAP3;CEBPG;FLVCR1
prerank,peptide biosynthetic process (GO:0043043),-0.36280248296214845,-1.5448905143859102,0.001669449081803005,0.18472922963516514,1.0,68/153,31.12%,RRBP1;RPS21;RPL37;RPL31;RPL9;RPS14;GGT5;RPSA;PCSK5;RPL3;RPLP1;MRPL32;RPL26;RPS11;RPL13;MRPS18A;RPL38;RPL27;RPS16;RPS4X;GSPT1;AGO2;RPL10;RPL7A;HARS2;RPL5;MRPL24;RPS27;RPL27A;RPS3;RPL36A;RPL35A;MRPS14;RPL37A;MRPS21;MRPL35;RPL32;WARS1;RPS7;RPS15;MRPL34;RPS8;RPL28;RPL22;RPL13A;MRPL13;MRPL9;RPL36;RPL30;RPS23;SRBD1;RPS17;RPS2;MRPL43;RPL39;MRPL11;RPS26;TNIP1;RPS15A;RPL15;RPL34;RPLP2;RPL18;MRPS17;RPL19;RPS13;COPS5;RPL8
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.6307011187422633,-1.544414986829876,0.03163444639718805,0.18493095418657568,1.0,8/11,32.99%,LIMD1;PUM1;WTIP;AJUBA;DHX9;FXR1;STAT3;PUM2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6568007118850145,-1.5441389663732838,0.0341726618705036,0.1848107526537645,1.0,2/10,0.62%,DAB2IP;SEMA6A
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.45257561768502147,-1.5432772385600964,0.018115942028985508,0.18554663164612875,1.0,15/40,17.12%,LEF1;FERMT2;DAB2;GCNT2;MTOR;TGFBR2;TGFB2;SMAD2;SMAD4;AXIN2;RGCC;NOTCH1;JAG1;FOXC1;CTNNB1
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.47743862589856445,-1.542299932435208,0.02280701754385965,0.18659734078114862,1.0,21/34,35.49%,RB1;INSR;LRP5;CUL3;EDN1;RGCC;CDC16;EDN3;NSMCE2;IGF1;IGF2;PDGFRB;ANAPC7;BTC;ANAPC11;ANAPC5;AURKA;PHIP;IL1A;ESPL1;DRD3
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.5029401019257878,-1.541878076069108,0.03716814159292035,0.1867522380103399,1.0,7/26,14.94%,CAV1;MFHAS1;DDX3X;WDFY1;LBP;FLOT1;IFI35
prerank,phospholipid translocation (GO:0045332),-0.4952119527443516,-1.541063164023361,0.022375215146299483,0.18736601326351843,1.0,10/28,16.71%,ATP10A;ATP8B1;PLSCR4;PLSCR2;MFSD2A;ATP10B;ANO6;PLSCR1;ABCA7;ATP9B
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.6068141527496903,-1.540057232370479,0.037037037037037035,0.18834241808306326,1.0,8/13,21.16%,ENG;KDR;TGFBR2;COL4A1;NOTCH4;CTNNB1;SEMA3E;DLL4
prerank,protein O-linked glycosylation via serine (GO:0018242),0.6391598050461548,1.539732937206026,0.03587443946188341,0.2963796461402751,1.0,7/10,18.85%,GALNT13;GALNT16;MGAT5B;GALNT3;GALNT2;POGLUT1;POGLUT2
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.41108343671387604,-1.5388339040531722,0.01232394366197183,0.18977056785910598,1.0,25/62,26.61%,NUP42;RAE1;RANBP2;LIMD1;NUP98;PUM1;SEC13;POLR2G;NUP153;AGO2;H3-3A;TPR;NUP214;IPO8;WTIP;TNRC6A;PPARG;NUP188;AJUBA;POLR2C;DHX9;POLR2L;FXR1;POLR2H;NUP88
prerank,regulation of JUN kinase activity (GO:0043506),-0.4691776756888475,-1.5387194474463466,0.03642987249544627,0.18939539891970275,1.0,13/33,25.12%,DAB2IP;DVL3;MAP3K5;PPEF2;PDCD4;EDN1;TAOK3;SASH1;RPS3;ARHGEF5;MAP3K7;AIDA;FZD10
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.6189520342570021,-1.5375162374686788,0.046181172291296625,0.19075985319218147,1.0,8/12,29.30%,LMO2;THRB;MED1;KLF9;CTSH;GAS2L1;RDX;BRD8
prerank,negative regulation of endopeptidase activity (GO:0010951),0.43002597017837346,1.536852756464781,0.006622516556291391,0.29940697647845355,1.0,12/47,12.71%,VTN;SPOCK3;SPOCK1;SERPIND1;SORL1;TIMP1;ANXA8;ANXA8L1;SERPINA2;SERPING1;PCID2;FETUB
prerank,positive regulation of neuron differentiation (GO:0045666),0.4450739517834085,1.5367225100298763,0.015521064301552107,0.29705762693411303,1.0,12/40,9.77%,BRINP3;BEND6;NBL1;NRCAM;VWC2;BRINP1;HOXD3;IMPACT;PROX1;BRINP2;ADRA2C;CPNE1
prerank,response to molecule of bacterial origin (GO:0002237),-0.40751460549260965,-1.5365923531139678,0.005136986301369863,0.19168094680508144,1.0,16/69,16.41%,FOXP1;PELI1;NOS3;SRR;IFNAR1;HNRNPA0;GGT5;GCH1;LBP;MAPKAPK2;JAK2;IRAK1;RPS6KA3;TNFAIP3;SMAD6;TAB2
prerank,positive regulation of glycolytic process (GO:0045821),-0.528041320302045,-1.5363508924550267,0.0338680926916221,0.19092486242589976,1.0,8/20,17.56%,ZBTB20;INSR;APP;PRKAA1;PFKFB3;PSEN1;IGF1;ARNT
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.528041320302045,-1.5363508924550267,0.0338680926916221,0.19092486242589976,1.0,8/20,17.56%,ZBTB20;INSR;APP;PRKAA1;PFKFB3;PSEN1;IGF1;ARNT
prerank,regulation of cell killing (GO:0031341),-0.5652499054525035,-1.5361688596389054,0.03663003663003663,0.19070156006130248,1.0,8/16,23.43%,RAC1;CR1L;ICAM1;TGFB2;CD55;MAPK8;CFH;FZD7
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.44567907484044067,-1.535898101845655,0.02268760907504363,0.19054900359814336,1.0,17/47,19.68%,DAB2IP;IGF1R;FOXO1;MID1;EGFR;TGFBR3;FAS;TGFB2;MAPK1;ARL6IP5;TAOK3;SEMA4C;MAP4K4;IGBP1;RAP2A;NOD2;KLHDC10
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.4530017560726126,-1.5354599577648476,0.02333931777378815,0.19062955486478503,1.0,15/44,20.79%,DAB2IP;LYN;PTPN1;PTPRJ;PDCD4;PRKCD;BMP4;STK38;SPRY4;PIK3CB;BMP7;CDK5RAP3;HYAL2;UCHL1;NF1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.4795459750889462,-1.5353031543721838,0.035381750465549346,0.19031552581849945,1.0,18/31,32.81%,RB1;DCUN1D3;KLF4;PKD2;DLG1;FAM107A;CDC73;CDK6;CDK2AP2;PTEN;CDKN2C;FHL1;E2F7;APC;CDKN2B;JADE1;WEE1;CDK4
prerank,response to interferon-beta (GO:0035456),-0.527355682742413,-1.5350203286483126,0.027624309392265192,0.19016525581504842,1.0,12/22,30.71%,UBE2K;IRGM;IRF1;IKBKE;IFITM3;PLSCR1;IFNAR2;IFITM2;TRIM6;BST2;CDC34;SHFL
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.5910981052889197,-1.5344289674080798,0.031914893617021274,0.190535042091991,1.0,8/13,26.25%,PLCG1;SP1;AKT3;FGF2;ITGA4;IGF2;HMGB1;ADAM17
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.5435259689491301,-1.5343888250447142,0.043243243243243246,0.19007977091631884,1.0,10/18,33.08%,NR3C1;FAM107A;KLF9;UBE2L3;BCL2L11;ANXA1;ZFP36L1;HNRNPU;SSTR2;AQP1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.46196870211576174,1.5342708933081817,0.022222222222222223,0.29938295233716566,1.0,7/34,3.70%,GRID2;MPP2;GABRG3;GRIN2B;GLRA1;GRIN2A;GABRA2
prerank,regulation of cellular component organization (GO:0051128),-0.3633704737475263,-1.5340258978005832,0.0017921146953405018,0.19017076152604706,1.0,50/135,20.63%,HIP1;TJP1;DAB2IP;RAPGEF2;SNCAIP;RUFY1;MLLT3;NET1;PTPN1;STON1;MTOR;TFRC;METTL4;RAB5B;ABL1;NEDD4;IRGM;AP2S1;RAP1A;SETD5;PLCE1;RAP1B;ROCK1;RASGRP2;RAB5A;PICALM;FAM107A;RAB4B;BCAR1;SOCS2;HJURP;RAPGEF1;SNX12;AGTR1;RPTOR;ARHGEF11;LTBP4;CEACAM1;HCFC1;HIP1R;ROCK2;MAD2L2;NCLN;ZFYVE16;STON2;BAP1;SLITRK2;CDK11B;RUFY2;DCUN1D5
prerank,positive regulation of cellular component organization (GO:0051130),-0.37875314161547474,-1.53298763848118,0.0,0.19112425861841575,1.0,32/107,18.45%,ATP10A;DAB2IP;IGF1R;SHANK3;RB1;TRABD2B;ASAP1;INSR;MPP7;DAB2;NEDD4L;CBLL1;GSK3B;TFRC;TGFB2;SPIDR;BNIP3;CDH5;TAL1;FNIP2;DCTN1;ICE1;FLOT1;RHOC;ABCB7;SLF2;GPX1;BCL2L11;BMP7;SUMO1;RPS3;CCL19
prerank,positive regulation of cell division (GO:0051781),-0.4540415401641477,-1.5325072991454392,0.0213903743315508,0.19122897952193474,1.0,10/38,14.01%,PRKCE;SVIL;PKP4;CUL3;FGF1;CDC14A;TAL1;KIF23;RHOA;PKN2
prerank,amide transport (GO:0042886),-0.4992210630365319,-1.5314699234790046,0.042435424354243544,0.19229331922607532,1.0,9/26,7.90%,ABCG2;CERT1;PLTP;SLC25A32;SLC5A6;SLC38A5;AQP11;ABCB9;TAP2
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.6450178165772009,-1.530832448197343,0.03278688524590164,0.19271245383973276,1.0,6/10,16.00%,BMP6;PPM1F;NOTCH4;RGCC;NOTCH1;MAD2L2
prerank,regulation of neuron projection development (GO:0010975),0.3463195698738115,1.5307192418962159,0.004866180048661801,0.3039303678717349,1.0,35/163,10.54%,MAGI2;CSMD3;LRRC4C;IL1RAPL1;CTNNA2;LRRC7;DCC;RIT2;PPFIA2;SCN1B;CCDC88A;SPOCK1;TENM3;FUT9;CDK5;CDKL5;TOX;NTNG2;NTNG1;ITM2C;KIDINS220;NDRG4;NCS1;PAK3;CAMK2B;NTRK2;PAK1;TANC2;PLA2G3;TSKU;PLPPR5;PTPRS;STMN2;MAG;ABI2
prerank,negative regulation of potassium ion transport (GO:0043267),-0.5971539909246819,-1.5300979173143903,0.03260869565217391,0.19309561639284403,1.0,8/13,28.55%,CAV1;NEDD4L;CASQ2;NOS1;PTK2B;KCNH2;CAB39;ACTN2
prerank,histone lysine demethylation (GO:0070076),-0.5063863038493176,-1.5300476355068804,0.02443609022556391,0.19266219771052634,1.0,14/25,31.75%,KDM2A;KDM6A;KDM6B;KDM3A;JMJD1C;HR;RIOX2;KDM7A;KDM5B;KDM1B;KDM3B;KDM4D;RIOX1;KDM4A
prerank,regulation of lymphocyte migration (GO:2000401),-0.6401818464821387,-1.5299747292819819,0.05169340463458111,0.1922512084633638,1.0,5/10,11.10%,JAM2;MSN;WASL;AKT1;STK10
prerank,"phagocytosis, engulfment (GO:0006911)",-0.4666937135679591,-1.5297955989092706,0.024013722126929673,0.19199305176274856,1.0,7/36,3.40%,GULP1;DOCK1;MYH9;RAC1;RHOBTB1;THBS1;ELMO1
prerank,adipose tissue development (GO:0060612),-0.6266029715608579,-1.529332531808693,0.03486238532110092,0.19218039333368844,1.0,5/11,17.06%,LRP5;SH3PXD2B;NAMPT;DGAT2;ARID5B
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.4911592673830908,-1.5292989327771938,0.022530329289428077,0.19173392485877722,1.0,9/28,20.17%,DAB2IP;CTSC;RNF139;SMURF1;PTK2;ECSCR;PSMC2;CDK5RAP3;PTEN
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.5038083419244744,-1.5292415449116716,0.038391224862888484,0.19131968566529828,1.0,11/27,13.32%,TJP1;WASF2;SHANK3;F11R;PAK2;CGNL1;PIK3R1;PPFIA1;ARAP1;ARHGAP28;MYOC
prerank,positive regulation of signaling (GO:0023056),0.44888004511648505,1.5288372531704033,0.018223234624145785,0.3050458736832413,1.0,9/37,12.35%,GRIK2;SYT1;RIMS2;RIMS1;CARTPT;HOMER1;CLSTN2;INPP5F;DLG4
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.49307559713887983,-1.5270827697187668,0.025,0.19410828336351443,1.0,9/28,17.78%,DAB2IP;DDX3X;ZDHHC3;NGF;CASP8;CRADD;GABARAP;TNFRSF1A;CASP8AP2
prerank,body fluid secretion (GO:0007589),0.5444788451808948,1.5270699301383492,0.04555808656036447,0.30600619002118734,1.0,3/15,9.25%,ERBB4;SLC22A4;VEGFA
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.4079403565755445,-1.5268555402030861,0.008865248226950355,0.19402380628854976,1.0,27/62,28.74%,MNAT1;MLLT3;CDK13;SETD2;CDK12;IWS1;EAF1;POLR2G;ERCC2;CDC73;RTF1;TCEA1;MLLT1;ERCC3;NELFB;ELOF1;ADRM1;ELOC;SUPT4H1;POLR2C;CCNK;POLR2L;POLR2H;LEO1;GTF2H3;CCNH;ELP2
prerank,regulation of stress fiber assembly (GO:0051492),-0.4044898443649112,-1.5238533916071961,0.015957446808510637,0.1980764542207695,1.0,28/74,16.65%,TJP1;WASF2;FERMT2;RAC1;F11R;PAK2;CGNL1;PXN;PIK3R1;ABL1;ARHGEF15;PPFIA1;ROCK1;PPM1F;RGCC;ARAP1;RHOA;ARHGAP28;LIMCH1;TPM1;WNT11;MYOC;RHOC;ARHGEF10;SORBS3;ROCK2;ARHGEF18;ALMS1
prerank,positive regulation of coagulation (GO:0050820),-0.6620446865149751,-1.5232824926457722,0.04145077720207254,0.19789163110304409,1.0,7/10,26.84%,ST3GAL4;THBS1;ENPP4;SERPINE1;HPSE;DMTN;F2R
prerank,positive regulation of hemostasis (GO:1900048),-0.6620446865149751,-1.5232824926457722,0.04145077720207254,0.19789163110304409,1.0,7/10,26.84%,ST3GAL4;THBS1;ENPP4;SERPINE1;HPSE;DMTN;F2R
prerank,positive regulation of wound healing (GO:0090303),-0.4712978487007478,-1.5231412352283007,0.014598540145985401,0.19757261546029034,1.0,12/36,11.88%,RREB1;ITGB1;ST3GAL4;FERMT2;PRKCE;THBS1;MTOR;PTK2;ENPP4;OCLN;MYLK;ARFGEF1
prerank,Golgi to endosome transport (GO:0006895),-0.5578500223871323,-1.5230155644577181,0.053003533568904596,0.19725523579519175,1.0,7/16,22.11%,VPS13A;EPS15;VPS13C;WIPI1;CORO7;AP4M1;KIF16B
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.4642988862270796,-1.5219810757465397,0.029565217391304348,0.19841354822867727,1.0,14/32,28.28%,ZBTB20;INSR;TMSB4X;APP;PPARA;PRKAA1;PFKFB3;PSEN1;IGF1;ARNT;PFKFB4;BEND3;PFKFB2;TREM2
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.601060073798795,-1.521960542524169,0.04021937842778794,0.19793984835462092,1.0,5/13,15.93%,ALG14;ALG12;ALG8;ALG11;ALG13
prerank,response to ionizing radiation (GO:0010212),-0.403315120637298,-1.5211300442605546,0.022181146025878003,0.19873764147194603,1.0,28/70,22.73%,DCUN1D3;NET1;ATM;UIMC1;MRNIP;XRCC4;SPIDR;INIP;NABP1;TP53;PRKAA1;INTS3;KAT5;BABAM2;NHEJ1;RNF168;GRB2;TRIM13;ANXA1;RFWD3;FANCD2;BRCC3;BRAT1;LIG4;BRCA1;BLM;GADD45A;INTS7
prerank,positive regulation of cytokinesis (GO:0032467),-0.47375280045066875,-1.5205584386109654,0.025454545454545455,0.19912773013186744,1.0,9/32,17.76%,PRKCE;SVIL;PKP4;CUL3;CDC14A;KIF23;RHOA;PKN2;GIPC1
prerank,regulation of store-operated calcium entry (GO:2001256),0.6267002895958323,1.5204374042697784,0.06278026905829596,0.3171866561422459,1.0,6/10,19.45%,EFHB;HOMER1;CASQ1;SLC8B1;GRAMD2A;CD84
prerank,peptidyl-lysine modification (GO:0018205),-0.3801123933353001,-1.5199824542340663,0.007326007326007326,0.19946752771908577,1.0,32/99,22.99%,SENP1;PLOD1;PLOD2;IFIH1;KAT2B;NUP42;RAE1;LOXL3;TRPM4;RANBP2;UBA2;SIRT5;NUP98;LOXL1;NSMCE2;NUP153;HDAC4;KAT5;PIAS2;SIRT3;TPR;SUMO1;SENP2;HDAC6;HDAC10;NUP214;PIAS4;CTH;TRIM28;LOX;NUP188;SENP6
prerank,regulation of complement activation (GO:0030449),0.4396046944247063,1.5199360515363716,0.04398148148148148,0.31552727434132327,1.0,10/40,13.29%,VTN;CPB2;PHB2;C9;CD81;SUSD4;C3AR1;CPN1;SERPING1;CLU
prerank,positive regulation of protein import (GO:1904591),-0.46803946915630995,-1.5196649133487,0.02531645569620253,0.1994393352866112,1.0,13/30,20.86%,UBR5;PIK3R1;PRKCD;CDH1;FLNA;PSEN1;ZPR1;TPR;MAVS;ZIC1;HYAL2;ARHGEF5;TRIM28
prerank,neuron migration (GO:0001764),0.416403671290082,1.519551662921413,0.008849557522123894,0.3137776002267593,1.0,18/48,11.64%,ADGRL3;SPOCK1;DNER;ASTN2;CDK5;CDKL5;NRCAM;ASTN1;MDGA1;DCDC2;GPM6A;NTRK2;SOX1;VEGFA;DCX;MAP1B;CCK;AUTS2
prerank,regulation of insulin secretion (GO:0050796),0.3723290963923923,1.519156901328241,0.0024096385542168677,0.3121248861552223,1.0,31/101,18.04%,KCNC2;ABCA12;BLK;SNAP25;GIP;GCK;NR1D1;KCNA5;CACNA1A;MTNR1B;EPHA5;CHGA;TRH;CACNA1D;ADRA2C;CACNA1E;GIPR;ADRA2A;GPER1;EIPR1;CCL5;NLGN2;GLUD1;BRSK2;MCU;BMP8A;ALOX5;SLC8B1;GLP1R;ABCC8;KCNG2
prerank,cellular potassium ion homeostasis (GO:0030007),0.5851093412737594,1.5187629434994223,0.05251141552511415,0.3104199352278495,1.0,5/13,8.71%,KCNMA1;ATP1A2;ATP12A;ATP1B1;ATP4A
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.5151161243917224,-1.5182606241511494,0.043478260869565216,0.2010617752500873,1.0,11/24,16.15%,TJP1;WASF2;F11R;PAK2;CGNL1;PIK3R1;PPFIA1;ARAP1;ARHGAP28;MYOC;ARHGEF18
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5230393095360274,1.5181544654585093,0.038202247191011236,0.30922078946401915,1.0,6/20,12.16%,ATP1A2;ATP1B1;CALM2;RYR2;SLC8A1;HRC
prerank,gene silencing by miRNA (GO:0035195),-0.4655801859145944,-1.5177729149220653,0.028862478777589132,0.20137816822253385,1.0,15/32,27.04%,TNRC6B;LIMD1;PUM1;ZC3H7B;SNIP1;NOTCH4;DICER1;AGO2;MOV10;WTIP;TNRC6A;AJUBA;CNOT8;RAN;CNOT1
prerank,hemidesmosome assembly (GO:0031581),-0.6286561966816003,-1.5176186479501608,0.042279411764705885,0.20110624134094787,1.0,4/11,8.83%,ITGA6;ITGB4;LAMA3;DST
prerank,positive regulation of chemotaxis (GO:0050921),-0.4429153737106667,-1.517579722852021,0.017793594306049824,0.20065118772859022,1.0,20/43,28.28%,THBS1;TMSB4X;KDR;PRKD2;IL6R;STX3;PPM1F;PRKD1;EDN3;FGF2;SMOC2;LGMN;CCL19;F3;PDGFRB;PTN;SEMA5A;ADAM17;MET;TREM2
prerank,regulation of cellular response to heat (GO:1900034),-0.3904517825774165,-1.516685401285815,0.008849557522123894,0.20151831647864182,1.0,22/77,15.78%,CREBBP;CD34;GSK3B;ATM;NUP42;MTOR;YWHAE;RAE1;CAMK2G;RANBP2;DNAJC7;NUP98;MAPKAPK2;SEC13;DNAJB6;MAPK1;RPTOR;NUP153;RPA3;RPA1;PTGES3;TPR
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4948647562022977,-1.5162982254972954,0.02127659574468085,0.201602547421665,1.0,10/27,11.66%,PTPN1;PIP4K2A;NCK1;IRS1;PIP4K2B;PRKCD;GRB10;GSK3A;GRB14;SLC27A4
prerank,pentose-phosphate shunt (GO:0006098),0.5966365010678546,1.5160240180299702,0.05357142857142857,0.3110245962848325,1.0,6/11,17.49%,PGLS;H6PD;TKT;RPIA;PGD;PGM2
prerank,response to reactive oxygen species (GO:0000302),-0.4225322890984519,-1.5159345265484259,0.018900343642611683,0.2016453177722211,1.0,21/54,20.81%,PKD2;EGFR;ADAM9;PXN;STK24;PTPRK;JUN;MAPK1;AKT1;TPM1;CAT;TXNRD2;MAPK8;GPX1;AGAP3;FYN;SOD1;RPS3;HYAL2;COA8;ERCC6L2
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5346805255241643,1.515875188349472,0.04740406320541761,0.30894816320107366,1.0,6/17,17.93%,NLGN1;RAB15;RAB3A;SYT4;CACNA1G;CACNA1I
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.5137600045664786,1.5157159921174124,0.049145299145299144,0.30690392287830337,1.0,7/22,12.08%,PDE4B;STAC2;HPCA;CACNB3;CACNB4;STAC;SRI
prerank,vasculogenesis (GO:0001570),-0.4676726692206214,-1.5147684827532641,0.034722222222222224,0.2028562690391303,1.0,12/32,12.19%,ENG;CAV1;KDR;SOX17;TGFBR3;TGFBR2;RASIP1;RAMP2;CUL7;ADM;RASA1;NOTCH1
prerank,purine nucleotide catabolic process (GO:0006195),-0.5911594759145515,-1.513562070581872,0.043243243243243246,0.20420260916198968,1.0,8/13,27.29%,NT5C2;NT5E;NT5C1A;GPX1;HINT1;GDA;NT5C;PNP
prerank,regulation of endocytosis (GO:0030100),-0.41555166045765846,-1.5135404137960125,0.022887323943661973,0.20372471741055345,1.0,24/61,20.15%,HIP1;RUFY1;DAB2;NEDD4L;CBLL1;PTPN1;STON1;RAB5B;ABL1;AP2S1;ROCK1;RAB5A;PRKD1;PICALM;RAB4B;SNX12;FLOT1;HIP1R;ABCA7;ZFYVE16;STON2;CCL19;GPC3;RUFY2
prerank,positive regulation of innate immune response (GO:0045089),-0.47095441223278683,-1.513428160859636,0.025547445255474453,0.20337734382535086,1.0,16/30,31.53%,UBE2K;NMI;LBP;AKIRIN2;PLSCR1;POLR3F;IFI35;NLRC5;GBP5;MAVS;DHX9;TRIM6;RIOK3;SPI1;PLA2G5;TRIM62
prerank,positive regulation of response to external stimulus (GO:0032103),-0.3648087025169097,-1.513426397788403,0.0035087719298245615,0.20288198837420993,1.0,44/128,28.28%,ETS1;ANKRD17;THBS1;APP;IL15;BMP6;SCARF1;NFKBIA;NMI;PDE2A;PDCD4;STX3;PUM1;NAPEPLD;PPM1F;AKIRIN2;FEM1A;DDX60;USP15;AGTR1;LPL;IL17RA;PLSCR1;POLR3F;IFI35;IL16;TNFRSF1A;GBP5;SASH1;CCL19;HYAL2;PDGFRB;GPR4;PTN;SERPINE1;RIPK1;CEBPA;DDT;DHX9;TNIP1;GPSM3;OASL;RIOK3;TREM2
prerank,protein hydroxylation (GO:0018126),-0.5625407373474757,-1.5133528090200719,0.045871559633027525,0.20249171180565492,1.0,5/15,9.07%,PLOD1;PLOD2;P3H2;OGFOD1;ASPH
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.5654700362437683,1.5125726708808342,0.06073752711496746,0.31079719708793485,1.0,5/14,9.75%,ANK3;ATP1B1;WNK2;WNK3;TESC
prerank,negative regulation of cell differentiation (GO:0045596),-0.34412025099233395,-1.5119890594064431,0.0016474464579901153,0.20414215385994036,1.0,64/181,25.22%,DAB2IP;ZBTB16;FOXO1;RB1;FERMT2;CRIM1;CAV1;LRP5;ASXL1;IL17RD;BMP5;SPRED2;TBX1;METTL14;COL5A1;EGFR;TRPM4;LIMD1;HES1;PPARA;LDLRAD4;NFKBIA;PDCD4;MED1;SUZ12;COL5A2;BMP4;YAP1;NOTCH4;ANKRD26;SMAD7;ZFPM1;ADGRV1;TWIST2;NOTCH1;CDC73;TMEM64;CDK6;TRIO;JAG1;SMAD6;MAD2L2;BMP7;SKI;HEY1;NELFB;GATA2;PPP2CA;PPARG;PTEN;ITGB3;IGF2;PTPN11;HDAC7;USH2A;PTK2B;MYOCD;TBX3;ADAMTS7;TRIB3;NEPRO;GPS2;EID2B;GDF10
prerank,organelle fission (GO:0048285),-0.5047019812308082,-1.511708956099985,0.037300177619893425,0.2040293205177569,1.0,6/24,6.71%,DNM3;CORO1C;TMCC1;MIEF1;DNM2;SEC16B
prerank,positive regulation of protein binding (GO:0032092),-0.423071473815922,-1.5112407694105698,0.024955436720142603,0.2042320266954521,1.0,28/56,27.52%,RAPGEF2;CLDN5;CAV1;GSK3B;APP;DTX3L;LRRK2;STK3;ABL1;SPPL3;BMP4;PSEN1;HFE;FLOT1;HIP1R;PPP2CB;MARK3;AKTIP;PPP2CA;TCF7L2;TERT;CAPRIN2;RALB;TRIB3;BMP2;LRP1;RAN;NMD3
prerank,positive regulation of programmed cell death (GO:0043068),-0.33102910332761787,-1.511142042166319,0.0,0.2038545838968545,1.0,91/272,25.06%,UNC13B;DAB2IP;ITGA6;MAP3K20;ITGB1;FOXO1;AKAP13;DCUN1D3;ARHGEF3;DAPK1;TNFAIP8;NET1;ATG7;ATM;MCF2L;LRRK2;UTP11;MAP3K5;DDX3X;PLEKHG5;TNFSF10;RASGRF2;RARG;RBM5;RYBP;STK3;ABL1;FOXO3;PSEN2;DNM2;FAS;ARHGEF12;SLIT2;RASSF2;BMP4;BNIP3;NGF;JUN;TGM2;ITSN1;ARHGEF2;ARL6IP5;LATS2;SOS2;CASP8;TP53;CRADD;PSEN1;SLC27A4;ARHGEF11;ANO6;CTNNBL1;STPG1;MAPK8;ATF4;TRIO;ERCC3;IAPP;HIP1R;ABR;ARHGEF18;BCL2L11;PREX1;HDAC6;CTNNB1;APH1A;TFAP4;SOD1;SIAH1;SOX4;RNPS1;BCL6;NF1;ARHGEF5;FOXL2;PNMA2;VAV2;ARHGEF1;CASP2;PHLDA3;GADD45A;SUDS3;ATF6;RIPK1;SFRP4;CYP1B1;CALHM2;HMGB1;FANK1;BMP2;APBB1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.6328885018010317,-1.5108020603083898,0.047619047619047616,0.20389385137163418,1.0,8/11,30.81%,TGFBR3;TGFBR2;TGFB2;SMAD7;USP15;BMP2;TGFBR1;TGFB1
prerank,pulmonary valve development (GO:0003177),-0.5487039863712349,-1.5107141660275778,0.04436860068259386,0.20350984496253402,1.0,14/18,17.95%,NOS3;BMPR2;NFATC1;TNFRSF1B;SLIT2;TGFB2;BMP4;NOTCH2;NOTCH1;JAG1;SMAD6;TNFRSF1A;HEY1;HEY2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5209132500207042,1.510294802078192,0.050997782705099776,0.31302939777822614,1.0,8/18,16.82%,ADCY10;AQP4;DNAAF1;NEK10;ROPN1L;SPAG17;CABYR;DNAAF2
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.37245315809883595,-1.5097074977688472,0.0070921985815602835,0.20452234293640015,1.0,44/108,23.64%,NXN;RSPO3;CBFB;TRABD2B;ESR1;ITGA3;APP;NFATC1;LRRK2;EMD;KREMEN1;VGLL4;OTULIN;RNF43;MACF1;NKD1;MDFIC;GRB10;CCNY;HMGXB4;PSEN1;SOX7;CDC73;WWOX;NOTUM;TAX1BP3;APCDD1;TCF7L1;TNFAIP3;DAAM2;HIC1;SKI;SENP2;CTNNB1;PPP2CA;CTNNBIP1;GPC3;TERT;CDK14;AMER1;RSPO2;FZD7;SFRP4;PPP1CA
prerank,angiogenesis involved in wound healing (GO:0060055),-0.6338300546527376,-1.5086432232865215,0.04585537918871252,0.2056215186005494,1.0,8/11,23.08%,CD34;ADIPOR2;KDR;MCAM;PRCP;GATA2;ITGB3;HPSE
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.4324425084697856,-1.508605662149176,0.02867383512544803,0.2051722146724094,1.0,12/46,12.95%,DAB2IP;SEMA6A;LYN;PTPN1;RANBP9;SPRED2;DLG1;EZR;SMAD4;TIMP3;CNKSR3;DUSP3
prerank,regulation of multicellular organism growth (GO:0040014),-0.5654001152065938,-1.5084433830939656,0.062264150943396226,0.20495583415621588,1.0,5/15,18.07%,GHR;APP;MFSD2A;IGF1;SOD1
prerank,nuclear export (GO:0051168),-0.3932269246477387,-1.5078657596376284,0.007326007326007326,0.2054069372309781,1.0,34/80,26.65%,SRSF11;NUP42;SMURF1;RAE1;CSE1L;SARNP;THOC2;XPO7;UPF3B;THOC7;DDX39B;DHX38;NUP153;SLU7;CHP1;HNRNPA1;TPR;THOC3;THOC1;LSG1;XPO4;NUP214;WASHC4;PHAX;SRRM1;RITA1;RNPS1;SRSF3;NUP188;POLDIP3;NXF1;NEMF;ATXN1;RAN
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.5319752055557673,-1.5066497139913952,0.046125461254612546,0.20676253845730375,1.0,8/18,26.25%,LYN;MTUS1;IL6R;SLIT2;EDN3;PTK2B;PTN;ADAM17
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.6321786153619916,-1.5064457952732537,0.04419889502762431,0.20656201750585632,1.0,6/10,18.94%,DDX39B;WDR76;FEM1B;THOC1;RFWD3;RPA2
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.5277222116727167,-1.5055525099298062,0.03558718861209965,0.2074091757939689,1.0,10/20,23.22%,PELI1;BIRC3;CASP8;CFLAR;FLOT1;ASAH1;PDCD6IP;OGT;HSP90AA1;RIPK1
prerank,ncRNA processing (GO:0034470),-0.3406728415621816,-1.5052331979285438,0.0017452006980802793,0.20738812085704447,1.0,86/200,30.40%,INTS8;TUT7;UTP11;RPL37;RPL31;RPL9;RPS14;WDR75;FARS2;RPF1;DDX10;SMAD1;SMAD2;EXOSC2;EXOSC1;RPL3;RPLP1;RPL26;ESF1;NOL9;DICER1;EXOSC3;XRN2;TUT4;RPL13;INTS3;UTP3;RPL38;RRP1;RPL27;RPS16;AGO2;RPL10;RPL7A;RPL5;PUS10;INTS9;DCAF13;EXOSC8;UTP14A;RPS27;RPL27A;WDR74;RPL36A;MDN1;RPL35A;UTP4;EXOSC5;BOP1;RPL37A;TRPT1;PES1;DROSHA;RPL32;EBNA1BP2;RPS7;RPS15;INTS7;RCL1;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS17;NOL8;EXOSC7;WDR46;RPS2;RPP30;RPL39;BYSL;RPL15;RPL34;WDR55;EMG1;WDR12;POP4;RPLP2;INTS5;UTP20;RPL18;INTS12;SSB;RPL19;FCF1
prerank,response to leucine (GO:0043201),-0.6260622625372257,-1.5052206853678556,0.024208566108007448,0.2064413477024075,1.0,6/10,18.69%,SESN1;MTOR;UBR2;RPTOR;LARS1;UBR1
prerank,cellular response to leucine (GO:0071233),-0.6260622625372257,-1.5052206853678556,0.024208566108007448,0.2064413477024075,1.0,6/10,18.69%,SESN1;MTOR;UBR2;RPTOR;LARS1;UBR1
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.6273531806543412,-1.5046768812567748,0.042105263157894736,0.20684880030309954,1.0,7/11,24.87%,RESF1;TASOR;TPR;DNMT1;PPHLN1;TRIM28;SETDB2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.48471148529993446,-1.5036467862350262,0.028268551236749116,0.20803617157585125,1.0,10/28,11.66%,PTPN1;PIP4K2A;NCK1;IRS1;PIP4K2B;PRKCD;GRB10;GSK3A;GRB14;SLC27A4
prerank,cellular response to oxidative stress (GO:0034599),-0.3660864891699761,-1.5033331057368895,0.006993006993006993,0.20799017426322494,1.0,40/118,22.38%,FOXO1;PKD2;DAPK1;LRRK2;EGFR;PXN;ABL1;FOXO3;PYROXD1;PRKCD;PTPRK;JUN;MAPK1;PRKD1;WNT16;AKT1;TP53;PRKAA1;ERO1A;TPM1;CAT;NCF2;TXNRD2;MAPK8;ATF4;MSRA;GPX1;AGAP3;NOX4;FANCC;ARNT;CCS;SOD1;RPS3;VRK2;ERCC6L2;TXNRD1;KEAP1;SLC25A24;NFE2L2
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.6347252454483174,-1.502993156788232,0.0518783542039356,0.20807458175073595,1.0,4/10,9.84%,CD200;LRCH1;WASL;AKT1
prerank,somite development (GO:0061053),-0.6126806137796107,-1.5027002823244755,0.046992481203007516,0.20809365316007547,1.0,4/11,7.19%,SMO;LOXL3;MEOX2;MTHFD1
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.4748143591418795,-1.5026383948210544,0.03853211009174312,0.2077003104277507,1.0,12/28,20.86%,UBR5;PIK3R1;PRKCD;CDH1;FLNA;PSEN1;ZPR1;TPR;MAVS;ZIC1;HYAL2;TRIM28
prerank,cholesterol biosynthetic process (GO:0006695),0.46580020700722086,1.5000039280789812,0.027842227378190254,0.33157479774507664,1.0,12/31,13.87%,IDI2;INSIG1;LSS;HSD17B7;CYP51A1;SC5D;ACLY;SQLE;NSDHL;FDFT1;DHCR24;IDI1
prerank,regulation of AMPA receptor activity (GO:2000311),0.4753411386183579,1.499652384555091,0.03153153153153153,0.3298754587418454,1.0,13/25,19.35%,NLGN1;SHANK1;CACNG8;CACNG3;MINK1;CACNG2;CACNG4;PRRT1;NLGN2;CACNG5;SHISA9;CNIH2;NLGN3
prerank,regulation of immune effector process (GO:0002697),0.42662932469067594,1.498720143506771,0.0387243735763098,0.3292192378856719,1.0,10/41,13.29%,VTN;CPB2;PHB2;C9;CD81;SUSD4;C3AR1;CPN1;SERPING1;CLU
prerank,regulation of response to external stimulus (GO:0032101),-0.35883032187033187,-1.4985624774875757,0.0070052539404553416,0.2135910469842101,1.0,32/121,20.85%,FOXP1;IL1R1;XIAP;ADGRA2;CAV1;CASP12;SEMA7A;TMSB4X;BIRC3;STK24;SAMHD1;CD55;IRF1;NMT1;CELF1;CASP8;AREL1;JAK2;AGTR1;MGLL;USP18;SAG;NR1D2;N4BP1;ANXA1;ZMPSTE24;ERAP1;NOD2;DAGLB;TKFC;BCL6;AKNA
prerank,metal ion export (GO:0070839),0.4539932779173278,1.4985055590753542,0.03644646924829157,0.32722254634387765,1.0,7/31,8.71%,ATP1A2;KCNA5;ATP12A;ATP2B4;SLC4A4;ATP1B1;ATP4A
prerank,regulation of dendrite extension (GO:1903859),0.5119193130397889,1.4981247629903784,0.0405982905982906,0.32569875871263626,1.0,10/18,20.23%,SYT1;RIMS2;RIMS1;CPNE9;RNF157;SYT4;SYT3;UNC13A;SYT17;CPNE5
prerank,positive regulation of dendrite extension (GO:1903861),0.5180389559660644,1.4969048711782638,0.0379746835443038,0.3258770688706652,1.0,10/17,20.23%,SYT1;RIMS2;RIMS1;CPNE9;RNF157;SYT4;SYT3;UNC13A;SYT17;CPNE5
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.5189012680868542,-1.4959899698968186,0.0375,0.21720315900452952,1.0,13/21,27.98%,CAV1;NCK1;DDIT4;RASSF2;PPM1F;NCK2;SMAD7;CNKSR3;PTEN;GADD45A;INPP5J;DMTN;NLRP2B
prerank,supramolecular fiber organization (GO:0097435),-0.32035557508733514,-1.495448920991047,0.0,0.21765442512625294,1.0,83/333,17.16%,HIP1;TLL1;COL8A1;ITGA6;PGM5;SHROOM4;COL12A1;COL4A2;SNCAIP;MYO1D;COL25A1;CLIP1;USP9X;CD2AP;RAC1;SHROOM3;PLOD1;TPM3;PLOD2;ADAMTS2;RHOBTB1;CORO1C;COL4A6;APP;ELMO1;RND3;CGNL1;P3H2;COL5A1;ITGB4;LOXL3;LAMA3;COL4A5;DLG1;TMOD3;COL4A1;TGFB2;COL8A2;COL5A2;MYH11;MYO1F;BIN3;DNAJB6;HSPG2;COLGALT2;LOXL1;TSPAN14;ARHGEF2;DST;SHROOM1;ARHGAP17;BCAR1;ADAM10;SHROOM2;FBLN5;P4HA1;COL6A3;FAT1;DCTN1;COL15A1;TSPAN5;RHOA;ACTN1;LMOD1;TPM1;SLAIN2;CHP1;RHOC;RHOG;COL26A1;ELMO2;H3-3A;IAPP;HIP1R;COL6A2;TUBGCP4;MAD2L2;CORO7;SLK;TUBGCP5;COLGALT1;ARHGAP12;APH1A
prerank,heart development (GO:0007507),-0.35187642666548813,-1.494383555714038,0.003527336860670194,0.21878355356862716,1.0,45/150,16.41%,TEK;ACVRL1;MEF2A;AKAP13;HEG1;INSR;PKD2;BMPR2;KAT2B;BMP5;MICAL2;SH3PXD2B;TBX1;SOX17;CDKN1B;TGFBR3;PDLIM5;TGFBR2;NIPBL;TGFB2;SMYD4;PTK2;RBP4;BMP4;MTHFD1;ECE1;MEF2C;WDR11;PLCE1;TBX2;PDLIM1;KDM6A;PCSK5;CASP8;RAMP2;KDM6B;ZFPM1;NOTCH1;PDLIM3;RBM20;FOXC1;FLRT2;BCOR;BMP7;TAB2
prerank,response to ketone (GO:1901654),-0.4917120387512198,-1.494280650896843,0.041970802919708027,0.21843139053472374,1.0,7/24,8.80%,ABHD2;CAV1;THBS1;TGFBR3;SLIT2;TGFB2;YAP1
prerank,positive regulation of biosynthetic process (GO:0009891),-0.4464063517018967,-1.493911896145515,0.029513888888888888,0.2184933227792856,1.0,19/40,31.57%,SORBS1;ZBTB20;MTOR;PPARA;BMP4;RAB27A;PLCG2;AKT1;RGCC;CREBL2;CREB1;MTPN;ADGRB1;SLC5A3;F2R;LARP6;RUNX1;TGFB1;TLR6
prerank,cellular zinc ion homeostasis (GO:0006882),-0.4845102557469746,-1.4934048790598176,0.04007285974499089,0.2188216093596514,1.0,14/26,25.53%,SLC39A10;SLC30A10;SLC39A8;SLC30A5;SLC39A6;SLC30A1;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.4652692945645844,1.4929150053762534,0.04524886877828054,0.3318445377290041,1.0,11/31,19.27%,SYT1;SYT5;SYT12;SYT11;ADRA2A;SYT4;SYT3;SYT9;CACNA1G;CACNA1I;SYT17
prerank,regulation of microglial cell activation (GO:1903978),0.5531366170350509,1.4921133644688354,0.05803571428571429,0.3310798298231147,1.0,5/15,13.14%,NR1D1;SYT11;SPHK1;GRN;LDLR
prerank,receptor-mediated endocytosis (GO:0006898),-0.3561296290740858,-1.4919562266065602,0.005253940455341506,0.2206404878103049,1.0,38/132,15.35%,FCHO2;ITGB1;DNAJC13;CALCRL;INSR;CAV1;DAB2;DNM3;EPS15;FNBP1L;RAMP1;LDLRAP1;TFRC;AP2B1;SCARF1;AP2A2;DNM2;LRP6;NEDD4;AP2S1;PI4KB;SNX9;HSPG2;GPR107;SCARB1;PICALM;IGF2R;RAMP2;GAK;STAB1;FCHSD2;ADM;AP1G1;LMBRD1;ACKR3;GRB2;LMBR1L;HIP1R
prerank,alpha-amino acid metabolic process (GO:1901605),0.4286246793132591,1.4918025915383666,0.028384279475982533,0.32935659285380126,1.0,15/45,14.38%,SLC25A13;ASNS;DDAH2;OAT;GADL1;GNMT;PYCR2;RIMKLA;ASPA;DPEP1;THAP4;GLS2;GLS;GLUD1;GPT2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.38067761538960004,-1.4917883951359925,0.010398613518197574,0.22039694125886988,1.0,20/86,12.19%,RBPMS;ZNF423;ENG;ACVRL1;CREBBP;DAB2;BMPR2;THBS1;BMP5;RNF111;BMP6;TGFB2;BMP4;CDH5;SMAD2;ACVR2A;SMAD4;JAK2;HFE;NOTCH1
prerank,vacuolar acidification (GO:0007035),0.5001447818302865,1.4916280903927455,0.03941908713692946,0.3273648404690549,1.0,7/21,11.39%,TMEM9;CLN3;GRN;CCDC115;ATP6V0D2;ATP6V0A2;DMXL2
prerank,external encapsulating structure organization (GO:0045229),-0.33400559158036364,-1.4915393841685338,0.0,0.22029842430267427,1.0,55/205,12.36%,VWF;COL8A1;ITGA6;ELN;SH3PXD2A;PECAM1;ADAMTSL3;ITGB1;JAM2;BSG;COL4A2;ADAMTS2;COL4A6;THBS1;ITGA3;APP;F11R;VIT;SPOCK2;ITGA1;SMOC1;KDR;COL5A1;ICAM1;ITGB4;MMP2;LAMA3;LAMA4;ITGB5;COL4A5;COL4A1;COL8A2;COL5A2;SLC39A8;HRNR;AGRN;HSPG2;LOXL1;CDH1;ADAMTS9;ADAMTS4;LAMA1;ADAMTS10;BGN;FBLN5;ADAMTS5;ADAMTS20;COL6A3;ADAMTS17;COL15A1;LAMA5;FGF2;COMP;THSD4;LAMC3
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.5482859602324403,-1.491326052834592,0.05128205128205128,0.220183119796486,1.0,12/17,34.51%,BMP4;NOTCH2;GALNT11;NOTCH1;JAG1;HEY1;HEY2;DLL4;BMP2;SNAI2;TGFB1;BMPR1A
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.42089211137043164,-1.4900870874056307,0.01876172607879925,0.22156703565835792,1.0,13/52,9.84%,SPTBN1;PRKCH;SORBS1;ITGB1;PRKCE;ITGA3;PTPN9;EGFR;PIK3R1;DLG1;STX3;EPB41L2;AKT1
prerank,iron ion transmembrane transport (GO:0034755),-0.6403390568401348,-1.4899086731532567,0.05166051660516605,0.22134932846916208,1.0,5/10,16.79%,SLC40A1;SCARA5;SLC39A8;ABCB7;SLC25A28
prerank,negative regulation of blood pressure (GO:0045776),-0.5831995522865423,-1.489734258876953,0.047186932849364795,0.22116397762915196,1.0,8/13,35.49%,NOS3;BMPR2;SCPEP1;PRCP;NOS1;APLN;NOS2;DRD3
prerank,response to thyroid hormone (GO:0097066),-0.5847837297599048,-1.4892217381223518,0.061946902654867256,0.22142348715652002,1.0,9/13,33.15%,LMO2;THRB;MED1;KLF9;CTSH;GAS2L1;RDX;BRD8;HPN
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5972278777798333,-1.4890944426368187,0.04936014625228519,0.22112803826373795,1.0,5/12,14.99%,PRKG1;DOCK4;MEF2C;TPM1;IGFBP5
prerank,regulation of RNA metabolic process (GO:0051252),-0.4073524173482069,-1.4877154885843857,0.023090586145648313,0.22296766214814853,1.0,18/59,14.58%,MBNL1;MBNL2;ZNF326;MITF;AHNAK;METTL4;TNFRSF1B;NOVA2;FUS;MED1;AHNAK2;CELF1;HNRNPF;RASA1;SON;CLK3;RBM20;RC3H1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.3180077976676265,-1.4875496443231964,0.0017064846416382253,0.22274360666992257,1.0,111/348,22.40%,LEF1;CLDN5;RESF1;UBR5;NOS3;INSR;KLF4;ETS1;CD34;TNRC6B;LIMS1;MED26;KLF2;GSK3B;ANXA2;PTPN1;APP;ATM;DTX3L;MITF;DDX3X;MTOR;SMO;TFRC;MSN;SP1;CTCF;BMP6;AFDN;GAS6;PDE2A;MED1;SEC16B;FGF1;BMP4;ECE1;MEF2C;EZR;CDH5;NGF;SMAD1;ACTA2;MAPK1;ROCK1;PPM1F;RAB27A;NOS1AP;YAP1;PLCG2;CELF1;GSK3A;OCLN;WNT16;PIK3CD;FGF7;RAMP2;AKT1;MYOM1;TASOR;TP53;PRKAA1;RGCC;PSEN1;BRAF;MAZ;HFE;NOTCH1;FGF2;WNT11;ZPR1;PLSCR1;MAPK8;ATF4;PIK3CB;AGO2;FAM98A;HCFC1;ROCK2;TADA3;RPL5;VSIR;TERF2;ANGPT1;PIK3R3;BMP7;IGF1;MOV10;SRPK2;DNMT1;CTSH;FUBP1;PPHLN1;HEY1;HEY2;RPS3;CITED2;VAMP3;GATA2;TNRC6A;PRKAB1;KRAS;F3;FGFR4;BRCA1;TRIM28;DLL4;WARS1;MAPK7;RPS7;NFE2L2;GABPA
prerank,negative regulation of TOR signaling (GO:0032007),-0.4472381356583102,-1.4873898382934119,0.030821917808219176,0.22253747143452504,1.0,14/36,20.40%,SH3BP4;SESN1;ATM;DDIT4;GSK3A;UBR2;PRKAA1;KPTN;CASTOR1;UBR1;RNF152;ITFG2;TMEM127;AKT1S1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.48231260303367535,-1.487270922951989,0.03308823529411765,0.22221402389947423,1.0,9/29,11.88%,TJP1;SHANK3;LIMA1;KANK3;SLIT2;PRKCD;KANK4;SMAD4;ARFGEF1
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.5110381906503043,-1.4860550045360927,0.05904059040590406,0.22377661047907155,1.0,10/21,16.67%,CORO1C;MACF1;PTK2;ROCK1;LDB1;RHOA;LIMCH1;DUSP3;ROCK2;SLK
prerank,glycerolipid catabolic process (GO:0046503),-0.5368548649620868,-1.4859562894619087,0.05244755244755245,0.22340421651254044,1.0,6/19,13.54%,GPCPD1;ABHD2;PLA2G4A;GDPD1;MGLL;GDPD3
prerank,cardiac atrium morphogenesis (GO:0003209),-0.5523806865562089,-1.4858429922544116,0.039723661485319514,0.22308379297152697,1.0,9/16,24.99%,ENG;BMPR2;TGFB2;NOTCH2;ZFPM1;NOTCH1;HEY2;DLL4;BMP2
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.4851780596270419,-1.4853084630169462,0.034782608695652174,0.2234511578252665,1.0,10/27,15.76%,CREBBP;KAT6B;KAT2B;KAT6A;PHF20;TRRAP;SGF29;PHF20L1;KAT5;RUVBL2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5306718684934808,-1.4852635670722196,0.05474452554744526,0.22302345514888056,1.0,7/18,17.78%,ITGB1;JAM2;SLC39A8;ROCK1;ITGA4;VCAM1;GOLPH3
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.5238062561024116,-1.4850880804664806,0.05545286506469501,0.22281430344765138,1.0,9/20,14.53%,PPP2R5A;DAB2;RHOQ;PPFIA1;PICALM;ABI3;PKDCC;CSK;NUMB
prerank,regulation of fat cell differentiation (GO:0045598),-0.39449686285558194,-1.4850305601525335,0.01565217391304348,0.22245360646670587,1.0,30/74,26.77%,ZBTB16;FOXO1;FERMT2;LRP5;ASXL1;TRPM4;FTO;YAP1;PPARD;AKT1;ANKRD26;ZFPM1;LPL;TMEM64;TRIO;TAF8;CREBL2;CARM1;CMKLR1;GATA2;PPARG;AAMDC;CREB1;SYAP1;TRIB3;GPS2;PTPRQ;BMP2;ZFP36L1;FRZB
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.5432149545501481,1.4848657519295638,0.07349665924276169,0.3391978944306498,1.0,5/16,12.16%,ATP1A2;CALM2;RYR2;SLC8A1;HRC
prerank,peptidyl-serine modification (GO:0018209),-0.33996685545673666,-1.483803919160759,0.0017241379310344827,0.22386742765974216,1.0,55/166,19.55%,PRKCH;DYRK1A;CSNK1A1;PRKCE;TLK2;GSK3B;ATM;MARK1;RPS6KA5;PAK2;LRRK2;NEK6;MTOR;PRKD2;TLK1;CSNK1G3;TGFBR2;RICTOR;GAS6;MAST4;MAST2;PRKCD;MAPKAPK2;PLK2;MAPK1;ROCK1;PRKD1;AKT3;LATS2;CLSPN;AKT1;STK32C;IKBKE;STK38;RPS6KA1;CSNK1G1;CSNK1D;ULK2;MKNK2;MAPK8;PKN2;RPS6KA3;MARK2;PKN3;ROCK2;MAPK12;SRPK2;MARK3;HIPK1;HPF1;IKBKB;GALNT1;VRK2;POGLUT3;PRKDC
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3847871785454972,-1.4820136478749324,0.019469026548672566,0.2262659238015927,1.0,27/82,16.46%,ZHX3;FERMT2;CRIM1;LRP5;BMPR2;SMOC1;IL6ST;TRPM4;LIMD1;BMP6;IL6R;PTK2;BMP4;MEF2C;PRKD1;YAP1;ACVR2A;TWIST2;NOTCH1;TMEM64;CDK6;HGF;ATF4;SMAD6;BMP7;IGF1;SKI
prerank,inositol lipid-mediated signaling (GO:0048017),-0.4160888619229648,-1.4819606962879002,0.03041144901610018,0.22587806645811478,1.0,17/50,16.38%,IGF1R;PLCB4;PLCB3;PIK3R1;IRS1;PLCB1;PI4KB;EZR;PIK3C2A;NGF;PLCE1;PIK3CD;RHOA;PIK3CB;GAB2;TNFAIP8L3;IGF1
prerank,regulation of dendritic spine development (GO:0060998),0.4986762699601344,1.4819099462923946,0.046189376443418015,0.3432541885217213,1.0,9/19,14.63%,NLGN1;PPFIA2;SHANK1;CAMK2B;TANC2;PTPRS;CPEB3;GRIN3A;APOE
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.3961899354166202,-1.4812065224605828,0.019230769230769232,0.22670924446734647,1.0,19/62,16.58%,ZBTB16;CREBBP;CBFB;LYN;TNRC6B;THBS1;KAT2B;CNOT4;KMT2E;HDAC1;MEF2C;SIN3A;ZFPM1;CDC73;ASH2L;CDK6;H3-3A;KMT2C;MOV10
prerank,axonemal dynein complex assembly (GO:0070286),0.47249635240022914,1.480640599350268,0.057007125890736345,0.3434840483978857,1.0,11/27,18.48%,DNAAF3;SPAG1;CCDC63;ODAD2;DNAAF5;DNAAF1;DNAI4;ODAD1;DNAAF2;LRRC49;ODAD3
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.39866924863099645,-1.4793244187981525,0.02491103202846975,0.22930547396168743,1.0,19/65,15.35%,HIP1;DAB2IP;AFAP1L2;EPS15;ITGA1;PTPRJ;EGFR;PTPN12;CBL;EPS15L1;RNF115;RHBDF2;AKT1;ARAP1;PTPN3;CEACAM1;DUSP3;GRB2;HIP1R
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.44548111251183414,-1.4789585584404012,0.04151624548736462,0.2294498718758498,1.0,13/39,15.65%,DAB2IP;EPS15;ITGA1;PTPRJ;EGFR;PTPN12;CBL;EPS15L1;RNF115;PTPN3;DUSP3;GRB2;LGMN
prerank,dopamine metabolic process (GO:0042417),-0.5251836394111088,-1.478717301208183,0.06761565836298933,0.2293561139639691,1.0,4/18,10.24%,SNCAIP;TGFB2;GCH1;MAOA
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.6145895252769362,1.4787078140206869,0.06100217864923747,0.3452843434126068,1.0,4/10,12.08%,PDE4B;CACNA2D1;CACNB3;SRI
prerank,transcription by RNA polymerase II (GO:0006366),-0.3199887644425591,-1.4781417575350229,0.0,0.2298784840639769,1.0,98/305,24.63%,RREB1;MNAT1;INTS8;CREBBP;CBFB;NR3C2;ESR1;MLLT3;TEAD4;MED26;MAML2;CDK13;RXRA;PRRX1;KAT2B;SETD2;DEK;TEAD1;NR3C1;THRB;NFIX;CDK12;NOTCH3;SP1;HDAC1;NFKB1;PPARA;RARG;RPRD2;IWS1;MED1;EAF1;MAML1;POLR2G;NOTCH2;NABP1;YAP1;PPARD;GTF2E1;GTF2E2;ERCC2;TAF11;CPSF7;NOTCH4;NFIC;MAZ;ICE1;MED17;NOTCH1;INTS3;CDC73;SNAPC1;RTF1;TCEA1;LSM11;TAF5L;TAF1C;MLLT1;SNRPE;ATF4;TAF8;ERCC3;NR1D2;NR2C1;PIR;INTS9;TAF7;GTF2I;RARA;TAF3;HDAC10;LSM10;NELFB;PHAX;HSF2BP;FIP1L1;ELOF1;ADRM1;TBL1X;PPARG;RARB;ELOC;MED27;HDAC7;TAF4B;INTS7;SNAPC3;TAF13;RXRG;MED20;SUPT4H1;POLR2C;CCNK;GMEB2;E2F3;TAF9;TFDP1;TAF15
prerank,negative regulation of hippo signaling (GO:0035331),-0.5932981066801566,-1.4779297389678316,0.06486486486486487,0.2297434315094418,1.0,7/12,23.64%,WWC2;VGLL4;LIMD1;MARK3;WTIP;MAP2K3;AJUBA
prerank,positive regulation of kinase activity (GO:0033674),-0.3584766174939415,-1.4775956138553572,0.01509433962264151,0.22976901215520684,1.0,23/107,8.85%,FLT1;TEK;IGF1R;RAPGEF2;TIE1;ROR1;INSR;IQGAP1;KDR;MERTK;EGFR;GAS6;MRNIP;DSTYK;LMO4;PTK2;RASSF2;RAP1A;SNX9;MRE11;EPHA4;MMD;FLT4
prerank,regulation of response to stress (GO:0080134),0.6173642298859964,1.4771604750698255,0.08131868131868132,0.3462965266367916,1.0,3/10,8.60%,OPRM1;ADCY8;CORO2B
prerank,negative regulation of growth (GO:0045926),-0.3601203781718381,-1.4770134986517727,0.016363636363636365,0.2301843010650744,1.0,47/121,25.55%,APBB2;SMARCA2;ACVRL1;RB1;DCUN1D3;BMPR2;SH3BP4;DDX3X;PTPRJ;SOX17;CDKN1B;VGLL4;CRLF3;SLIT2;TGFB2;NOTCH2;SMAD4;TP53;DCBLD2;NOTCH1;WNT11;ST7L;CCN3;RERG;NPR1;OSGIN2;HYAL2;PPP2CA;BCL6;CDKN2C;CAPRIN2;FHL1;MSX1;SERTAD2;HSPA1B;GNG4;APBB1;SIPA1;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;SERTAD3
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.5348346552485244,-1.4764705347746545,0.051188299817184646,0.2306275410143023,1.0,9/18,17.60%,HEG1;ITGA3;SCAI;RASIP1;CUL3;TNFAIP1;MYOC;KCTD10;ARHGAP35
prerank,atrial septum development (GO:0003283),-0.5694934187751156,-1.476444870399136,0.05357142857142857,0.23018474841875847,1.0,7/13,26.08%,BMPR2;TGFB2;NOTCH2;ZFPM1;HEY2;DAND5;GJA5
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.39909700350811445,-1.4764284680792494,0.012006861063464836,0.2297411382025618,1.0,20/59,24.76%,DAB2IP;ERC1;TAB3;BIRC3;NFKBIA;ROCK1;AKT1;NFKBIL1;ROCK2;TNFRSF1A;TAB2;IRAK2;IKBKG;MAP3K14;IKBKB;TBKBP1;NKIRAS2;RELA;RIPK1;MAP3K7
prerank,protein acetylation (GO:0006473),-0.4583121972783758,-1.4762103358018224,0.030575539568345324,0.22957855852530556,1.0,8/30,12.91%,FOXO1;CREBBP;KAT2B;KAT6A;NAA16;NAA80;NAA15;KAT5
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.4430498945073817,-1.4758225761436177,0.03741496598639456,0.2296871987535236,1.0,17/36,25.25%,LEF1;GNB1;TNRC6B;FZD6;NFATC1;FZD4;PLCB3;PLCB1;WNT11;AGO2;MOV10;CTNNB1;TNRC6A;TCF7L2;FZD5;MAP3K7;GNG2
prerank,regulation of protein phosphorylation (GO:0001932),-0.324460569640075,-1.475718066833307,0.0,0.22935702023999094,1.0,87/256,24.16%,TEK;DAB2IP;PECAM1;ENG;NSD1;PPP2R5A;INSR;BMPER;DAB2;RAC1;FAM20A;LYN;CORO1C;DVL3;APP;RALBP1;LIMK2;TBX1;LRRK2;KDR;NIBAN1;SLCO3A1;EGFR;TFRC;GAS6;ABL1;FAS;IL34;LRP6;SLIT2;CCND3;PTK2;IRGM;FGF1;BMP4;CDH5;PLCE1;FLT4;ACVR2A;OCLN;FGF7;AKT1;VEGFC;AXIN2;STAT2;ILK;FNIP2;FGF2;LIMCH1;CSNK1D;PTPN13;FLOT1;CHP1;CD40;HGF;ATF4;TRAF3IP1;DNAJC10;ROCK2;ANGPT1;PELI2;PIK3R3;BMP7;FYN;CDK5RAP3;MAVS;SOD1;RAP2A;AKTIP;CCND1;BRAT1;PPP2CA;PRKDC;KRAS;PTEN;ITGB3;IGF2;P2RY1;WARS1;CCN1;HSP90AA1;RIPK1;EIF2AK3;RALB;PLPP3;ARRB1;PPP2R5E
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.3987153002461849,1.4752890009131083,0.0228310502283105,0.3478614010010389,1.0,11/54,6.43%,KCNIP4;DPP10;KCNIP1;KCNMA1;DPP6;KCNJ3;AKAP6;KCNN2;GABBR2;CD63;CACNA1D
prerank,negative regulation of cellular process (GO:0048523),-0.30178345180884264,-1.4746606656762515,0.0,0.2304765901261031,1.0,187/521,27.14%,APBB2;DAB2IP;SMARCA2;IGFBP7;RAPGEF2;SP100;ACVRL1;JAM2;PPP1R13B;RB1;PODXL;FERMT2;NOS3;DCUN1D3;PTPN14;KLF4;ETS1;ABI1;PKD2;CBFA2T3;CD34;MYH9;LYN;BMPR2;PDS5B;CBLL1;CD200;SH3BP4;BTG3;APP;KAT2B;BMP5;RNF139;ITGA1;TBX1;ARID2;DDX3X;P3H2;THAP12;PTPRJ;SOX17;CDKN1B;TGFBR3;VGLL4;CRLF3;CTCF;DYSF;TNFRSF1B;RARG;RBM5;NCK1;NMI;PDCD4;SLIT2;TGFB2;SUZ12;AQP11;BMP4;BNIP3;PTPRK;CDK10;ARHGDIA;NGF;PLXND1;PLXNA4;PRKD1;RAF1;IRF1;CELF1;SMAD4;WNT16;CTBP2;ADAM10;VPS13C;CHMP4B;TP53;FRK;UBR2;KLF10;NOTCH4;AXIN2;NCK2;RGCC;LMNA;SOX7;TXNIP;JAK2;ZBTB7C;DCBLD2;RASA1;NOTCH1;FGF2;RAD18;ACTN1;CDC73;CTTNBP2NL;WNT11;CCN5;CDK6;TBRG1;PLSCR1;ST7L;PDE12;NUDT6;RNF167;IFI35;BTG2;MIF;ATG5;CCN3;FUZ;SMAD6;FOXO4;RERG;ANGPT1;BMP7;SKI;NPR1;GSDME;NOX4;PIP4P2;CTNNB1;TFAP4;ADARB1;OSGIN2;TNS2;ADGRG1;VAMP3;TES;HYAL2;BAP1;PPM1D;SOX4;PPP2CA;TGFBI;TMEM127;PTEN;BCL6;TOB1;LPCAT3;DLL4;BLM;WARS1;CDKN2C;ROR2;CAPRIN2;DIS3L2;NOS1;PTK2B;CCN1;FHL1;MYOCD;PARP16;BECN1;TXNDC12;MSX1;EIF2AK3;SFRP4;COPS8;CEBPA;CYP1B1;ATF5;SERTAD2;E2F7;SEMA5A;HSPA1B;PINX1;GNG4;PLXNB1;ADGRB1;BMP2;PLPP1;APBB1;SIPA1;SERTAD3;PTPN2;TPTE;NUPR2;CDKN3;APC;VPS35;EMILIN1;FRZB;RND1;F2R;FABP3;CGREF1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.37274145559264393,-1.474498792970577,0.012027491408934709,0.2302446266685731,1.0,29/94,17.21%,DAB2IP;ITPR1;PPP1R13B;MCL1;ATM;MAP3K5;DDX3X;FHIT;TNFRSF1B;STK24;ABL1;CUL3;PRKCD;BNIP3;ERN1;CUL2;PPM1F;ATP2A3;ARL6IP5;TP53;FNIP2;IKBKE;ERO1A;ATF4;DNAJC10;BBC3;BCL2L11;HIC1;HINT1
prerank,regulation of protein binding (GO:0043393),-0.3643419695970215,-1.4740867882661666,0.012389380530973451,0.2305050287277216,1.0,45/114,26.65%,RAPGEF2;CLDN5;CAV1;DAB2;GSK3B;APP;CRK;DTX3L;LRRK2;LDLRAP1;STK3;PRKCD;SPPL3;BMP4;ROCK1;NES;AKT1;PSEN1;ZFPM1;HFE;HDAC4;ACTB;FLOT1;MAPK8;BTBD1;MARK2;HIP1R;CTSZ;MITD1;PEX14;MARK3;AKTIP;PPP2CA;TFIP11;TCF7L2;CTNNBIP1;TERT;CAPRIN2;RALB;PPP1CA;TRIB3;BMP2;LRP1;HDAC5;RAN
prerank,cell-cell junction organization (GO:0045216),0.3752633161936383,1.4737431002936485,0.0136986301369863,0.3489266672462942,1.0,24/79,11.59%,CDH18;CADM2;CDH8;CTNND2;CDH20;CDH9;CDH10;CD177;PKP2;DCHS1;CDH19;CXADR;FLCN;CDH12;ANG;FSCN1;NECTIN3;SDK1;CDH7;CDH17;CDH24;CDHR3;CSF1R;CDH2
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.43154242221438766,1.4736336519571216,0.03935185185185185,0.346826903006046,1.0,11/39,7.32%,FGF14;ANK3;HECW1;FGF12;SCN1B;OSR1;GPD1L;WNK2;HECW2;WNK3;NETO1
prerank,protein localization to chromatin (GO:0071168),-0.5226417592081019,-1.472467950824028,0.054844606946983544,0.23267812675041186,1.0,9/18,17.79%,ESR1;NIPBL;MRNIP;SGF29;MCM9;WAPL;TASOR;RUVBL2;PPHLN1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.5675241832567418,1.4719294819857685,0.07226107226107226,0.3481034186907211,1.0,4/12,9.47%,DGKQ;H6PD;CLCN2;ABCA2
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.5220308796362654,-1.471678880965862,0.0544464609800363,0.23359896597231375,1.0,10/19,19.06%,BMPR2;TGFBR2;TGFB2;SMAD4;ZFPM1;NOTCH1;SMAD6;HEY1;HEY2;SOX4
prerank,manganese ion transport (GO:0006828),-0.561375018241528,-1.4708717388702064,0.05405405405405406,0.23447374960375597,1.0,5/14,16.74%,SLC30A10;TRPC4;SLC39A8;TRPC6;TRPC3
prerank,negative regulation of protein kinase activity (GO:0006469),-0.37510515160026553,-1.4698921214579204,0.011986301369863013,0.2357005282669127,1.0,30/88,22.39%,PTPRB;DAB2IP;RB1;CAV1;LRP5;CORO1C;PTPN1;CEP85;PAK2;CDKN1B;RTRAF;ABL1;LRP6;PPM1F;SH3BP5L;PRKRIP1;AKT1;CEACAM1;DUSP3;CHP1;TAF7;UBASH3B;ADARB1;CDK5RAP3;HYAL2;PTPRC;AKT1S1;NF1;WARS1;GADD45A
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.5297930837113125,-1.4698188645775694,0.054003724394785846,0.2353265803772578,1.0,11/18,36.43%,CD34;CD200;TGFB2;SMAD4;LGALS9;LRRC32;LTBP1;LILRB1;HIF1A;SMAD3;ITGB6
prerank,regulation of protein localization to nucleus (GO:1900180),-0.4297048476250221,-1.4692423934490804,0.045060658578856154,0.235791019908581,1.0,15/43,17.81%,CTNNA1;FERMT2;MFHAS1;GSK3B;LIMK2;DTX3L;TFRC;BMP4;YAP1;LATS2;AKT1;SIN3A;ILRUN;TPR;CDK5RAP3
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.5976488320894977,-1.4690577525554978,0.06642728904847396,0.23566189329835935,1.0,6/11,28.55%,CAV1;NEDD4L;CASQ2;KCNH2;CAB39;ACTN2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.32381312242504867,-1.4689302849100507,0.0017035775127768314,0.23538438070643025,1.0,69/248,16.07%,DAB2IP;XIAP;UBR5;ADGRA2;CSNK1A1;CAV1;DAB2;MLLT3;SMURF2;FZD6;GSK3B;DVL3;MCC;PSMA2;LRRK2;IGFBP4;DDX3X;ZNRF3;SOX13;SOX17;EGFR;EMD;KREMEN1;CSNK1G3;TRPM4;FZD4;LIMD1;HDAC1;FRMD8;NFKB1;RBX1;STK3;OTULIN;LRRK1;CUL3;LRP6;NKD1;PSME2;KLHL12;CTNND1;PSMB4;GLI3;GSK3A;LATS2;PPM1B;UBAC2;AXIN2;CCNY;ILK;PSEN1;SOX7;CSNK1G1;DKK2;CSNK1D;TMEM64;NOTUM;WNT11;PLEKHA4;PSMC2;LMBR1L;TMEM170B;LYPD6;USP34;PSMB2;FUZ;RUVBL2;PSMB1;MAD2L2;DAAM2
prerank,extracellular structure organization (GO:0043062),-0.3295911987087321,-1.4689251131713263,0.0,0.23491246451448966,1.0,54/204,12.36%,VWF;COL8A1;ITGA6;ELN;SH3PXD2A;PECAM1;ADAMTSL3;ITGB1;JAM2;BSG;COL4A2;ADAMTS2;COL4A6;THBS1;ITGA3;APP;F11R;VIT;SPOCK2;ITGA1;SMOC1;KDR;COL5A1;ICAM1;ITGB4;MMP2;LAMA3;LAMA4;ITGB5;COL4A5;COL4A1;COL8A2;COL5A2;SLC39A8;AGRN;HSPG2;LOXL1;CDH1;ADAMTS9;ADAMTS4;LAMA1;ADAMTS10;BGN;FBLN5;ADAMTS5;ADAMTS20;COL6A3;ADAMTS17;COL15A1;LAMA5;FGF2;COMP;THSD4;LAMC3
prerank,hippo signaling (GO:0035329),-0.4895084091362773,-1.4683296857474135,0.05244755244755245,0.23542598943013734,1.0,9/26,11.87%,TJP1;TEAD4;TEAD1;YWHAE;STK3;TJP2;YAP1;LATS2;SAV1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.5626445894691203,-1.4677872985080562,0.055865921787709494,0.23591404918727477,1.0,10/15,27.32%,TNRC6B;TENT4B;POLR2G;TENT4A;AGO2;BTG2;TNRC6A;TOB1;CNOT1;PABPC1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5585192766063074,-1.4676143161856614,0.058394160583941604,0.23577303053015514,1.0,8/15,25.77%,RSPO3;ZNRF3;RNF213;CSNK1D;DAAM2;GPC3;SFRP4;WNT5B
prerank,synaptic vesicle membrane organization (GO:0048499),0.5212970869033259,1.4673323282066,0.08314606741573034,0.35544641946861705,1.0,5/17,12.45%,SNAP25;STX2;PRRT2;SYP;SYNGR1
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.33894362468177897,-1.4669945040316594,0.008561643835616438,0.2363773576619658,1.0,66/166,28.42%,MNAT1;CREBBP;NR3C2;ESR1;TEAD4;MED26;MAML2;RXRA;KAT2B;TEAD1;NR3C1;THRB;NOTCH3;HDAC1;PPARA;RARG;MED1;MAML1;POLR2G;NOTCH2;YAP1;PPARD;GTF2E1;GTF2E2;ERCC2;TAF11;NOTCH4;TAF1B;BRF1;MAZ;MED17;NOTCH1;TAF1C;TAF8;ERCC3;NR1D2;NR2C1;CAVIN1;TAF7;RARA;TAF3;HDAC10;NCOA6;TBL1X;PPARG;RARB;MED27;HDAC7;TAF4B;UBTF;TAF1D;TAF13;RXRG;POLR2C;E2F3;TAF9;TAF15;POLR1E;POLR2L;POLR2H;HDAC5;RSF1;GTF2H3;MAML3;E2F2;CCNH
prerank,inorganic anion transmembrane transport (GO:0098661),0.382262324392162,1.4665273556806715,0.01650943396226415,0.354790264822022,1.0,13/63,9.50%,GLRA3;GABRG3;GABRB1;GABRB3;ANO3;GLRA1;GABRB2;GABRA2;SLC25A3;ANO4;SLC12A5;GABRA3;GABRA1
prerank,endothelial cell migration (GO:0043542),-0.4429766544723617,-1.4657868777027756,0.03898305084745763,0.23785411429545725,1.0,18/37,25.35%,NOS3;ADGRA2;MYH9;ID1;PLEKHG5;PXN;ABL1;CDH5;PLXND1;STARD13;RHOA;CCN3;LGALS8;GIPC1;CYP1B1;EGR3;TNFSF12;PIK3CA
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.5381154981002573,-1.4657193701649327,0.051001821493624776,0.2375014055377599,1.0,6/18,11.09%,DNAJC13;DAB2;MSN;EZR;MAPK1;SNX12
prerank,response to cytokine (GO:0034097),-0.352168034529392,-1.465641307156407,0.0017699115044247787,0.23713469980825694,1.0,35/141,13.89%,LEF1;IL1R1;OSMR;SP100;NFAT5;PTPN14;MCL1;APP;TRIM56;SETD2;PTPN9;LDLRAP1;MAP4K3;IL6ST;PTPN12;ADAM9;IL6R;GGT5;GCH1;MAPKAPK2;LIFR;HAX1;CASP8;ADAM10;IKBKE;JAK2;IFITM3;TIMP3;RHOA;IRAK1;HDAC4;PTPN13;CD40;PLSCR1;MAPK8
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.31611277022525375,-1.4654952169235775,0.0,0.23687977464555432,1.0,76/327,16.35%,APBB2;NFIA;RREB1;SMARCA2;ZNF423;ENG;ACVRL1;CREBBP;NSD1;RB1;BNC2;ZMIZ1;KAT6B;ERC1;INSR;ESR1;FOXN3;ZFHX3;IRF2;RPS6KA5;WWC2;ZSCAN21;MITF;NR3C1;SOX13;SOX17;PSPC1;SP1;VSX1;LIMD1;SIX1;RYBP;ABL1;DNM2;TRRAP;NSD3;FUS;NFYC;GTF2IRD1;MEF2C;SLC39A8;ZBTB4;ASCC1;NAB1;LDB1;PRDM2;GPBP1;SPTY2D1;SP3;USP13;TP53;HMG20A;PRRX2;SOX7;JMJD1C;CHD3;YAF2;NOTCH1;SFPQ;OGG1;ACTN4;TAF5L;ATF4;MZF1;GPBP1L1;NR1D2;HCFC1;TCF3;TCF7L1;FOXC1;MYBL2;NAB2;UBE2L3;FOXO4;CREBL2;HIC1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5546868912845919,-1.4651890860586605,0.0456140350877193,0.2369279552816219,1.0,5/15,6.37%,EDA;ANKRD11;TBX1;HDAC1;LRP6
prerank,regulation of cell population proliferation (GO:0042127),-0.29422223283091964,-1.4649727818437537,0.0,0.23683798003755982,1.0,231/691,27.22%,FLT1;TJP1;LEF1;GRK5;DAB2IP;IGF1R;SMARCA2;KITLG;IGFBP7;OSMR;RAPGEF2;ELN;CLDN5;ENG;ACVRL1;XIAP;NOS3;PTPN14;INSR;KLF4;ETS1;ABI1;PKD2;CBFA2T3;LRP5;LYN;ACER2;BMPR2;PDS5B;CD200;LIMS1;SH3BP4;RBFOX2;BTG3;PDGFD;THBS1;CDK13;GCNT2;APP;KAT2B;BMP5;RNF139;ITGA1;TBX1;ARID2;IL15;KDR;P3H2;THAP12;PTPRJ;EGFR;IL6ST;TFRC;CDKN1B;TRPM4;TGFBR2;CTCF;BMP6;HDAC1;IL6R;HES1;JAG2;RARG;SIX1;RBM5;IRS1;NMI;STX3;IL34;CUL3;DNAJA2;TGFB2;PTK2;STAT6;AQP11;FGF1;BMP4;STAMBP;PTPRK;CDK10;NGF;JUN;TBX2;BIRC6;ARHGEF2;RAF1;YAP1;NOP2;FLT4;IRF1;LIFR;CELF1;NAMPT;CTBP2;ADAM10;FGF7;AKT1;VEGFC;TP53;FRK;KLF10;EDN1;DOT1L;AXIN2;PTGFR;NCK2;STAT2;RGCC;LMNA;SOX7;JAK2;ZBTB7C;MAZ;EDN3;ACER3;AGTR1;NOTCH1;RHOA;FGF2;CDC73;HDAC4;CDC123;ASH2L;RHOG;CDK6;TBRG1;KSR1;RPS4X;MECP2;NUDT6;FAM98A;COPS9;JAG1;IFI35;BTG2;NUAK1;GAB2;FUZ;SMAD6;LGMN;FOXO4;RERG;IGF1;SKI;SRPK2;COX17;GSDME;NOX4;SIX4;RARA;CTSH;CTNNB1;TFAP4;ADARB1;TNS2;ADGRG1;CACUL1;CLCF1;TNFSF13;TBC1D8;TES;BAP1;PPM1D;SOX4;DUSP22;PRKDC;TCF7L2;TIMELESS;KRAS;TMEM127;PTEN;BCL6;ECRG4;FGFR4;PRC1;IL13RA1;TOB1;IGF2;DLL4;MDM2;NACC1;S1PR3;WARS1;CDKN2C;ROR2;PDGFRB;DIS3L2;LAMC2;PTK2B;TTK;RELA;MYOCD;PTN;ESM1;TBX3;HAS2;CEP131;SFRP4;COPS8;CEBPA;CYP1B1;ATF5;E2F7;HSPA1B;ACE2;PINX1;IL7;MVD;ADGRB1;BMP2;PLPP1;CDCA7;PTPN2;CNOT8;ZFP36L1;ADAM17;TBX6;RPS15A;TPTE;NUPR2;CDKN3;TNFRSF9;APC;FGF10;FRZB;F2R;KIF14;FABP3;CGREF1;HILPDA;IL12RB2
prerank,negative regulation of GTPase activity (GO:0034260),-0.49362420379019983,-1.4649006535607219,0.05525846702317291,0.2364959412549448,1.0,8/22,11.88%,DAB2IP;SH3BP4;F11R;LRCH1;LRRK2;RASA4;BCAS3;ARFGEF1
prerank,zinc ion homeostasis (GO:0055069),-0.46355023174998167,-1.4648980130692821,0.03374777975133215,0.23602803865147437,1.0,14/28,25.53%,SLC39A10;SLC30A10;SLC39A8;SLC30A5;SLC39A6;SLC30A1;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F
prerank,positive regulation of cell adhesion (GO:0045785),-0.38561592498496355,-1.4647987806821154,0.01092896174863388,0.23568898194261448,1.0,20/74,12.82%,RSU1;RAC1;ZFHX3;LIMS1;ATM;VIT;PRKD2;PTPRJ;ADAM9;AFDN;STX3;TGFB2;TGM2;PPM1F;EPHA4;FBLN2;JAK2;SMAD7;FRMD5;TPM1
prerank,cellular response to increased oxygen levels (GO:0036295),-0.6065069877485936,-1.4647344824448403,0.05156537753222836,0.2353386035497276,1.0,4/11,6.09%,FOXO1;CAV1;ATG7;FAS
prerank,chloride transport (GO:0006821),0.3804783893171419,1.464684922386064,0.025943396226415096,0.35631539446585325,1.0,18/74,14.47%,GLRA3;GABRG3;GABRB1;GABRB3;CLCNKA;ANO3;GLRA1;GABRB2;GABRA2;ANO4;CLCN2;SLC12A5;GABRA3;GABRA1;SLC12A4;SLC1A3;GABRE;SLC26A8
prerank,regulation of cholesterol storage (GO:0010885),-0.5526657838233341,-1.4640819069456545,0.06608695652173913,0.2360798167538289,1.0,6/15,20.11%,PPARA;PPARD;SCARB1;EHD1;LPL;PPARG
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.41041121533938907,-1.4639976328340154,0.024344569288389514,0.23576539550104633,1.0,13/52,9.84%,SPTBN1;PRKCH;SORBS1;ITGB1;PRKCE;ITGA3;PTPN9;EGFR;PIK3R1;DLG1;STX3;CNST;AKT1
prerank,regulation of glycogen metabolic process (GO:0070873),-0.5909245719942554,-1.463841954845146,0.05860805860805861,0.23553032227808787,1.0,3/12,9.84%,PPP1R3B;PPP1R3C;AKT1
prerank,regulation of vasoconstriction (GO:0019229),-0.4689219707806426,-1.4637713564467478,0.043478260869565216,0.23516291150408872,1.0,8/27,11.79%,CAV1;BMPR2;ADRA1B;ACE;TRPM4;ECE1;ADM;AGTR1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5395995113747706,-1.463744993662691,0.05169340463458111,0.23471915538293442,1.0,6/16,9.64%,PDGFD;PTPN1;PTPRJ;ABL1;PIK3C2A;BCAR1
prerank,calcium ion transmembrane transport (GO:0070588),0.3648134967292931,1.463169513183244,0.00663716814159292,0.35743327645363837,1.0,16/86,8.06%,TRPM3;SLC24A4;SLC24A2;GRIN2B;SLC25A23;RYR3;PHB2;ATP2B4;CACNA2D1;GRIN2A;CACNA1A;CACNB3;CACNA1D;SLC8A2;TMCO1;TRPM1
prerank,cellular protein modification process (GO:0006464),-0.2859247996028468,-1.4631422642994225,0.0,0.2352965048808845,1.0,227/983,17.01%,PTPRG;PTPRB;GRK5;PRKCH;PTPRM;PRKG1;FBXL7;IGFBP7;ZBTB16;ST3GAL6;KLHL5;SNRK;MAP3K20;ERG;ACVRL1;BCR;DCAF10;ST3GAL4;ST3GAL1;PPP2R5A;DCUN1D3;PTPN14;DYRK1A;INSR;PPM1H;CSNK1A1;NEK7;PTP4A2;DAPK1;FAM20A;LYN;PRKCE;BMPR2;PLOD2;TLK2;ST8SIA4;GSK3B;THBS1;CDK13;PRKACB;FBXL12;GCNT2;MTMR3;PTPN1;APP;ATG7;ZDHHC6;ATM;JAK1;MARK1;RPS6KA5;ZC3HAV1;PSMA2;LIMK2;PAK2;SIK1;LRRK2;ATG10;IGFBP4;MAN2A1;MAP3K5;PTPN9;MAP4K3;RAB1A;ALG10B;NEK6;MTOR;CUL9;CDK17;TIPARP;PRKD2;MERTK;PTPRJ;PARP4;CDK12;FBXL3;TLK1;DAD1;YES1;PTPN12;CSNK1G3;RAB2A;TGFBR2;B3GNT2;RBX1;PIGT;GAS6;STK3;STK24;BMX;ABL1;PPEF2;MAST2;LMO7;CUL3;DCAF5;TGFB2;SIRT5;PRKCD;PPM1L;PARP14;BRD2;BMP4;OGFOD1;ILKAP;PTPRK;CDK10;ERN1;PSME2;MAPKAPK2;PRAG1;CDC42BPA;AAK1;PLK2;PDIA6;TGM2;MAPK1;ROCK1;MTMR6;PHKA2;CUL2;PPM1F;MAML1;NAA80;SETD3;BIRC6;LOXL1;WSB2;RAB5A;PRKD1;AKT3;SPSB1;YWHAZ;PSMB4;ST3GAL2;PXK;GSK3A;ACVR2A;LATS2;PPM1B;PIK3CD;ADAM10;UBE2D3;AKT1;FEM1A;UBA7;SOCS2;FUT10;SIK3;CUL7;FRK;TAOK3;PRKAA1;FBXW8;WIPI1;WNK4;PPP1R12A;UBLCP1;STK10;ILK;KLHL13;FNIP2;PTPN3;IKBKE;ITIH2;BRAF;ERO1A;JAK2;STK38;IRAK1;LRRC41;UBE2E2;CSNK1D;PRKCSH;PTPN13;CTTNBP2NL;CLK3;ANO8;CCDC8;NOTUM;WNT11;FEM1C;CSK;MSLN;ASB1;SIRT3;FBXW11;CDK6;KLHL25;MKNK2;MAPK8;PKN2;BTBD1;B4GALT5;MSRA;PSMC2;MAP4K4;MARK2;HIF3A;LIPE;IGFBP5;SERPINC1;GMFB;PTAR1;FEM1B;PKN3;UBE2M;ROCK2;NUAK1;ATG5;ERCC8;PSMB2;ABCA7;UBE2L3;PSMB1;F5;DCAF13;PPP2CB;SRPK2;RAB11A;FYN;MARK3;HIPK1;RARA;PLAT;ANXA1;CDC42BPB
prerank,organic hydroxy compound transport (GO:0015850),-0.4486782788131735,-1.4628608689494893,0.050816696914700546,0.23529416761356267,1.0,8/36,8.86%,ABCC4;ATP8B1;SLCO1C1;RXRA;RALBP1;RBP4;SLC16A1;SLCO2B1
prerank,regulation of hemopoiesis (GO:1903706),-0.6196811334211568,-1.4623479143740974,0.06077348066298342,0.23557125091023867,1.0,2/10,1.23%,CREBBP;CBFB
prerank,endodermal cell differentiation (GO:0035987),-0.44771828839852496,-1.4622566466458442,0.043402777777777776,0.2352621320343897,1.0,10/31,13.40%,COL8A1;COL12A1;COL4A2;SETD2;MMP2;LAMA3;ITGB5;CDC73;RTF1;ITGA4
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.5796303359203511,-1.4621589157994634,0.0661764705882353,0.2349492506550875,1.0,3/13,6.52%,DAB2IP;PTPN1;NEDD4
prerank,positive regulation of autophagy (GO:0010508),-0.3767491539768042,-1.461999265241082,0.01444043321299639,0.23480375950321064,1.0,34/81,26.11%,FOXO1;DAPK1;GNAI3;SH3BP4;GSK3B;SESN1;LRRK2;KDR;LARP1;FOXO3;IRGM;BNIP3;PIK3C2A;PLK2;ROCK1;PRKD1;GSK3A;PRKAA1;TRIM14;MTDH;KAT5;PIK3CB;TRIM13;IKBKG;RNF152;ORMDL3;ATF6;TRIM68;HMGB1;MAP3K7;PLEKHF1;PLK3;EIF2AK4;TPCN1
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.409627211501646,-1.4615235355682257,0.027972027972027972,0.23519350580353876,1.0,23/51,24.99%,BMPER;CRIM1;BMPR2;SMURF2;SMURF1;SKIL;SMAD1;GREM2;ACVR2A;SMAD4;UBE2D3;SMAD7;NOTCH1;SMAD6;SKI;HTRA3;SMAD9;DAND5;PPARG;CHRDL1;ACVR2B;FBN1;BMP2
prerank,peptidyl-tyrosine modification (GO:0018212),-0.4044252791115525,-1.4614503833335877,0.028462998102466792,0.23486775714619698,1.0,16/56,12.16%,FLT1;TEK;DYRK1A;INSR;ABI1;LYN;KDR;EGFR;ABL1;PTK2;TPST2;EPHA4;FLT4;JAK2;ABI3;PKDCC
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6204901089820412,-1.461210449336071,0.060550458715596334,0.23478737894145357,1.0,3/10,8.04%,LYN;FAS;MAPK1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.49699970913136193,-1.4609968723216344,0.052158273381294966,0.2346827020110059,1.0,4/21,4.26%,FOXP1;PRKCH;SLC39A10;PRKD2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.5676515688679172,-1.4604069773265762,0.07078039927404718,0.23515563994045746,1.0,7/13,31.26%,CBFB;TGFBR2;GLI3;NKAP;PNP;RUNX1;SHH
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.43587788015606155,-1.4599144043319319,0.03942652329749104,0.23556791977723934,1.0,18/35,31.43%,ETS1;LYN;FOXO3;MED1;ABCB10;LDB1;ACVR2A;TAL1;ZFPM1;CDK6;ARNT;PRKDC;MAPK11;HSPA1B;ZFP36L1;SPI1;MAPK14;STAT3
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.4826131666719545,-1.4592160869575037,0.07312614259597806,0.2362771197121545,1.0,10/23,25.12%,DAB2IP;DVL3;MAP3K5;EDN1;TAOK3;SASH1;RPS3;ARHGEF5;MAP3K7;FZD10
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.36993206705591286,1.4588433448398508,0.012711864406779662,0.36473386381557177,1.0,16/76,11.23%,GRM5;CHRM2;HTR2C;OPRM1;CALCA;PTGER3;GRM1;HOMER1;TRHR;C3AR1;ADRA2A;GPR65;ADRA1D;ADRA1A;TACR1;NMUR2
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.4352902237327812,-1.4579226645396697,0.031141868512110725,0.23797019447070356,1.0,16/43,21.30%,SORBS1;PTPN1;PIP4K2A;NCK1;IRS1;PIP4K2B;PRKCD;GRB10;GSK3A;GRB14;SLC27A4;TNS2;GKAP1;IGF2;OGT;PTPN11
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.3803558845360132,-1.4572578073464737,0.023172905525846704,0.23865988813480912,1.0,21/74,17.12%,LEF1;DAB2IP;FERMT2;DAB2;IL17RD;GCNT2;BMP5;SPRED2;MTOR;TGFBR2;LDLRAD4;TGFB2;SMAD2;SMAD4;AXIN2;RGCC;SMAD7;FOXC1;MAD2L2;MCRIP1;CTNNB1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.381048874865415,-1.455909028366664,0.023214285714285715,0.24054628209390963,1.0,29/76,24.53%,CSNK1A1;CBFA2T3;DAB2;GSK3B;RNF139;LRRK2;SMURF1;RBX1;PTK2;RNF144B;HECTD1;GSK3A;DET1;GABARAP;SMAD7;CSNK1D;ZER1;ZYG11B;SUMO1;CDK5RAP3;RAD23A;PTEN;MDM2;SH3RF2;KEAP1;CEBPA;RCHY1;TRIB3;HSPA1B
prerank,postsynaptic membrane organization (GO:0001941),0.5234099925948105,1.455479972105322,0.046255506607929514,0.37014617014409296,1.0,6/17,14.63%,NRXN1;NLGN1;MUSK;DLG4;NLGN2;APOE
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5294475213988366,-1.4551506851563252,0.05656934306569343,0.24136682833694756,1.0,5/17,11.65%,TEK;BAIAP2L1;ABL1;HAX1;BCAS3
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.4537777493507295,1.4551480344157761,0.05555555555555555,0.368573683541493,1.0,10/30,8.20%,FGF12;SCN1B;KCNA5;SCN1A;CACNA2D1;PKP2;GPD1L;CACNA1D;RYR2;SCN5A
prerank,central nervous system myelination (GO:0022010),0.5820919687317416,1.4549971094248444,0.091324200913242,0.36659367203613175,1.0,6/11,16.50%,TENM4;MYRF;PLP1;ABCA2;CLU;B4GALT6
prerank,sterol biosynthetic process (GO:0016126),0.44159923101431736,1.4549666462353896,0.03926096997690531,0.36434578331964274,1.0,12/33,13.87%,IDI2;INSIG1;LSS;HSD17B7;CYP51A1;SC5D;ACLY;SQLE;NSDHL;FDFT1;DHCR24;IDI1
prerank,response to estrogen (GO:0043627),-0.45117905513505197,-1.454197969640062,0.052346570397111915,0.24252595742504085,1.0,11/31,23.81%,CAV1;ESR1;TRIM25;NCOA4;BCAS3;ASH2L;RARA;WBP2;CITED2;BRCA1;RBBP5
prerank,neurotransmitter uptake (GO:0001504),0.5673953645323421,1.4537274594194365,0.07655502392344497,0.36500274098545427,1.0,4/12,13.80%,ATP1A2;SNAP25;SLC29A4;SLC1A3
prerank,plasma membrane organization (GO:0007009),-0.40017260786822423,-1.4534644433332995,0.015706806282722512,0.2433468766556498,1.0,19/61,16.51%,SPTBN1;PLSCR4;MYOF;MYH9;CAVIN2;FNBP1L;A4GALT;COL5A1;PLSCR2;EHD2;DYSF;AHNAK2;SNX9;BIN3;CHMP4A;ANO6;PLSCR1;ABCA7;TLCD1
prerank,aromatic amino acid family metabolic process (GO:0009072),0.6045981416415726,1.4531555894281087,0.0951276102088167,0.3640144014052047,1.0,4/10,13.31%,QDPR;ASRGL1;THAP4;PCBD1
prerank,synaptic vesicle recycling (GO:0036465),0.4519149458557786,1.4527526696722441,0.04086021505376344,0.3626942396858569,1.0,6/31,6.00%,NLGN1;SYT1;SYT5;AMPH;CDK5;SNCG
prerank,pore complex assembly (GO:0046931),-0.5043222629049798,-1.4526615646293612,0.06715063520871144,0.24416468044325837,1.0,7/19,15.78%,AFDN;AHCTF1;NUP98;ADAM10;ANO6;NUP153;TPR
prerank,endochondral bone morphogenesis (GO:0060350),-0.6036610310822703,-1.4525816361763815,0.06329113924050633,0.24382996125164716,1.0,6/11,19.97%,BMPR2;BMP4;MEF2C;FOXC1;TRPV4;COL13A1
prerank,organic anion transport (GO:0015711),-0.38222382450337755,-1.4516642814658016,0.019891500904159132,0.24488667922370672,1.0,15/76,9.97%,ABCC4;ABCG2;SLC26A7;LRRC8C;SLCO2A1;SLCO1C1;SLC4A10;SLCO3A1;CA4;ABCC6;SLC39A8;LRRC8D;SLCO2B1;SLC35A3;SLC52A1
prerank,focal adhesion assembly (GO:0048041),-0.49003532859309434,-1.451654889875802,0.0718132854578097,0.24443183069551022,1.0,6/21,12.34%,SORBS1;THSD1;BCR;FERMT2;PTPRK;ACTN1
prerank,amino sugar metabolic process (GO:0006040),-0.6177356298639856,-1.4515801077489214,0.059033989266547404,0.24409370730013794,1.0,5/10,9.09%,ST3GAL1;ST6GAL1;CSGALNACT1;GFPT2;SLC35A3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.6143743150326595,-1.451069784106326,0.08135593220338982,0.24406100729366062,1.0,3/10,12.48%,CBFA2T3;PPARA;HDAC4
prerank,negative regulation of glycolytic process (GO:0045820),-0.6143743150326595,-1.451069784106326,0.08135593220338982,0.24406100729366062,1.0,3/10,12.48%,CBFA2T3;PPARA;HDAC4
prerank,gene expression (GO:0010467),-0.3072916887041572,-1.4503258221347055,0.0,0.2448476925134225,1.0,132/348,27.03%,RBPMS;MEF2A;SRSF11;RBMS1;RRBP1;NUP42;RPS21;THRB;RPL37;RAE1;SARNP;RPL31;RANBP2;THOC2;RPL9;RBM5;TASP1;RPS14;UPF3B;THOC7;NUP98;RPSA;RBMS2;UPF2;SEC13;AGFG1;TSPAN14;POLR2G;DDX39B;RPL3;RPLP1;MRPL32;RPL26;NOL9;PWP1;RPS11;TAF1B;HNRNPUL1;RBM39;DHX38;HNRNPF;XRN2;TSPAN5;TSPAN17;NUP153;RPL13;SLU7;MRPS18A;RPL38;DRG1;RPL27;RPS16;APOBEC1;MCM3AP;RPS4X;GSPT1;AGO2;RPL10;RPL7A;SYNCRIP;HARS2;TPR;RPL5;THOC3;CREBL2;THOC1;MRPL24;NOX4;RPS27;ADARB1;RPL27A;GOLPH3;NUP214;NXT1;RPS3;RPL36A;RPL35A;FIP1L1;TFIP11;SRRM1;MRPS14;RNPS1;GLE1;RPL37A;SRSF3;MRPS21;DROSHA;MRPL35;RBM3;RPL32;WARS1;RBM6;PTMA;RPS7;NUP188;RPS15;TSPAN33;MRPL34;RPS8;ALKBH5;RPL28;RPL22;RPL13A;MRPL13;MRPL9;RPL36;RPL30;MED20;RPS23;POLR2C;POLDIP3;SMG6;NXF1;SRBD1;RPS17;POLR2L;RPS2;MRPL43;MLF1;POLR2H;ATXN1;RPL39;MRPL11;RPS26;TNIP1;RPS15A;HNRNPL;HNRNPD;NUP88;MMS19;RPL15;RPL34
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5699488488276216,-1.4500607369543288,0.07246376811594203,0.24485853232684088,1.0,6/13,17.95%,TMSB4X;SIN3A;PSEN1;MAD2L2;HEY1;HEY2
prerank,regulation of protein neddylation (GO:2000434),-0.6154379448303228,-1.4499499132714548,0.07835820895522388,0.24459160517844888,1.0,6/10,20.63%,DCUN1D3;COPS9;RPL5;DCUN1D2;EPAS1;DCUN1D5
prerank,modification-dependent protein catabolic process (GO:0019941),-0.3321794091050219,-1.4496927647610245,0.006633499170812604,0.24456734184719361,1.0,91/193,35.77%,FBXL7;NEDD4L;SMURF2;UBE2K;TRIM25;CNOT4;RNF111;DTX3L;ZNRF3;SMURF1;RNF125;RNF213;RBX1;CBL;RNF43;UBE4B;CUL3;NEDD4;RNF40;RNF144B;BIRC6;ARRDC1;SPSB1;TRIP12;MIB1;FEM1A;AREL1;NTAN1;CDC16;ANAPC16;ATXN3;UBR4;FEM1C;UBE4A;KLHL25;RNF168;PSMC2;RC3H1;RNF167;MYLIP;UBE2L3;KCTD10;KLHL3;SIAH1;ADRM1;BUB1B;HERPUD1;ELOC;UBE2R2;MDM2;BUB3;KEAP1;NDFIP2;HACE1;FZR1;ARRB1;RCHY1;RNF146;TRPC4AP;ANAPC7;DTL;ARIH2;RNF34;RNF114;UBE2I;UBA1;RNF14;ANAPC11;CDC34;UBE2H;TRIM32;ANAPC10;ANAPC5;PSMD13;RNF11;PLK1;RNF19A;RBBP6;AURKA;FBXL14;UBE2A;RNF20;TOLLIP;KLHL15;WDR81;TOPORS;RNF185;UBE2G2;CDC20;NEDD8;OS9
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5878080747579154,-1.4491449142811654,0.07303370786516854,0.2450468938235824,1.0,6/11,32.98%,MFHAS1;LYN;TNFAIP3;TREM2;TLR6;TLR1
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.3678581249659316,-1.44841128177947,0.015985790408525755,0.24579140503728353,1.0,26/87,15.36%,EPS8;ESAM;RAC1;RHOBTB1;IQGAP1;F11R;RND3;CRK;MTOR;RICTOR;ABL1;RHOQ;PRKCD;CDK10;EZR;ARHGDIA;ROCK1;NOTCH2;FAM107A;ARHGAP17;ABI3;RHOA;RHOC;RHOG;HIP1R;ROCK2
prerank,cholesterol metabolic process (GO:0008203),0.37030649325561504,1.4474716397553156,0.009259259259259259,0.3724481542051417,1.0,22/68,15.42%,IDI2;AKR1D1;CYP46A1;INSIG1;PIP4P1;SULT2B1;LSS;HSD17B7;CYP51A1;ACLY;SQLE;NSDHL;TSKU;CYP27A1;CYP11B1;OSBPL5;FDFT1;DHCR24;ABCA5;IDI1;APOE;CLN8
prerank,hepaticobiliary system development (GO:0061008),-0.5066352785290088,-1.446630665788011,0.056239015817223195,0.24827906425029608,1.0,11/20,23.86%,PKD2;LSR;TGFBR3;NIPBL;PRKCSH;ARID5B;CDK5RAP3;CEBPG;CITED2;NF1;CEBPA
prerank,negative regulation of mitochondrion organization (GO:0010823),0.4312688906515663,1.4465947850353773,0.0405727923627685,0.37221210158900275,1.0,13/33,16.23%,OMA1;MPV17L;PSMD10;PRELID1;FLCN;TRIAP1;MAPT;TMEM14A;GHITM;FZD9;CLU;ADCK1;SLC35F6
prerank,regulation of interleukin-1 production (GO:0032652),-0.5424536793570361,-1.4456703007579832,0.07706093189964158,0.24943111595316714,1.0,6/15,26.84%,FOXP1;GAS6;CEACAM1;ANXA1;HMGB1;F2R
prerank,protein modification by small protein conjugation (GO:0032446),-0.30580694536786895,-1.445291405984882,0.0,0.24963289280985923,1.0,110/361,22.54%,FBXL7;WWP1;DCUN1D3;USP9X;BRAP;NEDD4L;CBLL1;SMURF2;IFIH1;UBE2K;ATG7;NUP42;CNOT4;RNF139;RNF111;FBXL17;DTX3L;ATG10;ZNRF3;SMURF1;CUL9;RAE1;FBXL3;TRPM4;RNF213;RANBP2;UBA2;RBX1;CBL;OTULIN;RNF43;LMO7;CUL3;NEDD4;RNF40;NUP98;CUL2;BIRC6;UHRF2;PDZRN3;ARRDC1;SPSB1;UBE2J2;DET1;UBE2D3;MIB1;UBA7;CUL7;UBR2;RNF25;FBXW8;AREL1;TNFAIP1;KLHL13;TRIM14;CDC16;NSMCE2;TSPAN17;NUP153;RAD18;CDC73;RTF1;ANAPC16;PIAS2;UFM1;ASB1;FBXW11;KLHL25;RNF168;MYLIP;DTX3;HIF3A;VCPIP1;UBE2M;UBE2V2;PEX14;TPR;UBE2L3;DCUN1D2;HERC2;TRIM13;MIB2;SUMO1;RFWD3;KCTD10;CDK5RAP3;NUP214;KLHL3;SDE2;EPAS1;UBR1;RNF152;USP7;PRKDC;PIAS4;TRIM47;WWP2;ELOC;HUWE1;BRCA1;DCUN1D5;TRIM28;UBE2R2;MDM2;CAND2;KEAP1;MOCS3;HACE1;NFE2L2;NUP188
prerank,cellular response to dsRNA (GO:0071359),-0.5476532980940971,-1.4451421798075168,0.07222222222222222,0.24941919240834057,1.0,9/15,28.25%,CAV1;IFIH1;FLOT1;PDE12;CGAS;MAVS;RALB;DHX9;RIOK3
prerank,organelle organization (GO:0006996),-0.30301548072310025,-1.4450922807711493,0.0015822784810126582,0.24902151064611264,1.0,99/388,18.40%,SEMA6A;ATP8B1;FGD5;SEC31A;NOS3;FGD6;CSNK1A1;CAV1;PKD2;ALAS1;PEX1;PDZD8;RAB3GAP1;COG1;DYM;EPS15;TMCC1;RANBP9;MARK1;ARHGAP10;FNBP1L;RAB7A;MICAL2;LRRK2;ARAP3;SYNE1;DIAPH1;RAB1A;GOLPH3L;RAB2A;LIMD1;ZMYM6;CNTNAP1;MAST4;MAST2;ATL2;TOR1B;SIRT5;SEC16B;ABCD3;WASL;PLCE1;MYO18A;USP6NL;SIPA1L3;PEX7;CEP78;PYROXD2;PRKD1;PLD2;DST;HAX1;VPS13C;CHMP4B;CHMP4A;CECR2;CUL7;TMEM135;FBXW8;AGTPBP1;GAK;BCAS3;ARFGEF1;MTX1;FAM174B;ZMYM4;GABPB1;TPM1;CSNK1D;MIEF2;CHMP2B;NEDD9;SIRT3;MCOLN1;AFG1L;TRAPPC12;HCFC1;RAB32;TNFAIP3;PI4K2B;VPS13D;TBC1D20;PEX14;BRWD3;FMNL2;CHMP5;CDC42BPB;LMAN2;FANCG;TMED5;ZFYVE16;VAPA;CAPZB;GOLPH3;PEX11A;NRF1;CFL1;TJAP1;WTIP
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.6046637606835635,-1.4450394074753332,0.05786618444846293,0.2486509681148625,1.0,3/10,14.94%,WDFY1;LBP;IFI35
prerank,telomere maintenance (GO:0000723),-0.40834655537054576,-1.4449978386859954,0.04401408450704225,0.24825615006658683,1.0,20/50,21.31%,SP100;STN1;ATM;SMC5;MRE11;NSMCE2;POLD3;RPA3;DNA2;RPA1;CTC1;PTGES3;TERF2;TEP1;WRN;RPA2;PRKDC;DCLRE1B;TERT;BLM
prerank,telomere organization (GO:0032200),-0.4216199768003949,-1.4448747107405064,0.0421792618629174,0.24801861731996944,1.0,19/43,21.31%,SP100;STN1;ATM;MRE11;DOT1L;POLD3;RPA3;DNA2;RPA1;CTC1;PTGES3;H3-3A;TERF2;WRN;RPA2;PRKDC;DCLRE1B;TERT;BLM
prerank,regulation of apoptotic process (GO:0042981),-0.292159633991654,-1.4445864477526846,0.0,0.24808842266421827,1.0,163/676,17.32%,HIP1;TJP1;LEF1;UNC13B;GRK5;TEK;DAB2IP;IGF1R;ITGA6;MAP3K20;ITGB1;FOXO1;AKAP13;PPP1R13B;XIAP;CREBBP;DCUN1D3;ERC1;MCL1;DAB2;ARHGEF3;DAPK1;ACER2;TNFAIP8;NET1;GSK3B;THBS1;ATG7;ATM;MCF2L;ARHGAP10;PAK2;UTP11;MAP3K5;DDX3X;PLEKHG5;KDR;TNFSF10;EGFR;IL6ST;BIRC3;TFRC;CD38;NAA16;TAX1BP1;IER3IP1;HDAC1;NFKB1;RASGRF2;RARG;CBL;RBM5;RYBP;GAS6;NFKBIA;PIK3R1;STK3;ABL1;ZBTB7A;FOXO3;DSTYK;PSEN2;DNM2;FAS;ARHGEF12;SLIT2;PTK2;MED1;AATF;RASSF2;STEAP3;BMP4;BNIP3;MEF2C;ARHGDIA;NGF;JUN;RNF144B;MYO18A;PLK2;TGM2;MRE11;ITSN1;BIRC6;NOTCH2;BNIP2;ARHGEF2;ANXA4;RAF1;YWHAZ;FLT4;ARL6IP5;SH3RF1;HAX1;LATS2;SOS2;CASP8;BCAR1;ADAM10;CFLAR;AKT1;NAA15;SOCS2;TP53;FLNA;CRADD;PRKAA1;AREL1;PERP;PSEN1;BRAF;JAK2;SLC27A4;ARHGEF11;ANO6;RASA1;SON;IRAK1;COMP;ACTN1;MTDH;RPS6KA1;PA2G4;CTNNBL1;ACTN4;CAT;NDRG1;RTKN;TCIM;WNT11;UFM1;STPG1;BABAM2;HGF;MAPK8;ATF4;RPL10;TRIO;RPS6KA3;SPTLC1;ZFAND6;ERCC3;MAP4K4;IAPP;MIF;HIP1R;PRDM9;SMAD6;ABR;ANGPT1;ARHGEF18;BCL2L11;IGF1;PREX1;SLK;SIX4;ANXA1;CTSH;CTNNB1;APH1A;API5;PPIF;TFAP4
prerank,positive regulation of MAPK cascade (GO:0043410),-0.3196138884612627,-1.4444623310767046,0.0034129692832764505,0.24784047314910604,1.0,63/245,16.73%,FLT1;TEK;DAB2IP;IGF1R;JCAD;RAPGEF2;FERMT2;ROR1;INSR;BMPER;MFHAS1;PDGFD;SEMA7A;IQGAP1;GCNT2;APP;ADRA1B;TBX1;CCL25;LRRK2;KDR;ICAM1;PRKD2;PTPRJ;MID1;EGFR;SLC30A10;GAS6;DSTYK;IL34;TGFB2;FGF1;RAP1A;ROCK1;NOTCH2;FLT4;ARL6IP5;PLCG2;EDN1;TAOK3;HTR2A;TPD52L1;PIK3R6;BRAF;EDN3;NOTCH1;FGF2;IRAK1;SEMA4C;CD40;ACKR3;KSR1;P2RY6;IAPP;MIF;ROCK2;ABCA7;TNFAIP8L3;MTURN;ANGPT1;PELI2;IGF1;GSDME
prerank,regulation of striated muscle contraction (GO:0006942),0.44982217013246234,1.444263537525515,0.0410958904109589,0.375082410188699,1.0,7/27,12.61%,ATP1A2;CALM2;RNF207;RYR2;SLC8A3;SRI;MYL2
prerank,positive regulation of cell death (GO:0010942),-0.39196890657579775,-1.4438225399109121,0.031413612565445025,0.24841696314952125,1.0,13/59,10.55%,SLC6A6;ACER2;GSK3B;LRRK2;MAP3K5;CDKN1B;RARG;DDIT4;BMP4;BNIP3;CELF1;PICALM;AXIN2
prerank,cellular response to cytokine stimulus (GO:0071345),-0.30235517432436787,-1.44281673697114,0.0,0.24969102103965787,1.0,155/416,29.63%,LEF1;DAB2IP;IL1R1;OSMR;ST3GAL6;GHR;ITGB1;FOXO1;ZEB1;NFAT5;PTPN14;MCL1;DAPK1;GSK3B;UBE2K;JAK1;LRCH1;CRK;CCL25;PTPN9;LDLRAP1;IFNAR1;ICAM1;PTPRJ;MMP2;SLC12A2;IL6ST;CDKN1B;PTPN12;IL6R;NFKB1;TNFRSF1B;CBL;GAS6;PIK3R1;FOXO3;PDE2A;STX3;IL34;STAT6;IRGM;LBP;GBP6;GRB10;ARHGEF2;YWHAZ;GREM2;IRF1;LIFR;GSK3A;S1PR1;HAX1;PIK3CD;AKT1;SOCS2;TP53;MAOA;IL4R;STAT2;RAPGEF1;JAK2;RHOA;LAMA5;FGF2;IRAK1;PTPN13;GBP4;CSK;CD40;HGF;MAPK8;PIK3CB;PDE12;ZFAND6;RC3H1;GRB2;FOXC1;SYNCRIP;GAB2;USP10;ASAH1;TPR;IL16;TNFRSF1A;BCL2L11;VCAM1;FYN;GSDME;IRAK2;ANXA1;GBP5;IL10RB;IL20RB;RPS3;CCL19;CLCF1;IKBKB;HYAL2;CCND1;IFNGR2;CXCL12;BCL6;F3;BRCA1;IL13RA1;INPP5D;PTPN11;ITGAM;IFNAR2;IL3RA;NFE2L2;HSP90AA1;RELA;RIPK1;CASP1;RPL13A;HAS2;MAPK11;PIM1;GBP3;CEBPA;ADAMTS7;PTGIS;SHPK;IL7;DHX9;ERBIN;PIK3CA;MT1X;LCN2;PTPN2;CRNN;IFITM2;ZFP36L1;LGALS9;IL12RB2;BAG4;TRIM6;HNRNPU;IL22;CXCL10;HMOX1;PTPN18;DUSP1;RORC;PLP2;IL2RA;AXL;HYAL3;CACTIN;WNK1;IL2RG;BIRC5;IFNLR1;SHMT1
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.4567038385195795,-1.4425722856778131,0.05574324324324324,0.24962821491352843,1.0,11/32,21.82%,SORBS1;ZBTB20;ADIPOR2;MTOR;PPARA;AKT1;CEACAM1;ASAH1;CREBL2;STAR;CREB1
prerank,regulation of signal transduction (GO:0009966),-0.33066461482839826,-1.4413333535540274,0.01060070671378092,0.25123368625240833,1.0,51/190,16.88%,GRK5;IGFBP7;SP100;CREBBP;RSPO3;CBFB;RGS3;ELF1;BRAP;ESR1;RGS5;GIT2;ITGA3;PTPN1;APP;CRK;FBXL17;LRRK2;IGFBP4;ZDHHC3;NCK1;PXN;RGS12;PLCB1;CD55;WDR11;PRAG1;TMEM204;PLCE1;PRKD1;MDFIC;LIFR;SOCS2;NCK2;MFNG;ILK;GALNT11;IRAK1;MGLL;CSK;PLSCR1;TCF7L1;IGFBP5;FUZ;CASTOR1;NCLN;FYN;UBASH3B;SENP2;IRAK2;KIF26A
prerank,positive regulation of signal transduction (GO:0009967),-0.31846128066650514,-1.4399734626876144,0.0052173913043478265,0.25317325936345675,1.0,85/238,24.99%,TEK;VWF;DAB2IP;JCAD;SORBS1;SHANK3;CREBBP;RSPO3;NOS3;ZMIZ1;PKD2;LIMS2;ASXL1;LIMS1;MAML2;KLF2;KAT2B;TTC23;LRRK2;PRKD2;SMO;LOXL3;IL6ST;BMP6;JAG2;GAS6;PIK3R1;IRS1;DSTYK;FAS;TGFB2;MACF1;FGF1;ERN1;AAK1;MAML1;TSPAN14;GRB10;YAP1;CTBP2;FLNA;CRADD;NOTCH4;TPD52L1;ILK;JAK2;TSPAN5;NOTCH1;CDC73;P2RY6;JAG1;TNFAIP3;AGPAT1;FGFBP3;CCN3;TRIM16;SMOC2;IGF1;SKI;ARNT;SASH1;RPS3;CITED2;NOD2;PTPRC;KIF7;GKAP1;PTEN;F3;ITGB3;IGF2;DLL4;TERT;PTPN11;TUBD1;PTK2B;ESM1;TRIM39;RSPO2;PTGIS;NEPRO;SMARCB1;GPS2;IL7;BMP2
prerank,heterochromatin organization (GO:0070828),-0.5501360806184741,-1.439270709729506,0.07180385288966724,0.25397565628021207,1.0,2/14,3.23%,MECOM;PRDM16
prerank,Golgi organization (GO:0007030),-0.3505684683488519,-1.4387618217512517,0.005136986301369863,0.25441589672910525,1.0,36/112,22.93%,ATP8B1;VTI1A;CSNK1A1;COG1;DYM;LRRK2;SYNE1;RAB1A;GOLPH3L;RAB2A;ATL2;SEC16B;MYO18A;USP6NL;PRKD1;YWHAZ;CUL7;FBXW8;GAK;BCAS3;ARFGEF1;FAM174B;CSNK1D;TRAPPC12;VCPIP1;PI4K2B;TBC1D20;LMAN2;TMED5;GOLPH3;TJAP1;GORASP2;HUWE1;HACE1;SEC22B;BET1
prerank,regulation of fibroblast migration (GO:0010762),-0.4989553475200358,-1.4385191485959123,0.06126126126126126,0.2543086238862495,1.0,9/20,14.73%,ITGB1;RAC1;PRKCE;CORO1C;THBS1;GNA12;PTK2;FGF2;HAS1
prerank,negative regulation of response to stimulus (GO:0048585),-0.39024651106879443,-1.4375623246844216,0.022770398481973434,0.25555386029658766,1.0,16/60,16.88%,KLF7;KLF4;BRAP;CD34;LYN;PTPN1;SLC30A10;SLIT2;AQP11;AKT3;VPS13C;MAP3K3;CDK6;TERF2;UBASH3B;KIF26A
prerank,regulation of hippo signaling (GO:0035330),-0.5197774004410526,-1.437209837860682,0.08892921960072596,0.2556179164051944,1.0,8/17,23.64%,MOB3B;WWC2;VGLL4;LIMD1;MARK3;WTIP;MAP2K3;AJUBA
prerank,mitochondrion transport along microtubule (GO:0047497),0.5475088203260475,1.4371039185777639,0.09601873536299765,0.3889341660569845,1.0,7/13,24.88%,SYBU;MAP1S;MAPT;NEFL;RHOT1;UBB;SPAST
prerank,axoneme assembly (GO:0035082),0.44758268179121846,1.4367133548553652,0.05034324942791762,0.3874886053430994,1.0,10/30,16.82%,DNAAF3;CFAP74;SPAG1;DNAAF1;DCX;DNAI4;FOXJ1;GAS8;SPAG17;DNAAF2
prerank,neuron projection development (GO:0031175),0.32205298729635917,1.436573988233751,0.006896551724137931,0.3854826405114683,1.0,36/168,9.80%,CNTNAP2;NLGN1;L1CAM;RASGRF1;PPP1R9A;CNTN4;BLK;CTNND2;SH3GL2;TMEM108;GPM6B;DOCK10;EPB41L3;SHTN1;CDK5;EPHB1;SHANK1;PLP1;NBL1;TNIK;ATXN10;PAK3;MAP2;MAP1S;NPY;GPM6A;PAK1;NYAP2;MAPT;POU4F1;NEFH;TSKU;GRM7;MINK1;ZFYVE27;STMN2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.6084568508617946,-1.4365204086302557,0.06521739130434782,0.25635879961419544,1.0,3/10,12.16%,ZBTB16;ACVRL1;PKDCC
prerank,positive regulation of cell junction assembly (GO:1901890),0.39211653028842414,1.4361955158700568,0.04090909090909091,0.38394658021003103,1.0,15/56,13.33%,CNTNAP2;PTPRD;NRXN1;GRID2;IL1RAPL1;NLGN1;EPHB1;SYNDIG1;NPHP4;IRX3;VEGFA;LRRC4B;CLSTN2;BDNF;NLGN2
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.4519737797442718,-1.4354065814146533,0.06043956043956044,0.25775928282936555,1.0,10/30,15.96%,ACVRL1;BMPR2;TENT4B;STN1;XRN1;DACH1;TP53;CTC1;HNRNPA1;TERF2
prerank,positive regulation of apoptotic process (GO:0043065),-0.31215165792756083,-1.4353590763721937,0.0034071550255536627,0.2573911929851752,1.0,96/293,25.06%,UNC13B;DAB2IP;ITGA6;MAP3K20;ITGB1;FOXO1;AKAP13;DCUN1D3;ARHGEF3;DAPK1;TNFAIP8;NET1;ATG7;ATM;MCF2L;SIK1;UTP11;MAP3K5;DDX3X;PLEKHG5;TNFSF10;RASGRF2;RARG;RBM5;RYBP;STK3;ABL1;FOXO3;PSEN2;DNM2;FAS;ARHGEF12;SLIT2;TGFB2;RASSF2;BMP4;BNIP3;NGF;JUN;TGM2;ITSN1;ARHGEF2;ARL6IP5;LATS2;SOS2;CASP8;TP53;CRADD;TPD52L1;PSEN1;SLC27A4;ARHGEF11;ANO6;CTNNBL1;STPG1;MAPK8;ATF4;TRIO;ERCC3;IAPP;HIP1R;ABR;ARHGEF18;BCL2L11;SRPK2;PREX1;CTNNB1;APH1A;TFAP4;SOD1;RPS3;SIAH1;SOX4;RNPS1;BCL6;NF1;ARHGEF5;FOXL2;PNMA2;VAV2;ARHGEF1;CASP2;PHLDA3;GADD45A;SUDS3;TRIM39;ATF6;RIPK1;SFRP4;CYP1B1;PTGIS;CALHM2;HMGB1;FANK1;BMP2;APBB1
prerank,phospholipid dephosphorylation (GO:0046839),0.417407131215957,1.434906559904802,0.04895104895104895,0.38463472457492276,1.0,13/37,12.18%,PIP4P1;PLPPR4;PLPPR1;PLPP2;SGPP1;MTMR2;PLPP4;MTMR10;MTMR11;PLPPR5;MTMR7;OCRL;INPP5F
prerank,protein import into mitochondrial matrix (GO:0030150),-0.5083831679964403,-1.433759404999333,0.06434782608695652,0.2596843048053589,1.0,10/18,36.31%,TOMM40;TIMM17B;DNAJC19;TOMM40L;TIMM50;TOMM20;TOMM70;DNLZ;TIMM23;PAM16
prerank,defense response to tumor cell (GO:0002357),-0.5974472935288302,-1.432597672851648,0.07581227436823104,0.2612812397631359,1.0,3/10,11.85%,KLF4;DAPK1;ABI3
prerank,protein deacetylation (GO:0006476),-0.42508398663444685,-1.432514084410089,0.039711191335740074,0.26098993898789014,1.0,18/41,23.74%,MIER1;PRDM5;RCOR1;HDAC1;SIRT5;MIDEAS;FLNA;SIN3A;HDAC4;SIRT3;MIER2;HDAC6;HDAC10;MIER3;TBL1X;HDAC7;SUDS3;MORF4L1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5046524155457225,-1.4324589082377006,0.07652173913043478,0.2606344780156737,1.0,8/20,13.55%,THBS1;PLCG1;PDCD4;RGCC;ANO6;ITGA4;ECSCR;CD40
prerank,positive regulation of cell projection organization (GO:0031346),0.34222226573675696,1.4314018848816592,0.01405152224824356,0.39014606579106603,1.0,22/115,9.80%,PTPRD;MAGI2;IL1RAPL1;ROBO2;LRRC7;GRIP1;RIT2;SCN1B;ROBO1;TENM3;FUT9;CDKL5;TOX;KIDINS220;NDRG4;CAMK2B;NTRK2;CARMIL1;PLA2G3;SLITRK1;PLPPR5;STMN2
prerank,copper ion transport (GO:0006825),-0.5811169736459791,-1.4312318538689404,0.08576642335766424,0.26232002160017054,1.0,8/11,34.81%,ATOX1;SLC31A1;STEAP3;COX17;STEAP2;ATP7B;STEAP4;CUTC
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.5550964966766913,-1.4311309993691832,0.10536044362292052,0.26203067054367224,1.0,11/13,35.75%,IFIH1;GAS6;AGPAT1;MAVS;TAF9;IL7;DHX9;TRIM44;AXL;TSLP;CD74
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.4241161949624752,-1.4308017218962967,0.0450281425891182,0.2621381196622321,1.0,12/43,14.62%,DAB2IP;EPS15;RAB7A;ITGA1;PTPRJ;EGFR;CBL;EPS15L1;RNF115;PTPN3;DUSP3;GRB2
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.3572167163498168,-1.4307032744388608,0.015228426395939087,0.2618188530397916,1.0,27/98,14.96%,SPTBN1;PRKCH;SORBS1;ITGB1;PPP1R13B;PRKCE;ITGA3;PTPN9;YWHAE;EGFR;MIEF1;PIK3R1;TCAF1;DLG1;STX3;YWHAZ;NMT1;CASP8;AKT1;TP53;MTCL1;MIEF2;CHP1;RHOG;MAPK8;STAC3;BBC3
prerank,regulation of actin filament polymerization (GO:0030833),-0.378097793749007,-1.430700385263084,0.031746031746031744,0.2613625543825588,1.0,25/69,22.90%,KANK3;ESAM;BAIAP2L1;PRKCE;NCK1;SLIT2;PRKCD;SNX9;KANK4;HAX1;NCK2;FCHSD2;ARFGEF1;RASA1;ARHGAP28;LMOD1;CDC42EP3;NCKAP1;HIP1R;GBA2;DBNL;FCHSD1;CDC42EP1;PTK2B;MTPN
prerank,regulation of astrocyte differentiation (GO:0048710),-0.5737372793551805,-1.4301681421817083,0.08170515097690942,0.2618487449836037,1.0,6/12,24.99%,HES1;EPHA4;NOTCH1;CLCF1;SERPINE2;BMP2
prerank,positive regulation of translation (GO:0045727),-0.35959020900307176,-1.4301532448612637,0.026223776223776224,0.2614139709043978,1.0,37/94,26.87%,THBS1;EIF3E;METTL14;DDX3X;MTOR;NIBAN1;PLD1;EIF3C;LARP1;UPF3B;SAMD4A;POLR2G;RPL26;ZCCHC4;EEF2;CDC123;EIF5A;EIF5AL1;LARP4B;RPS4X;AGO2;RPUSD4;MRPS27;RPL5;METTL5;MPV17L2;UQCC2;SOX4;PRKDC;RBM3;USP16;POLDIP3;KHDRBS1;DHX9;FXR1;HNRNPD;LARP6
prerank,regulation of MAP kinase activity (GO:0043405),-0.36294653251173115,-1.4297841428403804,0.026362038664323375,0.26160135550275104,1.0,25/92,14.15%,FLT1;DAB2IP;LYN;PDGFD;PTPN1;LRRK2;PTPRJ;CDK12;EGFR;PPEF2;IL34;PRKCD;FGF1;BMP4;EDN1;TPD52L1;PIK3R6;EDN3;STK38;FGF2;IRAK1;CD40;KSR1;SPRY4;PIK3CB
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5671290178991932,-1.4295386269453658,0.07777777777777778,0.26162655903733656,1.0,6/12,15.43%,BMP5;SLIT2;PLCB1;WASL;AKT1;CCN3
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.4430239461223082,-1.4291911915359348,0.04584040747028863,0.2618040883642157,1.0,16/31,36.31%,PEX1;PEX7;TOMM40;TIMM17B;PEX14;DNAJC19;TOMM40L;TIMM50;PEX6;TOMM20;TOMM70;AIFM1;PEX26;DNLZ;TIMM23;PAM16
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.2956231839202529,-1.4282839014610567,0.0,0.2629005124592188,1.0,155/532,23.92%,IL1R1;OSMR;GHR;SP100;ITGB1;FOXO1;PELI1;EDA;ZEB1;MCL1;TAB3;NOD1;LIMS1;TRAF5;TMSB4X;IRF2;ANXA2;TRIM25;JAK1;ADIPOR2;RPS6KA5;PSMA2;CRK;PAK2;CCL25;IL15;IFNAR1;ICAM1;PTPRJ;MID1;MMP2;CAMK2G;IL6ST;BIRC3;CDKN1B;MSN;IL6R;NFKB1;RBX1;TNFRSF1B;CBL;NFKBIA;PIK3R1;IRS1;SAMHD1;FOXO3;PDCD4;STX3;IL34;PLCB1;STAT6;PRKCD;LBP;TCP1;PSME2;RAP1B;TXNDC17;GRB10;YAP1;YWHAZ;PSMB4;GREM2;IRF1;LIFR;S1PR1;SMAD4;PIK3CD;AKT1;MAP3K3;SOCS2;TP53;MAOA;IL4R;STAT2;RAPGEF1;ILK;JAK2;HNRNPF;IFITM3;LAMA5;FGF2;IRAK1;CEACAM1;LCP1;ACTN4;IL17RA;EIF5A;CSK;FBXW11;CD40;MAP3K8;ACKR3;HGF;PIK3CB;PSMC2;GRB2;TALDO1;FOXC1;IFI35;IL17RE;MIF;GAB2;PSMB2;IL16;PSMB1;TNFRSF1A;PELI2;BCL2L11;TAB2;VCAM1;TNFRSF11B;FYN;IRAK2;ANXA1;PSMA8;IL10RB;SOD1;IL20RB;CFL1;IKBKG;CCL19;MAP3K14;CLCF1;EDAR;TNFSF13;IKBKB;NOD2;PSME1;CCND1;IFNGR2;CXCL12;TNFRSF25;BCL6;F3;PSMD4;IL13RA1;INPP5D;PTPN11;TNFSF8;PSMA7;ITGAM;PTK2B;LTBR;IFNAR2;IL3RA;HSP90AA1;RELA;FCGR1A;RIPK1;CASP1;PITPNA;PIM1;PSMD5;CEBPA;TRIM68
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.3552057542545207,-1.427724386104099,0.03052064631956912,0.2634010077244777,1.0,38/100,24.55%,EIF3H;CSNK1A1;CBFA2T3;DAB2;TLK2;GSK3B;LRRK2;FHIT;RBX1;GNA12;RYBP;RNF144B;HECTD1;GSK3A;DET1;GABARAP;SMAD7;HFE;FOXF2;CSNK1D;ZER1;N4BP1;ZYG11B;SUMO1;GIPC1;RAD23A;USP7;HERPUD1;OGT;MDM2;SH3RF2;KEAP1;TRIM39;CEBPA;RCHY1;TRIB3;HSPA1B;TAF9
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4533935362992148,1.4270814573555124,0.053613053613053616,0.39809020071603984,1.0,5/25,3.46%,GRID2;MPP2;GRIN2B;GLRA1;GRIN2A
prerank,negative regulation of organelle assembly (GO:1902116),-0.4296156327435945,-1.4266000685531741,0.05772811918063315,0.264851267178836,1.0,10/35,10.04%,KAT2B;LIMK2;LRRK2;CDK10;TBC1D30;YAP1;SCFD1;SMAD4;CHMP4B;CHMP4A
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.560054912089297,-1.4264210054189488,0.07933579335793357,0.26469954507442495,1.0,9/13,37.20%,NAMPT;NAXE;NUDT12;NAPRT;PARP16;PTGIS;PARP9;NAXD;NNMT
prerank,apoptotic process (GO:0006915),-0.3228643667837286,-1.4257741944399367,0.008635578583765112,0.2653717397925885,1.0,73/203,25.63%,HIP1;ZBTB16;SEMA6A;FOXO1;DAPK1;PRKCE;YARS1;CASP12;APP;ELMO1;TBX1;MAGI3;MTOR;PLAGL1;KREMEN1;TGFBR2;NFKBIA;STK3;FAS;PDCD4;DDIT4;PRKCD;BNIP3;RFK;NOTCH2;BNIP2;RAF1;PPARD;IRF1;IER3;ERCC2;CASP8;CFLAR;AKT1;TNFAIP1;JAK2;PLSCR1;ERCC3;NCKAP1;BBC3;DAP;IAPP;FEM1B;TNFRSF19;BCL2L11;THOC1;PAEP;IKBKG;SIAH1;RNF152;BRAT1;PPP2CA;CDK11B;TNFRSF25;LIG4;OGT;MDM2;CHEK1;CASP2;PTK2B;GADD45A;BIK;RIPK1;CASP1;AKAP1;AHCYL1;MAP3K7;TNFSF12;PLK3;PIK3CA;FXR1;MAGEH1;DMPK
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.3786404342207443,-1.4252434898198676,0.03185840707964602,0.26578147670858787,1.0,23/73,23.39%,HIP1;SENP1;ACER2;NOD1;CASP12;TNFSF10;FAS;NGF;ATP2A3;CASP8;CFLAR;CRADD;JAK2;BBC3;DAP;HIP1R;CASP8AP2;PPARG;F3;CASP2;RIPK1;CASP1;EIF2AK3
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.5557235616455617,-1.4246301036817304,0.07789855072463768,0.2663622149748392,1.0,4/13,14.45%,KPNA4;RANBP2;KPNA3;KPNA1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.5414114846464729,-1.4242940550672727,0.07222222222222222,0.266487809428448,1.0,8/16,16.74%,MEF2A;IL6ST;ROCK1;EDN1;PDE9A;ROCK2;IGF1;TRPC3
prerank,protein kinase A signaling (GO:0010737),-0.5638523658660411,-1.4242656133411524,0.08029197080291971,0.2660866473507866,1.0,4/12,12.71%,PRKACB;EZR;MYOM1;LCP1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.417964723793593,1.423804516206036,0.054945054945054944,0.4033501398523545,1.0,17/37,19.91%,TRIM36;BICD1;PHLDB1;PHLDB2;CYLD;MAPT;STMN2;MAPRE3;TPPP;STMN4;MAPRE1;CLASP2;SKA3;CAMSAP3;MAP6;MAP6D1;STMN3
prerank,cellular response to hexose stimulus (GO:0071331),-0.4827493841863945,-1.4236814801420783,0.06476190476190476,0.2666942885030397,1.0,6/23,10.64%,UNC13B;IGF1R;ZBTB20;GAS6;ERN1;PRKAA1
prerank,positive regulation of catalytic activity (GO:0043085),-0.4302136179926054,-1.4233437116776484,0.043936731107205626,0.2668186753639926,1.0,17/37,25.67%,CAV1;ABL1;PSEN2;PHACTR4;XRCC4;PSEN1;BCAS3;MAPK8;NHEJ1;APH1A;SOD1;WRN;NOD2;FGFR4;IGF2;MSH3;SLC5A3
prerank,muscle organ development (GO:0007517),-0.3921332260749013,-1.4223391836678554,0.03103448275862069,0.26808945797155004,1.0,20/54,25.68%,UTRN;MEF2A;TCF12;TEAD4;CHD2;TBX1;MKX;EMD;MEF2C;COL6A3;MAPK12;IGF1;LARGE1;SMTN;ITGA7;FHL1;EGR3;FXR1;POU6F1;ITGA11
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.4482502352965721,1.4217820176140763,0.06744186046511629,0.4055463544037047,1.0,13/28,19.91%,MAP2;MAP1S;MAPT;STMN2;MAP1B;MAPRE3;STMN4;MAPRE1;CLASP2;SKA3;CAMSAP3;MAP1A;STMN3
prerank,secondary alcohol biosynthetic process (GO:1902653),0.4442490599029366,1.4212951811948062,0.04827586206896552,0.40436044403835336,1.0,11/30,13.87%,IDI2;INSIG1;LSS;HSD17B7;CYP51A1;ACLY;SQLE;NSDHL;FDFT1;DHCR24;IDI1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.37966277645739543,-1.420741441276593,0.04212454212454213,0.27041655201692705,1.0,21/67,19.31%,ATP8B1;MYO10;PODXL;CAV1;RAC1;PLD1;TBC1D1;TBC1D2B;IFT140;USP6NL;RAB5A;TBC1D14;TBC1D22B;TBC1D22A;DYNC2LI1;ATG5;TBC1D20;CAPZB;TBC1D8;EPHA2;TBC1D17
prerank,cellular response to fluid shear stress (GO:0071498),-0.5625188427045447,-1.4206212151132735,0.0749063670411985,0.2701587709756558,1.0,7/12,23.34%,KLF4;PKD2;KLF2;MEF2C;MAPK7;NFE2L2;HAS2
prerank,regulation of gene expression (GO:0010468),-0.28138894649151286,-1.4200285478591488,0.0,0.27077806219215994,1.0,241/903,21.31%,FOXP1;LEF1;MBNL1;APBB2;NFIA;RREB1;SMARCA2;MBNL2;CLDN5;ZNF423;ENG;ACVRL1;AFF1;CREBBP;NSD1;RB1;BNC2;UBR5;NOS3;KAT6B;ERC1;INSR;KLF4;ETS1;CD34;ESR1;LYN;FOXN3;ZFHX3;TNRC6B;PRDM5;SLC7A5;LIMS1;MED26;GSK3B;IRF2;ZNF326;GCNT2;APP;ATM;RPS6KA5;WWC2;ZSCAN21;MITF;NR3C1;DDX3X;SOX13;AHNAK;KDR;MTOR;TIPARP;SOX17;SMO;HMG20B;PSPC1;TFRC;MSN;SP1;ZNF148;VSX1;METTL4;CTCF;LIMD1;BMP6;HDAC1;LARP1;NFKB1;SIX1;AFDN;RYBP;GAS6;ABL1;PDE2A;NOVA2;DNM2;TRRAP;TGFB2;NSD3;FUS;MED1;AHNAK2;SEC16B;NFYC;PARP14;FGF1;GTF2IRD1;BMP4;MEF2C;PUM1;EZR;SLC39A8;CDH5;NGF;ZBTB4;SMAD1;ASCC1;ACTA2;ZC3H7B;MAPK1;ROCK1;KDM6A;PPM1F;RAB27A;NOTCH2;NOS1AP;HNRNPAB;NAB1;YAP1;LDB1;PRDM2;CDH1;PLCG2;CELF1;GSK3A;PICALM;OCLN;WNT16;GPBP1;SPTY2D1;CASP8;SP3;PIK3CD;USP13;ADAM10;FGF7;RAMP2;AKT1;MYOM1;TP53;KDM6B;PRKAA1;POGZ;HMG20A;DICER1;RGCC;SNX12;PRRX2;PSEN1;SOX7;BRAF;TRIM14;JMJD1C;MAZ;PRDM6;HNRNPF;EDN3;CHD3;HFE;YAF2;NOTCH1;SON;FGF2;HDAC4;SFPQ;OGG1;CLK3;WNT11;ZPR1;TAF5L;CDK6;PLSCR1;MAPK8;MECP2;ATF4;MARF1;MZF1;PIK3CB;AGO2;GPBP1L1;RBM20;ICOSLG;RC3H1;FAM98A;NR1D2;HCFC1;GPX1;TCF3;TCF7L1;FOXC1;MYBL2;MIF;ROCK2;TADA3;ZNF462;PRDM9;NAB2;LGMN;RPL5;UBE2L3;VSIR;FOXO4;TERF2;CREBL2;ANGPT1;PIK3R3;BMP7;HIC1;IGF1;MOV10;SRPK2;DNMT1;CTSH;HDAC6;HINT1;HDAC10;PATZ1;FUBP1;HEY1;HEY2;CARM1;RPS3;WTIP;ZNF507;CITED2;GATA2;SOX4;TNRC6A;PPP2CA;PRKAB1;PTPRC;CAVIN4;UTP4;ATRX;NONO;KRAS;CDK11B;WWP2;PRDM1;BCL6;F3;FGFR4;BRCA1;PTBP3;ZSCAN26;TOB1;IGF2;DLL4;SRSF10;TERT;TRA2B;NKAP
prerank,cellular response to DNA damage stimulus (GO:0006974),-0.3027808717407474,-1.4200280774712881,0.0016155088852988692,0.2703206668168353,1.0,135/336,29.66%,FOXP1;SUSD6;MNAT1;FOXO1;XIAP;UBR5;MCL1;LYN;ACER2;PDS5B;TLK2;ATM;DTX3L;RNF169;PARP4;SMC5;NIPBL;KMT5B;TNFRSF1B;MRNIP;ABL1;SAMHD1;TRRAP;AATF;SPIDR;MAPKAPK2;ZBTB4;MRE11;STXBP4;SUV39H1;INIP;NABP1;MCM9;YAP1;TRIP12;RBBP8;UBA7;TP53;ZBTB40;WDR76;TAOK3;DOT1L;NSMCE3;FNIP2;PSEN1;IKBKE;ENDOV;PDS5A;RAD18;INTS3;OGG1;UBE2E2;RPA1;ASH2L;BABAM2;PNKP;XPC;RNF168;SLF2;ERCC3;GRB2;VCPIP1;CGAS;BTG2;ERCC8;MAPK12;USP10;BCL2L11;HIC1;HERC2;SUMO1;POLE2;RFWD3;FANCC;FANCG;HPF1;WRN;RPS3;IKBKG;AKTIP;NCOA6;CCND1;BRAT1;EPHA2;PRKDC;RAD54L;TIMELESS;BCL6;NSMCE4A;FANCL;BRCA1;DCUN1D5;CBX1;BAZ1B;TRIM28;CHRNA4;BLM;RFC4;CHEK1;CASP2;PWWP3A;GADD45A;YY1;USP16;RBM24;RBBP5;SETD7;MSH3;CCNK;TAF9;LIG1;INO80;IRF7;APBB1;PLK3;DTL;MCM7;NUPR2;APC;MMS19;GTF2H3;MCM10;EXO1;ZBTB38;ALKBH7;GNL1;XRCC2;APLF;UBA1;HINFP;RAD51AP1;BOD1L1;FBXO31;TDP1;CHD1L
prerank,anion transport (GO:0006820),-0.43804940302750134,-1.4199079866043849,0.04716981132075472,0.2700579148970554,1.0,8/33,9.05%,ABCG2;SLC26A7;LRRC8C;SLC13A4;LRRC8D;SLCO2B1;SLC17A5;SLC13A3
prerank,positive regulation of protein acetylation (GO:1901985),-0.5672781724789494,-1.419627287411912,0.07142857142857142,0.2700702175784565,1.0,8/12,30.00%,DDX3X;DIP2B;PRKAA1;KAT5;RAPGEF3;DIP2A;CEP295;FAM161A
prerank,sensory perception of taste (GO:0050909),0.5728034225254428,1.4192669677964787,0.09480812641083522,0.40664517378841214,1.0,3/10,14.59%,ASIC2;GNAT3;ASIC1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.44406810581364375,1.4189114368726288,0.054245283018867926,0.40524789918500437,1.0,13/29,16.34%,GRIK2;CLN3;SLC8A2;SYP;CAMK2B;NETO1;RAB3A;DLG4;SYNGR1;PPFIA3;APOE;NCDN;SHISA9
prerank,aortic valve morphogenesis (GO:0003180),-0.44840338324012335,-1.4187318462820675,0.0690846286701209,0.2713227233781021,1.0,14/30,17.95%,ELN;RB1;NOS3;TIE1;NFATC1;SLIT2;BMP4;ROCK1;NOTCH1;JAG1;ROCK2;SMAD6;HEY1;HEY2
prerank,detection of calcium ion (GO:0005513),0.5400024955408685,1.418229566549334,0.08796296296296297,0.4046398663845317,1.0,3/13,7.41%,SYT1;CALM2;RYR2
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.4709439390642133,-1.4178243610005532,0.06292517006802721,0.2724472097856821,1.0,12/26,24.04%,SETD2;KMT5B;TET2;SETD5;SUV39H1;SETD3;PRDM9;ANTKMT;WDR82;OGT;TET3;BEND3
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5657591908610063,1.4173771431768052,0.09821428571428571,0.4042913711659843,1.0,3/12,6.17%,SNAP25;STX2;PRRT2
prerank,cellular senescence (GO:0090398),-0.46036041312808224,-1.4172965241385724,0.05565217391304348,0.2729157852731079,1.0,18/27,41.98%,KAT6A;SMC5;PRKCD;TBX2;NSMCE2;TERF2;ECRG4;TBX3;CDKN2B;SPI1;MAPK14;MAPKAPK5;HMGA1;CDKN1A;MAP2K1;SIRT1;SMC6;PML
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.5371421520175399,1.417030239391953,0.08430913348946135,0.40279932735223517,1.0,4/13,17.93%,SYT1;SYT4;CACNA1G;CACNA1I
prerank,histone mRNA catabolic process (GO:0071044),-0.5365881591908077,-1.4168736300404838,0.07651245551601424,0.27317428636681956,1.0,6/15,13.97%,TUT7;TENT4B;ATM;XRN1;TUT4;TENT2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.39602461886285945,-1.416823477857111,0.04659498207885305,0.27233792406492197,1.0,19/50,26.61%,NUP42;RAE1;RANBP2;NUP98;PUM1;SEC13;POLR2G;NUP153;AGO2;H3-3A;TPR;NUP214;IPO8;TNRC6A;NUP188;POLR2C;POLR2L;POLR2H;NUP88
prerank,regulation of gene silencing by RNA (GO:0060966),-0.39602461886285945,-1.416823477857111,0.04659498207885305,0.27233792406492197,1.0,19/50,26.61%,NUP42;RAE1;RANBP2;NUP98;PUM1;SEC13;POLR2G;NUP153;AGO2;H3-3A;TPR;NUP214;IPO8;TNRC6A;NUP188;POLR2C;POLR2L;POLR2H;NUP88
prerank,regulation of protein kinase activity (GO:0045859),-0.34854584116411746,-1.4166667129161985,0.019469026548672566,0.2721472913297433,1.0,36/106,22.42%,RAPGEF2;RB1;IQGAP1;CEP85;PAK2;RTRAF;GAS6;MRNIP;LRP6;PTK2;RASSF2;RAP1A;SNX9;PLCE1;PPM1F;MMD;PRKRIP1;AKT1;CEACAM1;CHP1;TAF7;TAB2;UBASH3B;ALS2;CACUL1;SOD1;CCL19;CENPE;PTPRC;RAP2C;AKT1S1;NF1;WARS1;MAP2K3;PTK2B;CCN1
prerank,response to nutrient levels (GO:0031667),-0.5088143950733014,-1.4163450089129652,0.08775137111517367,0.2723081309294599,1.0,5/17,14.04%,MTOR;FAM107A;PRKAA1;RPTOR;ATF4
prerank,striated muscle tissue development (GO:0014706),-0.45356798952350946,-1.4163377578480068,0.062157221206581355,0.2718670919043684,1.0,10/29,9.75%,PGM5;CAV1;BMPR2;SVIL;BMP5;SIX1;RBP4;MEF2C;TBX2;CFLAR
prerank,blood circulation (GO:0008015),-0.4025581484785782,-1.416296742067842,0.04047217537942664,0.2714970274324649,1.0,21/49,21.72%,ELN;ACVRL1;MYOF;NOS3;ACE;MEOX2;ROCK1;SCPEP1;EDN3;AGTR1;GPX1;ROCK2;F5;NPR1;GUCY1A1;SOD1;PLN;TBC1D8;CXCL12;DLL4;GCLC
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.5030033629827713,-1.415719524537168,0.09074074074074075,0.2720976729411215,1.0,11/20,30.81%,ADAM9;NFKB1;PSEN2;ADAM10;PSEN1;APH1A;RELA;ADAM17;RHBDD1;MBTPS1;TGFB1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.3271804671025216,-1.4156541267938103,0.013201320132013201,0.27175154422048126,1.0,68/158,32.10%,PELI1;AKAP13;ROR1;TAB3;MIER1;ANKRD17;NOD1;TRAF5;TRIM25;PLEKHG5;NEK6;TNFSF10;BIRC3;TFRC;PLK2;PRKD1;ALPK1;CASP8;CFLAR;MAP3K3;FLNA;IKBKE;TRIM14;RHOA;IRAK1;MTDH;RHOC;CD40;TNFRSF19;TNFRSF1A;PELI2;TAB2;TFG;TRIM13;MIB2;VAPA;MAVS;IKBKG;CCL19;LURAP1;MAP3K14;EDAR;IKBKB;NOD2;TMEM9B;LTBR;NDFIP2;RELA;RIPK1;CASP1;TRIM68;MAP3K7;BRD4;F2R;SLC20A1;LGALS9;TRIM6;TIFA;HMOX1;BST2;RNF31;EEF1D;TRIM32;TICAM1;TRIM62;TLR6;TNIP2;LPAR1
prerank,ribosome biogenesis (GO:0042254),-0.3212290835753098,-1.415586003959546,0.013468013468013467,0.271412844192956,1.0,80/187,31.12%,UTP11;RPL37;RPL31;RPL9;RPS14;WDR75;PAK1IP1;RPF1;DDX10;EXOSC2;EXOSC1;RPL3;RPLP1;RPL26;ESF1;NOL9;EXOSC3;XRN2;RPL13;UTP3;RPL38;RRP1;RPL27;NIP7;RPS16;RPL10;RPL7A;RPL5;DCAF13;EXOSC8;UTP14A;RPS27;LSG1;RPL27A;WDR74;RPL36A;MDN1;RPL35A;DDX31;UTP4;EXOSC5;BOP1;RPL37A;PES1;ABCE1;RRS1;RPL32;EBNA1BP2;RPS7;RPS15;RCL1;RPL28;RPL22;RPL13A;RPL36;RPL30;NOP16;RPS17;NOL8;GLUL;EXOSC7;WDR46;RPS2;RPL39;NAF1;RAN;BYSL;RPL15;RPL34;WDR55;EMG1;WDR12;POP4;RPLP2;UTP20;RPL18;RPL19;FCF1;DHX29;RPL8
prerank,histone H3-K9 demethylation (GO:0033169),-0.5690156631137459,-1.4155037577179563,0.08888888888888889,0.27111501830275386,1.0,7/11,31.75%,KDM3A;JMJD1C;HR;KDM7A;KDM3B;KDM4D;KDM4A
prerank,peptidyl-lysine acetylation (GO:0018394),-0.5865913031333163,-1.4152936546246433,0.09059233449477352,0.27105842792021034,1.0,3/10,12.91%,CREBBP;KAT2B;KAT5
prerank,regulation of ossification (GO:0030278),-0.42774959097065746,-1.4152293285360515,0.054673721340388004,0.2707287871970498,1.0,12/36,17.52%,ZBTB16;BMPR2;SGMS2;LRP6;TGFB2;BMP4;MEF2C;S1PR1;NOTCH1;NOTUM;SMAD6;ANKH
prerank,regulation of microtubule depolymerization (GO:0031114),0.454974072647204,1.4139846026582692,0.07373271889400922,0.40772469362170866,1.0,9/25,17.71%,NAV3;APC2;MAP1S;STMN2;MAP1B;HDGFL3;CLASP2;CAMSAP3;MAP1A
prerank,cell differentiation in spinal cord (GO:0021515),0.5777227333407405,1.4139595555961022,0.11358574610244988,0.4055564995917179,1.0,3/10,5.07%,MDGA2;LHX1;MDGA1
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.5556240058063183,-1.413888265146349,0.09550561797752809,0.2728303354120266,1.0,7/12,31.65%,HES1;NOTCH1;JAG1;NELFB;HNRNPU;N4BP2L2;TCF15
prerank,protein sumoylation (GO:0016925),-0.3945240405415338,-1.4135270181498185,0.04823747680890538,0.27300406245945474,1.0,18/49,26.61%,IFIH1;NUP42;RAE1;TRPM4;RANBP2;UBA2;NUP98;NSMCE2;NUP153;PIAS2;TPR;SUMO1;NUP214;PIAS4;TRIM28;NUP188;SAE1;NUP88
prerank,regulation of receptor internalization (GO:0002090),0.41634723697028925,1.4130288357403673,0.05827505827505827,0.4055903992504,1.0,10/35,13.02%,MAGI2;ANKRD13B;WDR54;CD63;MTMR2;ATAD1;AHI1;VEGFA;DLG4;RSPO1
prerank,entry into host (GO:0044409),-0.5534727795731265,-1.4122560290123825,0.08905380333951762,0.27496013081132686,1.0,6/13,17.12%,CBLL1;CBL;CTNND1;CDH1;GRB2;CTNNB1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.3723343850867994,-1.411840702637156,0.03231597845601436,0.27520649398517294,1.0,32/78,26.36%,CSNK1A1;CAV1;CBFA2T3;DAB2;GSK3B;LRRK2;RBX1;RNF144B;HECTD1;GSK3A;DET1;BCAP31;GABARAP;SMAD7;CSNK1D;SGTA;ZER1;ZYG11B;SUMO1;RAD23A;HERPUD1;MDM2;SH3RF2;KEAP1;NFE2L2;FZR1;CEBPA;RCHY1;TRIB3;HSPA1B;PLK3;ARIH2
prerank,cation transport (GO:0006812),0.31463527246874756,1.4114656600124438,0.004830917874396135,0.4070314807509825,1.0,29/167,9.62%,TRPM3;KCNMA1;ATP1A2;KCNA6;SLC22A4;SCN8A;SLC22A1;SLC5A12;KCNA5;SCN1A;CATSPER4;KCNJ3;KCNH4;SLC4A4;KCNN2;CLN3;SCN3A;SLC7A8;KCNA2;ATP1B1;SCN2A;SLC8A2;SLC36A2;TRPM1;SCN5A;SLC29A4;KCNJ6;PANX2;SLC7A6
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.44249009068433437,-1.4113585665760942,0.05273069679849341,0.27555549660884876,1.0,16/32,25.94%,FOXN3;ATM;UIMC1;MRNIP;MRE11;CLSPN;TAOK3;BABAM2;CDK5RAP3;BRCC3;BRCA1;BLM;CHEK1;TRIM39;FZR1;DTL
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.40473163307467036,1.411065553008829,0.042986425339366516,0.4057386147257958,1.0,9/41,7.41%,SLC24A2;HTR2C;GRIN2B;RYR3;ATP2B4;CACNA2D1;GRIN2A;SLC8A2;RYR2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.4491122904900352,-1.4109800345206942,0.051601423487544484,0.2758042243076534,1.0,9/28,14.96%,DAB2IP;ITPR1;MAP3K5;ERN1;ATP2A3;ERO1A;ATF4;DNAJC10;BBC3
prerank,regulation of dendrite morphogenesis (GO:0048814),0.4289594506474808,1.4099780622157092,0.06153846153846154,0.40618695056111176,1.0,7/32,6.03%,PTPRD;IL1RAPL1;ADGRB3;HECW1;CDKL5;TNIK;HECW2
prerank,response to progesterone (GO:0032570),-0.4978352682857125,-1.4097384847801822,0.08912655971479501,0.27763996782443856,1.0,5/18,8.80%,ABHD2;CAV1;THBS1;TGFB2;YAP1
prerank,Golgi localization (GO:0051645),-0.5835726089173277,-1.40970584260538,0.08455882352941177,0.2772648279272388,1.0,5/11,16.94%,ARCN1;COPG1;YWHAZ;TBCCD1;RIPOR1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.4389918418864339,1.409571110983,0.07743362831858407,0.40487035316770154,1.0,11/29,17.17%,HSD17B12;ACSBG1;HACD1;ACLY;ACACA;ACSL3;ACSL6;TECR;SCD5;HACD2;SCD
prerank,regulation of mRNA stability (GO:0043488),-0.3339542278499144,-1.4086573334701187,0.010238907849829351,0.2786688590673128,1.0,56/145,28.54%,PSMA2;METTL14;GIGYF2;LARP1;FUS;PRKCD;FTO;XRN1;SAMD4A;PUM1;PSME2;MAPKAPK2;ROCK1;YWHAZ;EXOSC2;PSMB4;EXOSC1;CELF1;AKT1;AXIN2;EXOSC3;SERBP1;PARN;PDE12;PSMC2;RC3H1;ROCK2;ZC3H14;PSMB2;PSMB1;EXOSC8;PSMA8;NUP214;TNFSF13;PSME1;EXOSC5;DCP1A;PSMD4;PSMA7;METTL16;RBM24;PSMD5;THRAP3;TAF15;CARHSP1;EXOSC7;FXR1;IGF2BP2;ZFP36L1;PSMB10;HNRNPD;PSMA3;PABPC1;HNRNPU;TENT5C;SET
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.34953544493347916,-1.4083279814875842,0.029876977152899824,0.2788760743319703,1.0,27/101,13.55%,FLT1;DAB2IP;RAPGEF2;FERMT2;PKD2;PDGFD;LRRK2;DDX3X;EGFR;IL34;CCND3;IRGM;FGF1;AKT1;EDN1;TPD52L1;CCNY;PIK3R6;RGCC;EDN3;RPTOR;RHOA;FGF2;IRAK1;MTCP1;TCIM;CD40
prerank,motile cilium assembly (GO:0044458),0.5451763553919884,1.407459943995563,0.11804008908685969,0.40763430502063525,1.0,4/12,11.36%,DNAAF3;BBOF1;DNAAF1;BBS5
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.5440023016542928,-1.407112739634263,0.07944732297063903,0.2805598244055314,1.0,6/14,14.92%,GAB1;KDR;FLT4;PIK3CD;VEGFC;FOXC1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.46028006723318826,-1.4068455032137732,0.07427536231884058,0.28057309894103377,1.0,11/27,24.76%,MAP3K20;MAP3K5;NFKB1;MAPK1;FBXW11;MAP3K8;MAPK8;IKBKG;IKBKB;MAPK11;MAP3K7
prerank,regulation of acrosome reaction (GO:0060046),0.5688903775486363,1.4068259422675768,0.10416666666666667,0.40701087325656304,1.0,2/10,3.88%,GLRA1;SPINK13
prerank,regulation of kinase activity (GO:0043549),-0.35068457216765375,-1.4065304740577746,0.02564102564102564,0.2807333726316547,1.0,18/89,8.88%,FLT1;TEK;IGF1R;RB1;TIE1;ROR1;INSR;KDR;MERTK;EGFR;CDKN1B;DSTYK;LMO4;PLCE1;MRE11;EPHA4;FLT4;LDB1
prerank,rRNA metabolic process (GO:0016072),-0.32788620754918457,-1.4053325496049536,0.01936619718309859,0.28246110361065785,1.0,69/160,30.40%,UTP11;RPL37;RPL31;RPL9;RPS14;WDR75;RPF1;DDX10;XRN1;EXOSC2;EXOSC1;RPL3;RPLP1;RPL26;ESF1;NOL9;EXOSC3;XRN2;RPL13;UTP3;RPL38;RRP1;RPL27;RPS16;RPL10;RPL7A;RPL5;DCAF13;EXOSC8;UTP14A;RPS27;RPL27A;WDR74;RPL36A;MDN1;RPL35A;UTP4;EXOSC5;BOP1;RPL37A;PES1;RPL32;EBNA1BP2;RPS7;RPS15;RCL1;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS17;NOL8;EXOSC7;WDR46;RPS2;RPL39;BYSL;RPL15;RPL34;WDR55;EMG1;WDR12;POP4;RPLP2;UTP20;RPL18;RPL19;FCF1
prerank,chromatin organization (GO:0006325),-0.3373260919375632,-1.4048313912488655,0.021352313167259787,0.2829252360719794,1.0,43/132,24.98%,MECOM;SMARCA2;BAZ2B;RB1;CHD1;ESR1;KAT2B;SETD2;PRDM16;HDAC1;SMARCC1;ZBTB7A;BAZ1A;SETD5;SUV39H1;KDM6A;SMARCE1;EHMT1;KDM6B;HMG20A;SMARCC2;HDAC4;HMGN3;MCM3AP;SMARCD3;HCFC1;TCF7L1;DR1;RUVBL2;KDM5B;HDAC10;HMGN2;SMARCAD1;ATRX;BAZ1B;PWWP3A;TOP1;NPM3;SUPT4H1;SETD7;SMARCB1;SETDB2;INO80
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5237146054026578,-1.4035822793364472,0.07334525939177101,0.2847679258049011,1.0,6/16,13.27%,BMPR2;ACE;PLCB3;GSK3A;ADM;PRCP
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.586645377050292,-1.4022949865302312,0.1063063063063063,0.2865580657229225,1.0,4/10,16.50%,ST3GAL1;ST6GAL1;GNPDA2;GNE
prerank,axon guidance (GO:0007411),0.3078052325124784,1.4021400523237721,0.014218009478672985,0.4155837227150382,1.0,42/201,10.15%,NRXN3;NRXN1;ROBO2;UNC5D;L1CAM;DAB1;DCC;NCAM1;CNTN6;CNTN4;DSCAML1;EPHA6;ENAH;DSCAM;SCN1B;ROBO1;LHX1;VLDLR;EPHB1;TNR;DOK5;UNC5C;GFRA1;SEMA6D;EPHA5;EFNA3;EFNB3;SEMA3B;DOK6;GPC1;MYPN;SHC3;VSTM2L;EMB;CNTN2;SHC1;VEGFA;SPTBN2;SPTBN4;SLIT3;SLIT1;KIF5A
prerank,nucleotide catabolic process (GO:0009166),-0.5188800898760789,-1.401671424400233,0.09314586994727592,0.28724441967011616,1.0,13/16,42.83%,NT5C2;NT5E;SAMHD1;NT5C1A;GPX1;GDA;NT5C;PNP;DERA;VCP;NUDT15;NUDT3;XDH
prerank,superoxide metabolic process (GO:0006801),-0.4463572505758115,-1.4016523291112344,0.05017921146953405,0.2868241610628146,1.0,9/29,18.07%,SH3PXD2A;NOS3;SH3PXD2B;NCF2;PREX1;NOX4;NRROS;CCS;SOD1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5202043258041428,-1.4011276690657282,0.0763765541740675,0.287293840886549,1.0,8/16,21.21%,GCH1;NOS1AP;SCARB1;AKT1;S100A1;PIK3CB;TERF2;TERT
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.46771784502844915,-1.4008235631920156,0.0800711743772242,0.28732851578474117,1.0,8/24,14.53%,PPP2R5A;DAB2;RHOQ;PPFIA1;PICALM;ABI3;GDI1;NUMB
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.4291078754747207,1.4007021869795113,0.06490872210953347,0.41670683367910116,1.0,12/31,16.82%,DSCAML1;COL2A1;OSR1;HOXD3;MEGF8;FGFR2;HOXA4;EIF4A3;HOXA9;PDGFRA;TWIST1;HOXD4
prerank,COPII-coated vesicle budding (GO:0090114),-0.3777411554953348,-1.3989451168908147,0.042105263157894736,0.29024593205369587,1.0,26/68,22.93%,SEC31A;SEC24B;CTSC;TRAPPC3;TRAPPC9;RAB1A;SEC24A;CUL3;SEC16B;SEC24D;KLHL12;SEC13;SCFD1;PPP6R3;CSNK1D;SEC23B;CTSZ;TBC1D20;F5;TFG;VAPA;PREB;SEC24C;SEC22B;SAR1A;BET1
prerank,protein autophosphorylation (GO:0046777),-0.3236064280026156,-1.3989227746125243,0.012455516014234875,0.28981353746416105,1.0,34/157,11.47%,FLT1;GRK5;TEK;IGF1R;DYRK1A;INSR;DAPK1;LYN;GSK3B;ATM;PAK2;SIK1;LRRK2;NEK6;KDR;MTOR;PRKD2;CDK12;EGFR;STK24;BMX;ABL1;PTK2;ERN1;MAPKAPK2;AAK1;EPHA4;PRKD1;FLT4;AKT1;MAP3K3;TAOK3;STK10;JAK2
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.5597123433967426,-1.3980516111733547,0.09426987060998152,0.29096186912098,1.0,7/12,24.95%,CAV1;IFIH1;FLOT1;CGAS;MAVS;RALB;DHX9
prerank,vasculature development (GO:0001944),-0.515127420341833,-1.3978926735765218,0.07894736842105263,0.29080220577467764,1.0,11/16,29.92%,ACVRL1;BMPR2;CDH5;FLT4;NOTCH4;PDGFRB;ACVR2B;FOXF1;PIK3CA;STRA6;APLNR
prerank,mRNA destabilization (GO:0061157),-0.41678815358960014,-1.3970313052391414,0.06417112299465241,0.2919593753351048,1.0,17/38,27.04%,TUT7;METTL14;GIGYF2;FTO;PUM1;ROCK1;CELF1;TUT4;PDE12;RC3H1;ROCK2;MOV10;DIS3L2;METTL16;RBM24;ZFP36L1;CNOT1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3267167652729086,1.3968538648106632,0.01201923076923077,0.42375000112890665,1.0,26/124,9.80%,CNTNAP2;NLGN1;L1CAM;RASGRF1;PPP1R9A;CNTN4;BLK;SH3GL2;TMEM108;GPM6B;CDK5;TTC29;PLP1;PLEK;ATXN10;MAP2;TSGA10IP;NPY;GPM6A;CARMIL1;MAPT;POU4F1;CATIP;KIFAP3;ZFYVE27;STMN2
prerank,response to interferon-alpha (GO:0035455),-0.5235233206082679,-1.3958296949374656,0.0948905109489051,0.29371611511273227,1.0,9/16,29.09%,IFNAR1;GAS6;IFITM3;PDE12;TPR;IFNAR2;IFITM2;BST2;AXL
prerank,dorsal/ventral pattern formation (GO:0009953),0.46868690267247826,1.395809918607691,0.10967741935483871,0.42393927388852437,1.0,5/20,8.73%,DSCAML1;LHX1;NBL1;FBXL15;LMX1B
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5454430160235447,1.3957046737202243,0.08685968819599109,0.4220345380833159,1.0,6/13,12.16%,ANK3;CALM2;IRX3;SLC8A1;SRI;HRC
prerank,negative regulation of macrophage activation (GO:0043031),0.5121199544809721,1.3949916387762769,0.10430839002267574,0.4213766159170425,1.0,7/16,19.12%,LRFN5;NR1D1;SYT11;GRN;LDLR;FCGR2B;CX3CL1
prerank,chromatin remodeling (GO:0006338),-0.3470672174040969,-1.394829505744218,0.038869257950530034,0.295010668833051,1.0,35/100,26.75%,SMARCA2;BAZ2B;RB1;ESR1;KAT2B;ARID1B;HDAC1;SMARCC1;ZBTB7A;BAZ1A;SRCAP;KDM6A;SMARCE1;CECR2;KDM6B;SMARCC2;CHD3;HDAC4;ACTB;SMARCD3;HCFC1;DR1;RUVBL2;KDM5B;INO80B;SMARCAD1;ATRX;BAZ1B;TOP1;NPM3;SMARCB1;INO80;ERCC6;HDAC5;RSF1
prerank,positive regulation of receptor internalization (GO:0002092),0.4596346233960564,1.3941678428768787,0.08173076923076923,0.42123053999855575,1.0,5/22,9.25%,MAGI2;CD63;ATAD1;AHI1;VEGFA
prerank,negative regulation of calcium ion transport (GO:0051926),0.5146288193079158,1.3928186724578753,0.08676789587852494,0.4221809476106517,1.0,4/15,9.30%,ATP1A2;STC1;TRIM27;ADRA2A
prerank,adherens junction organization (GO:0034332),0.40018016324859873,1.3920392338829104,0.042735042735042736,0.42196605573246776,1.0,16/48,10.12%,CDH18;CADM2;CDH8;CDH20;CDH9;CDH10;INAVA;DCHS1;CDH19;CDH12;ANG;NECTIN3;CDH7;CDH17;CDH24;CDHR3
prerank,protein ADP-ribosylation (GO:0006471),-0.4424588054870607,-1.391775607960806,0.09608540925266904,0.3001679077899986,1.0,12/28,26.17%,ZC3HAV1;TIPARP;PARP4;SIRT5;PARP14;SIRT3;PARP11;HPF1;ART3;PARP16;PARP6;PARP9
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.569491916548165,1.3914610526348643,0.11546840958605664,0.4211899094993058,1.0,5/10,19.32%,LAPTM4B;TSKU;GATA6;HSP90AB1;CD24
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.44946637335159034,-1.3913793146961428,0.07517482517482517,0.30039469530274976,1.0,8/28,11.47%,RAC1;ADIPOR2;MITF;TNFRSF1B;MED1;SIRT5;NOS1AP;JAK2
prerank,positive regulation of vacuole organization (GO:0044090),-0.5894468088898874,-1.3908945966157829,0.1037567084078712,0.300801400948296,1.0,5/10,11.00%,RAB3GAP1;ANXA2;PIP4K2A;PIP4K2B;RAB3GAP2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.47272984039131194,-1.3902447158341953,0.07180385288966724,0.3016051827004475,1.0,11/23,22.61%,UACA;TMSB4X;DDX3X;NMI;PPM1B;IFI35;CCN3;C1QTNF3;BMP7;HDAC7;RELA
prerank,regulation of secretion by cell (GO:1903530),0.38007546585323726,1.3901930822414508,0.059770114942528735,0.42208036731914467,1.0,10/54,12.34%,STXBP5L;SYT1;RIMS2;RIMS1;RAB15;SYN1;RAB3C;RAB3A;MCTP2;LLGL1
prerank,heart contraction (GO:0060047),0.39417857087336383,1.3896978910746718,0.04926108374384237,0.42115805958098596,1.0,11/41,14.49%,SGCZ;ATP1A2;SCN1B;ATP1B1;RYR2;SCN5A;TNNC1;SLC8A1;MYL2;TNNI2;SCN2B
prerank,negative regulation of developmental process (GO:0051093),-0.3715036861914296,-1.389562598706411,0.04861111111111111,0.30236293241804046,1.0,23/69,17.95%,KLF7;NFIB;NOS3;TBX1;TFRC;GAS6;ARHGEF15;SUZ12;BMP4;BNIP3;ROCK1;TBX2;NOTCH4;NOTCH1;WNT11;CDK6;RC3H1;FOXC1;MIF;ROCK2;FUZ;HEY1;HEY2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.5579435936226325,-1.3892942398956145,0.11030741410488246,0.30243080204888456,1.0,7/12,24.87%,RESF1;TASOR;APOBEC1;DNMT1;PPHLN1;TRIM28;SETDB2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.49339068027278105,-1.3891628072907654,0.09963768115942029,0.30222032621398953,1.0,3/19,0.62%,DAB2IP;JCAD;SEMA6A
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.3688728024845948,-1.3890946512937055,0.03770197486535009,0.3018844517522195,1.0,30/72,27.04%,SP100;ACER2;ATM;CNOT4;PLAGL1;CDKN1B;E2F4;PLK2;RPL26;TP53;CRADD;RGCC;KAT5;NDRG1;BTG2;USP10;TFAP4;CARM1;SOX4;ATRX;MDM2;CASP2;GADD45A;E2F7;CNOT2;ARID3A;TFDP1;PLK3;CNOT8;CNOT1
prerank,regulation of biomineral tissue development (GO:0070167),-0.4548742800343798,-1.3886495588486691,0.08947368421052632,0.30226738480400767,1.0,11/26,17.95%,NOS3;SGMS2;GAS6;ROCK1;S1PR1;NOTCH1;NOTUM;ROCK2;ANKH;HEY1;HEY2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.5719590691343628,-1.3884425119974888,0.09982486865148861,0.3022171755513628,1.0,8/11,30.86%,MERTK;GAS6;CCL19;NOD2;CXCL12;IRF7;AXL;LILRB1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.45032550274229777,-1.388060501744915,0.0851063829787234,0.302408254047513,1.0,13/28,24.76%,TAB3;NOD1;OTULIN;IRGM;CASP8;IRAK1;TNFAIP3;TAB2;IRAK2;IKBKG;NOD2;RELA;MAP3K7
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.37976379013324624,-1.3879860709290173,0.05299145299145299,0.3020956889509307,1.0,31/61,27.27%,USP9X;EYA4;UIMC1;PRKD2;EGFR;MRE11;PPP1R10;RGCC;OTUD4;FGF2;BABAM2;HGF;MECP2;RNF168;ERCC8;SMOC2;CEBPG;BRCC3;WRN;RPS3;USP7;ATRX;FGFR4;BRCA1;TRIM28;PDGFRB;HMGB1;DHX9;ERCC6;FGF10;STPG4
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.5676714169291904,-1.3874128123177385,0.10469314079422383,0.30263816051372106,1.0,2/12,1.54%,FOXP1;KLF4
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.4623346561623354,-1.3869573092397347,0.07231040564373897,0.30297211852180184,1.0,9/25,17.95%,NSD1;RB1;ZBTB7A;DOT1L;SIN3A;MAD2L2;IGF1;HEY1;HEY2
prerank,regulation of cellular pH (GO:0030641),0.4383120468391097,1.3859058612120736,0.0718954248366013,0.4280772069526775,1.0,7/29,5.56%,CA2;SLC9A7;SLC4A4;SLC4A5;CLN3;SLC9A9;SLC4A2
prerank,regulation of urine volume (GO:0035809),-0.5836832978185489,-1.3858339160732935,0.09172661870503597,0.3047001240521537,1.0,7/10,41.34%,ADM;NPR1;HYAL2;HAS2;ADCY6;TFAP2B;NPR3
prerank,positive regulation of secretion by cell (GO:1903532),-0.36447187356014293,-1.3857532242013018,0.023381294964028777,0.3043781845080825,1.0,17/70,11.69%,UNC13B;CD2AP;GOLPH3L;SLC12A2;ADAM9;IER3IP1;BMP6;RAB2B;TGFB2;EZR;MYO18A;RAB27A;RAB5A;MYOM1;EDN1;RGCC;EDN3
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.3568071586883528,-1.385639322375758,0.02464788732394366,0.30413686937506834,1.0,27/80,16.85%,THBS1;EIF3E;METTL14;DDX3X;MTOR;NIBAN1;PLD1;SP1;EIF3C;UPF3B;PRKCD;SAMD4A;EPHA4;GSK3A;PICALM;RPL26;ZCCHC4;SLC2A13;EEF2;SIRT3;LARP4B;RPS4X;ROCK2;RPL5;TNFRSF1A;METTL5;SMPD2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.3842306984202334,-1.3838701921995389,0.04830053667262969,0.3069549001133407,1.0,27/55,31.23%,DAB2IP;CAV1;PAK2;TNFSF10;FAS;TP53;CRADD;TPD52L1;BCAP31;WWOX;BBC3;BCL2L11;GSDME;RPS3;SIAH1;HYAL2;G0S2;LTBR;BECN1;TRIM39;RIPK1;TNFSF12;TNFRSF12A;TGFBR1;DDIT3;PMAIP1;ING5
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.5415242161631909,-1.3838604732035447,0.08726003490401396,0.3065128685406844,1.0,3/13,5.48%,NOS3;TMSB4X;PPARA
prerank,thymus development (GO:0048538),-0.5432375254895003,-1.3834702729007908,0.09310344827586207,0.306824357408348,1.0,8/13,31.26%,TBX1;HES1;SIX1;SOD1;EPHB3;FGF10;TGFBR1;SHH
prerank,modulation by host of symbiont process (GO:0051851),-0.4301322338992494,-1.3832985752150468,0.07733812949640288,0.3067101507905727,1.0,7/31,9.48%,LEF1;CHD1;SP1;HDAC1;NAPEPLD;JUN;TAF11
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.4575584035644983,-1.382745069678412,0.07692307692307693,0.3072420889194463,1.0,8/25,15.33%,ITGA6;THBS1;APP;EGFR;ILK;PSEN1;PTGES3;MIF
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.4541704181690202,1.3824451289928983,0.07900677200902935,0.43425313699702495,1.0,15/23,24.34%,CCDC88A;TUBA1C;KIF5A;DYNC1I1;KIF1C;HOOK1;TUBB;MAP6;MAP6D1;HOOK3;DYNC1I2;CCDC88C;F8A1;KIF5C;KIF1B
prerank,positive regulation of inflammatory response (GO:0050729),-0.3536292064448661,-1.3824101998652618,0.03202846975088968,0.30737782519199797,1.0,25/86,24.95%,OSMR;ETS1;APP;IL15;IL6ST;NFKBIA;NMI;PDE2A;PDCD4;LBP;NAPEPLD;FEM1A;AGTR1;LPL;IL17RA;IFI35;IL16;TNFRSF1A;HYAL2;GPR4;SERPINE1;RIPK1;CEBPA;DDT;DHX9
prerank,monocarboxylic acid catabolic process (GO:0072329),0.4679319750284326,1.382368358564274,0.1,0.43231728897493255,1.0,4/21,5.87%,NUDT19;LPIN1;HAO1;CYP26B1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.5254044464054074,-1.382200359124535,0.10037174721189591,0.30732095806797705,1.0,9/15,30.24%,EHD2;ADAM9;EHD1;FLOT1;CD53;RAPGEF3;ADGRB1;TREM2;MAPK14
prerank,leukocyte tethering or rolling (GO:0050901),-0.5019290651459601,-1.3820717414544161,0.10351201478743069,0.3071049826395515,1.0,6/17,17.78%,ITGB1;JAM2;ROCK1;ITGA4;VCAM1;GOLPH3
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.45864441068318146,-1.380777193195462,0.08711433756805807,0.3090702298580786,1.0,12/25,28.05%,ZNF326;SETD5;EAF1;LDB1;DDX39B;THOC1;ZMYND11;TCEA2;SUPT4H1;CCNK;ERCC6;HTATSF1
prerank,sulfation (GO:0051923),0.5517559038393107,1.3807587413658988,0.11206896551724138,0.43401450278345444,1.0,2/11,4.15%,HS3ST5;SULT2B1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.45235718909076233,-1.380617131639812,0.0890909090909091,0.3088867122262609,1.0,15/25,33.47%,CDK13;CDK12;EAF1;LDB1;CDC73;RNF168;ZMYND11;NELFB;SUPT4H1;BRD4;LEO1;HNRNPU;LARP7;NELFA;NELFCD
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3739227624444542,-1.3797798988067986,0.04114490161001789,0.31008304729997166,1.0,27/65,31.27%,FOXP1;LEF1;CBFA2T3;MYH9;RXRA;DEK;IL15;TGFBR2;BMP4;CASP8;PIK3CD;GAB2;PIR;RARA;CCL19;EPHA2;PPARG;CEBPA;MT1G;LGALS9;GLO1;TREM2;SPI1;BATF2;RUNX1;MAPK14;SBNO2
prerank,endoderm formation (GO:0001706),-0.4151485535136525,-1.3794724470111914,0.07308377896613191,0.3101885054122624,1.0,8/35,5.76%,COL8A1;COL12A1;COL4A2;SETD2;SOX17;MMP2;LAMA3;ITGB5
prerank,T cell differentiation (GO:0030217),-0.40788869047506876,-1.379395351855139,0.06408094435075885,0.30984605026139217,1.0,24/40,40.89%,SOX13;JAG2;GLI3;PIK3CD;NHEJ1;LMBR1L;ANXA1;SOX4;PTPRC;LIG4;DLL4;PTPN2;ZFP36L1;ADAM17;FCER1G;SPI1;SHH;LFNG;ZAP70;GATA3;GPR89A;GPR89B;LCK;CD28
prerank,embryonic digestive tract development (GO:0048566),-0.4899231460565734,-1.3789979060684114,0.08765652951699464,0.3102159007913726,1.0,9/18,26.96%,NIPBL;TGFB2;GLI3;PCSK5;PKDCC;RARB;FOXF1;RBPMS2;STRA6
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.5643589823165682,-1.3789670835350072,0.09124087591240876,0.3097927706632617,1.0,7/11,36.17%,CBFB;VSIR;HMGB1;LGALS9;RUNX1;TWSG1;CD274
prerank,cellular response to chemical stress (GO:0062197),-0.3461242112601981,-1.3781637549499104,0.043243243243243246,0.3108195638686659,1.0,31/96,22.38%,FOXO1;CAV1;PKD2;ATG7;ATM;LRRK2;DDX3X;ABL1;FOXO3;FAS;PYROXD1;LRRC8D;PRKD1;PRKAA1;ERO1A;CAT;NCF2;TXNRD2;ATF4;MSRA;GPX1;NOX4;FANCC;CCS;SOD1;TRPV4;VRK2;TXNRD1;KEAP1;SLC25A24;NFE2L2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.5438321404056374,-1.377893929582461,0.0965391621129326,0.31083036799976127,1.0,9/12,32.19%,TP53;RFWD3;SDE2;RPA2;CCND1;PRKDC;PLK3;FBXO31;RPS27L
prerank,RNA 3'-end processing (GO:0031123),-0.37012928313816923,-1.3778488892709169,0.05944055944055944,0.3104743792011764,1.0,21/69,20.24%,SRSF11;TUT7;TENT4B;SARNP;THOC2;RPRD2;UPF3B;THOC7;DDX39B;TENT4A;CPSF7;DHX38;TUT4;SLU7;TENT2;THOC3;THOC1;FIP1L1;SRRM1;RNPS1;SRSF3
prerank,steroid metabolic process (GO:0008202),0.3550255505457427,1.3774142123224402,0.05543237250554324,0.4397279214741798,1.0,15/72,12.33%,AKR1D1;CYP46A1;AKR1C1;CYP24A1;SULT2B1;CYP26B1;LSS;HSD17B7;CYP51A1;HSD17B14;CYP27A1;GC;CYP11B1;FDFT1;DHCR24
prerank,regulation of monocyte differentiation (GO:0045655),-0.530535327835522,-1.377259986361111,0.10332749562171628,0.3111501390175474,1.0,7/14,26.06%,FOXP1;IL34;ACIN1;CDK6;CTNNBIP1;IRF7;ZFP36L1
prerank,negative regulation of peptidase activity (GO:0010466),0.3817553804005561,1.377146439368394,0.058315334773218146,0.4382941433210725,1.0,10/47,13.77%,VTN;SPOCK3;SPOCK1;ECM1;SERPIND1;TIMP1;SERPINA2;SERPING1;FETUB;CST3
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.5024384395539976,-1.3764905459116796,0.0855614973262032,0.31225177300555573,1.0,5/17,12.95%,PTPRJ;EZR;DGKZ;CEACAM1;DUSP3
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.3746962578540851,-1.3763503373381258,0.04339622641509434,0.3120684173124398,1.0,25/58,25.60%,ATM;UIMC1;KDM2A;SMC5;ZBTB7A;XRCC4;MRE11;NSMCE2;KAT5;BABAM2;NHEJ1;RNF168;UBE2V2;ERCC8;HERC2;SUMO1;BRCC3;PRKDC;PIAS4;LIG4;BRCA1;DCLRE1B;HMGB1;DCLRE1A;ERCC6
prerank,rRNA processing (GO:0006364),-0.31652039300074286,-1.3761093283941028,0.023890784982935155,0.3120209164702782,1.0,72/172,30.40%,UTP11;RPL37;RPL31;RPL9;RPS14;WDR75;RPF1;RRP15;DDX10;NOP2;EXOSC2;EXOSC1;RPL3;RPLP1;RPL26;ESF1;NOL9;EXOSC3;XRN2;RPL13;UTP3;RPL38;RRP1;RPL27;RPS16;RPL10;RPL7A;RPL5;DCAF13;EXOSC8;UTP14A;RPS27;RPL27A;WDR74;RPL36A;MDN1;RPL35A;UTP4;EXOSC5;PRKDC;BOP1;RPL37A;PES1;RPL32;EBNA1BP2;RPS7;RPS15;RCL1;RPL28;RPL22;RPL13A;RPL36;RPL30;RPS17;NOL8;EXOSC7;WDR46;RPS2;RPL39;BYSL;RPL15;RPL34;WDR55;EMG1;WDR12;POP4;RIOK3;RPLP2;UTP20;RPL18;RPL19;FCF1
prerank,cellular protein catabolic process (GO:0044257),-0.38053195821876906,-1.3758669916895983,0.06028368794326241,0.31210679277359493,1.0,22/59,24.07%,DAB2IP;CTSC;RAB7A;AP2B1;AP2A2;AP2S1;BNIP3;DENND3;CASP8;CAPN2;AFG1L;MYLIP;MAGEC2;CTSZ;LGMN;CTSH;AP2M1;MDM2;CTSF;CTSO;RIPK1;ADAMTS7
prerank,regulation of actomyosin structure organization (GO:0110020),-0.5519694542068553,-1.3757194057635342,0.10556621880998081,0.31194882029725285,1.0,6/13,20.98%,AKAP13;RAC1;ROCK1;ROCK2;ALMS1;ASAP3
prerank,vesicle coating (GO:0006901),-0.3776251279930556,-1.3756451929216933,0.05391304347826087,0.310714663700974,1.0,19/61,16.42%,SEC31A;SEC24B;CTSC;TRAPPC3;TRAPPC9;RAB1A;SEC24A;CUL3;SEC16B;SEC24D;KLHL12;SEC13;SCFD1;PPP6R3;CSNK1D;CTSZ;TBC1D20;F5;TFG
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.3776251279930556,-1.3756451929216933,0.05391304347826087,0.310714663700974,1.0,19/61,16.42%,SEC31A;SEC24B;CTSC;TRAPPC3;TRAPPC9;RAB1A;SEC24A;CUL3;SEC16B;SEC24D;KLHL12;SEC13;SCFD1;PPP6R3;CSNK1D;CTSZ;TBC1D20;F5;TFG
prerank,COPII vesicle coating (GO:0048208),-0.3776251279930556,-1.3756451929216933,0.05391304347826087,0.310714663700974,1.0,19/61,16.42%,SEC31A;SEC24B;CTSC;TRAPPC3;TRAPPC9;RAB1A;SEC24A;CUL3;SEC16B;SEC24D;KLHL12;SEC13;SCFD1;PPP6R3;CSNK1D;CTSZ;TBC1D20;F5;TFG
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.34068385091063014,-1.375414973571358,0.02847571189279732,0.3107403501348579,1.0,33/108,23.39%,HIP1;SENP1;DAPK1;ACER2;NOD1;CASP12;UACA;MAP3K5;DDX3X;TNFSF10;FAS;NGF;PPM1F;ATP2A3;ARL6IP5;CASP8;CFLAR;CRADD;BCAP31;SOX7;JAK2;BBC3;DAP;HIP1R;CASP8AP2;RPS3;PPARG;F3;FOXL2;CASP2;RIPK1;CASP1;EIF2AK3
prerank,regulation of hormone secretion (GO:0046883),-0.5078406333803106,-1.3753426162511107,0.10181818181818182,0.31044044105581325,1.0,9/15,38.27%,EDN1;EDN3;ANXA1;VAMP3;VAMP2;NMB;IL11;LIF;SNX6
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.5645931110836808,-1.3750215135591788,0.08880994671403197,0.3106001856977077,1.0,4/11,9.60%,PELI1;BIRC3;ARHGEF2;CASP8
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.5517976283216905,-1.3744785530609918,0.0959409594095941,0.31117491596194136,1.0,4/12,8.04%,LYN;IL34;PTK2;MAPK1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.47541126612171586,1.3743855365033737,0.1,0.4427594112956528,1.0,4/19,6.81%,PTPRD;IL1RAPL1;CDKL5;CAMK2B
prerank,positive regulation of nervous system process (GO:0031646),0.47747944088673,1.3738185465759225,0.10158013544018059,0.4420777701207536,1.0,5/18,2.82%,TENM4;MYRF;RIMS2;RIMS1;CARTPT
prerank,myelin assembly (GO:0032288),0.5684762441921952,1.37377539755401,0.12839506172839507,0.4400506937163892,1.0,6/10,17.29%,TENM4;EPB41L3;GPC1;ABCA2;TPPP;NCMAP
prerank,regulation of organelle assembly (GO:1902115),-0.3617280006908188,-1.3735559928917611,0.04903677758318739,0.31246839866585,1.0,26/72,22.99%,MTMR3;STX18;MSN;TBC1D1;TBC1D2B;IFT140;EZR;PLK2;USP6NL;RAB5A;TBC1D14;TBC1D22B;TBC1D22A;DYNC2LI1;TRAPPC12;ATG5;TBC1D20;ALMS1;TBC1D8;TBC1D17;RNF4;PDCD6IP;IFT20;TBC1D12;EVI5;SENP6
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.46647241959971675,-1.373337069074085,0.0933572710951526,0.31240628150076905,1.0,9/24,18.97%,TAB3;NOD1;CASP8;IRAK1;TNFAIP3;TAB2;IRAK2;IKBKG;NOD2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.5271170540699422,1.3728312329295744,0.0967032967032967,0.4401869621861756,1.0,8/13,16.34%,GRIK2;CLN3;SLC8A2;SYP;RAB3A;SYNGR1;PPFIA3;SHISA9
prerank,limb morphogenesis (GO:0035108),-0.47647194292387485,-1.3714818575674417,0.11864406779661017,0.3154115770431717,1.0,6/20,9.13%,MBNL1;NIPBL;LRP6;TGFB2;GLI3;PCSK5
prerank,smooth muscle contraction (GO:0006939),-0.5199912929095126,-1.3714243727197648,0.10575139146567718,0.315072471083154,1.0,9/14,23.84%,EDNRA;MYH11;PIK3C2A;ACTA2;ROCK1;MYLK;ROCK2;SMTN;TPCN2
prerank,peroxisome organization (GO:0007031),-0.4525015553500783,-1.371265309367969,0.09407665505226481,0.3148890135627141,1.0,12/25,31.65%,PEX1;SEC16B;ABCD3;PEX7;TMEM135;PEX14;PEX11A;PEX3;PEX6;PEX11B;PEX19;LONP2
prerank,negative regulation of cell aging (GO:0090344),-0.5055220316625403,-1.3711998242041143,0.1062618595825427,0.3145314180911965,1.0,7/16,21.21%,SLC30A10;AKT3;MAP3K3;CDK6;MIF;TERF2;TERT
prerank,cellular glucan metabolic process (GO:0006073),-0.5612256984951207,-1.3710767121911198,0.10507246376811594,0.3142905200739562,1.0,4/11,13.72%,GBE1;GSK3B;PPP1R3C;PHKB
prerank,regulation of muscle cell differentiation (GO:0051147),-0.42471921340117824,-1.3698803161352826,0.09191176470588236,0.31603579510565244,1.0,14/31,23.50%,CTNNA1;MEF2A;BOC;ABL1;MEF2C;CDON;BNIP2;TCF3;MAPK12;CTNNB1;IGF2;SPAG9;MYOCD;MAPK11
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.4579658572406124,1.3693952140662573,0.1053864168618267,0.44657245013035507,1.0,8/22,9.80%,MAGI2;SH3GL2;TMEM108;KIDINS220;NTRK2;MAPT;ACAP2;STMN2
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.4244658412915791,1.3693602969167609,0.09133489461358314,0.44457129186332645,1.0,7/29,13.72%,SYCP1;MAJIN;ZCWPW1;REC8;SYCP2;RAD21;SIRT7
prerank,negative regulation of signal transduction (GO:0009968),-0.30136332887474615,-1.3683146689034749,0.010067114093959731,0.3185577463782069,1.0,71/249,20.17%,NXN;DAB2IP;SEMA6A;RB1;TRABD2B;BRAP;LYN;ASXL1;NTN1;THBS1;PTPN1;NFATC1;BMP5;LRRK2;PTPRJ;EGFR;NOTCH3;PIP4K2A;PTPN12;VGLL4;NCK1;IRS1;ZBTB7A;RNF43;PHACTR4;HERC4;PALM;DDIT4;NEDD4;PIP4K2B;PRKCD;NKD1;ARRDC1;GRB10;GLI3;GSK3A;GRB14;AKT1;GLIS2;NFKBIL1;HMGXB4;MOSMO;MAZ;OTUD4;SLC27A4;FGF2;WWOX;TCIM;NOTUM;TAX1BP3;APCDD1;SPRY4;PIK3CB;TNFAIP3;IGFBP5;LGMN;GPR108;HIC1;UBASH3B;KIF26A;TNS2;HEY1;SIAH1;GATA2;PTPRC;RITA1;KIF7;CTNNBIP1;GPC3;WWP2;PTEN
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.47106867095331895,-1.3680989743882142,0.09230769230769231,0.3185241550533637,1.0,7/21,15.43%,RBPMS;DAB2;BMP6;BMP4;SMAD4;JAK2;CCN3
prerank,outer dynein arm assembly (GO:0036158),0.5188339674958236,1.3671037705979865,0.10829493087557604,0.4479199765437244,1.0,7/14,18.48%,CCDC63;ODAD2;DNAAF5;DNAAF1;ODAD1;LRRC49;ODAD3
prerank,cardiac ventricle development (GO:0003231),-0.48765797213219914,-1.3659259739547243,0.0967741935483871,0.3223532549688529,1.0,11/20,26.96%,ENG;HES1;PDE2A;HECTD1;NOTCH1;HEY1;HEY2;DAND5;DLL4;GJA5;STRA6
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.32355621271989415,-1.3654330004355952,0.017699115044247787,0.32287210135257116,1.0,56/144,25.30%,PPP1R13B;UBR5;GSK3B;YWHAE;EMD;MIEF1;GAS6;PIK3R1;TCAF1;HPS4;SEC16B;PRKCD;YWHAZ;CDH1;NMT1;GSK3A;UBE2J2;CASP8;UBE2D3;TP53;FLNA;PSEN1;BCAS3;ICE1;MTCL1;MIEF2;CHP1;ZPR1;MAPK8;BBC3;TPR;UBE2L3;FYN;RIPOR1;XPO4;MAVS;PCM1;ZIC1;OAZ2;HYAL2;BAP1;NPEPPS;TCF7L2;PPP3CC;HUWE1;TRIM28;VAMP2;ITGAM;PCNT;SAR1A;CEP131;FZD5;TFDP1;SAE1;RAPGEF3;PLK3
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.4235444112929052,-1.3651612520394605,0.0683453237410072,0.3229198516120962,1.0,10/35,21.16%,FLT1;PTPRM;CAV1;THBS1;MEF2C;RGCC;PPARG;NF1;NR2F2;DLL4
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.5233993749390258,-1.3650898403868599,0.09475465313028765,0.3226239391071464,1.0,5/15,15.35%,DAB2;WASL;AAK1;PIK3CB;HIP1R
prerank,mitochondrion distribution (GO:0048311),-0.5468469894449293,-1.364015451591851,0.10701754385964912,0.3242328129832267,1.0,3/12,3.71%,MEF2A;TRAK1;LRRK2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.4250128954689278,1.3633181392699703,0.09691629955947137,0.4548421654022422,1.0,7/27,7.22%,IL1RAPL1;CTNNA2;CCDC88A;NTNG2;NTNG1;NCS1;HOMER1
prerank,protein-containing complex subunit organization (GO:0043933),-0.3350262596971093,-1.3631914718306413,0.03237410071942446,0.3254184338503617,1.0,38/109,23.77%,SLC2A1;PARD3;MNAT1;CREBBP;CD2AP;RANBP9;TEAD1;MITF;HES1;FAS;KPNA3;NUP98;SNX9;WASL;YAP1;AFG3L2;PICALM;DET1;OCLN;TP53;HFE;CD40;PEX14;TPR;TUBGCP4;TFAP4;FANCC;IKBKG;VAMP3;WASF1;MDN1;MAGI1;MDM2;VAMP2;PTK2B;PPIH;NDUFAF1;CD247
prerank,regulation of lipid catabolic process (GO:0050994),0.4724398682983832,1.3628742814426145,0.09976798143851508,0.4537168826440781,1.0,5/19,15.13%,PDE3B;BSCL2;TYSND1;ADRA2A;APOC1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.4709857346077875,-1.3628374533686711,0.11290322580645161,0.3256324155805707,1.0,5/20,12.38%,LYN;PRKCE;LBP;IRAK1;MTDH
prerank,protein localization to membrane (GO:0072657),0.3022442517771089,1.3627368350207487,0.017326732673267328,0.45197953882523834,1.0,37/187,11.33%,KCNIP4;NRXN1;MAGI2;NLGN1;ABCA12;DLG2;LRRC7;DPP10;MAP7;ANK3;DPP6;CYP46A1;ANK1;RAB15;EPB41L3;TSPAN15;PKP2;RAB40C;TNIK;ATP1B1;RAB3C;CPE;CACNB3;WNK3;CD81;MYO5A;HGS;ARL3;ZFYVE27;SPTBN4;TESC;C2CD5;RAB3A;LIN7C;TSPAN32;PPIL2;NKD2
prerank,protein deacylation (GO:0035601),-0.46334657102496724,-1.3626955684101545,0.09285714285714286,0.3254174658526163,1.0,15/23,29.05%,HDAC1;SIRT5;SIN3A;HDAC4;ABHD17A;NOTUM;SIRT3;ABHD17C;HDAC6;HDAC10;HDAC7;LYPLA1;HDAC5;ABHD10;PPT1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.3680755317344227,-1.362451226932614,0.06794425087108014,0.32543773806542453,1.0,28/63,27.04%,ATM;CNOT4;PLAGL1;CDKN1B;E2F4;PLK2;RPL26;TP53;CRADD;RGCC;BTG2;RFWD3;CARM1;SDE2;RPA2;SOX4;CCND1;PRKDC;MDM2;CASP2;GADD45A;E2F7;CNOT2;ARID3A;TFDP1;PLK3;CNOT8;CNOT1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5421007936758178,-1.3624205751915535,0.11652173913043479,0.3250344469807929,1.0,2/12,0.62%,DAB2IP;SEMA6A
prerank,positive regulation of vasoconstriction (GO:0045907),-0.531860767911227,-1.36211817546381,0.10638297872340426,0.3252027710956586,1.0,3/13,4.94%,CAV1;ADRA1B;TRPM4
prerank,regulation of JNK cascade (GO:0046328),-0.3411149068594621,-1.3618709462464265,0.0497335701598579,0.32528256369009656,1.0,35/101,24.93%,MECOM;DAB2IP;IGF1R;MFHAS1;TRAF5;APP;MAP3K5;EGFR;TGFBR3;PLCB1;RASSF2;FLT4;SH3RF1;WNT16;TAOK3;TPD52L1;DUSP3;MAP4K4;TNFRSF19;MTURN;ZMYND11;RAP2A;CCL19;EDAR;NOD2;DUSP22;SH3RF2;PTK2B;LTBR;GADD45A;RIPK1;FZD7;HMGB1;GPS2;AIDA
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.3531983185282983,-1.3616249270880014,0.03505535055350553,0.32535136403665305,1.0,25/79,20.11%,DAB2IP;BMPER;CRIM1;BMPR2;SMURF2;THBS1;PTPN1;SMURF1;SLIT2;NEDD4;SKIL;SMAD1;ACVR2A;SMAD4;UBE2D3;SMAD7;NOTCH1;FGF2;SPRY4;SMAD6;SKI;HTRA3;SMAD9;DAND5;PPARG
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5370254152558273,1.3613369827334028,0.12577319587628866,0.4533349660293126,1.0,4/12,8.11%,TMEM9;CLN3;GRN;CCDC115
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.5060545178029547,-1.360842861039822,0.11604095563139932,0.3264539543842596,1.0,8/16,20.15%,IGF1R;INSR;OGFOD1;BNIP3;GSPT1;HDAC6;TBC1D25;GLE1
prerank,organic acid transport (GO:0015849),-0.3430472361501809,-1.360442025752011,0.046468401486988845,0.3267607038959832,1.0,23/94,13.79%,ABCC4;ABCG2;SLC6A6;SLC26A7;ATP8B1;SLCO1C1;SLC7A1;RXRA;SLC25A32;SLC5A6;SLC38A5;SLC16A1;SLC1A5;LRRC8D;SLCO2B1;PPARD;SLC13A3;MFSD2A;SLC25A11;SLC27A4;CEACAM1;SLC7A7;SFXN5
prerank,actin filament bundle assembly (GO:0051017),-0.4237103617211305,-1.360405214702086,0.08199643493761141,0.3263786098591545,1.0,10/33,13.20%,LIMA1;EPS8;BAIAP2L1;PLS3;EZR;SHROOM1;FAM107A;SHROOM2;LCP1;NEDD9
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.4354400603577272,-1.3598430951076141,0.09208103130755065,0.3269915316628801,1.0,6/26,9.03%,ST3GAL6;ST3GAL4;ST3GAL1;B3GNT2;B4GALT4;ST3GAL2
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.576410701723475,-1.3586129908347904,0.11029411764705882,0.32892495125121085,1.0,2/10,14.03%,GNB1;SAG
prerank,response to lipopolysaccharide (GO:0032496),-0.32291678880050173,-1.3583352376357032,0.015228426395939087,0.32901833096318983,1.0,29/138,16.45%,FOXP1;DAB2IP;PELI1;NOS3;SRR;IFNAR1;ADAM9;HNRNPA0;NFKB1;TNFRSF1B;GGT5;PDCD4;GCH1;IRGM;LBP;MEF2C;MAPKAPK2;SCARB1;NFKBIL1;JAK2;RHOA;IRAK1;CDC73;MAPK8;RPS6KA3;TNFAIP3;SMAD6;TAB2;CHMP5
prerank,DNA conformation change (GO:0071103),-0.5011055421094444,-1.3581934167457232,0.10307414104882459,0.32884490240225983,1.0,8/17,24.66%,KAT6A;TOP3A;ABL1;TOP3B;ERCC3;TOP1MT;TOP1;HMGB1
prerank,negative regulation of histone methylation (GO:0031061),-0.5752514047624102,-1.3580348474648836,0.12037037037037036,0.32868615363937825,1.0,6/10,30.94%,BCOR;DNMT1;BRCA1;AASS;WDR5;DNMT3B
prerank,protein-DNA complex disassembly (GO:0032986),-0.5061299186436548,-1.357973547212883,0.122040072859745,0.3283470996982518,1.0,5/16,13.91%,ARID2;SMARCC1;SMARCE1;SMARCC2;SMARCD3
prerank,T cell homeostasis (GO:0043029),-0.5808477088004644,-1.3579688751734713,0.1166077738515901,0.3278957364987821,1.0,3/10,9.84%,FAS;PPP2R3C;AKT1
prerank,water transport (GO:0006833),0.5366651337351971,1.3576172952013863,0.13452914798206278,0.46048023653669584,1.0,2/12,4.58%,PDPN;AQP4
prerank,filopodium assembly (GO:0046847),-0.5076419024319835,-1.3576062471520405,0.10877192982456141,0.32816660828323124,1.0,4/16,7.39%,FGD5;FGD6;DNM3;EZR
prerank,mitochondrion localization (GO:0051646),-0.4778062672287764,-1.3572397053554537,0.1042830540037244,0.3284226114107486,1.0,4/19,3.71%,MEF2A;TRAK1;MARK1;LRRK2
prerank,muscle tissue morphogenesis (GO:0060415),-0.5101493899392101,-1.3563156329085773,0.12159709618874773,0.32975285698599316,1.0,7/16,17.95%,TBX1;TGFBR3;BMP4;MYLK;ZFPM1;NOTCH1;HEY2
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.40618071199171313,-1.3549969782511693,0.09289617486338798,0.33186428391911704,1.0,12/38,18.16%,ANKRD17;BMP6;NMI;PUM1;AKIRIN2;DDX60;USP15;PLSCR1;POLR3F;IFI35;GBP5;SASH1
prerank,cellular response to starvation (GO:0009267),-0.3184963770847982,-1.3547609115422505,0.024518388791593695,0.33191729602712794,1.0,43/147,19.30%,FOXO1;BMPR2;SESN1;MTMR3;ATG7;SIK1;LRRK2;MAP3K5;MTOR;MAP1LC3B;PPARA;STK24;FOXO3;FAS;SEC13;MAPK1;MIOS;PRKD1;DAPL1;MFSD2A;TP53;KLF10;PRKAA1;WIPI1;GABARAP;RPTOR;ATP6V1E1;LARS1;KPTN;MAPK8;ATF4;ZFYVE1;HNRNPA1;DAP;NUAK1;ATG5;CASTOR1;GCN1;RIPOR1;LAMP2;WRN;RNF152;ITFG2
prerank,excitatory postsynaptic potential (GO:0060079),0.46973622684057126,1.3547164282682431,0.10837438423645321,0.4657246768165915,1.0,4/19,3.46%,GRID2;MPP2;GRIN2B;GRIN2A
prerank,activation of GTPase activity (GO:0090630),-0.34417163991159827,-1.3546338025930698,0.03473491773308958,0.33170692332383556,1.0,33/89,22.98%,TBC1D4;BCR;RALGAPA1;CORO1C;TBC1D1;TBC1D2B;ARHGEF15;TBC1D8B;USP6NL;SIPA1L3;TBC1D30;TBC1D14;MTSS2;TBC1D22B;TBC1D22A;BCAS3;SLC27A4;TAX1BP3;ARHGEF10;RHOG;ARHGAP22;ABR;ARHGAP29;TBC1D8;EPHA2;TBC1D17;TBC1D25;ARHGAP42;ARHGEF5;SYDE1;TBC1D12;EVI5;PIP5K1A
prerank,smooth muscle cell differentiation (GO:0051145),-0.5543979936446077,-1.3543406122257533,0.11867364746945899,0.3318336114184764,1.0,7/12,22.61%,MRTFB;BMP4;MEF2C;TMEM204;HEY1;HEY2;MYOCD
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.4318617859425722,-1.354276113515516,0.08880994671403197,0.3315049260416556,1.0,17/31,32.86%,CRIM1;LRP5;TRPM4;LIMD1;TWIST2;NOTCH1;TMEM64;CDK6;SMAD6;SKI;PPARG;HDAC7;GDF10;SUFU;BAMBI;RIOX1;PTCH1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.47396956478216656,-1.3536402038044062,0.09773123909249563,0.33229042343651594,1.0,8/20,23.27%,ENTPD1;APP;NT5E;TXNIP;ANO6;PSTPIP1;TXN;CASP1
prerank,regulation of cellular catabolic process (GO:0031329),-0.37112166846920536,-1.3535564808250127,0.06571936056838366,0.33204404202053045,1.0,22/62,24.23%,ITPR1;DAPK1;ACER2;MTMR3;ATM;LRRK2;PIP4K2A;ABL1;PIP4K2B;ROCK1;USP13;RPTOR;GPR137B;USP10;HDAC6;RAB39B;DRAM2;WDR41;KEAP1;MTMR4;TPCN2;TRIB3
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.44570249370951986,-1.3533519277457784,0.10344827586206896,0.33198656923043096,1.0,6/25,7.91%,CAV1;FAM20A;CNNM2;TMTC2;TRPM7;CNNM4
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4466500019468802,-1.353142362188715,0.09507042253521127,0.33196754511378845,1.0,10/22,26.46%,CDK13;CDK12;DDX39B;CDC73;THOC1;SUPT4H1;CCNK;BRD4;ERCC6;LEO1
prerank,response to prostaglandin E (GO:0034695),-0.5703949088060449,-1.3525627957411652,0.1259124087591241,0.3326664255177131,1.0,5/10,26.88%,GNB1;TGFBR3;CCL19;GNG2;ADCY6
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.3909927896603956,-1.3522528107982015,0.07446808510638298,0.33279233053036694,1.0,16/46,18.29%,ANXA2;JAK1;PAK2;MSN;PDCD4;PLCB1;TCP1;PSME2;RAP1B;JAK2;HNRNPF;LCP1;TALDO1;MIF;SOD1;CFL1
prerank,cellular response to ionizing radiation (GO:0071479),-0.3902782663999297,-1.3518392713280236,0.08035714285714286,0.33314670202568575,1.0,23/47,30.42%,MAP3K20;NET1;TLK2;ATM;NIPBL;SPIDR;YAP1;RPL26;TP53;GRB2;WRN;LIG4;MDM2;BLM;GADD45A;INTS7;INO80;TMEM109;KDM4D;RAD51AP1;SWI5;MAPK14;EEF1D
prerank,protein autoprocessing (GO:0016540),0.48536912486574363,1.3507761080764293,0.11241217798594848,0.4733277536804953,1.0,5/17,16.85%,OMA1;MYRF;KLK6;HTRA2;CASP4
prerank,GPI anchor metabolic process (GO:0006505),0.4316103059442471,1.3504115622193336,0.1,0.4721378016981783,1.0,7/26,12.14%,PGAP1;DPM1;PIGP;MPPE1;PIGB;PGAP3;GPLD1
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.5566425940679025,-1.3503063497849501,0.12476007677543186,0.33574008444109593,1.0,10/11,43.71%,TENT4B;EXOSC2;EXOSC3;PARN;EXOSC5;LARP7;EXOSC4;FBL;FBLL1;DKC1
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.35154613340583735,-1.3496526275877048,0.05381944444444445,0.3365354912640537,1.0,26/70,22.47%,TEK;RB1;FERMT2;PARVB;RAC1;PARVA;NTN4;PXN;PIK3R1;MEF2C;SIPA1L3;ILK;RHOA;LAMA5;ACTN1;LAMC3;ITGA4;ATF4;ATRNL1;VAMP3;EPHA2;FERMT3;ITGB3;LAMB1;USH2A;EPHB3
prerank,regulation of autophagy (GO:0010506),-0.3052414391021616,-1.3492526488813545,0.01048951048951049,0.3369126893003467,1.0,70/216,24.66%,ITPR1;FOXO1;MCL1;TAB3;DAPK1;ACER2;SH3BP4;TLK2;GSK3B;MTMR3;ATM;LRRK2;EXOC4;MTOR;PIP4K2A;RASIP1;ABL1;FOXO3;NEDD4;PIP4K2B;IRGM;BNIP3;ERN1;PIK3C2A;PLK2;ROCK1;PRKD1;TBC1D14;DAPL1;GSK3A;HAX1;USP13;AKT1;PRKAA1;TRIM14;RPTOR;VPS26A;MTDH;KAT5;ATP6V1E1;HGF;GPR137B;MAPK8;PIK3CB;DAP;EXOC8;USP10;TAB2;HDAC6;RAB39B;ATP6V0A1;WASHC1;RNF152;DRAM2;PRKAB1;UCHL1;WDR41;ORMDL3;CTSA;KEAP1;MTMR4;ATP6V1H;ATF6;GFAP;TPCN2;FZD5;TRIM68;TRIB3;RHEB;HMGB1
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.3187433287357908,-1.3491703633738998,0.021775544388609715,0.33660443294539755,1.0,47/151,22.11%,SGMS1;CERT1;ST3GAL4;ALAS1;ACER2;DEGS2;SGMS2;PLA2G4A;PRKD3;PRKD2;GSTT1;SPNS2;LPCAT1;ELOVL5;CERS4;GCH1;PPM1L;PAM;SLC44A1;PRKD1;STARD7;ST3GAL2;PCSK5;MFSD2A;GSTM2;ACER3;TYW1;MOCS2;B4GALT5;SPTLC1;GAL3ST2;CEPT1;CERS5;PCTP;ESD;VAPA;GOLPH3;HPGDS;LARGE1;DEGS1;ELOVL7;CDO1;LPIN2;GSTO2;LPCAT3;LCAT;MOCS3
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.3606122131342338,-1.3491089745648084,0.054514480408858604,0.33626429896835447,1.0,14/70,11.47%,DAB2IP;MCL1;GSK3B;DDX3X;IL6R;TNFRSF1B;FAS;TGFB2;NGF;GSK3A;CASP8;CRADD;GABARAP;JAK2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.5293168831915057,-1.3485998309709293,0.1170018281535649,0.33675725016931946,1.0,6/12,27.56%,CDYL;PCGF3;BRCA1;PCGF5;RBM15;HNRNPU
prerank,histone mRNA metabolic process (GO:0008334),-0.4386269757451367,-1.348486394658367,0.09874326750448834,0.33650367953738175,1.0,9/27,18.08%,TUT7;TENT4B;ATM;XRN1;TUT4;LSM11;TENT2;SNRPE;LSM10
prerank,negative regulation of T cell differentiation (GO:0045581),-0.568434982680109,-1.3476958689921277,0.13854351687388988,0.33760027439368273,1.0,3/10,9.10%,BMP4;IRF1;GLI3
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.4376125722054337,-1.347531491357423,0.0954861111111111,0.3375174925814294,1.0,9/26,21.21%,GCH1;NOS1AP;SCARB1;AKT1;S100A1;PIK3CB;TERF2;POR;TERT
prerank,negative regulation of cell population proliferation (GO:0008285),-0.2853976255853845,-1.3471933422945221,0.004901960784313725,0.3377085504535873,1.0,113/351,25.03%,DAB2IP;SMARCA2;IGFBP7;RAPGEF2;ACVRL1;NOS3;PTPN14;KLF4;ETS1;ABI1;PKD2;CBFA2T3;LYN;BMPR2;PDS5B;CD200;SH3BP4;BTG3;APP;MCC;KAT2B;BMP5;RNF139;ITGA1;ARID2;P3H2;THAP12;PTPRJ;EMD;CDKN1B;TGFBR3;VGLL4;CTCF;HES1;RARG;RBM5;NMI;TGFB2;RBP4;AQP11;BMP4;PTPRK;CDK10;NGF;RAF1;IRF1;CELF1;CTBP2;TP53;FRK;KLF10;AXIN2;NCK2;RGCC;LMNA;SOX7;JAK2;ZBTB7C;NOTCH1;CDC73;CDK6;TBRG1;NUDT6;TNFAIP3;IFI35;IGFBP5;BTG2;CCN3;FUZ;SMAD6;FOXO4;RERG;SKI;GSDME;NOX4;CTNNB1;TFAP4;ADARB1;TNS2;ADGRG1;TES;GATA2;BAP1;PPM1D;SOX4;TMEM127;CTNNBIP1;PPARG;PTEN;NF1;TOB1;DLL4;WARS1;CDKN2C;ROR2;DIS3L2;PTK2B;MYOCD;TBX3;SFRP4;COPS8;CEBPA;CYP1B1;ATF5;E2F7;HSPA1B;E2F3;TFDP1;PINX1;PLXNB1;ADGRB1;BMP2;PLPP1
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.3983079369842326,-1.3466456919514185,0.0875,0.33835849678166163,1.0,17/42,25.60%,SMARCA2;ARID1B;HDAC1;SMARCC1;SRCAP;SMARCE1;SPTY2D1;CECR2;SMARCC2;CHD3;ACTB;INO80B;VPS72;SMARCAD1;SMARCB1;INO80;ERCC6
prerank,response to glucocorticoid (GO:0051384),-0.43858539889204845,-1.3465804304566689,0.1104868913857678,0.3380533135676215,1.0,10/26,27.56%,NR3C1;ADAM9;SLIT2;FAM107A;UBE2L3;BCL2L11;ANXA1;PDCD7;ZFP36L1;HNRNPU
prerank,positive regulation of cell population proliferation (GO:0008284),-0.2813749181281753,-1.3465672625343204,0.005,0.3376382368891065,1.0,115/423,23.40%,FOXP1;FLT1;TJP1;LEF1;GRK5;PRKCH;IGF1R;KITLG;OSMR;CLDN5;INSR;LRP5;LYN;ACER2;PDGFD;THBS1;CDK13;GCNT2;BMP5;TBX1;IL15;KDR;EGFR;IL6ST;TGFBR3;TRPM4;TGFBR2;BMP6;HDAC1;IL6R;HES1;GAS6;IRS1;STX3;IL34;CUL3;DNAJA2;TGFB2;PTK2;AQP11;FGF1;BMP4;STAMBP;MEF2C;TBX2;YAP1;NOP2;FLT4;NES;LIFR;NAMPT;ADAM10;FGF7;AKT1;MAP3K3;VEGFC;EDN1;DOT1L;PTGFR;MAZ;EDN3;ACER3;NOTCH1;FGF2;HDAC4;SAAL1;CDC123;ASH2L;RHOG;CDK6;RPS4X;MECP2;FAM98A;COPS9;MIF;GAB2;LGMN;IGF1;SRPK2;COX17;RARA;CTSH;CACUL1;CLCF1;TNFSF13;TBC1D8;NOD2;SOX4;PTPRC;TCF7L2;KRAS;PTEN;LIG4;FGFR4;PRC1;IL13RA1;IGF2;LAMB1;DLL4;TERT;MDM2;NACC1;S1PR3;PDGFRB;LAMC2;PTK2B;TTK;CCN1;RELA;PTN;ESM1;TBX3;HPSE;HAS2;CEP131
prerank,protein monoubiquitination (GO:0006513),-0.4076936327740531,-1.3459086904571786,0.07526881720430108,0.33846597248071747,1.0,13/36,21.22%,TRIM25;DTX3L;RBX1;CUL3;RNF40;KLHL12;UBE2D3;RAD18;CDC73;OBI1;HUWE1;FANCL;UBE2R2
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.37529936175499595,-1.3458440703671701,0.06728971962616823,0.33814997729821816,1.0,22/54,24.97%,NXN;DCUN1D3;CAV1;IVNS1ABP;AKT1;SMAD7;SPOPL;CHP1;COPS9;TNFAIP3;N4BP1;RPL5;SENP2;CTNNB1;RPS3;SOX4;OGT;SH3RF2;ARRB1;HSPA1B;PINX1;ADGRB1
prerank,RNA stabilization (GO:0043489),-0.41183393078929,-1.3456237440838126,0.08680555555555555,0.33809437800055014,1.0,14/33,28.15%,LARP1;FUS;AXIN2;TENT2;PARN;TRDMT1;PHAX;RBM24;THRAP3;TAF15;NAF1;PABPC1;HNRNPU;TENT5C
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.5611403522173604,-1.3456189469053088,0.13097345132743363,0.3376492682552492,1.0,5/10,31.29%,ACADL;ACAD11;ACADVL;IVD;ACADS
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.3959362353943321,-1.344735175403336,0.06044905008635579,0.33897508495716017,1.0,15/42,14.15%,RSU1;RAC1;LIMS1;CORO1C;GCNT2;VIT;FZD4;PTK2;PPM1F;FBLN2;JAK2;NOTCH1;RHOA;ATXN3;PIK3CB
prerank,positive regulation of defense response (GO:0031349),-0.3435914306317662,-1.3447274985980586,0.05017921146953405,0.3385401258507612,1.0,30/89,28.25%,ETS1;APP;IL15;NFKBIA;NMI;PDE2A;PDCD4;MEF2C;NAPEPLD;AKIRIN2;FEM1A;AGTR1;LPL;IL17RA;PLSCR1;POLR3F;IFI35;IL16;TNFRSF1A;GBP5;HYAL2;GPR4;SERPINE1;RIPK1;CEBPA;DDT;DHX9;TNIP1;GPSM3;RIOK3
prerank,regulation of dendrite development (GO:0050773),0.4023664825978395,1.3439687644769607,0.0787746170678337,0.4865269856002697,1.0,8/37,6.03%,CSMD3;ADGRB3;DCC;HECW1;CDKL5;VLDLR;TNIK;HECW2
prerank,regulation of lipid kinase activity (GO:0043550),-0.547374595815595,-1.3434699674814854,0.12926391382405744,0.3405530892510049,1.0,3/11,5.82%,RB1;PPP2R5A;PIK3R1
prerank,regulation of calcium ion transport (GO:0051924),0.36323374226032035,1.3432050637537731,0.062360801781737196,0.4863834661228648,1.0,15/54,12.82%,STC1;CACNA2D1;BCL2;EFHB;WNK3;CACNA1D;CAMK2B;HOMER1;PLPP4;ADRA2A;LILRA5;SRI;HRC;CCL5;CASQ1
prerank,myoblast fusion (GO:0007520),0.5325599767272439,1.3429805623339384,0.13286713286713286,0.48481332097857843,1.0,4/12,6.52%,ADAM12;ADGRB3;ADAMTS15;CD81
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.45618362990344163,1.3429192625250628,0.11389521640091116,0.4828334971400258,1.0,6/20,11.91%,KCNMA1;ATP1A2;ATP12A;ATP1B1;ATP4A;SLC8A1
prerank,ERBB signaling pathway (GO:0038127),-0.35749260671403765,-1.3427629135267234,0.05253623188405797,0.34144680856109316,1.0,17/64,11.38%,GAB1;IQGAP1;RPS6KA5;PLCG1;EGFR;PTPN12;SLC30A10;CBL;PIK3R1;PTK2;PIK3C2A;PLCE1;MAPK1;BCAR1;AKT1;NCK2;BRAF
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.3097678992775278,-1.3409150181876808,0.024793388429752067,0.3446791645740173,1.0,44/182,16.77%,FOXP1;CLDN5;ENG;ACVRL1;RB1;RIN3;KLF4;CD34;ESR1;TNRC6B;SLC7A5;APP;KDR;TIPARP;SMO;ZNF148;HDAC1;NFKB1;TGFB2;PARP14;BMP4;MEF2C;NOTCH2;YAP1;CELF1;PICALM;OCLN;ADAM10;PRKAA1;DICER1;SNX12;PSEN1;NOTCH1;FGF2;APOBEC1;MECP2;AGO2;MIF;ROCK2;LGMN;TERF2;IGF1;MOV10;DNMT1
prerank,negative regulation of cellular senescence (GO:2000773),-0.5223354447559224,-1.3406318523432739,0.13092979127134724,0.344734786822925,1.0,6/13,21.21%,SLC30A10;AKT3;MAP3K3;CDK6;TERF2;TERT
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.31402748101680517,-1.3406108743705996,0.04363001745200698,0.3443219546424152,1.0,33/149,18.97%,PRKCH;EDA;ERC1;ROR1;CAV1;TAB3;NOD1;TRAF5;TRIM25;APP;RPS6KA5;PRKD2;SLCO3A1;TFRC;NFKB1;NFKBIA;ZBTB7A;PRKD1;ARHGEF2;CFLAR;RNF25;TRIM14;IRAK1;MTDH;FLOT1;CD40;TAB2;TRIM13;IRAK2;RPS3;IKBKG;IKBKB;NOD2
prerank,regulation of cell development (GO:0060284),-0.4102802527515023,-1.3405992040289174,0.09272727272727273,0.3438967998087856,1.0,9/36,17.95%,FOXO1;ADGRA2;HES1;NOTCH2;YAP1;AKT1;CTNNB1;HEY1;HEY2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.33951585097037396,-1.3402190603046358,0.06172839506172839,0.3442009994556903,1.0,38/93,25.78%,NSD1;CAV1;APP;PRKD2;EGFR;TFRC;GAS6;NCK1;DDIT4;IRGM;RASSF2;NGF;PPM1F;PRKD1;RAF1;HAX1;AKT1;NCK2;FNIP2;BRAF;SMAD7;RPTOR;CNKSR3;MTCP1;MIF;MAD2L2;CREBL2;HDAC6;TXN;PTEN;CAPRIN2;NOS1;HSP90AA1;AKAP9;SH2D3C;INPP5J;RAPGEF3;DMTN
prerank,steroid catabolic process (GO:0006706),0.5494048555487647,1.3397826163155369,0.13808463251670378,0.4885196256420476,1.0,3/10,13.05%,CYP24A1;HSD17B14;SPP1
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.45549282642627276,-1.3393667623517362,0.11299435028248588,0.345410572178219,1.0,9/21,24.73%,THBS1;MTUS1;IL34;PTK2;MAPK1;MIF;CMKLR1;PTK2B;DDT
prerank,double-strand break repair (GO:0006302),-0.3093393621162148,-1.3388130705289658,0.023728813559322035,0.3460592867048973,1.0,70/158,32.37%,ATM;UIMC1;DTX3L;KDM2A;SMC5;SAMHD1;ZFYVE26;XRCC4;SPIDR;MMS22L;MRE11;NABP1;MCM9;RBBP8;TENT4A;RAD54B;NSMCE2;SFPQ;RPA3;DNA2;KAT5;RPA1;BABAM2;MAPK8;NHEJ1;RNF168;UBE2V2;PALB2;MAD2L2;HERC2;SUMO1;RFWD3;HPF1;BRCC3;WRN;RPA2;BAP1;SMARCAD1;PRKDC;PIAS4;LIG4;BRCA1;RAD51AP2;BAZ1B;DCLRE1B;BLM;YY1;MORF4L1;HMGB1;INO80;DCLRE1A;APBB1;PARP9;TRIP13;POLL;XRCC2;AP5Z1;APLF;KDM4D;RAD51AP1;MDC1;TDP1;SWI5;RAD51D;HUS1B;CYREN;KDM4A;RMI1;MEIOB;PARP3
prerank,negative regulation of synaptic transmission (GO:0050805),0.4461748287169329,1.3385314105726072,0.09728506787330317,0.48962945907449423,1.0,6/23,11.22%,SLC24A2;SYT11;MTMR2;ATAD1;CBLN1;PRRT1
prerank,negative regulation of gene expression (GO:0010629),-0.28993203685253033,-1.3385101098460406,0.016366612111292964,0.34624939960214596,1.0,99/302,27.44%,FOXP1;CLDN5;ENG;ACVRL1;RB1;KLF4;CD34;DAPK1;ESR1;TNRC6B;SLC7A5;APP;KAT2B;RPS6KA5;RNF139;DDX3X;KDR;SRGN;TIPARP;SMO;GIGYF2;ZNF148;HDAC1;LARP1;NFKB1;TGFB2;SUZ12;PARP14;BMP4;ERN1;MEF2C;SAMD4A;NOTCH2;YAP1;CELF1;PICALM;OCLN;ADAM10;TASOR;PRKAA1;DICER1;RGCC;SNX12;PSEN1;NOTCH1;FGF2;ASB1;MECP2;AGO2;H3-3A;IGFBP5;N4BP1;SYNCRIP;BTG2;MIF;ROCK2;LGMN;TERF2;IGF1;MOV10;DNMT1;PPHLN1;HEY2;RPS3;CITED2;NUDT12;GATA2;PPM1D;TNRC6A;CAPRIN1;WWP2;PTBP3;TOB1;DLL4;TERT;DIS3L2;METTL16;NDFIP2;YY1;RPL13A;MRPL13;EIF2AK3;AEBP2;HSPA1B;SETDB2;BMP2;DIP2A;FXR1;IGF2BP2;CNOT8;PARP9;RPS26;DXO;EMILIN1;NANOS1;LGALS9;CNOT1;SLC24A3;TRIM6
prerank,regulation of innate immune response (GO:0045088),-0.36662601790575755,-1.3382812942161992,0.06284658040665435,0.3462358433416756,1.0,28/57,32.73%,XIAP;PTPN1;BIRC3;SAMHD1;NMI;IRF1;AKIRIN2;CASP8;USP18;PLSCR1;POLR3F;TNFAIP3;IFI35;N4BP1;GBP5;ERAP1;TKFC;ABCE1;PTPN11;IFNAR2;DHX9;PARP9;RIOK3;TREM2;CACTIN;LRP8;FGR;TRAFD1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.43670527394517433,-1.3382719178238676,0.07678244972577697,0.3458115212404677,1.0,10/25,24.53%,ETS1;FOXO3;MED1;ABCB10;ACVR2A;TAL1;ARNT;PRKDC;MAPK11;HSPA1B
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.46681582495639984,-1.3382120705300071,0.12588652482269502,0.3454647126551291,1.0,8/21,18.01%,MYH9;ADAM9;PSEN2;SPPL3;ADAM10;PSEN1;APH1A;ERAP1
prerank,mitochondrial genome maintenance (GO:0000002),-0.5485317942903272,-1.3380014312172974,0.13653136531365315,0.3454555501303148,1.0,3/11,8.59%,MEF2A;TOP3A;AKT3
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.49665817789542543,-1.3378682574735592,0.12588652482269502,0.34526086483459606,1.0,5/16,12.16%,RB1;PDS5B;NIPBL;POGZ;PDS5A
prerank,negative regulation of multicellular organismal process (GO:0051241),-0.30178363029632305,-1.3377053164885895,0.02707581227436823,0.3451576840348249,1.0,45/199,17.95%,PTPRG;DAB2IP;KLF7;NFIB;ZNF423;RB1;NOS3;BMPR2;IL17RD;CORO1C;GSK3B;MCC;BMP5;RPS6KA5;WWC2;ID1;SPRED2;IL15;SRGN;EGFR;LDLRAD4;LAMA4;GAS6;NOVA2;BMP4;MEF2C;RAB11FIP3;ROCK1;GSK3A;ADAMTS5;RGCC;SMAD7;ADM;NOTCH1;WNT11;ASB1;ATF4;N4BP1;ROCK2;SMAD6;MAD2L2;PCTP;PAEP;HEY1;HEY2
prerank,regulation of cytoskeleton organization (GO:0051493),-0.3289912006803052,-1.337317681345342,0.0466786355475763,0.34545794788830725,1.0,32/108,15.36%,TJP1;RAC1;RHOBTB1;GSK3B;IQGAP1;F11R;RND3;CRK;PAK2;DIAPH1;MTOR;RICTOR;ABL1;RHOQ;PTK2;PRKCD;CDK10;EZR;MAPK1;ROCK1;FAM107A;ARHGAP17;CAPN2;PRKAA1;RHOA;RHOC;RHOG;TRAF3IP1;SORBS3;MARK2;HIP1R;ROCK2
prerank,melanosome transport (GO:0032402),0.4690690236768894,1.3372437666250456,0.10633484162895927,0.48853612725240453,1.0,9/18,16.59%,MREG;RAB27B;MYO5A;BBS7;BBS4;BBS5;ARL6;MKKS;BBS2
prerank,pigment granule transport (GO:0051904),0.4690690236768894,1.3372437666250456,0.10633484162895927,0.48853612725240453,1.0,9/18,16.59%,MREG;RAB27B;MYO5A;BBS7;BBS4;BBS5;ARL6;MKKS;BBS2
prerank,regulation of cellular senescence (GO:2000772),-0.43038863044339987,-1.3372381628700027,0.10836501901140684,0.3451666540222869,1.0,10/28,15.96%,NEK6;SLC30A10;AKT3;YPEL3;MAP3K3;ABI3;CDK6;CGAS;NUAK1;TERF2
prerank,negative regulation of cytokine production (GO:0001818),-0.3104223608718886,-1.3372100542333765,0.02982456140350877,0.34476569327002493,1.0,37/163,18.05%,LEF1;KLF4;CD34;RAC1;CD200;THBS1;TMSB4X;IFIH1;TRIM25;RPS6KA5;SRGN;RNF125;TAX1BP1;PPARA;GAS6;PDCD4;EZR;ANXA4;UBA7;RGCC;IKBKE;ZFPM1;CEACAM1;KAT5;ASB1;TRAF3IP1;TNFAIP3;N4BP1;ILRUN;C1QTNF3;VSIR;RARA;ANXA1;GPATCH3;NLRC5;MAVS;CMKLR1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.4044720706900761,-1.3370587363542354,0.08860759493670886,0.34461760036351063,1.0,13/33,22.61%,KLF4;ETS1;TEAD1;NR3C1;FOXO3;TGFB2;JUN;TP53;FGF2;GATA2;PPARG;TERT;RELA
prerank,positive regulation of cellular process (GO:0048522),-0.27180035407253733,-1.3366460901671815,0.0016260162601626016,0.3450402970467692,1.0,157/565,23.43%,FLT1;TJP1;LEF1;GRK5;IGF1R;KITLG;OSMR;SLC6A6;CLDN5;PARD3;INSR;ETS1;CAV1;RAC1;LRP5;LYN;ACER2;ANKRD17;ZFHX3;PDGFD;THBS1;CDK13;GCNT2;BMP5;ATM;TBX1;IL15;DDX3X;KDR;PRKD2;MERTK;PTPRJ;EGFR;IL6ST;CDKN1B;SMC5;TRPM4;TGFBR2;BMP6;HDAC1;IL6R;HES1;TNFRSF1B;GAS6;IRS1;STX3;IL34;CUL3;DNAJA2;LRP6;TGFB2;PTK2;PRKCD;LBP;AQP11;FGF1;BMP4;STAMBP;TGM2;TBX2;RAB27A;EPHA4;NOP2;FLT4;EXOSC2;LIFR;CELF1;MFSD2A;NAMPT;ADAM10;FGF7;TAL1;ACACB;AKT1;VEGFC;EDN1;DOT1L;AXIN2;PRKAA1;PTGFR;DICER1;LMNA;MAZ;EDN3;ACER3;FRMD5;RPTOR;NOTCH1;FGF2;RAD18;RPS6KA1;HDAC4;PA2G4;TPM1;CDC123;ACTN4;FLOT1;ASH2L;RHOG;MAPK8;RPS4X;MECP2;RPS6KA3;FAM98A;COPS9;HCFC1;H3-3A;AGPAT1;GAB2;N6AMT1;ABCA7;LGMN;IGF1;TRIM13;SRPK2;COX17;TRPC3;RARA;CTSH;LMAN2;TULP1;ADGRG1;CACUL1;RAD23A;CLCF1;TNFSF13;CITED2;TBC1D8;RNF10;GATA2;SOX4;CCND1;BRAT1;KRAS;CXCL12;PTEN;NSMCE4A;FGFR4;PRC1;IL13RA1;IGF2;MDM2;NACC1;S1PR3;PDGFRB;CHEK1;LAMC2;PTK2B;TTK;RELA;PTN;ESM1;MTPN;TBX3;HAS2;CEP131;FZD7
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.32591968367593316,-1.3366020256106053,0.04964539007092199,0.34466403528272704,1.0,33/113,18.94%,UNC13B;DAB2IP;FERMT2;TRABD2B;ASAP1;MPP7;ESR1;GSK3B;ATM;DDX3X;TFRC;RBX1;RASIP1;SPIDR;CDH5;RAP1B;ERCC2;TAL1;TP53;FNIP2;ICE1;LCP1;RPA3;RPA1;RHOC;SLF2;ERCC3;PSMC2;BCL2L11;SUMO1;GBP5;RPS3;RPA2
prerank,cellular response to ATP (GO:0071318),0.4976206404120459,1.3361981695781244,0.12738853503184713,0.48908082739700437,1.0,4/14,14.11%,RYR3;CIB2;P2RX3;TAF1
prerank,muscle cell migration (GO:0014812),-0.5727410574175298,-1.3359639625508088,0.11721611721611722,0.3454512106749584,1.0,6/10,25.21%,SIX1;ROCK1;CCN3;PLAT;ITGB3;THBS4
prerank,histone deacetylation (GO:0016575),-0.38759579731028165,-1.335838738008516,0.09154929577464789,0.3452555110518227,1.0,17/43,23.74%,MIER1;PRDM5;RCOR1;HDAC1;MIDEAS;SIN3A;HDAC4;SFPQ;MIER2;HDAC6;HDAC10;MIER3;ELK4;SMARCAD1;TBL1X;SUDS3;MORF4L1
prerank,negative regulation of intracellular signal transduction (GO:1902532),-0.30691369901996324,-1.3356490509443972,0.021775544388609715,0.3452565592055887,1.0,65/190,23.64%,DAB2IP;ITPR1;CAV1;MCL1;CD2AP;ESR1;LYN;UACA;SH3BP4;THBS1;TMSB4X;CGNL1;WWC2;DDX3X;PTPRJ;VGLL4;PDE3A;LIMD1;PPARA;PPEF2;NMI;PDE2A;SLIT2;DDIT4;STAMBP;GSK3A;PPM1B;CASP8;AKT1;UBR2;THEM4;PRKAA1;PEBP1;DUSP3;PIK3CB;PIK3IP1;TRIM59;TNFAIP3;IFI35;CCN3;ABCA7;USP10;C1QTNF3;BMP7;MARK3;ARHGAP12;PPIF;ZMYND11;WTIP;UBR1;HYAL2;EPHA2;TMEM127;PTEN;HERPUD1;AKT1S1;NF1;MDM2;HDAC7;MAP2K3;PHLDA3;RELA;TRIM39;RIPK1;AJUBA
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.32967270121206305,-1.3355094881128322,0.05102040816326531,0.34508121117145685,1.0,22/113,10.05%,TEK;RREB1;NRP2;BMPR2;BMP5;TBX1;KDR;PRKD2;EGFR;BMP6;FGF1;BMP4;STXBP4;NOTCH2;PRKD1;AKT3;YAP1;FLT4;PIK3CD;FGF7;AKT1;VEGFC
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.39785785503556637,-1.335217411201916,0.1039426523297491,0.34525212273368194,1.0,14/36,21.87%,DAB2IP;MGA;RYBP;SUZ12;MAX;RBBP8;EHMT1;YAF2;PHC1;FOXO4;RNF2;BRCA1;PHC3;CHEK1
prerank,alcohol catabolic process (GO:0046164),0.5444708573749991,1.3350929305924006,0.15418502202643172,0.4898977954834639,1.0,4/10,14.63%,AKR1D1;CYP46A1;CYP27A1;APOE
prerank,autophagosome assembly (GO:0000045),-0.37090791902414033,-1.3349482066227059,0.0773286467486819,0.3453525457263829,1.0,22/52,27.26%,ATG7;RAB7A;RAB1A;SMURF1;MAP1LC3B;AMBRA1;IRGM;WIPI1;GABARAP;ULK2;RAB23;ATG5;STX12;EMC6;WDR45B;ATG16L2;BECN1;ATG2A;RAB19;ATG2B;UBXN2A;ATG3
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.3111385181241365,-1.3348606317704406,0.03,0.3450785001887091,1.0,44/150,20.79%,DAB2IP;PARD3;ENG;RB1;CAV1;LYN;CORO1C;CEP85;PAK2;SPRED2;LRRK2;NIBAN1;RTRAF;LDLRAD4;NCK1;PPEF2;LRP6;SLIT2;DDIT4;PRKCD;RASSF2;PPM1F;PRKRIP1;OCLN;AKT1;NCK2;SMAD7;CNKSR3;CEACAM1;PTPN13;CHP1;TRAF3IP1;DNAJC10;SMAD6;TAF7;UBASH3B;CDK5RAP3;PMEPA1;PTPRC;PRKDC;PTEN;SNX25;AKT1S1;NF1
prerank,regulation of protein kinase B signaling (GO:0051896),-0.3038037177061719,-1.3335345390607065,0.039723661485319514,0.34719380093209323,1.0,57/193,23.17%,HIP1;TEK;IGF1R;KITLG;ENG;ITGB1;GAB1;FERMT2;INSR;RAC1;MFHAS1;ESR1;THBS1;GCNT2;PTPRJ;EGFR;RICTOR;PPARA;GAS6;PIK3R1;IRS1;PTK2;FGF1;HAX1;RRAS;PIK3CD;FGF7;AKT1;THEM4;MAZ;FGF2;MTDH;MYOC;RHOG;HGF;PIK3CB;GRB2;IAPP;GAB2;TNFAIP8L3;ANGPT1;FYN;CCL19;HYAL2;EPHA2;TXN;TCF7L2;PTEN;F3;FGFR4;IGF2;PTPN11;PDGFRB;PHLDA3;HSP90AA1;HPSE;FRS2
prerank,response to estradiol (GO:0032355),-0.4210564080873715,-1.3334187053792355,0.08199643493761141,0.3470057402195496,1.0,10/31,17.12%,ESR1;NRIP1;EGFR;STRN3;GGT5;SOCS2;KAT5;RUVBL2;ANXA1;CTNNB1
prerank,stress-activated MAPK cascade (GO:0051403),-0.3602873573793103,-1.3331845781397584,0.06597222222222222,0.346999687066916,1.0,25/61,27.02%,MAP3K20;TAB3;NOD1;MAP3K5;MAP4K3;NFKB1;MAPK1;IRAK1;FBXW11;MAP3K8;MAPK8;TNFRSF19;MAP2K4;TAB2;IRAK2;IKBKG;IKBKB;NOD2;MAP2K3;MAPK11;SH2D3C;MAP3K7;GPS2;ZFP36L1;LGALS9
prerank,nucleosome disassembly (GO:0006337),-0.5200563854850092,-1.3329433218708624,0.13653136531365315,0.34660770931990637,1.0,5/14,13.91%,ARID2;SMARCC1;SMARCE1;SMARCC2;SMARCD3
prerank,chromatin disassembly (GO:0031498),-0.5200563854850092,-1.3329433218708624,0.13653136531365315,0.34660770931990637,1.0,5/14,13.91%,ARID2;SMARCC1;SMARCE1;SMARCC2;SMARCD3
prerank,substrate-dependent cell migration (GO:0006929),-0.520670833224135,-1.3317823084027924,0.11964285714285715,0.3484347768751378,1.0,6/14,19.32%,ANKS1A;CD2AP;NTN1;VEGFC;ITGA2;PTPRC
prerank,ameboidal-type cell migration (GO:0001667),-0.3765677454324862,-1.331193737342886,0.10189982728842832,0.34910906140865794,1.0,22/51,21.39%,SEMA6A;SEMA3C;CORO1C;SEMA7A;TBX1;PHACTR4;PDLIM1;AKT1;SEMA3G;SEMA6B;SEMA4C;PDXDC1;ITGA4;PKN2;PKN3;CCN3;SEMA5B;SEMA4A;SEMA3E;GPC3;SEMA4G;AMOTL2
prerank,actin filament bundle organization (GO:0061572),-0.4121484668810504,-1.331091075724422,0.10590277777777778,0.34884753071460173,1.0,10/33,13.20%,LIMA1;EPS8;BAIAP2L1;PLS3;EZR;SHROOM1;FAM107A;SHROOM2;LCP1;NEDD9
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.47358924468836566,-1.3310014477055454,0.13523131672597866,0.34858344429597965,1.0,10/20,21.05%,SEMA6A;SEMA3C;SEMA7A;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E;SEMA4G
prerank,endomembrane system organization (GO:0010256),-0.3085273224202787,-1.3306128452265786,0.022298456260720412,0.34885015799552765,1.0,47/178,18.82%,SPTBN1;ATP8B1;SEC31A;MYOF;DNAJC13;CSNK1A1;COG1;DYM;TMCC1;A4GALT;LRRK2;SYNE1;RAB1A;SRGN;GOLPH3L;RAB2A;DYSF;ATL2;TOR1B;SEC16B;ALS2CL;MYO18A;USP6NL;PRKD1;REEP3;CUL7;FBXW8;GAK;BCAS3;ARFGEF1;FAM174B;CSNK1D;CHMP2B;TRAPPC12;EXOC8;PI4K2B;TBC1D20;SUN1;TLCD1;LMAN2;ALS2;TMED5;VAPA;GOLPH3;WASHC4;TJAP1;AKTIP
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.343531417592583,-1.3300787345944796,0.06989247311827956,0.34947077994164544,1.0,29/80,25.91%,XIAP;DCUN1D3;CAV1;LRRK2;BIRC3;RBX1;CUL3;GSK3A;FAM107A;NSMCE3;SMAD7;MAGEC2;FANCM;UBE2L3;DCUN1D2;ANGPT1;SENP2;CDK5RAP3;PHF23;HUWE1;BRCA1;DCUN1D5;NDFIP2;AMER1;RCHY1;TRIB3;FANCI;RPS2;PEF1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.475218455827603,-1.3298223036226078,0.12226277372262774,0.3496155229295635,1.0,7/18,15.36%,TEK;CDH5;RAP1B;ROCK1;BCAS3;ARFGEF1;ROCK2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),-0.2989433410021878,-1.3282125793141468,0.020905923344947737,0.3524533787097673,1.0,62/214,22.42%,TEK;DAB2IP;RAPGEF2;SEMA6A;FERMT2;ROR1;BMPER;MFHAS1;LYN;PDGFD;SEMA7A;GCNT2;PTPN1;APP;RANBP9;SPRED2;CCL25;KDR;ICAM1;PRKD2;EGFR;TGFBR3;SLC30A10;GAS6;DLG1;DSTYK;RAP1A;EZR;NOTCH2;YWHAZ;FLT4;SMAD4;RRAS;HTR2A;BRAF;TIMP3;NOTCH1;FGF2;CNKSR3;CEACAM1;DUSP3;ACKR3;P2RY6;MIF;ABCA7;TNFAIP8L3;MTURN;ANGPT1;CCL19;NOD2;EPHA2;PTPRC;PTEN;FGFR4;ARHGEF5;PTPN11;P2RY1;ROR2;PDGFRB;PTK2B;APIP;CCN1
prerank,cardiac muscle contraction (GO:0060048),0.39273654612797354,1.3277719019711458,0.07281553398058252,0.5071810830448261,1.0,10/34,14.49%,ATP1A2;SCN1B;ATP1B1;GSN;RYR2;SCN5A;TNNC1;SLC8A1;TNNI2;SCN2B
prerank,plasma membrane invagination (GO:0099024),-0.42974297845085624,-1.3277452668114824,0.09515260323159784,0.352910492586766,1.0,11/29,24.25%,GULP1;DOCK1;MYH9;ELMO1;SNX9;RHOA;ARHGAP12;ITGAM;FCGR1A;ALKBH4;SNX18
prerank,diacylglycerol metabolic process (GO:0046339),0.4326999681111939,1.327726887577672,0.12153518123667377,0.505164950751648,1.0,6/23,12.65%,DGKK;DGKI;DGKQ;ANG;PGS1;MOGAT1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.42338381203672915,-1.3276374859894293,0.10649819494584838,0.3526816097200588,1.0,10/29,20.17%,DAB2IP;IL17RD;BMP5;SPRED2;LDLRAD4;SMAD7;FUZ;MAD2L2;PPP2CA;PTEN
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.3074502942496442,-1.3275215616533342,0.029159519725557463,0.3524788106652453,1.0,43/173,17.73%,SPTBN1;SPTAN1;SEC31A;SEC24B;VTI1A;COG5;CTSC;COG1;TRAPPC3;ARCN1;RAB1A;PROS1;RAB2A;IER3IP1;GAS6;SEC24A;ATL2;CUL3;SEC16B;CD55;SEC24D;KLHL12;SEC13;COPG1;SCFD1;BET1L;KDELR3;BCAP31;COPA;DCTN1;DCTN3;COPE;TRAPPC12;ERGIC2;USE1;CTSZ;TBC1D20;F5;TFG;LMAN2;TMED5;VAPA;CAPZB
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.49608648755908813,-1.32745552645034,0.11327433628318584,0.35216186714910486,1.0,4/15,12.71%,PRKCH;NFKB1;AGTR1;LPL
prerank,cytosolic transport (GO:0016482),-0.3281702916195053,-1.3269198634187611,0.046263345195729534,0.35281108860954785,1.0,32/108,23.00%,VPS13A;MYO1D;VTI1A;ERC1;EPS15;RAB7A;TMEM87B;HEATR5A;VPS54;RAB5A;STX8;VPS13C;BET1L;GAK;DCTN1;VPS26A;ANKFY1;AP1G1;VPS52;TBC1D23;CORO7;AP4M1;ANKRD27;WASHC1;VAMP3;AKTIP;TBC1D17;CLN5;SPAG9;KIF16B;EVI5;BECN1
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.5265594408712919,-1.326717600114481,0.14388489208633093,0.3527407258323164,1.0,6/13,20.89%,SORBS1;INSR;IRS1;AKT1;IGF1;IGF2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.48834478778071666,-1.3267040845399687,0.11259541984732824,0.3518795976451356,1.0,9/17,35.34%,JAK1;IRS1;SOCS2;IL7;IL2RG;BRWD1;STAT3;TSLP;IL7R
prerank,cellular response to interleukin-7 (GO:0098761),-0.48834478778071666,-1.3267040845399687,0.11259541984732824,0.3518795976451356,1.0,9/17,35.34%,JAK1;IRS1;SOCS2;IL7;IL2RG;BRWD1;STAT3;TSLP;IL7R
prerank,regulation of acute inflammatory response (GO:0002673),-0.47078802336965275,-1.3259191525212184,0.13134851138353765,0.3530180937684871,1.0,2/18,4.57%,OSMR;IL6ST
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.42769381553889396,-1.3249142482799534,0.10424028268551237,0.3545014760470216,1.0,11/31,15.35%,PPP1R13B;GSK3B;YWHAE;YWHAZ;NMT1;GSK3A;CASP8;TP53;MAPK8;BBC3;HIP1R
prerank,cellular response to hydroxyurea (GO:0072711),-0.5538974702932891,-1.3248392805879272,0.13652482269503546,0.3542305538860513,1.0,7/10,21.31%,DDI2;SPIDR;RTF2;NSMCE3;ATRX;TIMELESS;BLM
prerank,intracellular pH reduction (GO:0051452),0.4058976324141268,1.3246620282288961,0.0851063829787234,0.5110870166660447,1.0,12/33,19.05%,TMEM9;ATP6V1B2;ATP6V0C;ATP6V0D2;ATP6V0A2;ATP6V1G2;DMXL2;RAB39A;ATP6V0D1;RAB20;ATP6V1C1;ATP6V1A
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.4170821955931998,-1.32452138598628,0.11013986013986014,0.3544206716435454,1.0,8/30,10.98%,FLT1;MLLT3;KDR;ACE;BMP4;FLT4;TP53;PRRC2C
prerank,protein acylation (GO:0043543),-0.3945971141763638,-1.3243131045501422,0.10989010989010989,0.35437412083730946,1.0,7/38,8.25%,FOXO1;CREBBP;KAT2B;ZDHHC6;KAT6A;ZDHHC3;NAA80
prerank,synaptic vesicle endocytosis (GO:0048488),0.4046938492478215,1.3238942970645406,0.09956709956709957,0.5108828442215606,1.0,7/33,6.12%,NLGN1;SYT1;SYT5;AMPH;CDK5;SNCG;DNM1
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.3785035501987283,-1.3232898398514743,0.09982486865148861,0.3559145462230518,1.0,10/45,14.33%,DYRK1A;EGFR;NFKB1;PIK3R1;WDR75;BMP4;ERN1;TP53;ZPR1;RBM20
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.5063271450729115,-1.3229735594716867,0.12903225806451613,0.35611915925431004,1.0,3/14,5.78%,PKD2;TMSB4X;NFKBIA
prerank,cellular metal ion homeostasis (GO:0006875),0.32221788951831615,1.322731661878117,0.050808314087759814,0.5118893709393512,1.0,19/102,12.58%,SLC24A4;SLC24A2;HTR2C;KCNMA1;ATP1A2;STC1;ATP12A;ATP2B4;ATP2B2;ATP1B1;SLC8A2;RYR2;TMCO1;ATP4A;CCL13;ATP13A2;SLC8A3;SLC8A1;CCL5
prerank,calcium ion import (GO:0070509),0.41258071162234083,1.3225733598473266,0.10714285714285714,0.5101352825621961,1.0,10/28,17.93%,MS4A1;SLC25A23;CACNA1B;CACNA1A;CACNA1D;CACNA1E;SLC8A1;MCU;CACNA1G;CACNA1I
prerank,cellular copper ion homeostasis (GO:0006878),-0.5022848338483671,-1.322021162935603,0.12773722627737227,0.35757205502636413,1.0,3/14,4.50%,APP;ATOX1;SLC31A1
prerank,sulfate transport (GO:0008272),-0.5022569903543064,-1.3218978595012307,0.14210526315789473,0.3573588953098041,1.0,5/14,16.49%,SLC26A7;SLC26A2;SLC13A4;SLC25A11;SLC26A11
prerank,lipid droplet formation (GO:0140042),0.5510332329448951,1.3218416053235706,0.16363636363636364,0.5099842926473194,1.0,4/10,17.75%,BSCL2;SQLE;AUP1;CDS1
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.2832800059118341,-1.3217974076486736,0.01721170395869191,0.3571040058096239,1.0,67/308,18.51%,LEF1;PRKCH;IGF1R;RREB1;ZBTB16;GHR;FERMT2;CAV1;DAB2;BMPR2;SMURF2;GCNT2;ADRA1B;ADIPOR2;PRDM16;IL15;SHLD1;MTOR;SMO;TFRC;TRPM4;TGFBR2;KMT5B;SIX1;GAS6;PLCB1;TGFB2;MED1;STAT6;LBP;BMP4;SMAD2;RBM19;UCP2;ROCK1;GRB10;SMAD4;ACADL;PIK3CD;EHMT1;KDM6B;IL4R;AXIN2;KDM3A;RGCC;JAK2;FGF2;FLOT1;AGO2;B4GALT5;FOXC1;AGPAT1;MIF;ABCA7;TRIM16;C1QTNF3;MAD2L2;NPR1;ALMS1;SIX4;CTNNB1;ACSL1;CMKLR1;SOD1;CFL1;EPAS1;LURAP1
prerank,plasma membrane repair (GO:0001778),-0.5223677647174437,-1.32177459607214,0.12477396021699819,0.3567200097233653,1.0,4/13,6.64%,MYOF;MYH9;DYSF;AHNAK2
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.34767987232651765,-1.3216623558256508,0.06884057971014493,0.3565320970262537,1.0,17/66,13.55%,FLT1;DAB2IP;PDGFD;DVL3;LRRK2;MAP3K5;EGFR;IL34;FGF1;EDN1;TAOK3;TPD52L1;PIK3R6;EDN3;FGF2;IRAK1;CD40
prerank,neuromuscular process (GO:0050905),0.4855115251617685,1.3215207740035344,0.14184397163120568,0.5086734804464329,1.0,4/16,6.17%,NRXN1;SHANK1;CLN3;PRRT2
prerank,negative regulation of cellular protein localization (GO:1903828),-0.4045158072284126,-1.3208719084104874,0.10830324909747292,0.3576325568132573,1.0,10/34,15.36%,CTNNA1;MFHAS1;NEDD4L;GSK3B;PICALM;LATS2;SIN3A;TAX1BP3;ILRUN;ROCK2
prerank,positive regulation of macroautophagy (GO:0016239),-0.37283253546808565,-1.3203299838404579,0.099644128113879,0.3582584586971869,1.0,14/48,18.44%,RAB3GAP1;GNAI3;SESN1;KDR;PIP4K2A;LARP1;PIP4K2B;IRGM;BNIP3;RAB3GAP2;SPTLC1;VPS13D;TRIM13;IKBKG
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.38898455302526636,-1.320147180502027,0.10157618213660245,0.3581953420754619,1.0,12/43,9.17%,ZHX3;FERMT2;LRP5;BMPR2;IL6ST;BMP6;IL6R;BMP4;MEF2C;PRKD1;YAP1;ACVR2A
prerank,proton transmembrane transport (GO:1902600),0.39232555462583696,1.3198698672781506,0.10022271714922049,0.5107770398373391,1.0,7/36,8.71%,ATP1A2;ATP12A;SLC46A1;UCP3;SLC36A2;ATP6V0C;ATP4A
prerank,regulation of myoblast fusion (GO:1901739),-0.540835781355262,-1.3197532973262829,0.15302491103202848,0.3584896855001483,1.0,7/11,30.24%,EHD2;CFLAR;EHD1;FLOT1;CD53;ADGRB1;MAPK14
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5150298784810016,-1.31935216308069,0.14260249554367202,0.358758485262631,1.0,4/14,10.54%,ZEB1;CAV1;SPRED2;NOTCH4
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.4756650771161486,1.3191662656379626,0.14699331848552338,0.5105304416463614,1.0,9/17,20.73%,GGA3;NTRK2;SORL1;RTN4;CLU;APOE;RTN3;HAP1;RTN1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.5332426110791685,-1.3190866843022842,0.1366906474820144,0.3588344649888804,1.0,5/13,13.52%,GFPT2;GNPDA2;SLC35A3;GNPNAT1;UAP1
prerank,mesonephric tubule development (GO:0072164),0.4859038595546857,1.3188914477294449,0.12383177570093458,0.5091876949370994,1.0,6/15,7.53%,ROBO2;LHX1;NPNT;OSR1;WT1;FGFR2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.28122873505746515,-1.3180596559748514,0.01680672268907563,0.36041785041665086,1.0,80/366,16.35%,APBB2;NFIA;RREB1;SMARCA2;ZNF423;ENG;ACVRL1;CREBBP;NSD1;RB1;BNC2;KAT6B;ERC1;INSR;ESR1;FOXN3;ANKRD17;ZFHX3;IRF2;APP;RPS6KA5;WWC2;ZSCAN21;MITF;NR3C1;SOX13;SOX17;PSPC1;SP1;VSX1;LIMD1;SIX1;RYBP;ABL1;FOXO3;DNM2;TRRAP;NSD3;FUS;NFYC;GTF2IRD1;MEF2C;SLC39A8;ZBTB4;ASCC1;NAB1;LDB1;PRDM2;GPBP1;SPTY2D1;SP3;USP13;TP53;HMG20A;ORC5;PRRX2;SOX7;JMJD1C;CHD3;YAF2;NOTCH1;SFPQ;OGG1;OBI1;TAF5L;ATF4;MZF1;RPL10;GPBP1L1;NR1D2;HCFC1;TCF3;TCF7L1;FOXC1;MYBL2;NAB2;UBE2L3;FOXO4;CREBL2;HIC1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3240862203295038,-1.317472287858581,0.06118881118881119,0.3611656650040085,1.0,32/104,20.88%,BMPER;CRIM1;CAV1;BMPR2;SMURF2;IL17RD;PRDM16;SPRED2;SMURF1;TGFBR2;PPARA;LDLRAD4;ZBTB7A;ASPN;SKIL;SMAD1;SMAD2;ACVR2A;SMAD4;UBE2D3;SMAD7;NOTCH1;CCN3;SMAD6;SKI;PMEPA1;HTRA3;SMAD9;DAND5;PPARG;SNX25;STRAP
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.4667874306149826,-1.317169687400384,0.12345679012345678,0.36133572364524696,1.0,14/19,49.60%,PRKCE;NMI;LBP;IRAK1;ITGAM;LGALS9;PIK3AP1;CD14;TNIP3;TLR4;TICAM2;SCIMP;RAB11FIP2;LY96
prerank,muscle contraction (GO:0006936),-0.318021857411441,-1.3171056398917234,0.037102473498233215,0.36100723755955577,1.0,35/126,22.04%,UTRN;SORBS1;MYOF;GJC1;EDNRA;TPM3;ITGA1;EMD;DYSF;PXN;ITGB5;TMOD3;SNTB1;MYH11;ACTA2;ROCK1;ASPH;MYLK;CHRNB1;MYOM1;ARHGEF11;LMOD1;TPM1;SORBS3;ROCK2;SSPN;CALD1;CASQ2;MYL6;MYL12B;SMTN;GAMT;VCL;SNTA1;NOS1
prerank,negative regulation of secretion (GO:0051048),0.5405814671448003,1.3167879006359133,0.1572052401746725,0.5125558112963097,1.0,2/10,5.24%,NRG1;PTGER3
prerank,urogenital system development (GO:0001655),0.5235108975062568,1.31617821800747,0.17040358744394618,0.5120346761799803,1.0,3/11,6.07%,LHX1;OSR1;PAX2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.522265649429673,-1.3161607879173542,0.13533834586466165,0.36256646173778573,1.0,4/13,7.51%,RREB1;SOX13;SIX1;NAPEPLD
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3764352465948687,-1.3160224079411165,0.09215017064846416,0.3624172835674299,1.0,15/48,13.32%,RREB1;DOCK1;FERMT2;RAC1;CUX1;LIMS2;LIMS1;CRK;ABL1;FLNA;CUL7;FBXW8;ILK;NEDD9;MYOC
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.41856462919048903,-1.3158963240559753,0.11170212765957446,0.36221775733459266,1.0,18/29,36.91%,DCUN1D3;DTX3L;ABL1;FEM1A;SMAD7;MAGEC2;FEM1B;UBE2L3;DCUN1D2;DCUN1D5;TRIB3;RPS2;BAG5;PLK1;PARK7;BMI1;TOPORS;FBXO5
prerank,release of cytochrome c from mitochondria (GO:0001836),0.4593001400263091,1.315801748658161,0.13002364066193853,0.5108967581015741,1.0,9/17,25.59%,BCL2;GGCT;FZD9;CLU;MFF;FIS1;DNM1L;SFN;BOK
prerank,regulation of actin filament-based process (GO:0032970),-0.3487821870814365,-1.315629393088043,0.06390977443609022,0.36227501813717405,1.0,21/70,15.36%,RAC1;RHOBTB1;IQGAP1;F11R;RND3;CRK;MTOR;RICTOR;ABL1;RHOQ;PRKCD;CDK10;EZR;ROCK1;FAM107A;ARHGAP17;RHOA;RHOC;RHOG;HIP1R;ROCK2
prerank,positive regulation of nuclear division (GO:0051785),-0.44143608057669526,-1.3150783302240778,0.12637362637362637,0.3629345767036345,1.0,13/25,35.49%,INSR;LRP5;EDN1;RGCC;EDN3;IGF1;IGF2;PDGFRB;BTC;AURKA;PHIP;IL1A;DRD3
prerank,lipid transport (GO:0006869),-0.3272597227606935,-1.314660739697821,0.05123674911660778,0.3633582940662545,1.0,36/97,26.99%,ABCC4;PITPNC1;ATP8B1;CERT1;PLTP;SLCO2A1;SLCO1C1;RXRA;SLCO3A1;SPNS2;LBP;ABCD3;SLCO2B1;PPARD;SCARB1;MFSD2A;ABCA9;SLC27A4;CEACAM1;ABCA7;TNFAIP8L3;MFSD2B;PCTP;ACSL1;PRELID2;GLTP;OSBPL2;ABCA6;PITPNA;SLC10A3;PEX3;SLC27A3;ABCG4;STARD5;SLCO1B1;FABP3
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.4544126615027098,-1.3145907618400916,0.12115384615384615,0.3630958976222132,1.0,12/19,32.44%,CHMP4B;DRG1;CHMP2B;TPR;CHMP5;PDCD6IP;HSPA1B;CHMP3;HNRNPU;CCSAP;CHMP1A;PLK1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.3381620199895529,-1.314531233293591,0.06352087114337568,0.3627852545522087,1.0,33/87,27.78%,FBXL7;RB1;DCUN1D3;KLF4;PKD2;PSMA2;RBX1;DLG1;PSME2;PSMB4;FAM107A;RGCC;CDC73;CDK6;PSMC2;PSMB2;PSMB1;PSMA8;CDK2AP2;PSME1;PTEN;PSMD4;CDKN2C;PSMA7;FHL1;PSMD5;E2F7;PINX1;ZFP36L1;PSMB10;APC;PSMA3;CDKN2B
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5361610592652258,-1.31370173683371,0.1539855072463768,0.36402227757649347,1.0,6/12,20.89%,SORBS1;INSR;IRS1;AKT1;IGF1;IGF2
prerank,miRNA metabolic process (GO:0010586),-0.45766418725558494,-1.3132216180389633,0.11235955056179775,0.3645523715287979,1.0,12/20,35.42%,TUT7;TENT4B;DICER1;TUT4;PARN;AGO2;DROSHA;DIS3L2;RAN;SND1;TARBP2;DGCR8
prerank,glial cell differentiation (GO:0010001),0.4096085925578639,1.3131379880981313,0.11512415349887133,0.5156478387650815,1.0,9/28,12.81%,MYRF;CDK5;MMP24;PTPRZ1;PAX2;GPC1;CDH2;SLC8A3;TPPP
prerank,negative regulation of cell death (GO:0060548),-0.33735392850897317,-1.3129577529326957,0.05045045045045045,0.3646474519410731,1.0,26/88,16.68%,MECOM;FERMT2;CD34;CD200;GSK3B;LRRK2;INPP5A;TNFRSF1B;NCK1;BMP4;BNIP3;PRKD1;WNT16;AKT1;CHMP4B;CHMP4A;FGF2;RAD18;TM7SF3;WNT11;CCN5;PDE12;ATG5;CCN3;BMP7;FYN
prerank,nucleic acid metabolic process (GO:0090304),-0.35080200345426826,-1.3127269700379005,0.0726950354609929,0.3646617401095047,1.0,26/69,27.56%,RBFOX2;METTL14;NT5E;HNRNPA0;HNRNPR;HNRNPM;POLR2G;HNRNPA3;WTAP;HNRNPF;XRN2;DNA2;PDE12;HNRNPA1;WRN;WDR74;PCBP1;POLR2C;POLR2L;POLR2H;HNRNPL;HNRNPD;DXO;RAN;MMS19;HNRNPU
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.4566880955344407,-1.312682242212887,0.12454873646209386,0.36434197228329923,1.0,11/20,30.97%,RPS6KA5;DIP2B;PRKAA1;RUVBL2;SOX4;BRCA1;NOS1;ARRB1;DIP2A;GLYR1;RPS6KA4
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.5157314477956081,1.3118741197138697,0.1724137931034483,0.517087546874391,1.0,4/12,10.48%,ATIC;PAICS;ADSS2;ADSS1
prerank,B cell receptor signaling pathway (GO:0050853),0.393025941056593,1.3111217447413779,0.10730593607305935,0.516938398951121,1.0,5/32,3.49%,BLK;MS4A1;BLNK;NFATC2;BCL2
prerank,response to exogenous dsRNA (GO:0043330),-0.47153438622353294,-1.310910762925749,0.14260249554367202,0.36737436918288774,1.0,10/18,31.58%,CAV1;IFIH1;FLOT1;CGAS;MAVS;SLC3A2;RALB;DHX9;TICAM1;RFTN1
prerank,cell-cell junction assembly (GO:0007043),0.3510261671170475,1.3105482850934569,0.07990867579908675,0.5163734387220414,1.0,21/63,11.59%,CDH18;CDH8;CTNND2;CDH20;CDH9;CDH10;EPB41L3;PKP2;DCHS1;CDH19;FLCN;CDH12;FSCN1;CLDN11;CDH7;GJB2;CDH24;CDHR3;GJB6;PATJ;CDH2
prerank,positive regulation of transport (GO:0051050),-0.340278081580261,-1.3102715513788727,0.06228373702422145,0.3682941598205674,1.0,22/85,20.09%,DAB2;NEDD4L;CBLL1;GSK3B;ANXA2;RXRA;IL15;MERTK;GAS6;RAB27A;GSK3A;ACTB;FLOT1;CHP1;HIP1R;ABCA7;ANXA1;LMAN2;TULP1;CCL19;GATA2;GPC3
prerank,cell projection assembly (GO:0030031),-0.45255070784487755,-1.3097745067194027,0.13619402985074627,0.3688834713034732,1.0,7/22,14.72%,PARVB;RAC1;RHOJ;PARVA;RHOQ;RHOG;NCKAP1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.36046014380415314,-1.3097682261606483,0.08394160583941605,0.36846198917289713,1.0,23/57,27.64%,PAK1IP1;RPL26;RPL38;NIP7;RPS16;TGS1;RPL5;WDR74;RPL35A;DDX31;BOP1;PES1;RRS1;EBNA1BP2;RPS7;RPS15;NOP16;RPS17;GLUL;NAF1;BYSL;EMG1;WDR12
prerank,mammary gland development (GO:0030879),0.44768332438098346,1.309599437991264,0.10952380952380952,0.5166933007089434,1.0,3/21,1.29%,NRG1;ERBB4;WNT7B
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.40460512682545724,-1.3095057642773844,0.10931899641577061,0.36863616178685926,1.0,18/36,29.09%,UBE2K;GAS6;IRGM;PARP14;EDN1;AGPAT1;NLRC5;MAVS;RIPK1;CASP1;HSPA1B;IL7;TRIM44;PARP9;ADAM17;CD300LF;TRIM6;AXL
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.513709780653789,-1.3089076733519107,0.15770609318996415,0.3694475890373054,1.0,8/13,27.32%,TNRC6B;POLR2G;AGO2;BTG2;TNRC6A;TOB1;CNOT1;PABPC1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.4769756744471816,-1.3083810683849568,0.13286713286713286,0.370085445510089,1.0,8/17,19.68%,LYN;MID1;TGFB2;ARL6IP5;TAOK3;SEMA4C;NOD2;KLHDC10
prerank,inositol phosphate metabolic process (GO:0043647),-0.37387634190558106,-1.308077317503801,0.0807899461400359,0.3703202463223194,1.0,12/46,12.27%,PLCB4;INPP1;PLCG1;INPP5A;PLCB3;PLCB1;MINPP1;PLCE1;PLCG2;ITPKB;INPP4A;FGF2
prerank,C21-steroid hormone metabolic process (GO:0008207),0.46028233504288285,1.307921804539756,0.14942528735632185,0.5188657511039847,1.0,5/20,9.78%,AKR1D1;CYP46A1;AKR1C1;TSPOAP1;CYP11B1
prerank,smooth muscle tissue development (GO:0048745),-0.539378187859757,-1.307638611360532,0.1541095890410959,0.3708474116582194,1.0,9/10,33.81%,ENG;SMO;BMP4;MYLK;NF1;STRA6;SHH;PTCH1;EFEMP2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.39634274785677376,-1.307435753530879,0.10427350427350428,0.3708527028345168,1.0,15/37,23.28%,CAV1;NCK1;TP53;BCAP31;SFPQ;EIF5A;BBC3;BCL2L11;GSDME;SOD1;RPS3;SIAH1;RPS7;BECN1;MSX1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.3583061365107358,-1.3073232161705908,0.09836065573770492,0.3706361872890101,1.0,29/57,32.44%,FOXN3;ATM;UIMC1;MRNIP;MRE11;CLSPN;TP53;TAOK3;BABAM2;RFWD3;FANCD2;CDK5RAP3;BRCC3;SDE2;RPA2;CCND1;PRKDC;BRCA1;BLM;CHEK1;TRIM39;FZR1;DTL;RINT1;FBXO31;MDC1;HUS1B;RPS27L;PLK1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.34237318400831585,-1.3067470352924826,0.07867132867132867,0.3713646915076942,1.0,22/73,20.36%,KITLG;CBFB;TCF12;PSMA2;LMO2;METTL14;ABL1;PSME2;YAP1;LDB1;PSMB4;TAL1;PSMC2;TCF3;FOXC1;PSMB2;PSMB1;PSMA8;PSME1;GATA2;PRKDC;PSMD4
prerank,positive regulation of JNK cascade (GO:0046330),-0.34723336870330357,-1.3067105959021246,0.0740072202166065,0.37101053509792276,1.0,25/70,24.66%,DAB2IP;MFHAS1;TRAF5;APP;MAP3K5;PLCB1;RASSF2;FLT4;SH3RF1;WNT16;TAOK3;TPD52L1;TNFRSF19;MTURN;CCL19;EDAR;NOD2;DUSP22;SH3RF2;PTK2B;LTBR;GADD45A;RIPK1;FZD7;HMGB1
prerank,regulation of translational initiation (GO:0006446),-0.35670176327544445,-1.3058723074859002,0.06502636203866433,0.372310329729212,1.0,35/63,36.90%,EIF3H;EIF4H;EIF3E;DDX3X;LARP1;NCK1;EIF3B;POLR2G;EIF2B2;NCK2;CDC123;KLHL25;ATF4;AGO2;TPR;CTIF;GLE1;EIF2AK3;KHDRBS1;EIF2AK4;EIF5B;DNAJC3;MTIF2;EIF4G3;BOLL;EIF4A2;CEBPB;ATF3;EIF2B5;PAIP2B;MIF4GD;ALKBH1;EIF4EBP1;EIF4EBP3;PAIP2
prerank,regulation of DNA repair (GO:0006282),-0.383801309982733,-1.3053303349252197,0.10139860139860139,0.3729776290170978,1.0,17/44,20.86%,UBR5;EYA4;DEK;UIMC1;EGFR;TRIP12;AXIN2;BABAM2;RNF168;UBE2V2;ERCC8;CEBPG;BRCC3;RPS3;USP1;BRCA1;TRIM28
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4980096801884175,-1.3041419556158682,0.15221238938053097,0.37499166692804775,1.0,4/14,11.75%,ANKRD17;PUM1;DDX60;USP15
prerank,steroid biosynthetic process (GO:0006694),0.35467729435872664,1.3040138303836026,0.07560975609756097,0.5272278551503158,1.0,12/56,13.40%,AKR1D1;CYP46A1;INSIG1;LSS;CYP51A1;SC5D;OSBPL6;SQLE;CYP27A1;CYP11B1;FDFT1;OSBPL9
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.33618258976351845,-1.303854464486519,0.07678883071553229,0.3751661746170933,1.0,20/76,19.46%,DAB2IP;KLF4;CD200;TMSB4X;TAX1BP1;NFKBIA;OTULIN;ANXA4;NFKBIL1;IRAK1;CHP1;TNFAIP3;DAP;MTURN;BMP7;IRAK2;NLRC5;CDK5RAP3;CMKLR1;USP7
prerank,regulation of necroptotic process (GO:0060544),-0.4362557746467671,-1.303810102274402,0.13272727272727272,0.37483342757075316,1.0,10/23,23.22%,PELI1;BIRC3;ARHGEF2;CASP8;CFLAR;FLOT1;PDCD6IP;OGT;HSP90AA1;RIPK1
prerank,regulation of protein ubiquitination (GO:0031396),-0.3204100140781267,-1.303564199753654,0.06678383128295255,0.37491863542127785,1.0,39/108,24.97%,NXN;XIAP;CAV1;LRRK2;IVNS1ABP;BIRC3;CUL3;GSK3A;FAM107A;AKT1;NSMCE3;SMAD7;SPOPL;FOXF2;CHP1;TNFAIP3;N4BP1;UBE2L3;ANGPT1;SENP2;CDK5RAP3;SASH1;RPS3;WASHC1;SOX4;PHF23;HUWE1;BRCA1;OGT;SH3RF2;NDFIP2;AMER1;HSP90AA1;ARRB1;RCHY1;HSPA1B;FANCI;PINX1;ADGRB1
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.526405109285279,-1.3030415861305218,0.16970802919708028,0.3755953178271438,1.0,6/12,20.77%,SRR;MTHFD1;SERINC3;SERINC5;SEPHS2;CTH
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.30720361785250694,-1.3023624001707994,0.03356890459363958,0.37656369516623484,1.0,58/148,27.65%,PPP1R13B;ATM;RPL37;MTOR;KAT6A;PIP4K2A;TOP3A;RICTOR;HDAC1;PHF20;PAK1IP1;PIP4K2B;MRE11;NOP2;USP2;RBBP8;TAF11;AKT1;TP53;EHMT1;PRKAA1;CHD3;RPA3;DNA2;KAT5;RPA1;KMT5A;NUAK1;RPL5;TAF7;HIPK1;TAF3;CDK5RAP3;WRN;RPA2;PRKAB1;USP7;BOP1;PRDM1;BRCA1;RRS1;MDM2;BLM;RFC4;TAF4B;CHEK1;RPS15;TAF13;MAPK11;CCNG1;TAF9;TAF15;PLK3;PPP1R13L;PRR5;RNF34;PPP2R5C;EXO1
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.33642657580240715,-1.3016240406916384,0.08260105448154657,0.37755053264713967,1.0,28/85,20.92%,DAB2IP;ACVRL1;TIE1;LIMS1;MCC;BMP5;TBX1;EGFR;TGFBR3;BMP6;TGFB2;AQP11;FGF1;BMP4;PRKD1;YAP1;FGF7;FGF2;CDC73;CDK6;GPX1;ANGPT1;IGF1;SIX4;NOD2;PRKDC;TCF7L2;LAMB1
prerank,positive regulation of ion transport (GO:0043270),0.3566026857832524,1.301294565812923,0.10272536687631027,0.5324987454735464,1.0,11/48,12.58%,ANK3;SCN1B;PKP2;GPD1L;WNK3;CACNA1D;PLA2G3;SCN5A;ADRA2A;LILRA5;CCL5
prerank,establishment of protein localization to membrane (GO:0090150),-0.3471494561647481,-1.3012311985740745,0.0748663101604278,0.37791443403733294,1.0,33/66,36.63%,PARD3;RAB3GAP1;ZDHHC6;ZDHHC3;EGFR;AFDN;COX18;AQP11;RAB3GAP2;BRAF;RAB11A;ZDHHC1;GORASP2;REEP1;ZDHHC4;ZDHHC12;RAB3IP;ATG3;VPS37B;RTP4;RFTN1;GOLGA7B;ZDHHC9;SEC63;NPC1;ZDHHC22;RAB10;SYNE3;NCF1;VPS37C;ICMT;YIF1B;RABGEF1
prerank,regulation of spindle assembly (GO:0090169),-0.417160216985566,-1.3009273185577013,0.13432835820895522,0.3780634698034427,1.0,14/25,32.44%,CHMP4B;DRG1;CHMP2B;TPR;CHMP5;RNF4;PDCD6IP;SENP6;HSPA1B;CHMP3;HNRNPU;CCSAP;CHMP1A;PLK1
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5379580655035985,-1.3009030179937007,0.15539305301645337,0.3776814126552054,1.0,7/11,26.17%,TIPARP;PARP4;PARP14;PARP11;PARP16;PARP6;PARP9
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.4901197513631877,-1.3003837874221522,0.15037593984962405,0.3783958485806159,1.0,5/16,7.51%,RREB1;SOX13;SIX1;FTO;NAPEPLD
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.5372892753626296,-1.2992498967042456,0.13932980599647266,0.3803338839142482,1.0,6/11,30.81%,MEF2C;MYOCD;FRS2;FZD7;BMP2;TGFB1
prerank,membrane lipid biosynthetic process (GO:0046467),-0.3608370529534591,-1.2992414998881154,0.08480565371024736,0.3798976376736079,1.0,14/58,9.03%,SGMS1;CERT1;ST3GAL4;ACER2;DEGS2;SGMS2;PRKD3;PRKD2;SPNS2;ELOVL5;CERS4;PPM1L;PRKD1;ST3GAL2
prerank,purine nucleotide metabolic process (GO:0006163),-0.43173741623194967,-1.2990340416972161,0.11858407079646018,0.3798644919020364,1.0,11/24,27.29%,NT5C2;FHIT;NT5E;MTHFD1;NT5C1A;GPX1;HPRT1;GDA;PRPS2;NT5C;PNP
prerank,cellular response to interleukin-6 (GO:0071354),-0.42552909952093787,-1.2990192143514505,0.12966252220248667,0.37946350515329724,1.0,9/26,11.47%,ST3GAL6;JAK1;IL6ST;IL6R;NFKB1;CBL;YAP1;SMAD4;JAK2
prerank,apical protein localization (GO:0045176),-0.5512911880713138,-1.2986414367998103,0.14964788732394366,0.3798423527955162,1.0,4/10,12.61%,ATP8B1;SHROOM3;SHROOM2;ACTB
prerank,stem cell differentiation (GO:0048863),-0.3878322156494682,-1.2983411639634865,0.11929824561403508,0.3800185132858443,1.0,14/39,19.32%,MLLT3;SETD2;FBXL17;ACE;LRP6;TGFB2;MEF2C;PUM1;TP53;LMBR1L;FOXO4;METTL5;NELFB;PTPRC
prerank,regulation of neuron differentiation (GO:0045664),0.33232078680149074,1.2982897854838584,0.06928406466512702,0.5383942494927357,1.0,13/76,7.41%,BRINP3;NLGN1;CNTN4;YWHAG;BEND6;NBL1;NRCAM;VWC2;BRINP1;HOXD3;IMPACT;BRINP2;ADRA2C
prerank,response to peptide hormone (GO:0043434),-0.37748720876911396,-1.297907779814704,0.11775362318840579,0.38039877532083327,1.0,14/43,21.82%,CAV1;TGFBR3;IRS1;STAT6;ROCK1;AKT1;EIF2B2;STAT2;IGFBP5;ROCK2;TRIM16;ANXA1;OGT;CREB1
prerank,pyroptosis (GO:0070269),-0.49552814903563636,-1.29782537277623,0.14035087719298245,0.3801011510110464,1.0,7/15,29.62%,CASP8;GSDME;APIP;CASP1;DHX9;TREM2;NLRC4
prerank,dendritic spine morphogenesis (GO:0060997),0.48008095041531706,1.2974687068718176,0.16,0.5384963462370379,1.0,5/15,6.15%,CTNND2;DOCK10;EPHB1;SHANK1;PAK3
prerank,cellular protein metabolic process (GO:0044267),-0.27336588676386536,-1.2974022697749674,0.01309328968903437,0.38060869938861547,1.0,151/396,30.55%,DAB2IP;IGFBP7;ST3GAL6;ST3GAL1;PLOD2;MSRB3;ST8SIA4;APP;RRBP1;RPS21;IGFBP4;RPL37;PARP4;MMP2;RPL31;YES1;CSNK1G3;RPL9;GAS6;RPS14;ABL1;PSEN2;SPPL3;BMP4;RPSA;PDIA6;PHKA2;DENND3;AFG3L2;PCSK5;RPL3;RPLP1;MRPL32;RPL26;ADAM10;UBE2D3;LMCD1;UBA7;RPS11;FDX1;PSEN1;ITIH2;ERO1A;GALNT11;STK38;RPL13;MRPS18A;PRKCSH;RPL38;ANO8;NOTUM;FDXR;MSLN;RPL27;RPS16;RPS4X;GSPT1;AGO2;RPL10;RPL7A;MSRA;IGFBP5;SERPINC1;MAGEC2;UBE2M;HARS2;LGMN;RPL5;UBE2L3;F5;IGF1;MRPL24;RPS27;PLAT;CTSH;APH1A;RPL27A;RPS3;RPL36A;RPL35A;BAP1;CLN5;PRKDC;MRPS14;GPC3;WWP2;RPL37A;MRPS21;MFGE8;IGF2;LAMB1;MRPL35;RPL32;UBL4A;LOX;WARS1;RPS7;CCN1;CHRDL1;KTN1;RPS15;MRPL34;RPS8;RPL28;RIPK1;RPL22;RPL13A;MRPL13;MRPL9;RPL36;RPL30;RPS23;MSRB2;STOML2;FBN1;SRBD1;RPS17;PNPLA2;RPS2;MRPL43;SEC11A;RABGGTB;ADAM17;RPL39;MRPL11;RPS26;TNIP1;RPS15A;RPL15;RPL34;TMEM132A;DNAJC3;ATG3;MANBA;PAPPA;IGFALS;SCG3;RPLP2;UBE2I;LIPT1;DUSP12;YME1L1;RPL18;MRPS17;MBTPS1;CDC34;LTBP1;RPL19;AHSG;RPS13;COPS5
prerank,regulation of neuron death (GO:1901214),0.32758275560797345,1.2972421735473287,0.07009345794392523,0.537005673897346,1.0,22/82,15.00%,GRID2;DCC;GRIN2B;CDK5;EPHB1;EGR1;CHGA;NAE1;SNCG;SORL1;MAPT;FAIM2;KIR3DL2;TRIM2;ATP13A2;DHCR24;HTRA2;CCL5;CLU;SIGMAR1;LANCL1;GRM4
prerank,regulation of MAPK cascade (GO:0043408),-0.30436437010288037,-1.297078855341137,0.04990757855822551,0.380845773793268,1.0,40/157,16.73%,FLT1;TEK;DAB2IP;IGF1R;JCAD;ROR1;INSR;CAV1;LYN;IQGAP1;ADRA1B;PAK2;TBX1;KDR;PTPRJ;EGFR;TGFBR3;STK3;PPEF2;FAS;MAPK1;ROCK1;YWHAZ;FLT4;PLCG2;RRAS;TAOK3;PEBP1;FGF2;CEACAM1;DUSP3;MYOC;KSR1;MAP4K4;IAPP;ROCK2;ABCA7;PELI2;IGF1;GSDME
prerank,sensory perception of light stimulus (GO:0050953),0.32416147904992487,1.2969797012722866,0.08908685968819599,0.53563329397247,1.0,11/87,6.07%,PCDH15;COL2A1;EML2;COL1A1;CABP4;GRM8;RP2;FSCN2;OAT;EFEMP1;PAX2
prerank,artery development (GO:0060840),-0.4369466034922045,-1.2968641515445591,0.14659685863874344,0.3808787351519896,1.0,9/23,11.55%,ENG;ACVRL1;PKD2;BMPR2;TBX1;HES1;PDE2A;HECTD1;SMAD7
prerank,lysine catabolic process (GO:0006554),-0.522993288513765,-1.295438936402512,0.15245009074410162,0.38308285804945563,1.0,5/12,22.34%,DLD;OGDH;PHYKPL;ALDH7A1;AASS
prerank,lysine metabolic process (GO:0006553),-0.522993288513765,-1.295438936402512,0.15245009074410162,0.38308285804945563,1.0,5/12,22.34%,DLD;OGDH;PHYKPL;ALDH7A1;AASS
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.504484101661301,-1.295322159664735,0.16145833333333334,0.38291607970923286,1.0,6/13,22.56%,LRRK2;SCFD1;CHMP4B;CHMP4A;PHF23;SEC22B
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.37916545986995337,-1.2953022717834914,0.08687615526802218,0.38251229695042477,1.0,14/42,21.49%,YARS1;WARS2;NARS2;CARS2;FARS2;TARS3;LARS1;AIMP2;HARS2;DARS2;VARS2;FARSA;IARS2;WARS1
prerank,cellular sodium ion homeostasis (GO:0006883),0.4826194743505712,1.2951285007329816,0.1542056074766355,0.5387168968205504,1.0,5/15,11.91%,ATP1A2;ATP12A;ATP1B1;ATP4A;SLC8A1
prerank,positive regulation of exocytosis (GO:0045921),0.38351517716786304,1.29444773274905,0.12582781456953643,0.5384379113128122,1.0,13/35,19.82%,CADPS;RAB15;SMPD3;RAB27B;HGS;TSG101;ATP13A2;RAB3A;SDC4;CLASP2;CHMP2A;VPS4B;EXPH5
prerank,transcription preinitiation complex assembly (GO:0070897),-0.5304898929559754,-1.2941525656796398,0.15641476274165203,0.38447045252498896,1.0,5/12,16.25%,TAF11;TAF1B;BDP1;DR1;TAF7
prerank,regulation of cell size (GO:0008361),-0.43154464163987566,-1.2935191870428908,0.13518197573656845,0.38538868803261994,1.0,13/23,22.90%,RAC1;MTOR;MSN;RARG;EZR;EDN1;RPTOR;RHOA;LARS1;PTEN;AKT1S1;VAV2;MTPN
prerank,negative regulation of neuron projection development (GO:0010977),0.3519500045562858,1.2931612566804476,0.09198113207547169,0.5397010065446276,1.0,16/56,15.52%,NLGN1;DCC;SPOCK1;ITM2C;EFNB3;RTN4;TSKU;PTPRS;STMN2;MAG;OMG;PAQR3;NGEF;DENND5A;APOE;PTPRO
prerank,recombinational repair (GO:0000725),-0.33466086504811005,-1.2926693023594829,0.08089500860585198,0.3866582635290834,1.0,36/77,33.67%,SMC5;SAMHD1;ZFYVE26;SPIDR;MMS22L;MRE11;NABP1;MCM9;RBBP8;RAD54B;NSMCE2;SFPQ;RPA3;RPA1;PALB2;RFWD3;WRN;RPA2;BRCA1;RAD51AP2;BLM;YY1;MORF4L1;INO80;POLL;XRCC2;AP5Z1;KDM4D;RAD51AP1;SWI5;RAD51D;HUS1B;RMI1;MEIOB;RAD50;FAN1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.4582619423291826,-1.29228661709214,0.14206642066420663,0.38701142919684517,1.0,7/20,14.53%,PPP2R5A;DAB2;RHOQ;PPFIA1;PICALM;ABI3;NUMB
prerank,striated muscle contraction (GO:0006941),0.34986116558648506,1.2921066468691367,0.08924485125858124,0.5404514465813831,1.0,13/53,14.49%,SMPX;ATP1A2;SCN1B;STAC2;ATP1B1;RYR2;SCN5A;STAC;TNNC1;DTNA;SLC8A1;TNNI2;SCN2B
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.319127645455346,-1.291088012874299,0.07583774250440917,0.3890362342646304,1.0,45/114,27.42%,EDA;LIMS1;TRAF5;TMSB4X;PSMA2;BIRC3;TNFRSF1B;NFKBIA;FOXO3;PSME2;TXNDC17;PSMB4;TP53;ILK;JAK2;ACTN4;EIF5A;CD40;PSMC2;PSMB2;PSMB1;TNFRSF1A;TNFRSF11B;PSMA8;MAP3K14;EDAR;TNFSF13;IKBKB;PSME1;TNFRSF25;PSMD4;TNFSF8;PSMA7;PTK2B;LTBR;RELA;RIPK1;PSMD5;TNFSF12;ADAM17;PSMB10;TNFRSF9;TNFRSF12A;PSMA3;BAG4
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.4433342587606839,-1.290872032976749,0.1263537906137184,0.38905525547268743,1.0,11/22,28.90%,ERI3;RPS21;EXOSC2;NOL9;EXOSC3;EXOSC8;PES1;RRS1;EXOSC7;WDR12;UTP20
prerank,positive regulation of chromatin organization (GO:1905269),-0.5162457394984988,-1.2907250639547374,0.15070921985815602,0.3889105266863426,1.0,6/12,19.64%,MIER1;TAL1;SIN3A;H3-3A;TERF2;ATRX
prerank,histone modification (GO:0016570),-0.3184421398029273,-1.2906753944620115,0.06313993174061433,0.38856674154255944,1.0,32/109,20.76%,CREBBP;NSD1;KAT6B;EYA4;MIER1;PRDM5;RPS6KA5;KAT6A;RCOR1;HDAC1;PHF20;TRRAP;NSD3;PRKCD;MIDEAS;SGF29;PHF20L1;EHMT1;SIN3A;HDAC4;KAT5;PHC1;RUVBL2;MIER2;HDAC6;HDAC10;CARM1;MIER3;TBL1X;HUWE1;ATXN7;BAZ1B
prerank,cellular response to glucose stimulus (GO:0071333),-0.41218555277346314,-1.2905774443101177,0.12570356472795496,0.3883483836390863,1.0,6/30,10.64%,UNC13B;IGF1R;ZBTB20;GAS6;ERN1;PRKAA1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5035739094162898,1.2899904343198982,0.16590909090909092,0.5439011261382548,1.0,2/12,3.86%,B3GALT1;B3GALT5
prerank,regulation of cellular response to stress (GO:0080135),-0.31435543393594456,-1.2898295615661945,0.07042253521126761,0.3894114238243432,1.0,28/115,15.78%,CREBBP;MCL1;GSK3B;ATM;NUP42;NEK6;MTOR;YWHAE;RAE1;CAMK2G;RANBP2;ABL1;DNAJC7;NUP98;MAPKAPK2;SEC13;DNAJB6;MAPK1;IER3;RPTOR;NUP153;RPA3;RPA1;ATF4;PTGES3;ROCK2;NUAK1;TPR
prerank,positive regulation of cell cycle (GO:0045787),-0.3495287329166038,-1.2896465221365716,0.10278745644599303,0.38932698737137783,1.0,30/62,27.05%,PKD2;ANKRD17;APP;EGFR;CDKN1B;LRP6;CCND3;TGFB2;USP2;TAL1;AKT1;CCNY;RGCC;DUSP3;PKN2;HCFC1;SMOC2;LGMN;SRPK2;RARA;RAD23A;CITED2;CCND1;MDM2;CHEK1;TBX3;CCNYL1;ADAM17;RPS15A;USP19
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.3623856135015145,-1.2894263181530512,0.11423550087873462,0.3893255626119903,1.0,23/54,27.04%,ATM;CNOT4;PLAGL1;CDKN1B;E2F4;PLK2;RPL26;TP53;CRADD;RGCC;BTG2;CARM1;SOX4;MDM2;CASP2;GADD45A;E2F7;CNOT2;ARID3A;TFDP1;PLK3;CNOT8;CNOT1
prerank,calcium ion transport (GO:0006816),0.30646181012120155,1.2892578493008078,0.043795620437956206,0.5439842368500433,1.0,20/113,8.06%,TRPM3;SLC24A4;SLC24A2;MS4A1;RYR3;CACNA1B;ATP2B4;ATP2B2;CACNA2D1;CACNA1A;CACNB3;CACNG8;CACNA1D;SLC8A2;SELENOK;RYR2;TMCO1;CACNG3;CACNA1E;TRPM1
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.5022198726953255,-1.288793740839011,0.16636851520572452,0.39022417890416083,1.0,6/13,19.30%,SESN1;ATM;KPTN;CASTOR1;RNF152;ITFG2
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.4649114562670801,-1.288723453669808,0.15145985401459855,0.3899310995277237,1.0,4/17,3.37%,RAPGEF2;AKAP13;ADRA1B;ADCY9
prerank,cellular response to gamma radiation (GO:0071480),-0.48062316547709333,-1.2882235283200616,0.1609403254972875,0.39054096968876256,1.0,6/17,10.11%,MAP3K20;TLK2;ATM;YAP1;RPL26;TP53
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5351287366191338,1.288073094123667,0.17105263157894737,0.5450564093801121,1.0,4/10,11.42%,ENPP2;PLA2G7;PLA2G6;LIPC
prerank,cellular response to interleukin-12 (GO:0071349),-0.36899992505427626,-1.2875068587966354,0.11992945326278659,0.39166835601966354,1.0,16/48,18.29%,ANXA2;JAK1;PAK2;MSN;PDCD4;PLCB1;TCP1;PSME2;RAP1B;JAK2;HNRNPF;LCP1;TALDO1;MIF;SOD1;CFL1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5176720652160031,1.2870124941670595,0.18777292576419213,0.545915932012669,1.0,6/10,21.60%,HSF1;CPEB1;CPEB3;DHX36;PAF1;NCBP2
prerank,regulation of cellular component movement (GO:0051270),-0.36482603273304687,-1.2857990413614284,0.10881801125703565,0.39472016549952327,1.0,19/49,17.28%,SP100;ETS1;LYN;DIAPH1;EGFR;TGFBR3;ABL1;PRAG1;ROCK1;RAF1;ARAP1;RHOA;ACTN1;ACTN4;CDK6;PKN2;ROCK2;HDAC6;IGBP1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.3210445426793245,-1.2850503800355542,0.09074410163339383,0.39590137098449485,1.0,32/96,24.61%,SRSF11;NUP42;RAE1;SARNP;RANBP2;THOC2;UPF3B;THOC7;NUP98;UPF2;SEC13;AGFG1;DDX39B;DHX38;NUP153;SLU7;MCM3AP;TPR;THOC3;THOC1;NUP214;NXT1;FIP1L1;SRRM1;RNPS1;GLE1;SRSF3;NUP188;ALKBH5;POLDIP3;SMG6;NXF1
prerank,mitochondrion disassembly (GO:0061726),-0.39681390973994746,-1.2845875930475474,0.12717770034843207,0.39641544909937293,1.0,16/34,27.26%,ATG7;MAP1LC3B;AMBRA1;BNIP3;WIPI1;GABARAP;FUNDC1;ULK2;MARK2;ATG5;WDR45B;BECN1;ATG2A;FUNDC2;ATG2B;ATG3
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.41250065986410384,-1.2840495489857304,0.1164021164021164,0.39705717231093346,1.0,8/27,20.64%,PRKCH;NFKB1;PPARA;NFKBIA;AGTR1;LPL;PPARG;ITGB3
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.5034231300359482,-1.2839076549486492,0.14800759013282733,0.39691569966291035,1.0,4/13,12.29%,NFAT5;ETS1;RHOA;IRAK1
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.2841860766165511,-1.2837895137014461,0.03488372093023256,0.3966926381128054,1.0,68/234,24.95%,PRKCH;EDA;ERC1;ROR1;CAV1;TAB3;ESR1;NOD1;CD200;TRAF5;TRIM25;APP;RPS6KA5;ANXA3;PRKD2;SLCO3A1;SMO;TFRC;FZD4;NFKB1;NFKBIA;STK3;ZBTB7A;LRP6;PRKD1;ARHGEF2;PLCG2;CFLAR;AKT1;RNF25;EDN1;RGCC;IKBKE;TRIM14;IRAK1;MTDH;HDAC4;FLOT1;CD40;TCF3;ADCY1;TAB2;TRIM13;IRAK2;ARID5B;CTNNB1;CEBPG;MAVS;RPS3;IKBKG;IKBKB;NOD2;PPARG;PTEN;ARHGEF5;RELA;MYOCD;MTPN;RIPK1;CRTC1;TRIM68;PLPP3;HSPA1B;SMARCB1;TFDP1;MAP3K7;FANK1;DHX9
prerank,ventricular septum morphogenesis (GO:0060412),-0.418702266205351,-1.2834862443819948,0.13863216266173753,0.3968749001704385,1.0,15/27,19.06%,BMPR2;TGFBR3;TGFBR2;HES1;SLIT2;TGFB2;BMP4;SMAD4;SMAD7;ZFPM1;NOTCH1;HEY1;HEY2;CITED2;SOX4
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.3655017303567097,-1.2832161073759527,0.10973451327433628,0.3969989898756138,1.0,20/46,22.47%,TEK;FERMT2;PARVB;RAC1;PARVA;NTN4;PXN;PIK3R1;ILK;RHOA;LAMA5;LAMC3;ITGA4;ATRNL1;VAMP3;FERMT3;ITGB3;LAMB1;USH2A;EPHB3
prerank,embryonic skeletal system development (GO:0048706),0.3891124779892969,1.2830200905275249,0.14347826086956522,0.5547229934924034,1.0,12/35,16.82%,DSCAML1;COL1A1;OSR1;HOXD3;UCMA;DEAF1;MEGF8;SLC2A10;HOXA4;HOXA9;PDGFRA;HOXD4
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.40017708381843364,-1.2820706186423205,0.12318840579710146,0.39893557921716977,1.0,13/32,20.17%,ACVRL1;ACER2;CORO1C;THBS1;FAM107A;BCAS3;RASA1;MYOC;MAP4K4;JAG1;SEMA3E;DUSP22;PTEN
prerank,homeostasis of number of cells (GO:0048872),-0.515687858810786,-1.2804854871436258,0.18055555555555555,0.4020910028265649,1.0,7/12,26.84%,NOS3;NAPEPLD;NOTCH1;CCN3;LPCAT3;OCIAD2;F2R
prerank,cGMP-mediated signaling (GO:0019934),0.49747648655593907,1.2804668089819051,0.1912087912087912,0.559549888792918,1.0,2/13,0.78%,KCNC2;HTR2C
prerank,regulation of exosomal secretion (GO:1903541),0.4400293572635544,1.280136327475108,0.16452991452991453,0.5583765021098184,1.0,8/19,18.92%,ATP9A;SMPD3;HGS;TSG101;ATP13A2;SDC4;CHMP2A;VPS4B
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.296583766216302,-1.2800114318890974,0.04674457429048414,0.40260915738801856,1.0,62/175,26.87%,DAB2IP;EDA;LIMS1;TRAF5;TMSB4X;PSMA2;CCL25;BIRC3;TNFRSF1B;NFKBIA;FOXO3;PSME2;TXNDC17;ARHGEF2;PSMB4;AKT1;TP53;ILK;JAK2;ACTN4;EIF5A;CD40;ZFAND6;PSMC2;PSMB2;ASAH1;PSMB1;TNFRSF1A;TNFRSF11B;GSDME;PSMA8;RPS3;CCL19;MAP3K14;EDAR;TNFSF13;IKBKB;HYAL2;PSME1;TNFRSF25;PSMD4;BRCA1;TNFSF8;PSMA7;PTK2B;LTBR;NFE2L2;RELA;RIPK1;HAS2;PSMD5;GBP3;ADAMTS7;DHX9;ERBIN;TNFSF12;ZFP36L1;ADAM17;PSMB10;TNFRSF9;TNFRSF12A;PSMA3
prerank,positive regulation of phospholipase activity (GO:0010518),-0.4365525303600972,-1.2798034155361346,0.15369649805447472,0.4025959192500789,1.0,5/22,12.27%,FLT1;ESR1;PLCG1;AGTR1;FGF2
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.4447686173635903,1.2797290621844561,0.16017316017316016,0.5573720818263683,1.0,6/18,11.47%,HSD17B12;ACSBG1;HACD1;ACSL3;ACSL6;TECR
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.44325448832240255,-1.2794629318012318,0.15087719298245614,0.40285174704844856,1.0,8/21,20.46%,SLC30A10;PPARA;SIRT5;AATF;ABCB7;HDAC6;COA8;BRCA1
prerank,regulation of neuron apoptotic process (GO:0043523),0.3162271630320579,1.2790967357623015,0.062360801781737196,0.5570259043612377,1.0,28/96,17.26%,GRID2;CDK5;BCL2;TYRO3;CLN3;PTPRZ1;NAE1;NTRK2;VSTM2L;GRN;PLA2G3;POU4F1;BACE1;FAIM2;TRIM2;MAG;FZD9;NRBP2;CCL2;BDNF;FGF20;SIGMAR1;APOE;LANCL1;GRM4;ADAM8;MSH2;RETREG1
prerank,histone acetylation (GO:0016573),-0.3380950742442926,-1.2789403121748866,0.1051693404634581,0.40356471115691417,1.0,24/69,25.06%,LEF1;CREBBP;KAT6B;KAT2B;KAT6A;EP400;PHF20;TRRAP;SGF29;PHF20L1;KAT5;TAF5L;ZZZ3;TADA3;TRIM16;DR1;RUVBL2;JADE2;WDR5;MORF4L1;BEND3;TAF9;MAP3K7;APBB1
prerank,positive regulation of behavior (GO:0048520),0.5206399537527695,1.2787260341824658,0.2087912087912088,0.5560482982408924,1.0,3/10,10.11%,NLGN1;NR4A3;SGIP1
prerank,fatty acid biosynthetic process (GO:0006633),0.3384207104798563,1.27853149985638,0.10526315789473684,0.5545398692429306,1.0,19/63,17.17%,FADS1;ACSBG1;HACD1;ELOVL4;ACLY;ACACA;OXSM;ALOX12;LIPC;TECR;OLAH;ACOT7;SCD5;NDUFAB1;ALOX5;CYP1A1;HACD2;ASAH2;SCD
prerank,ion homeostasis (GO:0050801),0.3967127741322423,1.2782395811380889,0.13406593406593406,0.5533296049857581,1.0,7/30,7.87%,UNC80;SLC4A4;SLC4A5;WNK2;SLC4A2;WNK3;SLC12A5
prerank,positive regulation of protein processing (GO:0010954),0.4444783843975073,1.2779328624265363,0.1615720524017467,0.552094763137313,1.0,7/19,16.65%,MELTF;CLEC3B;GSN;PLGRKT;NKD2;ADAM8;KLKB1
prerank,secretion (GO:0046903),0.46653729383835396,1.2774713951979162,0.1728110599078341,0.5514033821966035,1.0,2/14,1.29%,SLC22A4;RIMS1
prerank,RNA processing (GO:0006396),-0.29219764309158075,-1.2771494710470297,0.03770197486535009,0.4069689521107334,1.0,54/176,21.55%,MBNL1;RBPMS;SRSF11;TUT7;TENT4B;RBMS1;PRPF3;SMU1;CDK12;IVNS1ABP;RSRC1;HNRNPA0;PPIG;RBM5;HNRNPR;FUS;PRPF6;RBMS2;CELF1;DDX39B;SF3B1;TENT4A;NOL9;DICER1;HNRNPUL1;RBM39;HNRNPF;XRN2;TUT4;SON;SFPQ;SLU7;APOBEC1;TENT2;YJU2;SCNM1;SF3A1;SYNCRIP;THOC1;SRPK2;ADARB1;USB1;ZMAT5;PPP2CA;TFIP11;SRRM1;NONO;RNPS1;TSEN34;DROSHA;RBM3;FASTKD5;LSM3;RBM6
prerank,error-prone translesion synthesis (GO:0042276),-0.4433835329108524,-1.2769533458256943,0.137291280148423,0.4069607627062165,1.0,8/21,23.23%,RPA3;REV1;RPA1;MAD2L2;POLE2;RPA2;RFC4;RFC1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.5055876180973007,-1.276870616644354,0.1766848816029144,0.40668612955682654,1.0,4/12,15.58%,ASXL1;KLF2;CTBP2;TRIM16
prerank,cell chemotaxis (GO:0060326),-0.351081231475331,-1.2768018620985202,0.08950086058519793,0.4063772590277021,1.0,21/60,24.90%,LEF1;PARVA;DOCK4;CCL25;PLEKHG5;PRKCD;CCR9;BCAR1;AGTR1;RHOG;ACKR3;HGF;ELMO2;CCN3;HOXB9;EPHA2;CXCL12;PDGFRB;PIP5K1A;SEMA5A;EGR3
prerank,cellular glucose homeostasis (GO:0001678),-0.37540830093513144,-1.2767099547803704,0.11632270168855535,0.40608020064205375,1.0,9/41,10.64%,UNC13B;IGF1R;ZBTB20;FOXO1;GAS6;PIK3R1;ERN1;LRRC8D;PRKAA1
prerank,neutral amino acid transport (GO:0015804),-0.40759818030006256,-1.2759764201894006,0.1601489757914339,0.4071409326415352,1.0,11/28,23.45%,SLC6A6;SLC7A5;SLC38A5;SLC1A5;SLC36A4;SLC43A1;SLC1A1;SLC6A7;SLC1A4;SLC3A2;SLC38A6
prerank,protein heterooligomerization (GO:0051291),0.45364594331709895,1.2757993247293622,0.17016806722689076,0.5540474130117645,1.0,2/17,0.90%,KCNC2;GRIN2B
prerank,negative regulation of leukocyte migration (GO:0002686),-0.5318963628723549,-1.2757450113059368,0.1725417439703154,0.40720621694200115,1.0,3/10,6.37%,CD200;BMP5;SLIT2
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.32261205061232906,-1.275553733112322,0.08304498269896193,0.4071756226906336,1.0,27/94,19.01%,IL1R1;PELI1;TAB3;NOD1;RPS6KA5;PSMA2;NFKB1;RBX1;NFKBIA;PLCB1;PSME2;PSMB4;MAP3K3;IRAK1;FBXW11;MAP3K8;PSMC2;PSMB2;PSMB1;PELI2;TAB2;IRAK2;PSMA8;IKBKG;IKBKB;NOD2;PSME1
prerank,protein localization to organelle (GO:0033365),-0.3063824166587262,-1.2752183837794302,0.0564373897707231,0.40745693817180545,1.0,41/133,21.65%,ZNF423;APP;LRRK2;DDX3X;YWHAE;EMD;SIX1;ZBTB7A;TOR1B;CEP250;IFT140;BMP4;CNTLN;UBE2J2;UBAC2;CROCC;GAK;LMNA;EHD1;WDR35;TSPAN17;CSNK1D;RPA1;SGTA;LMBRD1;TRAM2;ABCA7;BMP7;RAB11A;SIX4;RIPOR1;LAMP2;TULP1;GBP5;VAPA;RPA2;DCP1A;WDR83OS;MDM2;IFT20;VAMP2
prerank,neural crest cell migration (GO:0001755),-0.3877561999907697,-1.2739177238564054,0.1357142857142857,0.4099112453744316,1.0,12/36,18.35%,SEMA6A;SEMA3C;CORO1C;SEMA7A;TBX1;PHACTR4;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E
prerank,odontogenesis (GO:0042476),-0.39291227345371965,-1.2737796464312696,0.13204225352112675,0.4097879184816846,1.0,14/35,24.99%,EDA;ANKRD11;TBX1;HDAC1;LRP6;TGFB2;BMP4;AXIN2;FOXC1;BCOR;TUFT1;LAMB1;MSX1;BMP2
prerank,regulation of defense response to virus by host (GO:0050691),-0.40285859001319746,-1.2737074619738733,0.13595706618962433,0.4094949404741959,1.0,16/30,30.86%,DTX3L;SIN3A;TNFAIP3;CGAS;MAVS;ZDHHC1;RNF216;HSP90AA1;DHX9;EIF2AK4;TRIM44;PARP9;TRIM6;TOMM70;IFNLR1;LILRB1
prerank,polyol metabolic process (GO:0019751),-0.36348792323376644,-1.2736988746297617,0.11209964412811388,0.4090728820964123,1.0,11/46,10.99%,PLCB4;INPP1;PLCG1;INPP5A;PLCB3;PLCB1;MINPP1;PLCE1;PLCG2;ITPKB;INPP4A
prerank,axonal fasciculation (GO:0007413),0.5027497689232948,1.2733534487458855,0.19679633867276888,0.5587927329517969,1.0,4/12,8.64%,CNTN4;NRCAM;MEGF8;RTN4
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.376631610971809,-1.273214408522378,0.11926605504587157,0.40968420575209574,1.0,17/43,23.54%,FOXN3;ATM;UIMC1;MRNIP;MRE11;NABP1;CLSPN;TAOK3;INTS3;BABAM2;CDK5RAP3;BRCC3;BRCA1;BLM;CHEK1;TRIM39;FZR1
prerank,purine-containing compound catabolic process (GO:0072523),-0.502779319282865,-1.273185695513363,0.17781690140845072,0.409305542140582,1.0,7/13,27.29%,NT5C2;NT5E;NT5C1A;GPX1;GDA;NT5C;PNP
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4677104160174832,-1.2731502639663024,0.17537942664418213,0.4089194443762724,1.0,11/17,17.95%,NOS3;NFATC1;SLIT2;TGFB2;BMP4;NOTCH2;NOTCH1;JAG1;SMAD6;HEY1;HEY2
prerank,regulation of phospholipase C activity (GO:1900274),-0.47776188668370756,-1.2730903608578907,0.1751412429378531,0.4086028802874721,1.0,4/15,5.93%,FLT1;ESR1;PLCG1;ABL1
prerank,protein insertion into membrane (GO:0051205),-0.39107498133143537,-1.2729897002662738,0.12115732368896925,0.4083899376767376,1.0,11/32,21.65%,APP;EGFR;EMD;COX18;UBE2J2;SGTA;TRAM2;VAPA;WDR83OS;REEP1;VAMP2
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.45788219429474564,-1.2729110378475341,0.1474820143884892,0.4081116443512922,1.0,5/18,14.94%,DYSF;NMI;LBP;PLCG2;IFI35
prerank,histone H3-K4 methylation (GO:0051568),-0.4191463465039241,-1.2724857492416897,0.1551094890510949,0.40852831626255237,1.0,12/26,24.04%,TET2;KDM6A;ASH2L;PRDM9;KMT2C;WDR82;WDR5B;OGT;TET3;WDR5;RBBP5;BEND3
prerank,positive regulation of isotype switching (GO:0045830),-0.4687736037315755,-1.2724347532132476,0.17190388170055454,0.40819301302114025,1.0,7/15,18.59%,SHLD1;TFRC;KMT5B;CD40;MAD2L2;CLCF1;TNFSF13
prerank,keratan sulfate metabolic process (GO:0042339),-0.3938850815542613,-1.2722900306552143,0.14100185528756956,0.40809622132075746,1.0,6/31,9.03%,ST3GAL6;ST3GAL4;ST3GAL1;B3GNT2;B4GALT4;ST3GAL2
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.36091545793470214,-1.2721204347715405,0.11228070175438597,0.40799008127818776,1.0,15/49,16.58%,CBFB;TNRC6B;THBS1;KAT2B;CNOT4;KMT2E;HDAC1;MEF2C;SIN3A;ZFPM1;ASH2L;H3-3A;KMT2C;MTURN;MOV10
prerank,positive regulation of axonogenesis (GO:0050772),0.36877445328384395,1.271266350679665,0.1445221445221445,0.5624089045130224,1.0,13/43,13.54%,ROBO2;L1CAM;ROBO1;SHTN1;CDKL5;LIMK1;NTRK2;SLITRK1;MAPT;ZFYVE27;PLXNA2;BDNF;PLXNA1
prerank,positive regulation of cell growth (GO:0030307),0.3124659113211806,1.2708853476357982,0.07555555555555556,0.5614962051962736,1.0,20/96,11.30%,L1CAM;SYT1;RIMS2;RIMS1;CXCL16;SHTN1;CDKL5;AKAP6;BCL2;PSMD10;LIMK1;EXOSC9;SPHK1;CPNE9;ADNP2;KLHL22;MAPT;ZFYVE27;RNF157;SYT4
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.28639058505411563,-1.2702085373016982,0.0436241610738255,0.41161657945943336,1.0,53/208,18.97%,DAB2IP;PELI1;AKAP13;ROR1;TAB3;ESR1;MIER1;ANKRD17;NOD1;TRAF5;TRIM25;PLEKHG5;NEK6;TNFSF10;BIRC3;TFRC;PLK2;PRKD1;PLCG2;ALPK1;PPM1B;CASP8;CFLAR;MAP3K3;FLNA;IKBKE;TRIM14;RHOA;IRAK1;MTDH;RHOC;CD40;ZFAND6;TRIM59;TNFAIP3;TNFRSF19;USP10;TNFRSF1A;PELI2;TAB2;TFG;TRIM13;MIB2;VAPA;MAVS;ZMYND11;IKBKG;CCL19;LURAP1;MAP3K14;EDAR;IKBKB;NOD2
prerank,cellular response to nutrient levels (GO:0031669),-0.3463003423925002,-1.2697260432081419,0.09734513274336283,0.4121498685909536,1.0,19/62,18.18%,FOXO1;BMPR2;ATG7;LRRK2;MTOR;MAP1LC3B;PPARA;STK24;MFSD2A;FAM107A;KLF10;PRKAA1;WIPI1;RPTOR;LPL;ZFYVE1;RIPOR1;LAMP2;WRN
prerank,actin filament-based transport (GO:0099515),-0.43741527816328996,-1.2696402943694673,0.16152450090744103,0.41187644127744744,1.0,6/21,12.83%,MYO1D;FNBP1L;SYNE2;WASL;MYO1F;ACTN4
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.35695540264722103,-1.2694529565858699,0.124282982791587,0.41189721046261285,1.0,19/52,23.66%,SEC31A;PDIA5;ERN1;PDIA6;KLHDC3;GSK3A;SRPRA;CUL7;KDELR3;WIPI1;LMNA;DCTN1;EXTL3;ACADVL;DNAJB9;PREB;PARP16;FKBP14;TLN1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.42012331295844124,1.2690109734242492,0.141280353200883,0.5646686831923865,1.0,6/21,17.24%,NAV3;APC2;STMN2;HDGFL3;CLASP2;CAMSAP3
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5300246984440118,-1.2685185987678629,0.17657657657657658,0.41350392195422986,1.0,2/10,9.06%,CBFB;SH3RF1
prerank,negative regulation of cilium assembly (GO:1902018),-0.49811283205383217,-1.2684090977726925,0.18725868725868725,0.413295033635447,1.0,5/12,8.80%,LIMK2;MAP4;CDK10;TBC1D30;YAP1
prerank,blood vessel endothelial cell migration (GO:0043534),-0.4346401364248553,-1.2679701584477976,0.1643835616438356,0.4137898212825902,1.0,8/22,16.18%,MYH9;ID1;KDR;SLIT2;CDH5;AKT1;FGF2;PIK3R3
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.32894413765114344,-1.2675311484780583,0.10247349823321555,0.4142497178985728,1.0,27/76,24.76%,XIAP;DCUN1D3;CAV1;LRRK2;BIRC3;UBA2;CUL3;GSK3A;FAM107A;NSMCE3;SMAD7;HDAC4;UBE2L3;DCUN1D2;ANGPT1;SENP2;CDK5RAP3;PIAS4;PHF23;HUWE1;BRCA1;DCUN1D5;NDFIP2;AMER1;RCHY1;SAE1;FANCI
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.3654767450869132,-1.2674482214949434,0.13745704467353953,0.4139960839017205,1.0,16/48,22.01%,MCL1;ATM;TNFRSF1B;ABL1;DDIT4;TP53;FNIP2;IKBKE;BCL2L11;HIC1;HIPK1;EPHA2;PRKDC;BRCA1;CASP2;PHLDA3
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.49260684465571125,1.2673565676561993,0.17752808988764046,0.5671304413927176,1.0,4/12,19.14%,IL12RB1;IL23A;ZBTB1;PRKCQ
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.4617269296183285,-1.2670910205036734,0.17279411764705882,0.414240030520178,1.0,4/17,7.67%,XIAP;ITGA3;SLIT2;TMEM204
prerank,bile acid and bile salt transport (GO:0015721),-0.4187971280362835,-1.2668577360047386,0.15482695810564662,0.4143363941619001,1.0,4/24,2.90%,ABCC4;ATP8B1;SLCO1C1;RXRA
prerank,negative regulation of cell cycle process (GO:0010948),-0.341066093984256,-1.2662649504805779,0.09154929577464789,0.41509836504312114,1.0,22/61,24.58%,DAB2IP;MGA;RYBP;SUZ12;BMP4;MAX;RBBP8;WAPL;EHMT1;PPP1R10;YAF2;PHC1;FOXO4;TERF2;BMP7;RNF2;BRCA1;PHC3;CHEK1;TOM1L2;E2F7;TFDP1
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.38616112253352225,-1.26621658500125,0.157439446366782,0.4147304651301364,1.0,7/36,11.50%,SGMS1;DAB2IP;RB1;FAS;CRADD;TPD52L1;MAZ
prerank,histone H3-K4 trimethylation (GO:0080182),-0.5209618451446582,-1.2656183362951312,0.17905405405405406,0.41556707048660185,1.0,6/11,24.04%,TET2;PRDM9;WDR82;OGT;TET3;BEND3
prerank,mitotic sister chromatid segregation (GO:0000070),-0.31909420216132356,-1.2655399971770864,0.08333333333333333,0.4153042476967972,1.0,50/98,36.37%,RB1;PDS5B;NIPBL;CUL3;WRAP73;SMC4;TENT4A;CHMP4B;CHMP4A;POGZ;KIF23;PDS5A;CHMP2B;KMT5A;CHMP5;RAB11A;DSN1;CENPE;PRC1;PDCD6IP;RRS1;NCAPD2;DIS3L2;MCPH1;BECN1;NCAPH;KIF18B;EML4;NCAPH2;PINX1;INO80;RAN;CHMP3;KIF14;SPDL1;TUBG2;CDCA8;SET;TTN;CHMP6;CHMP1A;NUDC;PLK1;BOD1;PSRC1;MIS12;ESPL1;CSNK2A1;CSNK2A2;CHMP1B
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.4549943444678619,-1.2651311550806221,0.1827768014059754,0.4157868501309392,1.0,7/19,11.69%,NFAT5;NFATC1;NFATC4;INPP5A;PLCE1;EDN1;EDN3
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.38210141532855096,-1.264852296415918,0.13837638376383765,0.4159949336653134,1.0,10/37,11.82%,PARD3;UBE2K;APP;SPRED2;PPEF2;DDIT4;IRGM;MAPK1;SMAD7;RPTOR
prerank,regulation of cell adhesion (GO:0030155),-0.30539839384824535,-1.264852094353911,0.06545454545454546,0.41555704426145523,1.0,38/129,22.47%,RSU1;ACVRL1;PODXL;LYN;ZFHX3;CBLL1;ATM;PKP4;PRKD2;PTPRJ;ABL1;STX3;PTK2;CYTH1;ARHGDIA;PLXND1;TGM2;ROCK1;EPHA4;PLXNA4;ADAM10;PPP1R12A;FRMD5;RASA1;TPM1;ATXN3;ROCK2;NUAK1;ANGPT1;ADGRG1;PPP2CA;EPHA2;TGFBI;CXCL12;PTPN11;GPR4;PTK2B;EPHB3
prerank,regulation of cytokinesis (GO:0032465),-0.32768113171683844,-1.2647496533352025,0.10299625468164794,0.41537427213749284,1.0,24/78,25.30%,PRKCE;SVIL;SETD2;PKP4;AHCTF1;ZFYVE26;CUL3;CDC14A;RAB11FIP3;PLK2;BIRC6;KLHL13;KIF23;RHOA;PKN2;RAB11A;GIPC1;PLK4;CETN2;PRC1;KIF13A;BECN1;E2F7;PLK3
prerank,regulation of osteoclast differentiation (GO:0045670),0.3807548392250789,1.2645899273645869,0.13953488372093023,0.5728577807526806,1.0,7/33,15.02%,BGLAP;CARTPT;CAMK4;POU4F1;TMEM178A;TCTA;IL23A
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.3140458455667361,-1.2643406097789003,0.0782608695652174,0.41579463211011075,1.0,30/91,25.64%,ABCG2;APP;ATOX1;SLC39A10;SLC40A1;SLC31A1;TFRC;SLC30A10;BMP6;SCARA5;SLC39A8;SMAD4;HFE;HMOX2;ABCB7;SLC30A5;SLC39A6;SOD1;FLVCR1;SLC30A1;GLRX3;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;LCN2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.37901154476533316,-1.2640605168794283,0.13261648745519714,0.41598314314421775,1.0,13/39,14.85%,ACER2;CORO1C;THBS1;GCNT2;FZD4;RASA1;NOTCH1;RHOA;ACTN4;MYOC;SPRY4;MAP4K4;JAG1
prerank,cytosolic calcium ion transport (GO:0060401),0.3965913745551336,1.2639341513413211,0.15268817204301074,0.5726229874201253,1.0,8/28,11.91%,SLC25A23;CACNA2D1;CACNB3;SLC8A2;RYR2;TRPM1;ADRA1A;SLC8A1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.3775492632176224,-1.263823278183881,0.145985401459854,0.41607523484417575,1.0,14/39,18.76%,EFR3B;PIP4K2A;PIK3R1;PIP4K2B;PI4KB;PIK3C2A;ITPKB;PIK3CD;TTC7A;SOCS2;PIK3CB;PI4K2B;PIK3R3;TMEM150A
prerank,cellular calcium ion homeostasis (GO:0006874),0.2941743313691795,1.2637480775124776,0.0665083135391924,0.5711360185690179,1.0,25/133,12.58%,SLC24A4;SLC24A2;HTR2C;HCRTR1;STC1;ATP2B4;ATP2B2;ADCY8;CALCA;BCL2;CLN3;ATP1B1;SLC8A2;SELENOK;RYR2;TMCO1;CCL13;GPER1;TMEM178A;ATP13A2;SLC8A3;SLC8A1;HRC;FZD9;CCL5
prerank,response to hydrogen peroxide (GO:0042542),-0.3618224210247589,-1.2637344438318225,0.14583333333333334,0.4158460561299705,1.0,21/45,24.02%,NET1;MAP3K5;ADAM9;STK24;ABL1;PRKCD;ANKZF1;CAT;GPX1;TNFAIP3;FYN;ANXA1;HDAC6;PPIF;SOD1;RPS3;MAPK7;NFE2L2;RELA;RIPK1;CYP1B1
prerank,ventricular septum development (GO:0003281),-0.37962361818561535,-1.263648216454137,0.14912280701754385,0.4155800922736653,1.0,17/37,19.74%,BMPR2;TGFBR3;TGFBR2;HES1;PDE2A;SLIT2;TGFB2;HECTD1;SMAD4;SMAD7;ZFPM1;NOTCH1;HEY1;HEY2;CITED2;SOX4;DAND5
prerank,carboxylic acid metabolic process (GO:0019752),-0.3888989734373222,-1.263275643614314,0.13970588235294118,0.41596879221000715,1.0,5/33,3.70%,SLC2A1;ST3GAL1;ST6GAL1;PLA2G4A;CSGALNACT1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4973726137812466,-1.2626138886580456,0.18871252204585537,0.4169344041460004,1.0,3/13,10.16%,PKD2;NFKBIA;FLNA
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.4023822104678217,1.2625387157608277,0.16186252771618626,0.5726833202055958,1.0,7/27,12.34%,LPIN1;ETNK1;PLA2G3;PLA2G4E;PLA2G6;NAAA;CHKA
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5245623967756613,-1.262327092275707,0.1848013816925734,0.41709533967053714,1.0,3/10,12.97%,THBS1;AKT1;CTTNBP2NL
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.3127121171668298,-1.2617953252026568,0.09122203098106713,0.41778077181367307,1.0,30/107,20.26%,DAB2IP;ITPR1;GSK3B;THBS1;RNF139;ATG10;MAP3K5;NIBAN1;RASGRF2;NCK1;PIK3R1;CREB3L2;ERN1;JUN;ATP2A3;TP53;BCAP31;ERO1A;FLOT1;PDIA3;UFM1;ATF4;DNAJC10;BBC3;BCL2L11;CDK5RAP3;DNAJB12;DNAJB9;GORASP2;HERPUD1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.5370621433624908,-1.2617878433031433,0.20458553791887124,0.4173685435765284,1.0,4/10,18.97%,KDR;NAMPT;JAK2;NOD2
prerank,positive regulation of secretion (GO:0051047),0.5002640477891568,1.2615673693125673,0.19036697247706422,0.5733037302897375,1.0,3/11,12.14%,TRH;ACSL3;GPLD1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.4634596058996368,-1.2614237569608495,0.17996289424860853,0.4177044287705632,1.0,9/17,36.26%,KLF4;TMSB4X;ANXA4;ANXA1;ARRB1;CACTIN;TLR6;CD33;MAPKBP1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.4538295020766819,-1.2611912904211464,0.16485507246376813,0.4177885875629767,1.0,7/17,20.17%,PRKG1;CDKN1B;PDCD4;MEF2C;TPM1;PPARG;PTEN
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.39572733289696166,-1.2609553414644996,0.13761467889908258,0.417417129257092,1.0,14/32,31.36%,NUP42;RAE1;RANBP2;NUP98;SEC13;NUP153;XPOT;TPR;NUP214;NUP188;NUP88;RAN;SSB;NUP35
prerank,tRNA export from nucleus (GO:0006409),-0.39572733289696166,-1.2609553414644996,0.13761467889908258,0.417417129257092,1.0,14/32,31.36%,NUP42;RAE1;RANBP2;NUP98;SEC13;NUP153;XPOT;TPR;NUP214;NUP188;NUP88;RAN;SSB;NUP35
prerank,peptide catabolic process (GO:0043171),-0.42526872922204095,-1.2608306715863145,0.16906474820143885,0.4172484406677698,1.0,9/23,19.22%,CPQ;ACE;GGT5;ECE1;ENPEP;XPNPEP1;CTSH;ERAP1;NPEPPS
prerank,oligodendrocyte differentiation (GO:0048709),0.4194302929979717,1.2600985922683308,0.15368421052631578,0.575488429007423,1.0,7/19,17.63%,MYRF;CDK5;PTPRZ1;SLC8A3;TPPP;EIF2B1;SOX9
prerank,neutrophil activation (GO:0042119),-0.5005523956130677,-1.2599797851070014,0.18518518518518517,0.41860109542857776,1.0,4/12,16.59%,KMT2E;IL15;PRKCD;PREX1
prerank,purine ribonucleotide transport (GO:0015868),-0.45987005738452924,-1.259530883271691,0.17216117216117216,0.419091350982289,1.0,4/16,7.79%,ABCC4;LRRC8C;ABCC6;LRRC8D
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.3050412595833493,-1.2594047578516026,0.07692307692307693,0.4189450912884469,1.0,46/124,26.87%,LEF1;GNB1;RAC1;TNRC6B;SMURF2;FZD6;DVL3;NFATC1;PSMA2;SMURF1;VANGL1;FZD4;AP2B1;AP2A2;PLCB3;PLCB1;AP2S1;PSME2;PSMB4;RHOA;WNT11;AGO2;PSMC2;PSMB2;PSMB1;MOV10;CTNNB1;PSMA8;PSME1;TNRC6A;TCF7L2;AP2M1;PSMD4;ROR2;PSMA7;FZD7;SFRP4;PSMD5;FZD5;MAP3K7;FZD10;GNG2;PSMB10;FZD1;FRZB;PSMA3
prerank,nucleotide-excision repair (GO:0006289),-0.3157629351558177,-1.2583115929224291,0.09171075837742504,0.4208348447767586,1.0,40/101,31.32%,MNAT1;RNF111;RBX1;POLR2G;ERCC2;TP53;POLD3;TCEA1;OGG1;RPA3;ATXN3;RPA1;PNKP;XPC;ERCC3;ERCC8;FANCC;CETN2;RAD23A;RPA2;USP7;LIG4;COPS7A;RFC4;RFC1;COPS8;POLR2C;COPS4;LIG1;POLR2L;ERCC6;POLR2H;MMS19;GTF2H3;POLL;CCNH;PPIE;CHD1L;COPS5;HUS1B
prerank,Rac protein signal transduction (GO:0016601),-0.4561009394330051,-1.258146567992116,0.19572953736654805,0.42073164161991794,1.0,8/18,22.30%,EPS8;RAC1;ELMO1;RHOG;NCKAP1;DBNL;WASF1;HACE1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.36279622364490716,-1.2577810506558886,0.13013698630136986,0.4210710829951206,1.0,10/45,11.47%,SP100;IRF2;TRIM25;JAK1;ICAM1;MID1;CAMK2G;PRKCD;IRF1;JAK2
prerank,membrane organization (GO:0061024),-0.2818358378046193,-1.2576859627575316,0.04923599320882852,0.42083839423896785,1.0,68/227,21.65%,SPTBN1;HIP1;FCHO2;MYOF;CERT1;DAB2;DNM3;CORO1C;EPS15;TMCC1;FNBP1L;STX18;A4GALT;LDLRAP1;EGFR;TFRC;EMD;FZD4;AP2B1;AP2A2;DYSF;CBL;DNM2;TOR1B;COX18;RABEP1;AP2S1;EPS15L1;PIK3C2A;SNX9;WASL;AAK1;ITSN1;AGFG1;RAB5A;PICALM;IGF2R;REEP3;CHRNB1;CHMP4B;CHMP4A;ATP10B;GAK;ACTB;CHP1;CHMP2B;GRB2;HIP1R;MITD1;SUN1;ARPC4;CHMP5;TLCD1;REPS1;MOSPD3;VAPA;STON2;VAMP3;GLTP;AP2M1;HUWE1;M6PR;PDCD6IP;OSBPL2;LPCAT3;REEP1;RABIF;VAMP2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.33758217237034066,-1.2576483273115266,0.13143872113676733,0.4204742486879141,1.0,23/69,21.67%,IGF1R;PLCB4;PLCB3;PIK3R1;IRS1;PLCB1;PI4KB;EZR;PIK3C2A;NGF;PLCE1;PIK3CD;AKT1;EDN1;HTR2A;RHOA;PIK3CB;GAB2;IGF1;PTEN;NF1;OGT;PDGFRB
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.35957977825148574,-1.257386090741295,0.14,0.4205780198190468,1.0,16/46,25.54%,PLA2G4A;LPCAT1;PLD1;PLD2;DGKA;AGPAT4;DGKZ;ACP6;AGPAT3;AGPAT1;PLA2G12A;LCLAT1;DDHD2;GPD1;DGKH;DGKE
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.32547814522073204,-1.2573601365345728,0.11607142857142858,0.4202018511818491,1.0,29/85,24.53%,DAB2IP;CSNK1A1;CBFA2T3;DAB2;GSK3B;LRRK2;RBX1;RNF144B;HECTD1;GSK3A;DET1;USP13;GABARAP;SMAD7;CSNK1D;ATXN3;ECSCR;ZER1;PSMC2;ZYG11B;SUMO1;RAD23A;MDM2;SH3RF2;KEAP1;CEBPA;RCHY1;TRIB3;HSPA1B
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.3437539795410366,-1.257324225666361,0.10806174957118353,0.4198407775852173,1.0,18/59,17.01%,DYRK1A;GSK3B;LRRK2;PRKD2;TGFBR2;PRKCD;CDK10;CDC42BPA;MAPK1;ROCK1;PRKD1;GSK3A;AKT1;MAPK8;MARK2;ROCK2;HIPK1;CDC42BPB
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.44626432059724414,1.2571655578820755,0.15418502202643172,0.5818098228376177,1.0,8/17,17.51%,ATP1A2;SCN1B;CACNA2D1;CACNA1D;SCN5A;SLC8A1;SCN2B;CACNA1G
prerank,negative regulation of cell migration (GO:0030336),-0.2978994264388763,-1.2571628012365812,0.08098591549295775,0.4197614455175454,1.0,44/137,21.11%,PTPRG;DAB2IP;CLDN5;ENG;ACVRL1;RAC1;CORO1C;MCC;MITF;ARID2;PTPRJ;SCAI;LDLRAD4;AFDN;TCAF1;STK24;FOXO3;SLIT2;PTPRK;EPHA4;DACH1;CDH1;ZMYND8;SMAD7;FGF2;LIMCH1;TPM1;DUSP3;WNT11;HAS1;JAG1;IGFBP5;MIF;FUZ;ADARB1;ADGRG1;RAP2A;CITED2;HYAL2;DUSP22;RAP2C;PTEN;NF1;VCL
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.3635429219100743,1.2570917527555001,0.13921113689095127,0.5800048046268919,1.0,10/41,12.02%,ANK3;KCNMA1;KCNJ3;AKAP6;KCNN2;GABBR2;KCNJ6;STAC;KCNN3;GABBR1
prerank,response to organophosphorus (GO:0046683),0.4564305886688763,1.2569135833758243,0.1963470319634703,0.5785163683836037,1.0,3/16,5.28%,DGKQ;AKR1C1;TYMS
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4286943405800454,1.2568026945854853,0.1842696629213483,0.5768427734717392,1.0,6/20,14.53%,BICD1;PLEK;RPGRIP1L;RNF157;CCL5;MRAP2
prerank,autophagy of peroxisome (GO:0030242),-0.5061880838079822,-1.2566260386254091,0.1889483065953654,0.4205140269436889,1.0,2/12,4.77%,ATM;MAP1LC3B
prerank,quinone biosynthetic process (GO:1901663),-0.49061749938987703,-1.256598484797029,0.1742957746478873,0.4201459504148824,1.0,6/14,19.31%,FDXR;COQ9;UBIAD1;COQ6;COQ2;COQ8B
prerank,regulation of B cell apoptotic process (GO:0002902),-0.5007139473255208,-1.2562886361395176,0.1921641791044776,0.4203881964550784,1.0,2/12,2.03%,FOXP1;LYN
prerank,tRNA transport (GO:0051031),-0.38623771888106034,-1.2560790392881707,0.13358070500927643,0.4204122813835262,1.0,15/35,31.36%,NUP42;RAE1;RANBP2;NUP98;SEC13;NUP153;XPOT;TPR;NUP214;NUP188;NUP88;RAN;TOMM20;SSB;NUP35
prerank,skeletal muscle organ development (GO:0060538),-0.4122113698644233,-1.2559629800630872,0.1526032315978456,0.42023699152776733,1.0,13/26,28.65%,CAV1;SVIL;SIX1;MEF2C;CFLAR;SIX4;MYL6;LARGE1;FOXL2;FXR1;DISP1;STRA6;MSC
prerank,atrioventricular valve development (GO:0003171),-0.4906845300048076,-1.2557793138007403,0.1930783242258652,0.42019782378023685,1.0,5/14,12.19%,BMPR2;TGFBR2;TGFB2;ZFPM1;NOTCH1
prerank,membrane protein proteolysis (GO:0033619),-0.38097124952346856,-1.25566538753628,0.13793103448275862,0.4200218158712342,1.0,11/37,18.01%,MYH9;ADAM9;NFKB1;PSEN2;SPPL3;AFG3L2;ADAM10;PSEN1;CTSH;APH1A;ERAP1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.41005546922400055,-1.2553841094749527,0.15213675213675212,0.42022553821093006,1.0,19/26,45.32%,IL6ST;FLT4;ATF4;ARNT;BRCA1;HPSE;EIF2AK3;CYP1B1;TGFB1;SULF1;IL1A;SARS1;HIF1A;RORA;GATA4;ISL1;CCBE1;NODAL;IL6
prerank,cellular response to virus (GO:0098586),-0.3927917160007838,-1.255338651049948,0.14711033274956217,0.41990548216442297,1.0,15/30,30.24%,IFIH1;DDX3X;IRGM;EIF5A;LGALS8;GSDME;CCL19;HSP90AA1;MAPK11;VWCE;LGALS9;CXCL10;RIOK3;TOMM70;MAPK14
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.501513557588815,-1.2551783523702968,0.17443868739205526,0.41897104140720043,1.0,4/12,11.86%,RB1;CUL3;CDC16;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.501513557588815,-1.2551783523702968,0.17443868739205526,0.41897104140720043,1.0,4/12,11.86%,RB1;CUL3;CDC16;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.501513557588815,-1.2551783523702968,0.17443868739205526,0.41897104140720043,1.0,4/12,11.86%,RB1;CUL3;CDC16;NSMCE2
prerank,regulation of intracellular pH (GO:0051453),0.39005000305526805,1.2546907416773871,0.16379310344827586,0.5809518323547327,1.0,7/34,5.56%,CA2;SLC9A7;SLC4A4;SLC4A5;CLN3;SLC9A9;SLC4A2
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.5373238715175439,-1.2546400030789484,0.19597069597069597,0.41979875927268545,1.0,3/10,5.09%,LRP5;TBX1;TGFBR2
prerank,regulation of smooth muscle cell migration (GO:0014910),0.4353491718735239,1.2542522964444773,0.19426048565121412,0.5801934767292426,1.0,6/20,12.58%,VTN;IGFBP3;NDRG4;SORL1;PDGFA;CCL5
prerank,central nervous system development (GO:0007417),0.27055328704439063,1.2539963631628357,0.03058823529411765,0.5789068368640585,1.0,49/250,13.66%,CNTNAP2;ROBO2;ASIC2;CNTN6;IL1RAPL2;CNTN4;GRIN2B;DSCAML1;ADAM23;MYRF;ADAM22;SH3GL2;ADGRL3;NPAS1;SPOCK1;DNER;CDK5;GRIN2A;NRCAM;POMK;MEIS1;NDRG4;MEIS3;MDGA1;PITPNM1;SMG9;PTPRZ1;MAP1S;PROX1;HPCAL4;GSN;GRIK1;AHI1;NCAN;KLK6;DCX;POU3F3;HAPLN2;MOG;MBP;NMUR2;ARNT2;CDH2;SLC8A3;PBX4;TPPP;RPS6KA6;TUBGCP2;CAPG
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.43502845773902404,-1.2538527989777297,0.17540687160940324,0.42107371149323064,1.0,4/20,3.37%,RAPGEF2;AKAP13;ADRA1B;ADCY9
prerank,synaptonemal complex assembly (GO:0007130),0.4570052139511504,1.2534688026525558,0.18040089086859687,0.5764346096100165,1.0,4/15,12.99%,SYCP1;REC8;SYCP2;RAD21
prerank,synaptonemal complex organization (GO:0070193),0.4570052139511504,1.2534688026525558,0.18040089086859687,0.5764346096100165,1.0,4/15,12.99%,SYCP1;REC8;SYCP2;RAD21
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.41745788830072866,1.2532385333663612,0.1583710407239819,0.5751779366063461,1.0,10/22,20.71%,STAC2;AKAP6;ATP1B1;CALM2;RYR2;STAC;CASQ1;HTT;HAP1;VMP1
prerank,cellular response to UV-A (GO:0071492),0.5038770214673092,1.2530824537947016,0.18614718614718614,0.5736906462920297,1.0,4/11,13.12%,MME;CERS1;TIMP1;PPID
prerank,NAD biosynthetic process (GO:0009435),-0.4377902997698045,-1.253060627065924,0.18265682656826568,0.42234353325661494,1.0,12/20,37.20%,NAMPT;NADSYN1;NAXE;NUDT12;NAPRT;KYNU;PARP16;PTGIS;PARP9;NAXD;NMNAT3;NNMT
prerank,motor neuron axon guidance (GO:0008045),-0.467721962249458,-1.2529466045880895,0.2140221402214022,0.4221656803193878,1.0,6/15,13.44%,RAC1;NTN1;CHN1;SLIT2;EPHA4;RHOG
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.41731156388824503,1.2527970309317316,0.17792792792792791,0.5725957448345745,1.0,7/23,16.64%,FADS1;ACSBG1;ALOX12;ACOT7;ALOX5;CYP1A1;ASAH2
prerank,gas transport (GO:0015669),0.5176674829076335,1.2527527033490877,0.20815450643776823,0.5708197749263993,1.0,2/10,3.98%,CA2;NGB
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.4733993540030721,1.2524436071473157,0.18723404255319148,0.5697524861157036,1.0,5/14,9.70%,AK7;AK5;AK3;ENPP3;NME2
prerank,ncRNA export from nucleus (GO:0097064),-0.3821344640485139,-1.252238871185919,0.13138686131386862,0.42325922592203447,1.0,15/36,31.36%,NUP42;RAE1;RANBP2;NUP98;SEC13;NUP153;XPOT;TPR;NUP214;PHAX;NUP188;NUP88;RAN;SSB;NUP35
prerank,positive regulation of transferase activity (GO:0051347),-0.2942650817881366,-1.2522061005807084,0.08648648648648649,0.4228943060453189,1.0,42/142,22.47%,FLT1;TEK;IGF1R;TIE1;DCUN1D3;ROR1;INSR;KLF4;NEK7;CD200;DTX3L;KDR;MERTK;EGFR;DSTYK;LMO4;TCP1;MRE11;MAPK1;EPHA4;FLT4;GSK3A;HMBOX1;PNKP;PARN;PTGES3;MAGEC2;UBE2L3;DCUN1D2;CTNNB1;SERINC1;SERINC5;EPHA2;FGFR4;DCUN1D5;IGF2;ROR2;PDGFRB;RFC4;EPHB6;HSP90AA1;EPHB3
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.34630595137905695,-1.2521134999153483,0.12152777777777778,0.42266666606234293,1.0,19/51,27.81%,THBS1;IL6R;GAS6;MOSPD2;IL34;PTK2;MAPK1;VEGFC;EDN3;ANO6;LGMN;CMKLR1;CXCL12;PTN;SERPINE1;HMGB1;ADAM17;LGALS9;CXCL10
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5186761759313208,-1.2520845890945242,0.17032967032967034,0.42231454506082977,1.0,6/11,17.00%,RAPGEF2;LYN;MEF2C;PIK3CD;PIK3CB;ANXA1
prerank,regulation of TORC1 signaling (GO:1903432),0.3795495791327452,1.2517012875562255,0.14666666666666667,0.5698715807606973,1.0,8/33,8.51%,DGKQ;GPR137C;PIP4P1;RRAGA;STK11;FLCN;KLHL22;SEH1L
prerank,response to hydroxyurea (GO:0072710),-0.5085524405607171,-1.2515902327756714,0.20140105078809106,0.4229972868090749,1.0,7/11,21.31%,DDI2;SPIDR;RTF2;NSMCE3;ATRX;TIMELESS;BLM
prerank,negative regulation of cellular component movement (GO:0051271),-0.47449726188400126,-1.2508559334013947,0.18861209964412812,0.42415959994305036,1.0,5/15,12.34%,SP100;CRK;TGFBR3;FRMD5;ACTN1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.4699335637535259,-1.2507528648855597,0.18613138686131386,0.42397227913924496,1.0,4/14,8.04%,THBS1;IL34;PTK2;MAPK1
prerank,negative regulation of DNA replication (GO:0008156),0.4796635771230774,1.2498301601339097,0.19402985074626866,0.5730956924533038,1.0,4/13,11.18%,GMNN;GTPBP4;TERF1;ATR
prerank,regulation of axon guidance (GO:1902667),0.500254934764476,1.2495396199272035,0.21153846153846154,0.5720099421961278,1.0,5/10,24.18%,VEGFA;ZSWIM5;YTHDF1;ZSWIM8;MYCBP2
prerank,positive regulation of locomotion (GO:0040017),-0.4116600811048254,-1.2494485012956735,0.16176470588235295,0.42637187449555997,1.0,11/27,30.91%,NTN1;THBS1;SPOCK2;STX3;PPM1F;CAVIN1;CCL19;PDGFRB;TREM2;TGFB1;TRIM32
prerank,retrograde axonal transport (GO:0008090),0.4404068407137587,1.2487062559881272,0.19875776397515527,0.5723797597495305,1.0,7/16,19.23%,DLG2;TMEM108;KIF5A;KIF1C;NEFL;MAP1A;HAP1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.40594494729488784,1.2486505222389042,0.18493150684931506,0.5706648316414599,1.0,6/27,9.70%,AK9;AK7;TYMS;AK5;AK6;NME2
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.4519055631136144,-1.2485109513618409,0.2007366482504604,0.4280169931133014,1.0,7/17,25.58%,ALG14;ALG12;ALG8;DOLPP1;ALG13;MVD;DOLK
prerank,eosinophil chemotaxis (GO:0048245),0.46882506834780113,1.2484448508551134,0.2146341463414634,0.5675610980524252,1.0,5/14,19.12%,CCL13;CCL5;CCL2;CCL7;CX3CL1
prerank,eosinophil migration (GO:0072677),0.46882506834780113,1.2484448508551134,0.2146341463414634,0.5675610980524252,1.0,5/14,19.12%,CCL13;CCL5;CCL2;CCL7;CX3CL1
prerank,reverse cholesterol transport (GO:0043691),0.4766275674256866,1.2483696517732599,0.18620689655172415,0.565971372790744,1.0,5/13,14.63%,APOM;LIPC;ABCA5;CLU;APOE
prerank,sulfur compound biosynthetic process (GO:0044272),-0.3080809446141745,-1.2483211989792133,0.09948542024013722,0.42798733085406093,1.0,31/104,22.21%,ST3GAL6;ST3GAL4;ST3GAL1;SLC26A2;CSGALNACT1;GSTT1;B3GNT2;CHST15;GGT5;B4GALT4;SLC10A7;DSE;ST3GAL2;CHST11;CSPG4;GSTM2;BGN;MAT2B;B4GALT5;ANGPT1;ESD;HPGDS;MAT2A;B4GALT1;CDO1;CHST7;GSTO2;CTH;CHPF2;GCLC;METTL16
prerank,mitotic recombination (GO:0006312),-0.47329537505350955,-1.247625385502188,0.218018018018018,0.4290540748003494,1.0,11/15,42.06%,SMC5;DMC1;RAD54B;NSMCE2;TEP1;MSH3;RAD51D;RAD50;RAD52;SMC6;ERCC1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.539844365267423,-1.247490253530392,0.1960431654676259,0.4288957027469596,1.0,4/10,15.58%,PRKCH;MED1;FOXC1;TRIM16
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.30357459237242573,-1.247079083128087,0.08231173380035026,0.4293238978362523,1.0,36/118,18.40%,SP100;SHANK3;FERMT2;ADGRA2;BMPER;ETS1;NEDD4L;PDZD8;GSK3B;KIF13B;PAK2;TBX1;LRRK2;PDLIM5;ZMYM6;CHN1;NEDD4;MEF2C;PLXND1;EPHA4;FLT4;STAT2;ABI3;FGF2;ZMYM4;CEACAM1;RC3H1;MARK2;TNFAIP3;FMNL2;CTNNB1;ARHGAP35;CAPZB;RAP2A;CFL1;WTIP
prerank,primary miRNA processing (GO:0031053),-0.5190933289765733,-1.247030462297168,0.20631970260223048,0.4289939101417216,1.0,7/10,36.30%,SMAD1;SMAD2;PUS10;DROSHA;MRPL44;DGCR8;SMAD3
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.5187525265709139,-1.246944533890872,0.2176991150442478,0.4287604103333537,1.0,5/11,12.19%,FOXO1;GSK3A;SMAD4;LMNA;NOTCH1
prerank,positive regulation of ATPase activity (GO:0032781),0.3594395571081194,1.246825337184188,0.13443396226415094,0.5684123235711948,1.0,14/41,20.89%,PFN2;DNAJB11;ATP1B1;UHRF1;PFN1;DNAJC24;RYR2;MSH2;MYL4;DNAJB2;DNAJB1;VMP1;ATP1B2;CHTOP
prerank,protein ubiquitination (GO:0016567),-0.2576408352242264,-1.2468141123837848,0.017684887459807074,0.4286243715360017,1.0,157/471,27.44%,FBXL7;WWP1;PELI1;UBR5;CBFB;USP9X;BRAP;NEDD4L;CBLL1;ZNRF1;SMURF2;FBXL12;UBE2K;TRIM25;CNOT4;RNF139;PSMA2;RNF111;FBXL17;DTX3L;ZNRF3;SMURF1;CUL9;RNF125;FBXL3;RNF213;RBX1;CBL;OTULIN;RNF43;LMO7;UBE4B;CUL3;NEDD4;RNF40;PSME2;RNF115;RNF144B;KLHL12;CUL2;BIRC6;UHRF2;PDZRN3;ARRDC1;SPSB1;PSMB4;SH3RF1;TRIP12;UBE2J2;DET1;ZNRF2;UBE2D3;MIB1;TPP2;CUL7;UBR2;RNF25;FBXW8;AREL1;TNFAIP1;KLHL13;TRIM14;RMND5A;CDC16;HERC6;TSPAN17;RAD18;CDC73;RTF1;ANAPC16;UBE2E2;OBI1;UBE4A;ASB1;FBXW11;KLHL25;RNF168;PSMC2;RC3H1;RNF167;MYLIP;DTX3;HIF3A;VCPIP1;UBE2V2;ERCC8;PSMB2;PHC1;PEX14;UBE2L3;PSMB1;PELI2;HERC2;TRIM13;MIB2;CTNNB1;RFWD3;KCTD10;PSMA8;SPOP;SASH1;KLHL3;SDE2;EPAS1;RNF10;UBR1;SIAH1;RNF152;AKTIP;PSME1;TRIM3;NPEPPS;RNF4;USP7;PRKDC;TRIM47;WWP2;ELOC;PSMD4;HUWE1;FANCL;BRCA1;UBE2R2;MDM2;SH3RF2;CAND2;PSMA7;KEAP1;HACE1;NFE2L2;TRIM39;PSMD5;THOP1;TRIM68;ARRB1;RCHY1;TRIM7;RNF146;FBXO32;TRPC4AP;RNF38;FBXL22;FBXO17;ANAPC7;FBXO40;DTL;TRIM44;PSMB10;ARIH2;LEO1;RNF122;RNF103-CHMP3;PSMA3;RNF34;RNF103;ATG3;TRIM6
prerank,macrophage activation involved in immune response (GO:0002281),-0.49014180047358646,-1.2462153630174924,0.19925512104283055,0.4295104847886994,1.0,5/13,14.94%,DYSF;NMI;LBP;PLCG2;IFI35
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.5254026131552605,-1.2460923796665404,0.19715808170515098,0.429336256673505,1.0,4/10,14.26%,SETD2;SETD3;EHMT1;KMT5A
prerank,respiratory chain complex IV assembly (GO:0008535),-0.4292590756025876,-1.246015709110037,0.184070796460177,0.42907696509588217,1.0,7/21,19.59%,COX16;COX18;SCO1;COX17;COA6;COX10;COA8
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.37326491278689844,1.2459435923463196,0.13333333333333333,0.56890424425845,1.0,10/32,18.36%,NAV3;EML2;APC2;MAP2;STMN2;HDGFL3;MAPRE1;CLASP2;CAMSAP3;TUBB4A
prerank,bile acid metabolic process (GO:0008206),0.39489268223921953,1.2456616515419976,0.17045454545454544,0.5678365933340612,1.0,5/27,8.86%,AKR1D1;CYP46A1;AKR1C1;OSBPL6;CYP27A1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.42919369239198035,-1.2455632071561158,0.17582417582417584,0.42963251977792777,1.0,6/21,14.09%,PAN3;TUT7;CNOT4;SAMD4A;TUT4;PARN
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.4355123185975676,-1.245389930321889,0.1733800350262697,0.42956648885357507,1.0,11/20,30.01%,TNRC6B;LIMD1;CELF1;AGO2;MOV10;WTIP;TNRC6A;AJUBA;CNOT8;CNOT1;HELZ
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.36189895719416176,-1.2451610806077134,0.1512455516014235,0.4296433481993725,1.0,16/44,15.36%,FERMT2;RAC1;PXN;ABL1;ARHGEF15;PPM1F;RGCC;RHOA;LIMCH1;TPM1;WNT11;MYOC;RHOC;ARHGEF10;SORBS3;ROCK2
prerank,regulation of translation (GO:0006417),-0.2877134109466181,-1.2450817264352132,0.07228915662650602,0.4293947829077511,1.0,63/173,27.10%,EIF3H;DAPK1;THBS1;EIF4H;APP;RNF139;EIF3E;METTL14;DDX3X;MTOR;NIBAN1;GIGYF2;PLD1;EIF3C;LARP1;FOXO3;UPF3B;LTN1;EIF3B;OGFOD1;SAMD4A;RPL26;EIF2B2;ZCCHC4;EEF2;RPS6KA1;LARP4B;KLHL25;RPS4X;GSPT1;RPL10;RPS6KA3;IGFBP5;SYNCRIP;BTG2;RPL5;METTL5;RPS3;CTIF;RBM4B;SOX4;PRKDC;CAPRIN1;GLE1;TOB1;RBM3;MTPN;RPL13A;MRPL13;EIF2AK3;MTG2;POLDIP3;NEMF;DHX9;FXR1;IGF2BP2;EIF2AK4;CNOT8;HNRNPD;NANOS1;LARP6;CNOT1;EIF5B
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.49763848008964473,-1.2444634707056568,0.1974169741697417,0.43024155085799604,1.0,6/12,19.32%,CBFB;ELF1;LYN;ELF2;RC3H1;PTPRC
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.3524715453629069,-1.2441077837610428,0.12727272727272726,0.4305560033677693,1.0,20/48,25.93%,ZMIZ1;KAT2B;DEK;ARID1B;ATAD2B;SF3B1;TAF1B;ACTB;TAF1C;WBP2;ELOF1;BAZ1B;CHEK1;ATAD2;TAF1D;SERTAD2;POLR1E;POLR2L;ERCC6;POLR2H
prerank,protein glycosylation (GO:0006486),-0.3003572515756066,-1.2440922095464109,0.09217391304347826,0.430171310808385,1.0,24/125,10.84%,ST3GAL6;EOGT;ST3GAL4;ST3GAL1;PLOD1;PLOD2;ST8SIA4;GCNT2;TRAK1;GALNT10;ALG10B;MAN1C1;DAD1;MGAT4B;B3GNT2;GFPT2;TET2;FUT8;AQP11;SLC39A8;ST3GAL2;FUT10;ALG12;ALG8
prerank,histone lysine methylation (GO:0034968),-0.389174912065764,-1.2435937812817803,0.14794007490636704,0.43082416910631854,1.0,15/33,26.63%,PRDM5;SUV39H1;KDM6A;SETD3;DOT1L;ASH2L;SMYD1;N6AMT1;PRDM9;WDR82;WDR5B;WDR5;RBBP5;SETDB2;TRMT112
prerank,rRNA 3'-end processing (GO:0031125),-0.5388488613124708,-1.243547767056201,0.20550458715596331,0.43048976422773133,1.0,5/10,16.26%,ERI3;RPS21;EXOSC2;EXOSC3;EXOSC8
prerank,response to glucose (GO:0009749),-0.354936957193348,-1.243271199562096,0.147005444646098,0.43066220485453977,1.0,9/46,12.71%,UNC13B;IGF1R;ZBTB20;THBS1;GAS6;ERN1;EIF2B2;PRKAA1;LPL
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.4193093387100544,1.2428121627572553,0.17913832199546487,0.5738147880414837,1.0,6/22,12.48%,TAFA1;TOX;PTPRZ1;PROX1;INSM1;FZD9
prerank,sphingoid metabolic process (GO:0046519),0.49022834319910136,1.2423503134667224,0.19823788546255505,0.5731837654530125,1.0,6/12,16.64%,PLPP2;SPHK1;SGPP1;SPHK2;NAAA;ASAH2
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.28596708937388104,1.2422058403178338,0.07560975609756097,0.5717724237508981,1.0,30/152,12.02%,ADGRB3;GNAO1;CHRM2;GNAI2;ADGRL3;GRM8;ADCY8;GNAI1;CALCA;GNAL;ADGRG4;CNR1;PTGER3;GPR37;GNAT3;MTNR1A;CACNA1D;PF4;GIPR;ADCY7;ADRB3;ADRA2A;GPR65;TSHR;GPER1;LGR5;VIPR2;ADRA1D;HTR1D;GABBR1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.4294754703339045,1.2421294862148105,0.19599109131403117,0.5701197152772246,1.0,10/19,20.73%,GGA3;NTRK2;SORL1;RTN4;CLU;APOE;RTN3;FLOT2;HAP1;RTN1
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.4964089492448709,1.2418496881296213,0.21656050955414013,0.5690712146378285,1.0,3/11,11.42%,PLA2G7;PLA2G3;LIPC
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.5188096484730431,1.2415748074240225,0.2037914691943128,0.5680662846674789,1.0,2/10,2.53%,UBE2J1;INSIG1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5162748937922572,1.2415241696260924,0.1990521327014218,0.5664488478829838,1.0,4/10,6.03%,ATP1A2;HECW1;OSR1;HECW2
prerank,mRNA transport (GO:0051028),-0.3081913186570037,-1.240671670566327,0.12050359712230216,0.43583040024027414,1.0,32/101,24.61%,SRSF11;NUP42;RAE1;SARNP;RANBP2;THOC2;UPF3B;THOC7;NUP98;UPF2;SEC13;AGFG1;DDX39B;DHX38;NUP153;SLU7;MCM3AP;TPR;THOC3;THOC1;NUP214;NXT1;FIP1L1;SRRM1;RNPS1;GLE1;SRSF3;NUP188;ALKBH5;POLDIP3;SMG6;NXF1
prerank,nuclear pore complex assembly (GO:0051292),-0.5195599961097841,-1.2403658266249926,0.19622641509433963,0.43602584363509295,1.0,4/10,15.78%,AHCTF1;NUP98;NUP153;TPR
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.46067220554469385,-1.2403174050306793,0.19964973730297722,0.4357124741757872,1.0,8/15,32.49%,NR3C1;FAM107A;UBE2L3;BCL2L11;ANXA1;ZFP36L1;HNRNPU;SSTR2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.3960857419675326,1.2400762459112336,0.16985138004246284,0.5685467333863043,1.0,6/27,8.20%,PDE4B;CTNNA3;STC1;PKP2;RYR2;SCN5A
prerank,nucleosome organization (GO:0034728),-0.33924838140853275,-1.2400439290058098,0.12588652482269502,0.4358816355105455,1.0,16/55,19.64%,KAT6B;SETD2;ARID2;CTCF;SMARCC1;BRD2;SRCAP;SMARCE1;SPTY2D1;SMARCC2;MCM3AP;SMARCD3;H3-3A;PRDM9;VPS72;ATRX
prerank,aspartate family amino acid metabolic process (GO:0009066),0.4405854005206334,1.2397462290999428,0.19327731092436976,0.5676749692906526,1.0,4/18,8.00%,SLC25A13;ASNS;GADL1;ASPA
prerank,autophagosome organization (GO:1905037),-0.3496996458898702,-1.2397362832166932,0.1520572450805009,0.43609873667795446,1.0,21/50,27.26%,ATG7;RAB7A;RAB1A;MAP1LC3B;AMBRA1;IRGM;WIPI1;GABARAP;ULK2;RAB23;ATG5;STX12;EMC6;WDR45B;ATG16L2;BECN1;ATG2A;RAB19;ATG2B;UBXN2A;ATG3
prerank,establishment of melanosome localization (GO:0032401),0.427086485474838,1.2392440766659436,0.1891891891891892,0.5672714282973353,1.0,9/19,16.59%,MREG;RAB27B;MYO5A;BBS7;BBS4;BBS5;ARL6;MKKS;BBS2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3859319593784822,-1.2389544824739285,0.16013628620102216,0.4373837193518587,1.0,15/33,26.42%,IGF1R;PIK3R1;IRS1;PIK3C2A;PIK3CD;AKT1;EDN1;HTR2A;PIK3CB;IGF1;PTEN;NF1;PIK3CA;ZFP36L1;TPTE
prerank,peripheral nervous system development (GO:0007422),0.41262087538433645,1.2387351398607163,0.1606714628297362,0.5669290647213748,1.0,4/23,6.31%,ASIC2;SCN8A;NFASC;GPC1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.3318572585620699,-1.2387307360416018,0.11290322580645161,0.4373778287491795,1.0,28/73,26.60%,KAT2B;DEK;CTCF;SUZ12;SF3B1;TASOR;TAF1B;HDAC4;ACTB;TAF1C;MECP2;GPX1;H3-3A;DNMT1;HDAC6;PPHLN1;WBP2;KDM1B;PPM1D;BAZ1B;IGF2;TAF1D;AEBP2;POLR1E;POLR2L;ERCC6;POLR2H;HDAC5
prerank,"phototransduction, visible light (GO:0007603)",-0.47348007389006863,-1.2384784589126503,0.20036764705882354,0.43749412188794684,1.0,8/14,46.73%,GNB1;SAG;GNA11;PDE6G;PDE6B;RP1;GNAQ;RHO
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.4399375724106368,-1.2379798544029923,0.2089041095890411,0.4381563501694856,1.0,6/18,20.79%,DAB2IP;EMD;TP53;CDC73;SKI;NF1
prerank,DNA biosynthetic process (GO:0071897),0.4416941790618837,1.23746371791432,0.2152777777777778,0.5685073963882489,1.0,5/16,14.04%,WRNIP1;TYMS;POLD4;POLA1;PPIA
prerank,protein-containing complex disassembly (GO:0032984),-0.34473513445530574,-1.2369475576844504,0.14656771799628943,0.43991102326243947,1.0,17/54,26.83%,CSNK1A1;CAV1;LIX1L;GSK3B;DVL3;MAP1LC3B;LRP6;TECPR1;GABARAP;CTNNB1;LAMP2;AMER1;PPP1CA;FZD5;FZD1;APC;CHMP3
prerank,protein K63-linked ubiquitination (GO:0070534),-0.37150800865822653,-1.2359581129854433,0.15716753022452504,0.44157739905402377,1.0,12/41,20.14%,PELI1;TRAF5;TRIM56;NEDD4;RNF115;HECTD1;UBE2E2;RNF168;UBE2V2;RNF152;RNF4;WWP2
prerank,mitotic cell cycle phase transition (GO:0044772),-0.27868595294006704,-1.2357123450030854,0.05546218487394958,0.44168426801704297,1.0,73/203,29.15%,FBXL7;MNAT1;RB1;EPS8;FBXL12;FBXL17;PPP1R12B;YWHAE;FBXL3;CDKN1B;CRLF3;CEP57;DNM2;CUL3;PLCB1;CCND3;CEP250;MAX;PLK2;CUL2;CEP78;PPP2R2D;NES;LATS2;HAUS8;CHMP4B;TPD52L1;CCNY;PPP1R12A;CDC16;DCTN1;DCTN3;CSNK1D;PAFAH1B1;HAUS6;FBXW11;CDK6;GSPT1;CEP41;ALMS1;PLK4;PCM1;CACUL1;CETN2;CNTRL;CEP152;CCND1;TACC3;CDK14;CDKN2C;ODF2;CDC25A;HSP90AA1;PCNT;CEP131;AKAP9;AJUBA;CCNG1;CCNE2;E2F3;KHDRBS1;FBXL22;PLK3;ANAPC7;CDKN3;CCNJ;DYNLL1;ARPP19;CDKN2B;CCNH;HAUS1;BORA;HINFP
prerank,positive regulation of neurogenesis (GO:0050769),0.3206892670680022,1.235313229869033,0.13004484304932734,0.5725056406273169,1.0,14/68,13.54%,PTPRD;IL1RAPL1;ROBO2;OPRM1;MME;ROBO1;CDKL5;NTRK2;SLITRK1;VEGFA;GPER1;FZD3;PLXNA2;PLXNA1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.4639824044352384,-1.2349463038354886,0.21102661596958175,0.442941667749427,1.0,12/15,47.15%,IL17RA;GBP5;NOD2;STAT3;TICAM1;TLR6;HIF1A;CARD9;TLR4;TNF;IL6;MYD88
prerank,positive regulation of phospholipid transport (GO:2001140),0.5121742903921295,1.2347754967222868,0.2111368909512761,0.5721905133160697,1.0,3/10,14.63%,PRELID1;TRIAP1;APOE
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.4372869827690996,-1.2344240718526427,0.18661971830985916,0.44369728451003915,1.0,6/18,15.56%,ASH1L;SETD2;SUV39H1;SETD3;EHMT1;PRDM9
prerank,negative regulation of anoikis (GO:2000811),-0.46453635775192154,-1.2340767563009303,0.20475319926873858,0.44397095466237957,1.0,5/14,12.19%,ITGB1;CAV1;MCL1;PTK2;NOTCH1
prerank,regulation of type I interferon production (GO:0032479),-0.31429416774701435,-1.233885309237749,0.12589928057553956,0.44398571546954685,1.0,30/84,25.93%,CREBBP;IFIH1;TRIM25;TRIM56;RNF125;TAX1BP1;NFKB1;STAT6;MRE11;IRF1;UBA7;IKBKE;IRAK1;LRRFIP1;TRAF3IP1;POLR3F;TNFAIP3;ILRUN;CGAS;CTNNB1;GPATCH3;NLRC5;MAVS;PRKDC;RNF216;RELA;DHX9;IRF7;POLR2L;POLR2H
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.4452509928836036,-1.233577989414589,0.19133574007220217,0.44423289092359763,1.0,4/18,10.11%,ESR1;EGFR;BMP4;TP53
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.443979551858407,-1.233288765812082,0.22419928825622776,0.4444465918489028,1.0,3/17,6.51%,PODXL;ADAM9;TGFB2
prerank,methylguanosine-cap decapping (GO:0110156),0.5084272507461858,1.23291492458783,0.23094170403587444,0.5753155718239515,1.0,2/10,3.94%,PATL2;DCPS
prerank,negative regulation of phosphorylation (GO:0042326),-0.3165455344599115,-1.2323877831725376,0.11524822695035461,0.4458992343811239,1.0,25/85,21.55%,DAB2IP;CBFA2T3;LYN;CORO1C;LRRK2;NIBAN1;CDKN1B;PPARA;LRP6;SLIT2;BMP4;ROCK1;PRKRIP1;OCLN;HDAC4;PTPN13;CHP1;TRAF3IP1;DNAJC10;BMP7;CDK5RAP3;PRKDC;PTEN;WARS1;CDKN2C
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.34335425285887017,-1.2322731439169046,0.13588850174216027,0.4457132517138861,1.0,13/57,11.35%,DAPK1;NOD1;UACA;MAP3K5;DDX3X;TNFSF10;PPM1F;ARL6IP5;ASPH;CASP8;PERP;BCAP31;SOX7
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.33955496742420654,-1.2321346514351454,0.1310592459605027,0.4455812480071543,1.0,19/62,17.77%,AKAP13;RAC1;ARHGEF3;LYN;NET1;F11R;SHOC2;PRAG1;NGF;NOTCH2;RAPGEF1;JAK2;NOTCH1;PIK3CB;GRB2;MAP4K4;IGF1;ALS2;ADGRG1
prerank,eye development (GO:0001654),-0.34325345030063353,-1.2318467999264273,0.15818181818181817,0.4457003082984555,1.0,17/54,16.81%,PBX1;RAB3GAP1;SH3PXD2B;SMOC1;COL5A1;PBX3;NIPBL;TGFB2;RBP4;COL5A2;SIPA1L3;LAMA1;SHROOM2;FOXC1;SKI;FREM2;HIPK1
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.471675623368748,-1.2307737594990042,0.18971631205673758,0.44755124738273655,1.0,2/14,4.57%,OSMR;IL6ST
prerank,regulation of phosphorylation (GO:0042325),-0.2957296189100582,-1.2306172357054084,0.08453237410071943,0.4474822722936971,1.0,32/120,19.24%,ITGA6;LYN;CORO1C;THBS1;APP;NUP42;RAE1;EGFR;CDKN1B;RANBP2;ZBTB7A;PTK2;NUP98;BMP4;CDH5;SEC13;ROCK1;PRKRIP1;LDB1;STAT2;ILK;FNIP2;PSEN1;NUP153;PTGES3;MIF;TPR;BMP7;NLRC5;NUP214;IKBKB;PPP2CA
prerank,V(D)J recombination (GO:0033151),-0.5122935339788091,-1.2306075552938922,0.2333965844402277,0.44706863989394974,1.0,6/11,24.66%,XRCC4;TCF3;PRKDC;LIG4;LIG1;HMGB1
prerank,positive regulation of type I interferon production (GO:0032481),-0.32233846888836687,-1.2301167520454819,0.11839708561020036,0.4477013057761834,1.0,38/73,37.30%,CREBBP;IFIH1;TRIM56;SETD2;DDX3X;NFKB1;STAT6;MRE11;IRF1;IRAK1;LRRFIP1;FLOT1;POLR3F;CGAS;CTNNB1;MAVS;PRKDC;PTPN11;HSP90AA1;RELA;DHX9;IRF7;POLR2L;POLR2H;POLR3GL;RIOK3;TOMM70;POLR3K;IRF5;POLR2E;CD14;POLR3A;TBK1;TLR2;TLR8;GAPDH;G3BP1;NFKB2
prerank,positive regulation of exosomal secretion (GO:1903543),0.45313771275523784,1.2299621204878097,0.20501138952164008,0.5815285873735377,1.0,7/15,18.92%,SMPD3;HGS;TSG101;ATP13A2;SDC4;CHMP2A;VPS4B
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.5035671777954851,-1.2299272099286007,0.2076923076923077,0.4477220530958137,1.0,5/11,17.32%,SP100;TP53;KAT5;MAD2L2;TFAP4
prerank,carboxylic acid transport (GO:0046942),-0.3399828998207548,-1.2297881236434933,0.13457943925233645,0.4476108076956877,1.0,19/55,24.20%,SLC6A6;SLC7A1;SLC7A5;SLC16A12;SLC38A5;SLC16A9;SLC16A1;SLC1A5;SLC17A5;SLC13A3;SLC16A6;SLC36A4;SLC1A1;SLC6A7;SLC1A4;SLC3A2;SLC66A1;SLC38A6;SLC16A13
prerank,regulation of RNA splicing (GO:0043484),-0.325000812540743,-1.2297256927916838,0.14028776978417265,0.4473195688037187,1.0,25/69,22.21%,MBNL1;MBNL2;DYRK1A;ZNF326;AHNAK;METTL4;PIK3R1;FUS;AHNAK2;ERN1;CELF1;RBM39;HNRNPF;SON;CLK3;ZPR1;RBM20;JMJD6;SRPK2;SRSF3;PTBP3;SRSF10;TRA2B;CWC22;METTL16
prerank,protein localization to plasma membrane (GO:0072659),0.29165956232670787,1.2296146717863439,0.08354430379746836,0.5806624605108438,1.0,29/129,11.33%,KCNIP4;ABCA12;DPP10;MAP7;ANK3;DPP6;CCDC88A;ANK1;RAB15;EPB41L3;TSPAN15;PKP2;RAB40C;TNIK;ATP1B1;RAB3C;CACNB3;WNK3;CD81;NECTIN3;MYO5A;ZFYVE27;SPTBN4;TESC;C2CD5;RAB3A;TSPAN32;PPIL2;NKD2
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.4740785512135834,-1.2293694775067674,0.19814814814814816,0.44768256302463466,1.0,7/14,23.01%,KMT2E;SMAD4;PRDM9;DNMT1;CTNNB1;BRCA1;WDR5
prerank,ubiquinone metabolic process (GO:0006743),-0.47046467679170206,-1.2291515082573718,0.18579234972677597,0.4477877488040972,1.0,6/15,19.31%,FDXR;COQ9;UBIAD1;COQ6;COQ2;COQ8B
prerank,positive regulation of heart rate (GO:0010460),-0.45163566382758474,-1.2291056347060434,0.19144981412639406,0.4474646086249731,1.0,8/17,17.16%,ADRA1B;TRPM4;KCNQ1;EDN1;ADM;EDN3;TPM1;SCN3B
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.48561206471064766,1.2286116920088859,0.19111111111111112,0.581522945798678,1.0,7/12,19.04%,BICD1;NINL;BBS4;KIF3A;CEP19;HOOK3;CCDC120
prerank,regulation of endocytic recycling (GO:2001135),0.493231522211341,1.228608569443921,0.21218961625282168,0.579783220100637,1.0,6/11,12.18%,ATP9A;PLA2G3;SORL1;PLA2G4E;EIPR1;INPP5F
prerank,lipoprotein biosynthetic process (GO:0042158),-0.49660713767962816,-1.2285318940082233,0.19891500904159132,0.44830355417393847,1.0,4/11,20.12%,ATG7;ATG10;WIPI1;WDR45B
prerank,regulation of cartilage development (GO:0061035),-0.4433256625540016,-1.2285121539661754,0.2184557438794727,0.44791914830629553,1.0,5/18,16.33%,ZBTB16;BMPR2;BMP4;WNT11;TRPS1
prerank,negative regulation of cell growth (GO:0030308),-0.2992791061369472,-1.22850209131176,0.10307414104882459,0.44752464596785546,1.0,41/121,25.55%,APBB2;SMARCA2;ACVRL1;RB1;DCUN1D3;BMPR2;SH3BP4;DDX3X;PTPRJ;SOX17;CDKN1B;VGLL4;CRLF3;SLIT2;TGFB2;DIP2B;GSK3A;SMAD4;TP53;DCBLD2;SEMA3G;WNT11;ULK2;ST7L;CCN3;RERG;NPR1;OSGIN2;HYAL2;PPP2CA;BCL6;CDKN2C;CAPRIN2;FHL1;MSX1;SERTAD2;HSPA1B;GNG4;APBB1;SIPA1;SERTAD3
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.2678374045020612,-1.2284393766488566,0.048027444253859346,0.44723180922384875,1.0,64/259,19.61%,ABCC4;ABLIM1;RAPGEF2;ITGB1;EXOC6;FGD5;ASAP1;FGD6;PARVB;CD2AP;RAC1;DNM3;PARVA;NTN1;FNBP1L;EXOC4;RAB1A;EHD2;PTPDC1;SSX2IP;CEP250;IFT140;CDC14A;RAP1A;WDR11;EZR;RAB11FIP3;FXYD5;RAP1B;EXOC2;S1PR1;MYLK;PDE6D;FLNA;EMP1;EHD1;WDR35;GALNT11;ANO6;RAB8B;NOTCH1;IFT52;CFAP44;RAB23;TRAF3IP1;CEP41;MAP4K4;EXOC8;FUZ;DZIP1L;VSTM5;NUDCD3;EHD4;RAB11A;HDAC6;CFAP298;GOLPH3;PLK4;PCM1;RAP2A;TMEM17;KIF3B;IFT43;RAP2C
prerank,RNA export from nucleus (GO:0006405),-0.30550461161710124,-1.2282721394279874,0.12431444241316271,0.44719879016061337,1.0,33/100,24.61%,SRSF11;NUP42;RAE1;SARNP;RANBP2;THOC2;UPF3B;THOC7;NUP98;UPF2;SEC13;AGFG1;DDX39B;DHX38;NUP153;SLU7;MCM3AP;HNRNPA1;TPR;THOC3;THOC1;NUP214;NXT1;FIP1L1;SRRM1;RNPS1;GLE1;SRSF3;NUP188;ALKBH5;POLDIP3;SMG6;NXF1
prerank,protein localization to mitochondrion (GO:0070585),-0.5037507726268248,-1.22821114942859,0.23992994746059546,0.44691760507271794,1.0,3/11,9.84%,LRRK2;COX18;AKT1
prerank,positive regulation of phagocytosis (GO:0050766),-0.3514011628527875,-1.227952055277528,0.1596330275229358,0.4470442835333422,1.0,20/47,31.45%,IL15;MERTK;PTPRJ;GAS6;MYO18A;RAB27A;ANO6;ABCA7;LMAN2;TULP1;GATA2;PTPRC;IL15RA;CD300LF;FCER1G;TREM2;IL2RG;AHSG;RAB31;PLA2G5
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.3427620468967399,-1.2278522500678488,0.15070921985815602,0.44682002780152996,1.0,21/53,26.54%,EYA4;ATM;UIMC1;SPRED2;EGFR;PRKCD;BABAM2;RNF168;ERCC8;HIC1;CEBPG;BRCC3;RPS3;NSMCE4A;BRCA1;TRIM28;MSX1;DHX9;FXR1;ERCC6;FGF10
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.506059125718411,-1.2277352339770178,0.21755027422303475,0.44663924201597566,1.0,3/11,5.09%,LRP5;TBX1;TGFBR2
prerank,negative regulation of protein binding (GO:0032091),-0.3232742782206594,-1.2275854603879424,0.13986013986013987,0.446556758382421,1.0,17/71,15.77%,CAV1;DAB2;GSK3B;LRRK2;PRKCD;ROCK1;ATP2A3;NES;AKT1;ZFPM1;HFE;ACTB;ITGA4;MAPK8;CTSZ;MITD1;PEX14
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.4792974281523241,-1.226861636623517,0.1920152091254753,0.44766678169761537,1.0,3/13,8.44%,NRP2;PLXND1;PLXNA4
prerank,cellular response to interferon-beta (GO:0035458),-0.46933137298424266,-1.2268366688805494,0.2116788321167883,0.4472996919954,1.0,7/14,35.23%,UBE2K;IRGM;IRF1;IFITM2;TRIM6;CDC34;UBE2G2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.39693665049604426,-1.2268051663492454,0.17032967032967034,0.44695115938663244,1.0,6/30,7.55%,AKAP13;RAC1;ARHGEF3;NET1;F11R;PRAG1
prerank,protein modification by small protein removal (GO:0070646),-0.2720137164934032,-1.2266614235723017,0.07678571428571429,0.4468425082904461,1.0,91/252,27.05%,SENP1;USP9X;ESR1;ASXL1;SMURF2;IFIH1;KAT2B;PSMA2;UIMC1;USP24;BIRC3;NFKBIA;TRRAP;STAMBP;PSME2;SMAD1;SMAD2;JOSD1;PSMB4;USP2;SMAD4;CLSPN;USP13;TP53;OTUD1;USP40;INO80E;SMAD7;OTUD4;USP15;INO80D;RHOA;USP18;ACTB;ATXN3;BABAM2;PSMC2;HCFC1;TNFAIP3;VCPIP1;USP34;TADA3;PSMB2;USP10;PSMB1;FOXO4;SENP2;INO80B;PSMA8;BRCC3;RAD23A;KDM1B;IKBKG;PSME1;BAP1;USP7;JOSD2;ADRM1;UCHL1;PTEN;USP1;PSMD4;BRCA1;ATXN7;COPS7A;EIF3F;OGT;MDM2;PSMA7;CDC25A;KEAP1;YY1;MBD6;SENP6;BECN1;SUDS3;USP16;RIPK1;STAM2;COPS8;PSMD5;USP12;COPS4;MAP3K7;INO80;PSMB10;TNIP1;APC;TOMM20;PSMA3;USP19
prerank,aminoglycan biosynthetic process (GO:0006023),0.34458937790237004,1.2261406839109041,0.16083916083916083,0.5848252516713393,1.0,10/49,7.93%,GPC5;B3GALT1;HS3ST6;HS3ST5;B3GALT5;HS6ST2;GPC1;GALNT5;B4GALT7;HS3ST2
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.47413236201567754,-1.2260000887784928,0.22686025408348456,0.44786131180597827,1.0,2/14,2.95%,DAB2IP;PTPN1
prerank,regulation of mitochondrial fission (GO:0090140),-0.41313330769332735,-1.2256965839409106,0.2058319039451115,0.4481345413003126,1.0,7/24,12.94%,RALBP1;LRRK2;KDR;MIEF1;BNIP3;STAT2;MIEF2
prerank,negative regulation of lipid catabolic process (GO:0050995),0.4335339960622287,1.225668655643258,0.20386266094420602,0.5844405821444373,1.0,6/17,15.13%,PDE3B;BSCL2;SORL1;ADRA2A;GPLD1;APOC1
prerank,amino sugar biosynthetic process (GO:0046349),-0.4978963714552804,-1.2250056329542338,0.2182468694096601,0.4492297587933351,1.0,4/12,13.52%,GFPT2;GNPDA2;GNPNAT1;UAP1
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.3022952401811424,-1.2249221631852238,0.10211267605633803,0.4490162280940455,1.0,34/112,24.95%,FOXP1;CD34;THBS1;IFIH1;APP;PTPRJ;FRMD8;GAS6;LBP;MAPKAPK2;ARHGEF2;PLCG2;NFKBIL1;DICER1;PSEN1;JAK2;LPL;TNFAIP3;ILRUN;MIF;VSIR;IGF1;RARA;MAVS;CCL19;NOD2;PTPRC;PTPN11;ARFGEF2;RIPK1;FZD5;HMGB1;DDT;DHX9
prerank,mRNA export from nucleus (GO:0006406),-0.3049248060577944,-1.2249193181252014,0.11895910780669144,0.4485993343246469,1.0,33/102,24.61%,SRSF11;NUP42;RAE1;SARNP;RANBP2;THOC2;IWS1;UPF3B;THOC7;NUP98;UPF2;SEC13;AGFG1;DDX39B;DHX38;NUP153;SLU7;MCM3AP;TPR;THOC3;THOC1;NUP214;NXT1;FIP1L1;SRRM1;RNPS1;GLE1;SRSF3;NUP188;ALKBH5;POLDIP3;SMG6;NXF1
prerank,regulation of synapse organization (GO:0050807),0.39534633355520166,1.2248584234191564,0.17321016166281755,0.5847941242179102,1.0,7/26,9.85%,IL1RAPL1;CTNNA2;CDKL5;CLN3;MDGA1;CAMK2B;SLITRK4
prerank,protein deubiquitination (GO:0016579),-0.27144818456569086,-1.2244535569421344,0.06401384083044982,0.44919988842618563,1.0,79/242,23.87%,USP9X;ESR1;ASXL1;SMURF2;IFIH1;KAT2B;PSMA2;UIMC1;USP24;BIRC3;NFKBIA;OTULIN;TRRAP;MINDY1;STAMBP;PSME2;SMAD1;SMAD2;JOSD1;PSMB4;USP2;SMAD4;CLSPN;USP13;TP53;OTUD1;USP40;INO80E;SMAD7;OTUD4;USP15;INO80D;RHOA;USP18;ACTB;ATXN3;BABAM2;PSMC2;HCFC1;TNFAIP3;VCPIP1;USP34;TADA3;PSMB2;USP10;PSMB1;FOXO4;INO80B;PSMA8;BRCC3;RAD23A;KDM1B;IKBKG;PSME1;BAP1;USP7;JOSD2;ADRM1;UCHL1;PTEN;USP1;PSMD4;BRCA1;ATXN7;EIF3F;OGT;MDM2;PSMA7;CDC25A;KEAP1;YY1;MBD6;BECN1;SUDS3;USP16;RIPK1;STAM2;PSMD5;USP12
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.5098387876361199,-1.2241468590865434,0.21245421245421245,0.4494552323434103,1.0,3/10,9.84%,PRKCE;IRS1;AKT1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.5100087053295146,-1.2238312487399696,0.2344582593250444,0.44977271392028034,1.0,3/11,10.11%,EGFR;BMP4;TP53
prerank,positive regulation of cytokine production (GO:0001819),-0.2653423259284505,-1.2230232757597,0.048013245033112585,0.4510774836936702,1.0,116/292,34.60%,FOXP1;SPTBN1;IL1R1;AFAP1L2;CREBBP;CD34;NOD1;CD200;SLC7A5;IFIH1;APP;IL15;RAB1A;PRKD2;IL6ST;IL6R;NFKB1;PLCB1;STAT6;LBP;MRE11;ARHGEF2;FLT4;IRF1;PLCG2;PIK3CD;RGCC;ZFPM1;IRAK1;LPL;LRRFIP1;FLOT1;IL17RA;CD40;ATF4;POLR3F;AGPAT1;CGAS;MIF;ROCK2;C1QTNF3;IL16;RARA;ANXA1;CTNNB1;ARNT;GBP5;PAEP;CEBPG;MAVS;SOD1;RPS3;CCL19;LURAP1;HYAL2;NOD2;PTPRC;PRKDC;F3;BRCA1;PTPN11;RELA;SERPINE1;HPSE;RIPK1;EIF2AK3;MAPK11;CD276;FZD5;CYP1B1;STOML2;HSPA1B;HMGB1;MAP3K7;IL7;DHX9;IRF7;POLR2L;POLR2H;ADAM17;F2R;LGALS9;POLR3GL;HILPDA;IL12RB2;PNP;FCER1G;TRIM6;HMOX1;POLR3K;RUNX1;MAPK14;DDIT3;TNFRSF14;TGFB1;LILRB1;STAT3;TICAM1;TLR6;RFTN1;SULF1;IRF5;CEBPB;FGR;TLR1;NOS2;RAB7B;TLR5;POLR2E;CD14;IL1A;TSLP;NLRP3;POLR3A;PARK7;TBK1
prerank,adenine nucleotide transport (GO:0051503),-0.4448742600519935,-1.2229709048967266,0.208955223880597,0.4507844238334767,1.0,4/17,7.79%,ABCC4;LRRC8C;ABCC6;LRRC8D
prerank,transition metal ion transport (GO:0000041),-0.3704566771244999,-1.2219930201597329,0.18330308529945555,0.4526006588713096,1.0,10/35,16.74%,ATOX1;SLC31A1;TFRC;SLC30A10;TRPC4;SLC39A8;TRPC6;SLC30A5;COX17;TRPC3
prerank,ureteric bud development (GO:0001657),0.4385080263151531,1.221886115463472,0.21666666666666667,0.5915656542459407,1.0,6/17,7.53%,ROBO2;LHX1;NPNT;OSR1;WT1;FGFR2
prerank,protein transport (GO:0015031),-0.26051674099518063,-1.2216670038674773,0.030716723549488054,0.4528834543551253,1.0,94/332,22.66%,SPTBN1;TBC1D4;SEC31A;RUFY1;CALCRL;MYH9;ARF3;RAMP1;RAB7A;ARCN1;RAB1A;GOLPH3L;TLK1;TFRC;SCAMP2;SYNRG;TBC1D1;RAB5B;DNM2;STX3;TBC1D2B;MACF1;TANGO6;STEAP3;MON1A;TBC1D8B;WDR11;SNX9;SLC10A7;USP6NL;SEC13;COPG1;RAB5A;TBC1D30;ARRDC1;ARHGEF2;STX8;TBC1D14;SCFD1;ARL6IP5;TVP23A;RAMP2;TBC1D22B;COPA;RAB3GAP2;ARHGAP1;EHD1;TXNIP;TBC1D22A;HFE;VPS26A;RAB8B;ARL4A;GOLGA4;SLU7;ATP6V1E1;CHMP2B;MCOLN1;VPS45;REP15;RAB23;RAB24;RAB32;TOM1;SNX8;HERC2;SIL1;AP4M1;HDAC6;LAMP2;TMED5;GOLPH3;FAM91A1;ATP6V0A1;STX12;TBC1D8;VPS26C;SCAMP1;AP3B1;KIF3B;TBC1D17;TBC1D25;PPARG;ARL5C;KIF13A;CTSA;VAMP2;SNX13;PREB;TBC1D12;ATP6V1H;EVI5;SAR1A;ARL4C
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.38374585530785577,-1.221587254745581,0.19330855018587362,0.45265303633961923,1.0,12/30,24.55%,EIF3H;TLK2;FHIT;RYBP;HFE;SGTA;N4BP1;GIPC1;USP7;OGT;TRIM39;TAF9
prerank,epidermal cell differentiation (GO:0009913),-0.3616015714324707,-1.2212025163332043,0.16785714285714284,0.45307976290563867,1.0,15/41,22.98%,BCR;ADAM9;HDAC1;MED1;ERCC2;WNT16;TXNIP;ERCC3;JAG1;ASAH1;ANXA1;CTNNB1;EPHA2;USH2A;PIP5K1A
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.4854681262039876,-1.220202968999369,0.2140221402214022,0.454880136137399,1.0,5/13,18.97%,KDR;NAMPT;EDN1;JAK2;NOD2
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5005308471042387,-1.2198986445728175,0.2354014598540146,0.45511053706903454,1.0,4/11,8.96%,MAP3K5;STK24;PRKCD;ARL6IP5
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.38459909362874595,1.219336038263507,0.17926565874730022,0.596812500258275,1.0,5/27,9.50%,HTR2C;CALCA;GRM1;C3AR1;GPR65
prerank,response to interleukin-1 (GO:0070555),-0.3225713131358661,-1.2192247093532387,0.14160839160839161,0.4561184329534171,1.0,22/73,24.55%,DAB2IP;IL1R1;APP;CCL25;NFKB1;IRAK1;HDAC4;CD40;RC3H1;USP10;IRAK2;ANXA1;IGBP1;CCL19;HYAL2;RELA;HAS2;MAPK11;GBP3;ADAMTS7;PTGIS;TAF9
prerank,regulation of axon extension (GO:0030516),0.366600863101075,1.2183811519641083,0.19672131147540983,0.5976151430587436,1.0,14/37,14.63%,L1CAM;SHTN1;CDKL5;NRCAM;LIMK1;MAP2;MAPT;RTN4;PTPRS;ZFYVE27;MAG;TRIM46;OLFM1;APOE
prerank,positive regulation of embryonic development (GO:0040019),0.43362357617408276,1.2183152817509766,0.20642201834862386,0.5960534157247935,1.0,3/19,4.20%,TENM4;LHX1;OSR1
prerank,positive regulation of developmental growth (GO:0048639),0.3398117685928461,1.2182990429956209,0.168141592920354,0.5943388862084364,1.0,15/49,15.07%,L1CAM;SYT1;RIMS2;RIMS1;SHTN1;CDKL5;LIMK1;CPNE9;MAPT;ZFYVE27;RNF157;SYT4;BDNF;SYT3;UNC13A
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.33985031304023666,-1.2178609087967711,0.16007194244604317,0.45873857645240596,1.0,20/50,24.97%,NXN;CAV1;DTX3L;IVNS1ABP;ABL1;AKT1;SMAD7;SPOPL;CHP1;TNFAIP3;N4BP1;SENP2;RPS3;SOX4;OGT;SH3RF2;ARRB1;HSPA1B;PINX1;ADGRB1
prerank,positive regulation of organelle organization (GO:0010638),-0.37670177135684396,-1.2175337632848227,0.17557251908396945,0.4590747204119062,1.0,14/32,31.45%,RAB3GAP1;GSK3B;ANXA2;STX18;IRGM;RAB3GAP2;SORBS3;ANXA1;LIG4;KATNBL1;DOC2B;TREM2;SYNJ1;PLA2G5
prerank,mesenchyme development (GO:0060485),-0.45904434445220155,-1.2164458375055902,0.22535211267605634,0.46103306809824346,1.0,8/15,28.59%,PKD2;BMPR2;BMP4;WNT11;BMP7;BMP2;FOXF1;TGFBR1
prerank,negative regulation of cell adhesion (GO:0007162),-0.3151039367697787,-1.2150667051701873,0.14835164835164835,0.4636986873794261,1.0,29/72,27.14%,SEMA6A;ACVRL1;PODXL;ACER2;CBLL1;GCNT2;FZD4;PTK2;ARHGDIA;PLXND1;PLXNA4;CDH1;ADAM10;RASA1;NOTCH1;RHOA;JAG1;ANGPT1;PTPRC;TGFBI;SERPINE1;FZD7;CYP1B1;SEMA5A;PLXNB1;SIPA1;DMTN;RND1;SNAI2
prerank,glycine transport (GO:0015816),0.506036351828199,1.2148882437348163,0.23382045929018788,0.6020656632730322,1.0,3/10,9.20%,SLC7A8;SLC36A2;SLC6A5
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.4055599853061463,-1.2147551621213728,0.17513134851138354,0.46394772691546576,1.0,18/24,45.32%,IL6ST;FLT4;ATF4;ARNT;BRCA1;HPSE;EIF2AK3;CYP1B1;TGFB1;SULF1;IL1A;HIF1A;RORA;GATA4;ISL1;CCBE1;NODAL;IL6
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.26230107774634126,-1.2146647995792705,0.05374592833876222,0.4637209381171696,1.0,122/341,29.34%,FBXL7;WWP1;PELI1;USP9X;NEDD4L;ZNRF1;SMURF2;UBE2K;TRIM25;CNOT4;PSMA2;RNF111;FBXL17;DTX3L;ZNRF3;SMURF1;RNF125;RNF213;RBX1;CBL;RNF43;UBE4B;CUL3;NEDD4;RNF40;PSME2;RNF115;RNF144B;BIRC6;ARRDC1;SPSB1;PSMB4;TRIP12;GSK3A;UBE2D3;MIB1;FEM1A;AREL1;NTAN1;TNFAIP1;RMND5A;CDC16;SPOPL;ARMC8;ANAPC16;KAT5;ATXN3;UBR4;FEM1C;UBE4A;FBXW11;KLHL25;APPBP2;RNF168;PSMC2;RC3H1;RNF167;MYLIP;TNFAIP3;FEM1B;ERCC8;PSMB2;UBE2L3;PSMB1;AGAP3;TRIM13;CTNNB1;KCTD10;UBXN11;PSMA8;SPOP;KLHL3;RAD23A;SIAH1;PSME1;TRIM3;RNF4;ADRM1;BUB1B;UCHL1;TBL1X;WWP2;HERPUD1;ELOC;PSMD4;HUWE1;UBE2R2;MDM2;BUB3;PSMA7;KEAP1;NDFIP2;RNF216;HACE1;NFE2L2;FZR1;PSMD5;ARRB1;RCHY1;RNF146;TRPC4AP;MAEA;FBXL22;ZFAND2A;ANAPC7;DTL;PSMB10;ARIH2;RNF122;UBXN2A;PSMA3;KIF14;RNF34;PPP2R5C;RNF114;VPS37B;UBE2I;UBA1;ATE1;RNF14;RNF187;ANAPC11
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.4045868046572514,-1.21404002330874,0.21206581352833637,0.46467725128924253,1.0,13/24,23.50%,CTNNA1;MEF2A;BOC;ABL1;MEF2C;CDON;BNIP2;TCF3;MAPK12;CTNNB1;SPAG9;MYOCD;MAPK11
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.39803560750608985,1.2139539654483704,0.20474137931034483,0.6027783748439851,1.0,9/23,16.53%,HSD17B12;FAR1;ACSBG1;HACD1;ACSL3;ACSL6;TECR;ACOT7;HACD2
prerank,regulation of T cell mediated immunity (GO:0002709),-0.5189220622954974,-1.21326040802586,0.2318840579710145,0.46594349962520776,1.0,2/10,5.58%,TRPM4;TNFRSF1B
prerank,gland development (GO:0048732),-0.33503259433401794,-1.2122625404676204,0.17465753424657535,0.4677616785810642,1.0,27/59,28.59%,CAV1;PKD2;LSR;TBX1;MSN;TGFBR3;HES1;SIX1;EZR;NOTCH4;PRKCSH;WNT11;ANXA1;ARID5B;ARHGAP35;CDK5RAP3;CEBPG;SOD1;CITED2;NF1;EPHB3;TBX3;CEBPA;FGF10;STRA6;MET;TGFBR1
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.40803881439652717,-1.2121131153679527,0.2088495575221239,0.4676854731877216,1.0,12/22,30.15%,MED1;PTPRK;STXBP4;NOTCH2;PRKD1;FGF7;KLF9;CRNN;ZFP36L1;FGF10;SNAI2;SRSF6
prerank,regulation of blood circulation (GO:1903522),-0.3696332650524851,-1.210495249150948,0.1753472222222222,0.47092300522802005,1.0,9/34,18.24%,ACE;KCNQ1;ECE1;TBX2;AGTR1;S100A1;TPM1;KCNMB2;PLN
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.36737166153946277,-1.2104128152180824,0.17803030303030304,0.47067488034396726,1.0,14/37,24.55%,EIF3H;TLK2;FHIT;RYBP;HFE;SGTA;N4BP1;RPL5;GIPC1;USP7;OGT;RPS7;TRIM39;TAF9
prerank,potassium ion homeostasis (GO:0055075),0.3930312899290502,1.210324914724666,0.20666666666666667,0.6109783791842528,1.0,6/23,8.71%,KCNMA1;ATP1A2;ATP12A;ATP1B1;SLC12A5;ATP4A
prerank,mRNA processing (GO:0006397),-0.26071397634146215,-1.2101184295265088,0.07191780821917808,0.47091460156425363,1.0,97/287,28.50%,MNAT1;SRSF11;PRPF3;METTL14;SMU1;SARNP;PSPC1;CWF19L2;RSRC1;HNRNPA0;THOC2;RBM5;RPRD2;NOVA2;HNRNPR;UPF3B;FUS;THOC7;PRPF6;SF3B6;SPEN;ERN1;RBM19;HNRNPM;POLR2G;PHF5A;CELF1;DDX39B;SF3B1;ERCC2;PUF60;PRPF31;CPSF7;SNIP1;HNRNPA3;HNRNPUL1;EFTUD2;DHX38;DBR1;HNRNPF;SON;SFPQ;SLU7;CTNNBL1;SNRPE;ERCC3;SF3A1;HNRNPA1;SYNCRIP;THOC3;SRSF12;THOC1;CWC25;RBM4B;ZMAT5;BUD13;CD2BP2;FIP1L1;TFIP11;SRRM1;NONO;RNPS1;SRSF3;SRSF10;TRA2B;LSM3;RBM6;CWC22;PPIH;CMTR2;ALKBH5;RBM15;PCBP1;SUPT4H1;POLR2C;GEMIN7;USP39;POLDIP3;RNPC3;PDCD7;SF3B5;GCFC2;DHX9;POLR2L;PRPF40B;POLR2H;PRPF18;HNRNPL;HNRNPD;GTF2H3;PABPC1;HNRNPU;SCAF11;TXNL4A;LSM2;CCNH;CWC27
prerank,microvillus organization (GO:0032528),-0.4855655081543945,-1.209950870583263,0.22445255474452555,0.47088901308685976,1.0,8/13,19.61%,RAPGEF2;RAP1A;EZR;FXYD5;RAP1B;MAP4K4;RAP2A;RAP2C
prerank,regulation of anoikis (GO:2000209),-0.4289287250683946,-1.20979490131124,0.2224334600760456,0.4707872012423488,1.0,5/19,6.61%,ITGB1;CAV1;MCL1;SIK1;PTK2
prerank,regulation of blood coagulation (GO:0030193),-0.39857858616675756,-1.2097149879047762,0.21404109589041095,0.47054240933746255,1.0,12/27,26.84%,ST3GAL4;CAV1;CD34;THBS1;ENPP4;EDN1;TFPI;SERPINE2;SERPINE1;HPSE;DMTN;F2R
prerank,icosanoid secretion (GO:0032309),-0.48705152271895813,-1.2095592540322848,0.2239089184060721,0.470463012998732,1.0,2/12,4.51%,ABCC4;ACE
prerank,protein localization to cell junction (GO:1902414),-0.41527701608999007,-1.2094402468071828,0.19666048237476808,0.4702881060192488,1.0,7/22,7.60%,TJP1;FERMT2;HEG1;JAK1;PAK2;CGNL1;TJP2
prerank,negative regulation of chemotaxis (GO:0050922),-0.3791434489722687,-1.2092720829755033,0.18998272884283246,0.47024477756156013,1.0,13/31,18.35%,SEMA6A;SEMA3C;SEMA7A;THBS1;SLIT2;NOTCH1;SEMA3G;SEMA6B;SEMA4C;DUSP3;SEMA5B;SEMA4A;SEMA3E
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.34813800233342235,1.2089994232281152,0.17647058823529413,0.6128179888624901,1.0,8/38,8.20%,CTNNA3;SCN1B;KCNA5;KCNJ3;CACNA2D1;PKP2;CACNA1D;SCN5A
prerank,endodermal cell fate commitment (GO:0001711),-0.5031095531075641,-1.2089451330001488,0.2391713747645951,0.47053053600100986,1.0,3/10,12.45%,SOX17;CDC73;RTF1
prerank,regulation of protein acetylation (GO:1901983),-0.48229520838187334,-1.2086664617687612,0.21666666666666667,0.47072957763931383,1.0,7/12,34.58%,GSK3B;DDX3X;KAT5;RAPGEF3;CEP295;FAM161A;PARK7
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.44351915557998506,-1.20842958713292,0.2271062271062271,0.4708272093298342,1.0,5/17,11.55%,PARD3;SPRED2;PPEF2;DDIT4;SMAD7
prerank,histone H3 acetylation (GO:0043966),-0.35514632881569236,-1.2083729528437372,0.1836007130124777,0.47053459396739417,1.0,14/40,24.76%,LEF1;KAT6B;KAT2B;KAT6A;SGF29;LDB1;TAF5L;TADA3;TRIM16;DR1;JADE2;WDR5;TAF9;MAP3K7
prerank,negative regulation of translation (GO:0017148),-0.31221571283407196,-1.2081533133523659,0.12099644128113879,0.4706012770874413,1.0,32/87,27.04%,DAPK1;RNF139;EIF3E;METTL14;DDX3X;GIGYF2;LARP1;FTO;SAMD4A;PUM1;ROCK1;CELF1;AGO2;IGFBP5;SYNCRIP;BTG2;ROCK2;TPR;RPS3;CAPRIN1;TOB1;METTL16;RPL13A;RBM24;MRPL13;EIF2AK3;FXR1;IGF2BP2;EIF2AK4;CNOT8;NANOS1;CNOT1
prerank,cortical cytoskeleton organization (GO:0030865),-0.359279692838231,-1.207867940143635,0.1884328358208955,0.4708167164654017,1.0,17/41,18.83%,RAC1;RHOBTB1;RND3;DLG1;RHOQ;EZR;PPP2R3C;ROCK1;RHOA;LCP1;RHOC;RHOG;NCKAP1;ROCK2;FMNL2;TRPV4;IKBKB
prerank,regulation of cell death (GO:0010941),-0.3066689571103313,-1.2078373588534157,0.15495495495495495,0.4704573937946163,1.0,37/94,26.56%,FERMT2;ACER2;LRRK2;CDKN1B;TNFRSF1B;NCK1;BMP4;BNIP3;PRKD1;CELF1;WNT16;CHMP4B;AXIN2;ACER3;FGF2;RAD18;CHP1;WNT11;CCN5;PDE12;ATG5;CCN3;CTSZ;BMP7;TRIM13;SOX4;RRAS2;SLC25A24;CCN1;PARP16;BECN1;TXNDC12;HSPA1B;NOA1;LRP1;APC;VPS35
prerank,protein export from nucleus (GO:0006611),-0.3934033666949298,-1.2077700841736612,0.2246376811594203,0.4701798800620984,1.0,9/27,19.14%,NUP42;SMURF1;CSE1L;XPO7;CHP1;TPR;XPO4;NUP214;DUSP16
prerank,cation transmembrane transport (GO:0098655),0.34013339311969953,1.2076792911833123,0.18160919540229886,0.6147001478534007,1.0,11/44,11.70%,TRPM3;ASIC2;ATP1A2;SLC7A8;ATP1B1;MFSD12;TRPM1;SLC29A4;SLC6A5;ATP13A2;P2RX3
prerank,myoblast differentiation (GO:0045445),-0.46283308490016645,-1.207307506259923,0.22342342342342342,0.4708177012982629,1.0,8/14,19.87%,MBNL1;RB1;PLEKHM3;JAG1;MAPK12;IGF1;EPAS1;TCF7L2
prerank,cellular protein localization (GO:0034613),-0.2619740472044866,-1.2070372174418125,0.06779661016949153,0.47097169571748315,1.0,90/285,23.82%,TBC1D4;SEC31A;FERMT2;ESAM;ARF3;SH3PXD2B;ID1;ARCN1;LRRK2;RAB1A;SMURF1;EGFR;TLK1;RIC3;SYNRG;NIPBL;TBC1D1;RAB5B;CNTNAP1;STX3;TBC1D2B;COX18;CEP250;TBC1D8B;PTPRK;WDR11;CNTLN;SNX9;ITSN1;USP6NL;SEC13;RAB5A;TBC1D30;ARHGEF2;STX8;TBC1D14;SCFD1;OCLN;FGF7;FLNA;CROCC;TBC1D22B;AXIN2;WIPI1;COPA;FBLN5;RAB3GAP2;EHD1;TBC1D22A;VPS26A;ARL4A;SLU7;ABHD17A;WNT11;VPS45;RAB23;RAB24;RAB32;SNX8;ANGPT1;HERC2;SIL1;AP4M1;HDAC6;CTNNB1;TMED5;FAM91A1;HEY2;RAP2A;STX12;TBC1D8;VPS26C;AP3B1;TBC1D17;TBC1D25;WDR45B;ARL5C;VCL;REEP1;KIF13A;CTSA;SNX13;TBC1D12;EVI5;SAR1A;ARL4C;COPZ1;NPHP1;MYO7A;RAB19
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.479940062416264,-1.2063589174844778,0.2449725776965265,0.4720146699071799,1.0,1/12,0.40%,IL1R1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.4310170470745121,1.2057494953956334,0.2323008849557522,0.6183906245606725,1.0,7/16,22.55%,ACLY;ACACA;ACSS1;SCD5;SCD;ACAT1;HSD17B8
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.45539106099452387,-1.2055750432010874,0.2342007434944238,0.47335306890345125,1.0,7/14,29.20%,ARID2;MRNIP;FUS;TIMELESS;ERCC6;MMS19;RAD51AP1
prerank,negative regulation of cell motility (GO:2000146),-0.29752946824513693,-1.205218439181782,0.1449016100178891,0.47372516053425456,1.0,37/108,21.11%,CLDN5;ENG;ACVRL1;CRK;MITF;ARID2;PTPRJ;SCAI;LDLRAD4;AFDN;TCAF1;STK24;FOXO3;SLIT2;PTPRK;EPHA4;DACH1;CDH1;ZMYND8;SMAD7;FRMD5;LIMCH1;TPM1;DUSP3;WNT11;JAG1;IGFBP5;MIF;FUZ;ADARB1;RAP2A;CITED2;DUSP22;RAP2C;PTEN;NF1;VCL
prerank,response to ATP (GO:0033198),0.42137830470907356,1.2049595896917753,0.22795698924731184,0.6189175320633316,1.0,5/18,14.11%,DGKQ;RYR3;CIB2;P2RX3;TAF1
prerank,UV protection (GO:0009650),-0.5106040785267151,-1.2046369500536176,0.2697841726618705,0.47461051789177344,1.0,6/10,32.94%,ERCC2;CAT;GPX1;SDF4;MFAP4;SCARA3
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.3950208276530809,-1.2037591747538003,0.2078853046594982,0.476231558114858,1.0,6/24,8.56%,DAB2IP;PTPN1;PRKD2;NEDD4;TMEM204;GRB10
prerank,positive regulation of neuron projection development (GO:0010976),0.30264957166166434,1.2029766467458296,0.14320388349514562,0.6226877265949303,1.0,15/85,9.80%,MAGI2;LRRC7;RIT2;SCN1B;TENM3;FUT9;TOX;VLDLR;KIDINS220;NDRG4;CAMK2B;NTRK2;PLA2G3;PLPPR5;STMN2
prerank,regulation of wound healing (GO:0061041),-0.34942772821839935,-1.2027488120904855,0.1678832116788321,0.47808464839132764,1.0,11/42,17.00%,ITGB1;CAV1;PRKCE;CRK;PTK2;OCLN;MYLK;ARFGEF1;FGF2;TNFAIP3;ANXA1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.43823095960405933,-1.2025961078130996,0.21908127208480566,0.4779942045415299,1.0,7/18,11.47%,JAK1;IL6ST;IL6R;CBL;YAP1;SMAD4;JAK2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.38003003601094665,-1.2025131563812697,0.20614828209764918,0.47773850886872266,1.0,11/28,20.09%,ESAM;NAA80;HAX1;FCHSD2;RASA1;ARHGAP28;GBA2;DBNL;ARHGAP35;FCHSD1;CXCL12
prerank,positive regulation of protein kinase activity (GO:0045860),-0.2788903862866305,-1.2024515362063881,0.11552346570397112,0.47743685793007135,1.0,50/148,23.45%,DAB2IP;RAPGEF2;INSR;IQGAP1;PTPN1;PAK2;DDX3X;ACE;TGFBR2;IL6R;GAS6;MRNIP;STK3;IL34;TGFB2;PTK2;IRGM;PRKCD;RASSF2;RAP1A;SNX9;EPHA4;MMD;CLSPN;TAOK3;RPTOR;RHOA;MTCP1;NEDD9;MAP4K4;MARK2;NAB2;TAB2;NOX4;ALS2;CACUL1;CCL19;CENPE;PPP2CA;PTPRC;ITGB3;NRK;MAP2K3;PTK2B;CCN1;HSP90AA1;FCGR1A;PARP16;SYAP1;RALB
prerank,negative regulation of type I interferon production (GO:0032480),-0.3563243970958411,-1.2024057168064626,0.20475319926873858,0.4771176480453929,1.0,15/40,22.72%,IFIH1;TRIM25;RNF125;TAX1BP1;PPM1B;UBA7;IKBKE;TRAF3IP1;TNFAIP3;ILRUN;GPATCH3;NLRC5;MAVS;RNF216;YY1
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5033678723136321,-1.2023425008235884,0.2376599634369287,0.47682386396398835,1.0,3/10,15.36%,IL15;ROCK1;ROCK2
prerank,regulation of membrane repolarization (GO:0060306),-0.4684719591835169,-1.2022941985761335,0.22491349480968859,0.4765080223608141,1.0,5/13,6.70%,CAV1;NEDD4L;KCNJ2;YWHAE;KCNQ1
prerank,regulation of lamellipodium assembly (GO:0010591),-0.3666592237754246,-1.2020558341581176,0.2,0.4766281267775973,1.0,10/34,19.29%,WASF2;RAC1;PIK3R1;SLIT2;PLCE1;OCLN;ABI3;NCKAP1;CAPZB;EPHA2
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.30302228709210327,-1.2020060968923705,0.16145833333333334,0.4763141449974103,1.0,31/87,26.54%,RBFOX2;SPRED2;TBX1;CEP57;CBL;DSTYK;SHOC2;FGF1;HNRNPM;MAPK1;POLR2G;FGF7;HNRNPF;FGF2;TIAL1;GRB2;HNRNPA1;FLRT2;HYAL2;FGFR4;DLL4;PTPN11;KIF16B;FRS2;POLR2C;EGR3;POLR2L;POLR2H;ZFP36L1;FLRT3;FGF10
prerank,embryonic appendage morphogenesis (GO:0035113),-0.48472647650735684,-1.2013500156979933,0.23091603053435114,0.47734172144514603,1.0,3/12,6.51%,MBNL1;LRP6;TGFB2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.4902263851699842,-1.2012376129046487,0.2208029197080292,0.47716490799351396,1.0,5/12,15.49%,RANBP9;ROCK1;PICALM;ROCK2;ABCA7
prerank,cellular response to interleukin-1 (GO:0071347),-0.2849466214215035,-1.2008460856780252,0.10135135135135136,0.4776436740886144,1.0,44/143,24.76%,DAB2IP;IL1R1;PELI1;TAB3;NOD1;RPS6KA5;PSMA2;CCL25;NFKB1;RBX1;NFKBIA;PLCB1;PSME2;PSMB4;MAP3K3;IRAK1;FBXW11;CD40;MAP3K8;PSMC2;RC3H1;PSMB2;USP10;PSMB1;PELI2;TAB2;IRAK2;PSMA8;IKBKG;CCL19;IKBKB;HYAL2;NOD2;PSME1;PSMD4;PSMA7;RELA;HAS2;MAPK11;PSMD5;GBP3;ADAMTS7;PTGIS;MAP3K7
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.4722377518569566,-1.200528830059665,0.24862888482632542,0.4779048627381341,1.0,5/12,17.86%,PTPN14;NEDD4;BMP4;TPR;NUP214
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.5099144857791428,-1.2004368403357584,0.26258992805755393,0.47766294589407704,1.0,3/10,8.35%,DAB2IP;ANXA2;EPHA4
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.4129875900919256,-1.200031144035929,0.213768115942029,0.478154580553664,1.0,8/21,21.08%,NT5C2;NT5E;PDE2A;PDE9A;NT5C1A;HPRT1;HINT1;AMPD3
prerank,cell projection organization (GO:0030030),-0.38319254650490103,-1.2000084079025053,0.20817843866171004,0.4777930298201419,1.0,6/30,6.53%,ITGB1;PARVB;RAC1;RHOJ;PARVA;RHOQ
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.46229259611790086,1.1999742190359854,0.22988505747126436,0.6295136387377575,1.0,2/13,3.86%,B3GALT1;B3GALT5
prerank,endoplasmic reticulum organization (GO:0007029),-0.31653185205416406,-1.1997984527761427,0.16295025728987994,0.4778674117937898,1.0,22/72,21.65%,SEC31A;APP;TMCC1;STX18;LRRK2;EMD;ATL2;TOR1B;SEC16B;UBE2J2;REEP3;GAK;SGTA;VCPIP1;TRAM2;LMAN2;MOSPD3;VAPA;WDR83OS;LPCAT3;REEP1;VAMP2
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.39537106155390034,-1.1997562293283652,0.2037037037037037,0.4775380536995497,1.0,10/26,18.59%,ST3GAL4;ST3GAL2;ALG8;ALG11;B4GALT5;GK5;GAL3ST2;GOLPH3;GBGT1;LARGE1
prerank,autophagy of nucleus (GO:0044804),-0.4385537903455711,-1.1996396780949423,0.21739130434782608,0.4773634268107961,1.0,10/16,34.25%,ATG7;WIPI1;ULK2;ATG5;WDR45B;ATG2A;ATG2B;ATG3;ATG9A;WIPI2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.31692401626705585,-1.1995458773194496,0.14527027027027026,0.4771690170256389,1.0,23/69,24.95%,THBS1;IFIH1;APP;PTPRJ;FRMD8;LBP;ARHGEF2;PLCG2;PSEN1;JAK2;LPL;MIF;MAVS;CCL19;NOD2;PTPRC;PTPN11;ARFGEF2;RIPK1;FZD5;HMGB1;DDT;DHX9
prerank,AMP metabolic process (GO:0046033),0.44831851613867896,1.1991900046695059,0.2399103139013453,0.6299461763091642,1.0,4/13,10.48%,AK9;AK3;ADSS2;ADSS1
prerank,negative regulation of lipid storage (GO:0010888),-0.4204995589809441,-1.1987243415377973,0.2118491921005386,0.47859406132539495,1.0,8/19,28.28%,PPARA;NFKBIA;PPARD;PPARG;ITGB3;PNPLA2;PTPN2;TREM2
prerank,positive regulation of ERAD pathway (GO:1904294),-0.47737776768695517,-1.1986446968860047,0.2710951526032316,0.47835434978424957,1.0,7/13,22.38%,CAV1;USP13;BCAP31;ATXN3;SGTA;HERPUD1;NFE2L2
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.4476976942441012,-1.19857332660217,0.22661870503597123,0.47769823711076065,1.0,7/16,20.17%,ACVRL1;CORO1C;THBS1;FAM107A;BCAS3;DUSP22;PTEN
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.4476976942441012,-1.19857332660217,0.22661870503597123,0.47769823711076065,1.0,7/16,20.17%,ACVRL1;CORO1C;THBS1;FAM107A;BCAS3;DUSP22;PTEN
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.4431616746684992,-1.198518402921291,0.22123893805309736,0.4774154881621424,1.0,7/17,18.37%,ABHD2;NR3C1;MED1;BMP4;UBE2L3;BMP7;TFPI
prerank,relaxation of cardiac muscle (GO:0055119),0.4588188674566118,1.1983643221492262,0.23542116630669546,0.6305182174973174,1.0,5/13,11.91%,ATP1A2;ATP1B1;CHGA;GSN;SLC8A1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.46902254159271956,-1.1982179800050483,0.23655913978494625,0.47765170852046274,1.0,8/13,28.11%,PRPF3;PRPF6;PRPF31;SRSF12;CD2BP2;SRSF10;AAR2;LSM2
prerank,transition metal ion homeostasis (GO:0055076),-0.38467138230878883,-1.1982124571034747,0.22003577817531306,0.47724858395951925,1.0,7/28,14.16%,XIAP;SLC40A1;BDH2;PICALM;HFE;HMOX2;ABCB7
prerank,bone development (GO:0060348),-0.3596279938604489,-1.1980418493268177,0.2040072859744991,0.4771764328633493,1.0,12/39,13.32%,AKAP13;LRP5;PLS3;DYM;SH3PXD2B;LRP6;SLC10A7;TGM2;TP53;RPL13;NOTUM;MYOC
prerank,DNA repair (GO:0006281),-0.2595541681164072,-1.1973523327873083,0.08067226890756303,0.4783590098699753,1.0,102/284,29.66%,MNAT1;PDS5B;SETD2;ATM;UIMC1;DTX3L;PARP4;KMT5B;ABL1;TRRAP;XRCC4;FTO;ASCC1;MRE11;INIP;NABP1;ERCC2;RBBP8;TENT4A;TP53;DOT1L;NSMCE3;ENDOV;PDS5A;POLD3;RAD18;INTS3;OGG1;RPA3;DNA2;KAT5;ATXN3;RPA1;BABAM2;PNKP;XPC;MAPK8;RNF168;ERCC3;VCPIP1;FANCM;BTG2;UBE2V2;ERCC8;MAD2L2;HERC2;SUMO1;POLE2;RFWD3;FANCD2;FANCC;FANCG;HPF1;BRCC3;WRN;CETN2;RAD23A;RPA2;BAP1;PRKDC;RAD54L;PIAS4;TIMELESS;USP1;NSMCE4A;HUWE1;LIG4;FANCL;BRCA1;RAD51AP2;BAZ1B;ERCC6L2;TRIM28;CHRNA4;DCLRE1B;BLM;RFC4;CHEK1;PWWP3A;GADD45A;ALKBH5;MSH3;LIG1;FANCI;INO80;DCLRE1A;APBB1;ERCC6;PARP9;ASCC2;MMS19;TRIP13;GTF2H3;POLL;EXO1;XRCC2;APLF;HINFP;RAD51AP1;MDC1;TDP1;CHD1L
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.49256521361166195,-1.1969633313188859,0.2556131260794473,0.47885247755061383,1.0,5/11,19.06%,TGFB2;BMP4;JAG1;HEY2;SOX4
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4301115338902677,1.196402014005658,0.24774774774774774,0.6344454494222707,1.0,7/16,20.61%,CHGA;KLK6;GPER1;PRMT5;MRAP2;C3;GRP
prerank,melanosome localization (GO:0032400),0.39949957529698116,1.1961663300320382,0.24145299145299146,0.6333242541518783,1.0,9/21,16.59%,MREG;RAB27B;MYO5A;BBS7;BBS4;BBS5;ARL6;MKKS;BBS2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.30537395551777013,-1.195689604270278,0.15135135135135136,0.4813657658964663,1.0,32/93,24.99%,DAB2IP;MFHAS1;TRAF5;APP;MAP3K5;MID1;PLCB1;TGFB2;RASSF2;FLT4;ARL6IP5;SH3RF1;WNT16;TAOK3;TPD52L1;SEMA4C;TNFRSF19;MTURN;SASH1;CCL19;EDAR;NOD2;DUSP22;KLHDC10;SH3RF2;PTK2B;LTBR;GADD45A;RIPK1;FZD7;HMGB1;BMP2
prerank,response to copper ion (GO:0046688),-0.41158751809502725,-1.1954071608556112,0.22820037105751392,0.48155314911044755,1.0,13/20,35.95%,MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;ATP7B;ATP5F1D;AQP1;IL1A;MT3
prerank,ubiquinone biosynthetic process (GO:0006744),-0.4615973671800165,-1.194768911182228,0.22043010752688172,0.4825965126949602,1.0,6/15,19.31%,FDXR;COQ9;UBIAD1;COQ6;COQ2;COQ8B
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.34254227891918326,1.1945124274114671,0.18377088305489261,0.6363749289094927,1.0,11/44,12.02%,KCNMA1;KCNJ3;AKAP6;KCNN2;GABBR2;ATP1B1;WNK2;WNK3;KCNJ6;KCNN3;GABBR1
prerank,response to cadmium ion (GO:0046686),-0.3880150543818573,-1.1944559294663262,0.2184115523465704,0.482876219709948,1.0,14/26,25.53%,EGFR;JUN;MAPK1;AKT1;MAPK8;SUMO1;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.3716722290243483,-1.1940668724105246,0.20545454545454545,0.48334050707612736,1.0,14/29,34.60%,BIRC3;CASP8;UBE2D3;IKBKE;CD40;IKBKG;IKBKB;RIPK1;IRF7;CD300LF;TICAM1;TLR6;CD14;TBK1
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.4398491678325044,-1.1936846463994213,0.231203007518797,0.48378197872437473,1.0,6/16,21.30%,LRRK2;SEC16B;UBAC2;BCAP31;VAPA;BCAP29
prerank,regulation of cardiac conduction (GO:1903779),0.3225940952736813,1.193472396563929,0.18823529411764706,0.6375300635802794,1.0,12/54,12.89%,ATP1A2;RYR3;ATP2B4;ATP2B2;ATP1B1;NPPC;SLC8A2;RYR2;SLC8A3;SLC8A1;CASQ1;FXYD4
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.46101428621192575,-1.1931741648483383,0.24818840579710144,0.4840781146442419,1.0,7/13,31.43%,JAK1;IL15;PLCB1;GRB2;IL15RA;IL2RG;STAT3
prerank,cellular response to interleukin-15 (GO:0071350),-0.46101428621192575,-1.1931741648483383,0.24818840579710144,0.4840781146442419,1.0,7/13,31.43%,JAK1;IL15;PLCB1;GRB2;IL15RA;IL2RG;STAT3
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.2941709600881981,-1.1929385738056248,0.13184931506849315,0.4841906705798482,1.0,36/104,26.57%,DAB2IP;MNAT1;RB1;LRP5;DDX3X;CDK12;CDKN1B;ABL1;PPEF2;LRP6;CCND3;IRGM;AKT1;RPTOR;RHOA;ACTB;MTCP1;KSR1;CDK5RAP3;CCND1;PPP2CA;CNPPD1;BLM;CDKN2C;CDC25A;GADD45A;PARP16;SYAP1;RALB;CCNG1;TRIB3;CCNK;CCNE2;CAB39;CDKN3;CCNJ
prerank,positive regulation of DNA recombination (GO:0045911),-0.38015845181114527,-1.1928327983380917,0.2018348623853211,0.48403430974559536,1.0,9/27,16.00%,ARID2;SHLD1;TFRC;KMT5B;MRNIP;FUS;ERCC2;PRDM9;MAD2L2
prerank,mRNA 3'-end processing (GO:0031124),-0.31310162794664853,-1.192728504292279,0.17699115044247787,0.48387054708821536,1.0,21/78,20.24%,SRSF11;TENT4B;APP;SARNP;THOC2;RPRD2;UPF3B;THOC7;DDX39B;CPSF7;DHX38;CDC73;SLU7;LSM11;TENT2;THOC3;THOC1;FIP1L1;SRRM1;RNPS1;SRSF3
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.3552284053052037,-1.1924704540235185,0.20588235294117646,0.48401802912714764,1.0,14/40,23.11%,RNF139;SMURF1;GNA12;PTK2;HFE;FOXF2;SGTA;RPL5;CDK5RAP3;RAD23A;PTEN;PTK2B;RPS7;TRIM39
prerank,serine family amino acid metabolic process (GO:0009069),-0.44414119728006246,-1.1924395114630704,0.23713235294117646,0.4836663944209606,1.0,6/16,21.72%,SRR;MTHFD1;CDO1;SEPHS2;CTH;GCLC
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.46446113764376706,-1.192423087379478,0.23793103448275862,0.4832924096756459,1.0,6/13,18.45%,RAMP1;ALG10B;PLCB1;CHP1;IGF1;CCL19
prerank,dendrite morphogenesis (GO:0048813),0.35404673351328164,1.1923299248140553,0.20582120582120583,0.6389991761670212,1.0,11/35,12.35%,CTNNA2;CTNND2;DOCK10;EPHB1;SHANK1;DCDC2;PAK3;MAP2;MINK1;CELSR2;DLG4
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.2849532452949206,-1.1923289723945298,0.13089005235602094,0.4831025431184402,1.0,47/128,28.79%,FBXL7;MNAT1;FBXL12;FBXL17;PPP1R12B;YWHAE;FBXL3;CEP57;DNM2;PLCB1;CEP250;CEP78;NES;HAUS8;TPD52L1;CCNY;PPP1R12A;DCTN1;DCTN3;CSNK1D;PAFAH1B1;HAUS6;FBXW11;CEP41;ALMS1;PLK4;PCM1;CETN2;CNTRL;CEP152;CDK14;ODF2;CDC25A;HSP90AA1;PCNT;CEP131;AKAP9;AJUBA;KHDRBS1;FBXL22;PLK3;DYNLL1;ARPP19;CDKN2B;CCNH;HAUS1;BORA
prerank,positive regulation of macrophage activation (GO:0043032),-0.4322875936749613,-1.1921327977423517,0.24083769633507854,0.48311814469842823,1.0,11/17,48.48%,THBS1;LBP;CEBPA;TREM2;TLR6;TNIP2;STAP1;TLR4;TAFA3;WNT5A;CCL3
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.422276285126716,-1.1920896798249618,0.21731123388581952,0.48281645728674627,1.0,3/21,4.17%,MFHAS1;GSK3B;YWHAE
prerank,positive regulation of T cell proliferation (GO:0042102),-0.3365899377517815,-1.192055603500612,0.1602787456445993,0.4824749818131709,1.0,16/55,24.66%,SLC7A1;IL15;IL6ST;TFRC;NCK1;NCK2;ICOSLG;IGF1;VCAM1;ANXA1;RPS3;CCL19;PTPRC;IGF2;CD276;HMGB1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.41554086440429383,-1.1919900168205895,0.2381818181818182,0.48222116119993413,1.0,12/20,34.66%,PUM1;ZC3H7B;SNIP1;DICER1;AGO2;DROSHA;TERT;ZC3H7A;TSN;PUM2;TARBP2;MRPL44
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.455275147039951,1.1918815777079204,0.2398190045248869,0.6384838683673089,1.0,5/13,15.63%,INSIG1;CD81;SORL1;BRSK2;SAR1B
prerank,pre-miRNA processing (GO:0031054),-0.4500048918270314,-1.1915256347341099,0.22262773722627738,0.4828442614137683,1.0,5/14,21.03%,TUT7;DICER1;TUT4;AGO2;DROSHA
prerank,bile acid biosynthetic process (GO:0006699),0.3854302349051859,1.1914956755651942,0.23026315789473684,0.6378304156010334,1.0,6/24,16.99%,AKR1D1;CYP46A1;OSBPL6;CYP27A1;OSBPL9;ACOX2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.37608049274763744,-1.1914746380219536,0.2182468694096601,0.482571001522947,1.0,7/30,17.07%,FOXP1;DAB2;HDAC1;ZBTB7A;PIAS2;H3-3A;HDAC6
prerank,cardiac muscle tissue development (GO:0048738),-0.33673341471238905,-1.1914008343894573,0.20404721753794267,0.48232426227548597,1.0,15/50,12.19%,AKAP13;BMPR2;BMP5;SIK1;RBP4;BMP4;SMAD1;TBX2;MAML1;NOTCH2;ADAMTS9;SMAD4;KDM6B;ZFPM1;NOTCH1
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.3263860924482805,-1.1913421738557146,0.18416523235800344,0.48201286343118205,1.0,14/57,17.30%,GSK3B;ZDHHC6;RALBP1;KDR;TNFSF10;MIEF1;BNIP3;GSK3A;TP53;MIEF2;BBC3;HIP1R;BCL2L11;PPIF
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.3642317868885082,-1.1912466110667284,0.19963369963369965,0.4818136210885427,1.0,13/36,28.80%,MECOM;FOXO1;DLG1;EZR;TAOK3;DUSP3;IGBP1;ZMYND11;SH3RF2;GPS2;AIDA;TREM2;DUSP1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.49705905703952147,-1.1912221753180983,0.21915285451197053,0.4814544597333298,1.0,3/10,22.00%,KLF4;PTPRC;MAPK7
prerank,sodium ion homeostasis (GO:0055078),0.40621429092591677,1.191213425993976,0.23943661971830985,0.6368956885736383,1.0,5/21,11.91%,ATP1A2;ATP12A;ATP1B1;ATP4A;SLC8A1
prerank,protein tetramerization (GO:0051262),0.31519381500426796,1.1911613971929709,0.18859649122807018,0.6352795233183957,1.0,14/67,15.30%,HCN1;GRIN2B;MS4A1;SYCP1;RYR3;AQP4;GNMT;HOMER1;ACACA;ALDH1A2;GLS;GOLGA2;CBY1;TDO2
prerank,regulation of microtubule nucleation (GO:0010968),0.4765218695052965,1.1909171953796225,0.2510729613733906,0.6342516980745563,1.0,3/10,7.33%,EML2;ARHGEF7;PAK1
prerank,positive regulation of developmental process (GO:0051094),-0.27744238061573,-1.1903262897308327,0.1267361111111111,0.4830108802638831,1.0,34/164,14.44%,DAB2IP;RREB1;SLC6A6;ZBTB16;SHANK3;INSR;BMPR2;SMURF2;CORO1C;DVL3;ZDHHC6;RALBP1;BMP5;SHLD1;KDR;TFRC;TRPM4;FZD4;KMT5B;MIEF1;PLCB1;BMP4;BNIP3;RBM19;LMNA;PSEN1;EDN3;RPS6KA1;PA2G4;LLPH;MIEF2;AGO2;B4GALT5;RPS6KA3
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3011416222732798,1.1902083883228998,0.18313253012048192,0.6344430824604445,1.0,16/75,13.06%,SLC24A2;ATP1A2;KCNJ3;ATP12A;ATP2B4;CACNA2D1;SLC9A7;ATP1B1;SLC9A9;SLC8A2;SLC12A5;ATP4A;KCNJ6;SLC8A3;SLC8A1;SLC12A4
prerank,heart looping (GO:0001947),-0.35426299798035366,-1.1895846739720255,0.19469026548672566,0.48425873721491125,1.0,10/39,14.01%,ENG;PKD2;MICAL2;SOX17;SMO;TGFBR2;MEF2C;TBX2;NOTCH1;ZIC3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.4889532479815275,-1.1894784195137473,0.2673992673992674,0.4840712257149757,1.0,10/11,45.43%,TP53;ATF4;ATF6;DDIT3;CEBPB;ATF3;CREB3L1;ATF6B;CREB3L3;MBTPS2
prerank,telomere capping (GO:0016233),-0.43712303130054053,-1.1890896700356133,0.25190839694656486,0.4844991487240474,1.0,8/16,25.05%,STN1;MRE11;CTC1;TERF2;TFIP11;PRKDC;DCLRE1B;DCLRE1A
prerank,"transcription, DNA-templated (GO:0006351)",-0.2679493934274491,-1.1889882267107081,0.10570469798657718,0.4843171424870696,1.0,68/207,27.24%,RREB1;MNAT1;MEF2A;CBFB;MLLT3;DEK;THRB;NFIX;IVNS1ABP;NFKB1;FOXO3;IWS1;EAF1;POLR2G;GTF2E1;GTF2E2;ERCC2;TAF11;TP53;PWP1;TAF1B;NFIC;BRF1;CDC73;RTF1;TCEA1;DRG1;TAF5L;TAF1C;MLLT1;ATF4;ERCC3;MRPL12;PIR;CREBL2;TAF7;TAF3;NELFB;HSF2BP;NCOA6;RNPS1;ELOC;TAF4B;PTMA;UBTF;SNAPC3;TAF13;TCEA2;MED20;GTF3C4;SUPT4H1;POLR2C;CCNK;GMEB2;TAF9;TFDP1;TAF15;POLR2L;ERCC6;MLF1;POLR2H;TRIP11;LEO1;RSF1;MMS19;POLR3GL;TRIP13;GTF2H3
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.44184750472767115,-1.1887389745987,0.24196597353497165,0.4844694149444442,1.0,7/16,14.52%,CDK13;RSRC1;HNRNPM;PUF60;SFPQ;SLU7;SCNM1
prerank,glycoprotein metabolic process (GO:0009100),-0.3305302293693972,-1.188738293774466,0.19642857142857142,0.48405954234296833,1.0,22/53,27.55%,ST3GAL4;ST8SIA4;MAN2A1;MAN1C1;ST6GALNAC3;MGAT4B;FUT8;MAN1A2;ST3GAL2;ADAMTS9;PRKCSH;MAN1B1;B4GALT5;GAL3ST2;GOLPH3;LARGE1;ENGASE;HPSE;FBXO17;TNIP1;ST8SIA6;MANBA
prerank,positive regulation of viral life cycle (GO:1903902),0.38960243926629734,1.1885625789091998,0.24008810572687225,0.6373734947158136,1.0,6/22,18.32%,LGALS1;TYRO3;DDB1;TSG101;P4HB;CHMP2A
prerank,positive regulation of DNA replication (GO:0045740),-0.4396800205804925,-1.188486243881584,0.21934369602763384,0.48417628352659314,1.0,4/16,13.51%,STN1;EGFR;DNA2;CTC1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4628039745799273,1.1883040999310703,0.23943661971830985,0.6363862149486381,1.0,6/13,21.60%,CPSF1;TUT1;CSTF2T;CPSF2;CSTF2;NCBP2
prerank,regulation of mRNA catabolic process (GO:0061013),-0.2872515287302257,-1.1878183787725423,0.1497504159733777,0.48525244030412595,1.0,44/121,27.32%,ZC3HAV1;PSMA2;PRKCD;XRN1;SAMD4A;PUM1;PSME2;MAPKAPK2;YWHAZ;EXOSC2;PSMB4;EXOSC1;AKT1;EXOSC3;SERBP1;PARN;PSMC2;RC3H1;ZC3H14;PSMB2;PSMB1;EXOSC8;MOV10;PSMA8;NUP214;TNFSF13;PSME1;EXOSC5;DCP1A;PSMD4;PSMA7;RBM24;PSMD5;CARHSP1;EXOSC7;FXR1;IGF2BP2;CNOT8;ZFP36L1;PSMB10;HNRNPD;PSMA3;CNOT1;PABPC1
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.4998696000120363,-1.18754108550864,0.2697841726618705,0.48546675704688885,1.0,5/10,28.45%,SLC44A1;SMOX;ALDH7A1;CHDH;DMGDH
prerank,lamellipodium assembly (GO:0030032),-0.3861893466585308,-1.18741830087357,0.24314442413162707,0.4853331309265152,1.0,4/26,1.85%,ABLIM1;ITGB1;PARVB;RAC1
prerank,response to UV (GO:0009411),-0.30056903291872805,-1.187110078606214,0.1602787456445993,0.485611331293106,1.0,35/95,26.72%,CREBBP;DCUN1D3;MAP4K3;EGFR;UBE4B;NEDD4;PRKCD;PTPRK;ERCC2;RPL26;AKT1;TP53;NSMCE3;CAT;REV1;MAPK8;ATF4;ERCC3;COPS9;GPX1;N4BP1;ERCC8;RUVBL2;WRN;SDE2;CCND1;USP1;CDC25A;RELA;YY1;INO80;ERCC6;EIF2AK4;DTL;RHBDD1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.3782655299458064,-1.1865190295115515,0.21217391304347827,0.48652415221261197,1.0,7/29,12.85%,VTI1A;COG5;COG1;TRAPPC3;COPG1;COPA;COPE
prerank,positive regulation of filopodium assembly (GO:0051491),0.38353167867626464,1.186382238030575,0.21171171171171171,0.6401700706286091,1.0,6/24,8.91%,NLGN1;TENM1;TENM2;FSCN1;GPM6A;PLPPR5
prerank,protein neddylation (GO:0045116),-0.4661264368419492,-1.186371893442646,0.2344582593250444,0.48642742657566185,1.0,5/13,20.63%,DCUN1D3;RBX1;UBE2M;DCUN1D2;DCUN1D5
prerank,visual perception (GO:0007601),0.2970461772132098,1.1863530452587632,0.1793103448275862,0.6384782983270595,1.0,11/84,8.06%,COL2A1;EML2;COL1A1;CABP4;GRM8;RP2;FSCN2;OAT;EFEMP1;PAX2;TRPM1
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.2920902336773623,-1.185850298847625,0.14840989399293286,0.48718834287037627,1.0,35/110,23.64%,DAB2IP;RB1;TRABD2B;MPP7;GSK3B;DDX3X;TFRC;IRGM;SPIDR;CDH5;RAF1;TAL1;HJURP;FNIP2;ICE1;RHOC;SLF2;TRAF3IP1;HCFC1;IAPP;BCL2L11;NCLN;SUMO1;HDAC6;RPS3;TFIP11;PTPN11;WARS1;PREB;HSP90AA1;SAR1A;BIK;RALB;GFAP;AJUBA
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.3143066377519317,-1.1858223174325195,0.17712177121771217,0.4868337668543246,1.0,27/73,24.96%,CAV1;APP;PRKD2;EGFR;TFRC;GAS6;IRGM;NGF;PRKD1;RAF1;HAX1;AKT1;FNIP2;BRAF;RPTOR;MTCP1;MIF;MAD2L2;CREBL2;HDAC6;TXN;CAPRIN2;NOS1;HSP90AA1;AKAP9;SH2D3C;RAPGEF3
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.5011975646916327,-1.185339354143381,0.24820143884892087,0.48744683417255524,1.0,4/11,13.52%,GFPT2;GNPDA2;GNPNAT1;UAP1
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.49186420606279996,-1.1851438062640667,0.2578397212543554,0.4874787044379779,1.0,4/10,14.78%,MLLT3;ACE;TP53;LMBR1L
prerank,organelle transport along microtubule (GO:0072384),0.3682472387762958,1.1850066389302623,0.22975929978118162,0.6405582493928352,1.0,15/31,20.86%,BICD1;CLN3;MAP1S;MAPT;DYNC1I1;TMEM201;RAB6A;COPG2;HTT;BORCS5;TRAK2;BICDL1;RHOT1;HAP1;UBB
prerank,covalent chromatin modification (GO:0016569),-0.45163432328351333,-1.1842417507095628,0.2594594594594595,0.4890215342335091,1.0,3/14,7.41%,CHD1;HDAC1;SETD5
prerank,response to amyloid-beta (GO:1904645),0.33608954164471505,1.1837582300852847,0.19594594594594594,0.6424113095561107,1.0,7/44,4.29%,GRM5;MMP12;CACNA1B;CDK5;CACNA2D1;GRIN2A;CACNA1A
prerank,cellular response to organic cyclic compound (GO:0071407),-0.2786055204105567,-1.1833161380642123,0.1447587354409318,0.49072042259358245,1.0,36/141,15.81%,CTNNA1;RAPGEF2;GNB1;PKD2;ESR1;NRIP1;LRRK2;NR3C1;DIAPH1;TIPARP;EGFR;MSN;PDE3A;LARP1;PDE2A;MED1;KCNQ1;SPIDR;RAP1A;MEF2C;EZR;TGM2;RAP1B;CDH1;ARL6IP5;RAPGEF1;NCOA4;ACTB;KAT5;PDE12;P2RY6;IGFBP5;ROCK2;RUVBL2;ADCY1;UBE2L3
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.3373475578667795,-1.1833143515915356,0.1844484629294756,0.49031650411194827,1.0,20/52,24.70%,PPP1R13B;YWHAE;HPS4;YWHAZ;NMT1;GSK3A;UBE2J2;CASP8;UBE2D3;TP53;MAPK8;BBC3;UBE2L3;BAP1;NPEPPS;PPP3CC;HUWE1;FZD5;TFDP1;SAE1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.3477065193413976,-1.1828614497975014,0.20892857142857144,0.4909400448826009,1.0,14/38,19.61%,CAV1;PTPN1;APP;ACE;GAS6;IL34;SH3BP5L;EPHA4;NCK2;NEDD9;NOX4;HYAL2;PTPRC;RAP2C
prerank,protein localization to cell periphery (GO:1990778),0.27724932407811703,1.182845320186078,0.1325,0.6431686518757055,1.0,29/133,11.33%,KCNIP4;ABCA12;DPP10;MAP7;ANK3;DPP6;ANK1;RAB15;EPB41L3;TSPAN15;PKP2;RAB40C;TNIK;ATP1B1;RAB3C;CACNB3;WNK3;CD81;MYO5A;ARL3;ZFYVE27;SPTBN4;TESC;C2CD5;RAB3A;LIN7C;TSPAN32;PPIL2;NKD2
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.3894302910018826,-1.1828408155127539,0.23487544483985764,0.4905716646035958,1.0,10/26,15.65%,APP;HES1;CUL3;USP2;TAL1;PPP1R10;DUSP3;PKN2;SMOC2;LGMN
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.37700592849644854,-1.1823497645936416,0.2265193370165746,0.49119925821558813,1.0,11/29,26.55%,CAV1;THBS1;PAK2;TNFSF10;WWOX;HYAL2;G0S2;LTBR;RIPK1;TNFSF12;TNFRSF12A
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.3198413741274609,-1.1822058462244545,0.18538324420677363,0.49108149877870955,1.0,19/63,18.47%,DAB2IP;MCL1;TAB3;TLK2;MTOR;RASIP1;ROCK1;TBC1D14;DAPL1;GSK3A;MFSD2A;AKT1;PTPN3;TIMP3;HGF;DAP;TAB2;CDK5RAP3;WASHC1
prerank,myelination (GO:0042552),0.33203736166839626,1.1815217075154911,0.19230769230769232,0.6452102014501655,1.0,18/46,18.23%,MYRF;SCN8A;EPB41L3;PLP1;BCAS1;SCN2A;ACSBG1;NFASC;GPC1;KLK6;MBP;SLC8A3;TPPP;GAL3ST1;AMIGO1;B4GALT6;LGI4;CXCR4
prerank,positive regulation of protein transport (GO:0051222),-0.31244013863739256,-1.1812794325561522,0.17540687160940324,0.4927977285368268,1.0,27/67,25.30%,UNC13B;CD2AP;GOLPH3L;ADAM9;IER3IP1;BMP6;TGFB2;EZR;MYO18A;CNST;MYOM1;BCAS3;ICE1;CHP1;TPR;IGF1;RIPOR1;GOLPH3;PCM1;OAZ2;ARHGEF5;VAMP2;PCNT;CEP131;SYTL4;APBB1;PLK3
prerank,proteasomal protein catabolic process (GO:0010498),-0.27081097981570373,-1.1810023933879437,0.10437710437710437,0.49305460351201347,1.0,71/201,27.45%,WWP1;PELI1;NEDD4L;ZNRF1;SMURF2;UBE2K;RNF139;PSMA2;FBXL17;SMURF1;DDI2;RBX1;UBE4B;CUL3;NEDD4;PSME2;SPSB1;PSMB4;GSK3A;UBE2D3;AREL1;TNFAIP1;RMND5A;SPOPL;ARMC8;KAT5;ATXN3;FEM1C;FBXW11;APPBP2;PSMC2;FEM1B;ERCC8;PSMB2;PSMB1;AGAP3;TRIM13;CTNNB1;KCTD10;UBXN11;PSMA8;SPOP;DNAJB12;RAD23A;SIAH1;PSME1;TRIM3;RNF4;UCHL1;TBL1X;WWP2;PSMD4;HUWE1;MDM2;PSMA7;RNF216;HACE1;NFE2L2;PSMD5;ARRB1;MAEA;FBXL22;ZFAND2A;PSMB10;RNF122;UBXN2A;RHBDD1;PSMA3;KIF14;RNF34;PPP2R5C
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.3099763630619958,-1.1809615037716024,0.16987740805604204,0.4923137749864367,1.0,24/78,22.22%,SEC31A;SEC24B;RAB7A;AP2B1;AP2A2;SEC24A;DNM2;AP2S1;SEC24D;SEC13;DCTN1;KIF23;DCTN3;AP1G1;KIF11;LGMN;KIF15;KIF26A;CAPZB;CENPE;KIF3B;AP2M1;CTSF;SEC24C
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3099763630619958,-1.1809615037716024,0.16987740805604204,0.4923137749864367,1.0,24/78,22.22%,SEC31A;SEC24B;RAB7A;AP2B1;AP2A2;SEC24A;DNM2;AP2S1;SEC24D;SEC13;DCTN1;KIF23;DCTN3;AP1G1;KIF11;LGMN;KIF15;KIF26A;CAPZB;CENPE;KIF3B;AP2M1;CTSF;SEC24C
prerank,sphingosine metabolic process (GO:0006670),0.42226364726376836,1.1808889845409027,0.26077097505668934,0.6453196881916623,1.0,7/17,11.23%,PLPP2;SPHK1;SGPP1;ACER1;ABCA2;SPHK2;NAAA
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.45239347061141255,-1.1805453306070963,0.25092250922509224,0.4927836971982345,1.0,6/14,27.64%,NOL9;RPL7L1;BOP1;PES1;ZNHIT3;WDR12
prerank,energy reserve metabolic process (GO:0006112),-0.41498188501545274,-1.179826815730142,0.25220458553791886,0.4939987190997478,1.0,5/19,13.72%,GBE1;GSK3B;GFPT2;PPP1R3C;PHKB
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.4137877919817476,-1.1793276347854185,0.24319727891156462,0.49469204780704934,1.0,11/21,40.63%,LRRK2;NCK1;BCL2L11;HERPUD1;TXNDC12;EIF2AK3;DDIT3;PMAIP1;PARK7;CREB3L1;TMBIM6
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.40194538278274583,1.1791184015056575,0.24186046511627907,0.6487016436823206,1.0,5/21,8.20%,SCN1B;KCNA5;CACNA2D1;CACNA1D;SCN5A
prerank,lipid translocation (GO:0034204),-0.4118941503471344,-1.1789031636420924,0.24733096085409254,0.49523782758716955,1.0,6/21,16.71%,ATP10A;ATP8B1;RFT1;ATP10B;ABCA7;ATP9B
prerank,RNA splicing (GO:0008380),-0.2926353922819949,-1.1786652553521242,0.14209591474245115,0.4953796453924459,1.0,27/95,21.25%,MBNL1;SRSF11;PRPF3;SMU1;CDK12;IVNS1ABP;RSRC1;PPIG;FUS;PRPF6;DDX39B;SF3B1;DBR1;SFPQ;SLU7;YJU2;SCNM1;SYNCRIP;SRPK2;USB1;ZMAT5;PPP2CA;SRRM1;NONO;RNPS1;SRSF10;TRA2B
prerank,cellular response to retinoic acid (GO:0071300),0.34241319295512496,1.1779680966481312,0.21507760532150777,0.6502302952708061,1.0,9/42,12.40%,BRINP3;WNT7B;BRINP1;PAX2;BRINP2;ADNP2;TESC;WNT6;HTRA2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.39837747097469495,-1.177719230844273,0.22242647058823528,0.4970785061140369,1.0,6/22,12.11%,ADAM9;TNFRSF1B;SNX9;ROCK1;PTPN3;TIMP3
prerank,negative regulation of axonogenesis (GO:0050771),0.3710568156628653,1.1766942933381126,0.24557522123893805,0.6522504130736002,1.0,12/27,21.41%,DCC;EFNB3;MAP2;RTN4;PTPRS;MAG;OMG;TRIM46;LINGO1;RTN4R;RUFY3;NGFR
prerank,regulation of axonogenesis (GO:0050770),0.3260528446790285,1.1766889843511594,0.20454545454545456,0.6505198208921795,1.0,21/51,19.73%,LRRC4C;ROBO2;ROBO1;EFNB3;PAK3;NTRK2;PAK1;SLITRK1;RTN4;MAG;CDH2;OMG;PLXNA2;PLXNA1;BRSK2;AMIGO1;PLXNA3;LINGO1;MAP6;RTN4R;RUFY3
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3474332080226436,-1.176579930100836,0.2159709618874773,0.4992210812670871,1.0,11/41,19.05%,TJP1;PODXL;GCNT2;JAK1;AFDN;DENND6A;SMAD7;FLOT1;BMP7;CITED2;MAGI1
prerank,myotube differentiation (GO:0014902),0.4180440273291969,1.176484490645499,0.25055432372505543,0.649347731162717,1.0,4/17,10.41%,ADAM12;ADGRB3;ADAMTS15;PLD3
prerank,regulation of G0 to G1 transition (GO:0070316),-0.3491368051676564,-1.1762111481099375,0.22644927536231885,0.49962800233261767,1.0,14/38,21.87%,DAB2IP;MGA;RYBP;SUZ12;MAX;RBBP8;EHMT1;YAF2;PHC1;FOXO4;RNF2;BRCA1;PHC3;CHEK1
prerank,skeletal muscle tissue development (GO:0007519),-0.3679587862076308,-1.1759494965369965,0.22684310018903592,0.4998223739887314,1.0,13/32,30.33%,CAV1;SVIL;SIX1;MEF2C;CFLAR;SKI;SIX4;MYL6;FOXL2;KLHL41;MSC;CAV2;MYORG
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.34619764056783686,-1.1748888990230857,0.19887429643527205,0.5018546864318969,1.0,15/46,21.67%,FOXP1;ELN;THBS1;IL6R;BMP4;AKT1;EDN1;TNFAIP3;IGFBP5;IGF1;CTNNB1;PRKDC;TCF7L2;PPARG;PDGFRB
prerank,nitric oxide mediated signal transduction (GO:0007263),0.4318037399696209,1.1748282478293424,0.271689497716895,0.652248050771609,1.0,2/16,2.78%,KCNC2;DDAH2
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.3727872290746174,-1.1746611511747043,0.23118279569892472,0.501911819671193,1.0,13/30,28.42%,MNAT1;ERCC2;TAF1B;TAF1C;ERCC3;CAVIN1;UBTF;TAF1D;POLR1E;POLR2L;POLR2H;GTF2H3;CCNH
prerank,mitotic spindle assembly (GO:0090307),-0.345838652044569,-1.1745176307045164,0.2306338028169014,0.501838069492347,1.0,14/42,22.31%,STAG1;CCDC61;TOGARAM1;WRAP73;FLNA;KIF23;RHOA;ARHGEF10;STAG2;KIF11;RAB11A;KIF3B;PRC1;MISP
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.33868215450864153,-1.1745108924870478,0.22916666666666666,0.5014424401140934,1.0,9/43,8.09%,ENG;PKD2;MICAL2;SOX17;SMO;TGFBR2;HES1;MEF2C;TBX2
prerank,xenobiotic transport (GO:0042908),-0.42783735443890514,-1.1744837018744443,0.26631393298059963,0.5010986456512664,1.0,3/17,2.43%,ABCG2;SLC47A1;SLC7A5
prerank,cell cycle G2/M phase transition (GO:0044839),-0.2804772548800571,-1.174331184618138,0.15817223198594024,0.5010194816135174,1.0,47/129,28.79%,FBXL7;MNAT1;FBXL12;FBXL17;PPP1R12B;YWHAE;FBXL3;CEP57;DNM2;PLCB1;CEP250;CEP78;NES;HAUS8;TPD52L1;CCNY;PPP1R12A;DCTN1;DCTN3;CSNK1D;PAFAH1B1;HAUS6;FBXW11;CEP41;ALMS1;PLK4;PCM1;CETN2;CNTRL;CEP152;CDK14;ODF2;CDC25A;HSP90AA1;PCNT;CEP131;AKAP9;AJUBA;KHDRBS1;FBXL22;PLK3;DYNLL1;ARPP19;CDKN2B;CCNH;HAUS1;BORA
prerank,negative regulation of blood coagulation (GO:0030195),0.3422048962878767,1.1742278694141821,0.22966507177033493,0.6522432243306902,1.0,9/38,16.65%,VTN;CPB2;C1QTNF1;F8;PDGFA;SERPING1;APOE;PDGFRA;KLKB1
prerank,cellular component assembly (GO:0022607),-0.2603959049546741,-1.174210564806357,0.10193321616871705,0.5008841315602299,1.0,62/253,19.05%,SPTBN1;SLC2A1;PARD3;LIMA1;MNAT1;CREBBP;FERMT2;EPS8;PARVB;BAIAP2L1;CD2AP;RAC1;RHOJ;LIMS2;PARVA;LIMS1;PLS3;RANBP9;TEAD1;MITF;HES1;GAS6;TOGARAM1;FAS;KPNA3;RHOQ;EZR;SNX9;WASL;YAP1;YWHAZ;AFG3L2;PICALM;SHROOM1;FAM107A;DET1;OCLN;TP53;FLNA;SHROOM2;ILK;HFE;RHOA;ACTB;LCP1;NEDD9;RHOG;CD40;NCKAP1;HAS1;VCPIP1;PEX14;TUBGCP4;TLCD1;TFAP4;CALD1;FANCC;IKBKG;VAMP3;WASF1;MDN1;MAGI1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.30815693297569857,-1.1741561701578376,0.176056338028169,0.5006197913758074,1.0,24/79,22.22%,SEC31A;SEC24B;RAB7A;AP2B1;AP2A2;SEC24A;DNM2;AP2S1;SEC24D;SEC13;DCTN1;KIF23;DCTN3;AP1G1;KIF11;LGMN;KIF15;KIF26A;CAPZB;CENPE;KIF3B;AP2M1;CTSF;SEC24C
prerank,N-glycan processing (GO:0006491),-0.42880857818728857,-1.174154331822877,0.26444833625218916,0.5002153247697709,1.0,8/18,13.38%,ST8SIA4;MAN2A1;MAN1C1;MGAT4B;FUT8;MAN1A2;PRKCSH;MAN1B1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5091571631352082,-1.173961940204382,0.259581881533101,0.5002578198237441,1.0,6/10,31.82%,PARD3;PRKD3;DGKH;PLPP1;F2R;DGKD
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.2757586257092955,-1.173856647751692,0.12998266897746968,0.5001048237788924,1.0,41/151,22.06%,TEK;RAPGEF2;FERMT2;ROR1;BMPER;MFHAS1;PDGFD;SEMA7A;GCNT2;APP;CCL25;KDR;ICAM1;PRKD2;EGFR;SLC30A10;GAS6;DSTYK;RAP1A;NOTCH2;FLT4;HTR2A;BRAF;NOTCH1;FGF2;ACKR3;P2RY6;MIF;ABCA7;TNFAIP8L3;MTURN;ANGPT1;CCL19;NOD2;PTPRC;FGFR4;PTPN11;P2RY1;ROR2;PDGFRB;PTK2B
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.4284665068123259,-1.1738172098926924,0.24723247232472326,0.49980251503744494,1.0,9/18,28.04%,DAB2IP;MSN;VGLL4;EZR;CDK5RAP3;AMER1;HSP90AA1;VPS35;RDX
prerank,negative regulation of leukocyte activation (GO:0002695),0.43645452377665467,1.1736342826542914,0.25934065934065936,0.6523422232020987,1.0,6/15,19.45%,LRFN5;GRN;GPER1;HAVCR2;FCGR2B;CD84
prerank,telomere maintenance via recombination (GO:0000722),-0.4845944431426852,-1.1736242722266517,0.2742230347349177,0.4998774140368715,1.0,8/11,42.06%,SMC5;NSMCE2;TEP1;RAD51D;RAD50;ERCC4;SMC6;ERCC1
prerank,cell junction maintenance (GO:0034331),0.42925673503438727,1.1735324102309506,0.2535211267605634,0.6509430149765754,1.0,7/14,24.92%,CD177;CBLN1;CSF1R;NLGN2;PARD6A;CBLN2;CLDN1
prerank,regulation of protein catabolic process (GO:0042176),-0.29855360982269186,-1.1731053517935472,0.17152658662092624,0.50066560252023,1.0,36/99,26.50%,DAB2IP;WWP1;FOXO1;NEDD4L;SMURF2;GSK3B;ATG7;RAB7A;SMURF1;TIPARP;EGFR;CDKN1B;NEDD4;NKD1;PLK2;GSK3A;FLNA;AREL1;SNX12;AZIN1;TNFAIP3;MAD2L2;OAZ2;GPC3;WWP2;HUWE1;MDM2;CTSA;HACE1;SEC22B;FZR1;GFAP;ADGRB1;TNFSF12;DTL;APC
prerank,mitotic metaphase plate congression (GO:0007080),-0.3301200856757368,-1.172929440218606,0.21830985915492956,0.5006350315023704,1.0,28/51,39.59%,MAD1L1;CUL3;CHMP4B;CHMP4A;CHMP2B;CHMP5;RAB11A;CENPE;PDCD6IP;RRS1;BECN1;EML4;PINX1;CHMP3;KIF14;SPDL1;CDCA8;CHMP6;CHMP1A;NUDC;BOD1;NUF2;PSRC1;MIS12;CHMP1B;RMDN1;KIF2C;CCNB1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.43703013583597083,-1.1728861460333027,0.25678119349005424,0.5003332752647816,1.0,6/16,21.16%,JCAD;THBS1;AGTR1;FGF2;GATA2;DLL4
prerank,carbohydrate derivative transport (GO:1901264),-0.43012318604085126,-1.1727149180391685,0.23992673992673993,0.5003061273595811,1.0,5/18,9.30%,PLTP;LBP;SLC10A7;SCARB1;MFSD2A
prerank,RNA metabolic process (GO:0016070),-0.27945808207715145,-1.1723642634433067,0.13217391304347825,0.5006263017412396,1.0,45/127,26.53%,RBPMS;RBFOX2;RBMS1;METTL14;DDX3X;HNRNPA0;RBM5;HNRNPR;FTO;RBMS2;HNRNPM;POLR2G;RNASE3;DDX39B;NOL9;HNRNPA3;WTAP;DICER1;HNRNPUL1;RBM39;HNRNPF;XRN2;APOBEC1;TENT2;PARN;AGO2;HNRNPA1;SYNCRIP;THOC1;ADARB1;WDR74;TFIP11;RNASEH2C;DROSHA;RBM3;RBM6;PCBP1;POLR2C;DHX9;POLR2L;EXOSC7;POLR2H;ATXN1;HNRNPL;HNRNPD
prerank,actin cytoskeleton reorganization (GO:0031532),-0.3169800871089202,-1.1723021805089948,0.19710669077757687,0.5003459419270849,1.0,21/63,18.65%,GAB1;PARVB;MYH9;PARVA;PTPN1;RICTOR;EZR;CDC42BPA;S1PR1;BCAR1;FGF7;FLNA;PHACTR1;RHOA;NEDD9;GRB2;ANXA1;CDC42BPB;RAP2A;TRPV4;MKLN1
prerank,defense response to symbiont (GO:0140546),-0.29421916689917693,-1.1722852549108185,0.17474048442906576,0.4999824538234573,1.0,41/92,31.08%,IRF2;IFIH1;ATG7;TRIM56;SETD2;ABCC9;SAMHD1;DDIT4;BNIP3;IRF1;SERINC3;FLNA;STAT2;IFITM3;CD40;PLSCR1;PDE12;CGAS;MOV10;NLRC5;MAVS;ZMYND11;SERINC5;MAP3K14;PTPRC;EXOSC5;ABCE1;IFNAR2;RELA;IRF7;NCBP3;IFITM2;AGBL5;OASL;BST2;RSAD2;IFNLR1;SHFL;LILRB1;RTP4;PMAIP1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),-0.32501227789006654,-1.172142307118756,0.20297951582867785,0.49994227452132334,1.0,23/60,26.34%,KLF4;NEK7;ATM;PRKD2;TCP1;MAPK1;HMBOX1;RGCC;FGF2;HGF;PNKP;PARN;PTGES3;HNRNPA1;SMOC2;CTNNB1;FGFR4;PDGFRB;RFC4;HSP90AA1;CCT5;CCT2;NAF1
prerank,lymphocyte differentiation (GO:0030098),-0.3122988775888613,-1.172126076243304,0.18118466898954705,0.499581762355455,1.0,19/68,19.36%,PBX1;ITGB1;PTPRJ;JAG2;ZBTB7A;PLCG2;TPD52;PIK3CD;HDAC4;ITGA4;NHEJ1;LMBR1L;TCF3;VCAM1;CEBPG;CLCF1;SOX4;PTPRC;DNAJB9
prerank,defense response to virus (GO:0051607),-0.2905428130318682,-1.1720867325003312,0.16842105263157894,0.4992733027885549,1.0,45/100,31.08%,IRF2;IFIH1;ATG7;TRIM56;SETD2;ABCC9;CLPB;SAMHD1;DDIT4;BNIP3;IRF1;SERINC3;FLNA;STAT2;IFITM3;CD40;PLSCR1;PDE12;CGAS;MOV10;NLRC5;MAVS;ZMYND11;SERINC5;MAP3K14;PTPRC;ZDHHC1;EXOSC5;ABCE1;IFNAR2;RELA;AKAP1;IRF7;NCBP3;IFITM2;AGBL5;CXCL10;OASL;BST2;RSAD2;IFNLR1;SHFL;LILRB1;RTP4;PMAIP1
prerank,cellular response to interleukin-4 (GO:0071353),-0.48877186154644825,-1.171983951164584,0.2907801418439716,0.49910933932958856,1.0,2/10,6.72%,LEF1;STAT6
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.4092766252092137,1.171874276836458,0.26014319809069214,0.6538758136643891,1.0,4/18,5.12%,NLGN1;RIMS2;RIMS1;SYN1
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.27089775087767315,-1.1714444038404295,0.1261101243339254,0.49990656076754164,1.0,58/172,25.93%,RUFY1;MTMR3;ARF3;PLA2G4A;PIP4K2A;LPCAT1;PLD1;PIK3R1;BMX;PIP4K2B;PI4KB;SLC44A1;PIP5K1B;PIK3C2A;MTMR6;RAB5A;PLD2;STARD7;PLCG2;MFSD2A;PIK3CD;DGKA;AGPAT4;DGKZ;INPP4A;PIK3R6;MTMR12;FGF2;ACP6;AGPAT3;PTPN13;AGK;PLEKHA4;PLSCR1;PIK3CB;AGPAT1;PI4K2B;CEPT1;PIK3R3;PTDSS1;PCTP;PLA2G12A;LCLAT1;PTEN;LPIN2;DDHD2;LPCAT3;INPP5D;LCAT;MTMR4;GPD1;PIP5K1A;DGKH;CHAT;INPP5J;PIK3CA;DGKE;INPP5E
prerank,neuron fate commitment (GO:0048663),0.4501310958568703,1.1714011940498412,0.27294117647058824,0.6535492405647256,1.0,2/14,8.54%,MYT1L;POU4F1
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.29377805005021945,-1.1708288991721079,0.17850953206239167,0.5009314923455856,1.0,45/95,33.67%,SMC5;NIPBL;SAMHD1;ZFYVE26;SPIDR;MMS22L;MRE11;NABP1;MCM9;RBBP8;MCM4;RAD54B;NSMCE2;SFPQ;RPA3;RPA1;FANCM;PALB2;RFWD3;WRN;RPA2;RAD54L;BRCA1;RAD51AP2;BLM;YY1;MCM3;MORF4L1;INO80;MCM7;MCM5;POLL;XRCC2;AP5Z1;KDM4D;RAD51AP1;SWI5;RAD51D;MCM2;HUS1B;RMI1;MEIOB;RAD50;GINS2;FAN1
prerank,organic substance transport (GO:0071702),-0.2811947967664485,-1.1706456581789968,0.13445378151260504,0.500934862871649,1.0,22/121,9.94%,ABCG2;SLC47A1;PLTP;RUFY1;SLCO2A1;CALCRL;MYH9;RAMP1;RAB7A;SPNS2;SCAMP2;SLC19A2;SLC22A5;ABCB9;ABCD3;TAP2;ARRDC1;SLCO2B1;ARL6IP5;MFSD2A;RAMP2;ABCA9
prerank,myelin maintenance (GO:0043217),0.4856433885047832,1.1704901476748006,0.27149321266968324,0.6544124518981405,1.0,2/10,2.76%,MYRF;EPB41L3
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.34263212210996075,-1.169579119459823,0.21415270018621974,0.5028790025873668,1.0,9/40,14.91%,FLT1;EDNRA;ESR1;PLCG1;EGFR;HTR2A;FGF2;P2RY6;LPAR2
prerank,regulation of macrophage migration (GO:1905521),-0.48343395595065164,-1.169579093189831,0.26806083650190116,0.5024741080603239,1.0,2/10,3.25%,CD200;MTUS1
prerank,intracellular protein transport (GO:0006886),-0.2510251559196791,-1.1695301867321517,0.0847457627118644,0.5022008842640259,1.0,86/304,23.09%,TBC1D4;SEC31A;RASSF9;KIF13B;TRAK1;NUP42;ARF3;RAB7A;ARCN1;RAB1A;SMURF1;CSE1L;TLK1;SYNRG;TBC1D1;RAB5B;XPO7;STX3;TBC1D2B;COX18;HPS4;TBC1D8B;WDR11;SNX9;USP6NL;SEC13;RAB5A;TBC1D30;ARHGEF2;STX8;TBC1D14;SCFD1;SRPRA;AKT1;FUT10;PPP1R10;TBC1D22B;COPA;GABARAP;RAB3GAP2;EHD1;TBC1D22A;VPS26A;NUP153;ARL4A;SLU7;CHP1;VPS45;RAB23;VPS36;RAB24;RAB32;TPR;SNX8;HERC2;SIL1;AP4M1;HDAC6;LAMP2;TMED5;XPO4;GIPC1;FAM91A1;NUP214;NXT1;IPO8;STX12;TBC1D8;VPS26C;AP3B1;TBC1D17;AP4B1;TBC1D25;ARL5C;KIF13A;CTSA;TECPR2;SNX13;PREB;NUP188;TBC1D12;EVI5;SAR1A;ARL4C;HOMER3;COPZ1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.2821751112324523,-1.1693523565501998,0.1546572934973638,0.5022052690710355,1.0,29/119,16.18%,RUFY1;MTMR3;ARF3;EFR3B;PIP4K2A;PIK3R1;BMX;PIP4K2B;PI4KB;PIP5K1B;PIK3C2A;MTMR6;RAB5A;PLCG2;ITPKB;PIK3CD;TTC7A;SOCS2;INPP4A;PIK3R6;MTMR12;PIGV;FGF2;PTPN13;PLEKHA4;PIK3CB;PIGG;PI4K2B;PIK3R3
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.4621139179082153,-1.169335193521455,0.25932504440497334,0.5018376593702515,1.0,4/13,9.93%,ATG7;ATG10;UBA2;UBA7
prerank,cellular response to superoxide (GO:0071451),-0.49272448148928666,-1.169136270566774,0.26296296296296295,0.5018576455028448,1.0,3/10,18.07%,NOS3;CCS;SOD1
prerank,fluid transport (GO:0042044),0.46267939901420296,1.1690519374953945,0.2647058823529412,0.6569530266440042,1.0,2/12,4.58%,PDPN;AQP4
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3835531676625251,-1.1690127348961186,0.23992994746059546,0.5016919041546368,1.0,11/27,21.38%,SLC47A1;SLC7A1;SLC7A5;SLC38A5;ARL6IP5;SLC36A4;PRAF2;SLC1A1;SLC7A2;SLC1A4;SLC3A2
prerank,cellular response to cAMP (GO:0071320),-0.3578529643892191,-1.1685973867288035,0.23211169284467714,0.5022135626468466,1.0,14/30,26.06%,RAPGEF2;PKD2;PDE2A;KCNQ1;RAP1A;EZR;RAP1B;RAPGEF1;IGFBP5;SLC5A5;AKAP9;RAPGEF3;DMTN;ZFP36L1
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.32524918969811484,-1.168484751660478,0.20353982300884957,0.5020447457231964,1.0,19/54,23.61%,PAK1IP1;RPF1;RRP15;NOP2;RPL3;RPL26;NIP7;RPL10;RPL7A;RPL5;NLE1;WDR74;MDN1;RPL35A;BOP1;PES1;RRS1;EBNA1BP2;NOP16
prerank,liver development (GO:0001889),-0.36840014878830957,-1.1683577413766157,0.27256317689530685,0.5019270916970183,1.0,13/32,24.41%,PKD2;LSR;TGFBR3;PRKCSH;ZIC3;ANXA1;ARID5B;CDK5RAP3;CEBPG;CITED2;NF1;CEBPA;E2F7
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.39954642144608754,-1.1677917961949318,0.2518518518518518,0.5028317531518243,1.0,10/23,26.17%,JAK1;IRGM;PARP14;JAK2;SUMO1;NLRC5;IFNGR2;PPARG;PTPN2;PARP9
prerank,response to X-ray (GO:0010165),-0.44762218308158847,-1.1677714033491013,0.2899628252788104,0.5024839905273201,1.0,7/14,21.31%,ATM;NIPBL;XRCC4;ANXA1;BRCC3;LIG4;BLM
prerank,DNA metabolic process (GO:0006259),-0.25559749379010405,-1.1674967830739764,0.11967213114754098,0.5026627699306339,1.0,90/270,27.65%,SP100;MNAT1;PDS5B;STN1;ATM;NT5E;PARP4;DMC1;TOP3A;KMT5B;SAMHD1;TRRAP;TOP3B;MRE11;INIP;UHRF2;NABP1;RBBP8;MCM4;DOT1L;AXIN2;ORC5;NSMCE3;ENDOV;PDS5A;POLD3;RAD18;INTS3;OGG1;RPA3;DNA2;KAT5;RPA1;CTC1;PNKP;XPC;PTGES3;ERCC3;BTG2;UBE2V2;TOP1MT;TERF2;SRPK2;ORC2;DNMT1;SUMO1;POLE2;FANCC;FANCG;PRIM2;WRN;ORC4;RPA2;USP7;SMARCAD1;PRKDC;RAD54L;TCF7L2;TIMELESS;NSMCE4A;LIG4;FANCL;BRCA1;TRIM28;CHRNA4;DCLRE1B;TERT;BLM;RFC4;CHEK1;PWWP3A;GADD45A;MCM3;TOP1;NTHL1;RFC1;MSH3;SMARCB1;LIG1;HMGB1;INO80;POLA2;MCM7;RAN;MMS19;MCM5;GTF2H3;MCM10;POLL;EXO1
prerank,skeletal system development (GO:0001501),-0.27399393309837017,-1.1674369477249533,0.14432989690721648,0.5023968654315355,1.0,43/148,21.04%,TLL1;ZBTB16;AKAP13;EXT1;CDH11;TEAD4;PLS3;DYM;BMP5;ANKRD11;SH3PXD2B;BMP6;KIAA1217;TGFB2;ALPL;RBP4;CREB3L2;SLC10A7;TGM2;PCSK5;ADAMTS4;ETS2;PKDCC;RPL13;COMP;WWOX;NOTUM;WNT11;MYOC;RPS6KA3;EBP;TRPS1;BMP7;IGF1;TNFRSF11B;ANKH;CMKLR1;HYAL2;SOX4;COL13A1;HAPLN3;IGF2;HAPLN1
prerank,cellular lipid catabolic process (GO:0044242),0.37495231111961896,1.1669588814425793,0.25355450236966826,0.6612617796575401,1.0,4/27,7.62%,ENPP2;NUDT19;LPIN1;SMPDL3B
prerank,endocytic recycling (GO:0032456),-0.3282163789514086,-1.166342806928248,0.21645796064400716,0.5046020167601464,1.0,14/50,18.79%,EPS15;RAB7A;EHD2;RAB11FIP3;ANKRD50;SNX12;EHD1;VPS26A;VPS52;EHD4;ANKRD27;VPS35L;WASHC1;VPS26C
prerank,response to amino acid starvation (GO:1990928),-0.30318761546599293,-1.1662390191490544,0.1931407942238267,0.5044312260662671,1.0,21/72,19.30%,SESN1;MAP3K5;MTOR;LARP1;FAS;SEC13;MAPK1;MIOS;PRKD1;DAPL1;RPTOR;ATP6V1E1;LARS1;KPTN;MAPK8;ATF4;DAP;CASTOR1;GCN1;RNF152;ITFG2
prerank,canonical glycolysis (GO:0061621),0.374635085371904,1.1660195651944507,0.2471395881006865,0.6605416284991189,1.0,6/24,18.81%,GCK;TPI1;PKM;ENO2;HK1;HK3
prerank,glucose catabolic process to pyruvate (GO:0061718),0.374635085371904,1.1660195651944507,0.2471395881006865,0.6605416284991189,1.0,6/24,18.81%,GCK;TPI1;PKM;ENO2;HK1;HK3
prerank,lamellipodium organization (GO:0097581),-0.3758294492684944,-1.1653383324748652,0.2391713747645951,0.506092766594928,1.0,4/29,1.85%,ABLIM1;ITGB1;PARVB;RAC1
prerank,regulation of cell morphogenesis (GO:0022604),-0.37260610107655767,-1.164716383638105,0.236983842010772,0.5070689820687699,1.0,11/30,18.40%,FERMT2;PDZD8;ZMYM6;MACF1;MFSD2A;ZMYM4;FMNL2;MOV10;CAPZB;CFL1;WTIP
prerank,platelet degranulation (GO:0002576),-0.283856800619365,-1.1645292619142495,0.16295025728987994,0.5070947124866504,1.0,34/118,23.75%,ABCC4;VWF;PECAM1;PHACTR2;LYN;THBS1;TMSB4X;APP;PROS1;SRGN;GAS6;FAM3C;TGFB2;APOOL;VEGFC;FLNA;TIMP3;ACTN1;ACTN4;HGF;F5;IGF1;LAMP2;SOD1;NHLRC2;FERMT3;ITGB3;IGF2;VCL;LHFPL2;SERPINE1;SYTL4;TLN1;ITIH3
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.45458344045234655,-1.164408682018488,0.2709447415329768,0.5069477300951882,1.0,6/14,10.16%,LIMS2;LIMS1;LOXL3;PHACTR4;PRKD1;FLNA
prerank,regulation of centriole replication (GO:0046599),-0.4252231335153028,-1.1642787469611569,0.2595419847328244,0.5068504206878783,1.0,6/17,25.56%,KAT2B;PLK2;ALMS1;PLK4;BRCA1;CEP295
prerank,protein dephosphorylation (GO:0006470),-0.27830275343236094,-1.1638891723532396,0.16610738255033558,0.5073158284317698,1.0,38/135,20.31%,PTPRG;PTPRB;PTPRM;PPP2R5A;PTPN14;PPM1H;EYA4;MTMR3;PTPN1;PTPN9;PTPRJ;PTPN12;NCK1;PPEF2;PPM1L;ILKAP;PTPRK;MTMR6;PPM1F;PPP2R2D;PPM1B;PPP1R12A;UBLCP1;PTPN3;DUSP3;PTPN13;CTTNBP2NL;FBXW11;PPP2CB;UBASH3B;TNS2;PPM1D;DUSP16;DUSP22;PPP2CA;PTPRC;PTEN;PPP3CC
prerank,nuclear migration (GO:0007097),-0.45601942191814354,-1.1636642370191508,0.26964285714285713,0.5073997099011446,1.0,5/13,17.98%,SYNE2;DCTN1;PAFAH1B1;FBXW11;PCM1
prerank,regulation of cell aging (GO:0090342),-0.4775202218446983,-1.163590862485603,0.2642857142857143,0.5071633655425337,1.0,4/11,15.37%,NEK6;LMNA;MIF;NUAK1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.3754441451970103,-1.1634320242076823,0.2504472271914132,0.5071365984161503,1.0,11/26,25.25%,ITGB1;NEDD4L;YWHAE;DLG1;NEDD4;CASQ2;WWP2;VAMP2;FHL1;AKAP9;CAB39
prerank,positive regulation of macrophage migration (GO:1905523),-0.39962466702341215,-1.1631010733869933,0.26217228464419473,0.5074777006154868,1.0,4/19,8.04%,THBS1;IL34;PTK2;MAPK1
prerank,ncRNA catabolic process (GO:0034661),-0.3661496409346781,-1.1630719670721832,0.2365988909426987,0.507147459638829,1.0,10/28,25.27%,TENT4B;XRN1;EXOSC2;EXOSC3;TUT4;PARN;EXOSC8;EXOSC5;DIS3L2;EXOSC7
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.35766354256763533,-1.162335116864191,0.20909090909090908,0.508459312991101,1.0,14/30,34.60%,BIRC3;CASP8;UBE2D3;IKBKE;CD40;IKBKG;IKBKB;RIPK1;IRF7;CD300LF;TICAM1;TLR6;CD14;TBK1
prerank,import into cell (GO:0098657),-0.34551914468350264,-1.162116057944296,0.23508137432188064,0.5085338758383683,1.0,8/41,7.79%,SLC47A1;SLC6A6;SLC12A7;LRRC8C;SLC7A1;SLC7A5;SLC5A6;LRRC8D
prerank,positive regulation of lipid storage (GO:0010884),-0.39911441353116145,-1.1620796447057613,0.26071428571428573,0.5082055869776372,1.0,6/21,15.73%,NFKB1;SCARB1;EHD1;IKBKE;LPL;PLIN2
prerank,microvillus assembly (GO:0030033),-0.4601501678493308,-1.1611869518719502,0.2814814814814815,0.5099089215397823,1.0,8/14,19.61%,RAPGEF2;RAP1A;EZR;FXYD5;RAP1B;MAP4K4;RAP2A;RAP2C
prerank,negative regulation of heart contraction (GO:0045822),0.4602756629815081,1.1610813016501567,0.28982300884955753,0.6730104395146131,1.0,3/11,12.08%,ATP1A2;SPTBN4;SRI
prerank,vesicle transport along actin filament (GO:0030050),-0.4096698802186799,-1.1608896208503874,0.2595281306715064,0.5101702161620206,1.0,5/19,12.83%,MYO1D;FNBP1L;WASL;MYO1F;ACTN4
prerank,negative regulation of protein modification process (GO:0031400),-0.3022923000204732,-1.160863455792153,0.18914185639229422,0.5098414155387274,1.0,17/79,14.35%,DAB2IP;MFHAS1;LYN;CORO1C;GSK3B;LRRK2;NIBAN1;CDYL;LRP6;SLIT2;OCLN;PRKAA1;PTPN13;CHP1;PNKP;TRAF3IP1;DNAJC10
prerank,lipid biosynthetic process (GO:0008610),0.29397271670255815,1.16005331227112,0.18357487922705315,0.6742620282959435,1.0,18/77,15.88%,IDI2;FADS1;ACSS2;LSS;ELOVL4;CYP51A1;ACLY;ACACA;OXSM;ACSL6;GNPAT;LIPC;FDFT1;OLAH;SCD5;NDUFAB1;CLN8;ALOX5
prerank,negative regulation of hydrolase activity (GO:0051346),-0.32786287522029056,-1.1600495439313372,0.20848708487084872,0.511223871861969,1.0,11/49,13.15%,DAB2IP;SH3BP4;F11R;LRCH1;LRRK2;ZCCHC9;GPATCH2;RASA4;BCAS3;ARFGEF1;CHP1
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2826389223714737,-1.1597930692726564,0.18625678119349007,0.5113777431675531,1.0,41/109,26.42%,RUFY1;MTMR3;ARF3;PLA2G4A;PLCG1;PIP4K2A;PLCB3;PIK3R1;BMX;PLCB1;PIP4K2B;PI4KB;PIP5K1B;PIK3C2A;MTMR6;RAB5A;PLCG2;PIK3CD;INPP4A;PIK3R6;MTMR12;FGF2;PTPN13;PLEKHA4;PIK3CB;PI4K2B;PIK3R3;PIP4P2;PLA2G12A;LCLAT1;PTEN;PIGW;INPP5D;PDGFRB;MTMR4;PIP5K1A;INPP5J;PIK3CA;PLA2G4F;INPP5E;TPTE
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.33684555405872413,-1.1595499802696425,0.22260869565217392,0.511488497316174,1.0,14/49,23.39%,SGMS1;CAV1;MCL1;DDX3X;TP53;BCAP31;BBC3;BCL2L11;GSDME;PPIF;SIAH1;HERPUD1;BECN1;EIF2AK3
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.40741943587533347,-1.1592473151151954,0.2843691148775895,0.5117634732753504,1.0,7/19,12.27%,TGFBR3;VGLL4;RBP4;MEF2C;TBX2;NOTCH1;FGF2
prerank,anterograde axonal transport (GO:0008089),0.34878308137724656,1.159019779644154,0.24047619047619048,0.675571084371499,1.0,13/37,19.50%,DLG2;RAB27B;AP3S2;KIF5A;KIF3A;AP3M2;KIF1C;SNAPIN;NEFL;TRAK2;MAP1A;HAP1;MAPK8IP3
prerank,phospholipid metabolic process (GO:0006644),0.3016963107221878,1.1589953969722153,0.17972350230414746,0.6739472490623815,1.0,14/71,12.25%,ENPP2;IDI2;FADS1;PIP4P1;PLPPR4;PLPPR1;PLPP2;SMPD3;PLA2G3;PLA2G4E;PLPPR5;ABCA2;GNPAT;FDFT1
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.3549313600432918,-1.158850870359666,0.22614840989399293,0.5122550499823602,1.0,15/33,24.02%,NET1;MAP3K5;ABL1;PRKCD;ANKZF1;TNFAIP3;ANXA1;HDAC6;PPIF;RPS3;MAPK7;NFE2L2;RELA;RIPK1;CYP1B1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.27647438210312875,-1.1587434791644442,0.1811722912966252,0.5121151693936978,1.0,26/138,11.47%,PTPRG;FLT1;TEK;IGF1R;TIE1;ROR1;INSR;ABI1;LYN;BMPR2;KDR;MERTK;EGFR;IL6ST;YES1;PTK2;NGF;EPHA4;FLT4;LIFR;ACVR2A;BCAR1;MPZL1;FRK;RAPGEF1;JAK2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.4000742127100836,-1.1584828380212797,0.2585278276481149,0.5123164493041049,1.0,5/22,12.95%,PTPRJ;EZR;DGKZ;CEACAM1;DUSP3
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.2526574412609272,-1.1580072367380896,0.11330049261083744,0.512969331814758,1.0,103/314,27.45%,FBXL7;WWP1;PELI1;RB1;ECPAS;NEDD4L;ZNRF1;SMURF2;FBXL12;UBE2K;TRIM25;PSMA2;FBXL17;SMURF1;FBXL3;RBX1;UBE4B;CUL3;NEDD4;LTN1;PSME2;CUL2;ANKZF1;SPSB1;PSMB4;GSK3A;UBE2J2;UBE2D3;FEM1A;UBR2;AREL1;TNFAIP1;RMND5A;CDC16;SPOPL;ARMC8;ANAPC16;KAT5;ATXN3;FEM1C;SGTA;MAN1B1;UBE4A;FBXW11;ERLIN2;APPBP2;DNAJC10;PSMC2;FEM1B;ERCC8;PSMB2;PSMB1;AGAP3;TRIM13;CTNNB1;KCTD10;UBXN11;PSMA8;SPOP;DNAJB12;DMAC2;RAD23A;UBR1;SIAH1;PSME1;TRIM3;DNAJB9;RNF4;BUB1B;UCHL1;TBL1X;WWP2;HERPUD1;ECRG4;PSMD4;HUWE1;MDM2;BUB3;PSMA7;RNF216;HACE1;NFE2L2;FZR1;PSMD5;ARRB1;NEMF;MAEA;FBXL22;ZFAND2A;FBXO17;ANAPC7;FBXO38;PSMB10;TMUB1;RNF122;UBXN2A;RNF103-CHMP3;PSMA3;KIF14;USP19;RNF34;RNF103;PPP2R5C
prerank,alanine transport (GO:0032328),-0.47382512227838586,-1.157545408246835,0.30353817504655495,0.5136082939495145,1.0,3/10,20.54%,SLC6A6;SLC36A4;SLC1A4
prerank,negative regulation of ion transport (GO:0043271),0.37628539631170915,1.157512790495635,0.27505330490405117,0.6766203091807264,1.0,6/24,9.30%,GPM6B;STC1;SYT11;WNK2;WNK3;ADRA2A
prerank,T cell mediated immunity (GO:0002456),-0.4542266072662273,-1.1573798226441026,0.275797373358349,0.5136006792425423,1.0,6/13,32.76%,CD55;JAG1;CTSH;GNL1;EMP2;MYO1G
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.34435988495722386,-1.1573698146205398,0.2534965034965035,0.5132304058107302,1.0,6/36,11.78%,SHANK3;ITGB1;HDAC1;EDN1;JAK2;HFE
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.31731029585561193,1.157201372051261,0.23126338329764454,0.6757928747766506,1.0,13/52,11.29%,RBFOX1;KHDRBS2;CELF5;KHDRBS3;SRRM4;CELF4;CELF2;CELF6;FXR2;DDX17;RBFOX3;ZC3H10;RBM8A
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.3672244477238802,1.157093644070077,0.268018018018018,0.6743705521133542,1.0,6/25,18.81%,GCK;TPI1;PKM;ENO2;HK1;HK3
prerank,cell-matrix adhesion (GO:0007160),-0.29480942066950294,-1.1568045087821135,0.184981684981685,0.5141815449131716,1.0,33/95,23.08%,SORBS1;ITGB1;THSD1;BCR;FERMT2;CD34;RAC1;ITGBL1;ITGA3;ITGA1;ITGB4;ADAM9;ITGB5;PPFIA1;PTPRK;ADAMTS9;BCAM;FBLN5;ILK;ACTN1;MSLN;ITGA4;ITGA2;VCAM1;MKLN1;COL13A1;LYVE1;FERMT3;ITGB3;VCL;ITGA7;PIP5K1A;HPSE
prerank,metal ion homeostasis (GO:0055065),-0.34545977160502184,-1.1565322393524957,0.2230347349177331,0.5144208427513954,1.0,8/40,11.02%,SLC12A7;CAV1;FAM20A;CNNM2;TMTC2;SLC12A2;CNNM4;COX11
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.4241798853645974,-1.1560583002667426,0.2570921985815603,0.5150472973496724,1.0,10/16,41.60%,MCM4;RPA1;WRN;BLM;MCM7;MCM2;MCMDC2;HMGA1;TWNK;RECQL4
prerank,protein homooligomerization (GO:0051260),0.27917591323751606,1.155992737176386,0.17903930131004367,0.675827095347425,1.0,23/114,15.30%,KCNC2;MPP2;GLRA3;HCN1;SYCP1;RYR3;C9;ADCY8;ATL1;AQP4;GNMT;SLC1A2;ACACA;CARD11;ALDH1A2;P2RX3;GLS;SIGMAR1;GOLGA2;RNF112;ASIC1;CBY1;TDO2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3238516482676086,1.1558078535146987,0.2109004739336493,0.674676786487318,1.0,13/51,13.10%,CNTNAP2;EPB41L3;SHTN1;NBL1;TNIK;MAP1S;GPM6A;PAK1;NYAP2;MINK1;SRGAP2;SGK1;BDNF
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.3711679762052703,-1.155755481854001,0.24953095684803,0.5153655653373027,1.0,7/32,9.39%,RREB1;WASF2;RAC1;CORO1C;PIK3R1;PLCE1;OCLN
prerank,electron transport chain (GO:0022900),-0.42889959131501804,-1.1553982224928843,0.279296875,0.5157958642920771,1.0,5/15,19.79%,ENOX2;PDIA5;UQCRFS1;ETFRF1;POR
prerank,protein stabilization (GO:0050821),-0.2699434046447338,-1.155232887142609,0.15017064846416384,0.5157639103433449,1.0,59/168,27.57%,HIP1;USP9X;PARVA;DVL3;SOX17;NAA16;PIK3R1;STK3;HPS4;IRGM;PRKCD;RASSF2;TCP1;AAK1;STXBP4;EPHA4;CTNND1;USP2;USP13;NAA15;FLNA;PER3;SMAD7;FLOT1;CHP1;TBRG1;PTGES3;HCFC1;HIP1R;RPL5;CREBL2;IGF1;NCLN;SUMO1;LAMP2;TMEM88;STX12;SOX4;USP7;COA8;TBL1X;PTEN;CREB1;RPS7;HSP90AA1;GLMP;TRIM39;MSX1;PLPP3;CRTAP;HSPA1B;TAF9;CCT5;PEX6;TRIM44;CCT2;USP19;BAG4;BAG5
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.42880566331182735,-1.1552091753632907,0.2624356775300172,0.515418607226729,1.0,5/17,17.30%,CBFA2T3;PPARA;HDAC4;PDE12;PPIF
prerank,regulation of mitotic nuclear division (GO:0007088),-0.32816006704531425,-1.1548449975006239,0.23826714801444043,0.5158271858612938,1.0,32/55,41.41%,INSR;LRP5;CDK13;CUL9;BMP4;CUL7;EDN1;RGCC;EDN3;CCDC8;BMP7;IGF1;IGF2;PDGFRB;CHEK1;TOM1L2;BORA;DUSP1;CAV2;BTC;OBSL1;AURKA;PHIP;IL1A;DRD3;FBXO5;TOM1L1;AURKAIP1;CCNB1;CD28;PDXP;CDC25C
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.3004119212279557,-1.1547903923212752,0.21317157712305027,0.5155423922853328,1.0,18/76,14.72%,TEK;BAIAP2L1;PRKCE;NCK1;ABL1;SNX9;NES;HAX1;EDN1;NCK2;CFL2;FCHSD2;BCAS3;SYNPO2;LMOD1;CDC42EP3;SORBS3;NCKAP1
prerank,cellular response to estrogen stimulus (GO:0071391),-0.4407329318791246,-1.1546546460655787,0.29219600725952816,0.5154487885243367,1.0,11/14,43.67%,NCOA4;BCAS3;RARA;WBP2;PELP1;TRIM24;AR;CRHBP;SERPINB9;SFR1;OCSTAMP
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.4732783290150147,-1.154249018674881,0.2781818181818182,0.5156134730521867,1.0,8/11,45.95%,TCP1;CCT5;CCT2;LARP7;CCT3;CCT7;DKC1;CCT6A
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.4732783290150147,-1.154249018674881,0.2781818181818182,0.5156134730521867,1.0,8/11,45.95%,TCP1;CCT5;CCT2;LARP7;CCT3;CCT7;DKC1;CCT6A
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.3841606802460805,-1.1539258888146822,0.2548330404217926,0.5159663729313232,1.0,12/24,30.86%,DTX3L;SIN3A;CGAS;MAVS;ZDHHC1;HSP90AA1;EIF2AK4;TRIM44;PARP9;TRIM6;TOMM70;LILRB1
prerank,regulation of cell motility (GO:2000145),-0.2773576122985924,-1.1533760340738668,0.19204152249134948,0.5168058961701606,1.0,34/121,17.05%,RAC1;NTN1;TMSB4X;SPOCK2;CRK;DIAPH1;EGFR;ABL1;LMO4;ROBO4;MACF1;FGF1;PRAG1;PLXND1;ROCK1;PLXNA4;RAF1;LDB1;FGF7;AKT1;FLNA;LMNA;FRMD5;ABI3;RHOA;FGF2;CEACAM1;CDK6;PKN2;TBCCD1;ROCK2;CAVIN1;SLK;TMSB10
prerank,protein localization to Golgi apparatus (GO:0034067),-0.3745509593197163,-1.1532421325980904,0.26373626373626374,0.5166852345811461,1.0,10/27,21.42%,VPS13A;VPS13C;GAK;CSNK1D;VPS13D;RIPOR1;GBP5;GOLPH3;ARL5C;IFT20
prerank,protein destabilization (GO:0031648),-0.35993426434330467,-1.1530969941353768,0.25874125874125875,0.5166058643406638,1.0,11/32,18.31%,CREBBP;RNF139;SOX17;FBXL3;CUL3;IRGM;CDC73;FBXW11;SENP2;CTSH;RAD23A
prerank,keratan sulfate catabolic process (GO:0042340),0.4644297832643391,1.1528863910147202,0.2832618025751073,0.6814135132058152,1.0,5/11,21.57%,FMOD;PRELP;HEXB;OGN;ACAN
prerank,negative regulation of cell activation (GO:0050866),0.4392250048650821,1.1524220120843836,0.26244343891402716,0.6810226414252781,1.0,7/14,15.31%,C1QTNF1;NR1D1;PDGFA;GPER1;LDLR;APOE;PDGFRA
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.45347837483654463,-1.1522375108826386,0.2743055555555556,0.5180913444893096,1.0,6/12,30.70%,JAM2;APP;RHOA;CXCL12;CXCL10;TNFRSF14
prerank,neuromuscular junction development (GO:0007528),-0.37988436549700977,-1.151972582215035,0.26353790613718414,0.5182621576657679,1.0,7/24,11.74%,UNC13B;PPFIBP1;LRRK2;NEDD4;AGRN;PDZRN3;DCTN1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.36852367778550243,-1.1518697185209856,0.25225225225225223,0.5180763028923402,1.0,15/31,36.49%,DCUN1D3;RAB1A;MAGEC2;UBE2L3;DCUN1D2;PTEN;DCUN1D5;FZR1;TRIB3;RPS2;PLK1;BMI1;TOPORS;CDC20;UBE2C
prerank,extracellular transport (GO:0006858),0.4473032157595904,1.1516800413096526,0.28604651162790695,0.6815112408074571,1.0,6/12,16.82%,ADCY10;TSG101;ROPN1L;SPAG17;CABYR;DNAAF2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.3696080719725495,-1.15148268242575,0.24220183486238533,0.5185229902308263,1.0,9/29,18.94%,MNAT1;RBX1;ERCC2;RPA3;RPA1;XPC;ERCC3;CETN2;RPA2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.31198106509966755,1.150977234192074,0.2448512585812357,0.6818138098704376,1.0,14/59,16.99%,AKR1D1;CYP46A1;ELOVL4;ACLY;OSBPL6;ACACA;CYP27A1;OXSM;ALDH1A2;LIPC;OSBPL9;NDUFAB1;ALOX5;ACOX2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.4426428496641873,-1.1508064945812042,0.28804347826086957,0.5196582880639817,1.0,4/14,9.84%,PPARA;IRS1;MFSD2A;AKT1
prerank,regulation of stem cell differentiation (GO:2000736),-0.2931289622515978,-1.1506317427796744,0.21978021978021978,0.5196413039430329,1.0,32/89,28.41%,CBFB;TCF12;PSMA2;LMO2;HES1;ABL1;PSME2;YAP1;LDB1;PSMB4;TAL1;NOTCH1;PSMC2;JAG1;TCF3;PSMB2;PSMB1;PSMA8;NELFB;PSME1;GATA2;PRKDC;PSMD4;PSMA7;PTN;RBM24;PSMD5;SP7;PSMB10;PSMA3;HNRNPU;LMO1
prerank,negative regulation of nervous system development (GO:0051961),0.40894886440498246,1.150622863405733,0.2669491525423729,0.681141994399785,1.0,3/17,9.89%,ROBO2;SORL1;SLIT1
prerank,osteoclast differentiation (GO:0030316),-0.39406996372457825,-1.150484995406417,0.24817518248175183,0.5195591236050462,1.0,2/22,2.79%,FOXP1;ANXA2
prerank,cellular response to insulin stimulus (GO:0032869),-0.2779952447643204,-1.1504636084821358,0.18804920913884007,0.5192124886691958,1.0,43/124,26.80%,IGF1R;TBC1D4;SORBS1;FOXO1;GAB1;INSR;GSK3B;KAT2B;PIK3R1;IRS1;RHOQ;PIK3C2A;GRB10;GSK3A;ZNF106;NAMPT;GRB14;BCAR1;AKT1;SLC27A4;RAB8B;INSIG2;CEACAM1;ATP6V1E1;GRB2;DENND4C;FOXO4;PIK3R3;ATP6V0A1;PRKDC;PPARG;LPIN2;IGF2;VAMP2;ATP6V1H;SYAP1;TRIB3;SH2B2;PTPN2;ZFP36L1;APC;HDAC5;ATP6V0E2
prerank,nitrogen compound transport (GO:0071705),-0.2721475282850342,-1.150377472513581,0.1588447653429603,0.5190316196837256,1.0,29/141,13.74%,ABCG2;SLC6A6;CERT1;RUFY1;CALCRL;MYH9;SLC7A1;SLC7A5;RALBP1;RAMP1;RAB7A;SLC12A2;SCAMP2;SLC19A2;SLC38A5;SLC22A5;SLC44A1;SLC1A5;LRRC8D;ARRDC1;ARL6IP5;RAMP2;SLC52A1;SEC14L1;EDN1;TXNIP;SLC52A3;CHMP2B;SLC7A7
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.3762284020655815,-1.1503611969517447,0.2816399286987522,0.5186839741633509,1.0,12/28,25.92%,SHANK3;GSK3B;APP;ABL1;EPHA4;FAM107A;LGMN;ADCY1;CALB1;PTN;CALB2;EIF2AK4
prerank,sensory perception of pain (GO:0019233),0.38706122896204226,1.1501583606569463,0.2711864406779661,0.6808192969905086,1.0,3/21,4.61%,OPRM1;MME;KCNA2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.4037371358401101,1.1494587858337186,0.2748267898383372,0.6811262115712373,1.0,3/17,6.22%,ANK3;AKAP6;RNF207
prerank,DNA catabolic process (GO:0006308),0.45719921637010164,1.14943493479727,0.29764453961456105,0.6794970586101351,1.0,6/11,23.77%,MUS81;REXO4;DNASE1L1;FBH1;ISG20;DNASE1L2
prerank,response to calcium ion (GO:0051592),0.2805519922001693,1.1493461114466188,0.19230769230769232,0.678083174634139,1.0,19/102,9.77%,NLGN1;SYT1;SYT5;KCNMA1;RYR3;SLC25A13;ADCY8;SYT12;SYT11;HPCA;CALM2;HOMER1;RYR2;CPNE9;DPEP1;SCN5A;ACER1;PPP3CA;CPNE1
prerank,MAPK cascade (GO:0000165),-0.25073571863039235,-1.1491325681947426,0.12962962962962962,0.520983400554629,1.0,66/295,17.04%,SPTBN1;TEK;DAB2IP;KITLG;RAPGEF2;SPTAN1;SHANK3;MAP3K20;MEF2A;RASAL2;BRAP;IL17RD;JAK1;RANBP9;PSMA2;LRRK2;MAP3K5;KDR;YWHAE;EGFR;NFKB1;RASGRF2;RBX1;PIK3R1;IRS1;DLG1;SHOC2;CUL3;PTK2;FGF1;MEF2C;PSME2;MAPKAPK2;MAPK1;RAF1;PSMB4;FGF7;PDE6D;MAP3K3;TAOK3;RASA4;PTPN3;PEBP1;BRAF;JAK2;RASA1;FGF2;ABHD17A;FBXW11;MAP3K8;HGF;KSR1;MAPK8;ABHD17C;PIK3CB;PSMC2;GRB2;MAP4K4;PSMB2;MAPK12;PSMB1;ANGPT1;IGF1;FYN;MARK3;CTSH
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.471030780712014,-1.1490909534929756,0.2920517560073937,0.5206852246513904,1.0,5/11,24.29%,ZMIZ1;ARID1B;ELOF1;CHEK1;SERTAD2
prerank,protein polyubiquitination (GO:0000209),-0.2501605717048837,-1.1490653704292297,0.132013201320132,0.5203613394703837,1.0,93/297,26.36%,FBXL7;WWP1;PELI1;UBR5;CBFB;NEDD4L;ZNRF1;SMURF2;TRAF5;FBXL12;UBE2K;TRIM56;PSMA2;FBXL17;DTX3L;SMURF1;RNF125;FBXL3;RNF213;RBX1;LMO7;UBE4B;CUL3;NEDD4;PSME2;RNF115;RNF144B;SPSB1;PSMB4;HECTD1;TRIP12;UBE2J2;ZNRF2;UBE2D3;TPP2;UBR2;FBXW8;AREL1;TRIM14;RMND5A;CDC16;HERC6;UBE2E2;UBE4A;FBXW11;RNF168;PSMC2;RC3H1;RNF167;MYLIP;TNFAIP3;UBE2V2;ERCC8;PSMB2;UBE2L3;PSMB1;PELI2;MIB2;CTNNB1;PSMA8;SPOP;SASH1;KLHL3;SIAH1;RNF152;AKTIP;PSME1;TRIM3;NPEPPS;RNF4;WWP2;PSMD4;HUWE1;BRCA1;UBE2R2;MDM2;PSMA7;RNF216;HACE1;FZR1;PSMD5;THOP1;TRIM68;RNF146;FBXO32;FBXL22;FBXO17;ANAPC7;FBXO40;DTL;FBXO38;PSMB10;ARIH2
prerank,positive regulation of dendrite development (GO:1900006),-0.4801303911884923,-1.1479756142703303,0.29300567107750475,0.5225641894673331,1.0,2/10,3.14%,DAB2IP;BMP5
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.3837509034398788,-1.1478915508293872,0.27787934186471663,0.5223506355242958,1.0,6/23,19.32%,CAV1;CBL;SH3BP5L;HYAL2;DUSP22;PTPRC
prerank,ion transport (GO:0006811),0.2751482449733931,1.1476264230524826,0.1774193548387097,0.6815130257503107,1.0,23/111,14.47%,TRPM3;SLC24A4;SLC24A2;GABRB1;SLC5A12;GLRA1;SLC9A7;KCNN2;SLC9A9;SLC4A2;SLC8A2;SLC1A2;SLC36A2;SLC12A5;PANX2;VDAC2;SLC17A6;KCNN3;SLC8A3;SLC8A1;SLC12A4;SLC1A3;SLC26A8
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.294706302920636,-1.1472761499158175,0.2014260249554367,0.523403925041214,1.0,28/80,29.94%,VTI1A;ERC1;RAB7A;TMEM87B;HEATR5A;VPS54;TBC1D14;BET1L;SNX12;DCTN1;VPS26A;ANKFY1;VPS52;TBC1D23;SNX8;WASHC1;VAMP3;TBC1D17;CLN5;SPAG9;EVI5;RAB9B;RAB6B;VPS35;RBSN;PHETA2;GOSR2;STX5
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.4007885833024284,-1.147254596600205,0.2732142857142857,0.5230615699168942,1.0,8/20,24.53%,DCUN1D3;ZMIZ1;DCUN1D2;EPAS1;WASHC1;DCUN1D5;HSP90AA1;HSPA1B
prerank,membrane repolarization during action potential (GO:0086011),-0.4604139506162184,-1.1465499132772614,0.27787307032590053,0.524307720646305,1.0,7/13,28.18%,KCNJ2;YWHAE;KCNQ1;KCNE4;KCNH2;KCND3;ATP1A1
prerank,regulation of epidermal cell differentiation (GO:0045604),0.3837494293333445,1.146276125868676,0.2718676122931442,0.6837338970918436,1.0,6/21,8.12%,ABCA12;CTSK;SULT2B1;MAFG;SGPP1;MAFF
prerank,sensory perception of sound (GO:0007605),0.28340590784902364,1.146084633313667,0.21266968325791855,0.6826173258118221,1.0,13/88,9.74%,PCDH15;COL2A1;SLC26A5;LHFPL3;EML2;COL1A1;ATP2B2;COL11A2;DCDC2;TMC1;CACNA1D;GRM7;SPTBN4
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.32919893741684897,-1.1460565575934152,0.2509505703422053,0.5250600310580608,1.0,15/50,22.73%,CREBBP;FBXL17;TTC23;SMO;HERC4;WDR11;GLI3;GLIS2;MOSMO;FUZ;ZIC1;KIF7;GPC3;TUBD1;TULP3
prerank,toxin transport (GO:1901998),0.4649910416984569,1.145947036023446,0.2882882882882883,0.6813907911429785,1.0,4/10,12.77%,SLC22A1;SLC29A4;ANTXR1;ANTXRL
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.3938339636026711,-1.145575384735348,0.29009009009009007,0.5258073460911323,1.0,7/22,14.14%,SP100;LRRK2;MDFIC;GDI1;CHP1;UFM1;RAB23
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.3949730638310318,-1.145139444712046,0.2504472271914132,0.5255767321240771,1.0,9/20,27.15%,MAD1L1;ATM;TPR;MAD2L2;BUB1B;BUB3;TTK;APC;TRIP13
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.3949730638310318,-1.145139444712046,0.2504472271914132,0.5255767321240771,1.0,9/20,27.15%,MAD1L1;ATM;TPR;MAD2L2;BUB1B;BUB3;TTK;APC;TRIP13
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.3949730638310318,-1.145139444712046,0.2504472271914132,0.5255767321240771,1.0,9/20,27.15%,MAD1L1;ATM;TPR;MAD2L2;BUB1B;BUB3;TTK;APC;TRIP13
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3197201327243148,1.14486885081961,0.24361948955916474,0.6828424905765478,1.0,9/44,13.40%,AKR1D1;CYP46A1;INSIG1;SC5D;OSBPL6;SQLE;CYP27A1;ALOX12;OSBPL9
prerank,sensory organ development (GO:0007423),-0.3229288288070314,-1.1447251066676705,0.2517241379310345,0.5260821184702884,1.0,17/51,23.57%,PBX1;SH3PXD2B;SMOC1;PBX3;TGFB2;RBP4;ECE1;SIPA1L3;SHROOM2;FOXC1;FREM2;HIPK1;SIX4;PBX2;CHRDL1;ATF6;MYO7A
prerank,negative regulation of bone remodeling (GO:0046851),0.45038913270958825,1.1441662065152058,0.2662192393736018,0.6832310360386438,1.0,2/11,3.45%,CARTPT;CALCA
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.39214733320515494,-1.1438149780038782,0.29895104895104896,0.5277438327696602,1.0,12/22,44.17%,GSK3B;ROCK1;ROCK2;IKBKB;CRY2;BOD1L1;PPP1R1B;BOD1;FKBP1B;MASTL;STYXL1;TNF
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.29486503907245487,-1.1436503345932518,0.210896309314587,0.5277296427780871,1.0,29/86,22.06%,GHR;PECAM1;APP;PAK2;IL15;PTPRJ;EGFR;BMP6;IL6R;ABL1;PRKCD;ARHGEF2;PLCG2;HAX1;CSPG4;FGF7;TP53;JAK2;HGF;MIF;ANGPT1;IGF1;FYN;PTPRC;RAP2C;ITGB3;IGF2;PTPN11;PTK2B
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.285639460714793,-1.1433313449333888,0.21607142857142858,0.5277061172668901,1.0,27/104,20.36%,CREBBP;TAB3;LYN;PRKACB;RPS6KA5;PSMA2;PAK2;NFKB1;PRKCD;PSME2;RAF1;PSMB4;PLCG2;FBXW11;ICAM2;PSMC2;PSMB2;PSMB1;TAB2;FYN;PSMA8;IKBKG;IKBKB;PSME1;KRAS;NRAS;PSMD4
prerank,cellular response to lectin (GO:1990858),-0.285639460714793,-1.1433313449333888,0.21607142857142858,0.5277061172668901,1.0,27/104,20.36%,CREBBP;TAB3;LYN;PRKACB;RPS6KA5;PSMA2;PAK2;NFKB1;PRKCD;PSME2;RAF1;PSMB4;PLCG2;FBXW11;ICAM2;PSMC2;PSMB2;PSMB1;TAB2;FYN;PSMA8;IKBKG;IKBKB;PSME1;KRAS;NRAS;PSMD4
prerank,RNA transport (GO:0050658),-0.30258120506486075,-1.1431707264641626,0.2222222222222222,0.5277101773587745,1.0,21/71,20.24%,SRSF11;RAE1;SARNP;RTRAF;TGFBR2;THOC2;UPF3B;THOC7;DDX39B;DHX38;NUP153;SLU7;FLOT1;HNRNPA1;TPR;THOC3;THOC1;NUP214;SRRM1;RNPS1;SRSF3
prerank,macrophage differentiation (GO:0030225),-0.4480025645695286,-1.1429538942286033,0.2852112676056338,0.5278165909048849,1.0,3/13,9.60%,IL15;BMP4;CASP8
prerank,brain development (GO:0007420),0.26652467962580817,1.1428325785305988,0.18993135011441648,0.6854414737153959,1.0,19/136,7.58%,CNTNAP2;ROBO2;CTNNA2;CNTN4;GRIN2B;DSCAML1;ADGRL3;GRIN2A;POMK;MEIS1;NDRG4;MEIS3;MDGA1;PITPNM1;SMG9;PAX2;MAP1S;PROX1;BBS4
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.3824519071673326,1.1426048200168164,0.2811791383219955,0.6845057439188098,1.0,5/22,9.55%,RELL2;GADD45B;SPHK1;VEGFA;MINK1
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.33487147032994147,-1.1421886840759343,0.25257731958762886,0.5291674428433655,1.0,15/41,21.16%,ENG;TGFBR3;TGFBR2;TGFB2;BMP4;MEF2C;GSK3A;SMAD7;NOTCH1;TPM1;JAG1;HEY1;HEY2;SOX4;DLL4
prerank,regulation of T cell migration (GO:2000404),-0.40825164408134856,-1.141892220577722,0.3,0.5294474032539488,1.0,3/18,3.19%,CD200;APP;LRCH1
prerank,amino acid import across plasma membrane (GO:0089718),-0.3822536133316471,-1.141833367723599,0.2713310580204778,0.5291743006024316,1.0,5/24,7.64%,SLC47A1;SLC6A6;SLC7A1;SLC7A5;SLC1A5
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.28191922013963155,-1.1417786527667908,0.20481927710843373,0.5288834859043372,1.0,21/102,12.66%,TBC1D4;SORBS1;FOXO1;INSR;CAV1;PRKACB;KAT2B;ADCY9;SLC30A10;NFKB1;PIK3R1;IRS1;RHOQ;PRKCD;ADCY4;GSK3A;AKT1;CYSLTR2;RAB8B;INSIG2;CEACAM1
prerank,cellular response to glucose starvation (GO:0042149),-0.33301604336205376,-1.1410949964077763,0.2577132486388385,0.5300465058603112,1.0,19/41,34.07%,SESN1;MTMR3;SIK1;FOXO3;TP53;PRKAA1;KPTN;ATF4;HNRNPA1;NUAK1;ITFG2;BECN1;EIF2AK3;PMAIP1;CPEB4;NIM1K;TBL2;NUAK2;SZT2
prerank,cellular response to calcium ion (GO:0071277),0.3034249801941882,1.140958980751508,0.22274881516587677,0.6876621715369075,1.0,15/67,12.14%,NLGN1;SYT1;SYT5;RYR3;ADCY8;SYT12;SYT11;HPCA;CPNE9;DPEP1;SCN5A;ACER1;CPNE1;SYT4;GPLD1
prerank,regulation of chemotaxis (GO:0050920),-0.35760415484134606,-1.1404108407261393,0.2918918918918919,0.531209689438746,1.0,11/30,30.81%,ADGRA2;THBS1;STX3;PPM1F;DUSP3;CCL19;ZSWIM6;PDGFRB;PTPN2;TREM2;TGFB1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.28416001369673116,-1.1402143602765709,0.20677361853832443,0.5312158628783433,1.0,27/105,20.36%,CREBBP;TAB3;LYN;PRKACB;RPS6KA5;PSMA2;PAK2;NFKB1;PRKCD;PSME2;RAF1;PSMB4;PLCG2;FBXW11;ICAM2;PSMC2;PSMB2;PSMB1;TAB2;FYN;PSMA8;IKBKG;IKBKB;PSME1;KRAS;NRAS;PSMD4
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.4121693503978813,1.1398030487916562,0.26555023923444976,0.6892108227321831,1.0,4/15,4.83%,KCNA5;KCNJ3;KCNN2;ATP1B1
prerank,neurogenesis (GO:0022008),-0.33017542717072335,-1.1393685855021944,0.24521739130434783,0.5328062458643129,1.0,15/43,19.71%,TRAK1;METTL14;THOC2;SIX1;TGFB2;BTBD3;CDK6;BTBD1;FAT4;SIX4;ANXA1;NDUFS2;DAGLB;CLN5;RITA1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.2768099516536848,-1.1393115830288028,0.2179054054054054,0.5325546633379156,1.0,33/121,16.83%,GHR;PECAM1;LYN;PTPN1;PAK2;IL15;PTPRJ;ACE;IL6ST;BMP6;IL6R;HES1;GAS6;ABL1;IL34;PARP14;EPHA4;ARHGEF2;PLCG2;HAX1;CSPG4;FGF7;TP53;JAK2;NEDD9;STAP2;CD40;HGF;MIF;TNFRSF1A;ANGPT1;IGF1;NOX4
prerank,synaptic vesicle localization (GO:0097479),0.4428983886500794,1.1392546311635885,0.29850746268656714,0.6891711726832647,1.0,4/13,10.15%,NLGN1;CDK5;SYNDIG1;KIF5A
prerank,regulation of intracellular protein transport (GO:0033157),-0.3512426441237281,-1.138752329492326,0.26595744680851063,0.5334751298777265,1.0,15/32,25.30%,PTPN14;PTPN1;BMP4;BCAS3;ICE1;LCP1;TPR;RIPOR1;PCM1;OAZ2;NDEL1;VAMP2;PCNT;CEP131;PLK3
prerank,regulation of postsynapse organization (GO:0099175),0.3554835968561742,1.1383752464536026,0.2695852534562212,0.6901160024885716,1.0,7/28,10.54%,IL1RAPL1;PPFIA2;CDK5;CDKL5;HOMER1;TANC2;ABI2
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.4482556509341926,-1.1379284483574637,0.3131868131868132,0.5350052407070749,1.0,2/13,6.02%,ENTPD1;ENTPD6
prerank,DNA replication (GO:0006260),-0.2787879443254158,-1.1378102543220896,0.20869565217391303,0.5348995339746526,1.0,48/105,33.70%,MCMBP;RBMS1;ATM;TOP3A;BAZ1A;MRE11;MCM9;RBBP8;CLSPN;MCM4;ORC5;RPA3;DNA2;KAT5;REV1;RPA1;PNKP;TBRG1;TOP1MT;ORC2;POLE2;PTMS;WRN;ORC4;RPA2;TIMELESS;BRCA1;BLM;RFC4;CHEK1;MCM3;TOP1;RFC1;POLA2;MCM7;MCM5;MCM10;POLL;EXO1;SET;ING5;MCM2;RMI1;RAD50;GRWD1;ORC3;CDC6;PIF1
prerank,regulation of protein localization (GO:0032880),-0.31202444007967806,-1.1377237823334931,0.2351851851851852,0.5347077738656986,1.0,21/58,28.79%,DVL3;TRIM25;AFDN;DLG1;AAK1;DNAJB6;PPM1F;MMD;PICALM;TRIM14;MAPK8;TPR;DZIP1L;SUMO1;ITGB3;HSP90AA1;TRIM68;TMEM231;TRIM67;TRIM6;BORA
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.3537816590533034,-1.1355411312600288,0.28545454545454546,0.5394465381835037,1.0,10/29,25.37%,RPS21;RPS14;NOL10;UTP3;RPS16;DCAF13;UTP4;RRS1;RPS8;WDR46
prerank,spindle assembly (GO:0051225),-0.3041901369642725,-1.1355344766859907,0.252991452991453,0.5390587061674847,1.0,21/67,22.31%,NEK7;NEK6;STAG1;CCDC61;TOGARAM1;WRAP73;HAUS8;FLNA;RHOA;CSNK1D;ARHGEF10;HAUS6;STAG2;KIF11;TUBGCP4;RAB11A;TUBGCP5;RPS3;KIF3B;STARD9;MISP
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.4288735647851254,-1.134047813437618,0.3018181818181818,0.542122594142014,1.0,7/15,28.28%,PPARA;LPL;PLIN2;PPARG;PNPLA2;PLIN3;TREM2
prerank,sterol metabolic process (GO:0016125),0.29668409296143317,1.1332474403854569,0.22779043280182232,0.703241088743284,1.0,13/60,9.92%,CYP46A1;INSIG1;PIP4P1;SULT2B1;CYP26B1;CYP51A1;SC5D;SQLE;NSDHL;TSKU;CYP27A1;CYP11B1;OSBPL5
prerank,positive regulation of immune effector process (GO:0002699),-0.3654731739801127,-1.1329159822896286,0.2611111111111111,0.5443280523920728,1.0,5/27,11.08%,ANKRD17;PTPRJ;LBP;MYO18A;DDX60
prerank,metanephros development (GO:0001656),0.3585251307599431,1.1326011570172385,0.28211009174311924,0.7034702520659941,1.0,5/26,6.07%,ROBO2;WNT7B;OSR1;WT1;PAX2
prerank,zinc ion transmembrane transport (GO:0071577),-0.38035012525807615,-1.1325797951485894,0.2755632582322357,0.5447019866871262,1.0,7/22,20.73%,SLC39A10;SLC30A10;SLC39A8;SLC39A11;SLC30A5;SLC39A6;SLC30A1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.4087823889192631,1.1325118487067878,0.28314606741573034,0.7020170014638372,1.0,3/16,6.86%,CLDN18;CLDN14;CLDN11
prerank,tRNA metabolic process (GO:0006399),-0.4056170237158495,-1.1324478197007994,0.29294755877034356,0.5445924698438266,1.0,8/17,36.94%,FARS2;DARS2;TRPT1;RPP30;SSB;DTD2;SARS1;THG1L
prerank,sphingolipid biosynthetic process (GO:0030148),-0.3027904628660476,-1.1323464711689097,0.24428822495606328,0.5444293950800637,1.0,23/71,20.25%,SGMS1;CERT1;ACER2;DEGS2;SGMS2;A4GALT;PRKD3;PRKD2;SPNS2;ELOVL5;CERS4;PPM1L;PRKD1;ACER3;AGK;SPTLC1;ASAH1;CERS5;SMPD2;VAPA;LARGE1;DEGS1;ELOVL7
prerank,regulation of macrophage cytokine production (GO:0010935),-0.4482332281372896,-1.132157614409845,0.29783393501805056,0.5444897592005453,1.0,3/13,9.00%,SEMA7A;TGFB2;PLCG2
prerank,regulation of histone acetylation (GO:0035065),-0.34844459797895444,-1.1320169210312891,0.27717391304347827,0.5444220491970759,1.0,16/33,30.97%,RPS6KA5;IWS1;SETD5;RUVBL2;TAF7;BRCA1;CHEK1;NOS1;MYOCD;ARRB1;RAPGEF3;HDAC5;GLYR1;SET;SPI1;RPS6KA4
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.4110092331661471,-1.1315229885804565,0.30347349177330896,0.5452017120861712,1.0,12/17,48.63%,CD55;BACH2;JAG1;GNL1;STAT3;MYO1G;IL18;TLR4;BTN3A3;EBI3;SLA2;IL12B
prerank,positive regulation of DNA binding (GO:0043388),-0.35484512913112987,-1.1310021327446853,0.2690972222222222,0.5460102929269188,1.0,14/31,30.81%,RB1;HES1;NGF;FOXC1;IGF1;SKI;CEBPG;TXN;PPARG;HMGB1;PINX1;TRIM6;PLAUR;TGFB1
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.38418243561236937,-1.1308367868219424,0.27586206896551724,0.5459744750178251,1.0,8/22,17.05%,KANK3;TMSB4X;SLIT2;PRKCD;KANK4;ARFGEF1;HIP1R;TMSB10
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.30105183442852224,-1.130802987821884,0.2395644283121597,0.5456393957757101,1.0,21/70,21.85%,CBFB;TCF12;PSMA2;LMO2;ABL1;PSME2;YAP1;LDB1;PSMB4;TAL1;PSMC2;TCF3;FOXC1;PSMB2;PSMB1;PSMA8;PSME1;GATA2;PRKDC;PSMD4;PSMA7
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.4093795296559941,-1.1307436841213585,0.3006993006993007,0.5453704422091105,1.0,5/18,12.94%,RALBP1;KDR;MIEF1;BNIP3;MIEF2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.32019994225585446,-1.1304501506190703,0.2595978062157221,0.5456059407323027,1.0,17/51,15.36%,FERMT2;RAC1;PXN;ABL1;ARHGEF15;PPM1F;RGCC;RHOA;LIMCH1;SYNPO2;TPM1;WNT11;MYOC;RHOC;ARHGEF10;SORBS3;ROCK2
prerank,C-terminal protein amino acid modification (GO:0018410),0.4510560753661336,1.1301764713465885,0.3159041394335512,0.7071787392295383,1.0,3/11,12.14%,AGBL4;AGBL1;GPLD1
prerank,response to UV-B (GO:0010224),0.44201832047554224,1.1297715160178141,0.29646017699115046,0.7067117528530608,1.0,3/12,9.73%,MME;STK11;IL12A
prerank,organophosphate biosynthetic process (GO:0090407),0.3207631718565467,1.1296404256764154,0.2683982683982684,0.705431650813358,1.0,8/37,11.40%,ITPKA;FADS1;TKT;TPI1;GK;IP6K2;IPPK;GNPAT
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.3954355636736649,-1.1296397676031473,0.28785046728971964,0.547033833940568,1.0,6/19,15.96%,TENT4B;STN1;XRN1;CTC1;HNRNPA1;TERF2
prerank,mammary gland epithelium development (GO:0061180),0.4308770338266924,1.129033593177245,0.3120879120879121,0.7055075847364181,1.0,2/14,1.29%,ERBB4;WNT7B
prerank,membrane fusion (GO:0061025),-0.3441002033773056,-1.1285263027230046,0.2760511882998172,0.5491229175336301,1.0,12/33,22.30%,MYOF;DNM3;DYSF;DNM2;RABEP1;CHP1;VAPA;VAMP3;HUWE1;RABIF;VAMP2;HACE1
prerank,mRNA stabilization (GO:0048255),-0.3408814095206122,-1.1283670820952565,0.26811594202898553,0.5490999279853046,1.0,16/40,30.72%,HNRNPA0;LARP1;FUS;MAPKAPK2;AXIN2;SYNCRIP;ANGEL2;RBM24;THRAP3;TAF15;DHX9;PABPC1;HNRNPU;TENT5C;MAPK14;BOLL
prerank,protein N-linked glycosylation (GO:0006487),-0.2997796066703003,-1.1281813684162458,0.2486865148861646,0.5491386264569846,1.0,18/66,16.93%,ST3GAL1;ALG14;ST6GAL1;ALG10B;MAN1C1;DAD1;MGAT4B;GFPT2;FUT8;SLC39A8;ALG12;ALG8;OST4;ALG11;DOLPP1;ALG13;UGGT1;MGAT2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.4858774792869696,-1.127582209594124,0.3304195804195804,0.5501574117598521,1.0,10/10,51.45%,SMAD7;RC3H1;NFKBID;IL4;FOXP3;MALT1;RC3H2;TBX21;NFKBIZ;ZC3H12A
prerank,positive regulation of translational initiation (GO:0045948),-0.40244798784164154,-1.1272883391939832,0.31438721136767317,0.5504144828582542,1.0,5/18,12.82%,DDX3X;MTOR;LARP1;POLR2G;CDC123
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3831595728474667,-1.126994178500016,0.28822495606326887,0.5503369756009288,1.0,8/23,14.96%,PPP1R13B;YWHAE;YWHAZ;NMT1;CASP8;TP53;MAPK8;BBC3
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3831595728474667,-1.126994178500016,0.28822495606326887,0.5503369756009288,1.0,8/23,14.96%,PPP1R13B;YWHAE;YWHAZ;NMT1;CASP8;TP53;MAPK8;BBC3
prerank,innate immune response in mucosa (GO:0002227),-0.4807306050715541,-1.1268660116031324,0.3169811320754717,0.5502443241776898,1.0,9/10,51.96%,RNASE3;DEFA6;RPL39;NOS2;IL4;CAMP;BPIFB1;DEFB1;LTF
prerank,regulation of protein secretion (GO:0050708),0.26884272833562206,1.1267013822686527,0.2116279069767442,0.7105616175336369,1.0,31/119,18.04%,KCNC2;STXBP5L;SNAP25;GIP;GCK;KCNA5;CACNA1A;EXOC1;MTNR1B;CYP51A1;ANG;CACNA1D;ADRA2C;CACNA1E;GIPR;ADRA2A;IL12A;FRMD4A;EIPR1;ATP13A2;LLGL1;CCL5;PPID;PPIA;APOE;ALOX5;SLC8B1;ADAM8;GLP1R;ABCC8;KCNG2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.46480395905368194,1.1262827359687833,0.3372093023255814,0.7101511010128411,1.0,4/10,14.60%,DGKQ;GNMT;SIRT7;SELENOS
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.4474860450159204,-1.1261598104459825,0.30071174377224197,0.5515227141498299,1.0,5/12,31.57%,RAB27A;PLCG2;ADGRB1;SLC5A3;TLR6
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.28711885373558865,-1.1259513958435488,0.226890756302521,0.5516533122710932,1.0,23/86,14.72%,RB1;CLIP1;BAIAP2L1;RAC1;PRKCE;APP;NCK1;TOGARAM1;SNX9;OCLN;EDN1;NCK2;CFL2;PSEN1;FCHSD2;DCTN1;SYNPO2;LMOD1;SLAIN2;DRG1;CDC42EP3;GPX1;NCKAP1
prerank,integrated stress response signaling (GO:0140467),0.4155778159327902,1.1258852736166134,0.2962962962962963,0.7095597798575475,1.0,4/14,15.10%,OMA1;IMPACT;CCL2;EIF2AK1
prerank,protein modification process (GO:0036211),-0.29426723179754966,-1.125752603129114,0.22621184919210055,0.551759573523744,1.0,22/76,21.35%,ST3GAL6;ST3GAL1;PLOD2;ST8SIA4;PARP4;YES1;CSNK1G3;ABL1;PHKA2;UBE2D3;UBA7;ERO1A;STK38;MSRA;UBE2M;UBE2L3;PLAT;BAP1;PRKDC;WWP2;UBL4A;LOX
prerank,cellular response to leucine starvation (GO:1990253),-0.4694386481118603,-1.1252917510074194,0.3368606701940035,0.5524484783115416,1.0,4/10,16.82%,SESN1;MTOR;LARS1;GCN1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.37022247160002686,-1.1247269079466158,0.28822495606326887,0.5533533780076714,1.0,9/24,19.32%,ITPR1;PKD2;ITPR2;PLCG2;HTR2A;ERO1A;FGF2;CCL19;PTPRC
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.42083769148080863,1.1242097182636284,0.30837004405286345,0.7128225113397517,1.0,4/13,8.20%,KCNA5;KCNJ3;KCNN2;SCN5A
prerank,regulated exocytosis (GO:0045055),0.255814469427085,1.1240237290802808,0.18734177215189873,0.7117004335974303,1.0,31/173,13.29%,ABCA12;SYT1;PCLO;SYT5;BLK;RIMS2;SNAP25;RIMS1;CDK5;F8;SYT12;SYT11;CLEC3B;PLEK;CD63;RAB27B;ECM1;LY6G6F;PF4;STXBP2;TIMP1;VEGFA;PDGFA;RAB3A;VTI1B;CHID1;SYT4;SERPING1;SYNGR1;CDC37L1;CLU
prerank,histone methylation (GO:0016571),-0.367766105194429,-1.1237970005688618,0.30158730158730157,0.5550955971380911,1.0,8/26,18.02%,CREBBP;NSD1;NSD3;SUV39H1;EHMT1;SMYD1;N6AMT1;CARM1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.41644992031798517,1.1236101990268428,0.3150105708245243,0.711288037802223,1.0,4/14,9.70%,AK7;AK5;AK3;NME2
prerank,polyamine metabolic process (GO:0006595),-0.42870819448851333,-1.123450611853655,0.30505415162454874,0.555521290666254,1.0,5/13,23.10%,SMOX;HDAC6;HDAC10;OAZ2;SRM
prerank,regulation of interleukin-12 production (GO:0032655),-0.31910871427268717,-1.1233010233178158,0.26763110307414106,0.5554901805372044,1.0,9/47,18.45%,FOXP1;THBS1;MAST2;PLCB1;PLCG2;CD40;IL16;CMKLR1;CCL19
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.3490636385402924,-1.1222593731528387,0.2760511882998172,0.5575432789539259,1.0,13/33,28.93%,LYN;ACER2;ADAM9;TGFB2;PTK2;EPHA2;FERMT3;PTPN11;SERPINE1;CYP1B1;ADA;SNAI2;FOXC2
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.2995644893062943,-1.1221169984117765,0.2407079646017699,0.5574553068396758,1.0,29/68,32.12%,SLC2A1;PANK2;SLC25A32;SLC5A6;SLC19A2;MTHFD1;PDXK;RFK;AOX1;SLC52A1;SLC52A3;LMBRD1;MTHFD1L;PCCA;PCCB;GSTO2;CUBN;ALDH1L1;MTRR;PNPO;MTR;SHMT1;SLC19A3;SLC2A3;VNN1;HLCS;SLC25A19;SLC23A1;SLC23A2
prerank,keratinocyte differentiation (GO:0030216),-0.358707167080758,-1.1219641039937236,0.2701252236135957,0.5573877752036155,1.0,9/29,19.29%,BCR;ADAM9;MED1;WNT16;TXNIP;JAG1;ASAH1;ANXA1;EPHA2
prerank,spermatid development (GO:0007286),0.34126150771744657,1.1214316588740914,0.27564102564102566,0.7161639821345795,1.0,13/32,23.58%,DDX25;CCDC63;ZMYND15;BBS4;RNF8;MKKS;YTHDC2;NME5;SYCP3;IQCG;ACRBP;CIB1;TDRD5
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.3258623493740338,-1.1213961790529483,0.2914485165794066,0.5583453939058262,1.0,15/41,26.43%,PLA2G4A;ELOVL5;PTGS1;GSTM2;EPHX1;MGLL;GPX1;ACOX1;ACSL1;DAGLB;DEGS1;PTGR1;PNPLA8;CYP1B1;GPX4
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.3562767767059176,1.121306435131026,0.29333333333333333,0.7148765267083268,1.0,9/27,19.07%,HPCA;CALM2;CACNB3;CACNB4;ADRA2A;HRC;SELENON;CACNB1;PDE4D
prerank,positive regulation of interferon-beta production (GO:0032728),-0.34481391701679526,-1.1211713600771998,0.28256880733944956,0.5584912123860654,1.0,18/33,36.11%,IFIH1;TRIM56;DDX3X;IRF1;FLOT1;POLR3F;MAVS;PTPN11;HSP90AA1;DHX9;IRF7;RIOK3;TOMM70;IRF5;POLR3A;TBK1;TLR2;TLR8
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.41347571349948437,1.1208447623613518,0.31333333333333335,0.714561107628644,1.0,5/14,9.21%,PPP2R2B;PPP5C;PPP2R2C;PPP3CA;PPTC7
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.2790318081677954,-1.1205627515493919,0.24493554327808473,0.5594752056269935,1.0,21/95,10.57%,ST3GAL6;ST3GAL4;ST3GAL1;EXT1;GCNT2;CSGALNACT1;B3GNT2;GPC6;CHST15;NDST1;B4GALT4;SLC10A7;DSE;HS3ST3B1;AGRN;HSPG2;ST3GAL2;CHST11;CSPG4;HS3ST1;BGN
prerank,Golgi to plasma membrane transport (GO:0006893),-0.3217234430878608,-1.1203610684591838,0.2719298245614035,0.5595196461748837,1.0,15/47,22.58%,SPTBN1;EXOC6;STXBP6;EXOC4;GOLPH3L;MACF1;RABEP1;EXOC2;GOLGA4;EXOC8;GOLPH3;VPS35L;KIF13A;VAMP2;ARFGEF2
prerank,regulation of vacuole organization (GO:0044088),-0.39349527302737497,-1.1201340000657034,0.29464285714285715,0.5596477398081329,1.0,4/20,8.79%,ANXA2;MTMR3;RAB5A;TBC1D14
prerank,negative regulation of kinase activity (GO:0033673),-0.3054892819240414,-1.1197016164764,0.27827648114901254,0.5602628806129563,1.0,18/62,21.49%,RB1;PPP2R5A;CEP85;PAK2;CDKN1B;RTRAF;LRP6;PPM1F;PRKRIP1;AKT1;CEACAM1;CHP1;TAF7;UBASH3B;PTPRC;AKT1S1;NF1;WARS1
prerank,regulation of multicellular organismal development (GO:2000026),-0.368378269219241,-1.1195123412364598,0.30565371024734983,0.5602910392600905,1.0,5/25,10.19%,INSR;SOX17;NIPBL;TRIP12;EHMT1
prerank,gliogenesis (GO:0042063),-0.42661394608129,-1.119403330809274,0.30925925925925923,0.5601364793289372,1.0,6/15,18.34%,NFIB;METTL14;TGFB2;CDK6;ANXA1;NDUFS2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.36520344338000077,-1.1193623333210183,0.30017761989342806,0.5598261982447099,1.0,6/25,15.35%,HIP1;AFAP1L2;CBL;AKT1;ARAP1;HIP1R
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.2927951839378041,-1.1183787662298783,0.2568493150684932,0.5618025065288235,1.0,23/73,24.95%,THBS1;IFIH1;APP;PTPRJ;FRMD8;LBP;ARHGEF2;PLCG2;PSEN1;JAK2;LPL;MIF;MAVS;CCL19;NOD2;PTPRC;PTPN11;ARFGEF2;RIPK1;FZD5;HMGB1;DDT;DHX9
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.38454292222527825,-1.117575412532264,0.30286738351254483,0.5633188866799365,1.0,4/19,8.04%,THBS1;IL34;PTK2;MAPK1
prerank,vesicle organization (GO:0016050),-0.32506839096451673,-1.1172379940595576,0.27624309392265195,0.5636724364599676,1.0,15/46,18.82%,DNAJC13;CAV1;CD34;EPS15;FNBP1L;SRGN;ALS2CL;WASL;CHMP2B;EXOC8;PI4K2B;ALS2;ZFYVE16;WASHC4;AKTIP
prerank,calcium ion homeostasis (GO:0055074),0.276671955452404,1.1167813339669805,0.2700228832951945,0.7250566161794066,1.0,16/95,12.58%,SLC24A4;SLC24A2;HTR2C;STC1;ATP2B4;ATP2B2;ATP1B1;SLC8A2;RYR2;TMCO1;CCL13;ATP13A2;CIB2;SLC8A3;SLC8A1;CCL5
prerank,acute inflammatory response (GO:0002526),-0.3752713363855418,-1.1167536195268812,0.2949640287769784,0.5644096434647153,1.0,13/23,37.61%,IL6R;LBP;ANO6;PLSCR1;CTNNBIP1;F3;IL22;AHSG;VNN1;CEBPB;HPR;HP;CRP
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.3705852474623031,1.1166917957506914,0.30612244897959184,0.7236535942489475,1.0,5/25,9.33%,ANK3;ATP1B1;WNK2;WNK3;STAC
prerank,regulation of myotube differentiation (GO:0010830),-0.3749745159821311,-1.1162500059489842,0.3089887640449438,0.5651567595377884,1.0,11/24,26.60%,SIK1;HDAC1;MAML1;NOTCH1;HDAC4;SMYD1;CCN3;PIEZO1;RBM24;DMPK;HDAC5
prerank,regulation of muscle contraction (GO:0006937),0.35280257200360016,1.1161603460140976,0.2800875273522976,0.7235713538712436,1.0,6/26,12.61%,CHRM2;ATP1A2;TNNC1;NMUR2;SRI;MYL2
prerank,negative regulation of inflammatory response (GO:0050728),-0.2549366144935138,-1.1159536740697085,0.18537414965986396,0.5654214587080676,1.0,37/182,16.68%,TEK;GNB1;RB1;CALCRL;KLF4;MYH9;MFHAS1;LYN;CD200;PRKACB;ADCY9;RAMP1;PLCG1;YES1;PPARA;TNFRSF1B;GGT5;OTULIN;PRKCD;CDH5;PLK2;RHBDF2;ADCY4;PPARD;PLCG2;RAMP2;FEM1A;ADM;CYSLTR2;TNFAIP3;IAPP;CCN3;C1QTNF3;ADCY1;TNFRSF1A;IGF1;FYN
prerank,embryonic axis specification (GO:0000578),-0.41928196365300346,-1.1152641989110248,0.3242258652094718,0.5666769827426699,1.0,9/15,34.00%,SMAD2;TASOR;SMAD6;TBX3;FZD5;RIPPLY2;PTCH1;WNT7A;HOXD8
prerank,determination of heart left/right asymmetry (GO:0061371),-0.32186997575982756,-1.1149130668863994,0.28987993138936535,0.5671071191133137,1.0,8/42,8.09%,ENG;PKD2;MICAL2;SOX17;SMO;TGFBR2;MEF2C;TBX2
prerank,midbody abscission (GO:0061952),-0.40473591211149046,-1.1148331627384689,0.3156862745098039,0.5668731372476261,1.0,11/17,36.37%,CHMP4B;CHMP4A;CHMP2B;MITD1;CHMP5;PDCD6IP;CHMP3;CHMP6;CHMP1A;KIF20A;CHMP1B
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.2988648098098908,-1.1145410731657595,0.26126126126126126,0.5671622616853677,1.0,22/69,25.93%,INTS8;SP1;RPRD2;POLR2G;NABP1;GTF2E1;GTF2E2;TAF11;ICE1;INTS3;SNAPC1;TAF8;INTS9;PHAX;INTS7;SNAPC3;TAF13;POLR2C;CCNK;TAF9;POLR2L;POLR2H
prerank,macromolecule catabolic process (GO:0009057),-0.36845284808994105,-1.1143705915225048,0.32044198895027626,0.567152459706722,1.0,15/26,36.36%,SMURF1;MTOR;NEDD4;USE1;LGMN;SIAH1;CLN5;SNX25;KIF16B;BECN1;PPT1;TGFB1;CLPX;CLN6;TRIM24
prerank,ephrin receptor signaling pathway (GO:0048013),-0.28686902906049333,-1.1143146772393095,0.2577132486388385,0.566882569202442,1.0,32/82,22.47%,ANKS1A;RAC1;LYN;ARHGEF28;CRK;MMP2;YES1;AP2B1;AP2A2;PSEN2;CHN1;PTK2;AP2S1;WASL;ITSN1;ROCK1;EPHA4;NCK2;PSEN1;RASA1;RHOA;ACTB;ROCK2;ARPC4;FYN;APH1A;EPHA2;AP2M1;PTPN11;VAV2;EPHB6;EPHB3
prerank,regulation of cell growth (GO:0001558),-0.25042528977647777,-1.1141018220348613,0.1931407942238267,0.5669893073850122,1.0,67/204,25.55%,APBB2;SMARCA2;ACVRL1;RB1;DCUN1D3;BMPR2;SH3BP4;NET1;DDX3X;MTOR;PTPRJ;SOX17;EGFR;TFRC;CDKN1B;VGLL4;CRLF3;SLIT2;TGFB2;PLCE1;RASGRP2;EXOSC2;SMAD4;MFSD2A;FAM107A;BCAR1;ADAM10;AKT1;SOCS2;TP53;AGTR1;RPTOR;ARHGEF11;DCBLD2;LTBP4;RPS6KA1;CEACAM1;WNT11;ST7L;RPS6KA3;H3-3A;CCN3;N6AMT1;RERG;MAD2L2;NPR1;KIF26A;OSGIN2;HYAL2;BAP1;BRAT1;PPP2CA;CDK11B;BCL6;DCUN1D5;CDKN2C;CAPRIN2;FHL1;MTPN;MSX1;SERTAD2;HSPA1B;GNG4;INO80;APBB1;SIPA1;SERTAD3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.47081794142915834,-1.1139189608793276,0.34026465028355385,0.5670196084967806,1.0,4/10,17.32%,SP100;TP53;KAT5;TFAP4
prerank,regulation of chemokine production (GO:0032642),-0.3369403128389413,-1.113359710429038,0.2872340425531915,0.5679927624104536,1.0,24/36,48.17%,FOXP1;APP;IL6R;LPL;ACKR1;IL7;ADAM17;LGALS9;SNAI2;HMOX1;TREM2;TSLP;CD74;TLR2;HIF1A;IL18;SIGIRR;TLR4;TNF;IL6;TLR3;AGER;F2RL1;WNT5A
prerank,platelet aggregation (GO:0070527),-0.3429359237203498,-1.1129977614982622,0.302491103202847,0.5684331111301815,1.0,14/33,27.59%,MYH9;FLNA;ILK;ACTN1;ACTB;PIK3CB;CLIC1;UBASH3B;FERMT3;ITGB3;VCL;TLN1;MYL9;RAP2B
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3467686171520723,-1.1124314945074576,0.302491103202847,0.5693775919074607,1.0,10/30,16.38%,LYN;SHOC2;NGF;TGM2;NOTCH2;RAPGEF1;JAK2;NOTCH1;GRB2;IGF1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.4371300453051793,-1.1124287150485725,0.3393829401088929,0.5689768687806933,1.0,4/13,19.36%,PTPN1;NCK1;ABCA7;DNAJB9
prerank,negative regulation of autophagy (GO:0010507),-0.31053281889981754,-1.1112602703686079,0.2883959044368601,0.5713095788836757,1.0,13/54,16.41%,MCL1;TAB3;TLK2;ATG7;LRRK2;MTOR;RASIP1;TBC1D14;DAPL1;AKT1;HGF;DAP;TAB2
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.3753304281392004,-1.1112088158139537,0.31130434782608696,0.571038268340204,1.0,12/21,36.91%,MAD1L1;ATM;TPR;MAD2L2;BUB1B;BUB3;TTK;APC;TRIP13;PLK1;CDC20;FBXO5
prerank,regulation of cell division (GO:0051302),-0.28955247814461027,-1.1109094870172376,0.25357142857142856,0.5712950667177867,1.0,22/72,25.30%,MLLT3;SETD2;AHCTF1;ZFYVE26;FGF1;RAB11FIP3;PLK2;BIRC6;TAL1;KLHL13;TXNIP;RAB11A;PLK4;CETN2;CDK2AP2;PRC1;BLM;KIF13A;BECN1;KIF18B;TLE6;PLK3
prerank,regulation of synapse maturation (GO:0090128),0.4591440924171445,1.1106843567239475,0.3476297968397291,0.7383208128677101,1.0,3/10,6.81%,NRXN1;ANAPC2;CAMK2B
prerank,mitochondrial fission (GO:0000266),-0.4113277219825404,-1.1104321034255982,0.33448275862068966,0.5719903560865238,1.0,3/16,6.07%,DNM3;MIEF1;DNM2
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.3938800050013976,-1.1104054340112512,0.30397236614853196,0.5712598498827354,1.0,13/20,48.74%,GSTT1;GSTM2;ESD;HPGDS;GSTO2;GSTK1;MGST2;GSTM5;GSTA4;GSTM4;GSTP1;AKR1A1;GSTA2
prerank,glutathione derivative metabolic process (GO:1901685),-0.3938800050013976,-1.1104054340112512,0.30397236614853196,0.5712598498827354,1.0,13/20,48.74%,GSTT1;GSTM2;ESD;HPGDS;GSTO2;GSTK1;MGST2;GSTM5;GSTA4;GSTM4;GSTP1;AKR1A1;GSTA2
prerank,B cell differentiation (GO:0030183),-0.31735394458975374,-1.110377317782308,0.28191489361702127,0.5709228556420178,1.0,18/46,26.60%,ITGB1;PTPRJ;ZBTB7A;PLCG2;TPD52;HDAC4;ITGA4;NHEJ1;TCF3;VCAM1;CEBPG;CLCF1;PTPRC;DNAJB9;GPS2;PTPN2;ADAM17;HDAC5
prerank,regulation of transmembrane transport (GO:0034762),-0.3529344453990537,-1.1102384746041933,0.304270462633452,0.5708330585723425,1.0,13/31,26.89%,SLC2A1;NEDD4L;KCNJ2;NEDD4;OCLN;ACTB;CTTNBP2NL;KCNJ8;WWP2;PIM1;TRIB3;ACE2;KCNJ13
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.39012175783593717,-1.1099036798242015,0.3298245614035088,0.5712166842663343,1.0,3/19,6.73%,PPARA;IRS1;PRKCD
prerank,regulation of viral transcription (GO:0046782),-0.32567412100566956,-1.1097580991998062,0.2779783393501805,0.5711609747700793,1.0,20/39,33.95%,UBP1;POLR2G;MDFIC;TRIM14;IFITM3;TRIM13;NELFB;SUPT4H1;POLR2C;DHX9;POLR2L;POLR2H;RSF1;LARP7;TRIM32;TRIM62;NELFA;NELFCD;POLR2E;TARBP2
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.40592382757447953,-1.109632378729457,0.3190394511149228,0.5710370556108605,1.0,6/18,16.22%,NCK1;PIK3R1;ERN1;USP13;ATXN3;BCL2L11
prerank,negative regulation by host of viral process (GO:0044793),-0.46085774229925686,-1.1095569363680216,0.32460732984293195,0.5708127469140369,1.0,9/10,51.96%,VAPA;CCNK;EIF2AK4;CRP;CCL8;PTX3;PSMC3;ZC3H12A;LTF
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4344503282593635,1.1093065513852578,0.309255079006772,0.7407952041024951,1.0,6/12,24.39%,GMNN;WRNIP1;NUGGC;KAT7;WDR18;TIPIN
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.3734960373544848,-1.1092829973285698,0.3156934306569343,0.571062509762065,1.0,7/22,20.84%,RNF139;MAN1C1;MAN1A2;MAN1B1;TRIM13;UGGT1;EDEM2
prerank,signal transduction in response to DNA damage (GO:0042770),-0.3178555443447842,-1.109274324912647,0.2922794117647059,0.5706833820693195,1.0,17/49,25.60%,MAP3K20;ACER2;ATM;ABL1;CLSPN;TP53;DOT1L;NDRG1;GRB2;USP10;MAD2L2;ATRX;CHEK1;GADD45A;INTS7;E2F7;ERCC6
prerank,nucleic acid-templated transcription (GO:0097659),-0.3239073255447121,-1.1091401465154538,0.28842832469775476,0.5705906123052928,1.0,16/42,26.98%,MEF2A;THRB;POLR2G;PWP1;TAF1B;DRG1;CREBL2;RNPS1;TERT;PTMA;MED20;POLR2C;POLR2L;MLF1;POLR2H;MMS19
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3511905474498128,-1.108618276655394,0.29853479853479853,0.5714354247566783,1.0,11/29,27.04%,CBFB;ESR1;STRN3;YAP1;UFM1;CARM1;WBP2;BRCA1;SRARP;CNOT2;CNOT1
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.4477974473405356,-1.1085944133642969,0.34050179211469533,0.5710854663328493,1.0,5/12,17.12%,RB1;CTCF;WAPL;AXIN2;CTNNB1
prerank,protein targeting to membrane (GO:0006612),-0.28360252243310036,-1.1085693299007384,0.26512455516014233,0.5707440467668462,1.0,35/83,36.63%,PARD3;ZDHHC6;ZDHHC3;AQP11;ABCD3;SRPRA;CHMP4B;CHMP4A;RAB8B;SGTA;PEX14;SRP14;SIL1;ZDHHC1;ZDHHC4;PEX3;ZDHHC12;RAB3IP;SEC61A1;ATG3;VPS37B;PEX11B;PEX19;RTP4;GOLGA7B;ZDHHC9;SEC63;PEX26;ZDHHC22;SRP19;NCF1;VPS37C;ICMT;YIF1B;RABGEF1
prerank,polyol biosynthetic process (GO:0046173),0.4041173087625509,1.1085426674412158,0.32516703786191536,0.7412943025623082,1.0,5/16,10.42%,ITPKA;ISYNA1;CYP27A1;IP6K2;IPPK
prerank,icosanoid metabolic process (GO:0006690),-0.33161736795508906,-1.1083833636680986,0.2926391382405745,0.5707596064306999,1.0,17/40,32.41%,PLA2G4A;PON2;GGT5;MAPKAPK2;PTGS1;EPHX1;MGLL;GPX1;DAGLB;PTGR1;PNPLA8;CYP1B1;PTGIS;GPX4;TBXAS1;ALOX5AP;ALOXE3
prerank,regulation of pseudopodium assembly (GO:0031272),-0.4650243818720777,-1.1083657852761395,0.3170731707317073,0.569995683497525,1.0,9/10,50.29%,CDC42EP3;WASHC1;CDC42EP1;APC;CDC42EP5;CDC42EP4;CDC42EP2;F2RL1;CDC42
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.4650243818720777,-1.1083657852761395,0.3170731707317073,0.569995683497525,1.0,9/10,50.29%,CDC42EP3;WASHC1;CDC42EP1;APC;CDC42EP5;CDC42EP4;CDC42EP2;F2RL1;CDC42
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.31129730207124795,-1.1082971650947344,0.2735674676524954,0.5697496031297593,1.0,14/51,17.12%,NEK7;TENT4B;STN1;ATM;XRN1;TCP1;MAPK1;HMBOX1;CTC1;PNKP;PARN;HNRNPA1;TERF2;CTNNB1
prerank,negative regulation of protein processing (GO:0010955),-0.45042355504217213,-1.1080866972078713,0.3406193078324226,0.569850458719501,1.0,6/12,22.81%,THBS1;LRRK2;SNX12;CTSZ;SERPINE2;SERPINE1
prerank,sulfur amino acid metabolic process (GO:0000096),-0.36461727311873615,-1.1078878006131625,0.29684601113172543,0.5699235720952924,1.0,12/24,27.94%,MTHFD1;TXN2;MSRA;NOX4;CDO1;CTH;ADO;GCLC;MTRR;MPST;AHCY;MTR
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.3638551132037679,-1.107356891181311,0.31607142857142856,0.5708044617754199,1.0,15/26,36.91%,RB1;NEK6;CUL3;CDC16;NSMCE2;CENPE;ANAPC7;DUSP1;ANAPC11;ANAPC5;PLK1;CDC6;ESPL1;UBE2C;FBXO5
prerank,regulation of cytoplasmic transport (GO:1903649),-0.46055554357186834,-1.1073477228031146,0.34935304990757854,0.5704242481158683,1.0,3/11,8.04%,DNAJC13;LRRK2;MAPK1
prerank,cellular response to amino acid starvation (GO:0034198),-0.2891764532762036,-1.107218161110458,0.27256317689530685,0.5703395446431828,1.0,26/71,27.17%,SESN1;MAP3K5;MTOR;FAS;SEC13;MAPK1;MIOS;PRKD1;DAPL1;RPTOR;ATP6V1E1;LARS1;KPTN;MAPK8;ATF4;DAP;CASTOR1;GCN1;RNF152;ITFG2;ATP6V1H;EIF2AK3;RHEB;EIF2AK4;ATP6V0E2;WDR24
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.44756961491624037,-1.1071671113527106,0.3471223021582734,0.5700658427741926,1.0,3/12,16.33%,GCNT2;FLOT1;BMP7
prerank,C4-dicarboxylate transport (GO:0015740),0.40501439698853087,1.1064932967610652,0.3136792452830189,0.7457370676964704,1.0,3/14,6.54%,SLC25A13;LRRC8E;SLC1A2
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.3836683643305965,-1.1062718510020926,0.3146067415730337,0.5717027767815726,1.0,3/19,3.89%,IFIH1;SETD2;DDX3X
prerank,cellular response to oxygen levels (GO:0071453),0.45514100125323703,1.1056891182690896,0.33940774487471526,0.7464516604119399,1.0,4/10,19.05%,CCDC115;ATP6V0A2;ATP6V0D1;ATP6V1A
prerank,regulation of programmed cell death (GO:0043067),-0.2563824168533151,-1.1050561352465493,0.24149659863945577,0.5742001242093903,1.0,30/161,13.04%,MECOM;HIP1;PPP1R13B;CREBBP;DAPK1;ACER2;ATM;LRRK2;BIRC3;RARG;ABL1;ZBTB7A;FAS;STEAP3;BNIP3;TGM2;RAF1;HAX1;BCAR1;AKT1;TP53;CRADD;PERP;JAK2;ACER3;TM7SF3;ACTN1;ACTN4;NDRG1;RTKN
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.3790938465536749,-1.1046189029286788,0.33941605839416056,0.5747926019300259,1.0,5/21,11.89%,MITF;MED1;JUN;MED13;MED17
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.4553497138697108,-1.1043158032957445,0.3393177737881508,0.575113322655562,1.0,10/11,50.73%,SMAD7;HFE;CEACAM1;PTPRC;LILRB1;AHR;KLRD1;FOXP3;XCL1;KLRC1
prerank,androgen receptor signaling pathway (GO:0030521),-0.4516505917996627,-1.104186531391594,0.33507853403141363,0.5750239422056699,1.0,5/11,29.33%,ZMIZ1;KDM3A;PMEPA1;PLPP1;RNF14
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.42589806171822625,-1.1036198081767181,0.3456140350877193,0.5759258398737082,1.0,5/15,15.58%,PRKCH;MED1;BMP4;FOXC1;TRIM16
prerank,regulation of mitotic spindle organization (GO:0060236),-0.33454539010902595,-1.1035413527094229,0.29699248120300753,0.5756990682299988,1.0,23/35,40.85%,RAE1;CHMP4B;DCTN1;DRG1;CHMP2B;TPR;CHMP5;TACC3;PDCD6IP;HSPA1B;CHMP3;HNRNPU;CCSAP;BORA;CHMP1A;MAP9;PARP3;PLK1;PSRC1;CHMP1B;TPX2;CEP97;CLTC
prerank,regulation of T cell activation (GO:0050863),0.3136820582319871,1.1032081480404978,0.2911111111111111,0.7523238171409646,1.0,8/42,15.73%,TNFSF18;PAG1;PRELID1;VTCN1;CCL5;CCL2;CD47;SIRPA
prerank,glutamine family amino acid metabolic process (GO:0009064),0.33623729735500846,1.1027246535755704,0.2925170068027211,0.7520671530254256,1.0,16/33,25.82%,DDAH2;OAT;PYCR2;RIMKLA;GLS2;GLS;GLUD1;ART4;NIT2;RIMKLB;DDAH1;MTHFS;ALDH4A1;SIRT4;GCLM;FPGS
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.3701676113925145,-1.102639215443383,0.3102836879432624,0.5774459872223567,1.0,7/22,10.76%,LYN;RANBP9;SP1;EPHA4;GSK3A;PICALM;SLC2A13
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.28737016138808336,-1.102426498259313,0.26851851851851855,0.5775458203129377,1.0,25/72,26.54%,RBFOX2;SPRED2;CEP57;CBL;SHOC2;FGF1;HNRNPM;MAPK1;POLR2G;FGF7;HNRNPF;FGF2;TIAL1;GRB2;HNRNPA1;FLRT2;FGFR4;PTPN11;KIF16B;FRS2;POLR2C;POLR2L;POLR2H;FLRT3;FGF10
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.37169443993229334,-1.1022954827340914,0.30927835051546393,0.5774215585419903,1.0,6/23,15.68%,CBFA2T3;SIK1;PPARA;GSK3A;HDAC4;C1QTNF3
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.3675076587146734,-1.102289545151729,0.321880650994575,0.5770322554108106,1.0,5/24,9.39%,WASF2;RAC1;PIK3R1;PLCE1;OCLN
prerank,response to interleukin-4 (GO:0070670),-0.4606904927064681,-1.1017381361192926,0.3447653429602888,0.5779457478028792,1.0,1/10,0.16%,LEF1
prerank,modulation by symbiont of host process (GO:0044003),0.45707604893160714,1.1014321796251558,0.3576158940397351,0.7543191359912004,1.0,6/10,29.70%,HGS;UBB;MRC1;PGK1;RPS27A;UBC
prerank,glycolipid metabolic process (GO:0006664),-0.321671652359253,-1.1006962142677232,0.30134357005758156,0.5799868745428837,1.0,14/47,21.99%,ESYT2;ST3GAL6;ST3GAL4;ST6GALNAC3;ST3GAL2;ARSA;ASAH1;SMPD2;GBA2;GBGT1;GLTP;PIGW;CTSA;GLA
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.4254579331640835,-1.100256387177644,0.34328358208955223,0.5806016239886987,1.0,6/13,29.26%,ZMIZ1;ARID1B;ELOF1;CHEK1;SERTAD2;SPI1
prerank,negative regulation of translational initiation (GO:0045947),-0.42676992809578385,-1.1002394413740064,0.3391304347826087,0.5802401963403596,1.0,9/13,36.90%,EIF3E;LARP1;AGO2;TPR;EIF2AK4;PAIP2B;EIF4EBP1;EIF4EBP3;PAIP2
prerank,regulation of plasminogen activation (GO:0010755),0.43101465097686215,1.1002386439557978,0.3492407809110629,0.7561484419047974,1.0,3/12,7.09%,MELTF;CLEC3B;PLGRKT
prerank,negative regulation of ossification (GO:0030279),-0.36709226035015474,-1.1001623880140863,0.32971014492753625,0.5800338074311729,1.0,6/23,15.62%,SRGN;TRPM4;MEF2C;NOTCH1;BCOR;SMAD6
prerank,phosphatidic acid metabolic process (GO:0046473),-0.31262760670770706,-1.0999862261411673,0.3180147058823529,0.5800382940531481,1.0,16/48,25.54%,PLA2G4A;LPCAT1;PLD1;PLD2;DGKA;AGPAT4;DGKZ;ACP6;AGPAT3;AGPAT1;PLA2G12A;LCLAT1;DDHD2;GPD1;DGKH;DGKE
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4427407389716853,1.0997319967080947,0.33853006681514475,0.7560363501556806,1.0,2/11,0.95%,ANK3;BLK
prerank,positive regulation of histone deacetylation (GO:0031065),-0.44494028634436195,-1.0996928421823444,0.33992805755395683,0.580323368786709,1.0,3/12,8.54%,PRKD2;NIPBL;PRKD1
prerank,eye morphogenesis (GO:0048592),-0.3900281848529531,-1.0995256580137835,0.3596330275229358,0.5803416698587931,1.0,7/19,10.69%,COL5A1;NIPBL;RARG;COL5A2;NKD1;SHROOM2;AGTPBP1
prerank,insulin secretion (GO:0030073),0.37631333357787333,1.098757203660757,0.3304535637149028,0.7574165169408072,1.0,2/19,1.46%,RIMS2;PTPRN2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.3965267842907695,-1.0984494055662974,0.3333333333333333,0.5824597549515228,1.0,12/19,31.66%,ADK;POLD3;AMPD2;HPRT1;AMPD3;TERT;ADA;PNP;POLL;GMPR2;APRT;DCK
prerank,cellular response to nitrogen compound (GO:1901699),-0.38073018427354566,-1.0981648766552148,0.32989690721649484,0.5827557018386592,1.0,9/20,21.31%,DDI2;SPIDR;RTF2;NSMCE3;PDE12;ROCK2;ATRX;TIMELESS;BLM
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.45448936766617065,-1.0972102433641775,0.3684210526315789,0.5846768381002314,1.0,3/11,17.00%,SMAD7;RC3H1;ANXA1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.37891406356322266,-1.0970195773018203,0.31478260869565217,0.5847279265600576,1.0,11/21,38.32%,RAB1A;RPL5;MAD2L2;PTEN;RPS7;FZR1;PLK1;CDC20;UBE2C;FBXO5;BAG2
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.37616896582004977,-1.0968497105561437,0.3231046931407942,0.5847038457156506,1.0,5/22,7.85%,PDGFD;DDX3X;ACE;RASSF2;MRE11
prerank,negative regulation of complement activation (GO:0045916),-0.45966554324546527,-1.0968290252256425,0.3726937269372694,0.5843438286943871,1.0,2/10,7.02%,CR1L;CD55
prerank,barbed-end actin filament capping (GO:0051016),-0.39537258937677544,-1.0956195222950436,0.3279569892473118,0.5864017198964071,1.0,3/18,2.67%,EPS8;ADD3;SVIL
prerank,actin filament capping (GO:0051693),-0.39537258937677544,-1.0956195222950436,0.3279569892473118,0.5864017198964071,1.0,3/18,2.67%,EPS8;ADD3;SVIL
prerank,negative regulation of cell junction assembly (GO:1901889),-0.36647179523313655,-1.0954688176871934,0.32342007434944237,0.5863861387422122,1.0,11/25,20.17%,ACVRL1;CORO1C;THBS1;ACE;ROCK1;FAM107A;BCAS3;ROCK2;IKBKB;DUSP22;PTEN
prerank,macroautophagy (GO:0016236),-0.2643197578533849,-1.0953098183661745,0.29432624113475175,0.5863540439675459,1.0,51/118,36.26%,LIX1L;MTMR3;ATG7;ATG10;MAP1LC3B;PIP4K2A;AMBRA1;PIP4K2B;TECPR1;CHMP4B;CHMP4A;TOMM40;PRKAA1;WIPI1;GABARAP;FUNDC1;VTA1;CHMP2B;ZFYVE1;VPS36;ILRUN;ATG5;TOMM5;LAMP2;HDAC10;KLHL3;PRKAB1;PLEKHM1;BECN1;STAM2;VPS39;TOMM20;CHMP3;DYNLL1;ATG3;VPS37B;TOMM70;LIX1;CHMP6;ARL8B;VAMP8;TCIRG1;YOD1;WIPI2;TOMM6;GABARAPL2;VPS37C;VCP;MTMR14;CSNK2A1;CSNK2A2
prerank,regulation of RNA export from nucleus (GO:0046831),-0.44602015359030134,-1.0952946292126986,0.36116152450090744,0.5859949990629019,1.0,6/11,24.95%,SETD2;IWS1;NUP153;TPR;KHDRBS1;DHX9
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.43535113364395384,-1.0952480143133267,0.3574007220216607,0.5857129228936928,1.0,4/13,14.14%,GNAI3;LRRK2;RHOQ;RAB23
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.400542734611284,1.0952040224190411,0.32798165137614677,0.7663848670960727,1.0,2/15,8.37%,MAGI2;ACVR1B
prerank,aminoglycan metabolic process (GO:0006022),0.45498121609063474,1.0949478876261034,0.34151785714285715,0.7654358856888209,1.0,4/10,17.72%,B4GALT7;CHST9;B3GAT1;GAL3ST3
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.35406283632753666,-1.094902429433049,0.3376383763837638,0.5861677008601145,1.0,9/26,27.81%,SLC30A10;PPARA;RAB27A;PLCG2;ABCB7;COA8;ADGRB1;SLC5A3;SLC25A33
prerank,sterol transport (GO:0015918),-0.38787193094586225,-1.0936022824985643,0.3507853403141361,0.5888375694070188,1.0,5/19,21.53%,CAV1;LDLRAP1;STARD3;OSBPL2;LCAT
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.24015769858491812,-1.09346854416741,0.2198952879581152,0.588730193012462,1.0,76/241,28.11%,SRSF11;PRPF3;METTL14;SMU1;PSPC1;CWF19L2;RSRC1;HNRNPA0;RBM5;NOVA2;HNRNPR;UPF3B;FUS;PRPF6;SF3B6;SPEN;RBM19;HNRNPM;POLR2G;PHF5A;DDX39B;SF3B1;PUF60;PRPF31;CPSF7;SNIP1;HNRNPA3;HNRNPUL1;EFTUD2;DHX38;DBR1;HNRNPF;SFPQ;SLU7;CTNNBL1;SNRPE;SF3A1;HNRNPA1;SYNCRIP;SRSF12;CWC25;RBM4B;ZMAT5;BUD13;CD2BP2;FIP1L1;TFIP11;SRRM1;NONO;RNPS1;SRSF3;SRSF10;TRA2B;LSM3;RBM6;CWC22;PPIH;RBM15;PCBP1;POLR2C;GEMIN7;USP39;RNPC3;PDCD7;SF3B5;GCFC2;DHX9;POLR2L;PRPF40B;POLR2H;HNRNPL;HNRNPD;PABPC1;HNRNPU;TXNL4A;LSM2
prerank,organelle assembly (GO:0070925),-0.22930286264617228,-1.0930916401415725,0.18181818181818182,0.5892157876455162,1.0,94/384,21.53%,ABCC4;ABLIM1;PGM5;EXOC6;ASAP1;NEK7;CD34;PARVA;ATG7;FNBP1L;RAB7A;SH3PXD2B;EXOC4;DDX3X;RAB1A;NEK6;MAP1LC3B;EHD2;PTPDC1;LIMD1;CCDC61;SSX2IP;TMOD3;AMBRA1;CEP250;HPS4;IRGM;E2F4;IFT140;CDC14A;OGFOD1;WDR11;RAB11FIP3;EXOC2;PDE6D;HAUS8;CHMP4B;CHMP4A;FLNA;WIPI1;POGZ;GABARAP;PRRC2C;EHD1;WDR35;GALNT11;RAB8B;NOTCH1;IFT52;LMOD1;CSNK1D;VTA1;CHMP2B;CFAP44;ULK2;HAUS6;RAB23;ZFYVE1;TRAF3IP1;VPS36;CEP41;RC3H1;RAB32;EXOC8;ATG5;FUZ;TUBGCP4;DZIP1L;NUDCD3;EHD4;CHMP5;RAB11A;TUBGCP5;HDAC6;DBNL;CFAP298;EDC3;PLK4;PCM1;STX12;RPS3;TMEM17;CENPE;KIF3B;IFT43;EMC6;GORASP2;WDR45B;PDCD6IP;KIF27;ATG16L2;IFT20;STARD9;LSM3
prerank,axonal transport of mitochondrion (GO:0019896),0.44005640927596223,1.0923134862899702,0.3630434782608696,0.7717355359958673,1.0,7/11,25.15%,SYBU;MAPT;NEFL;TRAK2;HAP1;SPAST;ACTR10
prerank,epithelial cell migration (GO:0010631),-0.33084218059673004,-1.0923044500143728,0.3286219081272085,0.5906993492587279,1.0,11/37,15.17%,NOS3;ADGRA2;PLEKHG5;PXN;ABL1;PLXND1;ROCK1;STARD13;RHOA;PKN2;PKN3
prerank,actin crosslink formation (GO:0051764),-0.43987575647961735,-1.0920968935716517,0.3444639718804921,0.5907726854484585,1.0,4/12,12.71%,EPS8;BAIAP2L1;FLNA;LCP1
prerank,visual system development (GO:0150063),-0.3318219832341874,-1.0920446484858908,0.3169877408056042,0.5905051374384855,1.0,14/37,23.20%,PBX1;SH3PXD2B;SMOC1;PBX3;TGFB2;RBP4;SIPA1L3;FOXC1;FREM2;HIPK1;PBX2;ITGAM;CHRDL1;ATF6
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.34863139689368106,-1.091974304984446,0.3207885304659498,0.5902733911990112,1.0,11/27,35.99%,TAB3;IRAK1;TAB2;IRAK2;MAP3K7;TNIP1;TLR6;TLR1;TLR5;CD14;TLR2
prerank,negative regulation of nuclear division (GO:0051784),-0.45312619925246217,-1.091834909996642,0.34668989547038326,0.5902069379443382,1.0,7/11,38.90%,BMP4;BMP7;CHEK1;TOM1L2;FBXO5;TOM1L1;AURKAIP1
prerank,regulation of endopeptidase activity (GO:0052548),0.293519625389845,1.0915638842400366,0.3068181818181818,0.7723475615813645,1.0,11/59,12.71%,VTN;SPOCK3;SPOCK1;PRELID1;SERPIND1;TIMP1;A2ML1;ATP13A2;SERPINA2;SERPING1;FETUB
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.3837671128344776,-1.0914701266007916,0.34317343173431736,0.5906748801020545,1.0,7/20,15.61%,THBS1;PRKD2;DSTYK;FGF2;SPRY4;FGFBP3;SMOC2
prerank,cell junction organization (GO:0034330),-0.2905744285061295,-1.0914277700795803,0.3176895306859206,0.5903762081370114,1.0,18/71,12.61%,TJP1;APBB2;FERMT2;PPFIBP1;LIMS2;LIMS1;APP;TGFB2;PPFIA1;TJP2;AGRN;OCLN;FLNA;ILK;PSEN1;RAB8B;RHOA;ACTB
prerank,ether lipid metabolic process (GO:0046485),0.4059041234025971,1.0913757172585783,0.3398268398268398,0.7711987577662586,1.0,6/14,12.68%,FAR1;PLA2G7;PLA2G6;GNPAT;DHRS7B;PEDS1
prerank,cellular response to interferon-gamma (GO:0071346),-0.2830148998847967,-1.0910151726767578,0.2887323943661972,0.5909890804335545,1.0,25/88,23.92%,SP100;DAPK1;IRF2;TRIM25;JAK1;CCL25;ICAM1;MID1;CAMK2G;PRKCD;GBP6;IRF1;JAK2;GBP4;PDE12;SYNCRIP;VCAM1;GBP5;CCL19;IFNGR2;FCGR1A;CASP1;RPL13A;GBP3;TRIM68
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.36087733421836254,-1.09075264876442,0.3333333333333333,0.5912048688884398,1.0,10/25,27.75%,PRPF3;PRPF6;SF3B1;DBR1;SLU7;SRRM1;SRSF10;TRA2B;SCAF11;TXNL4A
prerank,negative regulation of coagulation (GO:0050819),0.40731727729464073,1.0905736969592832,0.3548387096774194,0.7719583476672087,1.0,2/14,2.07%,VTN;HS3ST5
prerank,snRNA transcription (GO:0009301),-0.29051287786717195,-1.090544567539523,0.2992957746478873,0.59133342062299,1.0,22/70,25.93%,INTS8;SP1;RPRD2;POLR2G;NABP1;GTF2E1;GTF2E2;TAF11;ICE1;INTS3;SNAPC1;TAF8;INTS9;PHAX;INTS7;SNAPC3;TAF13;POLR2C;CCNK;TAF9;POLR2L;POLR2H
prerank,neutrophil mediated immunity (GO:0002446),-0.22911563854552616,-1.090526899723193,0.1945337620578778,0.5909714521637681,1.0,102/432,21.99%,PTPRB;SPTAN1;PECAM1;DNAJC13;KCMF1;RAC1;CTSC;ADGRE5;IQGAP1;ANXA2;CDK13;ATG7;PSMA2;RAB7A;KMT2E;DDX3X;DIAPH1;ANXA3;PTPRJ;ACE;LPCAT1;PLD1;IDH1;AP2A2;NFKB1;TNFRSF1B;RAB5B;MOSPD2;ENPP4;PRKCD;CD55;RAP1A;CD93;HRNR;MAPK1;RAP1B;ROCK1;PDXK;OSTF1;RAB27A;TSPAN14;RNASE3;NBEAL2;IGF2R;RAB4B;STOM;ADAM10;FRK;PGLYRP1;STK10;PSEN1;EEF2;ALDOC;ANO6;ARMC8;RHOA;HMOX2;PA2G4;CEACAM1;CAT;UBR4;PRCP;RHOG;ARSA;LRG1;RAB24;PSMC2;MIF;CTSZ;TOM1;ASAH1;PSMB1;SRP14;CTSH;LAMP2;DBNL;DSN1;VAPA;PLEKHO2;ATP6V0A1;VPS35L;SCAMP1;NAPRT;PTPRC;FRMPD3;KCNAB2;B4GALT1;RAP2C;NRAS;DEGS1;ORMDL3;HUWE1;GYG1;CAP1;CD53;AMPD3;VCL;CTSA;VAMP2;NDUFC2;ITGAM;GLA
prerank,toll-like receptor signaling pathway (GO:0002224),-0.2831693933069151,-1.0904267499830567,0.2979094076655052,0.5907973821130379,1.0,34/84,36.11%,TAB3;BIRC3;NMI;LBP;MAPKAPK2;PLCG2;CASP8;UBE2D3;IRAK1;S100A1;RPS6KA3;LGMN;TAB2;IRAK2;IKBKG;IKBKB;ITGAM;RIPK1;HMGB1;MAP3K7;TNIP1;LGALS9;PIK3AP1;TICAM1;TLR6;RFTN1;TNIP2;SCARA3;TLR1;TLR5;CD14;S100A9;TLR2;TLR8
prerank,cellular response to drug (GO:0035690),-0.3535811405718543,-1.0903477045319432,0.33807829181494664,0.5906020697571794,1.0,7/25,10.11%,ACER2;TFRC;GAS6;KCNQ1;MEF2C;PPM1F;TP53
prerank,sphingolipid metabolic process (GO:0006665),-0.26958629315408217,-1.0900506112448003,0.2925531914893617,0.5909221301952664,1.0,34/108,21.99%,SGMS1;ESYT2;CERT1;ACER2;DEGS2;SGMS2;PRKD3;PRKD2;SPNS2;ST6GALNAC3;ELOVL5;CERS4;PPM1L;PRKD1;ACER3;PDXDC1;ARSA;AGK;ORMDL1;SPTLC1;ASAH1;CERS5;SMPD2;GBA2;VAPA;SERINC1;GLTP;PPP2CA;DEGS1;ORMDL3;ELOVL7;TEX2;CTSA;GLA
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3973452666586037,1.0899875384675521,0.3544857768052516,0.7719982657446917,1.0,4/16,10.48%,ATIC;PAICS;ADSS2;ADSS1
prerank,response to tumor necrosis factor (GO:0034612),-0.2778209672454562,-1.0898248320821744,0.28620689655172415,0.5910410018641807,1.0,30/91,26.06%,DAB2IP;CCL25;MAP4K3;ADAM9;GGT5;GCH1;ARHGEF2;CASP8;ADAM10;AKT1;JAK2;CD40;ZFAND6;ASAH1;GSDME;IGBP1;RPS3;CCL19;IKBKB;HYAL2;BRCA1;NFE2L2;RELA;RIPK1;HAS2;GBP3;ADAMTS7;DHX9;ERBIN;ZFP36L1
prerank,positive regulation of potassium ion transport (GO:0043268),0.31408446952475044,1.0895581816308386,0.3370044052863436,0.7717022481846832,1.0,9/38,12.02%,KCNMA1;KCNJ3;AKAP6;KCNN2;GABBR2;KCNJ6;ADRA2A;KCNN3;GABBR1
prerank,innate immune response (GO:0045087),-0.24211488495914146,-1.0889965120772045,0.22110552763819097,0.5926386564457763,1.0,77/217,32.09%,SP100;ANKHD1;MFHAS1;LYN;ANKRD17;IFIH1;TRIM25;APP;TRIM56;SETD2;DDX3X;RNASE7;YES1;CLPB;OTULIN;GCH1;PTK2;IRGM;LBP;RNASE3;PLCG2;ALPK1;PIK3CD;SERINC3;FRK;PGLYRP1;TRIM14;IFITM3;IRAK1;CD40;NCF2;TRIM59;TRIM13;SRPK2;FYN;NRROS;NLRC5;MAVS;IKBKG;SERINC5;IKBKB;DEFA6;NOD2;TKFC;ZDHHC1;PPARG;KYNU;TRIM28;PTK2B;RELA;TRIM39;AKAP1;TRIM68;HMGB1;IRF7;LCN2;IFITM2;RPL39;FCER1G;TRIM6;TIFA;CXCL10;TREM2;BST2;TRIM35;RNF187;IFNLR1;MASP2;SHFL;SRMS;TRIM32;MFAP4;TRIM62;VNN1;CORO1A;JCHAIN;IRF5
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4656701029142828,-1.0886522018329143,0.34452296819787986,0.5926475715876981,1.0,3/10,3.58%,NFAT5;NFATC1;NFATC4
prerank,calcineurin-mediated signaling (GO:0097720),-0.4656701029142828,-1.0886522018329143,0.34452296819787986,0.5926475715876981,1.0,3/10,3.58%,NFAT5;NFATC1;NFATC4
prerank,response to steroid hormone (GO:0048545),-0.33833450015212285,-1.0886492398938867,0.3339191564147627,0.5922584309997834,1.0,7/31,8.80%,ABHD2;CAV1;THBS1;NR3C1;TGFB2;MED1;YAP1
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.4590828465642635,-1.0884484325534407,0.3702290076335878,0.5923469333602405,1.0,2/10,1.62%,ENG;CAV1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.42802638614960453,-1.0878663569049902,0.3559928443649374,0.5932633073409679,1.0,4/13,15.78%,SHANK3;APP;LGMN;ADCY1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.3514837819087124,-1.0875256659428991,0.3314917127071823,0.5936763546325955,1.0,11/27,22.04%,UTRN;NEDD4L;SLMAP;DLG1;FXYD5;PTPN3;FXYD6;SCN3B;SCN4B;SNTA1;NOS1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.3194420949561801,-1.0873831049335345,0.3207207207207207,0.5936084212941869,1.0,11/42,21.87%,SETD2;ARID2;SHLD1;MRNIP;FUS;SPIDR;CGAS;MAD2L2;RPA2;TIMELESS;CHEK1
prerank,macrophage migration (GO:1905517),0.42366341148167863,1.0873107053614761,0.34080717488789236,0.7768541829011372,1.0,4/13,18.22%,CXCL17;CCL5;CCL2;EDNRB
prerank,protein localization to vacuole (GO:0072665),0.4129802674099059,1.0868052193710234,0.3247058823529412,0.7767597396565873,1.0,5/13,11.95%,MFSD1;CD81;RTN4;ATP13A2;RNF128
prerank,prostanoid biosynthetic process (GO:0046457),-0.41801511709667843,-1.086713785889629,0.3442028985507246,0.5947873159420993,1.0,10/15,30.65%,PLA2G4A;PTGS1;EDN1;PTGES3;MIF;DAGLB;PNPLA8;PTGIS;PRXL2B;TBXAS1
prerank,microtubule anchoring (GO:0034453),0.42306336426407803,1.0866793989877335,0.35634743875278396,0.775491803616819,1.0,4/12,17.24%,BICD1;BCCIP;CLASP2;CAMSAP3
prerank,neuron projection fasciculation (GO:0106030),0.452771415922791,1.0864010885124884,0.3501144164759725,0.7747165015724004,1.0,3/10,8.64%,CNTN4;NRCAM;RTN4
prerank,cellular response to metal ion (GO:0071248),0.25742761731669483,1.086360735331432,0.2621359223300971,0.7731463646573594,1.0,23/123,12.35%,NLGN1;SYT1;SYT5;DLG2;ANK3;RYR3;ADCY8;SYT12;SYT11;GLRA1;HPCA;HSF1;CPNE9;DPEP1;SCN5A;ACER1;ADCY7;CPNE1;CYP11B1;ATP13A2;SYT4;GPLD1;DLG4
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.3253298920451838,-1.0857281869486002,0.3184931506849315,0.5967324546049733,1.0,13/40,20.28%,MCL1;ABL1;PRKCD;IER3;WDR76;KMT5A;FEM1B;UBE2V2;RFWD3;ARMT1;RPA2;USP1;NSMCE4A
prerank,mRNA catabolic process (GO:0006402),-0.3151814856876237,-1.085593290099097,0.3388581952117864,0.5966617604769282,1.0,15/44,29.29%,TUT7;XRN1;ERN1;XRN2;TUT4;PDE12;RC3H1;NUDT12;DIS3L2;METTL16;THRAP3;HSPA1B;DXO;LSM2;NBDY
prerank,autophagy of mitochondrion (GO:0000422),-0.32625700261204293,-1.0849062778387994,0.3280141843971631,0.5978728422328992,1.0,16/38,27.26%,ATG7;MAP1LC3B;AMBRA1;BNIP3;WIPI1;GABARAP;FUNDC1;ULK2;MARK2;ATG5;WDR45B;BECN1;ATG2A;FUNDC2;ATG2B;ATG3
prerank,cristae formation (GO:0042407),-0.347479691333143,-1.0845042256109672,0.3441682600382409,0.5984418926100694,1.0,11/27,24.75%,CHCHD3;APOOL;AFG3L2;SAMM50;DMAC2L;ATP5F1E;UQCC3;ATP5F1C;ATP5MF;ATP5PO;IMMT
prerank,organophosphate catabolic process (GO:0046434),0.4415939923008151,1.0841989452678462,0.36225596529284165,0.777799805851949,1.0,1/11,1.48%,ENPP2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.4063323670523233,-1.0841787978404966,0.3553398058252427,0.5988351006550517,1.0,3/14,5.29%,SHLD1;TFRC;KMT5B
prerank,peptide hormone secretion (GO:0030072),-0.3532538024852072,-1.0841453667016987,0.3446969696969697,0.5985075386249669,1.0,7/26,17.00%,RAB1A;CAMK2G;EDN1;EDN3;LTBP4;SNX19;ANXA1
prerank,metal ion transport (GO:0030001),0.2665176943803825,1.0840361905330653,0.2946859903381642,0.7765874298884433,1.0,21/86,12.58%,RYR3;CACNA1B;ATP2B2;CACNA2D1;TUSC3;CACNA1A;CACNB3;CACNG8;CACNA1D;SLC8A2;SELENOK;RYR2;CACNG3;CACNA1E;NIPA1;SLC39A2;NMUR2;NIPAL1;SLC8A3;SLC8A1;CCL5
prerank,macrophage chemotaxis (GO:0048246),0.45255553791803027,1.0839204845878234,0.37276785714285715,0.7752500068475628,1.0,4/10,18.22%,CXCL17;CCL5;CCL2;EDNRB
prerank,regulation of phospholipase activity (GO:0010517),0.4451923981241065,1.0838915771475497,0.35864978902953587,0.7736597549652743,1.0,6/10,24.83%,FGFR2;RASGRP1;FGFR3;ANGPTL3;PDPK1;SNCA
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.4642884215419575,-1.0837181635491548,0.3914590747330961,0.5991497192832206,1.0,6/10,35.10%,TNFRSF1B;NOTCH1;TNFRSF1A;EMILIN1;TGFB1;FAP
prerank,positive regulation of protein secretion (GO:0050714),-0.2887046777884657,-1.0837171998552422,0.3118081180811808,0.5987528307765515,1.0,11/69,7.78%,UNC13B;MYRIP;CD2AP;GOLPH3L;ADAM9;IER3IP1;BMP6;TGFB2;RBP4;EZR;MYO18A
prerank,regulation of actin filament depolymerization (GO:0030834),-0.431996341961942,-1.0833390661576292,0.3683206106870229,0.5992837980955315,1.0,6/12,25.35%,LIMA1;CFL2;PLEKHH2;MTPN;SEMA5A;PIK3CA
prerank,ethanol metabolic process (GO:0006067),0.4248400718247205,1.0832629908642686,0.35095137420718814,0.7739545173252363,1.0,2/12,7.59%,ACSS2;ACSS1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3388938108247514,-1.083197703690915,0.33807829181494664,0.5991872164418526,1.0,13/32,28.42%,MNAT1;ERCC2;TAF1B;TAF1C;ERCC3;CAVIN1;UBTF;TAF1D;POLR1E;POLR2L;POLR2H;GTF2H3;CCNH
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.2759954255188095,-1.0830816907743561,0.28888888888888886,0.5990492838201591,1.0,20/91,11.99%,HIP1;RUFY1;DNAJC13;PTPN1;STON1;RNF139;LRRK2;PLD1;RAB5B;ABL1;AP2S1;MAPK1;RAB5A;SCFD1;SCARB1;PICALM;RAB4B;BET1L;SNX12;RAB8B
prerank,regulation of platelet activation (GO:0010543),0.36472303879637363,1.0822298270905055,0.3420479302832244,0.7754200581381715,1.0,7/21,15.31%,BLK;C1QTNF1;PLEK;PDGFA;TXK;APOE;PDGFRA
prerank,negative regulation of protein transport (GO:0051224),-0.36491875565261106,-1.0822214271301305,0.3590664272890485,0.6007134236411142,1.0,12/25,30.35%,RHBDF2;PPM1F;DPH3;SNX12;PKDCC;CSK;WWP2;NDFIP2;SERGEF;HMGCR;RSAD2;RHBDF1
prerank,regulation of receptor binding (GO:1900120),-0.45678327538011043,-1.0820697531334125,0.38,0.6006854069972186,1.0,3/10,11.78%,ATP2A3;GREM2;HFE
prerank,nitric oxide biosynthetic process (GO:0006809),-0.4154620442914501,-1.081659539144483,0.3568904593639576,0.6012614837541111,1.0,7/13,24.02%,NOS3;GCH1;AKT1;CYB5B;NQO1;NOS1;CYP1B1
prerank,cardiac muscle cell development (GO:0055013),0.36497816121069815,1.0814037231097688,0.3246753246753247,0.7764131938283267,1.0,8/20,15.31%,FHOD3;CXADR;ALPK3;VEGFA;MYLK3;SLC8A1;MYL2;PDGFRA
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.346733119090298,1.0808786084422954,0.3267543859649123,0.7762770806190364,1.0,4/25,3.86%,B3GALT1;NDST4;FUT9;B3GALT5
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.33393632492010833,-1.0808560159662497,0.33512544802867383,0.6028203742911779,1.0,12/35,18.65%,HIP1;RAC1;LDLRAP1;CBL;AAK1;PICALM;HFE;FLOT1;PIK3CB;HIP1R;CCL19;MKLN1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3477419284488434,-1.0807363453969585,0.3505338078291815,0.6027074885776904,1.0,7/26,12.27%,ITPR1;PKD2;ITPR2;PLCG2;HTR2A;ERO1A;FGF2
prerank,negative regulation of cell development (GO:0010721),-0.356419851858644,-1.080722481668573,0.3394495412844037,0.6023401198979667,1.0,13/25,38.83%,GSK3B;GSK3A;NOTCH1;IGF1;PCM1;FBN1;RFLNB;RFLNA;LILRB1;WNT7A;CCL11;PAX6;APPL2
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.45700060929952036,-1.080630265135459,0.3684210526315789,0.6021400717810321,1.0,8/10,30.86%,RAPGEF2;LYN;GAS6;CCL19;CXCL12;LGALS9;AXL;LILRB1
prerank,positive regulation of cell cycle process (GO:0090068),-0.2755120078026697,-1.0804623531695063,0.3127147766323024,0.6021364833598494,1.0,27/91,27.05%,MAP3K20;INSR;LRP5;PRKCE;SVIL;PKP4;CUL3;CDC14A;EDN1;RGCC;EDN3;KIF23;RHOA;PLSCR1;PKN2;TPR;IGF1;GIPC1;PLK4;ATRX;IGF2;PDGFRB;E2F7;INO80;CEP295;KIF14;USP19
prerank,nitric oxide metabolic process (GO:0046209),-0.40640283669078736,-1.080019993665512,0.3600713012477718,0.6028077677060274,1.0,7/14,24.02%,NOS3;GCH1;AKT1;CYB5B;NQO1;NOS1;CYP1B1
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.40640768178965914,-1.07999694880675,0.3486238532110092,0.6024673726602403,1.0,6/14,17.16%,DYRK1A;PSEN2;ADAM10;PSEN1;ABCA7;APH1A
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.4055921714281975,-1.0796258324592811,0.35892857142857143,0.6029635951515415,1.0,5/15,7.19%,TBX1;TGFBR2;NIPBL;SIX1;MTHFD1
prerank,regulation of proteolysis (GO:0030162),-0.3079882455178036,-1.0795708719087205,0.32685512367491165,0.6026722558870865,1.0,16/48,22.36%,CAV1;RNF139;DNAJC1;ASPH;CASP8;AKT1;PERP;SPOPL;LTBP4;FBXW11;PLAT;HDAC6;SPOP;FGFR4;OGT;SERPINE2
prerank,regulation of viral genome replication (GO:0045069),-0.2930831087043423,-1.0790443681843518,0.32006920415224915,0.6035084285725125,1.0,24/56,29.19%,IFIH1;ZC3HAV1;DDX3X;LARP1;PPARA;IFITM3;PLSCR1;PKN2;PDE12;N4BP1;SRPK2;ADARB1;MAVS;RAD23A;STAU1;PPIH;IFITM2;TNIP1;PABPC1;TRIM6;OASL;BST2;RSAD2;PPIE
prerank,acylglycerol catabolic process (GO:0046464),-0.3395022677668111,-1.0789399133889186,0.3574074074074074,0.6033395655968163,1.0,12/30,42.18%,ABHD2;MGLL;LPL;LIPE;PNPLA2;FABP3;LIPH;ABHD12;FABP4;LYPLA2;FABP12;DAGLA
prerank,phagosome acidification (GO:0090383),0.3503025789983595,1.0786739087201735,0.34754797441364604,0.7814008800646562,1.0,10/26,19.05%,ATP6V1B2;ATP6V0C;ATP6V0D2;ATP6V0A2;ATP6V1G2;RAB39A;ATP6V0D1;RAB20;ATP6V1C1;ATP6V1A
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.38969701674819984,-1.0785359617721846,0.36936936936936937,0.6039789068203664,1.0,4/17,12.66%,KLF7;CAV1;APOLD1;CEACAM1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.4140689457147786,1.078468855129917,0.36,0.7804079444132876,1.0,2/13,4.15%,BPNT2;SULT2B1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.39443848107493606,-1.0782118017096036,0.37056737588652483,0.6043334586554772,1.0,8/17,34.35%,RB1;CTCF;BUB3;TTK;MTBP;SPDL1;BOD1;MIS12
prerank,peptidyl-glutamic acid modification (GO:0018200),0.35310809705423196,1.0780231326489755,0.3617511520737327,0.7801319692788737,1.0,5/24,11.50%,AGBL4;TTLL8;TPGS1;TTLL10;TTLL5
prerank,sensory perception of mechanical stimulus (GO:0050954),0.26905957698738114,1.0780159174275243,0.3059360730593607,0.7785027625073907,1.0,12/85,9.74%,PCDH15;COL2A1;SLC26A5;LHFPL3;EML2;COL1A1;ATP2B2;COL11A2;DCDC2;CACNA1D;GRM7;SPTBN4
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.44974475707425676,-1.078009835184115,0.36082474226804123,0.6044037831864677,1.0,3/11,11.47%,JAK1;IL6ST;JAK2
prerank,negative regulation of microtubule polymerization (GO:0031115),0.42077714530174015,1.0776181550454251,0.3810623556581986,0.7780781147984902,1.0,6/12,18.36%,EML2;ARHGEF7;MAP2;STMN2;MAPRE1;TUBB4A
prerank,regulation of cellular respiration (GO:0043457),-0.39124642785674935,-1.0774581841841313,0.375,0.6053046618742488,1.0,3/17,3.95%,CBFA2T3;PRDM16;IFNAR1
prerank,cellular response to organonitrogen compound (GO:0071417),-0.265717623515219,-1.0772681024632784,0.30303030303030304,0.605394318745552,1.0,24/99,15.21%,CTNNA1;RAPGEF2;PKD2;SH3BP4;DIAPH1;MTOR;PDE3A;LARP1;PDE2A;SLIT2;KCNQ1;RAP1A;MEF2C;EZR;RAP1B;CDH1;CAPN2;RAPGEF1;RPTOR;ACTB;LARS1;P2RY6;IGFBP5;HTR1B
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.3950007246719432,-1.0767657527839052,0.3706293706293706,0.6061120814249129,1.0,6/17,11.05%,PKD2;EGFR;CCND3;AKT1;CCNY;RGCC
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.4059827602347378,-1.0766919437637095,0.37545787545787546,0.605869653205693,1.0,10/15,38.32%,DTX3L;ABL1;SMAD7;RPL5;MAD2L2;RPS7;BAG5;PARK7;FBXO5;BAG2
prerank,negative chemotaxis (GO:0050919),-0.3375061882943128,-1.0766301050374085,0.3534798534798535,0.6056175312286503,1.0,13/33,21.05%,SEMA6A;SEMA3C;NTN1;SEMA7A;SLIT2;RHOA;SEMA3G;SEMA6B;SEMA4C;SEMA4A;SEMA3E;ITGB3;SEMA4G
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.3636774638862831,-1.0765750874130469,0.3608617594254937,0.605353233267044,1.0,7/23,25.30%,PLK2;NABP1;INTS3;CDK5RAP3;BUB1B;CHEK1;PLK3
prerank,heart process (GO:0003015),0.40214294687854213,1.076163805275038,0.36343115124153497,0.7807703782748554,1.0,1/14,0.03%,SGCZ
prerank,positive regulation of response to wounding (GO:1903036),-0.356414875254664,-1.0759481256778638,0.3551912568306011,0.6064390902542885,1.0,7/24,11.88%,ITGB1;PRKCE;SCARF1;PTK2;OCLN;MYLK;ARFGEF1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.4415249333301827,-1.0748518612888704,0.3825136612021858,0.6086817699326258,1.0,3/11,10.97%,P3H2;OGFOD1;P4HA1
prerank,cellular component disassembly (GO:0022411),-0.29708193809635064,-1.074375502231565,0.3291814946619217,0.6094636323587526,1.0,12/53,15.16%,TLL1;BSG;SH3PXD2B;HTRA1;MMP2;CAPN2;ADAM10;ADAMTS4;ADAMTS5;LCP1;FLOT1;EXOC8
prerank,positive regulation of myelination (GO:0031643),0.42316095392597763,1.0743120292787869,0.3630434782608696,0.7849476115994378,1.0,2/11,1.02%,TENM4;MYRF
prerank,regulation of heart contraction (GO:0008016),0.26617617430798285,1.0739551454582594,0.30714285714285716,0.7843977718030511,1.0,17/90,12.89%,ATP1A2;RYR3;ATP2B4;ATP2B2;ATP1B1;CELF2;CALM2;NPPC;RNF207;SLC8A2;RYR2;SLC8A3;SLC8A1;SRI;HRC;CASQ1;FXYD4
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.3613481564796138,1.0733158840186938,0.3600867678958785,0.7847739472122889,1.0,4/21,6.31%,HS6ST3;HS3ST5;HS6ST2;GPC1
prerank,regulation of macrophage activation (GO:0043030),-0.33862893671035194,-1.0728611298083814,0.3418181818181818,0.612730901554243,1.0,7/30,15.33%,MFHAS1;CD200;THBS1;LBP;MYO18A;GPR137B;MIF
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.40494787499474183,-1.0726071344034023,0.37065637065637064,0.6129124122860178,1.0,5/15,15.65%,EGFR;PTPN12;RHBDF2;CEACAM1;LGMN
prerank,phagosome maturation (GO:0090382),0.3186425654191565,1.0725345148368697,0.3498964803312629,0.7854626662450671,1.0,12/35,19.05%,MREG;ATP6V1B2;ATP6V0C;ATP6V0D2;ATP6V0A2;ATP6V1G2;RAB34;RAB39A;ATP6V0D1;RAB20;ATP6V1C1;ATP6V1A
prerank,regulation of viral life cycle (GO:1903900),0.3573323082365438,1.0724748925893377,0.3747178329571106,0.7839816535910016,1.0,5/21,14.04%,HS3ST5;TYRO3;TRIM27;TSG101;PPIA
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.39546710195881457,1.0724413405341238,0.3730684326710817,0.782461734578683,1.0,14/14,60.49%,POU4F1;IL23A;TYROBP;ATP6AP1;IFNG;POU4F2;CSF1;TRAF6;IL12B;IL23R;TNF;OCSTAMP;TNFSF11;CCR1
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.35665549804887076,-1.0717367588530975,0.37364620938628157,0.6146508659213646,1.0,9/24,29.13%,ZBTB16;ACVRL1;PKDCC;TRPS1;PTPN11;ADAMTS7;SNAI2;TGFBR1;WNT9A
prerank,androgen metabolic process (GO:0008209),0.3715711027363759,1.0711285300324724,0.3696682464454976,0.7847771878781591,1.0,3/18,13.05%,AKR1D1;HSD17B7;SPP1
prerank,regulation of cell differentiation (GO:0045595),-0.2524728454672156,-1.071057020258418,0.2915194346289753,0.6158940587317754,1.0,38/148,20.89%,SLC6A6;CREBBP;CBFB;KLF4;ZFHX3;SPOCK2;TBX1;SIK1;SMOC1;NREP;SIX1;PTK2;SUZ12;NGF;ROCK1;RAF1;NOTCH4;MOSMO;SMAD7;EDN3;LTBP4;RPS6KA1;PA2G4;CDK6;ATF4;RPS6KA3;TAF8;NR1D2;TRPS1;MCRIP1;CDK5RAP3;HEY1;HEY2;UQCC2;PPP2CA;BCL6;NF1;IGF2
prerank,muscle cell development (GO:0055001),-0.3377442155033453,-1.0710101481208398,0.3544973544973545,0.6155904340074805,1.0,8/30,10.09%,ENG;MYOF;HES1;DYSF;MYH11;RAMP2;CHRNB1;NEBL
prerank,cellular response to organic substance (GO:0071310),-0.26184253262697177,-1.070723207398858,0.3221830985915493,0.6159022285087647,1.0,21/116,10.11%,LEF1;GHR;ACVRL1;NFAT5;PTPN14;KLF4;BMPR2;RAMP1;LRRK2;PTPN9;LDLRAP1;TIPARP;EMD;PTPN12;TGFBR2;SLIT2;ARL6IP5;ACVR2A;HAX1;RAMP2;SOCS2
prerank,defense response to bacterium (GO:0042742),-0.2635081836787443,-1.0699396684587315,0.3321678321678322,0.6173906784721307,1.0,38/105,33.08%,ANKRD17;NOD1;RAB1A;ANXA3;RNASE7;IL6R;IRGM;PRKCD;LBP;GBP6;RNASE3;PGLYRP1;STAB1;GBP4;MAVS;DEFA6;NOD2;DROSHA;SERPINE1;RPL30;ADGRB1;LCN2;ADAM17;RPL39;LYZL4;FCER1G;TREM2;SELP;MPEG1;NLRC4;TNFRSF14;TLR6;JCHAIN;CEBPB;FGR;LPO;NOS2;AQP1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.38676771072857996,-1.0699053335177362,0.34408602150537637,0.6170800502971875,1.0,5/18,19.59%,COX16;COX18;SCO1;COX17;COA8
prerank,mismatch repair (GO:0006298),-0.34619344938044483,-1.0697308102452254,0.3568904593639576,0.6170568838992411,1.0,11/27,27.65%,SETD2;ABL1;MCM9;POLD3;RPA3;RPA1;XPC;RPA2;MSH3;LIG1;EXO1
prerank,neutrophil degranulation (GO:0043312),-0.22470431861424708,-1.0695081481214364,0.2380191693290735,0.6172048783350093,1.0,100/425,21.99%,PTPRB;SPTAN1;PECAM1;DNAJC13;KCMF1;RAC1;CTSC;ADGRE5;IQGAP1;ANXA2;CDK13;ATG7;PSMA2;RAB7A;DDX3X;DIAPH1;ANXA3;PTPRJ;LPCAT1;PLD1;IDH1;AP2A2;NFKB1;TNFRSF1B;RAB5B;MOSPD2;ENPP4;PRKCD;CD55;RAP1A;CD93;HRNR;MAPK1;RAP1B;ROCK1;PDXK;OSTF1;RAB27A;TSPAN14;RNASE3;NBEAL2;IGF2R;RAB4B;STOM;ADAM10;FRK;PGLYRP1;STK10;PSEN1;EEF2;ALDOC;ANO6;ARMC8;RHOA;HMOX2;PA2G4;CEACAM1;CAT;UBR4;PRCP;RHOG;ARSA;LRG1;RAB24;PSMC2;MIF;CTSZ;TOM1;ASAH1;PSMB1;SRP14;CTSH;LAMP2;DBNL;DSN1;VAPA;PLEKHO2;ATP6V0A1;VPS35L;SCAMP1;NAPRT;PTPRC;FRMPD3;KCNAB2;B4GALT1;RAP2C;NRAS;DEGS1;ORMDL3;HUWE1;GYG1;CAP1;CD53;AMPD3;VCL;CTSA;VAMP2;NDUFC2;ITGAM;GLA
prerank,regulation of phagocytosis (GO:0050764),-0.3043875174224458,-1.0690984987847252,0.3464419475655431,0.6177690761279837,1.0,14/53,19.32%,IL15;MERTK;DYSF;GAS6;TGM2;RAB27A;SCARB1;PLSCR1;ABCA7;PIP4P2;LMAN2;TULP1;GATA2;PTPRC
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3654441957858535,-1.0689862033620134,0.3675675675675676,0.6176489071742032,1.0,6/22,14.55%,ESR1;MED1;TP53;MED13;MED17;PSMC2
prerank,membrane raft organization (GO:0031579),-0.40471822331843776,-1.0689060405517719,0.4070175438596491,0.6174587597238723,1.0,10/15,35.55%,ANXA2;NAXE;FLOT1;ABCA7;PPT1;EMP2;RFTN1;MYADM;NPC1;S100A10
prerank,regulation of neurotransmitter secretion (GO:0046928),0.32941657961657034,1.0686049269968232,0.3700980392156863,0.7910184078457595,1.0,6/32,10.68%,RIMS2;RIMS1;SYT11;SYN1;GPER1;MCTP2
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.35826491610386496,-1.0683032142137445,0.3623693379790941,0.6185428276487087,1.0,11/24,28.80%,LYN;MOSPD2;SLIT2;ANO6;CCN3;LGMN;CXCL12;SERPINE1;HMGB1;CXCL10;DUSP1
prerank,negative regulation of defense response (GO:0031348),-0.2810753942378312,-1.0682307886026385,0.34265734265734266,0.6183185618462225,1.0,18/77,15.91%,TEK;RB1;KLF4;MFHAS1;PPARA;OTULIN;NMI;PRKCD;CDH5;PPARD;PPM1B;FEM1A;TRAF3IP1;TNFAIP3;ILRUN;CCN3;C1QTNF3;TNFRSF1A
prerank,regulation of filopodium assembly (GO:0051489),-0.3188709282139716,-1.0680523706929528,0.34172661870503596,0.6183301096249171,1.0,11/38,11.65%,MYO10;FNBP1L;PIK3R1;PALM;RHOQ;PRKCD;WASL;AGRN;RAB5A;ARAP1;BCAS3
prerank,positive regulation of intracellular transport (GO:0032388),0.31370294897287976,1.0677422333005426,0.3501144164759725,0.7919639973171904,1.0,9/38,11.79%,ABCA12;TENM1;PGAP1;STK11;ZFAND1;SORL1;PLA2G4E;EIPR1;PRR5L
prerank,DNA methylation (GO:0006306),-0.35877419514593273,-1.0677393469410557,0.3509933774834437,0.618648612238586,1.0,9/23,24.04%,KMT2E;METTL4;EHMT1;N6AMT1;DNMT1;PPM1D;ATRX;MTRR;BEND3
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.3931805664585797,-1.0675935768053766,0.3592592592592593,0.6185990709363632,1.0,6/16,21.78%,CHMP4B;CHMP4A;VTA1;VPS36;CHMP5;TMEM50B
prerank,negative regulation of receptor internalization (GO:0002091),0.4290479870935094,1.0674367665864888,0.41037735849056606,0.7912245115446515,1.0,4/12,12.35%,ANKRD13B;WDR54;MTMR2;DLG4
prerank,mesenchymal to epithelial transition (GO:0060231),0.4324909123459578,1.0664480260579416,0.36574074074074076,0.7924510265379009,1.0,2/10,6.07%,WT1;PAX2
prerank,regulation of sensory perception of pain (GO:0051930),-0.44255873792699457,-1.0660846256817653,0.38155515370705245,0.6218512141031061,1.0,5/11,26.84%,MGLL;CCN3;ACP3;SPX;F2R
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.3603247534662624,1.0657035372089056,0.355119825708061,0.7931031683800515,1.0,3/20,5.98%,GCK;CDA;BCKDK
prerank,nucleoside catabolic process (GO:0009164),-0.44624195667009187,-1.0656571666502022,0.37681159420289856,0.6225101641327221,1.0,7/11,36.68%,NT5E;NT5C1A;NT5C;UPB1;UPP1;DERA;DPYS
prerank,hyaluronan metabolic process (GO:0030212),-0.3543152123616823,-1.065248113286114,0.3706422018348624,0.6231378924002902,1.0,11/23,32.00%,CEMIP2;FGF2;CHP1;HAS1;HYAL2;LYVE1;HAS2;HEXA;HYAL3;TGFB1;CEMIP
prerank,negative regulation of phosphatase activity (GO:0010923),-0.35410339001349955,-1.064982169978141,0.3592057761732852,0.6233562907536451,1.0,11/25,35.33%,GSK3B;TGFB2;ZCCHC9;GPATCH2;CHP1;SH3RF2;CRY2;BOD1L1;PPP1R1B;BOD1;FKBP1B
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.2838447598928649,-1.0648147848124005,0.34608695652173915,0.6233817561557925,1.0,28/68,36.92%,IFIH1;APP;IL6R;LBP;ARHGEF2;PLCG2;LPL;IL17RA;IL16;MAVS;HYAL2;NOD2;PTPN11;HMGB1;DHX9;F2R;LGALS9;STAT3;TLR6;TLR1;NOS2;RAB7B;IL1A;TSLP;CD74;TLR2;TLR8;SYK
prerank,response to amino acid (GO:0043200),0.3296496705825944,1.0647798187286204,0.34606741573033706,0.7943329058255632,1.0,5/31,10.51%,GLRA3;RRAGA;GLRA1;CPEB1;CPEB3
prerank,mitotic spindle organization (GO:0007052),-0.24953719872320568,-1.0644351792270428,0.33507853403141363,0.6238627005377709,1.0,74/153,39.98%,CLIP1;MAD1L1;MAP4;NEK6;RANBP2;STAG1;CCDC61;AHCTF1;TOGARAM1;NUP98;PLK2;SEC13;WRAP73;FLNA;KIF23;RHOA;PAFAH1B1;ARHGEF10;MECP2;STAG2;KIF11;RAB11A;RPS27;DSN1;CENPL;CENPE;NDEL1;KIF3B;BUB1B;CENPO;PRC1;BUB3;TTK;MISP;PCNT;CENPI;CENPH;EML4;CENPN;RAN;DYNLL1;SPC25;SPDL1;TUBG2;CDCA8;STMN1;BIRC5;EFHC2;WDR62;NUDC;CEP192;MAP9;PLK1;NUF2;CKAP5;AURKA;MIS12;SPC24;TNKS;CDC20;NUP43;VCP;LSM14A;RMDN1;TPX2;TUBG1;SPICE1;KIF2C;NSL1;DYNC1LI1;SMC3;CCNB1;CENPT;CENPM
prerank,regulation of isotype switching (GO:0045191),-0.4110225623132728,-1.0643317905643648,0.3815028901734104,0.6237003161551077,1.0,3/14,5.29%,SHLD1;TFRC;KMT5B
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.3686127278314917,1.0641832748452225,0.35913978494623655,0.794467956712639,1.0,3/18,5.19%,CHRM2;OPRM1;CHRM3
prerank,negative regulation of catalytic activity (GO:0043086),-0.3524577691850037,-1.0639929287756449,0.3752244165170557,0.6240675238325049,1.0,14/24,36.42%,NES;TP53;PPP1R12A;NOTCH1;APBA3;HDAC6;PLN;NOS1;PARP9;NOSIP;PHPT1;HP;MT3;ATP5IF1
prerank,extracellular matrix disassembly (GO:0022617),-0.29637699703750053,-1.0639876908985326,0.34234234234234234,0.6236762643937425,1.0,12/53,15.16%,TLL1;BSG;SH3PXD2B;HTRA1;MMP2;CAPN2;ADAM10;ADAMTS4;ADAMTS5;LCP1;FLOT1;EXOC8
prerank,positive regulation of RNA splicing (GO:0033120),-0.344525789405118,-1.0639833032706927,0.3516483516483517,0.6232904105024667,1.0,9/29,24.13%,DYRK1A;PIK3R1;NUP98;ERN1;ZPR1;RBM20;RBM3;TRA2B;THRAP3
prerank,neutrophil activation involved in immune response (GO:0002283),-0.22373973417861648,-1.063918677728445,0.2532258064516129,0.6230520465114203,1.0,100/428,21.99%,PTPRB;SPTAN1;PECAM1;DNAJC13;KCMF1;RAC1;CTSC;ADGRE5;IQGAP1;ANXA2;CDK13;ATG7;PSMA2;RAB7A;DDX3X;DIAPH1;ANXA3;PTPRJ;LPCAT1;PLD1;IDH1;AP2A2;NFKB1;TNFRSF1B;RAB5B;MOSPD2;ENPP4;PRKCD;CD55;RAP1A;CD93;HRNR;MAPK1;RAP1B;ROCK1;PDXK;OSTF1;RAB27A;TSPAN14;RNASE3;NBEAL2;IGF2R;RAB4B;STOM;ADAM10;FRK;PGLYRP1;STK10;PSEN1;EEF2;ALDOC;ANO6;ARMC8;RHOA;HMOX2;PA2G4;CEACAM1;CAT;UBR4;PRCP;RHOG;ARSA;LRG1;RAB24;PSMC2;MIF;CTSZ;TOM1;ASAH1;PSMB1;SRP14;CTSH;LAMP2;DBNL;DSN1;VAPA;PLEKHO2;ATP6V0A1;VPS35L;SCAMP1;NAPRT;PTPRC;FRMPD3;KCNAB2;B4GALT1;RAP2C;NRAS;DEGS1;ORMDL3;HUWE1;GYG1;CAP1;CD53;AMPD3;VCL;CTSA;VAMP2;NDUFC2;ITGAM;GLA
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.3612177577680944,1.063907034340922,0.38478747203579416,0.7937000723353544,1.0,8/21,19.12%,TOX;PROX1;INSM1;VEGFA;FZD9;FZD3;DISP3;CX3CL1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.29093012187382894,1.063836958626664,0.35267857142857145,0.7922930341720149,1.0,10/54,8.46%,GPC5;HS3ST6;HS3ST5;HPSE2;HS6ST2;GPC1;GALNT5;B4GALT7;HS3ST2;CHST9
prerank,striated muscle cell development (GO:0055002),-0.40641128448594765,-1.0636808667853268,0.37786259541984735,0.6232179641169823,1.0,3/14,12.75%,PGM5;TMOD3;LMOD1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.3848860491903441,1.0633665587764027,0.36538461538461536,0.7920655217408705,1.0,9/17,22.37%,ATP1A2;PKP2;ATP1B1;RYR2;SLC8A1;GJC3;GJA1;ATP1B2;ATP1A3
prerank,CENP-A containing chromatin organization (GO:0061641),0.3381695581663092,1.0633573967292023,0.368763557483731,0.7888775433791535,1.0,10/29,20.27%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;CENPK;CENPW;RBBP7;ITGB3BP;CENPA
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.3381695581663092,1.0633573967292023,0.368763557483731,0.7888775433791535,1.0,10/29,20.27%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;CENPK;CENPW;RBBP7;ITGB3BP;CENPA
prerank,wound healing (GO:0042060),-0.2900650163758357,-1.0633101960724929,0.3545966228893058,0.6236919618725542,1.0,16/62,13.27%,MYOF;MYH9;DYSF;TGFB2;MACF1;AHNAK2;FGF1;RAF1;DST;SCARB1;CFLAR;FUT10;DCBLD2;FGF2;TPM1;PRCP
prerank,rRNA catabolic process (GO:0016075),-0.38773285248378353,-1.0632942679281072,0.3587360594795539,0.6233323537408184,1.0,7/16,25.27%,XRN1;EXOSC2;EXOSC3;EXOSC8;EXOSC5;PELO;EXOSC7
prerank,mitochondrion organization (GO:0007005),-0.24745554708239187,-1.0632676260322969,0.3038194444444444,0.6229927551420533,1.0,66/165,34.86%,MEF2A;NOS3;ALAS1;DNM3;TRAK1;LRRK2;MIEF1;DNM2;CHCHD3;SIRT5;BNIP3;PYROXD2;AKT3;AFG3L2;HAX1;VPS13C;SAMM50;TOMM40;AGTPBP1;BCAP31;MTX1;GABPB1;MIEF2;SIRT3;AFG1L;HCFC1;RAB32;TIMM17B;VPS13D;TOMM5;FANCG;NRF1;DNAJC19;WASF1;HIGD2A;TERT;ATPAF1;GABPA;BIK;HIGD1B;TIMM50;TMEM11;STOML2;TIMM10;IMMP2L;TOMM20;RAB38;MTFR1;SLC25A33;RHOT2;CAV2;YME1L1;HIGD1A;TOMM70;PID1;MTM1;ATP5F1D;SPG7;TIMM10B;AIFM1;TIMM13;PARK7;ATP2A1;IFIT2;WDR81;NUBPL
prerank,cardiac muscle cell differentiation (GO:0055007),0.36547586680615685,1.0631260148160646,0.3767123287671233,0.7879814213000733,1.0,8/21,14.85%,NRG1;WT1;CXADR;ALPK3;IRX3;VEGFA;SLC8A1;CBY1
prerank,neuron apoptotic process (GO:0051402),0.3700075247168252,1.063075801884372,0.36768149882903983,0.7865630601258716,1.0,4/19,5.95%,CDK5;BCL2;SCN2A;NAE1
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.3823579830250347,1.0630747383103074,0.3899782135076253,0.7849825351579418,1.0,6/15,15.13%,APOM;PLA2G3;LIPC;ABCA5;APOE;APOC1
prerank,peptidyl-lysine methylation (GO:0018022),-0.3484588066787809,-1.0630284106663521,0.3498233215547703,0.6231664263103444,1.0,8/26,16.06%,SETD2;SUV39H1;SETD3;EHMT1;KMT5A;SMYD1;N6AMT1;ANTKMT
prerank,fatty acid transmembrane transport (GO:1902001),-0.3726479994120168,-1.0630226930989184,0.36900369003690037,0.622782625370042,1.0,4/19,10.86%,SLC2A1;ABCD3;ACACB;CPT1A
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.4099966641455607,-1.0630067869561997,0.39106145251396646,0.6224212654747217,1.0,5/14,14.99%,PRKG1;SLIT2;MEF2C;TPM1;IGFBP5
prerank,GPI anchor biosynthetic process (GO:0006506),0.32799304847339417,1.0627292664186025,0.3372093023255814,0.7844650925350416,1.0,6/30,11.22%,PGAP1;DPM1;PIGP;MPPE1;PIGB;PGAP3
prerank,cell proliferation in forebrain (GO:0021846),-0.45218456502534166,-1.0626964594302335,0.396584440227704,0.6227810232976553,1.0,6/10,33.23%,NUMB;PCM1;AKNA;KIF14;NUMBL;WNT7A
prerank,respiratory electron transport chain (GO:0022904),0.4110627380954009,1.0623066941241839,0.4052863436123348,0.7841472186600758,1.0,3/14,11.51%,SLC25A13;SDHA;NDUFA5
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.33209351032588663,-1.0618020351615525,0.3486238532110092,0.6245206305629085,1.0,9/33,18.44%,PRKD2;PTPRJ;EZR;DGKZ;CEACAM1;DUSP3;RC3H1;RPS3;IKBKG
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.3014569720648818,-1.0616668437522596,0.3415559772296015,0.6244485335685848,1.0,22/48,37.76%,NUP42;PRDM16;RAE1;RANBP2;ZBTB7A;NUP98;SEC13;NUP153;TPR;NUP214;OGT;NUP188;NOA1;NUP88;NUP35;NOS2;NUP43;HIF1A;GCGR;PGAM1;JMJD8;PRKAG2
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.3825966805377173,-1.0616177064550325,0.3775322283609576,0.6241543387920987,1.0,8/19,26.27%,GFPT2;GNPDA2;GNPNAT1;UAP1;NANS;SLC35D1;UAP1L1;PMM2
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.41539372528494584,-1.0595603966603948,0.37592592592592594,0.6285745850555194,1.0,7/13,27.52%,LSG1;ABCE1;RRS1;RPS15;NUP88;RAN;NMD3
prerank,histone H4 acetylation (GO:0043967),-0.30550611767033314,-1.0594614522516086,0.36151079136690645,0.6284247265072961,1.0,16/47,25.06%,LEF1;KANSL3;EP400;PHF20;TRRAP;ZZZ3;HCFC1;TADA3;TRIM16;RUVBL2;JADE2;OGT;WDR5;MORF4L1;BEND3;APBB1
prerank,cell cycle G1/S phase transition (GO:0044843),-0.2866185856640281,-1.0587675999476733,0.3409090909090909,0.6296809233916247,1.0,35/61,40.60%,MNAT1;RB1;CDKN1B;CRLF3;CUL3;MAX;PLK2;CUL2;LATS2;CDK6;GSPT1;CACUL1;CCND1;CDKN2C;CDC25A;CCNE2;E2F3;KHDRBS1;PLK3;CDKN3;CCNH;HINFP;CDC34;CUL5;CDK4;CCNE1;EIF4EBP1;NASP;CCNA2;PPP6C;TRIM71;CDKN1A;ACVR1;USP37;CDKN2D
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.41400359998949005,-1.058594832445102,0.39059674502712477,0.6296882776418327,1.0,2/13,5.04%,OGDH;IDH1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.2954771614004104,-1.0583683609547576,0.3665480427046263,0.629832231212826,1.0,20/54,29.11%,UBE2K;BIRC3;TAX1BP1;GAS6;OTULIN;CASP8;CFLAR;TNFAIP3;TNFRSF1A;HIPK1;IKBKG;IKBKB;RIPK1;CASP1;HSPA1B;GPS2;PTPN2;ADAM17;NLRP2B;RNF31
prerank,dopaminergic neuron differentiation (GO:0071542),0.36433724278130614,1.0580279891011997,0.3613053613053613,0.7955984978610968,1.0,3/19,9.25%,PHOX2A;LMX1B;VEGFA
prerank,prostaglandin biosynthetic process (GO:0001516),-0.3818188279430798,-1.0579644032071478,0.40613718411552346,0.6304154571915789,1.0,11/18,30.65%,PLA2G4A;PTGS1;EDN1;PTGES3;MIF;HPGDS;DAGLB;PNPLA8;PTGIS;PRXL2B;TBXAS1
prerank,negative regulation of cell projection organization (GO:0031345),0.29572458143463776,1.0578253905379327,0.3270588235294118,0.79465379050743,1.0,12/48,15.52%,DCC;GRIN2B;SPOCK1;ITM2C;TSKU;PTPRS;STMN2;MAG;PAQR3;DENND5A;APOE;PTPRO
prerank,translational termination (GO:0006415),-0.2657440341098184,-1.0578206845108258,0.3379549393414211,0.6303682416318497,1.0,34/95,26.75%,DAP3;PTCD3;MRPL32;MRPL47;MRPS23;MRPS18A;MRPL2;GSPT1;MRPS24;MRPL46;MRPS27;MRPL12;N6AMT1;MRPL58;MRPL24;MTRF1L;MRPL57;MRPS14;ABCE1;MRPS21;MRPL35;GFM2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS2;MRPS28;MRPS35;MRPL43;MRPL48;MRPL11;TRMT112;MRPS31
prerank,regulation of phosphatase activity (GO:0010921),-0.35783229205260075,-1.0575424729420047,0.39100346020761245,0.6306599409296098,1.0,8/24,24.99%,PPP1R2;ZCCHC9;GPATCH2;PPP6R3;CHP1;CDK5RAP3;SH3RF2;BMP2
prerank,positive regulation of phosphatase activity (GO:0010922),0.36213187764480453,1.0574352626009116,0.3860045146726862,0.7942847653319617,1.0,3/21,5.75%,MAGI2;PLEK;CALM2
prerank,Fc receptor signaling pathway (GO:0038093),-0.2585408191693766,-1.0571459227951214,0.3506944444444444,0.6311947689782454,1.0,38/110,27.31%,RAC1;TAB3;LYN;NFATC1;PSMA2;PAK2;PLCG1;NFKB1;PIK3R1;PSME2;JUN;MAPK1;PSMB4;PLCG2;FBXW11;MAPK8;PIK3CB;PSMC2;GRB2;GAB2;PSMB2;PSMB1;MAP2K4;TAB2;PSMA8;IKBKG;IKBKB;PSME1;PSMD4;VAV2;PSMA7;RELA;PSMD5;MAP3K7;PIK3CA;PSMB10;PSMA3;FCER1G
prerank,cellular protein-containing complex assembly (GO:0034622),-0.2491398190573783,-1.0568672213912025,0.31724137931034485,0.6315073312953685,1.0,53/159,26.83%,HIP1;FCHO2;STXBP6;EPS15;EIF4H;NCK1;PXN;AHCTF1;AP2S1;NUP98;PSMG2;TCP1;PIK3C2A;SNX9;SMAD1;SMAD2;PICALM;SMAD4;CHMP4B;CHMP4A;SAMM50;VBP1;NCK2;POGZ;NUP153;RPL38;PTGES3;TTC12;HIP1R;TPR;ANGPT1;CASQ2;DNAJB12;CENPE;VAMP3;PFDN6;ADRM1;TCF4;AP2M1;PSMD4;HIGD2A;VAMP2;HSP90AA1;NDUFAF1;ARL2;HIGD1B;DHX9;DRC1;PSMG1;CCT2;GPX4;IMMP2L;CHMP3
prerank,DNA strand elongation (GO:0022616),-0.3801811459488526,-1.056737266218352,0.3908918406072106,0.631402370346516,1.0,10/18,26.13%,MRE11;MCM4;POLD3;GINS3;GINS1;DCLRE1B;TERT;RFC4;MCM3;MCM7
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.3606306684851163,1.056574867657678,0.3804100227790433,0.7954205470862827,1.0,6/20,17.17%,FAR1;ACLY;ACACA;ACSL3;SCD5;SCD
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.37385257964262913,-1.0563915908448849,0.3929889298892989,0.6318190242783001,1.0,12/19,40.16%,ZMIZ1;GAS6;PPP2R3C;PRKDC;IL7;AXL;MMP14;SYK;ZAP70;MDK;GATA3;IL4
prerank,negative regulation of cell communication (GO:0010648),0.35286275172687326,1.055628903731999,0.36444444444444446,0.7967382157285949,1.0,3/21,3.44%,OPRM1;IGFBP3;GLRA1
prerank,regulation of cytokine production (GO:0001817),-0.25649071011152663,-1.055582124504307,0.33158813263525305,0.6333779873573006,1.0,26/126,20.24%,FOXP1;AFAP1L2;LYN;IFIH1;TRIM56;RPS6KA5;IL15;SRGN;TNFRSF1B;MAST2;MAPKAPK2;CASP8;PIK3CD;RGCC;FLOT1;ASB1;ICOSLG;AGPAT1;N4BP1;MIF;C1QTNF3;ANXA1;SOD1;LURAP1;PTPRC;BCL6
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.42826906926342967,-1.0552441916079198,0.4283121597096189,0.6337912593785389,1.0,2/12,1.62%,GJD3;CAV1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.296776117601779,-1.0551453387551546,0.3736842105263158,0.6336112242490078,1.0,17/56,15.74%,SPTBN1;STAMBP;SNX9;BIN3;ROCK1;CHMP4B;CECR2;CUL7;KIF23;RASA1;DCTN3;RHOA;SON;RTKN;RHOC;ROCK2;MITD1
prerank,dephosphorylation (GO:0016311),-0.24885581537233012,-1.0550847261869276,0.34053156146179403,0.633348735576886,1.0,29/147,13.71%,PTPRG;PTPRB;PTPRM;PPP2R5A;PTPN14;PPM1H;MTMR3;PTPN1;PTPN9;PTPRJ;PTPN12;PPEF2;ALPL;PPM1L;ILKAP;PTPRK;MTMR6;PPM1F;PPM1B;PPP1R12A;UBLCP1;PTPN3;DUSP23;ACP6;DUSP3;PTPN13;CTTNBP2NL;FBXW11;PNKP
prerank,protein processing (GO:0016485),0.25936054233414696,1.054982075708091,0.34541062801932365,0.7970580455008315,1.0,24/102,16.85%,OMA1;MYRF;C1RL;MME;MMP16;CLN3;CPE;TYSND1;METAP2;BACE1;KLK1;KLK6;SPCS3;ADAM19;CPN1;PCSK2;AEBP1;HTRA2;SPCS1;PCSK6;ECE2;EEF1AKMT4-ECE2;KLKB1;CASP4
prerank,cellular response to amino acid stimulus (GO:0071230),-0.32542769137425515,-1.0546028020368898,0.366120218579235,0.6341142207948801,1.0,10/33,18.69%,SH3BP4;SESN1;MTOR;CAPN2;UBR2;RPTOR;LARS1;CASTOR1;FYN;UBR1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.2687668004010417,-1.0541352885869135,0.3624161073825503,0.6348586984738493,1.0,26/88,22.58%,CLINT1;VPS13A;EXOC6;STXBP6;EPS15;APP;EXOC4;SCAMP2;DNM2;RABEP1;PUM1;SCFD1;EXOC2;VPS13C;AP1G1;ACBD3;EXOC8;CORO7;AP4M1;VPS35L;SCAMP1;AP4B1;RABIF;VAMP2;KIF16B;ARFGEF2
prerank,positive regulation of protein polymerization (GO:0032273),-0.2844163172118154,-1.0537873194966363,0.36622073578595316,0.6353009839707877,1.0,23/65,23.71%,CLIP1;BAIAP2L1;RAC1;PRKCE;NCK1;TOGARAM1;SNX9;OCLN;NCK2;FCHSD2;DCTN1;LMOD1;SLAIN2;DRG1;CDC42EP3;NCKAP1;RPS3;FCHSD1;CDC42EP1;PTK2B;HSP90AA1;AKAP9;ARL2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.4228682222882596,-1.0537203978198026,0.3901098901098901,0.6350637152025566,1.0,6/12,24.23%,ACADL;CEACAM1;ERLIN2;ACADVL;BRCA1;TRIB3
prerank,positive regulation of protein deacetylation (GO:0090312),-0.4011787695094473,-1.0536856074361343,0.39045936395759717,0.6347555269870983,1.0,2/14,5.18%,DYRK1A;NIPBL
prerank,anion transmembrane transport (GO:0098656),-0.28356215655002637,-1.053678052637158,0.35596026490066224,0.6343725545598262,1.0,20/67,21.38%,LRRC8C;SLC7A1;SLC7A5;SLC13A4;SLC16A12;SLC5A6;SLC38A5;SLC39A8;LRRC8D;ARL6IP5;SLC13A3;SLC35A3;SLC25A11;SLC36A4;SLC35B4;PRAF2;SLC25A1;SLC1A1;SLC7A2;SLC3A2
prerank,regulation of lipid storage (GO:0010883),-0.3611454412109389,-1.0535061700805453,0.38859180035650626,0.6343800708182739,1.0,9/22,28.14%,NFKB1;NFKBIA;FTO;IKBKE;LPL;ITGB3;PTPN2;HILPDA;ALKBH7
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.38177472568012916,1.0531461847849573,0.38949671772428884,0.8011613119052864,1.0,5/15,13.29%,PSMD10;PRELID1;TRIAP1;GHITM;CLU
prerank,neural tube closure (GO:0001843),-0.3194891007401778,-1.0530866489764603,0.3808630393996248,0.6349802086895894,1.0,10/34,18.67%,DVL3;LMO4;PHACTR4;LRP6;TGFB2;MTHFD1;SEMA4C;FUZ;SKI;MTHFD1L
prerank,positive regulation of insulin secretion (GO:0032024),0.31650516470490264,1.0529057814666345,0.35650224215246634,0.8002828981276955,1.0,10/36,15.32%,BLK;GCK;ADCY8;TRH;GPER1;PLA2G6;GPLD1;NLGN2;GLUD1;MCU
prerank,organic cation transport (GO:0015695),-0.36929645511148096,-1.052442074867246,0.3858695652173913,0.6361654672811019,1.0,5/20,10.06%,SLC47A1;RALBP1;SLC22A5;SLC44A1;SEC14L1
prerank,cell-cell junction maintenance (GO:0045217),-0.43933871662768614,-1.0523127489497162,0.39622641509433965,0.6360553821938216,1.0,2/11,1.30%,TJP1;FERMT2
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.3942473928765121,-1.052121745708286,0.39177101967799643,0.6361248034449768,1.0,4/15,9.10%,STOX2;RICTOR;TGFB2;CELF1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.27700089543755463,-1.0519514610135206,0.35701906412478335,0.6361455394438753,1.0,25/72,29.19%,MNAT1;RBX1;POLR2G;ERCC2;POLD3;TCEA1;RPA3;RPA1;ERCC3;ERCC8;RPA2;USP7;COPS7A;RFC4;RFC1;COPS8;POLR2C;COPS4;LIG1;POLR2L;ERCC6;POLR2H;GTF2H3;CCNH;PPIE
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.4508811987365323,-1.05189632406648,0.4249084249084249,0.6358867850124181,1.0,4/10,18.14%,MSN;EZR;RHOA;RAP2A
prerank,protein localization to cell surface (GO:0034394),-0.3407761511212566,-1.0514452191606094,0.3907637655417407,0.6365911477906498,1.0,9/26,17.12%,SMURF1;RIC3;PTPRK;FGF7;FLNA;FBLN5;WNT11;ANGPT1;CTNNB1
prerank,regulation of lipase activity (GO:0060191),-0.40526070174474527,-1.0513804187725875,0.4130052724077329,0.6363523182932631,1.0,4/13,13.34%,PCSK5;RHOA;LPL;RHOC
prerank,response to peptide (GO:1901652),0.319533023699538,1.051325344732739,0.36343115124153497,0.8035786251368944,1.0,5/33,4.32%,MMP12;CACNA1B;GNAI1;CACNA1A;INAVA
prerank,protein localization to chromosome (GO:0034502),-0.32865096483668765,-1.05093210251012,0.3616636528028933,0.6370602786103591,1.0,12/34,19.64%,RB1;ESR1;CTCF;MRNIP;XRCC4;MCM9;WAPL;RPA1;SLF2;TERF2;RPA2;ATRX
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.3473241164781611,-1.0509171718923913,0.3892857142857143,0.6366927928876777,1.0,10/23,34.02%,COX18;SAMM50;AGK;BCL2L11;HSP90AA1;TIMM10;TOMM70;PMAIP1;TIMM10B;TIMM13
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.43097676901917736,-1.050467184315365,0.4111111111111111,0.6373377480042137,1.0,5/11,19.59%,SLC30A10;PPARA;ABCB7;FYN;COA8
prerank,regulation of protein modification process (GO:0031399),-0.2967260804746863,-1.0502838298053192,0.37433155080213903,0.6373703287784278,1.0,11/50,11.30%,LYN;CORO1C;ATG7;KAT2B;SPRED2;ATG10;PTK2;CDH5;ASPSCR1;STAT2;FNIP2
prerank,stem cell development (GO:0048864),0.3779898569190314,1.0498718553064452,0.4057971014492754,0.80636962508678,1.0,3/16,11.59%,NRG1;NOLC1;CDH2
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.25764794251701295,-1.0488132690960663,0.3645833333333333,0.6404397892027803,1.0,38/109,27.31%,RAC1;TAB3;LYN;NFATC1;PSMA2;PAK2;PLCG1;NFKB1;PIK3R1;PSME2;JUN;MAPK1;PSMB4;PLCG2;FBXW11;MAPK8;PIK3CB;PSMC2;GRB2;GAB2;PSMB2;PSMB1;MAP2K4;TAB2;PSMA8;IKBKG;IKBKB;PSME1;PSMD4;VAV2;PSMA7;RELA;PSMD5;MAP3K7;PIK3CA;PSMB10;PSMA3;FCER1G
prerank,amino acid transport (GO:0006865),0.28585976142011277,1.048661467083238,0.375,0.8085635495973397,1.0,9/49,9.62%,SLC7A11;SLC7A4;PDPN;SLC6A15;SLC7A8;SLC36A2;SLC7A14;SLC25A45;SLC7A6
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.36173097971827156,-1.0484687229103993,0.41304347826086957,0.640891863693992,1.0,5/21,10.70%,PDZD8;MCUB;TGM2;AFG3L2;BCAP31
prerank,ganglioside biosynthetic process (GO:0001574),-0.38854145163263665,-1.0484247600681198,0.413854351687389,0.640612603221089,1.0,5/15,14.37%,ST3GAL1;ST8SIA4;ST6GALNAC3;ST3GAL2;B4GALT5
prerank,cellular response to copper ion (GO:0071280),-0.384938862803315,-1.0481832751971005,0.4011090573012939,0.6407577966737023,1.0,10/16,35.95%,MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F;AQP1;MT3
prerank,regulation of protein dephosphorylation (GO:0035304),-0.3124786466228023,-1.047625234974797,0.3719298245614035,0.6417244008432754,1.0,6/37,7.57%,PPP2R5A;MFHAS1;PPP1R2;PRKCD;SPPL3;CDH5
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.3358817218486293,-1.0475196952835626,0.3844765342960289,0.6415929223823991,1.0,7/29,12.82%,ENG;TGFBR3;S1PR1;SMAD7;ZFPM1;NOTCH1;TPM1
prerank,negative regulation of macroautophagy (GO:0016242),-0.3459704556088364,-1.0474555483328472,0.3882149046793761,0.6413265564466537,1.0,6/26,10.04%,LRRK2;MTOR;SCFD1;AKT1;CHMP4B;CHMP4A
prerank,regulation of establishment of planar polarity (GO:0090175),-0.2705224538801027,-1.0473526700717812,0.3655913978494624,0.6411536560590068,1.0,27/88,23.89%,RAC1;SMURF2;FZD6;DVL3;PSMA2;SMURF1;VANGL1;FZD4;AP2B1;AP2A2;AP2S1;PSME2;PSMB4;RHOA;WNT11;PSMC2;PSMB2;PSMB1;PSMA8;PSME1;AP2M1;PSMD4;ROR2;PSMA7;FZD7;PSMD5;FZD5
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.3909563783153077,-1.0471270406303017,0.4029574861367837,0.6413162061975319,1.0,4/15,12.39%,CUL3;STXBP4;PLCG2;CDC73
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.2695818966436305,-1.046571472270535,0.3869257950530035,0.642279469951757,1.0,23/80,18.72%,WASF2;EPS8;RAC1;FNBP1L;EPS8L2;PIK3R1;PALM;RHOQ;WASL;PLCE1;AGRN;OCLN;CROCC;ARAP1;BCAS3;CDC42EP3;FAM98A;NCKAP1;FUZ;ARHGAP35;CCL19;WASHC1;NDEL1
prerank,cranial nerve development (GO:0021545),0.4264305314284821,1.046554684379245,0.3961456102783726,0.8135078228187052,1.0,2/11,8.54%,PAX2;POU4F1
prerank,regulation of adaptive immune response (GO:0002819),0.36525726043494733,1.046552501599101,0.39952153110047844,0.8119209634316484,1.0,4/18,8.27%,SASH3;SAMSN1;TRIM27;ADCY7
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4181776022748891,1.0462248132621177,0.3914081145584726,0.8113622243322743,1.0,3/11,8.52%,PTPRT;SOCS3;HGS
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.39506668491033703,-1.0459734579033877,0.38761061946902653,0.6433226856612497,1.0,2/14,6.02%,ENTPD1;ENTPD6
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.2927042505829734,-1.0456123476390102,0.3690909090909091,0.6433988049702178,1.0,13/51,19.24%,EMD;AHCTF1;NUP98;SEC13;REEP3;CHMP4B;CHMP4A;LMNA;CHMP2B;CC2D1B;LBR;SUMO1;PPP2CA
prerank,mitotic nuclear membrane organization (GO:0101024),-0.2927042505829734,-1.0456123476390102,0.3690909090909091,0.6433988049702178,1.0,13/51,19.24%,EMD;AHCTF1;NUP98;SEC13;REEP3;CHMP4B;CHMP4A;LMNA;CHMP2B;CC2D1B;LBR;SUMO1;PPP2CA
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.4134810929907936,-1.0453579791124097,0.40036563071297987,0.6436278779267305,1.0,5/12,18.81%,STARD3;FDX1;FDXR;STARD3NL;STAR
prerank,iron ion homeostasis (GO:0055072),-0.28420885597080936,-1.0451003802642542,0.38175675675675674,0.6438307342692912,1.0,13/58,18.25%,ABCG2;SLC40A1;TFRC;BMP6;SCARA5;BDH2;PICALM;SMAD4;HFE;HMOX2;ABCB7;SOD1;FLVCR1
prerank,exit from mitosis (GO:0010458),-0.4247874575813829,-1.0450990814156917,0.4254937163375224,0.643435664037816,1.0,3/12,10.03%,EPS8;PPP2R2D;CHMP4B
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.36728963891149297,1.0447714331498494,0.4078091106290672,0.8142118193166641,1.0,4/18,7.38%,TENM4;OPALIN;PTPRZ1;SOX1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.29672017193460803,-1.0447479744090613,0.37683823529411764,0.643916242586542,1.0,21/47,31.57%,THBS1;TGFBR2;PRKCD;RAB27A;PLCG2;DHRS4;TP53;AGTR1;GRB2;SOD1;PDGFRB;ITGAM;GADD45A;RIPK1;ACE2;ADGRB1;SLC5A3;MAPK14;PID1;TGFB1;TLR6
prerank,cellular response to estradiol stimulus (GO:0071392),-0.3753861197000832,-1.0443743385737392,0.39399293286219084,0.6444432934093087,1.0,5/18,15.76%,ESR1;NRIP1;EGFR;KAT5;RUVBL2
prerank,regulation of protein autophosphorylation (GO:0031952),-0.3137064576346973,-1.044160931638129,0.37453874538745385,0.6446208455291901,1.0,6/36,7.85%,ENG;PPP2R5A;PDGFD;DDX3X;RASSF2;MRE11
prerank,protein complex oligomerization (GO:0051259),0.2621564274075586,1.0441136379177445,0.3458980044345898,0.8146075128601712,1.0,7/85,4.27%,KCNC2;MPP2;GLRA3;MS4A1;C9;ADCY8;ATL1
prerank,early endosome to late endosome transport (GO:0045022),-0.3724736957414656,-1.0438107178315799,0.38768115942028986,0.6450739527298784,1.0,7/20,23.00%,RAB7A;RAB5A;STX8;ANKRD27;AKTIP;KIF16B;BECN1
prerank,acute-phase response (GO:0006953),-0.4215859435180497,-1.0432574087412874,0.4301270417422868,0.6459970648298125,1.0,10/12,45.32%,IL6R;LBP;PLSCR1;IL22;AHSG;CEBPB;CRP;SIGIRR;ITIH4;IL6
prerank,histone H2B ubiquitination (GO:0033523),-0.4409622926864655,-1.04322795595339,0.45255474452554745,0.6456819335321221,1.0,3/10,12.39%,DTX3L;RNF40;CDC73
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.35094419702850344,-1.0429982184094275,0.3924050632911392,0.6457965095551189,1.0,6/23,8.04%,GNB1;LRRK2;ABL1;KCNQ1;TGM2;MAPK1
prerank,early endosome to Golgi transport (GO:0034498),0.4163187318705308,1.042776131137586,0.41163793103448276,0.816982681334989,1.0,4/11,14.67%,LMAN1;RAB6A;SURF4;TMED9
prerank,mesonephros development (GO:0001823),-0.43787918143602333,-1.0421975957153464,0.41312056737588654,0.647329409418471,1.0,3/11,7.18%,ZBTB16;FGF1;BMP4
prerank,phospholipid transport (GO:0015914),-0.29365021533437624,-1.0421400038238626,0.3929203539823009,0.647067932579181,1.0,14/52,20.94%,ATP10A;PITPNC1;ATP8B1;PLTP;SCARB1;MFSD2A;ATP10B;ABCA7;TNFAIP8L3;ATP9B;PCTP;PRELID2;OSBPL2;ATP11C
prerank,regulation of neuron projection arborization (GO:0150011),0.3891682054564305,1.0421133444583324,0.4017467248908297,0.8174273810553452,1.0,6/15,15.82%,GRIP1;NTNG2;NTNG1;DLG4;MYO9A;DVL2
prerank,monoacylglycerol metabolic process (GO:0046462),-0.4159541970929985,-1.042057675526982,0.425,0.6468614160692586,1.0,3/13,16.55%,PLA2G4A;MGLL;DGAT2
prerank,positive regulation of viral process (GO:0048524),-0.28680096531675087,-1.0419864554376528,0.40394973070017953,0.6466606133982932,1.0,28/60,33.95%,RAB7A;DDX3X;LARP1;PPARA;POLR2G;MDFIC;PKN2;PDE12;TBC1D20;SRPK2;ADARB1;RAD23A;NELFB;STAU1;PPIH;SUPT4H1;POLR2C;DHX9;POLR2L;POLR2H;RSF1;PABPC1;AXL;PPIE;NELFA;NELFCD;POLR2E;TARBP2
prerank,positive regulation of ossification (GO:0045778),-0.313483312820677,-1.0418604636529163,0.39892665474060823,0.6465746591403433,1.0,10/39,12.16%,ZBTB16;BMPR2;BMP6;TGFB2;BMP4;MEF2C;ACVR2A;ADGRV1;ANO6;PKDCC
prerank,skin development (GO:0043588),-0.28090020811881716,-1.0416276240164968,0.3776223776223776,0.646752156191241,1.0,12/65,11.42%,ITGA6;BCR;ITGA3;LSR;COL5A1;ITGB4;ADAM9;MED1;COL5A2;HRNR;WNT16;TXNIP
prerank,kidney development (GO:0001822),0.27282315993810596,1.0414157995400264,0.38516746411483255,0.8180225466974417,1.0,11/65,9.25%,ROBO2;MME;LHX1;OSR1;WT1;PAX2;HNF1B;VANGL2;PROX1;ARL3;VEGFA
prerank,protein autoubiquitination (GO:0051865),-0.2815334515049486,-1.0412283012613486,0.3621621621621622,0.6473382290559847,1.0,20/61,24.35%,CNOT4;DTX3L;RNF213;CUL3;RNF115;UHRF2;SH3RF1;UBE2D3;RAD18;OBI1;ERCC8;TRIM13;RNF10;RNF4;WWP2;BRCA1;MDM2;SH3RF2;TRIM68;RNF146
prerank,camera-type eye development (GO:0043010),0.3337964195825323,1.0408752282344371,0.3912037037037037,0.818076196260842,1.0,6/25,9.25%,TENM3;EFEMP1;WT1;PAX2;TSKU;VEGFA
prerank,GTP metabolic process (GO:0046039),-0.3985440406529536,-1.0405625911591374,0.3996383363471971,0.6484753126632425,1.0,4/15,14.14%,GNAI3;LRRK2;RHOQ;RAB23
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.4499340774780545,-1.0401631328179768,0.41889483065953653,0.6486258155608495,1.0,5/10,20.03%,AP2B1;AP2A2;AP2S1;MYLIP;AP2M1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.4499340774780545,-1.0401631328179768,0.41889483065953653,0.6486258155608495,1.0,5/10,20.03%,AP2B1;AP2A2;AP2S1;MYLIP;AP2M1
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.3483836129643769,-1.0398121743012594,0.3803339517625232,0.6490764887737224,1.0,14/23,51.45%,GAS6;CEACAM1;TNFAIP3;IGF1;NLRP2B;CARD16;NLRP3;CD33;GIT1;NLRP12;GSTP1;APOA1;FFAR4;ZC3H12A
prerank,positive regulation of growth (GO:0045927),-0.2814640057966089,-1.0395654587756218,0.3808630393996248,0.649285189569425,1.0,16/64,15.48%,INSR;DDX3X;EGFR;PLCB1;TGFB2;PPM1F;EXOSC2;MFSD2A;ADAM10;AKT1;RPTOR;RPS6KA1;ZPR1;RPS6KA3;H3-3A;N6AMT1
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.3623441375998408,-1.0395072885207968,0.3993115318416523,0.6486419492860577,1.0,5/20,12.25%,DLD;ACAD8;BCKDHA;ACADSB;SLC25A44
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.3623441375998408,-1.0395072885207968,0.3993115318416523,0.6486419492860577,1.0,5/20,12.25%,DLD;ACAD8;BCKDHA;ACADSB;SLC25A44
prerank,oligosaccharide biosynthetic process (GO:0009312),0.3587477282017541,1.0392502977591096,0.4090909090909091,0.8215557938994436,1.0,5/20,8.28%,B3GALT1;B3GALT4;FUT9;B3GALT5;ST6GALNAC5
prerank,regulation of protein transport (GO:0051223),-0.3409090729244032,-1.0392320944646283,0.40037243947858475,0.6488412351000199,1.0,11/27,22.24%,PTPN1;DNAJC1;RHBDF2;PPM1F;SCFD1;SNX12;LCP1;CHP1;NDEL1;WWP2;NDFIP2
prerank,homotypic cell-cell adhesion (GO:0034109),-0.3091517493916869,-1.0384727025836424,0.4101633393829401,0.6502281897758178,1.0,17/39,29.21%,MYH9;TJP2;FLNA;ILK;ACTN1;ACTB;PIK3CB;CLIC1;UBASH3B;FERMT3;ITGB3;VCL;TLN1;PLPP3;MYL9;RAP2B;MEGF11
prerank,brain morphogenesis (GO:0048854),0.42073513031399734,1.0384641729388453,0.408675799086758,0.822492639180996,1.0,6/12,16.59%,CTNNA2;PAX2;BBS4;SLC6A4;MKKS;BBS2
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.30736532032417585,1.038263347050603,0.36995515695067266,0.8214966355564307,1.0,8/41,13.10%,GRM5;DOCK3;NTRK2;ADRA2A;LILRA5;CSF1R;DLG4;BDNF
prerank,photoreceptor cell development (GO:0042461),0.3920695395776013,1.038154905623811,0.42950108459869846,0.820278355276269,1.0,4/14,9.43%,AHI1;ARL3;VEGFA;DCX
prerank,cellular response to oxygen-containing compound (GO:1901701),-0.2236117622575444,-1.0380900445350925,0.3459552495697074,0.6507172611235935,1.0,59/291,16.45%,DAB2IP;RAPGEF2;GNB1;FOXO1;PKD2;DAPK1;ESR1;LYN;NRIP1;SH3BP4;ATM;TBX1;MTOR;EGFR;PDE3A;ADAM9;FZD4;NFKB1;TNFRSF1B;PXN;IRS1;PDE2A;PDCD4;SLIT2;KCNQ1;IRGM;PRKCD;LBP;RAP1A;PTPRK;MEF2C;EZR;JUN;TGM2;MAPK1;RAP1B;PRKD1;CAPN2;AKT1;NFKBIL1;RAPGEF1;RPTOR;RHOA;IRAK1;CDC73;ACTB;LPL;TPM1;KAT5;WNT11;LARS1;MAPK8;P2RY6;TNFAIP3;IGFBP5;ROCK2;RUVBL2;AGAP3;CHMP5
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.29252024842128915,-1.0380438373581717,0.3952205882352941,0.6504431194464957,1.0,22/52,28.11%,PAN3;TUT7;CNOT4;SAMD4A;EXOSC2;EXOSC1;EXOSC3;TUT4;PARN;PDE12;RC3H1;EXOSC8;EDC3;EXOSC5;DCP1A;LSM3;NT5C3B;CNOT2;EXOSC7;CNOT8;CNOT1;LSM2
prerank,cellular response to heat (GO:0034605),-0.31843550939455656,-1.0378815543974333,0.4024390243902439,0.6504328959476886,1.0,11/35,18.49%,THBS1;YWHAE;ANO1;CLPB;FGF1;SLU7;ATXN3;TCIM;TPR;SUMO1;TRPV4
prerank,regulation of TOR signaling (GO:0032006),-0.2775405060518537,-1.0376936043650953,0.38761061946902653,0.6504798504144109,1.0,18/67,20.40%,SH3BP4;RICTOR;GNA12;GAS6;DDIT4;SEC13;MIOS;GSK3A;UBR2;PRKAA1;TTI1;RPTOR;LARS1;GOLPH3;UBR1;ITFG2;TMEM127;AKT1S1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3309488918555672,1.0372666280059688,0.3960880195599022,0.8214567347057594,1.0,5/26,6.42%,ATP2B4;AKAP6;EFHB;CAMTA1;FHL2
prerank,negative regulation of dephosphorylation (GO:0035305),-0.3700648094312094,-1.0368687854871736,0.3900184842883549,0.6520878101271903,1.0,4/18,13.15%,MFHAS1;ZCCHC9;GPATCH2;CHP1
prerank,chromatin remodeling at centromere (GO:0031055),0.32443733748734127,1.0367385263182818,0.4067796610169492,0.8214644265885455,1.0,10/31,20.27%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;CENPK;CENPW;RBBP7;ITGB3BP;CENPA
prerank,regulation of cytoplasmic translation (GO:2000765),0.39895184829863606,1.0366668256418152,0.41648106904231624,0.8201295288188591,1.0,4/14,17.25%,CPEB1;PKM;CPEB3;DHX36
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.3203177008516842,-1.0365624658008288,0.40480274442538594,0.6524816823553339,1.0,5/33,9.60%,LEF1;IL34;ACIN1;HAX1;CASP8
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.3163452461253651,-1.0363332138941304,0.43795620437956206,0.6526344930625487,1.0,18/33,37.98%,ETS1;FOXO3;MED1;ABCB10;ACVR2A;TAL1;MTURN;ARNT;PRKDC;MAPK11;HSPA1B;MAPK14;STAT3;RAB7B;SCIN;HOXA5;HIF1A;FES
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2671227378080668,1.0362305212187743,0.37336244541484714,0.8198978899688246,1.0,19/69,17.26%,BCL2;TYRO3;CLN3;PTPRZ1;NTRK2;VSTM2L;GRN;PLA2G3;POU4F1;MAG;FZD9;NRBP2;CCL2;BDNF;FGF20;APOE;ADAM8;MSH2;RETREG1
prerank,response to interleukin-6 (GO:0070741),-0.4369666823522727,-1.035990792983546,0.41847826086956524,0.6530815015449615,1.0,6/10,31.27%,ST3GAL6;NFKB1;RELA;PTGIS;PID1;SBNO2
prerank,post-translational protein modification (GO:0043687),-0.22061885794229796,-1.0357179352190327,0.3716216216216216,0.6533385071957216,1.0,109/332,30.55%,FBXL7;IGFBP7;ZBTB16;KLHL5;DCAF10;DCUN1D3;PTP4A2;FBXL12;APP;PSMA2;IGFBP4;RAB1A;CUL9;FBXL3;RAB2A;RBX1;GAS6;LMO7;CUL3;DCAF5;BMP4;PSME2;PDIA6;CUL2;WSB2;RAB5A;SPSB1;PSMB4;ADAM10;FEM1A;SOCS2;CUL7;FBXW8;KLHL13;ITIH2;LRRC41;PRKCSH;ANO8;CCDC8;NOTUM;FEM1C;MSLN;ASB1;FBXW11;KLHL25;BTBD1;PSMC2;HIF3A;IGFBP5;SERPINC1;FEM1B;UBE2M;ATG5;ERCC8;PSMB2;PSMB1;F5;DCAF13;RAB11A;PSMA8;KLHL3;EPAS1;PSME1;GPC3;ELOC;PSMD4;COPS7A;MFGE8;LAMB1;FN3KRP;PSMA7;KEAP1;CCN1;ASB7;CHRDL1;KTN1;WDR5;COPS8;PSMD5;RBBP5;FBN1;COPS4;FBXO32;PNPLA2;FBXL22;FBXO17;UBXN7;FBXO40;DTL;RABGGTB;PSMB10;RHBDD1;PSMA3;RAB38;TMEM132A;DNAJC3;ASB4;SCG3;KLHL41;NEURL2;FBXO31;DSCC1;ASB5;SUMF1;MBTPS1;OBSL1;LTBP1;AHSG;COPS5
prerank,positive regulation of calcium ion import (GO:0090280),0.40693125283782194,1.0355550984470407,0.4146341463414634,0.820474585965094,1.0,3/12,12.95%,STC1;SPHK2;CCL2
prerank,ether lipid biosynthetic process (GO:0008611),0.4122878259754387,1.0351485976943586,0.44222222222222224,0.8201214748759558,1.0,6/10,17.55%,FAR1;GNPAT;DHRS7B;PEDS1;CHPT1;LPCAT2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.26903069960730536,-1.034698032233975,0.3822525597269625,0.6553863017574865,1.0,32/78,28.42%,MNAT1;PKD2;EGFR;CDKN1B;CCND3;LATS2;AKT1;CCNY;RGCC;ACTB;TFAP4;CDK5RAP3;CCND1;CNPPD1;PTEN;NR2F2;BLM;CDKN2C;CDC25A;GADD45A;MYOCD;CEBPA;CCNYL1;CCNG1;CCNK;CCNE2;ADAM17;CDKN3;APC;CCNJ;CDKN2B;CCNH
prerank,protein targeting to peroxisome (GO:0006625),-0.33563784798666435,-1.0344904442319272,0.4163636363636364,0.6554931402225351,1.0,13/29,33.89%,PEX1;ABCD3;PEX7;RAB8B;ZFAND6;PEX14;PEX3;PEX6;PEX11B;HACL1;PEX19;LONP2;PEX26
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.3100450004591632,-1.0343944894602513,0.40409683426443205,0.6553000280028254,1.0,12/36,24.55%,EIF3H;TLK2;FHIT;RYBP;AQP11;HFE;N4BP1;GIPC1;USP7;OGT;TRIM39;TAF9
prerank,muscle cell differentiation (GO:0042692),-0.3223611736814103,-1.0340357860567837,0.3923611111111111,0.6557709680155779,1.0,8/32,12.80%,MRTFB;TBX1;SYNE1;MEF2C;TMEM204;CHRNB1;NEBL;SEMA4C
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.29504888145624203,1.0340287110210191,0.38497652582159625,0.8219895536087648,1.0,8/40,10.11%,MAGI2;VTN;BICD1;CD63;ATAD1;AHI1;VEGFA;SGIP1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.34526397327316577,-1.0339105119010505,0.4048059149722736,0.6556869552542545,1.0,14/24,38.67%,TENT4B;STN1;XRN1;CTC1;HNRNPA1;TERF2;PINX1;HNRNPU;TNKS2;PIF1;TNKS;DCP2;SLX4;ERCC4
prerank,relaxation of muscle (GO:0090075),0.3912105434009068,1.0333435178524848,0.42116630669546434,0.8224947089634238,1.0,4/13,11.91%,ATP1A2;ATP1B1;GSN;SLC8A1
prerank,regulation of cilium assembly (GO:1902017),-0.276907999470749,-1.0330214124767918,0.3726937269372694,0.6574815955675137,1.0,19/62,19.31%,LIMK2;TBC1D1;TBC1D2B;IFT140;CDK10;USP6NL;TBC1D30;TBC1D14;YAP1;CROCC;TBC1D22B;TBC1D22A;DYNC2LI1;ATG5;TBC1D20;FUZ;ARHGAP35;TBC1D8;TBC1D17
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.36252748391219297,-1.0327028652516572,0.43130434782608695,0.6578399325464974,1.0,6/20,11.05%,PKD2;EGFR;CCND3;AKT1;CCNY;RGCC
prerank,cellular response to alcohol (GO:0097306),-0.3065497087013089,-1.0325059466228956,0.4230769230769231,0.6579088832463095,1.0,14/42,21.31%,CTNNA1;GNB1;SMO;LARP1;LRP6;SPIDR;CDH1;PTGFR;KLF9;ADCY1;CTNNB1;GOLPH3;BRCA1;BLM
prerank,neuron remodeling (GO:0016322),-0.44182605440531864,-1.0324531413900577,0.4364937388193202,0.6576399465797774,1.0,3/10,5.32%,ANKS1A;APP;SCARF1
prerank,regulation of immune response (GO:0050776),-0.24592412663399205,-1.0321313384567006,0.36333333333333334,0.6579898861101764,1.0,25/135,18.01%,FOXP1;ITGB1;XIAP;CD34;LYN;CD200;IL15;ICAM1;CLEC2D;BIRC3;SAMHD1;TGFB2;IRF1;CASP8;PVR;CSK;ITGA4;CD40;PLSCR1;ICAM2;N4BP1;GPR108;VCAM1;ZMPSTE24;ERAP1
prerank,inflammatory response (GO:0006954),-0.23406073997307741,-1.0305504689469989,0.36678200692041524,0.6613706320203115,1.0,91/195,41.27%,AFAP1L2;RAC1;MFHAS1;ADGRE5;NOD1;THBS1;F11R;NFATC4;CCL25;PARP4;LOXL3;HNRNPA0;NFKB1;GGT5;MAPKAPK2;HSPG2;PXK;PIK3CD;PTGFR;ADM;AGTR1;MGLL;HDAC4;CD40;ADCY1;TNFRSF1A;NOX4;ANXA1;NRROS;AOC3;IL10RB;CMKLR1;IKBKG;CCL19;IKBKB;LY75;CDO1;RELA;ACKR1;HMGB1;PTGDR;BMP2;HDAC5;F2R;LGALS9;IL22;CXCL10;IL2RA;HYAL3;NLRC4;TGFB1;STAT3;TLR6;VNN1;CEBPB;TLR1;C5AR2;NOS2;TLR5;LAT;CD14;IL1A;NLRP3;PTGER1;S100A9;TBK1;CCRL2;SIGLEC1;HPR;HP;PROK2;CXCL5;TLR2;CCL11;ITCH;CXCL1;CRP;PTGER4;TNFRSF4;CCL4;IL18;PTGER2;CRHBP;CCR1;IL4;PPBP;ABCF1;CD44;CCL8;TUSC2;CRH
prerank,JNK cascade (GO:0007254),-0.30522560069846977,-1.0304809663735475,0.4099264705882353,0.6611505644435489,1.0,15/40,24.79%,TAB3;NOD1;MAP3K5;MAP4K3;IRAK1;MAPK8;TNFRSF19;MAP2K4;TAB2;IRAK2;IKBKG;NOD2;SH2D3C;MAP3K7;GPS2
prerank,negative regulation of transposition (GO:0010529),-0.3811043504628502,-1.0302583528934002,0.4230088495575221,0.6612654615454481,1.0,7/16,30.81%,TUT7;UBR2;TUT4;MOV10;TDRD9;DDX4;MYBL1
prerank,hyaluronan catabolic process (GO:0030214),-0.3696338215640248,-1.029329992954673,0.42638623326959846,0.6631695635712045,1.0,9/18,32.00%,CEMIP2;FGF2;CHP1;HYAL2;LYVE1;HEXA;HYAL3;TGFB1;CEMIP
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.24078999720359257,-1.0292557312137254,0.39372822299651566,0.6629541555682262,1.0,53/152,26.87%,XIAP;RSPO3;UBR5;ADGRA2;CAV1;SMURF2;PSMA2;LRRK2;DDX3X;EGFR;CSNK1G3;TRPM4;NFKB1;LRRK1;MACF1;PSME2;PSMB4;PPM1B;AXIN2;ILK;CDC73;CSNK1G1;DKK2;CSNK1D;PLEKHA4;PSMC2;TNFAIP3;LYPD6;USP34;PSMB2;PSMB1;DAAM2;SKI;PSMA8;PSME1;SOX4;TBL1X;GPC3;PSMD4;TERT;CAPRIN2;PSMA7;AMER1;RSPO2;SFRP4;PSMD5;RNF146;SEMA5A;BMP2;WNT5B;PSMB10;FGF10;PSMA3
prerank,amyloid-beta metabolic process (GO:0050435),-0.37416501192088536,-1.0284158229088023,0.4126984126984127,0.6645948535555016,1.0,6/16,17.16%,DYRK1A;ACE;PSEN2;PSEN1;ABCA7;APH1A
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.3882811974417488,-1.0283797843480629,0.41323792486583183,0.663880451464001,1.0,7/15,27.32%,TNRC6B;AGO2;TOB1;ZFP36L1;NANOS1;CNOT1;PABPC1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.3882811974417488,-1.0283797843480629,0.41323792486583183,0.663880451464001,1.0,7/15,27.32%,TNRC6B;AGO2;TOB1;ZFP36L1;NANOS1;CNOT1;PABPC1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.24057361473119768,1.0283120740168692,0.37825059101654845,0.8364718980401884,1.0,25/142,12.48%,ATP1A2;HCRTR1;C1QTNF1;ATP2B4;ATP2B2;ADCY8;CALCA;CLN3;CACNA1A;PTGER3;SLC8A2;RYR2;C3AR1;CCR6;GPER1;TMEM178A;ADRA1D;ADRA1A;CIB2;TACR1;NMUR2;SLC8A1;HRC;DLG4;FZD9
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.2825643283849545,-1.0272165610174193,0.387719298245614,0.6662653562821107,1.0,18/61,21.85%,CAV1;PSMA2;PANK2;PPARA;SIRT5;PSME2;PSMB4;AZIN1;PSMC2;PSMB2;PSMB1;PSMA8;OAZ2;PSME1;NQO1;PSMD4;FGFR4;PSMA7
prerank,amino acid transmembrane transport (GO:0003333),-0.29894622627111084,-1.0270027536603787,0.42142857142857143,0.6663980200596823,1.0,7/45,7.79%,SLC47A1;SLC6A6;SLC7A1;SLC7A5;SLC38A11;SLC38A5;LRRC8D
prerank,intracellular protein transmembrane transport (GO:0065002),-0.3014244333794594,-1.026900064751665,0.42132867132867136,0.6662316479776126,1.0,20/42,37.62%,PEX1;PEX7;TOMM40;TIMM17B;PEX14;DNAJC19;TOMM40L;TIMM50;PEX6;TOMM20;SEC61A1;TOMM70;SEC63;AIFM1;PEX26;DNLZ;TIMM23;PAM16;AKT2;ZFAND2B
prerank,cellular response to radiation (GO:0071478),-0.3046393944427445,-1.0266628290062845,0.4290909090909091,0.6664097762512062,1.0,23/40,40.43%,NET1;SPIDR;TP53;NSMCE3;GRB2;LIG4;BLM;GADD45A;INTS7;INO80;KDM4D;RAD51AP1;GPR52;SWI5;MAPK14;EEF1D;RRH;OPN1MW3;OPN1MW;GPR88;RAD1;CDKN1A;SIRT1
prerank,glycogen catabolic process (GO:0005980),0.3765696491234367,1.026321519699011,0.4083885209713024,0.8408190904240207,1.0,7/15,18.42%,AGL;PHKG1;PYGM;PYGB;PGM2;PGM2L1;PYGL
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.4396499636375447,-1.025587017843575,0.44814814814814813,0.6686120095418012,1.0,6/10,26.60%,SMAD4;BRCA1;CHEK1;SMARCB1;RAPGEF3;HDAC5
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.3866523066770874,-1.0255436809218326,0.4230769230769231,0.6683239108994371,1.0,5/15,20.29%,KDR;VEGFC;IL16;CXCL12;F3
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.337697677135413,-1.0253137490980906,0.43875685557586835,0.6684541929278941,1.0,13/25,33.19%,MTHFD1;ADK;AMPD2;HPRT1;AMPD3;PRPS2;ADA;PNP;GMPR2;APRT;SHMT1;DCK;GART
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.4009408402710973,1.025061442725561,0.4331896551724138,0.8431386782804136,1.0,4/11,13.72%,DDX11;NOP53;IPPK;SIRT7
prerank,regulation of response to interferon-gamma (GO:0060330),-0.3873424716538264,-1.0248704094916774,0.44623655913978494,0.6691590624497458,1.0,6/14,26.17%,JAK1;JAK2;SUMO1;IFNGR2;PTPN2;PARP9
prerank,T cell activation (GO:0042110),-0.275242358466601,-1.0246270761905447,0.39037433155080214,0.6693341589332262,1.0,35/69,41.00%,KIF13B;MSN;JAG2;NCK1;CTPS1;CASP8;PIK3CD;NCK2;LCP1;NHEJ1;ICOSLG;LMBR1L;CCL19;SOX4;PTPRC;DLL4;CD276;ADA;PTPN2;EIF2AK4;LFNG;PPP3CB;LAT;CD74;ZAP70;MDK;TNFRSF4;GATA3;GPR89A;GPR89B;CRTAM;LCK;IL4;CD28;CD44
prerank,transcription by RNA polymerase I (GO:0006360),-0.3169061966033991,-1.0244051210858531,0.4099264705882353,0.6695166203004159,1.0,13/34,28.42%,MNAT1;ERCC2;TAF1B;TAF1C;ERCC3;CAVIN1;UBTF;TAF1D;POLR1E;POLR2L;POLR2H;GTF2H3;CCNH
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.3443514160262379,-1.0243069740764792,0.415061295971979,0.6693582673816622,1.0,10/24,21.05%,SEMA6A;SEMA3C;SEMA7A;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E;SEMA4G
prerank,negative regulation of secretion by cell (GO:1903531),0.30146612450924787,1.0234125181883953,0.39902676399026765,0.8465779677150748,1.0,8/38,11.30%,IL1RAPL1;SYT11;CHGA;CYP51A1;TRH;GRM7;IL12A;SYT4
prerank,chondrocyte differentiation (GO:0002062),-0.31588281983640487,-1.0229385807396807,0.4267631103074141,0.6723082846169506,1.0,15/32,33.23%,NFIB;BMPR2;BMP4;CREB3L2;MEF2C;SNX19;CCN3;EIF2AK3;BMP2;WNT2B;WNT5B;RUNX1;TGFB1;SULF1;WNT7A
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.37584570026872827,-1.022667130789913,0.4207436399217221,0.6725634959226078,1.0,6/16,19.55%,DTX3L;SHLD1;KMT5B;PNKP;MAD2L2;PRKDC
prerank,nuclear membrane reassembly (GO:0031468),-0.2820358329029999,-1.0226276779867052,0.40545454545454546,0.6722585532112417,1.0,20/54,31.36%,EMD;AHCTF1;NUP98;SEC13;REEP3;CHMP4B;CHMP4A;LMNA;CHMP2B;CC2D1B;LBR;SUMO1;PPP2CA;NUP188;RAN;UBXN2A;CHMP3;UBE2I;CHMP6;NUP35
prerank,response to cholesterol (GO:0070723),-0.3672575015012506,-1.0216768131895964,0.4492753623188406,0.6741595783954079,1.0,4/17,7.68%,SMO;TGFBR2;LRP6;SMAD2
prerank,regulation of cellular localization (GO:0060341),0.28872015677363305,1.021465193890045,0.39285714285714285,0.8509100811089286,1.0,7/46,7.80%,ABCA12;BLK;NR1D1;EPHA5;MAP2;GSN;STXBP2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.33132723274629927,1.0212909725023547,0.41435185185185186,0.8498681376323143,1.0,8/26,14.46%,ABCA12;NR1D1;ADCY8;EPHA5;ADRA2A;PLA2G6;GPLD1;BRSK2
prerank,prostaglandin metabolic process (GO:0006693),-0.3378453876306562,-1.021184501873124,0.4353146853146853,0.6749301646167282,1.0,11/26,24.19%,PLA2G4A;PTGS1;EDN1;PTGES3;MIF;ACOX1;HPGDS;DAGLB;PTGR1;PNPLA8;PTGIS
prerank,glycoprotein biosynthetic process (GO:0009101),-0.2639731477263985,-1.021136148860918,0.4185639229422067,0.6746447244500903,1.0,18/79,18.59%,ST3GAL6;ST3GAL4;BMPR2;ST8SIA4;GCNT2;CSGALNACT1;ALG10B;DAD1;B3GNT2;ST3GAL2;CHST11;FUT10;B4GALT5;GAL3ST2;IGF1;GOLPH3;ST6GALNAC2;LARGE1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.38831784637988376,-1.0203014063922342,0.42908438061041293,0.6762281536940118,1.0,3/15,9.30%,SIK1;SCARB1;MFSD2A
prerank,male meiosis I (GO:0007141),-0.3825853718125381,-1.0201935024761735,0.44424131627056673,0.6761095151128947,1.0,7/16,30.92%,ZSCAN21;FOXJ3;HSF2BP;TDRD9;DDX4;MYBL1;FOXJ2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.4130951952698168,1.0200119002259627,0.4482758620689655,0.8523220922009859,1.0,3/11,12.40%,ST18;GSN;HTRA2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.41871320778446064,1.0196552497615325,0.44874715261959,0.8518078827158037,1.0,2/10,9.30%,ATP1A2;ADRA2A
prerank,carbohydrate homeostasis (GO:0033500),-0.2746874609305985,-1.0193456777459884,0.4201388888888889,0.677690203736017,1.0,9/67,10.64%,KLF7;IGF1R;INSR;TENT4B;ADIPOR2;IRS1;RBP4;HECTD4;PRKAA1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.39101268195015515,1.0190165422063684,0.417607223476298,0.8521702120726332,1.0,3/12,11.87%,LPIN1;VRK1;PRKCB
prerank,respiratory system development (GO:0060541),0.30906842071553636,1.018841236578074,0.4033018867924528,0.8511275821106521,1.0,7/32,9.25%,WNT7B;PDPN;WT1;PROX1;FGFR2;DNAAF1;VEGFA
prerank,regulation of cell communication (GO:0010646),-0.31240922893371215,-1.0187899255414614,0.424860853432282,0.6786723643007037,1.0,9/35,17.80%,GRK5;IGFBP7;PTPN1;CRK;SOCS2;MGLL;NCLN;ANXA1;CASQ2
prerank,apoptotic cell clearance (GO:0043277),-0.3264301890603195,-1.0185018066246034,0.4358047016274864,0.6789811098615821,1.0,14/30,28.28%,RAC1;RHOBTB1;THBS1;GAS6;TGM2;SCARB1;RHOG;RARA;ANXA1;ITGB3;HMGB1;ADGRB1;LRP1;TREM2
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.4201747840916539,1.01842354008797,0.4470842332613391,0.8508377963390089,1.0,2/11,4.84%,CD177;CAMK4
prerank,response to fatty acid (GO:0070542),-0.3817147769072564,-1.0182633536478924,0.44801512287334594,0.6791226537226316,1.0,4/17,12.71%,FOXO1;IRS1;FOXO3;LPL
prerank,type I interferon signaling pathway (GO:0060337),-0.3074656633967342,-1.0182150903922655,0.4204946996466431,0.6784234148907115,1.0,10/41,14.94%,SP100;IRF2;JAK1;IFNAR1;SAMHD1;IRF1;STAT2;IFITM3;IRAK1;IFI35
prerank,cellular response to type I interferon (GO:0071357),-0.3074656633967342,-1.0182150903922655,0.4204946996466431,0.6784234148907115,1.0,10/41,14.94%,SP100;IRF2;JAK1;IFNAR1;SAMHD1;IRF1;STAT2;IFITM3;IRAK1;IFI35
prerank,negative regulation of ATPase activity (GO:0032780),-0.37147856320699235,-1.0178602573005666,0.4336917562724014,0.6788778658291484,1.0,4/16,18.24%,PXK;TP53;PPIF;PLN
prerank,iron ion transport (GO:0006826),-0.2874592687305718,-1.0176539385235985,0.42802303262955854,0.6789943952626862,1.0,11/47,14.16%,SLC40A1;TFRC;DNM2;STEAP3;SCARA5;ARHGAP1;HFE;ATP6V1E1;MCOLN1;REP15;ABCB7
prerank,ceramide biosynthetic process (GO:0046513),-0.29969633928508704,-1.017213284289395,0.43119266055045874,0.6797042369405949,1.0,11/40,16.85%,SGMS1;ST8SIA4;DEGS2;SGMS2;ST6GALNAC3;CERS4;AGK;SPTLC1;ASAH1;CERS5;SMPD2
prerank,tricarboxylic acid metabolic process (GO:0072350),0.3937658997355955,1.0166052905479208,0.42857142857142855,0.8549573047321509,1.0,7/12,24.07%,ACLY;ACO1;IDH3A;GLUD1;ACO2;SIRT4;IDH2
prerank,negative regulation of bone mineralization (GO:0030502),-0.4008298836768521,-1.0164261121483331,0.45936395759717313,0.681167348962719,1.0,7/13,30.47%,SRGN;TRPM4;BCOR;PTK2B;RFLNB;RFLNA;AHSG
prerank,catecholamine biosynthetic process (GO:0042423),-0.41146316022641094,-1.016272476774733,0.44760213143872113,0.6811468613680401,1.0,2/11,6.59%,TGFB2;GCH1
prerank,oxoacid metabolic process (GO:0043436),0.3297610185363829,1.0160375698400363,0.3974358974358974,0.855117965984467,1.0,4/27,5.76%,BPNT2;SULT2B1;GNMT;HAO1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.41273904246266335,1.0160370759119284,0.44930875576036866,0.8535484685065845,1.0,2/11,5.71%,GMNN;DONSON
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.38073395628239315,1.0159974318514315,0.4322033898305085,0.8521002246429038,1.0,3/14,12.34%,LPIN1;ETNK1;CHKA
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.29804950456009205,-1.015984725643064,0.45179584120982985,0.6814465347565528,1.0,11/41,22.54%,NUP42;RAE1;RANBP2;ZBTB7A;NUP98;SEC13;NUP153;TPR;NUP214;OGT;NUP188
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.4248245692373265,-1.015769780743645,0.44041450777202074,0.6815612126530196,1.0,5/10,29.46%,PODXL;FERMT3;PIEZO1;ADA;WNK1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.4205303469957271,-1.0156594017963056,0.44423791821561337,0.6814523714866614,1.0,3/11,9.84%,NOS3;GCH1;AKT1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.35625538464959283,-1.0154093450301014,0.4648148148148148,0.6816669646737961,1.0,10/20,28.16%,BMP5;SIK1;ACADL;CEACAM1;ERLIN2;ACADVL;BRCA1;TRIB3;BMP2;PRMT3
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.4286458784263981,-1.0152929148292604,0.46194690265486726,0.6815604278415092,1.0,5/10,30.28%,ATF4;HERPUD1;NFE2L2;EIF2AK3;DDIT3
prerank,regulation of leukocyte migration (GO:0002685),0.3677781972046957,1.0142276119780333,0.4451901565995526,0.85591704807503,1.0,4/16,9.25%,TNFSF18;HOXA7;CD81;VEGFA
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.25934919630537423,-1.0139214902999718,0.4113345521023766,0.6845676940989507,1.0,36/86,33.06%,CREBBP;KLF2;PSMA2;LIMD1;RBX1;PSME2;CUL2;PSMB4;TP53;ATF4;PSMC2;HIF3A;PSMB2;PSMB1;GCN1;ARNT;PSMA8;EPAS1;PSME1;ELOC;PSMD4;PSMA7;CHEK1;MAPK7;NFE2L2;PSMD5;INO80;PSMB10;PSMA3;HMOX1;HIGD1A;DDIT3;STOX1;PSMD13;PSMB6;ATF3
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.31698613080977645,-1.0137559941758305,0.42628774422735344,0.6845736219810739,1.0,17/34,30.26%,PTPRB;PTPN1;PTPN9;PTPRJ;PTPN12;DUSP3;PTPN13;UBASH3B;TNS2;DUSP16;DUSP22;PTPN11;PTPRQ;PTPN2;PTPN18;DUSP1;DUSP6
prerank,negative regulation of biosynthetic process (GO:0009890),-0.3764931192494269,-1.0135549341576389,0.4368029739776952,0.6846547796289941,1.0,5/16,19.59%,SLC30A10;PPARA;CEACAM1;ABCB7;COA8
prerank,protein insertion into ER membrane (GO:0045048),-0.3075520646566249,-1.0134901991360714,0.45306859205776173,0.6844179484806852,1.0,12/37,21.65%,APP;EMD;UBE2J2;SGTA;TRAM2;VAPA;EMC9;EMC2;EMC6;WDR83OS;UBL4A;VAMP2
prerank,carbohydrate biosynthetic process (GO:0016051),0.3459164110384186,1.0134578653210524,0.4425531914893617,0.8567280515962681,1.0,5/21,8.28%,B3GALT1;B3GALT4;FUT9;B3GALT5;ST6GALNAC5
prerank,transcription by RNA polymerase III (GO:0006383),-0.32965216715571916,-1.0132196632778356,0.43884892086330934,0.6846694889258056,1.0,16/27,41.25%,IVNS1ABP;BRF1;ICE1;SNAPC1;SNAPC3;GTF3C4;POLR2L;POLR3GL;POLR3K;RO60;GTF3C3;GTF3C6;ELL;GTF3A;SNAPC5;POLR3G
prerank,negative regulation of lymphocyte activation (GO:0051250),0.3532516397790969,1.0132021153729804,0.4392935982339956,0.8559663183551683,1.0,3/21,5.71%,PAG1;SAMSN1;VTCN1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3796562192031241,-1.0131651715275534,0.44776119402985076,0.6843778987422952,1.0,6/16,23.01%,SMAD4;BCOR;DNMT1;CTNNB1;BRCA1;WDR5
prerank,negative regulation of signaling (GO:0023057),0.32312669736923183,1.0131056749407543,0.45454545454545453,0.8546997839082585,1.0,3/25,3.44%,OPRM1;IGFBP3;GLRA1
prerank,negative regulation of transferase activity (GO:0051348),-0.3220200842232436,-1.0128227022307765,0.45,0.6847971268244344,1.0,7/28,11.55%,GSK3B;DTX3L;CDKN1B;ABL1;GSK3A;TP53;SMAD7
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.2662691797781489,-1.0128038052737152,0.43622920517560076,0.6844508395482437,1.0,22/74,23.69%,CREBBP;PSMA2;LIMD1;RBX1;PSME2;CUL2;PSMB4;NOTCH1;PSMC2;HIF3A;PSMB2;PSMB1;ARNT;PSMA8;EPAS1;CITED2;PSME1;ELOC;PSMD4;PSMA7;NFE2L2;PSMD5
prerank,mitotic nuclear division (GO:0140014),-0.27048658858545255,-1.01274383253088,0.4402730375426621,0.684214075947229,1.0,35/71,39.51%,EPS8;STAG1;CCDC61;TOGARAM1;PPP2R2D;WRAP73;SMC4;CHMP4B;FLNA;RHOA;ARHGEF10;STAG2;KIF11;RAB11A;DSN1;NDEL1;KIF3B;MISP;KIF18B;INO80;RAN;TUBG2;CDCA8;CEP192;MAP9;PLK1;MIS12;ESPL1;UBE2C;LSM14A;TPX2;TUBG1;SPICE1;NSL1;SMC3
prerank,positive regulation of cellular component movement (GO:0051272),-0.3388316871812427,-1.0127130466718497,0.4500875656742557,0.6838893050434616,1.0,4/24,3.35%,ETS1;LYN;NTN1;SPOCK2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.2378132593237772,1.0125353203336136,0.4232558139534884,0.8549303961288434,1.0,34/140,19.45%,HTR2C;C1QTNF1;ADCY8;CACNA2D1;CALCA;CACNA1A;PTGER3;CACNB3;GRM1;RYR2;TRPM1;C3AR1;CCR6;GPR65;GPER1;ADRA1D;ADRA1A;CIB2;TACR1;NMUR2;P2RX3;SLC8A1;DLG4;BDKRB2;P2RX5;TAC4;PDGFRA;LPAR4;GLP1R;CCKBR;CXCR4;F2RL2;CD24;PTGIR
prerank,cellular response to ketone (GO:1901655),-0.30923005628123135,-1.0124219571386999,0.4539130434782609,0.6841936580896754,1.0,10/35,17.78%,GNB1;NR3C1;MSN;LARP1;PTGFR;NCOA4;KLF9;ROCK2;ADCY1;GOLPH3
prerank,aorta development (GO:0035904),-0.3921281943370211,-1.0123524912414963,0.44423791821561337,0.6839626450481137,1.0,6/14,9.23%,PKD2;TBX1;PDE2A;TBX2;HECTD1;ADAMTS9
prerank,inner dynein arm assembly (GO:0036159),0.4198269382626421,1.0121903412062978,0.4379391100702576,0.8544176350544394,1.0,2/10,8.25%,DNAAF5;DNAAF1
prerank,peptidyl-proline modification (GO:0018208),-0.3331157115084077,-1.0118315408019565,0.43783783783783786,0.6848183346339074,1.0,7/25,17.30%,P3H2;NKTR;PPIG;OGFOD1;FKBP5;FKBP10;PPIF
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.33861638532264676,-1.011814721799588,0.43223443223443225,0.6840582805635383,1.0,4/23,3.33%,CREBBP;DAB2;THBS1;RNF111
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.33861638532264676,-1.011814721799588,0.43223443223443225,0.6840582805635383,1.0,4/23,3.33%,CREBBP;DAB2;THBS1;RNF111
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.3345753721509933,1.0113683523372254,0.42316258351893093,0.8554283115191912,1.0,6/23,12.61%,PKP2;PROX1;FGFR2;IRX3;TNNC1;MYL2
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.25052500549115314,-1.0111133283556633,0.43006993006993005,0.6853005507243775,1.0,38/101,34.17%,DAB2IP;LYN;PRKCE;ADAM9;NFKB1;TNFRSF1B;PDCD4;IRGM;LBP;MEF2C;NFKBIL1;RHOA;IRAK1;MTDH;CDC73;MAPK8;TNFAIP3;CHMP5;DEFA6;NOD2;RELA;SERPINE1;CASP1;SHPK;HMGB1;CXCL10;AXL;CACTIN;MAPK14;TGFB1;LILRB1;SBNO2;TICAM1;TNIP2;CD14;IL1A;CARD16;NLRP3
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.405657251520997,-1.010951891383648,0.45045045045045046,0.6853082179702766,1.0,4/12,20.64%,PPARA;NFKBIA;PPARG;ITGB3
prerank,vitamin transport (GO:0051180),0.314386391758379,1.0109165899570978,0.4304635761589404,0.8552674593655405,1.0,8/29,12.08%,CBLIF;PDPN;SLC46A1;SLC19A1;SLC2A10;GC;SLC2A8;SLC35F3
prerank,maturation of LSU-rRNA (GO:0000470),-0.33124221395940506,-1.0108791950514826,0.44964028776978415,0.6850832699759857,1.0,8/26,22.80%,RPF1;RRP15;NOP2;RPL7A;RPL7L1;BOP1;PES1;ZNHIT3
prerank,phospholipid biosynthetic process (GO:0008654),0.2965905966691169,1.0104881082017725,0.4380733944954128,0.8549722668461424,1.0,10/36,13.87%,IDI2;FADS1;CLN3;HDHD5;FAR1;CPNE1;SPHK2;GNPAT;NUS1;IDI1
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.31313100664503235,-1.0104801621274953,0.44778761061946903,0.6857013840824765,1.0,7/34,14.35%,FOXO1;FERMT2;ASXL1;YAP1;ANKRD26;ZFPM1;TRIO
prerank,negative regulation of viral release from host cell (GO:1902187),-0.39822432404641817,-1.0104130525729624,0.42723880597014924,0.6854602422882781,1.0,9/13,46.26%,TRIM13;TRIM28;CHMP3;TRIM35;TRIM32;TRIM5;TRIM21;PML;MID2
prerank,regulation of centrosome cycle (GO:0046605),-0.3488274706440172,-1.0103724404484817,0.457089552238806,0.6851545107749144,1.0,14/21,42.30%,CHMP4B;CHMP2B;CHMP5;PDCD6IP;CEP131;ATF5;CHMP3;CHMP1A;AURKA;PKHD1;CHMP1B;MARK4;SIRT1;NAT10
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.2910317298217436,-1.0101879655924322,0.4209558823529412,0.6851894991179963,1.0,15/46,26.25%,ZNF423;RB1;ID1;IL15;LAMA4;NOVA2;ADAMTS5;NOTCH1;ATF4;PCTP;ALDH1A1;ACVR2B;RHEB;ACOT11;ADAM17
prerank,sister chromatid segregation (GO:0000819),-0.31647397364279123,-1.009999264236945,0.4283246977547496,0.6852259195576256,1.0,15/31,39.08%,RB1;WRAP73;SMC4;DSN1;KIF18B;INO80;RAN;TUBG2;CDCA8;PLK1;MIS12;ESPL1;TOP2A;TUBG1;NSL1
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.21943189746877337,-1.0094058118744824,0.3914590747330961,0.6862608738742064,1.0,82/264,27.75%,SRSF11;CDK13;PRPF3;METTL14;SMU1;PSPC1;CWF19L2;RSRC1;HNRNPA0;RBM5;NOVA2;HNRNPR;UPF3B;FUS;PRPF6;SF3B6;SPEN;RBM19;HNRNPM;POLR2G;PHF5A;DDX39B;SF3B1;PUF60;PRPF31;CPSF7;SNIP1;HNRNPA3;HNRNPUL1;EFTUD2;DHX38;DBR1;HNRNPF;SFPQ;SLU7;CTNNBL1;SNRPE;SCNM1;SF3A1;TGS1;HNRNPA1;SYNCRIP;SRSF12;SRPK2;CWC25;RBM4B;ZMAT5;BUD13;CD2BP2;FIP1L1;TFIP11;SRRM1;NONO;RNPS1;SRSF3;STRAP;SRSF10;TRA2B;LSM3;RBM6;CWC22;PPIH;COIL;RBM15;PCBP1;POLR2C;GEMIN7;USP39;RNPC3;PDCD7;SF3B5;GCFC2;DHX9;POLR2L;PRPF40B;POLR2H;HNRNPL;HNRNPD;PABPC1;HNRNPU;SCAF11;TXNL4A
prerank,L-amino acid transport (GO:0015807),-0.3254069657961154,-1.0092639118599047,0.4525043177892919,0.6862047022990276,1.0,10/28,21.38%,SLC7A1;SLC7A5;SLC38A5;ARL6IP5;SLC36A4;PRAF2;SLC1A1;SLC7A2;SLC1A4;SLC3A2
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.29761572381443513,-1.0087420605438469,0.45124282982791586,0.6870357648620928,1.0,11/41,22.54%,NUP42;RAE1;RANBP2;ZBTB7A;NUP98;SEC13;NUP153;TPR;NUP214;OGT;NUP188
prerank,regulation of inclusion body assembly (GO:0090083),-0.415691354760933,-1.0087038072274692,0.4500907441016334,0.6867140217042658,1.0,2/11,8.03%,SNCAIP;DNAJB6
prerank,intermediate filament organization (GO:0045109),0.36249604499785143,1.0085336040227109,0.4481236203090508,0.85946629392161,1.0,5/17,16.91%,PKP2;BFSP2;TCHH;NEFL;VIM
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.330823599928935,-1.0083053609979054,0.44320297951582865,0.6872626434637779,1.0,7/25,11.85%,LIMK2;SLIT2;PRKCD;CDK10;TBC1D30;YAP1;ABI3
prerank,regulation of gluconeogenesis (GO:0006111),0.3183289575123539,1.0081515592612778,0.4413145539906103,0.8591374883865552,1.0,7/27,17.18%,DGKQ;GCK;GNMT;DDB1;SIRT7;SELENOS;PGP
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3805189715516472,1.007233798644375,0.44946236559139785,0.860476698877781,1.0,4/14,10.48%,ATIC;PAICS;ADSS2;ADSS1
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.2782385598577635,-1.0072050601326863,0.45611015490533563,0.6894909163228047,1.0,13/56,18.97%,TAB3;NOD1;LBP;MAPKAPK2;PLCG2;ALPK1;IRAK1;S100A1;RPS6KA3;LGMN;TAB2;IRAK2;NOD2
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.3566221062403827,-1.007136937593361,0.4265975820379965,0.6892827131998772,1.0,3/18,11.38%,SLC2A1;OCLN;BRAF
prerank,cardiac conduction system development (GO:0003161),-0.34071153267310356,-1.0070394269324443,0.4665523156089194,0.6890960041318356,1.0,11/24,30.27%,BMP4;SMAD1;MAML1;NOTCH2;SMAD4;HEY1;HEY2;MSX1;GJA5;MSC;HCN4
prerank,regulation of cilium movement (GO:0003352),0.4257615756647963,1.0067189840429474,0.44612068965517243,0.8605831987336668,1.0,3/10,9.18%,ODAD2;DNAAF1;CFAP43
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.34051655757961763,1.0067017834833711,0.45253863134657835,0.85909412998343,1.0,6/20,16.03%,SLC25A23;PHB2;PMPCB;SLC8A3;MCU;SLC8B1
prerank,Golgi ribbon formation (GO:0090161),-0.39863770679873084,-1.0066411434101208,0.4490909090909091,0.6896368638258413,1.0,8/13,34.06%,VTI1A;MYO18A;TMED5;GOLPH3;TRIP11;FHDC1;STX6;VAMP4
prerank,negative regulation of axon extension (GO:0030517),-0.3255225861409682,-1.0057632276413633,0.433392539964476,0.691371090498525,1.0,10/30,18.35%,SEMA6A;SEMA3C;SEMA7A;DIP2B;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E
prerank,fatty acid beta-oxidation (GO:0006635),-0.2777073479500416,-1.0056449790626165,0.43257443082311736,0.6912749574626212,1.0,10/51,17.47%,HADHB;ABCD3;BDH2;PPARD;ACADL;ACAD11;CRAT;ACADVL;ACOX1;ACOX3
prerank,regulation of protein kinase A signaling (GO:0010738),-0.3545899203933487,-1.0053415088507793,0.44731977818853974,0.6915942668920461,1.0,5/20,15.33%,LRRK2;ADGRV1;TCIM;IAPP;MIF
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.35148381508284926,1.0053149710524527,0.4592274678111588,0.8617773900502936,1.0,4/19,6.12%,HS6ST3;HS3ST5;NDST4;HS6ST2
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.4137984482187095,-1.0050248653373737,0.45636363636363636,0.6919935973178671,1.0,5/12,21.30%,SORBS1;IRS1;GKAP1;IGF2;PTPN11
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.40873897833953116,-1.0048419174673473,0.42990654205607476,0.6916718553155683,1.0,6/11,29.59%,INPP1;INPP5A;PTEN;INPP5J;SYNJ1;SYNJ2
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.40873897833953116,-1.0048419174673473,0.42990654205607476,0.6916718553155683,1.0,6/11,29.59%,INPP1;INPP5A;PTEN;INPP5J;SYNJ1;SYNJ2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.33080065951439885,1.0042124370880814,0.4279176201372998,0.863558158776025,1.0,4/23,10.33%,NRG1;AKAP6;PROX1;MYLK3
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.3794227370062512,-1.004198085874549,0.4785714285714286,0.6927693547495568,1.0,5/16,12.27%,PKD2;SIX1;FGF1;BMP4;FGF2
prerank,protein homotetramerization (GO:0051289),0.2830641892776642,1.003818679848017,0.4357298474945534,0.8631800825595418,1.0,11/49,15.30%,HCN1;SYCP1;RYR3;AQP4;GNMT;ACACA;ALDH1A2;GLS;GOLGA2;CBY1;TDO2
prerank,regulation of protein metabolic process (GO:0051246),-0.2918804942174779,-1.0036153220163306,0.44525547445255476,0.6937416453823739,1.0,14/44,22.90%,KLF4;NEDD4L;KLF2;APP;ACE;SPOPL;LTBP4;MAPK8;ROCK2;ABCA7;SPOP;MDM2;MAPK7;MTPN
prerank,protein targeting to mitochondrion (GO:0006626),-0.27993821641310684,-1.003469455200733,0.4673913043478261,0.6936547419300931,1.0,22/52,36.31%,SAMM50;TOMM40;BCAP31;AGK;IMMP1L;TIMM17B;TOMM5;DNAJC19;TOMM40L;HSP90AA1;TIMM50;TIMM10;PMPCA;IMMP2L;TOMM20;TOMM70;TIMM10B;AIFM1;TIMM13;DNLZ;TIMM23;PAM16
prerank,ceramide metabolic process (GO:0006672),-0.28244317300395017,-1.0032599212090223,0.4444444444444444,0.693739814018872,1.0,16/49,20.08%,SGMS1;ACER2;DEGS2;SGMS2;ST6GALNAC3;CERS4;ACER3;AGK;ORMDL1;SPTLC1;ASAH1;CERS5;SMPD2;PPP2CA;DEGS1;ORMDL3
prerank,signal transduction by p53 class mediator (GO:0072331),-0.325359298441285,-1.0031252316663182,0.45454545454545453,0.6936872210168094,1.0,8/30,19.64%,PPP1R13B;ACER2;FHIT;TP53;NDRG1;USP10;HINT1;ATRX
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.3085721246982774,-1.0029161009466203,0.45964912280701753,0.6938070951211451,1.0,17/34,34.14%,DAB2IP;MFHAS1;LYN;NFKBIL1;OTUD4;TNFAIP3;GPR108;GPS2;CD300LF;NLRP2B;TREM2;CACTIN;TICAM1;TLR6;RAB7B;CD14;LRRC14
prerank,cellular response to amyloid-beta (GO:1904646),0.2999362719845249,1.0029048013468649,0.46697038724373574,0.8644477626342996,1.0,5/35,4.29%,GRM5;CDK5;CACNA2D1;GRIN2A;CACNA1A
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4310920513390114,-1.0028812574712387,0.4776386404293381,0.6934964246277406,1.0,6/10,36.68%,NT5E;NT5C1A;NT5C;UPB1;UPP1;DPYS
prerank,response to cAMP (GO:0051591),-0.3003915117086665,-1.0027678947370924,0.4303571428571429,0.6933750313922176,1.0,8/37,11.03%,RAPGEF2;PKD2;PDE2A;KCNQ1;RAP1A;EZR;RAP1B;RAPGEF1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.32627054839788666,-1.002756700607492,0.44661921708185054,0.6930148536735194,1.0,6/26,13.89%,ADIPOR2;ELOVL5;ACADL;CEACAM1;ERLIN2;ACADVL
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.2833592236350693,-1.002661113327519,0.45535714285714285,0.6928713739832728,1.0,12/47,16.68%,RAPGEF2;CAV1;CD34;SIK1;NFKB1;ACADL;CEACAM1;ERLIN2;ACADVL;ROCK2;C1QTNF3;FYN
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.2625864249467045,-1.0025329968222347,0.4427083333333333,0.6927918914984127,1.0,21/80,19.16%,ARF3;STX18;ARCN1;RAB1A;GOLPH3L;COPG1;SCFD1;KDELR3;COPA;KIF23;COPE;ERGIC2;KIF11;USE1;KIF15;ATP9B;KIF26A;LMAN2;GOLPH3;CENPE;KIF3B
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.31888614996715997,-1.0018963226216064,0.4463276836158192,0.693904347845563,1.0,12/30,29.11%,HPS4;GSK3A;UBE2J2;UBE2D3;UBE2L3;BAP1;NPEPPS;HUWE1;FZD5;SAE1;ARIH2;RNF31
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.36498261082557704,-1.00125601800929,0.475,0.6950669806108545,1.0,4/18,7.39%,CTSC;MSN;VGLL4;EZR
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.31371889086654786,-1.0006516184686105,0.4504672897196262,0.6961261857428671,1.0,8/31,14.78%,PARD3B;PARD3;MSN;DLG1;EZR;RHOA;MTCL1;MARK2
prerank,monocyte chemotaxis (GO:0002548),-0.3102280242851839,-1.0001647033052878,0.46441281138790036,0.6969352222698424,1.0,3/32,5.33%,FLT1;CCL25;IL6R
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.3471854060305498,1.0000565629399285,0.45594713656387664,0.8717619353107833,1.0,4/18,6.65%,MELTF;PDPN;DDR2;FSCN1
prerank,cellular response to peptide (GO:1901653),-0.27391869568914123,-0.9999409651682296,0.43033509700176364,0.6970692047381238,1.0,16/56,16.68%,IGF1R;CAV1;NOD1;GSK3B;APP;ICAM1;EPHA4;ARHGEF2;TP53;PSEN1;ITGA4;LGMN;IGF1;CHMP5;VCAM1;FYN
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.38423894490712224,-0.9987466674761991,0.47689463955637706,0.6996399610391033,1.0,3/15,6.02%,ENTPD1;CMPK1;ENTPD6
prerank,peptidyl-arginine modification (GO:0018195),0.37330355621089073,0.9982083232256073,0.4399092970521542,0.8758972034907186,1.0,4/15,15.90%,PADI1;PADI2;PRMT5;ART4
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.3979349546333893,-0.9981281136124945,0.4649910233393178,0.7007750832705754,1.0,7/12,35.02%,TIPARP;PARP11;PARP16;PARP6;TNKS2;PARP3;TNKS
prerank,positive chemotaxis (GO:0050918),-0.3615833874731402,-0.9969351532443473,0.45774647887323944,0.7032491131239744,1.0,8/17,32.78%,PTPRJ;FGF7;ANGPT1;SEMA5A;FGF10;MET;CORO1A;TSC2
prerank,histone H2A ubiquitination (GO:0033522),-0.3579431192177789,-0.9967562282841874,0.4798598949211909,0.7032745668424505,1.0,6/17,19.04%,DTX3L;RYBP;UBR2;RNF168;BCOR;RNF2
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.3397084720209478,-0.995499602940596,0.4673721340388007,0.7058907924826823,1.0,4/21,5.78%,PLTP;CAV1;RXRA;NFKBIA
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.30915289809773716,-0.9954398059355298,0.46096654275092935,0.7056307014010562,1.0,9/31,19.36%,SHLD1;TFRC;KMT5B;RBP4;MAD2L2;CLCF1;VAMP3;PTPRC;DNAJB9
prerank,regulation of interleukin-4 production (GO:0032673),-0.3442546520493874,-0.9953274496575333,0.4631956912028725,0.7054977045775833,1.0,2/21,2.43%,LEF1;SLC7A5
prerank,DNA recombination (GO:0006310),-0.2971378273524509,-0.9952566801627442,0.45955882352941174,0.7052719724652735,1.0,18/37,35.33%,DMC1;MRE11;RAD54B;RPA1;HDAC10;WRN;RAD54L;LIG4;BLM;MSH3;HMGB1;EXO1;XRCC2;RAD51D;TSN;RAD50;ENDOG;RAD52
prerank,regulation of bone mineralization (GO:0030500),-0.27786571647485825,-0.9942153048075506,0.4572425828970332,0.7073745242259097,1.0,21/55,24.99%,BMPR2;SGMS2;SRGN;TRPM4;BMP6;BMP4;MEF2C;ACVR2A;S1PR1;ADGRV1;ANO6;PKDCC;NOTUM;BCOR;BMP7;ANKH;PTK2B;CCN1;PTN;ACVR2B;BMP2
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.28970908191223327,-0.9941481592579885,0.45,0.7071393556000092,1.0,16/42,33.08%,RNASE7;IL6R;IRGM;LBP;RNASE3;DEFA6;DROSHA;SERPINE1;RPL30;ADGRB1;TREM2;SELP;MPEG1;TNFRSF14;NOS2;AQP1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3178134935469911,0.994129021126702,0.4436936936936937,0.8870854152792816,1.0,8/25,16.74%,RIT2;PLEK;SLC8A2;MAPT;P2RX3;P2RX5;HTT;CDH13
prerank,regulation of mitotic cell cycle (GO:0007346),-0.2295304278319058,-0.9939833205328749,0.45666666666666667,0.7071186624688486,1.0,47/171,21.85%,TTC28;AFAP1L2;RB1;NEK7;BTG3;IQGAP1;CDK13;APP;PSMA2;SIK1;NEK6;CUL9;CDKN1B;RNF40;CDK10;PSME2;PSMB4;USP2;ERCC2;TAL1;CUL7;PTPN3;CDC16;ANAPC16;DUSP3;CCDC8;XPC;PKN2;ERCC3;PSMC2;FOXC1;BTG2;PSMB2;SMOC2;LGMN;PSMB1;TFAP4;PSMA8;CDK5RAP3;PSME1;BUB1B;CDK11B;ANGEL2;PSMD4;MDM2;BUB3;PSMA7
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.29798639522514786,-0.9939069073428908,0.4644808743169399,0.706935630049452,1.0,15/38,29.11%,LRRK2;HPS4;GSK3A;HAX1;UBE2J2;UBE2D3;UBE2L3;BAP1;NPEPPS;HUWE1;FZD5;SAE1;ARIH2;BAG4;RNF31
prerank,microtubule anchoring at centrosome (GO:0034454),0.41126226539635174,0.9936793939134855,0.45879732739420936,0.8869432414958061,1.0,6/10,19.04%,NINL;BBS4;KIF3A;CEP19;HOOK3;CCDC120
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.30121696097211437,-0.9936406785887477,0.4646098003629764,0.7071757141105273,1.0,5/36,6.54%,SPTBN1;RAB7A;GOLPH3L;AFDN;MACF1
prerank,regulation of telomerase activity (GO:0051972),-0.2918254075428928,-0.99332597403219,0.46236559139784944,0.707526756657026,1.0,11/45,14.30%,KLF4;NEK7;ATM;PARP4;TCP1;MAPK1;TP53;HMBOX1;PNKP;PARN;PTGES3
prerank,protein O-linked glycosylation (GO:0006493),-0.24866248980955494,-0.9931336322258356,0.43270868824531517,0.7075955422978215,1.0,14/96,6.30%,EOGT;ST3GAL4;ST3GAL1;PLOD1;TMTC1;PLOD2;ST6GAL1;TRAK1;TMTC2;GALNT10;GXYLT2;B3GNT2;TET2;C1GALT1
prerank,leukotriene biosynthetic process (GO:0019370),-0.3806710846061936,-0.9930946195221396,0.4635036496350365,0.7072972489029383,1.0,2/14,5.88%,PLA2G4A;GGT5
prerank,positive regulation of transmembrane transport (GO:0034764),0.3731595573243156,0.9930760156783641,0.44522144522144524,0.8873152526704337,1.0,4/13,10.50%,CA2;NR4A3;C2CD5;AZIN2
prerank,cellular respiration (GO:0045333),0.28734630197033084,0.9927373974297201,0.47619047619047616,0.8868493732962377,1.0,17/41,27.03%,SLC25A13;UQCR10;NR4A3;UQCRH;SDHA;NDUFA5;NDUFS8;LYRM7;NDUFS7;MDH2;UQCRB;ME3;MTLN;PPARGC1A;OXA1L;MTFR1L;NDUFS1
prerank,negative regulation of reproductive process (GO:2000242),0.358322324190064,0.9926358567411423,0.4732142857142857,0.8855868228116536,1.0,6/17,22.56%,SPINK13;NPPC;TIMP1;ACVR1C;GJA1;WDR77
prerank,positive regulation of response to stimulus (GO:0048584),-0.29257299769702516,-0.9923830251323674,0.4468864468864469,0.7086061682378716,1.0,13/40,25.39%,IFIH1;IL15;TGFB2;PRKCD;YPEL3;ILK;ABI3;CGAS;MAVS;NSMCE4A;TAF9;DHX9;FXR1
prerank,cholesterol efflux (GO:0033344),0.34125599593888073,0.9923622113847431,0.4752941176470588,0.8848523111514032,1.0,8/20,22.89%,APOM;TSKU;ABCA5;APOE;APOC1;SOAT2;SOAT1;ABCG1
prerank,double-strand break repair via break-induced replication (GO:0000727),0.39479106982549317,0.9922313377631657,0.45813953488372094,0.883721464191288,1.0,4/12,14.66%,GINS4;CDC45;MUS81;CDC7
prerank,sodium ion import across plasma membrane (GO:0098719),-0.36471609253011505,-0.9916665906468098,0.46003552397868563,0.7099279342562755,1.0,4/17,11.32%,SLC9A2;SLC12A2;TRPM4;SLC9A5
prerank,proteasome assembly (GO:0043248),-0.4095293722661176,-0.9915462335821131,0.48404255319148937,0.7098256197265147,1.0,7/11,32.21%,PSMG2;ADRM1;PSMD4;PSMD5;PSMG1;OTUD6B;PSMD13
prerank,mitotic chromosome condensation (GO:0007076),-0.3239686226307418,-0.9914548610797054,0.46901172529313234,0.7096468950870038,1.0,14/26,36.26%,RB1;SMC4;TENT4A;KMT5A;NCAPD2;MCPH1;NCAPH;NCAPH2;SET;TTN;CHMP1A;PLK1;CSNK2A1;CSNK2A2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.3312658265895446,-0.9912843791910603,0.48044692737430167,0.7096420643525069,1.0,7/24,20.39%,ABCG2;ALAS1;ABCB10;SUCLA2;FLVCR1;COX10;RSAD1
prerank,protein targeting (GO:0006605),-0.24044985759635137,-0.9911504348936447,0.45869947275922673,0.7095765163141811,1.0,58/118,39.54%,PARD3;RASSF9;PEX1;KIF13B;TRAK1;ZDHHC6;ZDHHC3;HPS4;AQP11;SRPRA;FUT10;TOMM40;BCAP31;GABARAP;ZFAND6;TIMM17B;TOMM5;SRP14;AP4M1;LAMP2;GIPC1;DNAJC19;ZDHHC1;AP4B1;ZDHHC4;HOMER3;PEX6;ZFAND2A;ZDHHC12;RAB3IP;TIMM10;TOMM20;SEC61A1;ATG3;VPS37B;TOMM70;HACL1;PEX19;RTP4;GOLGA7B;LONP2;ZDHHC9;SEC63;TIMM10B;ZDHHC22;TIMM13;NCF1;VPS37C;TIMM23;ICMT;YIF1B;RABGEF1;ZFAND2B;CDC37;TAOK2;AIP;LTBP2;RTP3
prerank,lytic vacuole organization (GO:0080171),0.29675945258194236,0.9911500810875992,0.49266247379454925,0.8854678363820181,1.0,14/32,23.82%,CLN3;CLVS2;CLVS1;HPS1;GRN;GNPTAB;HOOK1;SNAPIN;TPP1;HOOK3;ACP2;LAMTOR1;GAA;NAGPA
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.34329702442842724,0.9907862135401261,0.48089887640449436,0.8850172296493145,1.0,5/20,10.48%,ATIC;PAICS;AK3;ADSS2;ADSS1
prerank,response to chemokine (GO:1990868),-0.3838512159487714,-0.9907801924674523,0.46897810218978103,0.7100272523849771,1.0,7/13,29.46%,LRCH1;SLC12A2;RHOA;FOXC1;CXCL12;DUSP1;WNK1
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.3144928502582624,-0.9907717654700794,0.4862068965517241,0.7096497257560657,1.0,12/28,24.53%,CLIP1;RAC1;TOGARAM1;OCLN;DCTN1;SLAIN2;DRG1;MECP2;RPS3;AKAP9;ARL2;HSPA1B
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.237622156595621,0.9900295793705813,0.4618937644341801,0.8858111106250813,1.0,20/110,10.78%,ADGRB3;ADGRL3;ADCY8;CALCA;GNAL;GPR101;ADGRG4;CNR1;PTGER3;ADRA2C;PF4;ADCY7;ADRB3;ADRA2A;GPR65;TSHR;GPER1;LGR5;ADRA1D;ADRA1A
prerank,neural crest cell development (GO:0014032),-0.2891143811377822,-0.9897538190382706,0.4608208955223881,0.7116339736664768,1.0,13/44,18.35%,SEMA6A;SEMA3C;CORO1C;SEMA7A;TBX1;PHACTR4;KLHL12;SEMA3G;SEMA6B;SEMA4C;SEMA5B;SEMA4A;SEMA3E
prerank,cellular response to osmotic stress (GO:0071470),-0.34345718990345986,-0.9894259187798544,0.4638447971781305,0.7119858609121157,1.0,6/21,9.43%,PKD2;RCSD1;DDX3X;LRRC8D;ARHGEF2;MYLK
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.3551904991024498,-0.9889430990525784,0.46557971014492755,0.7127576613065929,1.0,9/18,26.60%,HDAC1;GSK3A;NOTCH1;HDAC4;CCN3;FRS2;FZD7;BMP2;HDAC5
prerank,glucose homeostasis (GO:0042593),-0.25345297397382627,-0.9889350123952578,0.4734133790737564,0.7123737559085238,1.0,10/83,8.47%,KLF7;IGF1R;FOXO1;INSR;ADIPOR2;PIK3R1;IRS1;RBP4;LRRC8D;HECTD4
prerank,myotube cell development (GO:0014904),-0.4246590549628074,-0.9885812974708424,0.4821092278719397,0.7128064716376106,1.0,6/10,36.45%,SIX1;IGF1;SKI;CAV2;MYORG;ACTA1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.40949474540360314,0.9884475961628224,0.46539379474940334,0.8892556455871188,1.0,3/10,6.03%,HECW1;OSR1;HECW2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.38762196115796677,-0.9882607513668915,0.5046210720887245,0.7131675845676788,1.0,5/13,22.46%,NOS3;GCH1;AKT1;MTHFD1L;HSP90AA1
prerank,negative regulation of double-strand break repair (GO:2000780),-0.30970094309976803,-0.9877449995267756,0.47289719626168225,0.71402016288767,1.0,8/30,19.48%,UBR5;RNF169;SHLD1;TRIP12;OGG1;CGAS;MAD2L2;TFIP11
prerank,cellular response to hormone stimulus (GO:0032870),0.25398289606521085,0.98771234889925,0.4733178654292343,0.889941703837423,1.0,11/69,9.96%,ROBO2;NCOA2;ATP1A2;GCK;AKR1C1;WT1;NR4A3;ADRA2A;CYP11B1;SLIT3;GPER1
prerank,regulation of oxidoreductase activity (GO:0051341),-0.383904077823407,-0.9874366425598169,0.47282608695652173,0.7143773533184922,1.0,6/13,35.95%,ABL1;HDAC6;NOD2;SZT2;HP;MT3
prerank,vesicle transport along microtubule (GO:0047496),0.3251842146240791,0.9873305759840647,0.47345132743362833,0.8895851658991591,1.0,11/23,19.74%,CLN3;KIFAP3;KIF5A;KIF3A;DYNC1I1;KIF1C;HTT;TRAK2;BICDL1;HAP1;FYCO1
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.4172473667680911,-0.9870481616063775,0.48034188034188036,0.7148747250727465,1.0,5/11,20.96%,STX18;ATL2;VCPIP1;MOSPD3;LPCAT3
prerank,positive regulation of TOR signaling (GO:0032008),0.2915729657502485,0.9869314342799628,0.463302752293578,0.8893872653840595,1.0,7/40,8.51%,GPR137C;PIP4P1;RRAGA;HDAC3;FLCN;KLHL22;SEH1L
prerank,mesoderm development (GO:0007498),-0.3577574476877019,-0.9864669737689534,0.49559082892416223,0.7159129697959156,1.0,4/18,11.47%,TIE1;TBX1;BMX;JAK2
prerank,organophosphate ester transport (GO:0015748),-0.3319536047740331,-0.9863206468480907,0.4726930320150659,0.7158600038388451,1.0,8/24,23.47%,PITPNC1;PLTP;SCARB1;TNFAIP8L3;PCTP;PRELID2;OSBPL2;PITPNA
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.36819427285465595,-0.9862642857318634,0.49391304347826087,0.7155965793654713,1.0,3/15,7.56%,ADAM9;TNFRSF1B;SNX9
prerank,response to growth factor (GO:0070848),-0.29317893128489536,-0.986236466826744,0.4676524953789279,0.7152675653104048,1.0,12/41,22.04%,ACVRL1;KLF4;BMPR2;EMD;TGFBR2;ACVR2A;AKT1;HDAC6;CTNNB1;EPHA2;MAPK7;NOS1
prerank,apoptotic mitochondrial changes (GO:0008637),0.2972713569355854,0.986219896964818,0.4745011086474501,0.8900616348798722,1.0,3/32,3.75%,ERBB4;BCL2;GGCT
prerank,ncRNA 3'-end processing (GO:0043628),-0.37765470289815434,-0.9858936671087478,0.4701627486437613,0.7157156201505391,1.0,8/14,30.25%,INTS8;INTS7;ELAC2;TOE1;TRNT1;INTS5;INTS12;SSB
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.278737005959511,-0.9855072583179088,0.47198641765704585,0.7162530456802295,1.0,12/49,16.38%,GHR;LYN;IL15;IL6ST;IL6R;HES1;PARP14;JAK2;STAP2;CD40;TNFRSF1A;IGF1
prerank,mitochondrial translational termination (GO:0070126),-0.2524612598421573,-0.9852424161770554,0.47294938917975565,0.716508393324715,1.0,30/88,26.75%,DAP3;PTCD3;MRPL32;MRPL47;MRPS23;MRPS18A;MRPL2;MRPS24;MRPL46;MRPS27;MRPL12;MRPL58;MRPL24;MTRF1L;MRPL57;MRPS14;MRPS21;MRPL35;GFM2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS2;MRPS28;MRPS35;MRPL43;MRPL48;MRPL11;MRPS31
prerank,T cell migration (GO:0072678),-0.38556206957092987,-0.9852028957917774,0.49536178107606677,0.7162050502438798,1.0,4/13,9.65%,SLC12A2;MSN;S1PR1;PIK3CD
prerank,primary alcohol metabolic process (GO:0034308),-0.32670617773540894,-0.9851952992342626,0.4781849912739965,0.7158186827069081,1.0,9/25,26.70%,RBP4;RDH10;NAPEPLD;GDPD1;GDPD3;IGF1;RETSAT;CYP1B1;GDE1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.4233191427844623,-0.9847766581166544,0.4818181818181818,0.7164120489335315,1.0,4/10,19.26%,RNF125;SEC14L1;GPATCH3;TKFC
prerank,positive regulation of heart contraction (GO:0045823),-0.3499599270252486,-0.9847745401794404,0.4701492537313433,0.7160182328214216,1.0,7/19,11.69%,TRPM4;TGFB2;KCNQ1;GSK3A;EDN1;ADM;EDN3
prerank,ureteric bud morphogenesis (GO:0060675),-0.37109499038009486,-0.9846988800225744,0.4766187050359712,0.7158131622792154,1.0,5/16,13.26%,PKD2;SIX1;BMP4;FGF2;WNT11
prerank,regulation of amyloid fibril formation (GO:1905906),-0.37601121851949293,-0.9843719941773015,0.4711033274956217,0.7161990136759825,1.0,5/15,19.65%,APP;VBP1;PSEN1;IAPP;PFDN6
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.3006128660348601,-0.9843682454268794,0.4769503546099291,0.7158130146630932,1.0,7/35,12.19%,GHR;CAV1;CRLF3;HES1;DOT1L;JAK2;NOTCH1
prerank,negative regulation of lipid metabolic process (GO:0045833),0.33378304127405645,0.9842880920016535,0.5076586433260394,0.8945040618925578,1.0,5/22,15.13%,PDE3B;BSCL2;ADRA2A;GPER1;APOC1
prerank,L-glutamate transmembrane transport (GO:0015813),0.4050666080956979,0.9842441239649631,0.4606205250596659,0.8931011762397737,1.0,3/10,13.80%,SLC25A13;SLC1A2;SLC1A3
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.24375744656516132,-0.983461059813566,0.46757679180887374,0.7176284786094432,1.0,30/98,24.60%,INSR;KLF4;SLCO1C1;THBS1;ANXA2;IFNAR1;RAB1A;TGFBR2;PPARA;NFKBIA;ECE1;PPARD;DHRS4;ACACB;AKT1;TP53;AGTR1;STARD4;GRB2;AGPAT1;ANGPT1;IL10RB;VAMP3;PPARG;PDGFRB;GADD45A;RIPK1;SFRP4;ARRB1;ACE2
prerank,L-serine metabolic process (GO:0006563),-0.4162971747640743,-0.98344754327189,0.49256505576208176,0.7172751906373758,1.0,5/10,29.63%,SRR;SERINC3;SERINC5;PSAT1;SHMT1
prerank,secondary alcohol metabolic process (GO:1902652),0.27536117163841006,0.9834028073282872,0.47902869757174393,0.8941469604430071,1.0,12/42,15.42%,PIP4P1;SULT2B1;SQLE;NSDHL;TSKU;CYP27A1;CYP11B1;OSBPL5;IDH3A;ABCA5;APOE;CLN8
prerank,cellular response to inorganic substance (GO:0071241),0.3282783748016676,0.9829511309837589,0.4744186046511628,0.89400020175573,1.0,4/21,8.04%,KCNC2;DDX11;ADCY10;DPEP1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.3297251568066946,-0.9828694221882042,0.5037453183520599,0.7182501759005532,1.0,10/23,26.84%,GHR;CRLF3;HES1;JAK2;NOTCH1;IL10RB;PTK2B;OCIAD2;CYP1B1;F2R
prerank,cytoplasmic microtubule organization (GO:0031122),-0.27351151480169833,-0.9827490155794907,0.4888507718696398,0.7181436664447086,1.0,16/54,19.18%,CLIP1;LIMK2;DLG1;EZR;DST;DCTN1;RHOA;SLAIN2;CHP1;TUBGCP4;RAB11A;SLK;TUBGCP5;PCM1;TRPV4;CLIP2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.3291086526666488,-0.9825552458979384,0.4964912280701754,0.7182360965310792,1.0,8/24,24.65%,POLD3;RPA3;RPA1;RPA2;LIG4;RFC4;RFC1;LIG1
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.3164870558059921,-0.9825368865240891,0.46842105263157896,0.7178713163393918,1.0,12/28,24.03%,EGFR;NOTCH3;ZBTB7A;ARRDC1;AKT1;TCIM;HEY1;GATA2;RITA1;WWP2;DLL4;ARRB1
prerank,negative regulation of cell cycle (GO:0045786),-0.2587017125407109,-0.9825264168002961,0.4915254237288136,0.7175069385527699,1.0,31/73,30.86%,PPP1R13B;RB1;BTG3;CDKN1B;PDCD4;BMP4;PTPRK;LATS2;PTPN3;CDK6;NUDT6;RNF167;FOXC1;BTG2;BMP7;TFAP4;ANGEL2;PTEN;NR2F2;MYOCD;CEBPA;BMP2;SIPA1;NUPR2;APC;NLRP2B;DUSP1;TRIM35;TGFB1;CHMP1A;LILRB1
prerank,regulation of interleukin-6 production (GO:0032675),-0.24762825331933644,-0.9824312298630096,0.5096660808435852,0.7173323375526612,1.0,36/96,36.11%,AFAP1L2;CD200;IFIH1;APP;IL6R;GAS6;LBP;MAPKAPK2;ARHGEF2;PLCG2;LPL;IL17RA;TNFAIP3;C1QTNF3;IL16;MAVS;HYAL2;NOD2;PTPN11;ARRB1;HMGB1;DHX9;F2R;LGALS9;TREM2;STAT3;TLR6;TLR1;C5AR2;NOS2;RAB7B;IL1A;TSLP;CD74;TLR2;TLR8
prerank,detection of mechanical stimulus (GO:0050982),-0.34897315527789713,-0.9824235624903668,0.4990825688073395,0.7169518341793303,1.0,9/19,31.64%,PIEZO2;PKD2;PTK2;CTNNB1;PKD2L1;PIEZO1;TTN;JUP;LHFPL5
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.34483401683721726,-0.9823761995614172,0.4876660341555977,0.7166698361876772,1.0,8/20,18.83%,DLG1;RHOQ;ROCK1;LCP1;NCKAP1;ROCK2;FMNL2;IKBKB
prerank,amyloid fibril formation (GO:1990000),-0.27670644708759606,-0.9823664322174503,0.47735191637630664,0.7163027204113684,1.0,17/51,23.22%,SNCAIP;USP9X;APP;HSPG2;TSPAN14;ADAM10;TSPAN5;H3-3A;IAPP;APH1A;SIAH1;TGFBI;MFGE8;MDM2;CALB1;TSPAN33;RIPK1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.37445081661889446,-0.9822022396077705,0.47619047619047616,0.7163363203304347,1.0,3/15,8.91%,PPARA;ELOVL5;PPARD
prerank,histone H4 deacetylation (GO:0070933),-0.41220214076731304,-0.9817067089725021,0.48154981549815495,0.7171057163943795,1.0,4/10,19.54%,RCOR1;HDAC1;HDAC4;SMARCAD1
prerank,B cell activation (GO:0042113),-0.2598217127872739,-0.9811105935356946,0.48672566371681414,0.7181615875292989,1.0,19/68,19.36%,ITGB1;PTPRJ;ZBTB7A;MEF2C;PLCG2;TPD52;CTPS1;CASP8;PIK3CD;HDAC4;ITGA4;CD40;NHEJ1;TCF3;VCAM1;CEBPG;CLCF1;PTPRC;DNAJB9
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.26809296355609763,-0.981080843420741,0.49005424954792043,0.7178279962231916,1.0,21/65,26.87%,FBXL7;PSMA2;RBX1;PSME2;NABP1;PSMB4;INTS3;PSMC2;PSMB2;PSMB1;PSMA8;CDK5RAP3;PSME1;PSMD4;PSMA7;CHEK1;FHL1;PSMD5;PINX1;PSMB10;PSMA3
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.30184052348133017,-0.9807531960743512,0.5072202166064982,0.7182328841535185,1.0,5/33,11.25%,HIP1;AFAP1L2;CBL;AKT1;ARAP1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.30854323355944424,-0.9807001751381205,0.48633879781420764,0.7179826729557003,1.0,9/32,17.12%,NEK7;ATM;TCP1;MAPK1;HMBOX1;PNKP;PARN;HNRNPA1;CTNNB1
prerank,positive regulation of T cell activation (GO:0050870),-0.2674217756529757,-0.9803485158721646,0.5104529616724739,0.7184302798402585,1.0,12/62,19.32%,ZMIZ1;SLC7A1;IL15;IL6ST;TFRC;NCK1;NCK2;VCAM1;ANXA1;CCL19;NOD2;PTPRC
prerank,dicarboxylic acid transport (GO:0006835),0.30190736862951084,0.9802197860859015,0.47139588100686497,0.9008712843975554,1.0,8/28,14.47%,PDPN;SLC25A13;SLC46A1;SLC1A2;SLC19A1;SLC1A3;SLC13A5;SLC26A8
prerank,inositol phosphate biosynthetic process (GO:0032958),0.39305770046514676,0.980107115182599,0.47649572649572647,0.8996875303398489,1.0,3/11,10.42%,ITPKA;IP6K2;IPPK
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.41002545140815,-0.9796522865137766,0.5017543859649123,0.7196874978739607,1.0,3/10,13.32%,LRRK2;KDR;MYOC
prerank,maintenance of protein location in nucleus (GO:0051457),-0.336475393476951,-0.9793446669182578,0.5026178010471204,0.7200354349201689,1.0,10/20,34.93%,SP100;SYNE1;TAF8;SUN1;TAF3;ARL2;HNRNPU;MORC3;PARK7;TOPORS
prerank,nuclear body organization (GO:0030575),-0.38461885049778427,-0.978629384058118,0.46808510638297873,0.7213851082884049,1.0,4/12,16.59%,ETS1;SERBP1;ZPR1;SRPK2
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.2645273981196769,-0.9783557239518195,0.4886561954624782,0.721625941347739,1.0,15/63,19.32%,SLC7A1;IL15;IL6ST;TFRC;CD38;NCK1;MEF2C;NCK2;CD40;MIF;VCAM1;ANXA1;CCL19;CLCF1;PTPRC
prerank,glucan catabolic process (GO:0009251),0.36181085949575503,0.9782751733212539,0.4711111111111111,0.9037129501938737,1.0,7/15,18.42%,AGL;PHKG1;PYGM;PYGB;PGM2;PGM2L1;PYGL
prerank,melanocyte differentiation (GO:0030318),-0.4031480757657745,-0.978163088715153,0.514760147601476,0.7216974713082409,1.0,3/11,9.66%,MITF;MEF2C;USP13
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.34003943720946284,-0.9780839954417171,0.4716312056737589,0.7215109828584538,1.0,8/20,26.50%,CDKN1B;LATS2;TFAP4;PTEN;NR2F2;MYOCD;CEBPA;APC
prerank,potassium ion import across plasma membrane (GO:1990573),0.28036337971396896,0.9779692932278814,0.5193621867881549,0.9030480185853613,1.0,7/41,8.79%,ATP1A2;KCNJ3;ATP12A;ATP1B1;SLC12A5;ATP4A;KCNJ6
prerank,response to muscle stretch (GO:0035994),0.3642239950727753,0.9778274470511125,0.47737556561085975,0.901975690827801,1.0,4/15,11.91%,GSN;RYR2;CDH2;SLC8A1
prerank,regulation of establishment of cell polarity (GO:2000114),-0.36146478279697525,-0.9775422532887377,0.4826325411334552,0.7224219088694627,1.0,6/16,15.36%,CDH5;RAP1B;ROCK1;BCAS3;ARFGEF1;ROCK2
prerank,secretory granule organization (GO:0033363),-0.41397238796389113,-0.9772396079255892,0.4811643835616438,0.7227512403546722,1.0,7/10,45.11%,SRGN;F2R;BLOC1S2;BLOC1S1;F2RL3;BLOC1S3;DTNBP1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.39112211296076194,0.9772159360535098,0.46618357487922707,0.902302795154607,1.0,3/11,6.16%,ENPP2;PDPN;ARHGEF7
prerank,regulation of response to oxidative stress (GO:1902882),0.39646011329569386,0.9770302972413761,0.49137931034482757,0.901317454513037,1.0,6/11,27.55%,ALOX5;SELENON;ACOX2;GGT7;AIFM2;PINK1
prerank,amide biosynthetic process (GO:0043604),-0.2807531704828502,-0.976957753503364,0.5152603231597845,0.7230260712374597,1.0,11/47,16.85%,SGMS1;DEGS2;SGMS2;CERS4;PAM;PCSK5;AGK;SPTLC1;ASAH1;CERS5;SMPD2
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.3445452537986649,-0.9767365806328614,0.500875656742557,0.7231729541935408,1.0,7/21,27.02%,KDR;MAPK1;IGF1;CTSH;ZFP36L1;FGF10;LGALS9
prerank,fibrinolysis (GO:0042730),0.3779824364463538,0.9766789073361294,0.4813953488372093,0.9008770341861262,1.0,1/13,1.24%,CPB2
prerank,protein localization to lysosome (GO:0061462),0.3057295147057916,0.9759339097597949,0.4634703196347032,0.901592430529001,1.0,8/28,11.95%,MFSD1;GGA3;CD81;SORL1;HGS;RTN4;ATP13A2;RNF128
prerank,phospholipid catabolic process (GO:0009395),-0.3280163647441975,-0.975924679348002,0.4772313296903461,0.7247514701404649,1.0,4/24,13.54%,GPCPD1;PLA2G4A;GDPD1;GDPD3
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.29687985895130586,0.9754546892618071,0.49321266968325794,0.9015603397116061,1.0,8/31,13.75%,NRG1;PKP2;PROX1;RYR2;FGFR2;TNNC1;MYL2;ZFPM2
prerank,acylglycerol metabolic process (GO:0006639),0.2855487312084197,0.9750095850188494,0.5010526315789474,0.9014313838671788,1.0,9/37,16.51%,DGKK;DGKI;DGKQ;GK;PGS1;APOE;APOC1;ABHD6;SEL1L
prerank,phosphate ion transport (GO:0006817),0.3526675766850494,0.9749970321377293,0.46420323325635104,0.8999563190390086,1.0,2/16,4.64%,SLC34A1;SLC25A3
prerank,catecholamine metabolic process (GO:0006584),-0.38062602288769476,-0.9747675187189988,0.512998266897747,0.7272374623907885,1.0,1/14,1.18%,SNCAIP
prerank,regulation of myoblast differentiation (GO:0045661),-0.3057698202361441,-0.974643223854662,0.5053956834532374,0.7271359373148764,1.0,16/32,31.55%,BOC;PLCB1;BMP4;MEF2C;NOTCH1;SMYD1;TBX3;RBM24;EID2B;ZFP36L1;LRRC8A;KLHL41;MAPK14;TGFB1;XKR8;SOSTDC1
prerank,histone deubiquitination (GO:0016578),-0.34704514596738645,-0.9743567784029649,0.5,0.7273854836037086,1.0,7/18,23.18%,UIMC1;TRRAP;USP15;BRCC3;USP7;ATXN7;USP16
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.2327081056620923,-0.9743358382346051,0.5357142857142857,0.7270418395027766,1.0,41/129,24.43%,XIAP;UBR5;ADGRA2;CAV1;SMURF2;PSMA2;LRRK2;DDX3X;EGFR;CSNK1G3;TRPM4;NFKB1;LRRK1;PSME2;PSMB4;PPM1B;AXIN2;ILK;CSNK1G1;DKK2;CSNK1D;PLEKHA4;PSMC2;LYPD6;USP34;PSMB2;PSMB1;DAAM2;PSMA8;PSME1;SOX4;TBL1X;GPC3;PSMD4;CAPRIN2;PSMA7;AMER1;SFRP4;PSMD5;RNF146;SEMA5A
prerank,regulation of neuron migration (GO:2001222),-0.32248850595920514,-0.9742379403422928,0.4757630161579892,0.7268970231514538,1.0,6/26,11.61%,DAB2IP;RAPGEF2;SEMA6A;NIPBL;ARHGEF2;PHACTR1
prerank,positive regulation of viral transcription (GO:0050434),-0.3211498825270609,-0.9740651510324099,0.4972972972972973,0.7269403440121812,1.0,12/25,33.73%,POLR2G;MDFIC;NELFB;SUPT4H1;POLR2C;DHX9;POLR2L;POLR2H;RSF1;NELFA;NELFCD;POLR2E
prerank,response to alcohol (GO:0097305),0.3029872628515047,0.9740265753675386,0.4779735682819383,0.9014032090104281,1.0,5/27,9.89%,GRIN2B;GLRA1;GRIN2A;ABCA2;SLIT3
prerank,peptidyl-threonine modification (GO:0018210),-0.2628348906636715,-0.9738830877828903,0.5077452667814114,0.7269635867432902,1.0,21/66,19.55%,DYRK1A;GSK3B;LRRK2;PRKD2;TGFBR2;PRKCD;CDK10;CDC42BPA;MAPK1;ROCK1;PRKD1;GSK3A;AKT1;GALNT11;MAPK8;MARK2;ROCK2;HIPK1;CDC42BPB;GALNT1;PRKDC
prerank,positive regulation of integrin activation (GO:0033625),-0.3923577582342628,-0.9734740613117694,0.5172413793103449,0.7275791267443377,1.0,3/11,8.05%,FERMT2;RASIP1;RAP1B
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.3382379174075211,0.9734501970846039,0.5010799136069114,0.9017192196317921,1.0,3/19,6.49%,BPNT2;SULT2B1;SLC35B2
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.24965983831485783,-0.9734198102921799,0.4949664429530201,0.7272963375221864,1.0,21/88,16.79%,DAB2IP;TRABD2B;MPP7;GSK3B;RAB7A;STX18;TFRC;SPIDR;CDH5;TAL1;RGCC;FNIP2;ICE1;SYNPO2;FLOT1;RHOC;SLF2;TPR;BCL2L11;BMP7;SUMO1
prerank,translational elongation (GO:0006414),-0.2445077067288555,-0.9732250957392475,0.5104529616724739,0.7273807242841486,1.0,35/101,27.22%,DAP3;LTN1;PTCD3;MRPL32;MRPL47;EEF2;MRPS23;MRPS18A;MRPL2;MRPS24;MRPL46;MRPS27;MRPL12;MRPL58;MRPL24;MRPL57;MRPS14;MRPS21;MRPL35;GFM2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS2;NEMF;MRPS28;MRPS35;MRPL43;MRPL48;TUFM;EEF1B2;MRPL11;MRPS31;EEF1G
prerank,regulation of interferon-alpha production (GO:0032647),-0.32187810410048323,-0.9729803538797928,0.49063670411985016,0.7275553088332274,1.0,3/23,3.89%,IFIH1;SETD2;DDX3X
prerank,cAMP-mediated signaling (GO:0019933),-0.3216123349397222,-0.972719315393018,0.5038022813688213,0.7277462369151372,1.0,5/24,6.05%,RAPGEF2;ADGRG6;PDE7B;PDE3A;PDE2A
prerank,negative regulation of response to external stimulus (GO:0032102),-0.24210197902527375,-0.9727009582290974,0.5148342059336823,0.7273923669525596,1.0,24/105,15.91%,TEK;RB1;KLF4;MFHAS1;CRK;PPARA;OTULIN;NMI;PRKCD;CDH5;EPHA4;PPARD;PPM1B;FEM1A;NFKBIL1;FGF2;DUSP3;RTN4RL1;TRAF3IP1;TNFAIP3;ILRUN;CCN3;C1QTNF3;TNFRSF1A
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.31911784652023345,-0.9724814080811869,0.49642857142857144,0.7275171178515436,1.0,9/27,23.28%,DYRK1A;ATM;SPRED2;YJU2;KMT5A;MIF;HIC1;MDM2;MSX1
prerank,epidermis development (GO:0008544),0.26193628900936977,0.9724526758546036,0.49107142857142855,0.9032601338723673,1.0,10/56,14.33%,OVOL3;ZNF750;POU2F3;SCEL;FGFR2;ACER1;LAMB3;CERS3;GATA6;COL7A1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.31798067260317764,-0.9723026518712773,0.5084175084175084,0.7275509521504738,1.0,14/26,35.99%,BIRC3;IRF1;NFKBIL1;OTUD4;FLOT1;GPR108;GPS2;IRF7;NLRP2B;TREM2;CACTIN;TLR5;LRRC14;TLR2
prerank,glucose import (GO:0046323),-0.39094177557428433,-0.9720255004095067,0.515370705244123,0.7277971468692843,1.0,3/13,11.66%,SLC2A1;RAB4B;SLC27A4
prerank,snRNA 3'-end processing (GO:0034472),-0.3457389019983298,-0.9714437877614168,0.5165441176470589,0.7287788502670215,1.0,11/19,29.96%,INTS8;EXOSC2;EXOSC3;EXOSC8;USB1;EXOSC5;INTS7;EXOSC7;TOE1;INTS5;INTS12
prerank,defense response to fungus (GO:0050832),-0.35467905134283906,-0.9711997927610267,0.504725897920605,0.7289904718850294,1.0,12/17,53.00%,RNASE7;PLCG2;S100A9;GAPDH;CARD9;CLEC4D;BCL10;HRG;S100A8;CLEC6A;LTF;CLEC4E
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.3320967096072198,-0.9706918128970717,0.5054151624548736,0.7298263587340169,1.0,9/22,23.28%,ATM;SPRED2;RPL37;EIF5A;HIC1;CDK5RAP3;RPS7;RPS15;MSX1
prerank,oligodendrocyte development (GO:0014003),0.3602040687754497,0.9696107769475328,0.5063025210084033,0.9103002530557245,1.0,5/15,16.50%,MYRF;PLP1;TPPP;EIF2B1;B4GALT6
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.22817118414031623,-0.9688666595779052,0.5165794066317626,0.7336833609944554,1.0,47/145,26.92%,FBXL7;PSMA2;YWHAE;CEP57;RBX1;CEP250;PSME2;CEP78;PSMB4;HAUS8;DCTN1;DCTN3;CSNK1D;PAFAH1B1;HAUS6;MECP2;CEP41;PSMC2;PSMB2;PSMB1;ALMS1;RAB11A;PSMA8;PLK4;PCM1;CETN2;CNTRL;CEP152;PSME1;CCND1;PSMD4;ODF2;PSMA7;CDC25A;HSP90AA1;FHL1;PCNT;CEP131;AKAP9;PSMD5;PINX1;BRD4;DTL;PSMB10;PSMA3;KIF14;DYNLL1
prerank,positive regulation of calcium ion transport (GO:0051928),0.28423186644242443,0.9688609975714749,0.4966292134831461,0.9110897250893331,1.0,9/36,14.36%,STC1;WNK3;CACNA1D;SPHK2;LILRA5;P2RX3;CCL5;CCL2;P2RX5
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.3294318085191412,0.9685975318531405,0.48625792811839325,0.9103985961459422,1.0,7/22,18.98%,CYP24A1;GC;CBR1;ALDH1A2;LRAT;CYP1A1;RBP1
prerank,activation of protein kinase activity (GO:0032147),-0.23954361533672933,-0.9675853787835418,0.5383244206773619,0.7363605451553898,1.0,25/106,16.38%,GHR;INSR;PRKACB;ADCY9;PAK2;MTOR;TGFBR2;RICTOR;GAS6;STK3;ABL1;TGFB2;PRKCD;FGF1;ADCY4;CLSPN;AKT1;TAOK3;JAK2;IRAK1;MAP4K4;MARK2;ADCY1;ANGPT1;IGF1
prerank,engulfment of apoptotic cell (GO:0043652),-0.37341990585752993,-0.9675094487465498,0.5215146299483648,0.7361524285096201,1.0,3/15,2.75%,RAC1;RHOBTB1;THBS1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.32101428927880094,0.9674526202510719,0.49321266968325794,0.9122932911184684,1.0,4/22,10.42%,RASL11A;DDX11;DHX33;IPPK
prerank,diol biosynthetic process (GO:0034312),0.36493721686759095,0.9672909794681991,0.5049019607843137,0.9113321573883615,1.0,5/15,9.92%,QDPR;SPHK1;ACER1;ABCA2;SPHK2
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.40970778063042745,-0.9672908242821633,0.524390243902439,0.7362862407085553,1.0,3/11,7.39%,DAB2;MSN;EZR
prerank,positive regulation of lipid localization (GO:1905954),-0.39696896461584236,-0.9671547912978156,0.4972972972972973,0.7362193765685787,1.0,5/11,27.15%,NFKB1;IKBKE;LPL;LRP1;HILPDA
prerank,regulation of embryonic development (GO:0045995),-0.29662127717525427,-0.9670373578863007,0.5128205128205128,0.7361170140956814,1.0,7/34,10.19%,INSR;SOX17;NIPBL;PLCB1;RBM19;TRIP12;EHMT1
prerank,tRNA aminoacylation (GO:0043039),-0.2895717173444658,-0.9667235031037639,0.5133689839572193,0.73647487511732,1.0,10/37,21.49%,YARS1;WARS2;FARS2;LARS1;AIMP2;HARS2;DARS2;FARSA;IARS2;WARS1
prerank,maturation of 5.8S rRNA (GO:0000460),-0.3480826308716547,-0.9665397225422928,0.5046554934823091,0.7364886477601976,1.0,5/17,20.70%,RPF1;RRP15;NOL9;PRKDC;PES1
prerank,melanosome organization (GO:0032438),-0.3211557653173078,-0.9661779879579556,0.5109489051094891,0.7369859281028577,1.0,7/26,21.54%,HPS4;BLOC1S5;SHROOM2;AP1G1;RAB32;AP3B1;KIF13A
prerank,protein-DNA complex assembly (GO:0065004),-0.2372774440080369,-0.9660484429900705,0.5293103448275862,0.7369045338761584,1.0,38/116,27.24%,MNAT1;KAT6B;PSMA2;DMC1;RBX1;BRD2;PSME2;PSMB4;ERCC2;SPTY2D1;MCM4;ORC5;RPA3;RPA1;XPC;ERCC3;PSMC2;H3-3A;PSMB2;PSMB1;ORC2;PSMA8;CETN2;ORC4;RPA2;PSME1;ATRX;TCF4;PSMD4;PSMA7;MCM3;PSMD5;MCM7;PSMB10;RSF1;PSMA3;MCM5;GTF2H3
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.41122438617913215,-0.9659789270050197,0.47201492537313433,0.7366690477045396,1.0,8/10,50.61%,DNMT1;ATRX;BRCA1;DNMT3B;MYB;SIRT1;RIF1;PRDM12
prerank,in utero embryonic development (GO:0001701),0.31166546161485736,0.9656758909844254,0.49148418491484186,0.9145813201163947,1.0,7/25,11.41%,WNT7B;FLCN;FGFR2;LMX1B;VEGFA;ZNF568;ARNT2
prerank,respiratory tube development (GO:0030323),-0.31596181295641673,-0.9651920600801349,0.4903677758318739,0.7382066067354808,1.0,9/28,14.01%,ITGA3;LOXL3;RBP4;FGF1;BMP4;PCSK5;FGF7;FGF2;ZIC3
prerank,bone morphogenesis (GO:0060349),-0.36636594236761305,-0.9648454921371953,0.4955595026642984,0.7386317092443907,1.0,3/14,6.37%,LRP5;BMPR2;LRP6
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.24278595466293845,0.9647651486399782,0.5364238410596026,0.9158538344726455,1.0,20/84,16.06%,RBFOX1;KHDRBS2;CELF5;KHDRBS3;SRRM4;CELF4;CELF2;QKI;CELF6;SRPK1;FXR2;DDX17;RBFOX3;ZC3H10;RBM8A;TIA1;NOVA1;U2AF2;SF3B4;HNRNPK
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.3879831281363245,-0.9639012113706174,0.5135623869801085,0.7405439081936191,1.0,5/13,21.30%,SORBS1;IRS1;GKAP1;IGF2;PTPN11
prerank,anterior/posterior axis specification (GO:0009948),-0.3585802118596161,-0.9629939184523137,0.4990859232175503,0.7423131458864592,1.0,8/15,34.00%,TASOR;SKI;TBX3;FZD5;RIPPLY2;DDIT3;SHH;HOXD8
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4058690735640251,-0.9628856650419214,0.5085034013605442,0.7421767744009724,1.0,3/10,14.55%,ESR1;TP53;PSMC2
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.40542878063535637,-0.9627506309608329,0.5353901996370236,0.7421241913032107,1.0,6/10,27.31%,CSGALNACT1;DSE;PXYLP1;XYLT2;CSGALNACT2;XYLT1
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.21858148297630403,-0.9624229169445422,0.5499124343257443,0.7425549012158419,1.0,37/198,14.94%,PTPRB;PLCB4;LIMK2;PAK2;PANK2;PLA2G4A;LRRK2;INPP1;MTOR;PLCG1;PIP4K2A;INPP5A;LIMD1;GFPT2;PLCB3;ACYP2;PLCB1;ALPL;PIP4K2B;MINPP1;PLCE1;PLCG2;ITPKB;PIK3CD;AKT1;INPP4A;PFKFB3;ALDOC;DUSP23;ACP6;LPL;DUSP3;PNKP;AGK;PIK3CB;GK5;AGPAT1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.38924818749190293,0.9622524440538839,0.4909090909090909,0.9218025741726961,1.0,2/10,14.86%,RCC2;RACGAP1
prerank,regulation of interferon-beta production (GO:0032648),-0.28111388015578276,-0.9622323633946744,0.5393474088291746,0.7425999908809205,1.0,23/46,36.11%,IFIH1;TRIM56;DDX3X;IRF1;PPM1B;FLOT1;POLR3F;MAVS;PTPN11;RNF216;HSP90AA1;YY1;DHX9;IRF7;RIOK3;CACTIN;TOMM70;LILRB1;IRF5;POLR3A;TBK1;TLR2;TLR8
prerank,actin nucleation (GO:0045010),0.3266471510889034,0.9621156537399413,0.5170068027210885,0.9206951662449386,1.0,7/21,19.43%,SPIRE1;TRIM27;ARPC5L;ARPC5;SPIRE2;WHAMM;ARPC1A
prerank,mRNA metabolic process (GO:0016071),-0.24042076146632796,-0.9620699911002083,0.5262237762237763,0.7425866442179963,1.0,26/90,28.11%,SRSF11;PRPF3;HNRNPA0;HNRNPR;ERN1;CELF1;TP53;SON;SFPQ;LSM11;SNRPE;SF3A1;LSM10;NUDT12;NONO;LSM3;DIS3L2;METTL16;ALKBH5;SUPT4H1;USP39;HSPA1B;PRPF18;DXO;SCAF11;LSM2
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.32101699286831276,-0.9620622041165395,0.5232142857142857,0.7422095979828273,1.0,3/23,6.37%,RAC1;MOSPD2;SLIT2
prerank,inositol phosphate catabolic process (GO:0071545),-0.3807576947239357,-0.961499711003137,0.4805914972273567,0.7431697033143707,1.0,6/12,29.59%,INPP1;INPP5A;PTEN;INPP5J;SYNJ1;SYNJ2
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.40345438055549754,-0.9610642440453516,0.5340909090909091,0.7433856777958839,1.0,3/11,19.09%,NOTCH4;AGO2;TNRC6A
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.40345438055549754,-0.9610642440453516,0.5340909090909091,0.7433856777958839,1.0,3/11,19.09%,NOTCH4;AGO2;TNRC6A
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.29342378864049495,0.9610570020050422,0.503448275862069,0.9223723360905113,1.0,6/31,10.54%,NLGN1;PPFIA2;CDK5;CAMK2B;TANC2;ABI2
prerank,regulation of chromosome segregation (GO:0051983),-0.35390643950020617,-0.9609970788586035,0.519434628975265,0.7431451112962627,1.0,13/16,48.28%,SMC5;PUM1;RAD18;PUM2;CDC6;CSNK2A1;CSNK2A2;IHO1;KIF2C;SMC6;AURKB;RMI2;HORMAD1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.3689440044142545,0.9606338194682563,0.5187793427230047,0.9220673261890096,1.0,6/14,21.60%,CPSF1;TUT1;CSTF2T;CPSF2;CSTF2;NCBP2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.27688083823313314,0.9601656628984783,0.5023474178403756,0.9219285733203414,1.0,7/44,7.85%,TENM1;PFN2;SPIRE1;PFN1;BAIAP2L2;GSN;CARMIL1
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.31360245455140184,-0.95980090544499,0.527306967984934,0.7455347127327118,1.0,8/23,30.86%,GAS6;VSIR;RARA;HMGB1;LGALS9;AXL;DDIT3;LILRB1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.2524953920252646,-0.9597498538429329,0.5274914089347079,0.7452486167242718,1.0,19/77,20.26%,ITGA6;RB1;MCL1;THBS1;DDX3X;BMP4;BIRC6;CAAP1;SH3RF1;CFLAR;AKT1;MAZ;HGF;GPX1;IGF1;PPIF;ZMYND11;TCF7L2;HERPUD1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.38003712512672483,0.9596104340996108,0.5022727272727273,0.9221320360061558,1.0,3/12,9.25%,LHX1;PAX2;VEGFA
prerank,negative regulation of viral genome replication (GO:0045071),-0.28502813037913527,-0.9596022185997318,0.5346715328467153,0.7451994410707561,1.0,16/40,30.71%,RESF1;IFIH1;ZC3HAV1;TASOR;IFITM3;PLSCR1;N4BP1;SRPK2;MAVS;IFITM2;TNIP1;TRIM6;OASL;BST2;RSAD2;SHFL
prerank,mitochondrial gene expression (GO:0140053),-0.28128053180924756,-0.9591712667354466,0.5363321799307958,0.7458077616878989,1.0,20/42,29.86%,FOXO3;PTCD3;MRPL47;MRPS18A;MRPL2;MRPS24;MRPL12;MRPL57;NDUFA7;MRPS14;IARS2;MRPS21;GFM2;FASTKD5;MRPS2;NOA1;MRPS28;SLC25A33;GATB;MRPS17
prerank,epithelium development (GO:0060429),-0.2378171012417317,-0.9591452637385116,0.5267702936096719,0.7454659240122624,1.0,17/107,11.52%,PKD2;CD34;TBX1;KDR;SOX17;SMO;LOXL3;MEOX2;SIX1;MTHFD1;TBX2;BDH2;ANXA4;MFSD2A;CPT1A;JAK2;ALDOC
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.3379824112284896,-0.9588325380275876,0.5043782837127846,0.7458399179656987,1.0,4/20,9.16%,MCL1;GSK3B;FAS;GSK3A
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.3634281041181504,-0.9586598094590937,0.5217391304347826,0.7458701373986283,1.0,9/15,36.49%,NEK6;CDC16;TPR;CENPE;TACC3;ANAPC7;PLK1;CDC6;UBE2C
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.3108816948222943,0.9585369012349125,0.531322505800464,0.9238290756561489,1.0,9/25,24.83%,NPSR1;AKAP6;GPER1;CASQ1;CX3CL1;TRPC1;PDPK1;CAPN3;SNCA
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3132192174598712,0.9584813145559241,0.5225653206650831,0.9224910549552013,1.0,9/22,17.71%,MAP2;MAP1S;MAPT;MAP1B;AEBP1;MAPRE3;APOE;CAMSAP3;MAP1A
prerank,regulation of smooth muscle contraction (GO:0006940),0.3291784605983283,0.9584602880728788,0.48878923766816146,0.9210571694650409,1.0,4/20,11.23%,CHRM2;CHRM3;SPHK1;NMUR2
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.4069469249843497,-0.9582220037291188,0.5144927536231884,0.7461569100159258,1.0,2/10,17.54%,CEP250;TULP1
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.4069469249843497,-0.9582220037291188,0.5144927536231884,0.7461569100159258,1.0,2/10,17.54%,CEP250;TULP1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.2908828857126025,0.9577559481071497,0.5286624203821656,0.9216683899158571,1.0,10/30,17.76%,UBE2J1;TUSC3;DPM1;MCFD2;UGGT2;LMAN1;RPN2;OSTC;RPN1;MGAT1
prerank,regulation of platelet aggregation (GO:0090330),0.3346817486277372,0.9576712805516392,0.48394495412844035,0.9204402681364835,1.0,3/17,1.83%,BLK;C1QTNF1;PDPN
prerank,embryonic eye morphogenesis (GO:0048048),-0.39639050169632617,-0.9571937495505134,0.5299295774647887,0.7481987818958383,1.0,3/11,8.09%,RARG;LRP6;TBX2
prerank,O-glycan processing (GO:0016266),0.25830098209361785,0.9569866682492085,0.5424836601307189,0.921068544952293,1.0,12/54,17.24%,MUC20;GALNT15;GALNT13;GALNT12;GALNT5;GALNT14;POFUT1;C1GALT1C1;MUC16;GALNT3;GALNT2;GALNT6
prerank,heterochromatin assembly (GO:0031507),-0.3285342053280921,-0.9568755649499442,0.5112359550561798,0.7485784187114266,1.0,4/20,14.82%,ZNFX1;HDAC1;SUV39H1;H3-3A
prerank,positive regulation of immune system process (GO:0002684),-0.35530508833166013,-0.9568420725119584,0.5282331511839709,0.7482592574390375,1.0,5/16,17.00%,IL15;TGFB2;PIK3CD;PIK3CB;ANXA1
prerank,histone exchange (GO:0043486),0.2880127322082223,0.9558595343681969,0.5333333333333333,0.9229881227460403,1.0,12/37,20.27%,SMARCA5;CENPS;ACTR6;MIS18BP1;OIP5;RUVBL1;RNF8;CENPK;CENPW;RBBP7;ITGB3BP;CENPA
prerank,negative regulation of developmental growth (GO:0048640),0.29170686887629776,0.9557276164220703,0.5336322869955157,0.9219298472034256,1.0,10/30,19.83%,DCC;MAP2;RTN4;PTPRS;MAG;TRIM46;SLC6A4;BBS2;RTN4R;FGFR3
prerank,glycolytic process (GO:0006096),0.2944934885544416,0.9554322028946329,0.5125284738041003,0.9212856969349871,1.0,5/28,15.04%,GCK;TPI1;PKM;ENO2;HK1
prerank,protein oxidation (GO:0018158),-0.39841636003154496,-0.9554051204805036,0.5203094777562862,0.7512792642058905,1.0,5/11,35.05%,LOXL3;LOXL1;LOX;SUMF1;LOXL4
prerank,histone monoubiquitination (GO:0010390),-0.31427028265352774,-0.9552392058599591,0.5555555555555556,0.7512876791826414,1.0,7/24,19.04%,DTX3L;RYBP;RNF40;CDC73;RNF168;BCOR;RNF2
prerank,B cell proliferation (GO:0042100),0.338915913635532,0.9551339842868611,0.5066666666666667,0.9207268941780956,1.0,2/17,3.49%,MS4A1;BCL2
prerank,regulation of fibroblast proliferation (GO:0048145),-0.27827281387831326,-0.9550493688511139,0.5063520871143375,0.7513323604936469,1.0,12/45,20.79%,DAB2IP;EMD;GAS6;TP53;CDC73;CDK6;MIF;IGF1;SKI;CTNNB1;LIG4;NF1
prerank,cGMP metabolic process (GO:0046068),-0.3950583780423097,-0.9550408324665584,0.5148148148148148,0.7509493072138071,1.0,5/12,24.28%,PDE2A;PDE9A;NPR1;GUCY1A1;GUCY2C
prerank,intestinal absorption (GO:0050892),-0.37520223936868147,-0.9547249665984225,0.528695652173913,0.7513061603062905,1.0,3/13,7.60%,F11R;KCNQ1;TJP2
prerank,inner mitochondrial membrane organization (GO:0007007),-0.2722217999268062,-0.9546891321081155,0.546448087431694,0.7510107158169244,1.0,22/47,34.02%,CHCHD3;APOOL;AFG3L2;SAMM50;MTX1;DMAC2L;AGK;ATP5F1E;UQCC3;ATP5F1C;ATP5MF;ATP5PO;TMEM11;IMMT;TIMM10;TOMM70;ATP5F1D;SPG7;MICOS10;TIMM10B;ATP5MC2;TIMM13
prerank,establishment of spindle orientation (GO:0051294),-0.3036670117687318,-0.9545163742696334,0.5424954792043399,0.7510172390730353,1.0,7/28,22.31%,ITGB1;MAP4;DCTN1;PAFAH1B1;FBXW11;NDEL1;MISP
prerank,negative regulation of protein polymerization (GO:0032272),-0.3087283551852765,-0.9543797355585644,0.5044404973357016,0.7509413461222085,1.0,8/27,15.35%,KANK3;DYRK1A;SLIT2;PRKCD;CDH5;KANK4;ARFGEF1;HIP1R
prerank,renal absorption (GO:0070293),-0.3975683842066588,-0.9541675729000092,0.5155963302752293,0.7510416488991419,1.0,5/10,23.34%,KCNQ1;WNK4;KLHL3;HYAL2;HAS2
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.28845049765968467,0.9533632434135862,0.5252747252747253,0.924535399047852,1.0,4/32,5.75%,MAGI2;PPP1R7;CAMTA1;CALM2
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.2844767531488346,0.9533561657807013,0.521551724137931,0.9230705838316385,1.0,5/35,5.39%,HTR2C;RIMS2;DGKQ;AKAP6;EPHA5
prerank,positive regulation of telomerase activity (GO:0051973),-0.29791152613175564,-0.9529460155819341,0.5227272727272727,0.7534803444353568,1.0,9/33,17.12%,KLF4;NEK7;TCP1;MAPK1;HMBOX1;PNKP;PARN;PTGES3;CTNNB1
prerank,positive regulation of viral genome replication (GO:0045070),-0.3033295063350656,-0.9516738002167949,0.5353901996370236,0.7560255124898603,1.0,9/29,18.77%,DDX3X;LARP1;PPARA;PKN2;PDE12;SRPK2;ADARB1;RAD23A;STAU1
prerank,fatty acid transport (GO:0015908),-0.3459121424516994,-0.9513980600160563,0.5351043643263758,0.7562780975104032,1.0,8/17,31.16%,PPARD;MFSD2A;SLC27A4;ACSL1;PPARG;SLC27A3;FABP3;SLC27A6
prerank,regulation of amyloid-beta formation (GO:1902003),0.2907933503438937,0.9513524319805309,0.5257009345794392,0.9275041336047527,1.0,9/34,14.63%,LRRTM3;GGA3;NTRK2;SORL1;RTN4;ABCA2;CLU;GSAP;APOE
prerank,phosphate ion homeostasis (GO:0055062),0.3842075876816024,0.9512461217248726,0.5106837606837606,0.926312625907721,1.0,1/10,1.56%,SLC34A1
prerank,sympathetic nervous system development (GO:0048485),-0.3539389268177485,-0.9511938989440425,0.5150976909413855,0.7563940972362758,1.0,4/15,20.79%,NRP2;CTNNB1;SOX4;NF1
prerank,zymogen activation (GO:0031638),0.27396169463147757,0.9509189610352425,0.5197215777262181,0.9258579714644708,1.0,5/39,10.27%,OMA1;C1RL;GRIN2A;KLK1;RIPK2
prerank,autonomic nervous system development (GO:0048483),0.33948590955332364,0.950822893359501,0.5226244343891403,0.92470837765886,1.0,1/17,0.37%,PHOX2A
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.3300762474532946,0.9507880441752838,0.5182012847965739,0.9233445777561167,1.0,3/17,12.58%,VTN;NR4A3;CCL5
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.27889269604832323,-0.9507297183766504,0.5262237762237763,0.7571050601677037,1.0,16/45,21.97%,BTG3;CDKN1B;BMP4;PLK2;NABP1;RGCC;PTPN3;FOXC1;BTG2;BMP7;CTNNB1;BUB1B;ANGEL2;BCL6;CHEK1;TOM1L2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.3050900617908744,0.9506450308915436,0.5496688741721855,0.9222838010361516,1.0,5/26,5.58%,PFN2;SHANK1;PLEK;LIMK1;PFN1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.31256383073185473,0.9504983168513024,0.5353075170842825,0.9212471684264925,1.0,7/23,12.18%,PIP4P1;MTMR2;MTMR10;MTMR11;MTMR7;OCRL;INPP5F
prerank,substantia nigra development (GO:0021762),0.27893595713941677,0.9504208732640792,0.5325301204819277,0.9200125508130905,1.0,8/37,13.71%,PLP1;CALM2;MAOB;CNP;PADI2;CCDC14;MBP;GLUD1
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.32578814906249226,-0.9503290594972634,0.5257731958762887,0.757679100141695,1.0,3/22,5.58%,SLC7A5;TRPM4;TNFRSF1B
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.41051639492908887,-0.9501706569749614,0.5452898550724637,0.7576687521398997,1.0,3/10,8.34%,SHANK3;APP;RAB5A
prerank,negative regulation of endocytosis (GO:0045806),-0.31815740929760056,-0.9499289080226626,0.53584229390681,0.757851796919217,1.0,4/24,9.18%,CAV1;RAC1;PRKD1;PICALM
prerank,negative regulation of histone acetylation (GO:0035067),-0.3873690927891572,-0.9499028991401194,0.5217391304347826,0.7575147916711648,1.0,5/11,29.26%,SIN3A;TAF7;BRCA1;SET;SPI1
prerank,peptide metabolic process (GO:0006518),-0.25002375741105565,-0.9494803430418646,0.5411764705882353,0.7581580253640805,1.0,20/75,19.51%,CPQ;GSTT1;ACE;PSEN2;GSTT2;SPPL3;ABCB9;PCSK5;ENPEP;GSTM2;PSEN1;CPXM2;GPX1;HPGDS;ERAP1;SOD1;DNPEP;CPXM1;NPEPPS;CLN5
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.38987805546781784,-0.9494197419222199,0.5251396648044693,0.7579031044239893,1.0,5/10,32.72%,LYN;CD40;BTLA;LILRB1;FGR
prerank,ruffle organization (GO:0031529),-0.35514010756284603,-0.9493852004566989,0.5321100917431193,0.7575918878051808,1.0,2/16,1.85%,LIMA1;RAC1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.22946795343399723,-0.9491747582288175,0.5894736842105263,0.7576986739267952,1.0,50/125,35.67%,CLIP1;MAD1L1;SETD2;MAP4;NEK6;RANBP2;AHCTF1;NUP98;PLK2;SEC13;PAFAH1B1;MECP2;KIF11;RPS27;DSN1;CENPL;CENPE;NDEL1;KIF3B;BUB1B;CENPO;TACC3;BUB3;TTK;PCNT;CENPI;CENPH;EML4;CENPN;RAN;DYNLL1;SPC25;SPDL1;TUBG2;CDCA8;STMN1;BIRC5;EFHC2;WDR62;NUDC;PLK1;NUF2;CKAP5;AURKA;MIS12;SPC24;ESPL1;TNKS;CDC20;NUP43
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.3227776271832108,-0.9489099265231133,0.5245346869712352,0.7579110427388873,1.0,5/22,22.00%,KLF4;GCNT2;FLOT1;BMP7;MAPK7
prerank,glycoprotein catabolic process (GO:0006516),0.3393513307176743,0.9486787048303016,0.5161290322580645,0.9236832965202032,1.0,2/17,5.88%,MMP12;FBXO2
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.2518856463044658,-0.948639447118174,0.5526770293609672,0.758145114848343,1.0,24/66,36.11%,FOXP1;APP;CASP8;JAK2;LPL;PANX1;TNFAIP3;TRIM16;IGF1;GBP5;CCL19;NOD2;CASP1;FZD5;F2R;LGALS9;NLRP2B;NLRC4;STAT3;TLR6;CARD16;NLRP3;CD33;TLR8
prerank,glycogen metabolic process (GO:0005977),-0.30908787693381456,-0.9482752331623711,0.5427574171029669,0.7586060477164903,1.0,6/27,13.72%,GBE1;GSK3B;PHKA2;PPP1R3C;GYS1;PHKB
prerank,digestive tract development (GO:0048565),-0.2946166659476111,-0.9481132950310875,0.5265017667844523,0.7585833234897424,1.0,8/32,14.01%,CLMP;SMO;NIPBL;TGFB2;GLI3;PCSK5;PKDCC;ZIC3
prerank,positive regulation of T cell differentiation (GO:0045582),-0.288520386635157,-0.9479993851699553,0.5424028268551236,0.7584650994731268,1.0,16/36,40.16%,LEF1;ZMIZ1;GLI3;VSIR;SOX4;BCL6;NKAP;IL7;PNP;SHH;VNN1;ZAP70;MDK;GATA3;TESPA1;IL4
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.34306901683947194,0.9476587981921225,0.5394456289978679,0.9251262186059881,1.0,2/17,5.75%,MAGI2;CALM2
prerank,dendritic spine organization (GO:0097061),-0.3087414528151123,-0.9473628859806774,0.5523978685612788,0.7595682665173209,1.0,4/26,2.92%,IGF1R;SHANK3;INSR;ITGA3
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.37516631681801277,-0.9471012458099508,0.5280289330922242,0.7598088179251061,1.0,4/13,16.35%,ATM;SPRED2;RPL26;HIC1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.3919768752200937,-0.9467844480957813,0.527001862197393,0.7601875440996768,1.0,7/10,47.15%,AKT1;TREM2;TICAM1;TLR6;MIA3;TLR4;MYD88
prerank,regulation of cell-cell adhesion (GO:0022407),-0.2795239788071811,-0.9467428919251993,0.5690909090909091,0.759883377909646,1.0,12/39,22.47%,PTPRG;PODXL;AFDN;PTK2;CDH1;SMAD7;CEACAM1;JAG1;CITED2;MAGI1;FERMT3;EPHB3
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.2811543628848976,-0.9457234181738247,0.5565693430656934,0.7618204781569647,1.0,16/39,24.02%,UTRN;NEDD4L;YWHAE;TCAF1;NEDD4;TRPC6;FXYD5;PTPN3;FXYD6;SCN3B;PPIF;SCN4B;WWP2;FHL1;RIPK1;AHCYL1
prerank,regulation of cell cycle process (GO:0010564),-0.23420752414233653,-0.9454948846266052,0.5691489361702128,0.761969423585222,1.0,38/104,33.28%,DCUN1D3;CDK13;MAD1L1;SETD2;CEP85;CUL9;AHCTF1;ZFYVE26;CEP250;RAB11FIP3;PLK2;BIRC6;CUL7;KLHL13;CCDC8;KIF11;RAB11A;CTNNB1;PLK4;CETN2;PRC1;KIF13A;CHEK1;BECN1;ATF5;PLK3;APC;USP19;CDKN2B;BORA;CAV2;OBSL1;MAP9;PLK1;SND1;KIF20A;E4F1;AURKA
prerank,nerve growth factor signaling pathway (GO:0038180),0.39665891521497454,0.9446287639173921,0.4933920704845815,0.9326494109610205,1.0,2/10,4.54%,MAGI2;KIDINS220
prerank,negative regulation of platelet activation (GO:0010544),-0.36295885115842874,-0.9439501859442676,0.5478723404255319,0.7652134212444216,1.0,4/16,12.66%,PRKG1;NOS3;PRKCD;CEACAM1
prerank,negative regulation of JNK cascade (GO:0046329),-0.29817719964529454,-0.9434468635286596,0.5451263537906137,0.7660725794801475,1.0,8/31,24.93%,MECOM;PDCD4;TAOK3;DUSP3;ZMYND11;SH3RF2;GPS2;AIDA
prerank,protein K48-linked deubiquitination (GO:0071108),0.3012653496625636,0.9431716188431997,0.5645161290322581,0.935515963524505,1.0,11/23,24.59%,OTUD7A;USP25;OTUD7B;USP50;USP5;USP33;USP20;OTUB2;USP8;OTUB1;OTUD5
prerank,cellular amide metabolic process (GO:0043603),0.22655522442844944,0.9429645064839047,0.5970873786407767,0.9346566857997199,1.0,24/102,16.64%,ABCA12;MME;PLPP2;SLC46A1;SMPD3;CPE;SLC19A1;PLA2G4E;OXSM;ALDH1L2;ABCA2;CPN1;AEBP1;ACSL6;MCCC2;NAAA;ACOT2;ACOT7;ACBD6;AASDHPPT;NSMAF;CLN8;MIPEP;ASAH2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.3875426186648872,-0.9418629619808411,0.5406871609403255,0.7693249463992036,1.0,4/11,15.43%,RIN3;SLIT2;MIF;CCN3
prerank,B cell homeostasis (GO:0001782),-0.39432059689122917,-0.9418557615468383,0.5183150183150184,0.7689417569426878,1.0,4/10,14.90%,LYN;MEF2C;PPP2R3C;TNFAIP3
prerank,positive regulation of dendritic spine development (GO:0060999),0.3162525884786386,0.9416840140904686,0.5754060324825986,0.9370609759720696,1.0,6/20,17.25%,NLGN1;SHANK1;CAMK2B;CPEB3;APOE;DHX36
prerank,positive regulation of histone acetylation (GO:0035066),-0.3200576979232183,-0.9414727583658336,0.5410447761194029,0.7694625822347049,1.0,12/23,36.27%,RPS6KA5;SMAD4;RUVBL2;WBP2;BRCA1;NOS1;ARRB1;SMARCB1;GLYR1;RPS6KA4;MUC1;LIF
prerank,intracellular cholesterol transport (GO:0032367),-0.3610063440889085,-0.9411833819201734,0.5381750465549349,0.7697363146558559,1.0,5/15,20.56%,LDLRAP1;LRP6;STARD4;STAR;OSBPL2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.24292968776802626,-0.9411825449384693,0.5926573426573427,0.7693390118722536,1.0,27/85,23.89%,RAC1;SMURF2;FZD6;DVL3;PSMA2;SMURF1;VANGL1;FZD4;AP2B1;AP2A2;AP2S1;PSME2;PSMB4;RHOA;WNT11;PSMC2;PSMB2;PSMB1;PSMA8;PSME1;AP2M1;PSMD4;ROR2;PSMA7;FZD7;PSMD5;FZD5
prerank,positive regulation of organelle assembly (GO:1902117),-0.2696970400203999,-0.9410830784047152,0.5719626168224299,0.7691561493202878,1.0,11/44,17.97%,ASAP1;RAB3GAP1;STX18;PIP4K2A;PIP4K2B;CROCC;RAB3GAP2;LCP1;FUZ;ARHGAP35;PLK4
prerank,regulation of organelle organization (GO:0033043),-0.24098785106933868,-0.940945011796091,0.5651438240270727,0.769070891036073,1.0,13/80,9.73%,TJP1;F11R;PAK2;STX18;DIAPH1;MSN;PDE2A;PTK2;EZR;ARMH3;USP6NL;MAPK1;CAPN2
prerank,protein prenylation (GO:0018342),-0.3970506248678576,-0.9409138430219881,0.5191256830601093,0.7687528350897992,1.0,6/10,39.13%,PTAR1;PGGT1B;RABGGTB;RCE1;RABGGTA;CHML
prerank,regulation of calcium ion import (GO:0090279),0.31453141543512897,0.9407541428019994,0.5511111111111111,0.9383003158759372,1.0,6/21,12.95%,STC1;WNK3;TRIM27;PLPP4;SPHK2;CCL2
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.3009185222279166,-0.940566183234598,0.5361010830324909,0.769187321736379,1.0,14/29,41.41%,LARP1;FUS;AXIN2;RBM24;THRAP3;TAF15;PABPC1;HNRNPU;TENT5C;TENT5B;VIP;TENT5D;DND1;NOCT
prerank,microtubule polymerization or depolymerization (GO:0031109),0.3051182219279763,0.9401896451376764,0.5514018691588785,0.938476467601281,1.0,10/24,26.48%,MAPT;STMN2;TPPP3;TPPP;HDGFL3;STMN4;STMN3;NCKAP5;KIF18A;FGF13
prerank,regulation of chromatin binding (GO:0035561),-0.39565934333485486,-0.9401287449132398,0.5782918149466192,0.7698290315600366,1.0,4/10,10.43%,BTAF1;DTX3L;WAPL;HMBOX1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.39809648401678804,-0.9400577093948329,0.5611015490533563,0.769599751656559,1.0,5/10,25.17%,SETD5;DIP2B;PRKAA1;MYOCD;DIP2A
prerank,regulation of mRNA processing (GO:0050684),0.28562932689094583,0.939916725688978,0.5136363636363637,0.9378358078258914,1.0,8/32,16.06%,KHDRBS2;KHDRBS3;QKI;SRPK1;PTCD2;SAFB;TIA1;HNRNPK
prerank,cardiolipin metabolic process (GO:0032048),-0.3687504020255095,-0.9398600085231037,0.5522935779816514,0.7696950251695817,1.0,2/13,3.63%,HADHB;PLA2G4A
prerank,positive regulation of cell aging (GO:0090343),-0.39188717237516846,-0.9397732644877516,0.5504761904761905,0.7694883607576113,1.0,4/11,15.17%,YPEL3;LMNA;ABI3;CGAS
prerank,negative regulation of neuron death (GO:1901215),0.23178133312246946,0.9392521174916788,0.5763097949886105,0.9383736714414089,1.0,21/93,13.39%,CDK5;BCL2;TYRO3;CLN3;CHGA;PTPRZ1;NTRK2;VSTM2L;GRN;PLA2G3;SORL1;POU4F1;KIR3DL2;MAG;ATP13A2;HTRA2;FZD9;NRBP2;CCL2;BDNF;FGF20
prerank,actin polymerization or depolymerization (GO:0008154),-0.2667147152566184,-0.9391119181636126,0.5425531914893617,0.7706224359940823,1.0,15/50,20.38%,ABI1;RAC1;SVIL;MICAL2;DIAPH1;WASL;FAM107A;CFL2;JAK2;PREX1;CORO7;CFL1;PSTPIP1;WASF1;DSTN
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3050658094126934,-0.9387125419715125,0.5711711711711712,0.7711660508417916,1.0,11/27,28.28%,PLTP;CAV1;RXRA;NFKBIA;ABCA7;EEPD1;PPARG;LPCAT3;GPS2;LRP1;TREM2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.32631952744765613,-0.9386722469827121,0.527336860670194,0.770463282105269,1.0,7/21,27.14%,EYA4;MCL1;AKT1;TERT;MAPK7;HSPA1B;SNAI2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.32631952744765613,-0.9386722469827121,0.527336860670194,0.770463282105269,1.0,7/21,27.14%,EYA4;MCL1;AKT1;TERT;MAPK7;HSPA1B;SNAI2
prerank,positive regulation of reproductive process (GO:2000243),0.2893356299946039,0.9385690151720648,0.5476718403547672,0.938887428609942,1.0,5/31,10.93%,CFAP69;GLRA1;ACVR1B;VEGFA;TACR1
prerank,mitochondrial membrane organization (GO:0007006),0.2856693008945281,0.9382613217214171,0.5428571428571428,0.9383040935934946,1.0,8/32,12.01%,BCL2;HSPA9;MFN1;SLC25A4;MTX3;CHCHD6;DNAJC11;GHITM
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.3001150904815789,-0.9382532631601213,0.5454545454545454,0.7710473724952711,1.0,9/26,19.01%,LYN;PSME2;EPHA4;PICALM;ROCK2;VSIR;FYN;APH1A;PSME1
prerank,connective tissue development (GO:0061448),-0.2885551903592337,-0.9382285764334176,0.5693693693693693,0.7707052414760284,1.0,5/35,9.54%,ZBTB16;LRP5;SH3PXD2B;CREB3L2;NAMPT
prerank,cellular defense response (GO:0006968),-0.2763099744605276,-0.9378732658307751,0.5785714285714286,0.7711336535909854,1.0,9/40,23.00%,ITGB1;ZNF148;LBP;CCR9;NCF2;RAB23;PTK2B;RELA;BECN1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.31259039265578176,-0.9371392969440665,0.5935828877005348,0.772497404725916,1.0,11/26,24.02%,NOS3;ACER2;GCH1;AKT1;ACER3;SPTLC1;ASAH1;CYB5B;NQO1;NOS1;CYP1B1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.37316343380235173,0.9369923032960127,0.543046357615894,0.9404926418596754,1.0,4/12,15.37%,CDA;DPYSL5;DPYD;DPYSL2
prerank,lung epithelium development (GO:0060428),0.38195092870852354,0.9367671928777592,0.5388349514563107,0.9396751854576306,1.0,3/10,14.58%,WNT7B;FOXJ1;RCN3
prerank,cilium organization (GO:0044782),-0.21042644051895387,-0.9365781275744749,0.6209964412811388,0.773405822321128,1.0,44/209,19.26%,ABCC4;ABLIM1;EXOC6;ASAP1;PKD2;PARVA;FNBP1L;EXOC4;RAB1A;EHD2;PTPDC1;SSX2IP;CEP250;IFT140;CDC14A;WDR11;RAB11FIP3;CEP78;EXOC2;PDE6D;FLNA;EHD1;WDR35;GALNT11;RAB8B;NOTCH1;IFT52;CFAP44;RAB23;TRAF3IP1;CEP41;EXOC8;FUZ;DZIP1L;NUDCD3;EHD4;RAB11A;HDAC6;CFAP298;PLK4;PCM1;TMEM17;KIF3B;IFT43
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.22558005779493723,-0.9365198434002101,0.6123893805309735,0.7731578403216034,1.0,17/117,11.72%,GNB1;CALCRL;MYH9;LYN;PRKACB;ADCY9;RAMP1;PLCG1;YES1;GGT5;PLK2;RHBDF2;ADCY4;PLCG2;RAMP2;ADM;CYSLTR2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.22664360854644106,-0.9362389444252494,0.6104129263913824,0.7734294801132824,1.0,17/116,11.72%,GNB1;CALCRL;MYH9;LYN;PRKACB;ADCY9;RAMP1;PLCG1;YES1;GGT5;PLK2;RHBDF2;ADCY4;PLCG2;RAMP2;ADM;CYSLTR2
prerank,cellular response to zinc ion (GO:0071294),-0.353767892894296,-0.9359200910400817,0.5420560747663551,0.773762794480873,1.0,9/15,25.53%,HVCN1;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F
prerank,negative regulation of immune system process (GO:0002683),0.3322159562208872,0.9355780968333037,0.5310492505353319,0.9417139869223707,1.0,6/16,17.74%,FCRLB;HOXA7;GPER1;COL3A1;SOX9;FCGR2B
prerank,primary neural tube formation (GO:0014020),-0.29636848070046257,-0.9352485394134316,0.5794573643410853,0.7749072622666445,1.0,9/30,18.67%,LMO4;PHACTR4;LRP6;TGFB2;MTHFD1;SEMA4C;FUZ;SKI;MTHFD1L
prerank,regulation of protein localization to membrane (GO:1905475),0.29657988984312605,0.934551262245388,0.5553047404063205,0.9432952174294363,1.0,5/28,6.96%,GPC5;CDK5;CLN3;GPC1;GSN
prerank,regulation of fibrinolysis (GO:0051917),-0.37234266933344085,-0.9344444102619984,0.5585106382978723,0.7763560971961964,1.0,9/13,49.67%,THBS1;SERPINE1;USF1;FAP;APOH;PLG;F11;HRG;F2
prerank,negative regulation of hormone secretion (GO:0046888),-0.39725433066038585,-0.9342438177110429,0.5683453237410072,0.7764204363018994,1.0,5/10,36.27%,RAB11FIP3;RAB11FIP1;RAB11FIP5;IL11;LIF
prerank,long-chain fatty acid import into cell (GO:0044539),-0.38771426119071195,-0.9327139377894629,0.5714285714285714,0.7796280878177858,1.0,4/10,23.42%,SLC2A1;SLC27A4;ACSL1;SPX
prerank,peptidyl-asparagine modification (GO:0018196),0.2820781121935747,0.9325620418915175,0.5655913978494623,0.9478286524448201,1.0,10/31,17.76%,UBE2J1;TUSC3;DPM1;MCFD2;UGGT2;LMAN1;RPN2;OSTC;RPN1;MGAT1
prerank,negative regulation of metabolic process (GO:0009892),-0.25602444580048545,-0.9325540333384745,0.5523978685612788,0.7796106805025813,1.0,9/54,14.04%,ZNF423;RB1;ID1;IL15;LAMA4;NOVA2;ADAMTS5;NOTCH1;ATF4
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.24005708975563475,-0.9324144299651694,0.5753176043557169,0.7795393295361565,1.0,29/88,27.04%,DAB2IP;DAPK1;RNF139;DDX3X;GIGYF2;LARP1;NFKB1;DNAJC1;SAMD4A;AKT1;EDN1;IGFBP5;SYNCRIP;BTG2;PLAT;HDAC6;CDK5RAP3;RPS3;CAPRIN1;TOB1;SERPINE2;RPL13A;MRPL13;EIF2AK3;FXR1;IGF2BP2;CNOT8;NANOS1;CNOT1
prerank,regulation of microtubule polymerization (GO:0031113),-0.2762713399459435,-0.9322336411927551,0.5810344827586207,0.7795577246518529,1.0,10/40,13.02%,DYRK1A;CLIP1;RAC1;ABL1;TOGARAM1;CDH5;OCLN;DCTN1;SLAIN2;DRG1
prerank,transepithelial transport (GO:0070633),-0.35009790172473504,-0.9320527803195635,0.5817223198594025,0.7795780494097382,1.0,2/15,4.55%,ABCG2;SLC12A2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.38046016658984294,0.9319935661622796,0.5414746543778802,0.9480429148495899,1.0,2/11,6.48%,BCL2;TRIAP1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.27238797312185237,-0.9319789899481112,0.5893805309734513,0.7793380471914914,1.0,10/41,16.92%,CD34;GAS6;LBP;NFKBIL1;DICER1;TNFAIP3;ILRUN;VSIR;IGF1;RARA
prerank,negative regulation of transport (GO:0051051),-0.2661778068729195,-0.9311657655073512,0.584055459272097,0.7807890930602558,1.0,15/51,22.24%,RAB7A;DYSF;PPM1F;PRKD1;ARL6IP5;PXK;SNX12;CTTNBP2NL;PLSCR1;ABCA7;PIP4P2;WWP2;PTEN;ITGB3;NDFIP2
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.28924908472275435,-0.9305438160376986,0.5827205882352942,0.7818463287626328,1.0,9/35,17.12%,NEK7;ATM;TCP1;MAPK1;HMBOX1;PNKP;PARN;HNRNPA1;CTNNB1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.35489574815121677,-0.930344740537032,0.566793893129771,0.7819108167808584,1.0,3/15,11.78%,TGFB2;SMAD7;HFE
prerank,cognition (GO:0050890),-0.2726696883298169,-0.9295109015128549,0.5599250936329588,0.7834341312365414,1.0,8/42,9.33%,SHROOM4;ST3GAL4;SOBP;APP;NIPBL;SETD5;MFSD2A;FAM107A
prerank,negative regulation of histone modification (GO:0031057),0.3493201461235736,0.9293451569751832,0.557919621749409,0.9543348023534297,1.0,4/14,15.43%,PRMT6;SPHK2;THAP7;TWIST1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.3492254090339101,-0.9291353053314619,0.5695970695970696,0.7838836501954111,1.0,6/16,24.23%,ACADL;CEACAM1;ERLIN2;ACADVL;BRCA1;TRIB3
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.211634693484279,0.9285670283813835,0.6439024390243903,0.95519711464414,1.0,29/163,14.60%,PDE4B;BLK;MS4A1;BLNK;PSMC5;PAG1;NFATC2;BCL2;CD3G;PSMD10;GRAP2;VTCN1;PAK3;PAK1;PIK3R2;PSMD14;VAV3;RIPK2;MOG;CARD11;PSMB7;RBCK1;PRKCB;PSMA4;TXK;PSMD1;PSMF1;EIF2B1;PSMB8
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.40359657323475323,-0.928494042181832,0.5942549371633752,0.7849701660645267,1.0,5/10,21.21%,MECP2;KDM1B;PCGF3;IGF2;PCGF5
prerank,negative regulation of B cell proliferation (GO:0030889),-0.3802864606385199,-0.9283384154738683,0.559322033898305,0.7849145644511157,1.0,2/11,3.17%,LYN;ATM
prerank,lipoprotein catabolic process (GO:0042159),-0.3825906161590634,-0.927248318563708,0.5570698466780238,0.7870849324192201,1.0,8/11,39.94%,ABHD17A;NOTUM;ABHD17C;LYPLA1;ABHD10;PPT1;ABHD17B;LYPLA2
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.3924662279127305,-0.9271873474955609,0.5701275045537341,0.7868383376252471,1.0,5/10,38.33%,HDAC6;AOC3;HP;MT3;ETFBKMT
prerank,positive regulation of interferon-gamma production (GO:0032729),0.25791848505943754,0.9269971040196661,0.5795454545454546,0.9581944877216982,1.0,9/48,15.02%,PDE4B;TRIM27;IL12A;IL12RB1;RASGRP1;CD226;TXK;SLAMF6;IL23A
prerank,cellular iron ion homeostasis (GO:0006879),-0.2553267620240975,-0.9269914520081446,0.5979381443298969,0.7868871455317025,1.0,11/55,18.25%,ABCG2;SLC40A1;TFRC;BMP6;SCARA5;SMAD4;HFE;HMOX2;ABCB7;SOD1;FLVCR1
prerank,nuclear pore organization (GO:0006999),-0.3564659040391178,-0.9268797150857037,0.5787476280834914,0.7867725873726799,1.0,4/14,15.78%,AHCTF1;NUP98;NUP153;TPR
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.2993100524927379,-0.9267408928130851,0.5812274368231047,0.7866962117603862,1.0,13/29,29.39%,UBE2K;PTPN1;SAMHD1;STAT2;USP18;NLRC5;MAVS;ABCE1;PTPN11;IFNAR2;PTPN2;TRIM6;CACTIN
prerank,regulation of mast cell degranulation (GO:0043304),0.3547827328268943,0.9267120520133582,0.5519630484988453,0.9575704996637971,1.0,3/14,9.92%,BLK;STXBP2;SPHK2
prerank,mitochondrial translational elongation (GO:0070125),-0.23822677680507554,-0.9266769028803742,0.624113475177305,0.786446444731885,1.0,30/88,26.75%,DAP3;PTCD3;MRPL32;MRPL47;MRPS23;MRPS18A;MRPL2;MRPS24;MRPL46;MRPS27;MRPL12;MRPL58;MRPL24;MRPL57;MRPS14;MRPS21;MRPL35;GFM2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS2;MRPS28;MRPS35;MRPL43;MRPL48;TUFM;MRPL11;MRPS31
prerank,tube closure (GO:0060606),-0.2902658939928318,-0.9263421646374056,0.5802707930367504,0.7868047309291203,1.0,9/31,18.67%,LMO4;PHACTR4;LRP6;TGFB2;MTHFD1;SEMA4C;FUZ;SKI;MTHFD1L
prerank,cellular response to light stimulus (GO:0071482),-0.24801918516584787,-0.9262686528738279,0.6190476190476191,0.7865809303843065,1.0,13/66,15.76%,GNB1;CREBBP;NEDD4;PRKCD;PTPRK;RPL26;TP53;NSMCE3;SAG;ATF4;COPS9;N4BP1;RUVBL2
prerank,heme biosynthetic process (GO:0006783),-0.3167059302876425,-0.9253485116502963,0.5671641791044776,0.7882696993171604,1.0,3/22,8.14%,ABCG2;ALAS1;ABCB10
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.35542239180413426,0.9251456504872453,0.5598194130925508,0.9606211643800797,1.0,4/13,16.40%,TOX;CAMK4;FOXJ1;ADAM8
prerank,cellular response to acid chemical (GO:0071229),-0.299122266786668,-0.9250859933912757,0.5817843866171004,0.7885003816772136,1.0,6/27,13.63%,SH3BP4;KLF2;MTOR;CAPN2;RPTOR;LARS1
prerank,regulation of T cell proliferation (GO:0042129),-0.2564336928265191,-0.92493884766761,0.6092592592592593,0.7884799689558385,1.0,13/61,23.62%,SLC7A1;IL15;IL6ST;TFRC;TNFRSF1B;NCK1;NCK2;VCAM1;ANXA1;CCL19;PTPRC;TNFSF8;CD276
prerank,camera-type eye morphogenesis (GO:0048593),-0.3874755198133768,-0.9248789746667103,0.5734265734265734,0.7882287720159962,1.0,5/10,20.79%,LRP6;TBX2;SHROOM2;SKI;NF1
prerank,zinc ion transport (GO:0006829),-0.31366238422839476,-0.9248159021270632,0.5706713780918727,0.7879720455388006,1.0,6/21,20.73%,SLC30A10;SLC39A8;SLC39A11;SLC30A5;SLC39A6;SLC30A1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.30260343778850063,0.9246646601191829,0.574468085106383,0.9605211141236337,1.0,6/24,15.32%,SLC25A13;ADRB3;NR4A3;LYRM7;MRAP2;GFPT1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.35870573857222376,-0.9241947021556128,0.5740740740740741,0.7890489128397082,1.0,5/13,12.27%,TGFBR3;MEF2C;TBX2;NOTCH1;FGF2
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.3500476688852181,-0.9235021780897084,0.5905096660808435,0.790253080956645,1.0,4/16,15.40%,ESR1;RBFOX2;NCOA4;TADA3
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.2985199524720887,-0.9234649153112873,0.5862676056338029,0.7899341271337836,1.0,4/27,12.29%,NFAT5;ETS1;RHOA;IRAK1
prerank,negative regulation of immune effector process (GO:0002698),0.355901086706265,0.9228684251583439,0.5448577680525164,0.9643144655435697,1.0,4/13,15.25%,GRN;ENPP3;HAVCR2;CD47
prerank,skeletal system morphogenesis (GO:0048705),0.2670266146665088,0.9226443585608867,0.6043478260869565,0.9634976358456592,1.0,14/42,19.98%,DSCAML1;HOXD3;CYP26B1;MEGF8;FGFR2;RAB33B;HOXA4;HOXA9;PDGFRA;HOXD4;FBN2;HHIP;FGFR3;DYNC2I1
prerank,apoptotic DNA fragmentation (GO:0006309),-0.3477952456895468,-0.9225542832943593,0.5793103448275863,0.7916176028461672,1.0,6/16,24.66%,CECR2;DICER1;KPNA1;EXOG;FOXL2;HMGB1
prerank,response to insulin (GO:0032868),-0.2402533309572699,-0.9224936853441765,0.6169844020797227,0.7913469964729308,1.0,13/80,12.66%,TBC1D4;SORBS1;FOXO1;INSR;KAT2B;PIK3R1;IRS1;RHOQ;GSK3A;AKT1;RAB8B;INSIG2;CEACAM1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3378639907965572,0.9219455233518508,0.5513392857142857,0.9640274563593315,1.0,7/16,18.42%,AGL;PHKG1;PYGM;PYGB;PGM2;PGM2L1;PYGL
prerank,negative regulation of cellular component organization (GO:0051129),0.23755164817824997,0.9218702672887816,0.614190687361419,0.9627754306553257,1.0,15/74,13.93%,TMEFF2;SYT11;APOM;IMPACT;MTMR2;HSF1;CARMIL1;SORL1;XRCC5;VEGFA;PRKCZ;NOP53;RUBCN;CLU;LRSAM1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.2626996531115408,-0.9217424810164482,0.5888689407540395,0.7926789142347166,1.0,18/49,28.28%,GSK3B;DDX3X;LDLRAD4;RAF1;TRAF3IP1;IAPP;SMAD6;HDAC6;ANKRD27;PMEPA1;TFIP11;RPL13A;HMGB1;AIDA;KIF14;NLRP2B;RIOK3;TREM2
prerank,7-methylguanosine RNA capping (GO:0009452),-0.29163864880477963,-0.9216618978162119,0.6122448979591837,0.7920619305042393,1.0,10/31,28.42%,MNAT1;POLR2G;ERCC2;ERCC3;CMTR2;POLR2C;POLR2L;POLR2H;GTF2H3;CCNH
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.29163864880477963,-0.9216618978162119,0.6122448979591837,0.7920619305042393,1.0,10/31,28.42%,MNAT1;POLR2G;ERCC2;ERCC3;CMTR2;POLR2C;POLR2L;POLR2H;GTF2H3;CCNH
prerank,histone H3-K36 demethylation (GO:0070544),-0.39279036343569085,-0.9215443562119313,0.5899814471243042,0.7919234186349574,1.0,3/10,14.06%,KDM2A;RIOX2;KDM7A
prerank,actin filament network formation (GO:0051639),0.38007747659091873,0.921441207637178,0.5593952483801296,0.9625429346272262,1.0,6/11,20.84%,SPIRE1;FHOD3;CARMIL1;SPIRE2;FHOD1;PLS1
prerank,negative regulation of cyclase activity (GO:0031280),0.3441319837641892,0.9210741037894976,0.6017699115044248,0.9620546179328728,1.0,2/14,4.62%,GNAI2;GABBR2
prerank,negative regulation of RNA splicing (GO:0033119),-0.3212037174672976,-0.9205593208348112,0.5865921787709497,0.7937491496430757,1.0,8/19,30.51%,SRSF12;SFSWAP;RNPS1;PTBP3;SRSF10;RPS26;SRSF6;RPS13
prerank,centromere complex assembly (GO:0034508),0.2761821232730109,0.9205585277147456,0.5781584582441114,0.9620286215872313,1.0,11/36,20.27%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;CENPK;CENPW;DLGAP5;RBBP7;ITGB3BP;CENPA
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.32659608039473415,0.9201892789308831,0.5770114942528736,0.9615652617206141,1.0,4/17,8.20%,PKP2;GPD1L;RYR2;SCN5A
prerank,microtubule nucleation (GO:0007020),-0.3199446387048725,-0.9199407796378427,0.5851449275362319,0.7948100382326665,1.0,9/19,30.18%,RANBP9;SLAIN2;CSNK1D;TUBGCP4;TUBGCP5;NDEL1;AKAP9;TUBG2;TUBGCP3
prerank,regulation of telomere capping (GO:1904353),-0.3103171322839764,-0.9197568654317292,0.6102003642987249,0.7948153436391715,1.0,13/23,38.35%,NEK7;ATM;MAPK1;PNKP;TERF2;USP7;SMG6;HNRNPD;TNKS2;RAD50;TNKS;MAPKAPK5;MAPK15
prerank,proteoglycan biosynthetic process (GO:0030166),-0.28587376750365895,-0.9193110540714213,0.59245960502693,0.7954609531642545,1.0,6/31,12.14%,EXT1;BMPR2;CSGALNACT1;HS3ST3B1;CHST11;EXTL3
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.38751617967161295,-0.919037905371345,0.5865921787709497,0.795668834377124,1.0,2/10,7.02%,TGFBR2;CD55
prerank,transferrin transport (GO:0033572),-0.28285475520939196,-0.918885493914457,0.5926640926640927,0.7956335228125839,1.0,8/33,13.99%,TFRC;DNM2;STEAP3;ARHGAP1;HFE;ATP6V1E1;MCOLN1;REP15
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.2729466820578115,-0.9188647344198189,0.5812274368231047,0.7952801666904084,1.0,9/40,14.12%,SLC7A5;SLC38A11;SLC5A6;SLC38A5;SLC16A1;SLC13A3;SLC25A11;SLC7A7;SLC36A4
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.33180254895090233,-0.9188638358210187,0.5791433891992551,0.7948838405975637,1.0,6/18,25.25%,CAV1;NEDD4L;SLC43A1;PPIF;KCNH2;CAB39
prerank,replicative senescence (GO:0090399),-0.3619026901375948,-0.9184614406200442,0.6003521126760564,0.7954233655454691,1.0,6/12,22.81%,ATM;WNT16;TP53;TERT;CHEK1;SERPINE1
prerank,inorganic ion transmembrane transport (GO:0098660),-0.3698305265519878,-0.9184602881512035,0.5815602836879432,0.7950280008198534,1.0,3/12,4.94%,PKD2;ABCC9;TRPM4
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.3455175892714601,-0.9183189871892975,0.574585635359116,0.7949530198785677,1.0,4/15,10.57%,CSGALNACT1;DSE;CSPG4;BGN
prerank,dicarboxylic acid catabolic process (GO:0043649),0.341271601933998,0.91741154541751,0.5863539445628998,0.9680198639773703,1.0,5/13,22.04%,ASPA;GLUD1;GAD1;DDO;MTHFS
prerank,triglyceride biosynthetic process (GO:0019432),0.3226868284400786,0.9173646725371141,0.5471698113207547,0.9667199608261647,1.0,3/18,12.65%,LPIN1;GK;MOGAT1
prerank,metanephric mesenchyme development (GO:0072075),0.36988218178202203,0.9173556846944905,0.5496828752642706,0.9652863337546574,1.0,3/10,6.07%,OSR1;WT1;PAX2
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.2969367490056816,-0.9172968027510193,0.5866900175131349,0.7968772009996908,1.0,10/29,27.81%,JAM2;GAS6;MOSPD2;ANO6;LGMN;CXCL12;SERPINE1;HMGB1;LGALS9;CXCL10
prerank,negative regulation of receptor binding (GO:1900121),-0.3902320434699411,-0.9172463932074284,0.5896946564885496,0.7965840219584207,1.0,2/10,11.78%,ATP2A3;HFE
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.29286549190487304,-0.916913663960503,0.5992217898832685,0.7969752536707455,1.0,13/28,32.37%,DTX3L;SHLD1;KMT5B;MRNIP;PNKP;MAD2L2;TFIP11;PRKDC;ERCC6;PARP9;KDM4D;CYREN;PARP3
prerank,organonitrogen compound catabolic process (GO:1901565),-0.25068143940952886,-0.916558163118878,0.6055045871559633,0.7974175210303378,1.0,18/57,22.25%,CPQ;PLA2G4A;MTOR;ACE;GNPDA2;TXN2;ENPEP;PDXDC1;GGACT;USE1;SMPD2;ERAP1;SIAH1;NPEPPS;CLN5;CTH;ADO;PNPLA8
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.3507478799972509,0.9165126973716119,0.5859872611464968,0.9661989544490717,1.0,2/13,4.62%,GNAI2;GABBR2
prerank,regulation of cholesterol transport (GO:0032374),0.3124868257228446,0.9162763053456571,0.5726872246696035,0.9654829052990285,1.0,9/20,27.51%,OSBPL6;ABCA2;NUS1;ABCA5;APOC1;LAMTOR1;NR1H2;ARV1;TTC39B
prerank,regulation of cell projection organization (GO:0031344),0.3567982132462494,0.9161107953998123,0.5870535714285714,0.9644832393548276,1.0,3/13,7.70%,NTNG2;NTNG1;ERMN
prerank,regulation of lipid metabolic process (GO:0019216),-0.22989425067293684,-0.9161057962609741,0.6535836177474402,0.7981233297791481,1.0,25/88,20.44%,CREBBP;CAV1;RXRA;PANK2;SP1;PPARA;MED1;NFYC;GGPS1;PPARD;ACACB;HELZ2;SIN3A;C1QTNF2;SMARCD3;NR1D2;TGS1;DHCR7;ABCA7;TNFAIP8L3;CARM1;NCOA6;TBL1X;PPARG;FGFR4
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.30368513862816926,-0.9150293927536419,0.5830388692579506,0.8002409254111631,1.0,8/24,21.91%,MCL1;FOXO3;TGFB2;ATF4;SRPK2;CTNNB1;NF1;ITGAM
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.3671762626426559,-0.9149091964789844,0.5807017543859649,0.8000938750968896,1.0,5/11,34.02%,AGK;TIMM10;TOMM70;TIMM10B;TIMM13
prerank,determination of bilateral symmetry (GO:0009855),-0.29645340900121075,-0.9142130930137209,0.5716814159292035,0.8013010286807474,1.0,8/24,21.58%,PKD2;TBX1;GALNT11;NOTCH1;ZIC3;CITED2;KIF3B;CFAP53
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3071615059260548,-0.9137157150626303,0.5953237410071942,0.802079496279004,1.0,7/24,24.01%,ACVRL1;BMPR2;DACH1;TERF2;RPS3;BLM;MSH3
prerank,positive regulation of ruffle assembly (GO:1900029),0.34774580979010195,0.9134168246008316,0.5936794582392777,0.9706754604821511,1.0,2/13,5.58%,NLGN1;PFN1
prerank,regulation of lymphocyte activation (GO:0051249),0.3513052630377633,0.9133951438817713,0.5535714285714286,0.9692905205253298,1.0,2/12,12.58%,PAG1;CCL5
prerank,positive regulation of endocytosis (GO:0045807),-0.2668988468550494,-0.9131273156088642,0.6025179856115108,0.8030869664332966,1.0,10/45,13.06%,HIP1;DAB2;NEDD4L;CBLL1;LDLRAP1;CBL;HFE;ANO6;ANKFY1;FLOT1
prerank,regulation of interleukin-2 production (GO:0032663),-0.2652141052833418,-0.9130906908241577,0.5909090909090909,0.8027673370565233,1.0,14/43,24.76%,SPTBN1;CD34;PRKD2;EZR;PLCG2;KAT5;TNFAIP3;ANXA1;RPS3;PTPRC;HDAC7;HOMER3;STOML2;MAP3K7
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.32949770568735437,-0.9130532849463083,0.6028119507908611,0.802446760671417,1.0,4/18,8.54%,CD200;RPS6KA5;PRKD2;PRKD1
prerank,positive regulation of peptidase activity (GO:0010952),-0.31687608555053826,-0.912657220225011,0.575091575091575,0.8029058223472526,1.0,6/20,19.01%,PSME2;MAPK12;VSIR;CTSH;APH1A;PSME1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.23802133485014584,0.9124473711080551,0.6522781774580336,0.9704963251399861,1.0,15/70,17.55%,ENPP2;PCYT1B;LPIN1;PLA2G7;PLA2G3;PLA2G4E;PLA2G6;LIPC;MBOAT7;GPLD1;CHKA;CHPT1;SLC44A2;MBOAT2;LPCAT2
prerank,regulation of ion transmembrane transport (GO:0034765),-0.28200481446928516,-0.9123534189406454,0.6078767123287672,0.8031786972640268,1.0,12/33,24.02%,NEDD4L;KCNJ2;YWHAE;NEDD4;KCNQ1;ANO6;KCNJ8;CASQ2;WWP2;KCNH2;AKAP9;AHCYL1
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.3713363619357294,-0.9121564572901876,0.5666666666666667,0.8032025202030251,1.0,5/12,15.57%,LAMA3;LAMA5;ACTB;TRAF3IP1;FUZ
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.3029258516829547,-0.9120072563099909,0.5909878682842288,0.8031562661880443,1.0,7/24,15.58%,PRKCH;CBFB;MED1;ROCK1;FOXC1;ROCK2;TRIM16
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.38850830744335085,-0.9119611250888272,0.5970149253731343,0.802848276827346,1.0,7/10,34.66%,DICER1;AGO2;DROSHA;TERT;TSN;TARBP2;MRPL44
prerank,negative regulation of protein depolymerization (GO:1901880),0.2922642601331127,0.9116355879765712,0.5853658536585366,0.9713561251550796,1.0,6/24,17.24%,NAV3;APC2;STMN2;HDGFL3;CLASP2;CAMSAP3
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.26264654403002907,-0.9115749495554581,0.6256590509666081,0.8033160898865429,1.0,10/43,16.92%,CD34;GAS6;LBP;NFKBIL1;DICER1;TNFAIP3;ILRUN;VSIR;IGF1;RARA
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.38008809070100325,-0.9109385213342717,0.5761821366024519,0.804347444579695,1.0,3/11,6.70%,KCNJ2;YWHAE;KCNQ1
prerank,leukotriene metabolic process (GO:0006691),-0.3195192516857767,-0.9108696621838337,0.5846702317290553,0.8041079778147963,1.0,3/19,7.48%,PLA2G4A;GGT5;MAPKAPK2
prerank,cellular response to purine-containing compound (GO:0071415),0.37353798371583596,0.9104155239569497,0.5792811839323467,0.9733867822988234,1.0,3/10,11.91%,RYR3;RYR2;SLC8A1
prerank,cardiac cell development (GO:0055006),0.36710750103792,0.91031168400674,0.5711009174311926,0.9722194098269251,1.0,4/11,11.91%,CXADR;ALPK3;VEGFA;SLC8A1
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.29186364922123337,-0.910248989495008,0.5860869565217391,0.8050875560714796,1.0,11/31,26.72%,DAB2IP;PTPN1;ERN1;TM7SF3;ATXN3;HDAC6;DNAJB12;HSPA14;HSPA13;HSPA1B;RHBDD1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.2909480339010294,0.9102424676830456,0.6134831460674157,0.9709596053212529,1.0,3/24,6.48%,TMEM161A;BCL2;TRIAP1
prerank,RNA biosynthetic process (GO:0032774),0.27824064610828303,0.9101584197600928,0.58719646799117,0.9697431666538497,1.0,5/31,10.43%,TBPL1;SMARCA5;TAF5;POLA1;PRMT5
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.30092389023071087,-0.9100575122209335,0.59245960502693,0.8050996554420815,1.0,12/23,32.44%,UBE2K;APP;IRGM;MAPK1;RPTOR;BMP7;CAB39;TRIM6;STOX1;TGFB1;CEMIP;PLK1
prerank,intestinal lipid absorption (GO:0098856),-0.3775634294749824,-0.9093301135945592,0.5784671532846716,0.8063557608859705,1.0,1/11,0.85%,LIMA1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.33348394600588815,-0.9092628901398175,0.5746924428822495,0.8061157751244086,1.0,11/17,41.00%,DYRK1A;YJU2;MIF;MDM2;SNAI2;RNF34;ARMC10;CD74;SIRT1;PTTG1IP;CD44
prerank,SNARE complex assembly (GO:0035493),-0.3895601920027949,-0.9091719096423654,0.5716814159292035,0.80591875119751,1.0,5/10,34.06%,STXBP6;VAMP3;VAMP2;VAMP8;VAMP4
prerank,fatty acid elongation (GO:0030497),0.3469163265845321,0.909017168418748,0.5903083700440529,0.9715662806212334,1.0,5/13,19.34%,HACD1;ELOVL4;TECR;HACD2;HACD3
prerank,response to organonitrogen compound (GO:0010243),0.27248858642049995,0.9089840309781915,0.5762331838565022,0.9702281432773313,1.0,3/38,4.32%,GLRA3;GLRA1;INAVA
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.271027046954119,0.90877949733285,0.6089887640449438,0.969361858228082,1.0,11/38,20.27%,SMARCA5;CENPS;MIS18BP1;OIP5;RUVBL1;HIRA;CENPK;CENPW;RBBP7;ITGB3BP;CENPA
prerank,diol metabolic process (GO:0034311),0.3146902816269111,0.9078622743266206,0.5973451327433629,0.9705064604635316,1.0,6/19,11.23%,PLPP2;SPHK1;SGPP1;PRKG2;SPHK2;NAAA
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.35151061069509815,0.9075858627607898,0.5723404255319149,0.9699149400573752,1.0,2/12,6.82%,FADS1;FADS2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.2968861735006425,-0.9074891713288671,0.6169844020797227,0.8093253624285216,1.0,11/26,23.71%,CLIP1;RAC1;TOGARAM1;OCLN;DCTN1;SLAIN2;DRG1;RPS3;TRPV4;AKAP9;ARL2
prerank,positive regulation of proteolysis (GO:0045862),-0.25448346571106834,-0.9071954080119567,0.6336805555555556,0.8095820219187161,1.0,12/55,21.11%,CTSC;ADAM9;TNFRSF1B;SNX9;ASPH;CASP8;PERP;FBXW11;MAPK12;CTSH;FGFR4;OGT
prerank,regulation of neurotransmitter transport (GO:0051588),0.33426505262268347,0.9071636416494119,0.597051597051597,0.9697162500549401,1.0,3/16,10.68%,RIMS1;SYN1;MCTP2
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.2692623267647893,-0.9068285492207601,0.5959780621572212,0.8100009188343658,1.0,9/39,13.47%,MYO1D;TRAK1;FNBP1L;RAB1A;WASL;MYO1F;ACTN4;PAFAH1B1;FBXW11
prerank,regulation of adenylate cyclase activity (GO:0045761),0.29958718985213234,0.9066409554160089,0.6319148936170212,0.9698005085742788,1.0,3/22,6.43%,GNAI2;GABBR2;CACNA1D
prerank,nucleus organization (GO:0006997),-0.2607091767443704,-0.906544756404722,0.6159420289855072,0.8102632630570454,1.0,16/47,31.36%,SYNE1;NUP98;REEP3;CHMP4B;CHMP4A;CHMP2B;TPR;SUN1;CHMP5;PDCD6IP;ATXN7;DMPK;CHMP3;CHMP6;CHMP1A;NUP35
prerank,maturation of SSU-rRNA (GO:0030490),-0.27676547599229967,-0.9065279340714579,0.6132596685082873,0.8099029776196337,1.0,15/34,42.30%,RPS14;NOL10;UTP3;RPS16;DCAF13;UTP4;RPS8;WDR46;RIOK3;SRFBP1;RRP36;DHX37;TSR2;RPS28;NAT10
prerank,arachidonic acid metabolic process (GO:0019369),-0.27948425883608313,-0.9063650929439698,0.5992779783393501,0.8098957382657649,1.0,12/35,26.43%,PLA2G4A;PTGS1;EPHX1;MGLL;PTGES3;GPX1;HPGDS;DAGLB;PNPLA8;CYP1B1;PTGIS;GPX4
prerank,modified amino acid transport (GO:0072337),-0.34072490277881773,-0.9063353772915423,0.6053571428571428,0.809561660114682,1.0,3/15,5.23%,SLC16A12;SLC25A32;SLC5A6
prerank,polarized epithelial cell differentiation (GO:0030859),-0.359738883340438,-0.9058025903898723,0.5992647058823529,0.8103731861528981,1.0,4/13,18.14%,MSN;EZR;RHOA;RAP2A
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.3174067665379306,-0.9054151539254571,0.5871559633027523,0.8108448791714876,1.0,3/19,5.88%,PARD3B;PARD3;DLG1
prerank,positive regulation of cellular protein localization (GO:1903829),-0.24354445738254069,-0.9052595291533767,0.6466431095406361,0.8107777954336762,1.0,17/69,17.81%,FERMT2;GSK3B;LIMK2;DTX3L;TFRC;RIC3;STX3;CEP250;YAP1;AKT1;CROCC;PRKAA1;GPR137B;TRAPPC12;ABCA7;FYN;CDK5RAP3
prerank,mitotic cytokinesis (GO:0000281),-0.26085219655722974,-0.9050543697638278,0.6309090909090909,0.8108463833831758,1.0,13/47,15.74%,SPTBN1;STAMBP;SNX9;ROCK1;CHMP4B;CUL7;KIF23;RASA1;SON;RTKN;RHOC;ROCK2;MITD1
prerank,bicarbonate transport (GO:0015701),-0.29792644001274055,-0.9050499849343866,0.5845864661654135,0.8104570687505076,1.0,4/25,7.50%,SLC26A7;SLC4A10;CA4;SLC39A8
prerank,positive regulation of cation channel activity (GO:2001259),0.2631479774082277,0.9049878938573287,0.6337719298245614,0.9729200969083522,1.0,7/40,12.95%,ANK3;STAC2;AKAP6;CALM2;STAC;CASQ1;CCL2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.3568954130822212,-0.9046913353415038,0.5938628158844765,0.8108435145550379,1.0,7/14,36.68%,NT5E;NT5C1A;NT5C;UPB1;UPP1;CAD;DPYS
prerank,protein import into peroxisome matrix (GO:0016558),-0.3626051294961398,-0.9045462321627022,0.5941278065630398,0.8107584673187134,1.0,3/12,15.77%,PEX1;PEX7;PEX14
prerank,fat cell differentiation (GO:0045444),-0.24870063077807805,-0.9043902594078651,0.6319444444444444,0.8107177851791648,1.0,24/57,35.18%,FOXO1;KLF4;PRDM16;TMEM120A;ZBTB7A;MED1;CTBP2;SMAD6;C1QTNF3;SENP2;ERAP1;TCF7L2;PPARG;CEBPA;ATF5;WNT5B;SDF4;STEAP4;PID1;TRIM32;ALOXE3;IL11;NR4A2;ADIG
prerank,mesenchymal cell development (GO:0014031),0.31931044243171514,0.9042640698397183,0.6060606060606061,0.9735444058494852,1.0,3/18,11.59%,NRG1;NOLC1;CDH2
prerank,lipid droplet organization (GO:0034389),0.3048974919842485,0.9041179283499029,0.5748898678414097,0.9725467875642074,1.0,6/22,17.75%,BSCL2;SQLE;PPID;PPIA;AUP1;CDS1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.30599799647915177,-0.9040383796289875,0.6050269299820467,0.8111209898761171,1.0,8/22,26.50%,CDKN1B;LATS2;TFAP4;PTEN;NR2F2;MYOCD;CEBPA;APC
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.3687941756877118,-0.9039588188037602,0.5864661654135338,0.8108882628568844,1.0,2/12,5.85%,PPARA;IRS1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.2199529412338954,0.903769996517638,0.6606741573033708,0.9721011522314469,1.0,15/107,12.58%,SLC24A4;SLC24A2;HTR2C;STC1;ATP2B4;ATP2B2;ATP1B1;SLC8A2;RYR2;TMCO1;CCL13;ATP13A2;SLC8A3;SLC8A1;CCL5
prerank,regulation of ATP metabolic process (GO:1903578),-0.25398798288492747,-0.903490852300612,0.6653992395437263,0.8115438341399511,1.0,24/54,39.22%,NUP42;RAE1;RANBP2;ZBTB7A;NUP98;SEC13;NUP153;TPR;NUP214;UQCC2;OGT;NUP188;BEND3;NUP88;SLC25A33;NUP35;NUP43;HIF1A;ATP5IF1;PGAM1;JMJD8;PRKAG2;COX7A1;NUP50
prerank,T cell receptor signaling pathway (GO:0050852),-0.2155964023038628,-0.9034890916397439,0.7061769616026711,0.8111517767641875,1.0,43/138,25.35%,PSMA2;PAK2;PLCG1;PRKD2;PTPRJ;NFKB1;NCK1;PIK3R1;SPPL3;PSME2;PSMB4;PLCG2;THEMIS;BCAR1;PIK3CD;EIF2B2;CSK;FBXW11;PIK3CB;ICOSLG;PSMC2;RC3H1;PSMB2;PSMB1;TAB2;FYN;PSMA8;IKBKG;IKBKB;PSME1;PTPRC;PSMD4;INPP5D;PSMA7;RELA;FYB2;CD276;PSMD5;CD247;STOML2;MAP3K7;KHDRBS1;PIK3CA
prerank,selective autophagy (GO:0061912),-0.2501575998232258,-0.9033220629101885,0.6428571428571429,0.8111141125708742,1.0,16/56,26.92%,ATM;RAB7A;MAP1LC3B;AMBRA1;WDFY3;UFM1;ULK2;ATG5;LGALS8;HDAC6;KLHL3;PCNT;BECN1;ATG2A;ATG2B;DYNLL1
prerank,multivesicular body organization (GO:0036257),-0.28413763601899694,-0.9028337587145502,0.6206896551724138,0.8117909990776904,1.0,14/31,30.85%,RAB27A;CHMP4B;CHMP4A;VTA1;CHMP2B;VPS36;CHMP5;RAB11A;PDCD6IP;STAM2;CHMP3;VPS37B;CHMP6;CHMP1A
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.3273715165187187,-0.9025729605468763,0.6017241379310345,0.8119730893060007,1.0,7/17,30.81%,BMP4;RGCC;VSIR;F2R;LARP6;RUNX1;TGFB1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.35847155953998844,0.902487788521513,0.5816993464052288,0.9742376738506493,1.0,5/12,24.80%,CDA;UCK2;UCK1;TK1;TK2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.25143356997702443,-0.9019414696291919,0.6433691756272402,0.813040904044615,1.0,18/55,26.87%,FBXL7;PSMA2;RBX1;PSME2;PSMB4;PSMC2;PSMB2;PSMB1;PSMA8;PSME1;PSMD4;PSMA7;FHL1;PSMD5;ATF5;PINX1;PSMB10;PSMA3
prerank,phagosome-lysosome fusion (GO:0090385),0.3765252257434058,0.9011303499695981,0.5494505494505495,0.9766555191547097,1.0,4/10,15.84%,CLN3;RAB34;RAB39A;RAB20
prerank,response to retinoic acid (GO:0032526),-0.2471948888605966,-0.9008259651471663,0.6422182468694096,0.8151527297770631,1.0,9/59,6.79%,LYN;ACER2;ASXL1;RXRA;ATM;TBX1;FZD4;RARG;RBP4
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.33771940366231845,-0.9008127949552783,0.5897435897435898,0.8147842645570321,1.0,8/16,33.13%,DMAC2L;ATP5F1E;ATP5F1C;ATP5MF;ATP5PO;STOML2;ATP5F1D;ATP5MC2
prerank,anterior/posterior pattern specification (GO:0009952),-0.2510173189533166,-0.9008065605881138,0.6530612244897959,0.8144025111340382,1.0,12/53,18.39%,LRP5;BMPR2;TBX1;HES1;HOXB6;SMAD2;PCSK5;HOXC6;SKI;HEY1;HEY2;HOXB9
prerank,regulation of pH (GO:0006885),0.3605267816421905,0.9007459647727207,0.6,0.9762883106689413,1.0,1/11,3.49%,SLC9A7
prerank,cellular response to unfolded protein (GO:0034620),-0.2986078664895584,-0.900618970419221,0.6232638888888888,0.8144501966879782,1.0,5/26,12.34%,DAB2IP;PTPN1;ERN1;ABCB10;TM7SF3
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.315825685304284,0.9005795551155529,0.6086956521739131,0.9753071765867246,1.0,3/17,8.20%,SCN1B;CACNA2D1;SCN5A
prerank,neurotrophin signaling pathway (GO:0038179),-0.3112287385539789,-0.9003387631368269,0.6159420289855072,0.8146540094744447,1.0,7/21,14.62%,RAPGEF2;DDIT4;RAP1A;NGF;BCAR1;RAPGEF1;GRB2
prerank,chromosome organization (GO:0051276),-0.22585145390298328,-0.9001437307430341,0.6792452830188679,0.814720728642361,1.0,36/99,30.82%,RAE1;HDAC1;RBX1;ABL1;ZBTB7A;SUV39H1;LDB1;EHMT1;DOT1L;AXIN2;HMG20A;HMGN3;XPC;H3-3A;TCF7L1;RFWD3;HDAC10;CETN2;HMGN2;TCF7L2;LIG4;COPS7A;PWWP3A;CENPH;COPS8;SUPT4H1;SETD7;MSH3;COPS4;HDAC5;CDCA8;PHF19;CDAN1;BRWD1;COPS5;BAHD1
prerank,lymphocyte mediated immunity (GO:0002449),-0.3654888989631764,-0.9000902026762626,0.5931899641577061,0.8144443828052663,1.0,7/12,45.63%,CD55;JAG1;GNL1;MYO1G;BTN3A3;KLRD1;SLA2
prerank,regulation of interleukin-13 production (GO:0032656),-0.35648229593876496,-0.9000012908020597,0.6003552397868561,0.8142518481837626,1.0,1/13,0.16%,LEF1
prerank,ceramide transport (GO:0035627),-0.36024519013928147,-0.8999041810270797,0.599640933572711,0.81407063433276,1.0,2/12,1.27%,CERT1;PLTP
prerank,actin filament depolymerization (GO:0030042),-0.3653527319421145,-0.8998092261009959,0.6090909090909091,0.8138988700561497,1.0,4/11,20.38%,MICAL2;CFL2;CFL1;DSTN
prerank,cellular response to glucagon stimulus (GO:0071377),-0.32626371662169085,-0.8997394469322268,0.602996254681648,0.8136617719446722,1.0,5/17,15.78%,PRKACB;ADCY9;ADCY4;CYSLTR2;ADCY1
prerank,regulation of primary metabolic process (GO:0080090),-0.2176916647106539,-0.8995787406527297,0.6754850088183422,0.8136262517156884,1.0,37/126,20.44%,CREBBP;RXRA;PSMA2;SP1;PPARA;MED1;NFYC;PSME2;GGPS1;PSMB4;PPARD;ACACB;HELZ2;SIN3A;AZIN1;C1QTNF2;SMARCD3;PSMC2;NR1D2;TGS1;DHCR7;ROCK2;PSMB2;ABCA7;PSMB1;TNFAIP8L3;PSMA8;CARM1;OAZ2;PSME1;NCOA6;PRKAB1;TBL1X;PPARG;NQO1;PSMD4;FGFR4
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.22190147951116154,-0.8992812420129888,0.6921708185053381,0.8138957276059808,1.0,48/117,35.11%,BSG;DLD;PANK2;SLC5A6;PPARA;GGT5;ACSF2;SLC16A1;PPARD;SCPEP1;THEM4;CPT1A;ACADSB;ABAT;SLC27A4;PDHB;LPL;IGF1;HOGA1;GBA2;MTHFD1L;PCCA;PPARG;PCCB;KYNU;GAMT;PTGR1;PNPLA8;ACOT6;ACSF3;CKMT1A;ACOT11;GLO1;SGPL1;ALKBH7;ME2;HACL1;HAGH;LDHA;VNN1;HLCS;NPC1;FASN;ADH1A;ME1;CYP4B1;ECHDC3;ALDH8A1
prerank,epithelial cell-cell adhesion (GO:0090136),-0.36767887379529907,-0.8991051670824891,0.6007326007326007,0.8138632135281104,1.0,6/11,29.01%,ITGB5;CCN3;VCL;KIFC3;THBS4;JUP
prerank,mitotic cytokinetic process (GO:1902410),-0.30929973856213844,-0.899006121204893,0.5984251968503937,0.8136876489625371,1.0,11/20,32.65%,CHMP4B;CHMP4A;RHOA;CHMP2B;MITD1;CHMP5;PDCD6IP;CHMP3;CHMP6;CHMP1A;KIF20A
prerank,nucleotide metabolic process (GO:0009117),0.298703831302529,0.8986429541686106,0.6045977011494252,0.9790734949932578,1.0,7/23,17.00%,AK7;AK5;ENPP3;NME2;RNASEH2B;GUK1;AK1
prerank,positive regulation of lymphocyte activation (GO:0051251),0.2782946311176523,0.898577375690916,0.6099773242630385,0.977844947202707,1.0,7/28,19.14%,IL12A;CCL2;XRCC6;IL23A;CD47;SIRPA;PRKCQ
prerank,regulation of DNA replication (GO:0006275),-0.25404512469218865,-0.898092561460375,0.6372007366482505,0.8152623106214653,1.0,10/49,13.51%,ACVRL1;ANKRD17;STN1;EGFR;WAPL;ORC5;PDS5A;OBI1;DNA2;CTC1
prerank,response to nitric oxide (GO:0071731),0.3440718620711519,0.8980618646964544,0.6105990783410138,0.9778361203678,1.0,2/13,8.04%,KCNC2;DPEP1
prerank,embryonic organ morphogenesis (GO:0048562),0.25987788919493016,0.8976427731263841,0.6494845360824743,0.9775121838283494,1.0,8/42,10.01%,DSCAML1;EFEMP1;HOXD3;MEGF8;RYR2;FGFR2;MFAP2;HOXA4
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.3658590067501354,-0.8975586213345241,0.5925266903914591,0.8161219623020713,1.0,3/11,13.25%,NEDD4L;PICALM;TAX1BP3
prerank,replication fork processing (GO:0031297),-0.26765828484442844,-0.8973189732007097,0.6153846153846154,0.8162362345572027,1.0,11/38,21.31%,SAMHD1;MMS22L;MRE11;ZGRF1;DNA2;FANCM;THOC1;RFWD3;WRN;ATRX;BLM
prerank,positive regulation of DNA repair (GO:0045739),-0.2610761688580075,-0.896603239009278,0.6339285714285714,0.8173974286154354,1.0,20/46,26.54%,EYA4;UIMC1;EGFR;SPIDR;BABAM2;RNF168;SLF2;ERCC8;HDAC10;CEBPG;BRCC3;RPS3;TIMELESS;BRCA1;TRIM28;FAM168A;HMGB1;DHX9;ERCC6;FGF10
prerank,cilium-dependent cell motility (GO:0060285),0.29970695727522756,0.8956558784653766,0.5942982456140351,0.9815383839377587,1.0,2/22,4.01%,TEKT1;CFAP54
prerank,positive regulation of cyclase activity (GO:0031281),-0.34691606236390593,-0.895561899416946,0.6143911439114391,0.8192631818498972,1.0,7/14,35.15%,NOS3;MAPK8;NF1;NOS1;MAPK14;NOS2;STIM1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.2705115843081422,0.8953888142180804,0.6494382022471911,0.9808723941315953,1.0,11/32,23.18%,NPSR1;AKAP6;CALM2;GPER1;CASQ1;HTT;CX3CL1;HAP1;TRPC1;PDPK1;CAPN3
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.32785133302613056,-0.8953279820723796,0.5955473098330241,0.8193653161290833,1.0,7/16,16.38%,TGFBR3;MEF2C;TBX2;EDN1;NOTCH1;FGF2;IGF1
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.2964147597406295,-0.8947666517031212,0.62,0.8201877182778329,1.0,6/23,22.31%,ITGB1;DCTN1;PAFAH1B1;FBXW11;NDEL1;MISP
prerank,protein localization to cilium (GO:0061512),-0.2784657442989399,-0.8947052765993011,0.6379928315412187,0.8199225402916293,1.0,9/32,22.73%,ZNF423;RABEP1;IFT140;EHD1;WDR35;CSNK1D;TULP1;IFT20;TULP3
prerank,glucose transmembrane transport (GO:1904659),-0.3263050594556771,-0.8946494697635595,0.6282722513089005,0.819642880974217,1.0,4/18,13.25%,SLC2A1;PPARD;RAB4B;SLC2A9
prerank,tRNA methylation (GO:0030488),0.26660280520541585,0.894347110967975,0.6363636363636364,0.9822923979294174,1.0,12/34,25.66%,GTPBP3;TRMT13;TRMT10A;PRORP;FTSJ1;NSUN6;METTL2A;METTL2B;TRMT5;THUMPD3;TRMT1L;THUMPD2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.35180690479505805,-0.8939031557979978,0.6106346483704974,0.8208487851577666,1.0,3/13,11.47%,JAK1;IL6ST;JAK2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.265694873593146,0.8929883202622382,0.6422222222222222,0.9845043194424417,1.0,10/35,17.32%,FAR1;ACLY;ACACA;HMGCLL1;ALOX12;HMGCL;SCD5;ALOX5;SCD;GGT7
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.27059036723873464,-0.8928670267462496,0.6502732240437158,0.8226939805760923,1.0,13/33,27.86%,CDKN1B;PSME2;STXBP4;PLCG2;CDC73;TCIM;PSME1;PTEN;TRIM39;INO80;CRNN;KIF14;MN1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.23604834227320776,-0.8928581267193192,0.66728280961183,0.8223189623645353,1.0,14/75,15.36%,GRK5;RGS3;RGS5;GIT2;ZDHHC3;RGS12;PLCB1;PLCE1;ROCK1;NMT1;EDN1;MGLL;SAG;ROCK2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.29834940277277633,-0.8927368728865465,0.6130742049469965,0.8221919052413241,1.0,5/25,11.33%,RIN3;RAC1;APP;PICALM;PSEN1
prerank,regulation of protein polymerization (GO:0032271),0.26424907924533214,0.8926784831132711,0.6453744493392071,0.9839480969381103,1.0,8/35,12.81%,PFN2;PFN1;PAK3;MAP2;MAPT;TPPP3;MAPRE3;TPPP
prerank,regulation of autophagosome maturation (GO:1901096),0.3410018598781598,0.8926086732052926,0.6019184652278178,0.9827443165608378,1.0,6/13,23.93%,CLN3;RUBCN;FYCO1;CLEC16A;SMCR8;UBQLN4
prerank,histone H4-K5 acetylation (GO:0043981),-0.3341775079811722,-0.8923235884332401,0.6207513416815742,0.8222834842996658,1.0,6/15,23.01%,KANSL3;PHF20;HCFC1;JADE2;OGT;WDR5
prerank,histone H4-K8 acetylation (GO:0043982),-0.3341775079811722,-0.8923235884332401,0.6207513416815742,0.8222834842996658,1.0,6/15,23.01%,KANSL3;PHF20;HCFC1;JADE2;OGT;WDR5
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.2244841043014352,-0.8921919564383735,0.6972972972972973,0.8222092584168503,1.0,40/95,37.54%,DAB2IP;ADAM9;NFKB1;TNFRSF1B;PDCD4;IRGM;LBP;MEF2C;NFKBIL1;RHOA;IRAK1;CDC73;MAPK8;TNFAIP3;CHMP5;DEFA6;NOD2;RELA;SERPINE1;CASP1;FZD5;SHPK;HMGB1;CXCL10;AXL;CACTIN;MAPK14;LILRB1;SBNO2;TICAM1;TNIP2;CD14;IL1A;CARD16;NLRP3;CXCL5;TLR2;CD274;CTR9;CXCL1
prerank,phosphatidylserine metabolic process (GO:0006658),-0.27750564687861023,-0.891696848796173,0.6576576576576577,0.822933362215949,1.0,8/32,20.96%,PLA2G4A;MBOAT1;PLSCR1;PTDSS1;PLA2G12A;SERINC1;SERINC5;LPCAT3
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.30845590577464155,-0.891093093075158,0.6194029850746269,0.8238805418557543,1.0,2/20,7.02%,IL1R1;CD55
prerank,regulation of microtubule-based process (GO:0032886),0.2646561660350327,0.8904063835723799,0.6077586206896551,0.9874198306910895,1.0,11/36,18.68%,TRIM36;BICD1;PHLDB1;PHLDB2;CYLD;MAPT;TPPP;CLASP2;CAMSAP3;MAP6;MAP6D1
prerank,error-free translesion synthesis (GO:0070987),-0.3037439097189331,-0.8903815566977751,0.6423357664233577,0.8250076985799202,1.0,7/22,24.17%,RPA3;REV1;RPA1;RPA2;RFC4;RFC1;RCHY1
prerank,acidic amino acid transport (GO:0015800),-0.3217291222617669,-0.8903806239907902,0.6265270506108203,0.8246140747587294,1.0,6/17,20.00%,SLC6A6;LRRC8D;ARL6IP5;GIPC1;PRAF2;SLC1A1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.3249729505473186,-0.8903382462563454,0.6331058020477816,0.8243111853771266,1.0,7/17,27.81%,MOSPD2;ANO6;LGMN;CXCL12;SERPINE1;HMGB1;CXCL10
prerank,negative regulation of proteolysis (GO:0045861),-0.2713680002977293,-0.8901523486057691,0.6596558317399618,0.8243069867107922,1.0,10/34,17.07%,LRRK2;DNAJC1;ROCK1;EPHA4;AKT1;SNX12;PTPN3;TIMP3;PLAT;HDAC6
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.36244484899685575,-0.890015319970924,0.6197183098591549,0.8242161816165731,1.0,6/12,36.49%,RAB1A;PTEN;FZR1;PLK1;CDC20;UBE2C
prerank,regulation of cellular protein localization (GO:1903827),-0.2567243589431869,-0.8898003026994641,0.6529516994633273,0.8243089653378336,1.0,17/45,23.85%,DVL3;PTPN1;SETD2;GPC6;SPIDR;PPM1F;PRKAA1;HFE;LCP1;VCPIP1;CTNNB1;NDEL1;KCNAB2;GPC3;HSP90AA1;RALB;RAB11FIP5
prerank,negative regulation of hemostasis (GO:1900047),0.3437295611650092,0.8896351826457836,0.6004566210045662,0.9880625044219515,1.0,1/12,0.27%,VTN
prerank,cellular response to UV (GO:0034644),0.22603751898899194,0.8894537793956963,0.6825396825396826,0.9871691292166123,1.0,14/76,14.11%,MME;TMEM161A;CERS1;RHNO1;USP28;STK11;IMPACT;TRIAP1;DDB1;TIMP1;BMF;ATR;PPID;TAF1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3496352871647731,0.8890485949954743,0.5879629629629629,0.9854140280226634,1.0,2/12,6.42%,ATP2B4;FHL2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.3496352871647731,0.8890485949954743,0.5879629629629629,0.9854140280226634,1.0,2/12,6.42%,ATP2B4;FHL2
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.2995594052894254,0.8887709836870487,0.6509009009009009,0.9847676864916983,1.0,3/20,7.35%,CHRM2;CHRM3;LY6G6D
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.34880303860894246,0.8886737738614284,0.604494382022472,0.9836411103984759,1.0,2/11,7.33%,MUC20;PAK1
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.29054164974650615,0.8875079680146564,0.6482300884955752,0.9853109823754819,1.0,6/24,11.97%,PDE3B;GNAI1;PEX5L;PDE11A;RNF157;PRKAR1B
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.32871782499203606,0.8873177445856361,0.5878378378378378,0.9844197912757563,1.0,9/15,21.98%,SCN1A;TMC1;TMC2;KIT;WHRN;MKKS;COL11A1;PDZD7;KCNK4
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.32064549856850616,-0.8870694385316839,0.6265709156193896,0.8299059055836944,1.0,2/17,5.85%,RAC1;MOSPD2
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.2808627274920955,-0.8870537386614044,0.6441605839416058,0.8295378660637757,1.0,14/31,28.11%,POLR2G;EXOSC2;EXOSC1;EXOSC3;EXOSC8;EDC3;EXOSC5;DCP1A;LSM3;DIS3L2;NT5C3B;EXOSC7;CNOT8;LSM2
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.24510136371287544,-0.8865399911187442,0.672945205479452,0.8302507373825122,1.0,14/57,19.24%,GHR;LYN;IL15;IL6ST;IL6R;HES1;PARP14;JAK2;STAP2;CD40;TNFRSF1A;IGF1;CLCF1;PPP2CA
prerank,central nervous system neuron development (GO:0021954),-0.3324661748586137,-0.8864616020866121,0.6120527306967984,0.8300264849073412,1.0,7/15,22.46%,RAPGEF2;LHX6;B4GALT5;GBA2;ARHGAP35;PTEN;HSP90AA1
prerank,protein localization to nucleus (GO:0034504),-0.2174033008771899,-0.8861142681287703,0.7162162162162162,0.830391776577607,1.0,33/102,26.65%,YWHAE;CSE1L;SIX1;ZBTB7A;TOR1B;BMP4;SEC13;AKT1;PPP1R10;LMNA;NUP153;TBRG1;TAF8;ABCA7;TPR;BMP7;SIX4;TAF3;NUP214;NXT1;IPO8;WRN;RRS1;MDM2;NUP188;MSX1;ARL2;E2F3;PINX1;NOL8;RANBP6;NUP88;RAN
prerank,positive regulation of telomere maintenance (GO:0032206),-0.2771846337640416,-0.8860889734810836,0.6453900709219859,0.8300442687534174,1.0,6/31,13.71%,NEK7;ATM;MRE11;MAPK1;PPP1R10;PNKP
prerank,megakaryocyte differentiation (GO:0030219),-0.3651369704153987,-0.8858799466159774,0.5886654478976234,0.8300981105267231,1.0,3/11,11.57%,MED1;TAL1;ZFPM1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.27775247412660986,-0.8857925767821856,0.6265709156193896,0.8299010808230033,1.0,19/30,41.00%,DYRK1A;DDX39B;ACKR3;YJU2;MIF;THOC1;RPS3;CXCL12;MDM2;SNAI2;TRIM32;CD74;FBXO5;DDIAS;SIRT1;PTTG1IP;CDKN2D;SFRP2;CD44
prerank,lysosome organization (GO:0007040),0.2596124998546481,0.8857013566433677,0.675,0.987282115276344,1.0,15/36,24.38%,CLN3;CLVS2;CLVS1;HPS1;GRN;GNPTAB;HOOK1;SNAPIN;TPP1;HOOK3;ACP2;LAMTOR1;GAA;NAGPA;VPS33A
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.34936369188893157,-0.8852663347153802,0.6210526315789474,0.8306038468938632,1.0,7/13,30.31%,GREM2;NRROS;DAND5;CHRDL1;FBN1;BMP2;LTBP1
prerank,nuclear membrane disassembly (GO:0051081),0.3244608355266462,0.8851383990523739,0.6114790286975718,0.9873842646754115,1.0,6/14,23.84%,LPIN1;VRK1;PRKCB;AKAP8L;CDK1;CTDNEP1
prerank,protein alkylation (GO:0008213),0.2929041500071243,0.8850768610561516,0.6336206896551724,0.9861546158945338,1.0,9/22,25.29%,METTL21A;EEF1AKMT2;SNRPD3;PCMT1;PRMT2;VCPKMT;PRMT8;EEF1AKMT1;FAM98B
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.28137893307978157,0.8844968909555476,0.6437768240343348,0.9863239878762433,1.0,4/25,7.41%,CTNNA3;PKP2;CXADR;RYR2
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.33861369169665984,0.8838846790377785,0.6549295774647887,0.986557814189357,1.0,3/13,15.02%,IL12A;IL12RB1;IL23A
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.30665187042344144,-0.8837797920036247,0.6382608695652174,0.8335077779033911,1.0,2/19,5.85%,RAC1;MOSPD2
prerank,acetyl-CoA metabolic process (GO:0006084),0.32041566450613634,0.8835919569864618,0.6336405529953917,0.9859417243043868,1.0,7/15,21.27%,ACLY;ACACA;ACSS1;TDO2;HMGCS1;ACAT1;MVK
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.37112150690565465,-0.8834634919617905,0.627906976744186,0.8337975922551628,1.0,3/10,21.93%,TUT7;TUT4;DIS3L2
prerank,activation of protein kinase B activity (GO:0032148),0.2797120702764332,0.8833270023724936,0.6666666666666666,0.9852407159548742,1.0,5/29,9.30%,NRG1;CCDC88A;ANG;ADRA2C;ADRA2A
prerank,neural crest cell differentiation (GO:0014033),-0.31102673226335475,-0.8827412400168037,0.6116322701688556,0.8349612062567743,1.0,4/18,7.81%,FBXL17;LRP6;MEF2C;KLHL12
prerank,protein kinase B signaling (GO:0043491),-0.30326487639106525,-0.8822789505304127,0.6355475763016158,0.8355663148264456,1.0,10/23,26.06%,KDR;GAS6;AKT1;THEM4;PIK3R3;IGF1;EPHA2;PTEN;PLK3;ZFP36L1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.30981507714714873,-0.8821237499828246,0.6123188405797102,0.8354986555947926,1.0,11/19,51.45%,TNFAIP3;IGF1;NLRP2B;CARD16;NLRP3;CD33;GIT1;GSTP1;APOA1;FFAR4;ZC3H12A
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.266455983870464,0.8816692447877723,0.6607142857142857,0.9881159615967015,1.0,10/32,23.18%,NPSR1;AKAP6;GPER1;P2RX3;CASQ1;P2RX5;CX3CL1;TRPC1;PDPK1;CAPN3
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.3696287556547573,-0.8811992949776661,0.6166365280289331,0.8367078451970102,1.0,1/10,1.54%,KLF4
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.3696287556547573,-0.8811992949776661,0.6166365280289331,0.8367078451970102,1.0,1/10,1.54%,KLF4
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.33044548319487554,-0.8811096727222099,0.6401446654611211,0.836492794209501,1.0,7/16,42.75%,PDE12;PPIF;UQCC2;SLC25A33;VCP;COX7A1;ABCD1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.29964592547440955,-0.8807351398301586,0.6441281138790036,0.83689506796156,1.0,6/23,16.91%,SMO;SIX1;BMP4;PIK3CD;FGF2;SIX4
prerank,carbohydrate transport (GO:0008643),-0.3663816324398222,-0.8804837913881082,0.6261022927689595,0.837046241406,1.0,6/11,33.08%,AQP11;SLC26A6;SLC2A2;SLC23A1;SLC23A2;AQP1
prerank,piRNA metabolic process (GO:0034587),0.2991898511587014,0.8799657074083075,0.645021645021645,0.9910641670865782,1.0,19/19,70.12%,TDRKH;PIWIL2;EXD1;TEX15;PLD6;PIWIL1;TDRD1;BTBD18;GPAT2;ASZ1;HENMT1;MOV10L1;MAEL;FKBP6;PIWIL4;TDRD12;MYBL1;DDX4;TDRD9
prerank,protein maturation (GO:0051604),0.21690461416007964,0.8794129837370966,0.7435294117647059,0.9911199886693542,1.0,22/95,15.48%,MME;MMP16;DNAJB11;TSPAN15;CLN3;CPE;TYSND1;METAP2;SORL1;BACE1;ADAM19;TESC;CPN1;PCSK2;AEBP1;TSPAN32;PCSK6;NAA40;NFU1;NDUFAB1;ECE2;EEF1AKMT4-ECE2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.3123142483756854,-0.879280427744674,0.64376130198915,0.8392455431269247,1.0,4/20,6.52%,NEDD4L;PRKCE;YWHAE;NEDD4
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.3474096015656749,-0.8792625501486896,0.6431226765799256,0.8388824259556461,1.0,5/12,25.34%,MTHFD1;AMPD2;HPRT1;PRPS2;ADA
prerank,cardiocyte differentiation (GO:0035051),-0.3753885428279889,-0.8788833076825141,0.6205673758865248,0.8392761675862672,1.0,4/10,10.26%,AKAP13;SIK1;TGFB2;KDM6B
prerank,membrane repolarization (GO:0086009),0.320382086660664,0.878532563514353,0.6166666666666667,0.9921142691460307,1.0,2/15,4.83%,ATP1A2;ATP1B1
prerank,mRNA methylation (GO:0080009),-0.33296403661371354,-0.8782578551213476,0.6265270506108203,0.8401531381098482,1.0,3/15,10.78%,CBLL1;METTL14;WTAP
prerank,regulation of extracellular matrix organization (GO:1903053),-0.32753798632208814,-0.8782131347947305,0.6232394366197183,0.8398328994129803,1.0,2/15,1.37%,RB1;TIE1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.3627202003428385,-0.8781913435745015,0.6327586206896552,0.8394816379177608,1.0,2/11,7.35%,TGFB2;MEF2C
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.3633318717987266,-0.8777195105360452,0.6216696269982238,0.8396949302555888,1.0,3/11,17.80%,PKD2;GSTM2;CASQ2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.3633318717987266,-0.8777195105360452,0.6216696269982238,0.8396949302555888,1.0,3/11,17.80%,PKD2;GSTM2;CASQ2
prerank,translesion synthesis (GO:0019985),-0.2609264394817816,-0.8774722766944273,0.645045045045045,0.839865191533741,1.0,13/42,25.94%,TRIM25;POLD3;RPA3;REV1;RPA1;USP10;MAD2L2;POLE2;RPA2;RFC4;RFC1;RCHY1;DTL
prerank,chordate embryonic development (GO:0043009),0.23824176171474445,0.8768335312460983,0.6908665105386417,0.9950664706748262,1.0,12/55,11.41%,WNT7B;COL1A1;UCMA;FLCN;PROX1;DEAF1;FGFR2;LMX1B;VEGFA;ZNF568;ALDH1A2;ARNT2
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.27187659420950827,-0.8767356248832698,0.6748251748251748,0.8410526666640317,1.0,11/35,27.42%,POLD3;OGG1;RPA3;RPA1;PNKP;RPA2;RFC4;NTHL1;RFC1;LIG1;POLL
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.34968165385232564,0.8764971707569422,0.6036446469248291,0.9945766313386866,1.0,3/11,19.14%,IL12RB1;IL23A;PRKCQ
prerank,base conversion or substitution editing (GO:0016553),0.3523921407671611,0.876207311024026,0.6137931034482759,0.9939427382399532,1.0,2/11,14.01%,ADARB2;NUDT16
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.3033342094834446,0.8761072231347561,0.6277533039647577,0.9928343947284054,1.0,3/18,11.67%,CARTPT;TMEM178A;TCTA
prerank,"base-excision repair, AP site formation (GO:0006285)",0.3128464353218371,0.8760216850242589,0.6379690949227373,0.9916714548851273,1.0,7/17,24.11%,TERF1;UNG;ACD;ERCC5;TERF2IP;NEIL2;TDG
prerank,regulation of double-strand break repair (GO:2000779),-0.264006097512269,-0.8755259934161418,0.6831501831501832,0.8432541111491366,1.0,7/39,9.15%,UBR5;SETD2;DEK;RNF169;MRNIP;SPIDR;TRIP12
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.23133520324942197,-0.875382910969788,0.7053726169844021,0.8431461207491663,1.0,22/72,26.87%,PSMA2;BIRC3;PSME2;PSMB4;AKT1;DICER1;IRAK1;FBXW11;PSMC2;PSMB2;PSMB1;PSMA8;MAP3K14;PSME1;PSMD4;PSMA7;RELA;COPS8;PSMD5;MAP3K7;PSMB10;PSMA3
prerank,import into nucleus (GO:0051170),0.22035663827857585,0.8751700750488195,0.7142857142857143,0.9925272806481518,1.0,6/73,4.18%,MMP12;SPRN;PHB2;NUP62CL;TNPO3;DDX20
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.37128663778565996,-0.8749447169611584,0.6443661971830986,0.8436410680649574,1.0,5/10,28.47%,RUVBL2;ZNHIT3;TAF9;NAF1;NUFIP1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.22512051942350286,0.8748164491950319,0.6861313868613139,0.9920604418994838,1.0,12/65,16.40%,KCND2;FMN2;SCN2A;CPEB1;VEGFA;NOP53;SLC8A3;GATA6;HIPK2;TWIST1;P4HB;ADAM8
prerank,non-motile cilium assembly (GO:1905515),-0.27830863445765464,-0.874341608711722,0.663003663003663,0.8444890372882605,1.0,9/30,18.62%,TOGARAM1;CEP250;DCTN1;CSNK1D;FUZ;RPGRIP1;TBC1D32;PCM1;TMEM17
prerank,B cell activation involved in immune response (GO:0002312),0.32824761082970805,0.874117670881314,0.6328828828828829,0.9924191756487714,1.0,5/13,17.74%,BATF;RNF8;GPR183;MSH2;FCGR2B
prerank,negative regulation of protein catabolic process (GO:0042177),-0.25881363249585615,-0.8738761052513937,0.6803571428571429,0.8450524694135627,1.0,10/40,17.81%,DAB2IP;EGFR;ROCK1;FLNA;SNX12;PTPN3;TIMP3;AZIN1;MAD2L2;CDK5RAP3
prerank,termination of RNA polymerase II transcription (GO:0006369),0.2692508175839777,0.8733353270862465,0.6533018867924528,0.9930402717216972,1.0,16/33,29.41%,MED18;CPSF1;CSTF2T;SNRPD3;CLP1;CPSF2;SCAF8;CSTF2;NCBP2;SETX;CPSF4;CSTF3;PCF11;SNRPF;TTF2;PABPN1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.35516047119667193,-0.8729162842659342,0.6403508771929824,0.8466292690457788,1.0,3/12,2.83%,PODXL;IQGAP1;PROM1
prerank,regulation of mitochondrial fusion (GO:0010635),-0.35865585853634063,-0.872694647550218,0.643859649122807,0.8467153158741727,1.0,3/11,7.28%,ZDHHC6;TFRC;BNIP3
prerank,regulation of integrin activation (GO:0033623),-0.3279109619006808,-0.8726080570613819,0.6557377049180327,0.8465065635427234,1.0,3/15,8.05%,FERMT2;RASIP1;RAP1B
prerank,negative regulation of innate immune response (GO:0045824),0.2625458245961627,0.8724395296283624,0.6601307189542484,0.9939494913505591,1.0,8/34,15.63%,TYRO3;TTLL12;GRN;SUSD4;SERPING1;OAS3;CNOT7;LYAR
prerank,global genome nucleotide-excision repair (GO:0070911),-0.28761565454332394,-0.8718376180319812,0.6451016635859519,0.8477265982473617,1.0,6/26,18.21%,RNF111;RBX1;ERCC2;XPC;ERCC3;CETN2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.23949528975644865,-0.8716827570982002,0.6919014084507042,0.8476821423205457,1.0,25/55,37.07%,RAC1;THBS1;TGFBR2;SIRT5;AATF;DHRS4;TP53;AGTR1;GRB2;BRCA1;PDGFRB;GADD45A;RIPK1;CYP1B1;ACE2;SLC25A33;MAPK14;PID1;PDK3;BST1;TFAP2A;RAC2;MT3;PARL;FOXM1
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.3076234428126363,-0.8711534502121352,0.6549165120593692,0.8483686989270639,1.0,3/18,9.23%,BPGM;SAMHD1;ADAMTS9
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.30642447239310944,0.8708681258602075,0.6456521739130435,0.996586520828967,1.0,4/17,17.63%,SULT2B1;AHI1;FOXJ1;SOX9
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.27031183710342743,-0.8706970889689885,0.6506469500924215,0.848897961882127,1.0,12/33,24.82%,STN1;MRE11;PPP6R3;RPA1;CTC1;PTGES3;TERF2;DCLRE1B;TERT;HSP90AA1;RFC1;PINX1
prerank,axon extension (GO:0048675),-0.29738117847001966,-0.8706255580753953,0.6722222222222223,0.8486546106259885,1.0,6/23,16.15%,NRP2;USP9X;SLIT2;SPG11;ULK2;SEMA5B
prerank,cilium assembly (GO:0060271),0.18348238624338173,0.8703186218452661,0.8747152619589977,0.9966186765512568,1.0,60/296,16.59%,DNAAF3;CFAP74;YWHAG;TEKT1;KIF17;RP2;BBOF1;B9D1;CFAP54;EXOC7;EXOC1;DYNC2H1;DCDC2;VANGL2;NINL;GSN;TTC8;BBS7;MAK;NPHP4;BBS4;PLA2G3;AHI1;DNAAF1;ARL3;RPGRIP1L;CFAP43;KIFAP3;DCX;KIF3A;SNX10;HAUS5;DYNC2I2;BBS5;CEP70;OCRL;DYNLRB2;IQCB1;CEP135;ARL6;BBS1;RPGR;CEP162;MKS1;FOXJ1;CEP72;CFAP70;CEP19;MAPRE1;GAS8;CFAP410;KIF3C;IFT172;ATP6V0D1;IFT22;MKKS;IFT81;TMEM138;WDR90;BBS2
prerank,response to UV-A (GO:0070141),0.33089561648021826,0.8702378930708239,0.6524663677130045,0.9954641265258205,1.0,4/14,13.12%,MME;CERS1;TIMP1;PPID
prerank,mitochondrial translation (GO:0032543),-0.21699429394028472,-0.8701359734200367,0.7378472222222222,0.8492913597026127,1.0,34/104,26.75%,DAP3;PTCD3;MRPL32;MRPL47;MRPS23;MRPS18A;MRPL2;MRPS24;MRPL46;MRPS27;MRPL12;MRPL58;MRPL24;MTRF1L;MRPL57;NDUFA7;MRPS14;IARS2;MRPS21;MRPL35;GFM2;MRPL54;MRPL34;MRPL13;MRPL9;MRPS2;NOA1;MRPS28;MRPS35;MRPL43;MRPL48;TUFM;MRPL11;MRPS31
prerank,regulation of centrosome duplication (GO:0010824),-0.2738724368441696,-0.8696877594030212,0.6647619047619048,0.8497949654264254,1.0,15/29,42.30%,PLK2;CHMP4B;CHMP2B;CHMP5;ALMS1;PDCD6IP;CEP131;CEP295;CHMP3;CHMP1A;PKHD1;CHMP1B;SPICE1;SIRT1;NAT10
prerank,positive regulation of hormone secretion (GO:0046887),-0.31821387195167783,-0.869656801128793,0.654320987654321,0.8494614231601956,1.0,4/17,15.68%,EDN1;EDN3;HFE;C1QTNF3
prerank,cAMP biosynthetic process (GO:0006171),0.35874756290920723,0.8694970551347204,0.6023529411764705,0.9959736784519493,1.0,4/10,14.39%,ADCY8;ADCY10;ADCY7;ADCY3
prerank,lung development (GO:0030324),-0.2718907968125354,-0.8693042502133139,0.6833910034602076,0.8497801605855076,1.0,9/33,14.01%,ITGA3;LOXL3;RBP4;FGF1;BMP4;FGF7;FGF2;WNT11;ZIC3
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.26658537577783903,0.8692195828248682,0.6618705035971223,0.9952868971533622,1.0,6/32,10.53%,CDK5;CDC45;TYMS;NPAT;POLA1;TFDP2
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.2872459735195411,-0.8688168991319309,0.6703296703296703,0.8503692802489291,1.0,6/25,17.30%,TNFSF10;BNIP3;TP53;BBC3;BCL2L11;PPIF
prerank,regulation of feeding behavior (GO:0060259),0.343555955240623,0.8684828402954822,0.6166666666666667,0.9957376393907077,1.0,4/11,23.47%,NR4A3;SGIP1;CFAP20;AGRP
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.2869934934698916,-0.8682603481321218,0.6439114391143912,0.8511396080095075,1.0,9/25,27.29%,SPTBN1;PRKD2;PLCG2;ANXA1;RPS3;PTPRC;STOML2;MAP3K7;PNP
prerank,ERBB2 signaling pathway (GO:0038128),0.2620603151431511,0.8677334914210747,0.643956043956044,0.9962420978362045,1.0,2/31,0.56%,NRG1;ERBB4
prerank,negative regulation of catabolic process (GO:0009895),0.24097644205203506,0.8677057012853729,0.6835748792270532,0.9949569260760306,1.0,10/47,15.71%,PDE3B;FMN2;BSCL2;CYP51A1;SF3B3;ADRA2A;AZIN2;CST3;APOC1;ZDHHC7
prerank,modulation by host of viral genome replication (GO:0044827),-0.34302193117161994,-0.8671698004517973,0.6452762923351159,0.8530248769005611,1.0,7/13,41.09%,TBC1D20;VAPA;CCNK;EIF2AK4;IFI27;FBXL2;CCL8
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.3494747798636058,0.8668094944980888,0.6491596638655462,0.9957977479831664,1.0,3/12,7.41%,CTNNA3;PKP2;RYR2
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.31047970716290363,-0.8666927869993322,0.661319073083779,0.8535872407448625,1.0,6/18,15.36%,SP1;EPHA4;GSK3A;PICALM;SLC2A13;ROCK2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.369904553885311,-0.8666730462720114,0.655536028119508,0.853229651943387,1.0,3/10,12.66%,PRKG1;PRKCD;CEACAM1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.34613290473972597,-0.866647207857055,0.6325823223570191,0.8528783456922627,1.0,3/12,19.75%,PLK2;NABP1;BUB1B
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.3187982288840271,-0.8657278759404202,0.643859649122807,0.8543365588999019,1.0,5/17,16.18%,KDR;SLIT2;AKT1;FGF2;PIK3R3
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.24226559245893506,0.8657220596222786,0.7071428571428572,0.997134897408205,1.0,10/48,14.39%,ADCY8;ADCY10;AK5;NPPC;SLC35B2;ADCY7;ADSS2;ADSS1;ACOT7;ADCY3
prerank,regulation of protein kinase C signaling (GO:0090036),0.32222826717804637,0.8652876217080374,0.6546762589928058,0.996844261509444,1.0,4/14,10.78%,GPD1L;VEGFA;SPHK2;ADRA1A
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.29993296473589415,-0.8652084350353416,0.6368613138686131,0.8549911531901077,1.0,9/20,27.89%,SMAD1;SMAD4;NOTCH1;ATF4;SMAD9;NFE2L2;RELA;BMP2;CARF
prerank,peroxisomal membrane transport (GO:0015919),-0.28278046055783224,-0.8651009456025835,0.6799276672694394,0.8548206825805631,1.0,9/27,30.08%,PEX1;ABCD3;PEX7;RAB8B;PEX14;PEX3;PEX6;PEX11B;PEX19
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.24102600778542704,0.8650105439182859,0.6858407079646017,0.9961803664742073,1.0,11/48,19.68%,NPSR1;AKAP6;CALM2;GPER1;SRI;HRC;CASQ1;SELENON;PDE4D;CX3CL1;TRPC1
prerank,response to zinc ion (GO:0010043),-0.28311318201964153,-0.8648294880122313,0.6759259259259259,0.8549668183047676,1.0,11/25,25.53%,PAM;SLC30A5;HVCN1;MT1A;MT1H;MT1M;MT1E;MT1G;MT1X;MT1B;MT1F
prerank,neuron maturation (GO:0042551),0.30056200905612673,0.8647415240633398,0.6545842217484008,0.9955173724055418,1.0,8/18,20.83%,ADGRB3;SRRM4;ACTL6B;B4GALT6;LGI4;C3;CX3CL1;MTCH1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.2956463903377263,-0.8646545976882165,0.6690909090909091,0.8549246995348845,1.0,9/22,26.87%,PSMA2;PSMB4;PSMB2;PSMB1;PSMA8;PSMA7;NFE2L2;PSMB10;PSMA3
prerank,negative regulation of wound healing (GO:0061045),-0.2822995548721391,-0.8645967030045083,0.6526315789473685,0.8546506960150875,1.0,9/28,22.81%,CD34;CRK;SLC12A2;EDN1;FGF2;TFPI;PTEN;SERPINE2;SERPINE1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.2200956302432635,-0.8637005482541793,0.75,0.8561401719793823,1.0,24/82,24.26%,YWHAE;CEP57;CEP250;CEP78;HAUS8;TP53;DCTN1;DCTN3;CSNK1D;PAFAH1B1;HAUS6;CEP41;ALMS1;PLK4;PCM1;CETN2;CNTRL;CEP152;ODF2;HSP90AA1;PCNT;CEP131;AKAP9;ATF5
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.30402625206240863,0.8636259466026194,0.6352941176470588,0.9969495544715777,1.0,2/17,3.34%,GET1;CAMLG
prerank,negative regulation of viral transcription (GO:0032897),-0.3421745348635762,-0.8629544415525743,0.685823754789272,0.8572051415345163,1.0,7/13,31.53%,UBP1;TRIM14;IFITM3;TRIM13;LARP7;TRIM32;TRIM62
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.3179693950354163,-0.8624258071790957,0.6381461675579323,0.8579178692103642,1.0,8/16,46.17%,CEBPG;VAMP2;ARL8B;CORO1A;RAET1E;TUBB4B;SLAMF7;KLRK1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.34425343755937454,-0.862215230143812,0.6553571428571429,0.8579431532488047,1.0,3/12,21.21%,ESR1;PPARG;TERT
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.32379376561495476,0.861695624104373,0.6481069042316259,1.0,1.0,4/14,15.61%,ATP2B4;PKIB;PRKAR1B;HTT
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.3021333200080122,-0.8604248498835123,0.6764705882352942,0.8612113497132691,1.0,5/19,22.34%,DLD;OGDH;PHYKPL;ALDH7A1;AASS
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.3339707732585301,-0.8597634407505325,0.6466302367941712,0.8621655109872645,1.0,7/14,29.13%,PTPN11;ADAMTS7;RFLNB;SNAI2;RFLNA;TGFBR1;WNT9A
prerank,negative regulation of establishment of protein localization (GO:1904950),0.35198318186443395,0.8597341352932854,0.6484560570071259,1.0,1.0,3/10,8.60%,TERF1;MAPT;CORO2B
prerank,regulation of cholesterol efflux (GO:0010874),-0.26954944622646104,-0.8593245585844456,0.6823734729493892,0.8627001970230963,1.0,8/30,20.11%,PLTP;CAV1;RXRA;NFKBIA;NAXE;ABCA7;EEPD1;PPARG
prerank,regulation of stem cell proliferation (GO:0072091),-0.308685341049979,-0.8591452368466547,0.6403508771929824,0.8626824371565684,1.0,6/17,27.56%,ACE;YAP1;PTPRC;TERT;ZFP36L1;HNRNPU
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.3316853957526319,-0.8589848605724296,0.6672727272727272,0.8626032632996543,1.0,3/15,7.18%,SMO;SIX1;BMP4
prerank,glycogen biosynthetic process (GO:0005978),-0.3456917163328347,-0.8586397655259252,0.6408450704225352,0.8624970673400045,1.0,4/12,20.66%,GBE1;PPP1R3C;GYS1;GYG1
prerank,glucan biosynthetic process (GO:0009250),-0.3456917163328347,-0.8586397655259252,0.6408450704225352,0.8624970673400045,1.0,4/12,20.66%,GBE1;PPP1R3C;GYS1;GYG1
prerank,mitochondrial fusion (GO:0008053),-0.3106751468933328,-0.8584167740995212,0.6815742397137746,0.8625437289027645,1.0,4/18,12.94%,MIEF1;CHCHD3;AFG3L2;MIEF2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.3550087873462213,0.8577574666682196,0.6460554371002132,1.0,1.0,10/10,64.52%,CBARP;CALM1;CALM3;GNB5;DRD4;FMR1;DRD2;GPR35;CRHR1;DRD3
prerank,positive regulation of leukocyte activation (GO:0002696),-0.3013974019198597,-0.8574105981676561,0.6635687732342007,0.8641721979690354,1.0,2/18,6.78%,THBS1;LBP
prerank,synaptic vesicle transport (GO:0048489),-0.34884481493936825,-0.8572599653842679,0.6575091575091575,0.8640907495170275,1.0,4/11,13.33%,DNM2;RAB27A;TMEM230;SPG11
prerank,base-excision repair (GO:0006284),-0.24544557838712822,-0.8571445197479246,0.7130281690140845,0.8639245551629289,1.0,15/48,27.42%,POLD3;OGG1;RPA3;DNA2;RPA1;PNKP;WRN;RPA2;HUWE1;RFC4;NTHL1;RFC1;LIG1;ERCC6;POLL
prerank,cytoplasmic translational initiation (GO:0002183),-0.3142686063308141,-0.8570771726739504,0.6611418047882136,0.863667844911417,1.0,5/17,31.01%,EIF4H;EIF3A;EIF3I;EIF4A2;DHX29
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.351667080041408,0.8569836762145675,0.6255411255411255,1.0,1.0,1/10,0.27%,VTN
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.31501328899444175,-0.8562234056490661,0.6733212341197822,0.8649808803676052,1.0,4/18,12.61%,SPTBN1;LDLRAP1;STX8;ACTB
prerank,"wound healing, spreading of cells (GO:0044319)",-0.2826921364463197,-0.8562087399353719,0.6769825918762089,0.8646109808888188,1.0,7/24,13.34%,ACVRL1;COL5A1;FLNA;RHOA;CEACAM1;LCP1;RHOC
prerank,regulation of DNA recombination (GO:0000018),-0.2645261006951963,-0.8560433185917324,0.7012302284710018,0.8645448045131031,1.0,10/32,24.01%,SETD2;SPIDR;MRE11;KPNA1;THOC1;RPA2;SMARCAD1;BLM;CHEK1;MSH3
prerank,RNA catabolic process (GO:0006401),-0.24439840114935238,-0.8558078557925205,0.7298311444652908,0.8646085657908196,1.0,14/46,28.11%,ERN1;RNASE3;XRN2;DNA2;ZPR1;NUDT12;RNASEH2C;DIS3L2;METTL16;HSPA1B;EXOSC7;HNRNPD;DXO;LSM2
prerank,linoleic acid metabolic process (GO:0043651),0.30577901095498117,0.8555541758882442,0.6434977578475336,1.0,1.0,4/17,15.88%,FADS1;FADS2;ALOX12;ALOX5
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.335053018126083,0.8553411167698973,0.6792035398230089,1.0,1.0,2/12,5.75%,MELTF;RCC2
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.335053018126083,0.8553411167698973,0.6792035398230089,1.0,1.0,2/12,5.75%,MELTF;RCC2
prerank,histone H3 deacetylation (GO:0070932),-0.32420137192311893,-0.8546766339320776,0.6546762589928058,0.8664844133735268,1.0,5/15,19.54%,HDAC1;HDAC4;SFPQ;ELK4;SMARCAD1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.3333582976345561,0.8545787780070432,0.6140350877192983,1.0,1.0,5/12,20.98%,ACSL3;APOC1;P4HB;SOAT2;SOAT1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.27964672672768043,-0.8542390781180595,0.7013232514177694,0.8669758286859831,1.0,13/25,38.62%,CHMP4B;CHMP4A;VTA1;CHMP2B;CHMP5;TMEM50B;CHMP3;CHMP6;CHMP1A;LEPROTL1;VCP;CHMP1B;RILP
prerank,DNA replication checkpoint signaling (GO:0000076),0.3004683144107682,0.8542314304442803,0.6484018264840182,1.0,1.0,4/16,15.81%,CDC45;NAE1;RAD9B;ORC1
prerank,regulation of p38MAPK cascade (GO:1900744),0.26007945399590143,0.8539127646915841,0.7191780821917808,1.0,1.0,8/35,12.19%,RELL2;GADD45B;SPHK1;CYLD;VEGFA;MINK1;PHLPP1;RASGRP1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.3087799583763231,-0.8537622291552561,0.697841726618705,0.8675090448250468,1.0,11/18,45.95%,TCP1;PARN;RUVBL2;CCT5;CCT2;NAF1;CCT3;DCP2;CCT7;DKC1;CCT6A
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.30836564691797597,-0.8534663867462492,0.7055555555555556,0.8676733890224462,1.0,7/17,35.88%,PLA2G4A;PLA2G12A;LCLAT1;PLA2G4F;PLA2G5;LPGAT1;PLBD1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.3605857139167381,-0.8533791213606351,0.6720720720720721,0.8674453320181219,1.0,1/10,0.53%,RAPGEF2
prerank,calcium-mediated signaling (GO:0019722),-0.21537706348837457,-0.8533133651053023,0.7569573283858998,0.8671817359113827,1.0,16/93,11.79%,LRRK2;KDR;PLCG1;PTPRJ;EGFR;TRPM4;IRGM;STIMATE;PLCE1;CCR9;PLCG2;EDN1;PRKAA1;BCAP31;PTGFR;AGTR1
prerank,estrogen metabolic process (GO:0008210),0.3117780993512479,0.853192271472468,0.6814988290398126,1.0,1.0,5/15,24.55%,HSD17B7;HSD17B14;CYP1A1;HSD17B8;HSD17B2
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.22564017957561483,-0.8530707203673938,0.736283185840708,0.8672757098993616,1.0,12/72,11.88%,SHANK3;LIMA1;KANK3;DYRK1A;SLIT2;PRKCD;CDH5;KANK4;ARHGEF2;SMAD4;VBP1;ARFGEF1
prerank,intracellular lipid transport (GO:0032365),-0.29079367014214585,-0.852916034791483,0.6478102189781022,0.8671957000324604,1.0,4/21,10.86%,CERT1;ABCD3;ACACB;CPT1A
prerank,aerobic respiration (GO:0009060),0.28754173238578906,0.8525222022402423,0.6910377358490566,1.0,1.0,9/20,26.13%,UQCR10;UQCRH;NDUFS8;NDUFS7;MDH2;UQCRB;ME3;OXA1L;MTFR1L
prerank,negative regulation of insulin secretion (GO:0046676),-0.318636166163517,-0.8522959079499859,0.6788321167883211,0.868036937323679,1.0,2/17,5.85%,KLF7;IRS1
prerank,regulation of ruffle assembly (GO:1900027),0.2818626759770758,0.852237657281522,0.6763392857142857,1.0,1.0,3/23,5.58%,NLGN1;PFN2;PFN1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.24690966977381773,0.8521918415369701,0.7188940092165899,1.0,1.0,7/39,15.32%,BLK;GCK;TRH;GPER1;NLGN2;GLUD1;MCU
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.36163635913786296,-0.851930825022984,0.6459412780656304,0.8683637933626038,1.0,6/10,41.65%,EMC9;EMC2;EMC6;EMC3;MMGT1;EMC8
prerank,organelle fusion (GO:0048284),-0.292997572264432,-0.8515869064643734,0.6861313868613139,0.8686558513418277,1.0,4/22,12.94%,MIEF1;CHCHD3;AFG3L2;MIEF2
prerank,regulation of Golgi organization (GO:1903358),-0.30697367007767606,-0.8515096032647506,0.6608391608391608,0.8684046988603865,1.0,4/17,8.04%,STX18;ARMH3;USP6NL;MAPK1
prerank,aminoglycan catabolic process (GO:0006026),0.2677712238143878,0.851318075031613,0.680089485458613,1.0,1.0,3/28,6.31%,GPC5;HPSE2;GPC1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.2285449733503382,-0.8513151960529407,0.7314487632508834,0.8684055537809022,1.0,20/67,23.69%,PSMA2;ITGB5;PSME2;TAP2;PSMB4;PDIA3;NCF2;PSMC2;PSMB2;PSMB1;PSMA8;IKBKG;VAMP3;IKBKB;PSME1;PSMD4;PSMA7;SEC22B;FCGR1A;PSMD5
prerank,regulation of myelination (GO:0031641),0.26545094322607937,0.8512851396463741,0.711864406779661,1.0,1.0,3/25,5.85%,TENM4;MYRF;PTPRZ1
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3141523061970851,-0.8512770328964532,0.657608695652174,0.868083510795478,1.0,9/17,24.99%,HES1;TNFRSF1B;IL34;DICER1;NOTCH1;CLCF1;SERPINE2;PTN;BMP2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3029883109261301,-0.8510499255257425,0.6678899082568808,0.8681002703544066,1.0,9/18,37.74%,RNF139;MAN1B1;TRIM13;UGGT1;EDEM2;RNF103;RNF185;OS9;RNF5
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.32281660421235736,-0.8509281983962,0.6764705882352942,0.8679414215837454,1.0,4/15,33.41%,SMOX;SRM;DDC;AANAT
prerank,regulation of cholesterol esterification (GO:0010872),0.34487942600999477,0.8508155312656965,0.6301075268817204,1.0,1.0,5/10,22.89%,ABCA2;APOE;APOC1;LAMTOR1;ABCG1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.25946405253758176,0.8503632205617337,0.7266514806378133,1.0,1.0,6/33,9.96%,IGFBP3;TAFA5;NDRG4;ANG;IL12A;GPER1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.3305231634326826,-0.8498101692238544,0.6643478260869565,0.8697308487137398,1.0,7/14,45.35%,LRRK2;HERPUD1;TXNDC12;PARK7;CREB3L1;TMBIM6;BCL2L1
prerank,regulation of protein localization to cell surface (GO:2000008),-0.2634532980165749,-0.8497168588410302,0.7142857142857143,0.8695166124312854,1.0,9/33,19.39%,NEDD4L;RIC3;STX3;PICALM;HFE;TAX1BP3;ABCA7;CTNNB1;KCNAB2
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.26394023666325245,-0.849579895127352,0.7085610200364298,0.8693579159152005,1.0,20/31,48.63%,PLCB1;PLCG2;CD40;IL16;CCL19;MAPK11;HMGB1;LGALS9;MAPK14;IRF5;TLR2;SYK;MDK;ISL1;TLR4;SCIMP;TLR3;IL23R;AGER;IL12B
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3202443626970086,-0.8491341698490132,0.6660482374768089,0.8698369802824465,1.0,4/15,14.62%,DDIT4;NGF;BCAR1;GRB2
prerank,positive regulation of B cell activation (GO:0050871),-0.24043834995573699,-0.8484433886974685,0.7450271247739603,0.8708295397179548,1.0,12/50,19.32%,SHLD1;TFRC;CD38;KMT5B;MEF2C;PPP2R3C;CD40;MIF;MAD2L2;CLCF1;NOD2;PTPRC
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.2154382667908533,-0.8484013396180203,0.7684391080617495,0.870506984632936,1.0,25/88,26.92%,FBXL7;FBXL12;PSMA2;FBXL17;FBXL3;RBX1;PSME2;CUL2;PSMB4;FBXW11;PSMC2;PSMB2;PSMB1;PSMA8;DMAC2;PSME1;PSMD4;PSMA7;PSMD5;FBXL22;FBXO17;FBXO38;PSMB10;PSMA3;KIF14
prerank,regulation of trophoblast cell migration (GO:1901163),0.3154989824858376,0.8477070966088991,0.6879271070615034,1.0,1.0,5/14,19.14%,ACVR1B;TIMP1;VEGFA;ACVR1C;GJA1
prerank,digestive tract morphogenesis (GO:0048546),-0.3244735274658872,-0.8474385316307976,0.6432432432432432,0.871938525300159,1.0,6/14,26.96%,SOX17;NIPBL;EPHB3;FOXF1;RBPMS2;STRA6
prerank,sulfur amino acid catabolic process (GO:0000098),-0.35734287184345265,-0.8471106090181495,0.6678832116788321,0.8722155910999106,1.0,8/10,41.18%,TXN2;CTH;ADO;MTRR;MPST;BLMH;CBS;TST
prerank,regulation of macroautophagy (GO:0016241),-0.20959216184333063,-0.8466408453139419,0.7933579335793358,0.8727503536310677,1.0,24/105,19.78%,GNAI3;SESN1;LRRK2;EXOC4;KDR;MTOR;LARP1;NEDD4;BNIP3;ERN1;AKT1;PRKAA1;RPTOR;VPS26A;ATP6V1E1;MAPK8;EXOC8;TRIM13;HDAC6;ATP6V0A1;IKBKG;PRKAB1;TBC1D25;UCHL1
prerank,protein catabolic process (GO:0030163),-0.23419650760033137,-0.8464149073491399,0.7531305903398927,0.8727823201250999,1.0,27/59,38.37%,DAB2IP;MTOR;DDI2;DENND3;ADAMTS9;CEACAM1;MAGEC2;USE1;LAMP2;PSMA8;SIAH1;CLN5;HSP90AA1;RIPK1;FBXO17;MANBA;ATE1;PPT1;PMAIP1;CLPX;UBE2G2;VCP;CLN6;TRIM24;RNF5;DDI1;HSPA8
prerank,phasic smooth muscle contraction (GO:0014821),0.35000015297113907,0.8460865037474221,0.6636771300448431,1.0,1.0,4/10,22.63%,PTGER3;HTR1D;EDNRB;TIFAB
prerank,eye photoreceptor cell development (GO:0042462),0.31230254520419437,0.8460506950736867,0.67170626349892,1.0,1.0,3/15,9.25%,BBS4;RPGRIP1L;VEGFA
prerank,negative regulation of T cell activation (GO:0050868),0.2560815099285261,0.8460304122861572,0.7197452229299363,1.0,1.0,5/35,13.29%,PAG1;VTCN1;SDC4;HAVCR2;CD86
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.26213253263958924,0.845954365980614,0.7321428571428571,1.0,1.0,11/30,21.67%,ACSBG1;HACD1;ELOVL4;ACSL6;TECR;ACOT2;HACD2;ACOX2;HACD3;PEX2;ABCD4
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.28064559049648136,-0.8459164897161532,0.6988636363636364,0.8733325884496823,1.0,12/25,44.17%,PPARA;CBL;HFE;PPARG;ACE2;CHMP6;RAMP3;SNX6;CRHBP;SLC6A9;VPS25;TNF
prerank,regulation of cellular amide metabolic process (GO:0034248),0.2581556302436932,0.8456651664661315,0.7442922374429224,1.0,1.0,2/32,1.40%,GRM5;DDX25
prerank,postreplication repair (GO:0006301),-0.24744599562253927,-0.8453918276020446,0.7348754448398577,0.8739711214284415,1.0,12/45,23.23%,TRIM25;POLD3;RAD18;RPA3;REV1;RPA1;UBE2V2;USP10;RPA2;BRCA1;RFC4;RFC1
prerank,retinol metabolic process (GO:0042572),-0.33115647503216994,-0.8452992457376572,0.6875,0.8737444284145353,1.0,6/14,33.86%,RBP4;RDH10;RETSAT;CYP1B1;RDH12;ADH1A
prerank,vasodilation (GO:0042311),0.3137973019380912,0.8448914006491701,0.6487695749440716,1.0,1.0,3/13,9.96%,KCNMA1;ADRB3;GPER1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.33274744516105426,0.8444588576305556,0.6745182012847966,1.0,1.0,2/11,5.11%,DGKQ;EGR1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.19311351812414887,-0.8440928571998079,0.8745819397993311,0.8757153743963713,1.0,54/184,26.92%,PSMA2;NEK6;YWHAE;CEP57;CUL3;CEP250;CDC14A;PSME2;CEP78;PSMB4;ERCC2;HAUS8;RGCC;CDC16;DCTN1;DCTN3;ANAPC16;CSNK1D;PAFAH1B1;HAUS6;XPC;CEP41;ERCC3;PSMC2;PSMB2;PSMB1;ALMS1;TFAP4;PSMA8;PLK4;PCM1;CETN2;CNTRL;CEP152;CENPE;PSME1;BUB1B;PSMD4;BUB3;ODF2;PSMA7;HSP90AA1;PCNT;CEP131;AKAP9;FZR1;PSMD5;INO80;ANAPC7;ZFP36L1;PSMB10;PSMA3;KIF14;DYNLL1
prerank,isotype switching (GO:0045190),0.35143665427442833,0.8440850117226651,0.664367816091954,1.0,1.0,4/10,17.14%,CCR6;BATF;RNF8;MSH2
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.22573780953051567,-0.8439013158263287,0.7618213660245184,0.87569203552114,1.0,21/71,24.07%,USP9X;CTSC;FBXL17;DDI2;CASP8;CAPN2;CHMP4B;ATXN3;ZER1;TNFAIP3;CTSZ;LGMN;ZYG11B;CTSH;HDAC6;PSMA8;PDCD6IP;MDM2;CTSF;CTSO;ADAMTS7
prerank,histone ubiquitination (GO:0016574),-0.28525935826099835,-0.8437301200774122,0.6888489208633094,0.8756194929582268,1.0,6/21,20.37%,DTX3L;RNF40;UBR2;CDC73;PHC1;HUWE1
prerank,glucose metabolic process (GO:0006006),0.22402724465675072,0.8432146139116059,0.763855421686747,1.0,1.0,4/58,5.09%,OMA1;SLC25A13;DCXR;TPI1
prerank,transport along microtubule (GO:0010970),-0.33836777682292885,-0.8427523670421622,0.6604127579737336,0.877062454588415,1.0,3/13,13.33%,APP;COPG1;SPG11
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3092234633746074,0.8425587948220955,0.6873508353221957,1.0,1.0,6/15,21.87%,ATL1;RTN4;ZFYVE27;RTN3;REEP4;ARL6IP1
prerank,antibacterial humoral response (GO:0019731),0.3025496447566668,0.8423014623435974,0.6516129032258065,1.0,1.0,3/16,10.06%,RNASE6;ANG;PLA2G6
prerank,pinocytosis (GO:0006907),0.34588509000848877,0.8422663230786233,0.6697892271662763,1.0,1.0,5/10,21.21%,CARMIL1;RAB34;SNX33;SNX5;MAPKAPK3
prerank,nuclear membrane organization (GO:0071763),-0.2921821950960674,-0.8420293653061257,0.6830985915492958,0.878038338760692,1.0,4/19,11.74%,EMD;TOR1B;CHMP4B;DCTN1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.3433383007923311,0.8415762935846722,0.6510638297872341,1.0,1.0,2/11,6.22%,AKAP6;RNF207
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.22437744101620116,-0.8413938184817605,0.7791741472172352,0.8789416231972565,1.0,17/68,22.12%,GNAI3;NT5C2;LRRK2;RHOQ;ACSF2;TPST2;SULT1A1;PDE9A;THEM4;AMPD2;RAB23;HPRT1;HINT1;ACOT9;EPHA2;AMPD3;BPNT1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.30596842961459214,-0.8404659115770428,0.6763636363636364,0.8803880454462494,1.0,4/17,18.16%,BMP6;CD55;NFKBIL1;SASH1
prerank,regulation of viral entry into host cell (GO:0046596),0.26207733966825464,0.8403966642548515,0.7218543046357616,1.0,1.0,4/30,7.21%,HS3ST5;LGALS1;GSN;TRIM27
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.3446377834777327,0.8401092313757215,0.694949494949495,1.0,1.0,2/10,7.85%,PLEK;CARMIL1
prerank,negative regulation of lyase activity (GO:0051350),0.30369518630505665,0.8399348686192651,0.7193763919821826,1.0,1.0,2/16,4.62%,GNAI2;GABBR2
prerank,glycolipid biosynthetic process (GO:0009247),0.24530775170440394,0.8398774292256612,0.7450549450549451,1.0,1.0,10/38,16.86%,DPM1;ST8SIA5;ST6GALNAC5;PIGP;MPPE1;PIGB;PGAP3;ST8SIA3;B4GALT6;PIGQ
prerank,response to metal ion (GO:0010038),0.21936051030317524,0.839576321608953,0.7632743362831859,1.0,1.0,10/67,10.02%,KCNMA1;SLC34A1;SLC25A13;BCL2;PPP5C;CALM2;HOMER1;MAPT;PPP3CA;HAAO
prerank,regulation of metal ion transport (GO:0010959),0.3059121450369253,0.8395475387621951,0.6834061135371179,1.0,1.0,4/16,12.08%,CACNA2D1;BCL2;CAMK2B;SRI
prerank,response to interferon-gamma (GO:0034341),-0.2265744205881882,-0.8393730513095204,0.774822695035461,0.8820885423952238,1.0,21/67,30.71%,SP100;DAPK1;CCL25;GCH1;GBP6;IFITM3;GBP4;CD40;PDE12;SYNCRIP;GBP5;CCL19;KYNU;CASP1;RPL13A;GBP3;IFITM2;LGALS9;BST2;SLC26A6;SHFL
prerank,positive regulation of B cell proliferation (GO:0030890),0.2642339403165359,0.8392198582503,0.7045454545454546,1.0,1.0,5/29,10.26%,NFATC2;BCL2;SASH3;CD81;VAV3
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.3479363546536116,-0.8384859082019129,0.6719022687609075,0.8833653140884766,1.0,4/10,24.98%,ATRX;STOML2;E2F7;INO80
prerank,regulation of receptor recycling (GO:0001919),-0.30923985178312585,-0.8383981259245463,0.6742160278745645,0.8831342327342616,1.0,4/16,22.11%,ANXA2;ECE1;VAMP3;KIF16B
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.2721108791495384,0.838312220227476,0.7266514806378133,1.0,1.0,4/26,12.08%,ATP1A2;CALM2;ADRA2A;SRI
prerank,glycosphingolipid metabolic process (GO:0006687),-0.24432743568088378,-0.838181078527566,0.7482014388489209,0.8831220499522439,1.0,11/42,21.99%,ESYT2;A4GALT;ST6GALNAC3;ARSA;ASAH1;SMPD2;GBA2;LARGE1;GLTP;CTSA;GLA
prerank,ganglioside metabolic process (GO:0001573),0.28587370304554965,0.8381110431999907,0.6990950226244343,1.0,1.0,6/20,17.68%,B3GALT4;ST6GALNAC5;ABCA2;HEXB;ST8SIA3;ST8SIA2
prerank,TOR signaling (GO:0031929),0.26791590898467044,0.838093036000637,0.7334801762114538,1.0,1.0,6/26,11.79%,CCDC88A;FLCN;RHEBL1;RPS6KB1;CARD11;PRR5L
prerank,peptide cross-linking (GO:0018149),-0.2763127024081194,-0.8380828715387146,0.7135036496350365,0.8829235866095414,1.0,18/25,49.30%,THBS1;TGM2;ABCA7;ANXA1;CD247;EVPL;FCGR3A;KRT10;TGM7;TGM4;DSP;TGM1;SPRR1A;LORICRIN;TGM6;TGM5;NDNF;EPB42
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.344230966590112,-0.8376036091666064,0.6741573033707865,0.8834280479220061,1.0,4/12,22.06%,DIAPH1;UBASH3B;CASQ2;PTK2B
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.2787839209963891,-0.8375352263925624,0.698905109489051,0.883171426351482,1.0,7/26,27.14%,EYA4;MCL1;AKT1;TERT;MAPK7;HSPA1B;SNAI2
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.26361114920294526,0.8374342705041745,0.7262180974477959,1.0,1.0,6/29,13.86%,ACLY;OXSM;ACSL6;ACOT2;ACOT7;ACBD6
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.26361114920294526,0.8374342705041745,0.7262180974477959,1.0,1.0,6/29,13.86%,ACLY;OXSM;ACSL6;ACOT2;ACOT7;ACBD6
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.3127629669064881,-0.8372898143708806,0.6771217712177122,0.8832323970991217,1.0,6/15,20.71%,RTRAF;ERN1;TSEN15;TSEN34;TRPT1;RTCB
prerank,thyroid hormone generation (GO:0006590),-0.35958002955601465,-0.8371887247969503,0.677007299270073,0.8830290616425664,1.0,1/10,0.41%,CPQ
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.34172428182373576,-0.8363929024988885,0.6906474820143885,0.8842127444095181,1.0,8/12,52.74%,TREM2;IL18;STAP1;TNF;TAFA3;IL6;CCL3;IL1B
prerank,chromosome condensation (GO:0030261),-0.2533173925494918,-0.836241431661661,0.7324185248713551,0.884104631106552,1.0,17/36,36.26%,RB1;ACIN1;SMC4;TENT4A;KMT5A;NCAPD2;MCPH1;NCAPH;NCAPH2;SET;TTN;CHMP1A;PLK1;AIFM1;TOP2A;CSNK2A1;CSNK2A2
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.3536331704361278,-0.8359607519589275,0.7099236641221374,0.8842392359080894,1.0,8/10,51.27%,ANO6;TREM2;RAB31;APPL2;STAP1;F2RL1;NCKAP1L;CD300A
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.31913642020378524,-0.8359081865211012,0.7098540145985401,0.8839329470938118,1.0,5/15,20.74%,DDX3X;MKNK2;HNRNPA1;PPIF;GSTO2
prerank,membrane lipid catabolic process (GO:0046466),0.33855384081982187,0.8353893998399101,0.6931567328918322,1.0,1.0,3/10,15.24%,ENPP2;SMPDL3B;FUCA1
prerank,tRNA processing (GO:0008033),0.22368155589904745,0.8349389392478321,0.7636761487964989,1.0,1.0,17/61,22.05%,QTRT2;TRMT10B;CPSF1;PTCD1;TRMT6;DDX1;TRMT10A;CLP1;FTSJ1;AARS2;ANKRD16;QTRT1;TRIT1;CSTF2;NSUN6;ADAT2;THUMPD1
prerank,cellular response to alkaloid (GO:0071312),-0.30413806373425273,-0.8346293666856176,0.7069943289224953,0.8859561703354516,1.0,6/17,21.31%,SPIDR;TGM2;GSTM2;HTR1B;CASQ2;BLM
prerank,magnesium ion transport (GO:0015693),0.3205381777920746,0.8339440319245145,0.672686230248307,1.0,1.0,4/12,16.15%,TUSC3;NIPA1;NIPAL1;NIPAL2
prerank,protein heterotetramerization (GO:0051290),0.32300439358377064,0.8339249484995807,0.6804347826086956,1.0,1.0,1/13,0.90%,GRIN2B
prerank,retinoic acid metabolic process (GO:0042573),0.3088877567920463,0.833870881558321,0.7019027484143763,1.0,1.0,4/14,22.31%,CYP26B1;ALDH1A2;BCO2;CYP26C1
prerank,response to organic cyclic compound (GO:0014070),-0.23770095444500075,-0.833777561619782,0.7583187390542907,0.8871433254103231,1.0,22/52,31.88%,ESR1;LRRK2;TIPARP;STRN3;GGT5;ALPL;ARL6IP5;SOCS2;IGFBP5;ANXA1;CTNNB1;SLC1A1;FGFR4;KYNU;PAQR7;CYP1B1;GLDC;TGFB1;PMAIP1;STAT3;HLCS;CHRNB2
prerank,protein K63-linked deubiquitination (GO:0070536),0.2570531048816123,0.8335849036814347,0.7459954233409611,1.0,1.0,6/31,10.37%,OTUD7A;USP25;CYLD;OTUD7B;PSMD14;USP50
prerank,endosome organization (GO:0007032),0.23988010035709284,0.8335051264605654,0.7382978723404255,1.0,1.0,9/41,12.09%,TMEM9;RNF26;DNM1;LAPTM4B;ANXA8;ANXA8L1;USP50;SNX10;PHETA1
prerank,embryonic heart tube development (GO:0035050),-0.32287367865719196,-0.8334250341484135,0.713472485768501,0.8874077381105967,1.0,3/14,8.09%,SOX17;HES1;TBX2
prerank,nucleoside salvage (GO:0043174),0.3459253875794323,0.8330688810579631,0.6702586206896551,0.9998976992948255,1.0,5/10,24.80%,CDA;UCK2;UCK1;TK1;TK2
prerank,positive regulation of rRNA processing (GO:2000234),0.3415015123794907,0.8330398924304613,0.6909090909090909,0.9987051982089219,1.0,3/10,13.72%,BUD23;DIMT1;SIRT7
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.27808479171850164,0.8326250049877297,0.7065727699530516,0.9983579760388464,1.0,4/21,8.27%,ADCY8;ADCY10;NPPC;ADCY7
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.2880683826889081,0.8326111238060697,0.6806167400881057,0.9971442072686113,1.0,4/18,15.63%,RASL11A;DHX33;SIRT7;LYAR
prerank,regulation of Rac protein signal transduction (GO:0035020),0.307283427275429,0.8325821867603952,0.7036144578313253,0.9959620399340259,1.0,3/16,11.64%,RASGRF1;ARHGAP24;AUTS2
prerank,carnitine metabolic process (GO:0009437),-0.33727910673632255,-0.8325587166549483,0.6824817518248175,0.8886482371074799,1.0,7/12,32.48%,ACADL;CPT1A;CRAT;TMLHE;BBOX1;SHMT1;CPT2
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.3151411884221228,-0.832552787929181,0.6843971631205674,0.888255791969819,1.0,8/14,42.75%,CRAT;ACOX1;ACOX3;ECI2;EHHADH;ACOXL;SCP2;ABCD1
prerank,lipid homeostasis (GO:0055088),-0.22998355964015588,-0.8325097402403586,0.7722222222222223,0.8879433636505796,1.0,18/57,28.28%,ZBTB20;DDX3X;PRKAA1;ORMDL1;NR1D2;ACOX1;TLCD1;DGAT2;ACOX3;ORMDL3;PPARG;PNPLA8;CEBPA;PNPLA2;TLCD3B;USF2;FABP3;TREM2
prerank,regulation of catabolic process (GO:0009894),-0.29820296759040194,-0.8319146827729139,0.7142857142857143,0.8886721014098196,1.0,2/18,2.03%,ITGB1;NEDD4L
prerank,regulation of mRNA polyadenylation (GO:1900363),0.2962386842248582,0.8313374294673068,0.6899563318777293,0.9973851016289658,1.0,4/17,13.56%,HSF1;CPEB1;CPEB3;CCNT1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.24849944675613062,-0.8311295011049243,0.7134935304990758,0.8897408809249541,1.0,14/38,29.39%,DAB2IP;ESR1;PPM1B;CASP8;TRIM59;TNFAIP3;USP10;ZMYND11;TRIM39;RIPK1;TNIP1;RIOK3;TREM2;CACTIN
prerank,fatty acid metabolic process (GO:0006631),0.1987845498922461,0.8308493450302371,0.8622327790973872,0.997183781398878,1.0,23/115,16.99%,NUDT19;LPIN1;ACSBG1;ELOVL4;ACLY;ACACA;ACSL3;CPT1B;OXSM;CPT1C;ACSL6;ALOX12;NAAA;GNPAT;LIPC;AASDH;ACOT2;ACOT7;NDUFAB1;MECR;ALOX5;CYP1A1;ACOX2
prerank,ribosomal small subunit assembly (GO:0000028),0.30641712194063797,0.8307771177957013,0.7057522123893806,0.9961157855828734,1.0,5/16,16.89%,RRP7A;ERAL1;XRCC5;ABT1;PWP2
prerank,high-density lipoprotein particle assembly (GO:0034380),0.34321306645098215,0.8304794897316435,0.6697038724373576,0.9954842993604187,1.0,3/10,14.63%,APOM;ZDHHC8;APOE
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.22236041193518444,-0.8303570260135379,0.7875,0.8907623390457663,1.0,23/70,27.31%,PSMA2;ITGB5;PSME2;TAP2;PSMB4;PDIA3;NCF2;PSMC2;PSMB2;PSMB1;PSMA8;IKBKG;VAMP3;IKBKB;PSME1;PSMD4;PSMA7;SEC22B;FCGR1A;PSMD5;PSMB10;PSMA3;FCER1G
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.3041931501776542,0.829958117943535,0.7038724373576309,0.9953380132633527,1.0,5/15,19.43%,TRIM27;ARPC5L;ARPC5;WHAMM;ARPC1A
prerank,regulation of water loss via skin (GO:0033561),0.3101898947976172,0.8297196779199398,0.6968973747016707,0.9933579746069248,1.0,1/15,0.47%,ABCA12
prerank,establishment of skin barrier (GO:0061436),0.3101898947976172,0.8297196779199398,0.6968973747016707,0.9933579746069248,1.0,1/15,0.47%,ABCA12
prerank,establishment of protein localization to organelle (GO:0072594),0.2132224547145932,0.8296230540708515,0.7928571428571428,0.9923198754284787,1.0,17/72,22.11%,MMP12;SPRN;PHB2;NUP62CL;TNPO3;RYR2;RANBP17;RPAIN;LRSAM1;HK1;HIKESHI;POM121;NUP107;FAM53B;FAM53C;PRICKLE1;NUP93
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.3200142486768595,-0.8295187457287182,0.7145390070921985,0.8919316210071006,1.0,4/14,18.76%,RPUSD4;MRPS27;MPV17L2;UQCC2
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.29227005088801244,0.8292869220981286,0.7008928571428571,0.9918414903066756,1.0,5/16,18.77%,IL12A;RASGRP1;CD226;SLAMF6;CADM1
prerank,positive regulation of metabolic process (GO:0009893),-0.20328333285310582,-0.8282782587398456,0.8429319371727748,0.8938129228230965,1.0,15/103,11.47%,IGF1R;INSR;CAV1;ADIPOR2;PRDM16;STAT6;UCP2;GRB10;ACADL;ACACB;EHMT1;KDM6B;IL4R;KDM3A;JAK2
prerank,positive regulation of actin nucleation (GO:0051127),-0.34649631426692384,-0.8280748771326735,0.686411149825784,0.8937737664012312,1.0,4/11,18.92%,WASF2;FCHSD2;NCKAP1;WASF1
prerank,positive regulation of neutrophil migration (GO:1902624),-0.29559377626839967,-0.826636922423239,0.7445652173913043,0.8960039105626636,1.0,2/18,5.85%,RAC1;MOSPD2
prerank,response to axon injury (GO:0048678),-0.2951883020845016,-0.8262702378059509,0.7205882352941176,0.8962641830091959,1.0,6/18,28.28%,NREP;RTN4RL1;SOD1;FLRT3;MTR;TREM2
prerank,proteolysis (GO:0006508),0.17686128034016782,0.826065811553687,0.9537275064267352,0.9972201401646552,1.0,46/252,17.46%,CPB2;TMPRSS11D;MMP12;MME;TRHDE;MMP16;CELA3A;MMP24;MMP25;PAPPA2;CLN3;CTSK;CPA2;CPE;FBXO2;TYSND1;METAP2;PRSS57;USP25;BACE1;SPCS3;TMPRSS7;ADAM19;CPN1;CPNE1;PCSK2;AEBP1;UFSP2;HTRA2;SPCS1;PCSK6;CPA4;CPA3;CLPP;ATG4D;ECE2;EEF1AKMT4-ECE2;MIPEP;TPP1;LONP1;ATG4B;KLKB1;CASP4;PSMB5;PGPEP1;NAPSA
prerank,positive regulation of dephosphorylation (GO:0035306),-0.27159388609914104,-0.8259938022633926,0.7393617021276596,0.8963689635223165,1.0,4/27,7.57%,PPP2R5A;PRKCD;SPPL3;CDH5
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.24194629359326222,0.8257608500386588,0.76,0.9966096430062632,1.0,10/37,16.39%,KIF17;DYNC2H1;KIFAP3;KIF3A;DYNC2I2;DYNLRB2;KIF3C;IFT172;IFT22;IFT81
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.34523311057548056,-0.8254756296380436,0.7037735849056603,0.8969580444457932,1.0,2/11,14.71%,CAT;GPX1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.332730160465236,0.824901696827257,0.6823529411764706,0.9972323363335454,1.0,1/10,0.75%,ANK3
prerank,positive regulation of lyase activity (GO:0051349),-0.3161430109325896,-0.8248786849917237,0.7027522935779816,0.8976133213576414,1.0,8/14,41.71%,NOS3;NF1;NOS1;NOS2;PARK7;STIM1;FXN;CACNA1C
prerank,aromatic amino acid family catabolic process (GO:0009074),0.3060647662986977,0.8248396588318669,0.6976241900647948,0.9961428180124846,1.0,3/15,15.30%,QDPR;HAAO;TDO2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.23118596996432625,-0.8246763990075716,0.7635726795096323,0.8975851082936224,1.0,23/50,33.59%,MNAT1;CDKN1B;CCND3;ACTB;CDK5RAP3;CCND1;CNPPD1;BLM;CDKN2C;CDC25A;GADD45A;CCNG1;CCNK;CCNE2;CDKN3;CCNJ;CDKN2B;CCNH;CCND2;STOX1;CDK5R1;CCNE1;CDC6
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.3382405821126532,-0.8243553560021659,0.7007299270072993,0.8977757161941867,1.0,7/11,47.27%,H3-3A;ATRX;ASF1B;ASF1A;NASP;HAT1;CABIN1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.26939048739037313,0.8241044975494699,0.7494646680942184,0.996389775735757,1.0,9/22,23.75%,HSPA9;ISCA2;NFU1;CIAO3;NUBP2;NUBP1;NFS1;CIAPIN1;LYRM4
prerank,skeletal muscle contraction (GO:0003009),0.2873760195859373,0.8240061171622474,0.7181208053691275,0.9953696785099405,1.0,4/19,13.30%,STAC2;STAC;TNNC1;TNNI2
prerank,phagolysosome assembly (GO:0001845),0.3294673033316377,0.8238891863177794,0.6712328767123288,0.9943921009970179,1.0,4/12,15.84%,CLN3;RAB34;RAB39A;RAB20
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.32786994494358035,0.8238252819264282,0.6757369614512472,0.9933081627156989,1.0,3/12,12.14%,ADCY8;PLA2G6;GPLD1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.31269481757423295,0.8235491681106598,0.7250554323725056,0.9926525307168609,1.0,4/14,13.14%,NR1D1;SYT11;GRN;LDLR
prerank,T cell differentiation in thymus (GO:0033077),-0.31377466762818224,-0.8231280086627434,0.7190226876090751,0.899594996116862,1.0,6/14,31.26%,GLI3;PTPRC;LIG4;ZFP36L1;ADAM17;SHH
prerank,actin filament polymerization (GO:0030041),-0.26134334062338294,-0.8230657953068073,0.7617328519855595,0.8993074854212801,1.0,9/29,18.92%,RAC1;DIAPH1;WASL;FAM107A;JAK2;PREX1;CORO7;PSTPIP1;WASF1
prerank,cyclooxygenase pathway (GO:0019371),0.33810696122699546,0.822604716768238,0.6598639455782312,0.9934366584330201,1.0,2/10,10.63%,PTGDS;CBR1
prerank,mitochondrion morphogenesis (GO:0070584),0.3204175978899375,0.8220719190243121,0.7077625570776256,0.9933305805604289,1.0,5/11,23.28%,SLIRP;MFF;FIS1;MYH14;DNM1L
prerank,ERAD pathway (GO:0036503),-0.2177515208844117,-0.822026131472058,0.8156996587030717,0.9007699560687029,1.0,24/83,27.19%,ECPAS;TRIM25;RNF139;UBE4B;ANKZF1;UBE2J2;USP13;ATXN3;SGTA;MAN1B1;UBE4A;ERLIN2;DNAJC10;TRIM13;UGGT1;DNAJB12;DNAJB9;HERPUD1;FBXO17;TMUB1;RHBDD1;RNF103-CHMP3;USP19;RNF103
prerank,lymphocyte chemotaxis (GO:0048247),-0.25366635969895873,-0.8210114231855533,0.7717391304347826,0.9021520613214384,1.0,5/34,9.65%,CCL25;SLC12A2;CYP7B1;GAS6;PIK3CD
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.278383772849577,-0.8207420761008172,0.7175843694493783,0.9018366114912086,1.0,6/21,18.94%,RBX1;ERCC2;RPA3;RPA1;ERCC3;RPA2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.278383772849577,-0.8207420761008172,0.7175843694493783,0.9018366114912086,1.0,6/21,18.94%,RBX1;ERCC2;RPA3;RPA1;ERCC3;RPA2
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.3217245150798196,-0.8206469458631077,0.7266313932980599,0.90161519782688,1.0,5/13,27.04%,ZC3HAV1;RC3H1;MOV10;CNOT8;CNOT1
prerank,tRNA modification (GO:0006400),0.21678142628991695,0.8203242097306953,0.8272138228941684,0.9956596474945663,1.0,19/62,23.09%,QTRT2;TRMT6;GTPBP3;TRMT13;TRMT10A;PUS1;FTSJ1;AARS2;ANKRD16;QTRT1;TRIT1;NSUN6;TPRKB;METTL2A;METTL2B;ADAT2;THUMPD1;TRMT5;THUMPD3
prerank,response to glucagon (GO:0033762),-0.29044649415114054,-0.8193846686993538,0.7238805970149254,0.9035230308947246,1.0,5/19,15.78%,PRKACB;ADCY9;ADCY4;CYSLTR2;ADCY1
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.26742127584017406,-0.8193561996139831,0.725925925925926,0.9031694041276476,1.0,3/25,2.50%,ITGB1;CD200;PARVA
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.3180459303676634,-0.8192387389612377,0.6876122082585279,0.9029726509705817,1.0,4/13,19.32%,HES1;DOT1L;JAK2;PTPRC
prerank,interstrand cross-link repair (GO:0036297),-0.23209293292822425,-0.8192059519122175,0.7758620689655172,0.9026275224700359,1.0,17/53,25.05%,MCM9;RPA3;RPA1;RNF168;FANCM;RFWD3;FANCD2;FANCC;FANCG;RPA2;USP1;FANCL;RAD51AP2;ERCC6L2;DCLRE1B;FANCI;DCLRE1A
prerank,diterpenoid metabolic process (GO:0016101),0.22207662919005414,0.8188564578815007,0.7882882882882883,0.9974807860080596,1.0,8/55,14.63%,GPC5;AKR1C1;APOM;GPC1;SDC4;LRAT;AKR1B10;APOE
prerank,morphogenesis of an epithelium (GO:0002009),-0.27365034902625385,-0.8184210403528154,0.7504424778761062,0.9036541997939268,1.0,8/25,21.11%,LAMA3;LRP6;LAMA5;ACTB;TRAF3IP1;ARHGAP12;TIMELESS;VCL
prerank,DNA damage checkpoint signaling (GO:0000077),-0.2635772220893659,-0.8180698933990351,0.7517985611510791,0.9038789565946258,1.0,4/28,10.47%,MAP3K20;ATM;CLSPN;DOT1L
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.2982919410504838,-0.817490367422544,0.7097966728280961,0.9045429081528013,1.0,2/17,4.87%,PLA2G4A;LPCAT1
prerank,Golgi to lysosome transport (GO:0090160),-0.33589978127547243,-0.8172564329963838,0.7235188509874326,0.9045519978135063,1.0,4/11,16.96%,GAK;ANKFY1;AP1G1;AP4M1
prerank,regulation of viral release from host cell (GO:1902186),-0.2804940810185008,-0.8169833589203213,0.75,0.9046374525201248,1.0,10/21,33.32%,TRIM25;CHMP2B;TRIM13;TRIM28;CHMP3;VPS37B;TRIM35;TRIM32;TRIM62;TRIM5
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.2766152206776539,-0.8167837163097195,0.7459749552772809,0.904583158831144,1.0,8/23,22.06%,DIAPH1;PSEN2;NOS1AP;FYN;UBASH3B;CASQ2;NOS1;PTK2B
prerank,ribosome assembly (GO:0042255),-0.23356581173887625,-0.8167810503278423,0.7817531305903399,0.9041875179419958,1.0,15/47,24.41%,DDX3X;RPS14;RPSA;NOP2;RPL3;RPL10;RPL5;NLE1;MPV17L2;RPS27;MDN1;BOP1;RRS1;RPS15;MRPS2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.2732755707687744,-0.8166497553237022,0.7311827956989247,0.9040069182564554,1.0,14/24,36.28%,KLF2;TP53;NOTCH1;ATF4;GCN1;MAPK7;NFE2L2;ATF6;DDIT3;CEBPB;ATF3;MUC1;MT3;HIF1A
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.3432962932848683,-0.8163114555645699,0.7294117647058823,0.9041766068312272,1.0,6/10,45.85%,RC3H1;LGALS9;CD274;CRTAM;PDCD1LG2;FOXP3
prerank,defense response to protozoan (GO:0042832),-0.3300715463918151,-0.816261702252611,0.7450980392156863,0.9038567476646738,1.0,3/12,13.55%,GBP6;GBP4;CD40
prerank,negative regulation of cartilage development (GO:0061037),-0.3222234364576933,-0.81582257112392,0.7043795620437956,0.9042221372372787,1.0,6/13,29.13%,WNT11;PTPN11;ADAMTS7;SNAI2;TGFBR1;WNT9A
prerank,regulation of neuroblast proliferation (GO:1902692),0.29676312933936266,0.8157275101227248,0.6986301369863014,1.0,1.0,3/15,12.48%,TAFA1;VEGFA;FZD3
prerank,regulation of actin nucleation (GO:0051125),0.31914626490897696,0.8155452298486602,0.7133182844243793,1.0,1.0,12/12,68.11%,GSN;WHAMM;CORO1B;PICK1;ARFIP2;WASHC5;ARFIP1;ARF1;ARPIN;VIL1;SCIN;CORO1A
prerank,lipid oxidation (GO:0034440),0.31810599681506574,0.8152531942969331,0.6991341991341992,1.0,1.0,3/12,15.88%,PLA2G7;ALOX12;ALOX5
prerank,sphingosine biosynthetic process (GO:0046512),0.33310413492893187,0.8151269276771,0.7028985507246377,0.9989622915567637,1.0,4/11,9.92%,SPHK1;ACER1;ABCA2;SPHK2
prerank,sphingoid biosynthetic process (GO:0046520),0.33310413492893187,0.8151269276771,0.7028985507246377,0.9989622915567637,1.0,4/11,9.92%,SPHK1;ACER1;ABCA2;SPHK2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.2965579861415733,0.8150475042901995,0.7454128440366973,0.9979116611813266,1.0,7/15,25.40%,NYNRIN;ZC3H12B;ZC3H12C;NUDT16;RNASEH1;LACTB2;POP7
prerank,detection of visible light (GO:0009584),-0.30360489463216334,-0.8149377145209672,0.7052238805970149,0.9054043976223353,1.0,11/16,54.28%,CEP250;TULP1;GNA11;PDE6B;RP1;GNAQ;RHO;GNAT1;REEP6;GNAT2;CACNA1F
prerank,regulation of B cell proliferation (GO:0030888),0.23662333418915585,0.8148181640097699,0.7652582159624414,0.9972071521379964,1.0,5/44,6.52%,BLK;NFATC2;BCL2;SASH3;CD81
prerank,cardiac myofibril assembly (GO:0055003),0.2967312960482159,0.814052839481112,0.6984478935698448,0.99747878625217,1.0,5/15,15.31%,FHOD3;PROX1;MYLK3;MYL2;PDGFRA
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.30018526520420763,-0.8137871626442533,0.7432188065099458,0.9069858527387741,1.0,9/16,34.42%,BOC;PLCB1;MEF2C;SMYD1;RBM24;LRRC8A;MAPK14;XKR8;HIF1AN
prerank,mitochondrial protein processing (GO:0034982),0.32786562404520414,0.8133672306309256,0.6967741935483871,0.9976247673201479,1.0,3/11,15.79%,OMA1;PMPCB;MIPEP
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.3276462407575639,-0.8129333196673072,0.7178030303030303,0.9081213276954423,1.0,7/12,31.43%,PROM1;NKD1;AGTPBP1;TULP1;MYO7A;SDK2;STAT3
prerank,regulation of peptidase activity (GO:0052547),0.2813210001866996,0.812848530037236,0.7248908296943232,0.9974131180158463,1.0,6/19,14.60%,ECM1;A2ML1;ATP13A2;CST3;RCN3;PSMB8
prerank,response to hexose (GO:0009746),-0.26812004768724795,-0.8126485314085798,0.7532228360957642,0.9082138356288025,1.0,10/25,33.43%,THBS1;EIF2B2;LPL;TCF7L2;VAMP2;PFKL;SELENOT;MAFA;EIF2B4;EIF2B5
prerank,acyl-CoA metabolic process (GO:0006637),-0.2475561885712671,-0.8125651844703967,0.7660311958405546,0.9079476476759253,1.0,8/35,18.87%,OGDH;ACSF2;SUCLG2;ACACB;THEM4;HMGCS2;SUCLA2;ACOT9
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.18725212389385468,-0.8123910574238238,0.9195205479452054,0.9078488243159645,1.0,47/170,26.53%,FOXP1;AFF1;PRDM5;MTMR3;APP;HMG20B;CTCF;NOVA2;KDM6A;HNRNPAB;PRDM2;CDH1;KDM6B;POGZ;HMG20A;PSEN1;TRIM14;PRDM6;EDN3;RASA1;FLOT1;CDK6;MARF1;ROCK2;ZNF462;PRDM9;IGF1;FUBP1;ZNF507;MKLN1;PTPRC;CAVIN4;PRDM1;TOB1;NKAP;KIF16B;MTMR4;TRIM39;RFXANK;PCBP1;TRIM68;UBAP2;IGF2BP2;CRNN;TRIM44;ZFP36L1;HNRNPD
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.3001484533237892,-0.81162219799785,0.7145421903052065,0.9088328538226917,1.0,9/16,36.68%,NT5E;TET2;NT5C1A;CRMP1;NT5C;UPB1;UPP1;DPYSL4;DPYS
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.31479148627121223,0.8110683778531456,0.7278911564625851,0.9997250458621315,1.0,5/13,19.34%,HACD1;ELOVL4;TECR;HACD2;HACD3
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.23475337568152246,-0.8109357072378188,0.7897526501766784,0.909665336818303,1.0,17/46,36.31%,AKT1;TOMM40;BCAP31;TIMM17B;TOMM5;DNAJC19;TOMM40L;TIMM50;TIMM10;TOMM20;TOMM70;TIMM10B;AIFM1;TIMM13;DNLZ;TIMM23;PAM16
prerank,neuron projection extension (GO:1990138),0.24857733854024217,0.8108469836615261,0.7433628318584071,0.9989512934266775,1.0,7/32,11.64%,SH3GL2;TMEM108;CDK5;IMPACT;CPNE1;MAP1B;AUTS2
prerank,renal system development (GO:0072001),-0.22698187060599218,-0.8108115469144143,0.784070796460177,0.9094770930779885,1.0,11/52,14.92%,SOX17;ACE;SIX1;C1GALT1;TGFB2;RBP4;BMP4;PCSK5;AGTR1;TRAF3IP1;FOXC1
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.27413991510754904,-0.8107589219113167,0.7371323529411765,0.9091682434829769,1.0,5/22,10.11%,CDKN1B;BMP4;ROCK1;PRKRIP1;TP53
prerank,activation of phospholipase C activity (GO:0007202),0.2561108255602087,0.8103109115741123,0.7824175824175824,0.9988045422351357,1.0,7/29,13.29%,PHB2;ANG;NTRK2;ADRA1A;TXK;BDNF;CD86
prerank,positive regulation of double-strand break repair (GO:2000781),-0.2417983936720699,-0.809383418401751,0.7946257197696737,0.9111959959267845,1.0,7/39,6.93%,DTX3L;ARID2;SHLD1;KMT5B;MRNIP;FUS;SPIDR
prerank,mitochondrial transport (GO:0006839),-0.22575271774010688,-0.8092513874749231,0.8129496402877698,0.9110275305647089,1.0,22/53,34.02%,COX18;BNIP3;ABCB10;STARD3;TOMM40;BCAP31;TMEM14C;TIMM17B;TOMM5;PPIF;FLVCR1;DNAJC19;SLC25A24;HSP90AA1;TIMM10;TOMM20;TOMM70;PMAIP1;SPG7;SLC25A5;TIMM10B;TIMM13
prerank,positive regulation of cilium assembly (GO:0045724),0.2837771090175952,0.8090824188577641,0.7462039045553145,1.0,1.0,6/18,20.52%,CCDC88A;BBS4;CEP135;HTT;HAP1;SEPTIN9
prerank,glial cell development (GO:0021782),-0.2630344509462482,-0.8077957794980363,0.7588028169014085,0.9131581407346557,1.0,14/25,37.42%,APP;EIF2B2;CDK6;NRROS;SOX4;NF1;NSUN5;EIF2B4;EIF2B5;PRDM8;S100A9;MT3;TLR2;MDK
prerank,activation of protein kinase A activity (GO:0034199),-0.29505662211179395,-0.8076834729075076,0.7532710280373832,0.912967090231673,1.0,3/16,8.02%,PRKACB;ADCY9;ADCY4
prerank,regulation of axon regeneration (GO:0048679),-0.33006322387086573,-0.8075679082480858,0.7096774193548387,0.9127593932565362,1.0,4/12,13.05%,SCARF1;STK24;EPHA4;RTN4RL1
prerank,regulation of mast cell activation (GO:0033003),-0.3416227111174499,-0.8072439366190688,0.7472727272727273,0.9129137984209058,1.0,4/10,26.85%,LYN;PLSCR1;MILR1;CD300LF
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.23906687469022356,-0.8071203612047391,0.7972270363951474,0.9127399077271743,1.0,10/40,17.30%,TNFSF10;BNIP3;AKT1;TP53;HGF;GPX1;BBC3;BCL2L11;IGF1;PPIF
prerank,DNA methylation or demethylation (GO:0044728),-0.2891533910649532,-0.806737267479888,0.7478260869565218,0.9126074359843672,1.0,7/19,24.04%,KMT2E;EHMT1;DNMT1;PPM1D;ATRX;MTRR;BEND3
prerank,DNA alkylation (GO:0006305),-0.2891533910649532,-0.806737267479888,0.7478260869565218,0.9126074359843672,1.0,7/19,24.04%,KMT2E;EHMT1;DNMT1;PPM1D;ATRX;MTRR;BEND3
prerank,glycerolipid metabolic process (GO:0046486),0.3258030428921851,0.8067150716450276,0.7286652078774617,1.0,1.0,3/11,17.18%,DGKQ;GAL3ST1;PGP
prerank,epithelial cell differentiation (GO:0030855),-0.2062479597793844,-0.8066591234293252,0.842560553633218,0.9123343607267952,1.0,15/88,14.85%,DAB2;TBX1;KDR;HDAC1;SIX1;E2F4;BMP4;BDH2;ANXA4;AKT1;KDM6B;CPT1A;ALDOC;ACADVL;JAG1
prerank,multivesicular body assembly (GO:0036258),-0.2567861975928024,-0.8064567430451969,0.7562380038387716,0.9122834546674564,1.0,13/30,30.85%,CHMP4B;CHMP4A;VTA1;CHMP2B;VPS36;CHMP5;RAB11A;PDCD6IP;STAM2;CHMP3;VPS37B;CHMP6;CHMP1A
prerank,retinoid metabolic process (GO:0001523),0.20737007907639715,0.8061564784379643,0.8370535714285714,1.0,1.0,10/71,14.63%,GPC5;AKR1C1;APOM;CYP26B1;GPC1;ALDH1A2;SDC4;LRAT;AKR1B10;APOE
prerank,cellular response to lipid (GO:0071396),-0.18365389733161971,-0.8060008311471458,0.9181184668989547,0.9126483183549134,1.0,34/191,16.45%,DAB2IP;ESR1;LYN;NRIP1;ATM;TBX1;NR3C1;EGFR;MSN;ADAM9;FZD4;NFKB1;TNFRSF1B;IRS1;PDCD4;MED1;IRGM;LBP;MEF2C;NFKBIL1;NCOA4;RHOA;IRAK1;CDC73;LPL;KAT5;WNT11;MAPK8;TNFAIP3;ROCK2;RUVBL2;ADCY1;UBE2L3;CHMP5
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.24007527356349856,-0.8058863831965095,0.7664884135472371,0.9124336713670635,1.0,11/39,23.23%,RBX1;ERCC2;POLD3;OGG1;RPA3;RPA1;ERCC3;RPA2;RFC4;NTHL1;RFC1
prerank,lysosome localization (GO:0032418),0.23616223323331503,0.8056521991995316,0.7898230088495575,1.0,1.0,11/37,19.87%,PIP4P1;CHGA;FLCN;NR4A3;RAB3A;RAB34;KIT;SNAPIN;BORCS5;MAP6;VPS33B
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.3417140525589876,-0.8053414779760063,0.7129629629629629,0.9129522341811755,1.0,4/10,14.75%,MTOR;ADAM9;FGF7;MAP4K4
prerank,regulation of protein targeting to membrane (GO:0090313),-0.2629728168464045,-0.8052917727537403,0.7747747747747747,0.9126260351872634,1.0,7/28,16.68%,MIEF1;TCAF1;GDI1;MTCL1;MIEF2;CHP1;FYN
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.3178478605498107,-0.8051527647112382,0.7177121771217713,0.9124669015182901,1.0,5/13,17.95%,TGFBR2;GSK3A;SMAD4;NOTCH1;HEY2
prerank,peptidyl-amino acid modification (GO:0018193),0.3378919512127725,0.8048158708432869,0.7015945330296127,1.0,1.0,3/10,19.08%,METAP2;METAP1;FKBP7
prerank,negative regulation of telomere maintenance (GO:0032205),-0.30122517240314783,-0.8047870486545408,0.7307001795332136,0.9126875960806061,1.0,10/15,42.06%,ATM;TERF2;SMG6;PINX1;TNKS2;RAD50;TNKS;SLX4;ERCC4;ERCC1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.29667675693996143,0.8034117885451763,0.7227488151658767,1.0,1.0,2/15,6.48%,BCL2;TRIAP1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.2685662419743128,0.8028860558052539,0.7438752783964365,1.0,1.0,3/21,12.21%,GRIN2B;USP50;PCID2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.3297897953910932,0.802800158990543,0.7303370786516854,1.0,1.0,4/10,15.10%,SMPD3;SPHK2;PLA2G6;NSMAF
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.3297897953910932,0.802800158990543,0.7303370786516854,1.0,1.0,4/10,15.10%,SMPD3;SPHK2;PLA2G6;NSMAF
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.30871954422082365,0.8027127212538867,0.7346491228070176,1.0,1.0,3/12,14.60%,TMEFF2;PF4;SELENOS
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.2921715201691574,-0.802503410619175,0.7576301615798923,0.9161309729828873,1.0,7/16,28.28%,HDAC1;ROCK1;ABCA7;MYOCD;LRP1;HMGCR;TREM2
prerank,protein import (GO:0017038),0.19956496866351478,0.8021528994513413,0.8789346246973365,1.0,1.0,22/84,22.11%,MMP12;SPRN;PHB2;NUP62CL;TNPO3;ATAD1;RANBP17;RPAIN;CLU;APOE;HIKESHI;POM121;SNX33;NUP107;GDAP1;FAM53B;FAM53C;FIS1;PEX2;ACBD5;PRICKLE1;NUP93
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.27966043305494215,0.8020520652951141,0.746031746031746,1.0,1.0,5/17,18.77%,IL12A;RASGRP1;CD226;SLAMF6;CADM1
prerank,negative regulation of immune response (GO:0050777),-0.18710694815538664,-0.8015532943286713,0.9207207207207208,0.9173152510317386,1.0,25/154,15.78%,GNB1;CALCRL;MYH9;LYN;PRKACB;ADCY9;RAMP1;PLCG1;YES1;GGT5;NMI;PLK2;RHBDF2;ADCY4;PLCG2;PPM1B;RAMP2;ADM;CYSLTR2;TRAF3IP1;RC3H1;TNFAIP3;ILRUN;IAPP;ADCY1
prerank,nucleocytoplasmic transport (GO:0006913),-0.23578140222954483,-0.8014230357006349,0.800376647834275,0.9171309575767336,1.0,12/40,26.21%,RSRC1;NUP98;BACH2;SNRPE;HNRNPA1;LSG1;NXT1;PHAX;RITA1;GEMIN7;NEMF;ATXN1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.3168419138492372,-0.8009833520586087,0.7527075812274369,0.9174822460096963,1.0,9/13,41.00%,DYRK1A;YJU2;MIF;MDM2;SNAI2;CD74;SIRT1;PTTG1IP;CD44
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.33977064811375,-0.8006752029672608,0.7249544626593807,0.9175851054134666,1.0,3/10,18.61%,NCK1;JUN;CITED2
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.29023501627056003,0.8006606461355219,0.7557077625570776,1.0,1.0,7/16,19.31%,B3GALT4;ST8SIA5;ST6GALNAC5;ST8SIA3;B4GALT6;ST8SIA2;ST8SIA1
prerank,striated muscle cell differentiation (GO:0051146),-0.2946293196727125,-0.8004897532251276,0.7373188405797102,0.917492689487465,1.0,4/16,10.26%,AKAP13;SIK1;MEF2C;KDM6B
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.29791071857222823,0.8004175834151838,0.739514348785872,1.0,1.0,5/15,15.10%,SMPD3;SPHK1;SPHK2;PLA2G6;NSMAF
prerank,protein import into nucleus (GO:0006606),0.20733656116826374,0.800324689084752,0.858139534883721,0.999996700892605,1.0,5/66,3.44%,MMP12;SPRN;PHB2;NUP62CL;TNPO3
prerank,modulation by symbiont of entry into host (GO:0052372),-0.29367400829326334,-0.8000156763445693,0.7402597402597403,0.9179284031393219,1.0,4/16,11.39%,CAV1;TRIM25;EXOC2;TRIM14
prerank,positive regulation of bone mineralization (GO:0030501),-0.24319592497809728,-0.7998646585584728,0.8045375218150087,0.9177942481531182,1.0,8/35,12.16%,BMPR2;BMP6;BMP4;MEF2C;ACVR2A;ADGRV1;ANO6;PKDCC
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.2909817818004685,-0.7990823104005048,0.7639405204460966,0.9187092770762753,1.0,7/18,22.95%,CD34;EZR;KAT5;TNFAIP3;PTPRC;HDAC7;HOMER3
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.28958935074720604,0.7989696156479227,0.735981308411215,1.0,1.0,16/16,71.07%,BCKDK;SCARB2;PDK2;PDK1;MLYCD;PRKN;ADIPOQ;FOXK2;ADIPOR1;SIRT1;GNB3;RORA;PDK3;FOXK1;PDK4;RORC
prerank,regulation of osteoblast proliferation (GO:0033688),0.2813578826150241,0.7989524867928185,0.7467532467532467,1.0,1.0,4/17,15.09%,NELL1;FGFR2;ATRAID;EIF2AK2
prerank,DNA replication initiation (GO:0006270),0.23611172196358196,0.7987416374661335,0.75,0.9994234008827773,1.0,9/37,16.00%,GMNN;MCM8;CDC45;POLA1;PURA;POLE4;CDC7;ORC1;CDK2
prerank,response to iron ion (GO:0010039),0.31085113928797636,0.7985936918789354,0.7014925373134329,0.9985280489901392,1.0,2/12,8.01%,BCL2;ACO1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.260443755663317,0.7984549143252379,0.7586206896551724,0.9976026884791356,1.0,6/24,19.07%,AKAP6;CALM2;SRI;HRC;SELENON;PDE4D
prerank,endoderm development (GO:0007492),0.3068184394352229,0.7982194469463858,0.724373576309795,0.9968672526445366,1.0,2/13,6.44%,LHX1;DUSP4
prerank,negative regulation of viral process (GO:0048525),-0.2212149361269977,-0.79809095112903,0.8058608058608059,0.9198888517181789,1.0,23/57,31.53%,IFIH1;ZC3HAV1;UBP1;TRIM14;IFITM3;PLSCR1;N4BP1;TRIM13;SRPK2;MAVS;TRIM28;IFITM2;TNIP1;CHMP3;TRIM6;OASL;BST2;TRIM35;RSAD2;LARP7;SHFL;TRIM32;TRIM62
prerank,dendritic cell migration (GO:0036336),-0.2977306911227793,-0.7979906991259647,0.7318435754189944,0.9196619086535811,1.0,2/16,4.94%,EPS8;TRPM4
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.2504915960868651,-0.7978588066517328,0.7904929577464789,0.91949229027137,1.0,3/30,6.54%,SPTBN1;GOLPH3L;MACF1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.3178203315633975,0.797462594486854,0.7096018735362998,0.9970354532149772,1.0,2/12,6.48%,BCL2;TRIAP1
prerank,DNA-dependent DNA replication (GO:0006261),0.1889134290725585,0.7969078260457466,0.9079903147699758,0.9968438254776395,1.0,25/128,17.13%,GMNN;GINS4;WRNIP1;PSMC5;MCM8;PSMD10;CDC45;POLD4;PSMD14;POLA1;PSMB7;RPAIN;PSMA4;PURA;SIRT7;POLE4;PSMD1;PSMF1;PSMB8;CDC7;ORC1;CDK2;PSMD7;PSMB5;PSMD2
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.2014866119680375,-0.796648058311252,0.8784029038112523,0.9211179270609186,1.0,21/90,21.69%,IGF1R;CAV1;ADIPOR2;PRDM16;STAT6;UCP2;GRB10;ACADL;EHMT1;KDM6B;IL4R;KDM3A;JAK2;ALMS1;ACSL1;CMKLR1;EPAS1;PRKAB1;G0S2;OGT;DIO2
prerank,cAMP metabolic process (GO:0046058),0.30316297501615364,0.7962160570774159,0.7451923076923077,0.9969241897256745,1.0,3/13,8.27%,ADCY8;ADCY10;ADCY7
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.27405597918518115,-0.7960758188478779,0.7544802867383512,0.921677632869514,1.0,5/21,10.57%,CSGALNACT1;CHST15;CHST11;CSPG4;BGN
prerank,mononuclear cell differentiation (GO:1903131),-0.26674619375952857,-0.7960435676519985,0.7791970802919708,0.9213301088746669,1.0,4/24,7.18%,MYH9;LYN;GAS6;BMP4
prerank,histone H2A acetylation (GO:0043968),0.28886575675076503,0.7952554333935424,0.7429245283018868,0.9975156831903982,1.0,4/16,13.99%,MEAF6;SPHK2;RUVBL1;NAA40
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.3085258416184291,-0.794814007938047,0.7347670250896058,0.9229744165700738,1.0,5/13,28.90%,RPS21;NOL9;RRS1;RCL1;UTP20
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.32452085040465684,0.794458840676877,0.7196467991169978,0.9978037747428751,1.0,3/10,18.89%,ADRA2A;TGFA;HBEGF
prerank,basement membrane organization (GO:0071711),-0.30769553339318295,-0.7943350308862143,0.7446043165467626,0.9233588096289821,1.0,5/14,15.07%,NTN4;COL4A1;RAMP2;NID1;FLRT2
prerank,serine family amino acid catabolic process (GO:0009071),-0.33438128913022236,-0.7940752558534536,0.7559633027522936,0.9233650447826288,1.0,6/10,40.11%,DLD;GLDC;SHMT1;GCSH;DAO;CBS
prerank,aerobic electron transport chain (GO:0019646),0.20654603689921716,0.7939985365634312,0.8660907127429806,0.9974688831290953,1.0,15/68,17.29%,COX6A2;UQCR10;NDUFA1;UQCRH;SDHA;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFAB1;COX6A1;NDUFS7;NDUFB6;NDUFA11
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.295146259729135,-0.793896764862779,0.7477477477477478,0.9232529449084974,1.0,8/16,40.38%,TGFB2;FOXC1;PTN;RBM24;SP7;TCF15;LTBP3;GATA4
prerank,gastrulation (GO:0007369),-0.300104642843247,-0.7937563214887916,0.7357414448669202,0.9230746182005543,1.0,4/15,13.61%,LRP5;SMAD2;TASOR;LMBRD1
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.28280839979903016,-0.7936493188224256,0.7537037037037037,0.9228500395575643,1.0,2/18,3.07%,ESR1;KAT2B
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.24146083845444152,0.7933551742869237,0.776255707762557,0.9974588138233109,1.0,9/31,23.01%,PYCR2;LSS;CYP51A1;FDFT1;ALOX5;NOXRED1;NFS1;LIAS;PRLR
prerank,chromatin assembly (GO:0031497),-0.2347774003973573,-0.7933518634790732,0.8336380255941499,0.9229321391368002,1.0,7/38,15.56%,KAT6B;CTCF;BRD2;SPTY2D1;TP53;H3-3A;PRDM9
prerank,positive regulation of T cell migration (GO:2000406),-0.27641625119490654,-0.7932974965805133,0.7546125461254612,0.9226161880670048,1.0,8/20,30.70%,APP;ADAM10;RHOA;CXCL12;ADAM17;CXCL10;WNK1;TNFRSF14
prerank,protein targeting to lysosome (GO:0006622),-0.2818613152158171,-0.7932906060234814,0.7601410934744268,0.9222282326665929,1.0,7/20,20.42%,RAB7A;NEDD4;NCOA4;AP4M1;LAMP2;ZFYVE16;M6PR
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.2654182643816863,0.7928776297016352,0.7881548974943052,0.9971069426108586,1.0,3/20,7.48%,BCL2;SELENOK;TMCO1
prerank,pseudouridine synthesis (GO:0001522),-0.3095531997692558,-0.7926008459021229,0.7567567567567568,0.9229640272712237,1.0,5/13,29.48%,PUS10;TRUB1;PUSL1;RPUSD2;GAR1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.2299313424821838,0.7924226893488608,0.8211920529801324,0.9967453068549854,1.0,10/38,17.29%,NDUFA1;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFAB1;NDUFS7;NDUFB6;NDUFA11
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.23750540465263562,0.7923428155683649,0.7846153846153846,0.9957295889039687,1.0,5/34,13.29%,PHB2;INAVA;SASH3;SPHK2;CD86
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.24093021416869248,-0.7918236422003168,0.8194690265486726,0.9238232189108456,1.0,7/35,15.37%,PPP1R2;GSK3B;ITGA1;MTOR;PPP1R12A;PPP6R3;NUAK1
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.3035072662658707,-0.7915418243060192,0.7463503649635036,0.9238644943152354,1.0,4/14,29.64%,DAGLB;NOS1;CHAT;SLC22A2
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.30863655005452134,-0.7913817361900413,0.7386569872958257,0.9237234232298754,1.0,2/14,7.02%,TGFBR2;CD55
prerank,activation of adenylate cyclase activity (GO:0007190),0.23155716729389514,0.790675227737493,0.7981651376146789,0.9975197561785765,1.0,8/35,14.39%,ADCY8;GIPR;ADCY7;ADRB3;TSHR;LGR5;ACR;ADCY3
prerank,positive regulation of histone modification (GO:0031058),-0.24187495524524613,-0.7906683803485516,0.8072727272727273,0.9244853753155843,1.0,10/33,30.97%,RPS6KA5;NIPBL;RUVBL2;BRCA1;SAP30BP;NOS1;ARRB1;GLYR1;APLNR;RPS6KA4
prerank,negative regulation of response to wounding (GO:1903035),-0.2827773279217641,-0.7905638197953219,0.7605893186003683,0.9242434507462781,1.0,4/19,13.05%,CRK;EPHA4;FGF2;RTN4RL1
prerank,protein polymerization (GO:0051258),-0.2207238731837776,-0.78999273318887,0.8446428571428571,0.9247657873077902,1.0,14/55,18.92%,RAC1;UBE2K;DIAPH1;WASL;FAM107A;CHMP4B;CHMP4A;JAK2;PREX1;CORO7;CASQ2;TRPV4;PSTPIP1;WASF1
prerank,positive regulation of neuron death (GO:1901216),0.22040710012177916,0.7891683370996497,0.8340807174887892,0.9989760964036691,1.0,6/46,8.61%,GRIN2B;CDK5;EGR1;GRN;MAPT;BACE1
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.2545580081527991,-0.7888546244776877,0.7822141560798548,0.9261146252719409,1.0,6/26,15.01%,NMI;PPM1B;NFKBIL1;TRAF3IP1;TNFAIP3;ILRUN
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.26674194613375934,-0.7887128251207028,0.7673992673992674,0.9259344150251467,1.0,10/24,30.94%,SUZ12;TASOR;H3-3A;DNMT1;PPHLN1;PPM1D;AEBP2;PHF19;SPI1;DNMT3B
prerank,glycerophospholipid catabolic process (GO:0046475),0.2511532198076803,0.7885580817052932,0.7787810383747178,0.9988613557084822,1.0,6/27,12.18%,ENPP2;PLA2G7;PLA2G4E;PLA2G6;LIPC;INPP5F
prerank,DNA duplex unwinding (GO:0032508),-0.22426541315492635,-0.7882676259779727,0.8336448598130841,0.9262454890122939,1.0,19/50,33.70%,RBX1;MRE11;MCM9;ERCC2;MCM4;RPA1;XPC;ERCC3;ANXA1;WRN;CETN2;BLM;DHX9;MCM7;GTF2H3;CHD1L;MCM2;RAD50;PIF1
prerank,regulation of neutrophil migration (GO:1902622),-0.34301535883877343,-0.7879997661342043,0.7368421052631579,0.9262383518259698,1.0,2/10,13.44%,RAC1;RHOG
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.33712453101547035,-0.7879926543007586,0.7435897435897436,0.9258469999901509,1.0,2/10,4.84%,PTPRJ;PTPN12
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.3205471864638494,0.7877749414266518,0.7276995305164319,0.999085602646829,1.0,3/10,10.58%,PDE3B;PDE11A;RNF157
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.289728603384753,-0.7876552740368,0.7672413793103449,0.9260002466474118,1.0,8/16,39.65%,BMP4;RGCC;F2R;LARP6;RUNX1;TGFB1;HDAC2;CREB3L1
prerank,negative regulation of chemokine production (GO:0032682),-0.30092975588032767,-0.7873993971109281,0.7611408199643493,0.9259882886749174,1.0,1/14,1.54%,KLF4
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.3102817398173439,0.7871017537217867,0.7319819819819819,0.9990190115988616,1.0,3/11,15.69%,STK26;LANCL1;P4HB
prerank,regulation of nuclear division (GO:0051783),-0.27747606339521946,-0.7863881893962995,0.7597042513863216,0.9271582114944099,1.0,4/20,13.19%,CDK13;CUL9;CUL7;CCDC8
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.3106632509284997,0.78623645528559,0.729957805907173,0.9993759476042795,1.0,3/12,13.45%,INSIG1;RER1;KDELR2
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.2681691759898766,-0.7856878222133755,0.7942307692307692,0.9278438423785731,1.0,3/22,5.40%,GHR;CRLF3;HES1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.2561288200257914,-0.7855993383219363,0.7968197879858657,0.9275786140095618,1.0,6/27,14.28%,KHNYN;XRN1;ERN1;DICER1;PARN;PDE12
prerank,second-messenger-mediated signaling (GO:0019932),0.199018256482034,0.7852031440567705,0.898876404494382,0.9999947853789398,1.0,21/82,22.17%,PPP1R9A;KSR2;DDAH2;CHRM3;SPHK1;RYR2;CCR6;RCAN2;MCTP2;NMUR2;RCAN3;APOE;MCU;HRH1;EDNRB;CXCR4;PPP2R1A;SAMD14;DDAH1;BTK;PDPK1
prerank,regulation of membrane depolarization (GO:0003254),-0.28594575176303544,-0.7847648844159798,0.7860869565217391,0.928459468133719,1.0,9/18,30.27%,NEDD4L;LRRK2;PTPN3;SMAD7;SCN3B;FHL1;GJA5;HCN4;RANGRF
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.32382007726562057,0.784609457644315,0.7511210762331838,0.999885518305835,1.0,2/10,8.44%,ATP5MC1;VPS9D1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.21383152163636926,-0.7842470020017515,0.8797250859106529,0.9288749626086851,1.0,20/69,27.19%,ECPAS;TRIM25;UBE4B;ANKZF1;UBE2J2;SGTA;MAN1B1;UBE4A;ERLIN2;DNAJC10;TRIM13;DNAJB12;DNAJB9;HERPUD1;EDEM2;FBXO17;TMUB1;RNF103-CHMP3;USP19;RNF103
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.26849117417641294,-0.7841038727651689,0.7974217311233885,0.9287020758580287,1.0,11/23,35.90%,HERC4;GLI3;GLIS2;MOSMO;KIF7;GPC3;TULP3;SUFU;PTCH1;MGRN1;VCP
prerank,ncRNA transcription (GO:0098781),0.2972635718359281,0.7839538591569789,0.7590361445783133,0.9998676067602279,1.0,6/13,24.10%,ANG;SIRT7;RPAP2;USPL1;NIFK;SPIN1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.2646069555522874,-0.7828975408345209,0.7830882352941176,0.9301576008041328,1.0,13/24,39.62%,CTSC;PSME2;EPHA4;GPX1;PSME1;PTK2B;RHBDF1;ATP5IF1;DNAAF4;UBE3A;NUDT15;PSME3;EFNA1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.2875597625600145,-0.7828811958244892,0.7752212389380531,0.929783188909008,1.0,8/17,31.63%,AKT1;SFPQ;SOD1;MAPK7;NFE2L2;BAG5;TREM2;VNN1
prerank,arachidonic acid secretion (GO:0050482),-0.3337267325801961,-0.7828594061738201,0.7662835249042146,0.929018947470078,1.0,5/10,35.49%,ACE;ANXA1;PNPLA8;PLA2G5;DRD3
prerank,arachidonate transport (GO:1903963),-0.3337267325801961,-0.7828594061738201,0.7662835249042146,0.929018947470078,1.0,5/10,35.49%,ACE;ANXA1;PNPLA8;PLA2G5;DRD3
prerank,G1/S transition of mitotic cell cycle (GO:0000082),-0.20172161786004694,-0.7826167492484177,0.8986254295532646,0.9290035676004731,1.0,29/83,29.98%,MNAT1;RB1;CDK17;CDKN1B;CRLF3;CUL3;MAX;PLK2;CUL2;LATS2;CDK6;GSPT1;CACUL1;CCND1;CDK14;CDKN2C;CDC25A;CDK18;CCNE2;E2F3;TFDP1;KHDRBS1;BRD4;PLK3;CDKN3;CDK16;CCNH;HINFP;CDC34
prerank,cholesterol homeostasis (GO:0042632),0.20485236193058534,0.7820766585919794,0.894484412470024,1.0,1.0,21/64,23.55%,NR1D1;INSIG1;AKR1C1;APOM;TSKU;ABCA2;LIPC;ABCA5;LDLR;GRAMD1B;APOE;SOAT2;DISP3;CD24;SOAT1;ANGPTL3;LAMTOR1;ABCG1;CNBP;NR1H2;TMEM97
prerank,female gamete generation (GO:0007292),-0.24954342055394352,-0.781919448681346,0.791095890410959,0.9297165657922539,1.0,6/29,15.56%,USP9X;DMC1;MCM9;PARN;MARF1;PRDM9
prerank,prostanoid metabolic process (GO:0006692),-0.3079956358854545,-0.7818608591039101,0.7526501766784452,0.9294096790172277,1.0,4/13,21.13%,PTGS1;ACOX1;HPGDS;PTGR1
prerank,cholesterol transport (GO:0030301),-0.22580670162509292,-0.7818539743426469,0.8178506375227687,0.9290245573356594,1.0,11/45,21.53%,LIMA1;CAV1;LDLRAP1;SCARB1;STARD3;STARD4;ABCA7;STX12;STAR;OSBPL2;LCAT
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.2757949795371999,-0.7816017246013686,0.7633451957295374,0.9290255481308977,1.0,5/19,15.59%,MTOR;RPTOR;ICE1;POLR3F;NAB2
prerank,peptidyl-methionine modification (GO:0018206),-0.3095667570325689,-0.7813035975514587,0.7385159010600707,0.9290777358764082,1.0,2/12,10.04%,NAA16;NAA15
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.2712213731097041,-0.7810246439390564,0.7928436911487758,0.9291053798629609,1.0,7/21,31.45%,PLA2G4A;MBOAT1;PLA2G12A;LPCAT3;PLA2G4F;OSBPL10;PLA2G5
prerank,negative regulation of neuron differentiation (GO:0045665),-0.27205598373724327,-0.7809007056490751,0.7800369685767098,0.9289017188084899,1.0,7/22,25.92%,GSK3B;HES1;MED1;BMP7;HEY1;NEPRO;EIF2AK4
prerank,protein localization to microtubule organizing center (GO:1905508),0.28602713234987,0.7806962988719269,0.7839080459770115,1.0,1.0,3/15,10.63%,BBS4;SNX10;CCDC14
prerank,response to acidic pH (GO:0010447),-0.3077318034746259,-0.7805350397180902,0.7647058823529411,0.9290713876716642,1.0,5/13,23.85%,CHP1;LGMN;PKD2L1;GPR4;RAB11FIP5
prerank,rRNA modification (GO:0000154),0.26594261656321305,0.7802428734003201,0.802660753880266,1.0,1.0,7/21,22.42%,MTERF4;BUD23;TFB1M;DIMT1;TSR3;THUMPD1;NOP10
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.2080995836548232,-0.779223193392845,0.8795811518324608,0.9307057104217336,1.0,22/64,32.80%,PLA2G4A;ELOVL5;ACADL;GSTM2;EPHX1;CPT1A;ACAD9;SLC27A4;MGLL;GPX1;ACOX1;ACSL1;DAGLB;PNPLA8;CYP1B1;SLC27A3;GPX4;HACL1;ELOVL2;ALOXE3;CPT2;ELOVL6
prerank,positive regulation of cell killing (GO:0031343),-0.3090625515885488,-0.7791481198868883,0.7866419294990723,0.9304081457593638,1.0,3/13,23.43%,RAC1;MAPK8;FZD7
prerank,cartilage development (GO:0051216),-0.22256338180066126,-0.7786948017007603,0.8489208633093526,0.930660616419924,1.0,19/49,33.23%,ZBTB16;NFIB;BMP4;CREB3L2;MEF2C;FGF2;SNX19;CCN3;TRPV4;HYAL2;BMP2;WNT2B;WNT5B;TRIP11;HYAL3;RUNX1;TGFB1;SULF1;WNT7A
prerank,extracellular matrix assembly (GO:0085029),0.25310742180777546,0.7776888615423473,0.8058035714285714,1.0,1.0,4/23,8.36%,GPM6B;NTNG2;NTNG1;LAMB3
prerank,establishment of protein localization to extracellular region (GO:0035592),0.22720806077637787,0.7776650187328631,0.815068493150685,1.0,1.0,8/39,16.51%,RAB15;PDIA4;RAB3C;TANGO2;RAB3A;RCN3;COPG2;SEL1L
prerank,spliceosomal snRNP assembly (GO:0000387),-0.23175484501722954,-0.7775465507835282,0.8425760286225402,0.9319929586387596,1.0,13/38,28.11%,PRPF3;PRPF6;PRPF31;SNRPE;TGS1;SRSF12;CD2BP2;STRAP;SRSF10;COIL;GEMIN7;AAR2;LSM2
prerank,acylglycerol biosynthetic process (GO:0046463),0.25828507543332535,0.777464666631863,0.7901785714285714,1.0,1.0,4/23,12.65%,LPIN1;ANG;GK;MOGAT1
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.2203403179512958,-0.7770514037913204,0.8702702702702703,0.9323802373990487,1.0,17/51,31.57%,APP;CASP8;JAK2;LPL;PANX1;TRIM16;IL16;GBP5;CCL19;NOD2;CASP1;FZD5;HMGB1;LGALS9;NLRC4;STAT3;TLR6
prerank,mRNA splice site selection (GO:0006376),0.24329337557588349,0.7769287568577357,0.8169934640522876,1.0,1.0,4/30,6.47%,CELF5;CELF4;CELF2;CELF6
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.3064153591522913,-0.7765856281604103,0.7654545454545455,0.9326901413348515,1.0,6/13,31.55%,BMP4;NOTCH1;TBX3;EID2B;TGFB1;SOSTDC1
prerank,nuclear envelope organization (GO:0006998),-0.2750382500980415,-0.7762453109755906,0.7866894197952219,0.9328137598974643,1.0,4/20,15.90%,EMD;TOR1B;REEP3;SUN1
prerank,neutrophil migration (GO:1990266),-0.21294405020057794,-0.7754692948516633,0.8871527777777778,0.9335395514537195,1.0,7/58,11.69%,PECAM1;BSG;CCL25;TGFB2;PIK3CD;EDN1;EDN3
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.25117413519088616,-0.7754471607582982,0.8330434782608696,0.9331690558985828,1.0,14/26,40.43%,LRRK2;AKT1;ATF4;FYN;TXN;MAPK7;NFE2L2;BAG5;PYCR1;VNN1;PARK7;PDE8A;GATA4;SIRT1
prerank,regulation of T cell differentiation (GO:0045580),-0.24013192649278078,-0.7747228473525959,0.802536231884058,0.9338447887161146,1.0,3/33,5.93%,CBFB;ZMIZ1;ABL1
prerank,ribosomal large subunit assembly (GO:0000027),-0.25938676578326336,-0.7743354615735725,0.8051001821493625,0.9340278023305202,1.0,8/24,20.94%,NOP2;RPL3;RPL10;RPL5;NLE1;MDN1;BOP1;RRS1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.2937851059115331,-0.7738385662920728,0.7777777777777778,0.9343134849058548,1.0,11/15,48.63%,CD55;GLI3;NKAP;PNP;SHH;HSPH1;SYK;EBI3;IHH;IL23R;IL12B
prerank,sterol homeostasis (GO:0055092),0.2015275883187841,0.7733980560532517,0.8857142857142857,1.0,1.0,21/65,23.55%,NR1D1;INSIG1;AKR1C1;APOM;TSKU;ABCA2;LIPC;ABCA5;LDLR;GRAMD1B;APOE;SOAT2;DISP3;CD24;SOAT1;ANGPTL3;LAMTOR1;ABCG1;CNBP;NR1H2;TMEM97
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.3037996831162085,-0.773312286755398,0.7731397459165155,0.9346681664455224,1.0,7/13,33.47%,RNF168;NELFB;SUPT4H1;HNRNPU;LARP7;NELFA;NELFCD
prerank,regulation of interferon-gamma production (GO:0032649),0.20040855974812768,0.7731635474325007,0.8839285714285714,1.0,1.0,12/71,15.73%,PDE4B;TRIM27;IL12A;IL12RB1;RASGRP1;CD226;HAVCR2;TXK;SLAMF6;IL23A;CD47;SIRPA
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.2719224349135785,-0.7723774701610324,0.7771639042357275,0.9356308591907838,1.0,8/20,32.03%,PLOD2;PLSCR1;PTDSS1;GAMT;GCLC;CNDP2;HAGH;MGST2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.2774179664762343,-0.7722364643574435,0.7970204841713222,0.9354566184098285,1.0,7/19,19.32%,KDR;PTPRJ;STIMATE;BCAP31;PTGFR;VCAM1;PTPRC
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.256562041830863,-0.771993963773595,0.8061041292639138,0.9354084069221255,1.0,7/25,17.07%,FBXL17;CUL3;ATXN3;ZER1;ZYG11B;UGGT1;HDAC6
prerank,intraciliary retrograde transport (GO:0035721),-0.31091045805090634,-0.7718970265486045,0.7912885662431942,0.9351685243428371,1.0,4/12,19.26%,IFT140;WDR35;DYNC2LI1;IFT43
prerank,establishment of vesicle localization (GO:0051650),-0.2774151937899381,-0.7717539539416676,0.8112522686025408,0.9349644724251142,1.0,7/18,18.44%,LIMK2;DNM2;RAB27A;TMEM230;SPG11;RAB11A;IKBKG
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.31998752706868716,-0.7717140937164749,0.7572463768115942,0.9346332536882686,1.0,4/11,26.46%,CDC73;AHCYL1;ZFP36L1;LEO1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.32896389763888934,-0.7715362926671548,0.7707948243992606,0.9344840757299503,1.0,7/10,45.95%,TCP1;CCT5;CCT2;CCT3;CCT7;DKC1;CCT6A
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.22764333221097716,0.7707446723313008,0.8398058252427184,1.0,1.0,5/38,11.70%,MAGI2;FLCN;GPER1;NOP53;PHLPP1
prerank,protein localization to condensed chromosome (GO:1903083),-0.3124702055054145,-0.7697822520715158,0.7854545454545454,0.9366553903997465,1.0,8/12,47.06%,BUB3;TTK;MTBP;SPDL1;MIS12;AURKB;CHAMP1;KNL1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.30796203366389885,-0.7697304516609357,0.7637051039697542,0.9363346541421187,1.0,3/12,13.13%,NFIB;EPHA4;PAFAH1B1
prerank,natural killer cell activation (GO:0030101),-0.25979929127597146,-0.7696431947276062,0.8032200357781754,0.9360588984147971,1.0,3/23,9.65%,PBX1;CASP8;PIK3CD
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.19572285595037028,0.7693147367627985,0.9020501138952164,1.0,1.0,23/84,20.79%,PATL2;GGA3;TYMS;ENC1;SPHK1;NTRK2;SORL1;RTN4;FXR2;CPEB3;EIF4A3;CNOT7;CLU;EIF4E2;APOE;EIF2AK2;DHX36;IGF2BP3;RTN3;HAP1;SAMD4B;RTN1;RBM4
prerank,fatty acid oxidation (GO:0019395),-0.2096087758879997,-0.7687330625352584,0.8839285714285714,0.9369302406984592,1.0,9/57,15.50%,HADHB;ADIPOR2;ABCD3;BDH2;PPARD;ACADL;ACAD11;ACADVL;ACOX1
prerank,pre-replicative complex assembly (GO:0036388),0.20390218140170532,0.7685812507363753,0.8688524590163934,1.0,1.0,14/64,17.13%,GMNN;PSMC5;MCM8;PSMD10;PSMD14;PSMB7;PSMA4;PSMD1;PSMF1;PSMB8;ORC1;PSMD7;PSMB5;PSMD2
prerank,negative regulation of myotube differentiation (GO:0010832),-0.3128350539555452,-0.7684855511448447,0.7736549165120594,0.9368756691277368,1.0,4/12,15.43%,HDAC1;NOTCH1;HDAC4;CCN3
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.2738039857802781,0.768351800723966,0.7645788336933045,1.0,1.0,2/18,5.71%,PAG1;VTCN1
prerank,steroid hormone biosynthetic process (GO:0120178),-0.24746833110635985,-0.7678440778312492,0.8256880733944955,0.9373854834222294,1.0,7/29,18.81%,MED1;STARD3;FDX1;FDXR;STARD3NL;DHCR7;STAR
prerank,placenta development (GO:0001890),-0.31232906082015316,-0.7676305691925281,0.8085867620751341,0.9373038780021513,1.0,5/12,24.41%,PTK2;CUL7;SOD1;PPARG;E2F7
prerank,cobalamin metabolic process (GO:0009235),0.2724440802767829,0.7663946094532786,0.785876993166287,1.0,1.0,3/17,13.46%,CBLIF;MMAB;MMAA
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.3010775546321717,0.7663760046287494,0.7884187082405345,1.0,1.0,2/10,12.58%,OXSR1;CCL5
prerank,ear morphogenesis (GO:0042471),-0.2656105933531648,-0.7662692258812002,0.8021015761821366,0.9387838493092516,1.0,3/20,5.59%,TBX1;NIPBL;SIX1
prerank,oligosaccharide metabolic process (GO:0009311),-0.22150053089172805,-0.7656932672520665,0.8775137111517367,0.9392105427310401,1.0,6/46,9.03%,ST3GAL6;ST3GAL4;ST8SIA4;ST6GALNAC3;FUT8;ST3GAL2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.3118141759840747,0.7655879844846575,0.7586206896551724,1.0,1.0,4/10,17.06%,EGR1;SORL1;CLU;HSP90AB1
prerank,regulation of intracellular transport (GO:0032386),0.22132634193941098,0.765465792240632,0.8517699115044248,1.0,1.0,12/38,20.79%,ATP9A;MAP2;PLA2G3;NEFH;ATP13A2;INPP5F;MLC1;NUMA1;AAAS;HAP1;REEP5;RBM4
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.2951362758844469,-0.7653385939891787,0.7672253258845437,0.9393393389245442,1.0,8/14,46.44%,IRAK1;COPS8;MAP3K7;TLR6;ZFP91;CARD14;MALT1;TLR3
prerank,regulation of rRNA processing (GO:2000232),-0.28257862848452886,-0.7652198127962793,0.7946902654867256,0.9391051200336382,1.0,2/16,5.92%,KAT2B;WDR75
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.19874164684714374,0.7651234370522584,0.9050772626931567,1.0,1.0,15/69,17.29%,COX6A2;UQCR10;NDUFA1;UQCRH;SDHA;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFAB1;COX6A1;NDUFS7;NDUFB6;NDUFA11
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.30027485020891853,-0.7638545801934038,0.7414104882459313,0.9406580345202578,1.0,3/12,13.36%,CHMP4B;CHMP4A;SGTA
prerank,potassium ion export across plasma membrane (GO:0097623),-0.30457210327047946,-0.7637234374086528,0.7744227353463587,0.9404524222942838,1.0,5/13,27.47%,KCNK5;KCNQ1;KCNE4;KCNH2;KCND3
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.322544380171299,-0.7636914419946006,0.7791519434628975,0.9401070442727466,1.0,2/10,9.16%,GRB10;GSK3A
prerank,mucosal immune response (GO:0002385),-0.28731220678785413,-0.7636882813968509,0.7749077490774908,0.9397147945650997,1.0,13/15,54.27%,RNASE3;DEFA6;RPL39;IFNLR1;NOS2;RAB17;IL4;CAMP;BPIFB1;DEFB1;FFAR2;LTF;PIGR
prerank,axonal transport (GO:0098930),0.22829870326984636,0.763574767927757,0.8275862068965517,1.0,1.0,8/36,16.69%,TMEM108;SYBU;AP3S2;MAPT;KIF3A;AP3M2;SNAPIN;NEFL
prerank,regulation of keratinocyte migration (GO:0051547),-0.30995341711643165,-0.7633201703275051,0.7977736549165121,0.9398398387806862,1.0,5/12,20.17%,MTOR;ADAM9;FGF7;MAP4K4;PTEN
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.27279690056748607,-0.7631112248277986,0.7965779467680608,0.939717917719452,1.0,8/18,26.13%,MCM4;POLD3;GINS3;GINS1;RFC4;MCM3;LIG1;MCM7
prerank,monocyte differentiation (GO:0030224),-0.3273145468078555,-0.7630833093137406,0.7967625899280576,0.9393643304344497,1.0,5/10,25.51%,MYH9;BMP4;PIR;PPARG;MT1G
prerank,programmed necrotic cell death (GO:0097300),-0.276496494709615,-0.7627493344071516,0.8238434163701067,0.9394551218606557,1.0,14/18,49.60%,TRPM7;PPIF;RIPK1;ALKBH7;IPMK;TICAM1;CD14;MLKL;TLR4;TICAM2;TLR3;ITPK1;RIPK3;LY96
prerank,histone H2A monoubiquitination (GO:0035518),-0.27590049122364824,-0.761805544409734,0.8175182481751825,0.9403935153198688,1.0,6/17,21.21%,RYBP;RNF168;BCOR;PCGF3;RNF2;PCGF5
prerank,chondroitin sulfate metabolic process (GO:0030204),0.23757184540386245,0.7617822569494939,0.8344671201814059,1.0,1.0,8/30,13.61%,DSEL;CHSY3;NCAN;CHST9;HEXB;CHST12;CHSY1;UGDH
prerank,retina homeostasis (GO:0001895),-0.2578457121630385,-0.7617725443922695,0.8183556405353728,0.9400368823397806,1.0,10/23,33.72%,ACTB;POTEF;TULP1;SOD1;CCDC66;POC1B;PRDX1;JCHAIN;CRB2;ACTG1
prerank,negative regulation of neurogenesis (GO:0050768),-0.23733866150733576,-0.7614102980604762,0.8424015009380863,0.9401032305423923,1.0,9/34,22.67%,RAPGEF2;ARHGDIA;GDI1;NOTCH1;RHOA;PCM1;PTEN;NF1;PTN
prerank,cell part morphogenesis (GO:0032990),0.2848861350688121,0.7613898632679422,0.7790432801822323,1.0,1.0,5/13,23.28%,SLIRP;MFF;FIS1;MYH14;DNM1L
prerank,regulation of steroid metabolic process (GO:0019218),-0.2611412506657949,-0.7611754196142871,0.8321299638989169,0.9400536148137301,1.0,6/23,19.85%,PANK2;ACADL;ACADVL;ASAH1;STAR;FMO5
prerank,negative regulation of cellular metabolic process (GO:0031324),0.22871756063255252,0.7605853947397294,0.8693586698337292,1.0,1.0,9/37,18.22%,ANKRD13B;WDR54;PAX2;MTMR2;ABCA2;DLG4;APOE;OPTN;EDNRB
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.3155750551820129,-0.7602366764540989,0.7960644007155635,0.9409415956984838,1.0,4/10,33.53%,LRP6;CTNNB1;FZD1;WNT3
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.2866745401882245,-0.7601882913945234,0.8111510791366906,0.9406152179021596,1.0,5/15,26.34%,TCP1;RUVBL2;CCT5;CCT2;NAF1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.24569602161925858,-0.7593851110160809,0.824468085106383,0.9412941663880862,1.0,11/27,27.31%,CSGALNACT1;CHST15;CHST11;CSPG4;BGN;CHST7;CHPF2;PXYLP1;XYLT2;CSGALNACT2;XYLT1
prerank,neutrophil chemotaxis (GO:0030593),0.20753932566275873,0.7589395144350721,0.8818181818181818,1.0,1.0,8/53,14.71%,PDE4B;CXADR;PF4;CCL13;CCL5;CCL2;PPIA;CCL7
prerank,positive regulation of cell development (GO:0010720),-0.23777734705086656,-0.7587946068476584,0.8478664192949907,0.9417043241212125,1.0,4/31,7.84%,PDE3A;SPEN;BMP4;TGM2
prerank,inorganic anion transport (GO:0015698),0.20624355812751344,0.7584092977106138,0.8909090909090909,1.0,1.0,10/53,16.03%,SLC34A1;CLCNKA;GLRA1;ANO4;CLCN2;ENPP3;SLC26A8;RACGAP1;SLC4A11;SLC13A1
prerank,tRNA wobble base modification (GO:0002097),-0.2857973206899947,-0.7583516200464004,0.7950191570881227,0.9419051941872542,1.0,8/14,40.13%,DPH3;TRMT9B;MOCS3;KTI12;CTU2;ALKBH1;ELP4;ELP3
prerank,ganglion development (GO:0061548),-0.30859634030142635,-0.758263731082624,0.7876106194690266,0.9416391656562402,1.0,1/11,0.76%,NRP2
prerank,regulation of phosphate metabolic process (GO:0019220),-0.2845829214080253,-0.7580000003741602,0.7893772893772893,0.9416034318901159,1.0,10/16,42.55%,PSEN1;IGBP1;IKBKB;SMG6;MCM7;SMG7;PGAM1;GNB3;IL4;SRPX2
prerank,apoptotic nuclear changes (GO:0030262),0.2469057864763136,0.757821233582258,0.8484848484848485,1.0,1.0,6/24,15.22%,BLCAP;H1-0;GPER1;HMGB2;ACVR1C;DEDD2
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.22348327929001746,-0.7575696894058568,0.85,0.9417950420591348,1.0,8/40,12.16%,BMPR2;BMP6;BMP4;MEF2C;ACVR2A;ADGRV1;ANO6;PKDCC
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.30491158565299753,-0.7575182212303911,0.7676950998185118,0.941462345166757,1.0,9/12,46.51%,MAD1L1;CENPE;BOD1;NUF2;MIS12;RMDN1;KIF2C;CDT1;CHAMP1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.24080555000513654,-0.7569656804047336,0.8356643356643356,0.9418006602354858,1.0,6/32,17.21%,PPP1R13B;FHIT;DDIT4;TP53;HIPK1;HINT1
prerank,negative regulation of defense response to virus (GO:0050687),0.30405090867818196,0.7555207667848338,0.7705627705627706,1.0,1.0,3/10,14.02%,RNF26;TSPAN6;PCBP2
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.2801074515150069,-0.7553852930503051,0.8014059753954306,0.9435072471102072,1.0,3/15,16.62%,GGT5;GGACT;HOGA1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.24801562225794926,0.7550725661356953,0.8363228699551569,1.0,1.0,2/23,6.18%,PPEF1;METAP2
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.24834930955715867,-0.7548844317742455,0.8190127970749543,0.943784901633746,1.0,11/25,36.26%,EPHA4;HFE;SGTA;RPL5;RPS7;TRIM39;PRKCG;OPHN1;GABARAPL2;CSNK2A1;CSNK2A2
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.27760254050839805,-0.7545850125903759,0.8068965517241379,0.943774923464537,1.0,2/16,6.13%,PPARA;PDCD4
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.3048507023209606,-0.7539848625313814,0.7873134328358209,0.9441669344499822,1.0,1/12,2.01%,ESR1
prerank,glutamate metabolic process (GO:0006536),0.2625441220123088,0.7539500267532042,0.8113636363636364,1.0,1.0,9/19,27.41%,OAT;GLS2;GLS;GLUD1;GAD1;MTHFS;GCLM;FPGS;ALDH5A1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.29934946931441414,-0.7537315010216004,0.8069565217391305,0.9441339809674016,1.0,4/13,18.07%,BMP5;NFKB1;ERLIN2;SOD1
prerank,tRNA wobble uridine modification (GO:0002098),-0.2820560734338711,-0.7536829258786015,0.8171641791044776,0.9438076467841384,1.0,8/14,40.13%,DPH3;TRMT9B;MOCS3;KTI12;TRMU;CTU2;ELP4;ELP3
prerank,negative regulation of protein metabolic process (GO:0051248),-0.21493006244719404,-0.7530850561189565,0.881508078994614,0.9442235502050474,1.0,12/48,20.64%,EGFR;NFKB1;ROCK1;FLNA;VBP1;EDN1;SNX12;AZIN1;IAPP;MAD2L2;PFDN6;ITGB3
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.2855375439272937,0.7526588233560428,0.8101545253863135,1.0,1.0,2/14,6.31%,SHISA2;GPC1
prerank,sarcomere organization (GO:0045214),0.23923671456793555,0.7519022277016951,0.8405797101449275,1.0,1.0,4/27,12.82%,FHOD3;MYPN;MYLK3;CASQ1
prerank,cellular macromolecule catabolic process (GO:0044265),-0.2101866132504502,-0.7517915303818373,0.8908765652951699,0.9455058748761767,1.0,12/49,27.55%,DAB2IP;DENND3;RNASE3;ADAMTS9;XRN2;MAGEC2;RNASEH2C;RIPK1;EXOSC7;FBXO17;HNRNPD;MANBA
prerank,glutathione biosynthetic process (GO:0006750),0.2982039898765872,0.7515031126515138,0.8043010752688172,1.0,1.0,1/11,3.75%,GGCT
prerank,determination of left/right symmetry (GO:0007368),0.22278045684784825,0.751146645016754,0.8666666666666667,1.0,1.0,10/36,16.20%,ODAD2;MEGF8;BBS7;DNAAF1;PKD1L1;ENKUR;LEFTY1;ARL6;FOXJ1;MKKS
prerank,regulation of lymphocyte proliferation (GO:0050670),0.2711730181985068,0.7503094304859507,0.7968036529680366,1.0,1.0,2/16,9.73%,TNFSF18;IL12A
prerank,regulation of glucose metabolic process (GO:0010906),0.2284873823822962,0.7502136640091831,0.8631090487238979,1.0,1.0,6/34,14.60%,DGKQ;GNMT;BCKDK;GPLD1;SIRT7;SELENOS
prerank,epiboly involved in wound healing (GO:0090505),-0.2744357839067211,-0.7501534124522837,0.8194174757281554,0.9473620863820017,1.0,7/16,22.42%,FLNA;RHOA;CEACAM1;LCP1;RHOC;ARHGAP35;CCN1
prerank,regulation of mitochondrion organization (GO:0010821),0.21116380953118952,0.7497576819190374,0.898989898989899,1.0,1.0,16/47,23.28%,OMA1;PRMT6;FLCN;MAPT;ATP13A2;INF2;HTRA2;SIRT7;RHOT1;MFF;VDAC1;FIS1;PISD;SQSTM1;USP36;DNM1L
prerank,regulation of phospholipid metabolic process (GO:1903725),0.31044468434368977,0.74898946543536,0.7965367965367965,1.0,1.0,2/10,6.82%,PHB2;MTMR2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.23469984365586471,-0.7489310863712461,0.8333333333333334,0.9485774143019975,1.0,10/32,24.21%,LPCAT1;SLC44A1;STARD7;MFSD2A;CEPT1;PCTP;LPIN2;LPCAT3;LCAT;CHAT
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.2639979258240197,-0.7485152755116755,0.8151408450704225,0.9487470836526875,1.0,7/19,30.81%,BMP4;RGCC;EMILIN1;F2R;LARP6;RUNX1;TGFB1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.2543820911632705,-0.7482649107728736,0.8249566724436742,0.9486720978171226,1.0,14/21,43.01%,MECP2;RAB11A;CCND1;CDC25A;BRD4;DTL;STOX1;CDK4;DYRK3;FBXO5;ATAD5;CCNB1;CDC25C;RAD51C
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.27757028513238724,0.7477428477047404,0.7820224719101123,1.0,1.0,2/14,7.07%,PELI3;TRAIP
prerank,response to purine-containing compound (GO:0014074),0.26942675548622647,0.7474236193206283,0.8028169014084507,1.0,1.0,2/17,7.41%,DGKQ;RYR2
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.2247778931491727,-0.7473772086633595,0.8692579505300353,0.9494208757394671,1.0,10/37,23.23%,RBX1;ERCC2;POLD3;RPA3;RPA1;ERCC3;RPA2;RFC4;NTHL1;RFC1
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.27046453986902275,-0.7472919748137263,0.8181818181818182,0.9491410222532451,1.0,5/17,28.06%,FERMT2;PTPRC;TERT;HNRNPU;N4BP2L2
prerank,negative regulation of gluconeogenesis (GO:0045721),0.3006288309742917,0.7469155674736899,0.7730496453900709,1.0,1.0,1/11,1.95%,GCK
prerank,negative regulation of interferon-beta production (GO:0032688),0.3079082448606216,0.7467748491824963,0.7835990888382688,1.0,1.0,3/10,15.73%,REL;PTPRS;SIRPA
prerank,chemical homeostasis (GO:0048878),-0.20203731577035297,-0.7464696310339958,0.8947368421052632,0.9498022941843567,1.0,18/61,24.91%,ZBTB20;NEDD4L;SLC4A10;TENT4B;DDX3X;AQP11;WNK4;NR1D2;ACOX1;TLCD1;ACOX3;KLHL3;PPARG;SLC66A1;PNPLA8;CEBPA;PNPLA2;TLCD3B
prerank,positive regulation of cellular senescence (GO:2000774),-0.31881627799699763,-0.7462968383577943,0.8078358208955224,0.9496287175088736,1.0,3/10,15.17%,YPEL3;ABI3;CGAS
prerank,ESCRT complex disassembly (GO:1904896),-0.3199917814108072,-0.7462540494627503,0.8139963167587477,0.9489003003710504,1.0,3/10,16.45%,VTA1;CHMP2B;CHMP5
prerank,ESCRT III complex disassembly (GO:1904903),-0.3199917814108072,-0.7462540494627503,0.8139963167587477,0.9489003003710504,1.0,3/10,16.45%,VTA1;CHMP2B;CHMP5
prerank,regulation of spindle organization (GO:0090224),-0.26480310892056474,-0.7462401999623378,0.8282828282828283,0.9485278376958216,1.0,9/18,34.17%,RAE1;DCTN1;RNF4;TACC3;SENP6;BORA;MAP9;PARP3;PSRC1
prerank,lymphocyte proliferation (GO:0046651),-0.2549922641822446,-0.7458056558430007,0.8568840579710145,0.948721159310775,1.0,7/22,21.96%,MSN;MEF2C;CTPS1;CD40;LMBR1L;PTPRC;ELF4
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.19936506574166432,0.7457600062340373,0.8982300884955752,1.0,1.0,12/56,17.29%,FOXRED1;NDUFA1;NDUFAF3;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFAB1;NDUFS7;NDUFB6;NDUFA11
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.19936506574166432,0.7457600062340373,0.8982300884955752,1.0,1.0,12/56,17.29%,FOXRED1;NDUFA1;NDUFAF3;NDUFA10;NDUFA5;NDUFS8;NDUFB5;NDUFC1;NDUFAB1;NDUFS7;NDUFB6;NDUFA11
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.3041468661957576,-0.7453695135934526,0.8342541436464088,0.9488837386176879,1.0,2/12,11.64%,LY6E;IFITM3
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.20593645668115884,0.7448327099803469,0.9030837004405287,1.0,1.0,8/48,13.25%,ROBO1;TTLL12;PELI3;TRAIP;PADI2;SLIT3;OAS3;CNOT7
prerank,protein localization to centrosome (GO:0071539),0.263253974465899,0.7441901401819578,0.8430913348946136,1.0,1.0,5/17,18.81%,BBS4;SNX10;CCDC14;GOLGB1;HOOK3
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.30063008651225503,-0.7436555990211354,0.7931034482758621,0.9506800652721359,1.0,4/12,21.42%,PTPRJ;CBL;F3;IFT20
prerank,regulation of aerobic respiration (GO:1903715),-0.27957491281088465,-0.7433783025903384,0.8292682926829268,0.9506441336165136,1.0,1/15,1.76%,CBFA2T3
prerank,neuron projection regeneration (GO:0031102),-0.3128626736569864,-0.743089349442486,0.7967914438502673,0.9505966460124619,1.0,4/10,27.94%,NREP;RTN4RL1;PTN;MTR
prerank,epithelial structure maintenance (GO:0010669),-0.30469906579770967,-0.742958236303822,0.806049822064057,0.9503770634202985,1.0,6/11,37.72%,RBP4;NOD2;STRAP;MUC13;PIWIL4;MUC6
prerank,tetrapyrrole metabolic process (GO:0033013),0.2599717821677531,0.7428710609890485,0.8171296296296297,1.0,1.0,3/18,13.46%,CBLIF;MMAB;MMAA
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.1745217782936839,-0.7423771115880696,0.9774859287054409,0.9506959515806248,1.0,39/132,26.36%,EIF4H;RBM5;RPS14;PRPF6;RPSA;NOP2;CELF1;DDX39B;RPL3;SF3B1;PUF60;CPSF7;DICER1;CDC73;RPL38;SNRPE;RPL10;PTGES3;TGS1;RPL5;NLE1;SRPK2;RPS27;MDN1;PRKDC;BOP1;STRAP;RRS1;SRSF10;HSP90AA1;RPS15;COIL;EIF3A;GEMIN7;USP39;GCFC2;DHX9;NAF1;PRPF18
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.2528825114975859,-0.7420031873239126,0.8410714285714286,0.9507763119908327,1.0,4/22,20.24%,CBFB;IRF1;VSIR;BCL6
prerank,tyrosine metabolic process (GO:0006570),0.2999811687904087,0.7417927206451838,0.7628635346756152,1.0,1.0,11/11,70.02%,THAP4;GSTZ1;FAH;IL4I1;TAT;PAH;TH;IYD;DCT;HGD;TYR
prerank,regulation of defense response to virus (GO:0050688),-0.2868079427186969,-0.7415272089365904,0.8276481149012568,0.9509491383336498,1.0,8/14,29.58%,PPM1B;TRAF3IP1;TNFAIP3;ILRUN;ZMPSTE24;RNF216;DHX9;IFNLR1
prerank,immunoglobulin mediated immune response (GO:0016064),0.3059191795904712,0.7411818088593443,0.8113636363636364,1.0,1.0,2/10,17.74%,CD81;FCGR2B
prerank,regulation of immunoglobulin production (GO:0002637),0.2459787397750144,0.7408734985615211,0.8355555555555556,1.0,1.0,2/23,4.82%,PHB2;SASH3
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.2774973623664667,0.7402456744026432,0.8081264108352144,1.0,1.0,6/14,22.88%,XRCC5;ATR;ACD;TPP1;TERF2IP;BRCA2
prerank,lipoxygenase pathway (GO:0019372),-0.279524976859909,-0.7399169784094596,0.8461538461538461,0.9525481233611314,1.0,5/14,32.41%,PON2;GPX1;GPX4;ALOX5AP;ALOXE3
prerank,DNA packaging (GO:0006323),0.26614939636127394,0.7396885364070357,0.8365384615384616,1.0,1.0,2/16,6.57%,M1AP;H1-0
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.30475550969664983,-0.7396663718724932,0.8078291814946619,0.9524547899422702,1.0,2/11,9.30%,SCARB1;MFSD2A
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.2383049862249616,0.7395527433533924,0.8584070796460177,1.0,1.0,4/27,9.59%,DDR2;SPHK1;S100A6;PDGFA
prerank,neuromuscular synaptic transmission (GO:0007274),-0.266837480313155,-0.7390986904749863,0.838475499092559,0.9527716374558433,1.0,6/18,24.21%,ERC1;CHRNB1;FCHSD2;STAC3;FCHSD1;CHAT
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.23657194153298472,-0.738745282681683,0.8511029411764706,0.9527900892109066,1.0,12/29,28.11%,EXOSC2;EXOSC1;EXOSC3;EXOSC8;EDC3;EXOSC5;DCP1A;LSM3;NT5C3B;EXOSC7;CNOT8;LSM2
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.2733435038598871,-0.7385516619770445,0.8236331569664903,0.9526180712850054,1.0,2/16,5.48%,TMSB4X;PPARA
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.251647564361684,0.7383683955375039,0.8325581395348837,1.0,1.0,4/18,16.23%,MPV17L;TMEM14A;FZD9;SLC35F6
prerank,snRNA processing (GO:0016180),-0.2703928174266668,-0.7383177472475867,0.8025134649910234,0.9525086049202236,1.0,7/16,29.96%,INTS8;INTS3;INTS9;INTS7;TOE1;INTS5;INTS12
prerank,negative regulation of locomotion (GO:0040013),-0.29738858995737283,-0.7373073758781222,0.7879858657243817,0.9533575314082442,1.0,3/12,12.95%,CRK;FRMD5;DUSP3
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.31225263038500584,-0.7372511990615026,0.8211678832116789,0.9530314305343126,1.0,4/10,25.05%,TERF2;TFIP11;DCLRE1B;DCLRE1A
prerank,positive regulation of superoxide anion generation (GO:0032930),0.2775971872224795,0.7372024755999605,0.7906976744186046,1.0,1.0,2/13,8.42%,CD177;MAPT
prerank,ncRNA metabolic process (GO:0034660),-0.2205482978003144,-0.7369304626984229,0.8759259259259259,0.9530429279012608,1.0,6/37,14.23%,TUT7;TENT4B;DICER1;TUT4;PARN;AGO2
prerank,genitalia development (GO:0048806),-0.2984909484298446,-0.7362628435951593,0.8191304347826087,0.9534533901498052,1.0,6/12,31.26%,FOXF2;DNAJC19;PTPN11;TBX3;STRA6;SHH
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.2114672948902494,-0.7361757196955181,0.904424778761062,0.953165335128029,1.0,9/47,14.25%,KLF4;APP;NFKB1;NFKBIA;FOXO3;AKT1;EDN1;AGTR1;RPL10
prerank,positive regulation of type 2 immune response (GO:0002830),0.2766729388759887,0.7358931029472194,0.8177966101694916,1.0,1.0,3/14,13.29%,CD81;PRKCZ;CD86
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.29497771489438385,-0.7357772816740604,0.8159851301115242,0.9532384958728426,1.0,3/12,10.57%,DSE;CSPG4;BGN
prerank,glycosaminoglycan catabolic process (GO:0006027),0.2018184215701932,0.7345963529647122,0.9196428571428571,1.0,1.0,8/55,11.97%,GPC5;HPSE2;GPC1;NCAN;FMOD;PRELP;HEXB;SDC4
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.2542833557888586,-0.7345895243747671,0.8282647584973166,0.9542685817467368,1.0,4/20,13.67%,ZBTB16;LDB1;CDC73;CDK6
prerank,myofibril assembly (GO:0030239),-0.21326204444686067,-0.7342482565769407,0.9092627599243857,0.9542821608559824,1.0,6/42,12.82%,PGM5;TMOD3;CSRP2;CFLAR;LMOD1;TPM1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.20064525042690812,0.7342374423740368,0.9099307159353349,1.0,1.0,13/53,18.50%,PSMC5;PSMD10;BCKDK;PSMD14;PSMB7;PSMA4;PSMD1;PSMF1;PSMB8;PSMD7;PSMB5;PSMD2;PSMB3
prerank,regulation of dephosphorylation (GO:0035303),-0.2737378307756772,-0.7335845261305174,0.8138297872340425,0.9546599205460918,1.0,5/15,24.30%,MTMR3;IGBP1;CDK5RAP3;MTMR4;SMG6
prerank,glycerophospholipid metabolic process (GO:0006650),0.1864002621204021,0.7335470723586563,0.9411764705882353,1.0,1.0,13/75,12.14%,CLN3;HDHD5;PLEK;FAR1;PLA2G7;PLA2G3;PIGP;PLA2G4E;CPNE1;PLA2G6;PIGB;CSF1R;GPLD1
prerank,positive regulation of chemokine production (GO:0032722),-0.21406454077394238,-0.7333298353327403,0.8873483535528596,0.954579314083173,1.0,17/44,38.51%,APP;DDX3X;IL6R;LPL;IL17RA;MAVS;HMGB1;IL7;ADAM17;LGALS9;HMOX1;TSLP;CD74;TLR2;HIF1A;SYK;IL18
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.2873047210836732,-0.733327776641985,0.82174688057041,0.9541902218733724,1.0,5/13,30.12%,ITGB1;LPL;PPARG;FCER1G;CD9
prerank,positive regulation of mRNA processing (GO:0050685),0.2466776378108704,0.7331036217905299,0.8395604395604396,1.0,1.0,8/21,21.60%,CELF4;SF3B4;DHX36;DAZAP1;PRDX6;RBMX;PAF1;NCBP2
prerank,cellular response to hypoxia (GO:0071456),-0.17577863951271705,-0.7330990778220446,0.9691252144082333,0.9540545559424691,1.0,38/126,28.32%,CREBBP;PSMA2;MTOR;LIMD1;RBX1;BNIP3;PSME2;SUV39H1;CUL2;PSMB4;TP53;RGCC;LMNA;NDRG1;PSMC2;HIF3A;PSMB2;PSMB1;BMP7;ARNT;PSMA8;EPAS1;PSME1;NPEPPS;ELOC;PSMD4;TERT;MDM2;PSMA7;PSMD5;PTGIS;PLK3;ZFP36L1;PSMB10;PSMA3;HILPDA;HMOX1;ANGPT4
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.2717433495657309,-0.7328014911730031,0.8276481149012568,0.9540248974913171,1.0,4/15,16.34%,RAB3GAP1;SRPRA;RAB3GAP2;SRP14
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.2230820734998789,0.7327861938693395,0.8584269662921349,1.0,1.0,7/29,18.77%,IL12A;IL12RB1;RASGRP1;CD226;SLAMF6;IL23A;CADM1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.2299634509279412,0.7324863946920411,0.8662131519274376,1.0,1.0,4/26,11.67%,CARTPT;HOXA7;TMEM178A;TCTA
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.2618072144702857,-0.7321852652595805,0.8374558303886925,0.9543915596690155,1.0,10/18,40.43%,AKT1;NONO;MAPK7;NFE2L2;BAG5;VNN1;PARK7;HIF1A;TRAP1;SIRT1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.26036710315882,-0.7318486798916289,0.8402903811252269,0.954388370132623,1.0,4/19,18.07%,CAT;GPX1;ACOX1;SOD1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.2719392444337556,-0.7313865844716808,0.8286778398510242,0.9545545132338338,1.0,4/16,16.38%,BMP5;IGFBP4;IGFBP5;IGF1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.2028637102015275,-0.7307417733972228,0.8933566433566433,0.9549054050982652,1.0,9/53,19.01%,DAB2IP;GNA12;PSME2;FOXF2;ECSCR;PSMC2;GPX1;RAD23A;PSME1
prerank,negative regulation of interleukin-6 production (GO:0032715),0.23189598171689602,0.7306482262916383,0.8700440528634361,1.0,1.0,6/27,19.12%,SYT11;PTPN6;FOXJ1;SELENOS;SIRPA;CX3CL1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.20098771472128157,-0.7298603587571121,0.8950930626057529,0.9554840278428476,1.0,27/62,40.79%,MCL1;LRRK2;DDX3X;ARHGEF2;AKT1;ACKR3;PPIF;CXCL12;HERPUD1;MDM2;MAPK7;NFE2L2;TXNDC12;SNAI2;BAG5;PLAUR;TRIM32;VNN1;ARMC10;PARK7;DDIAS;CREB3L1;SIRT1;PTTG1IP;CDKN2D;TMBIM6;SFRP2
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.2852365533367578,0.7295734678475988,0.7853982300884956,1.0,1.0,1/11,5.44%,GNAT3
prerank,protein lipidation (GO:0006497),0.19518642733330915,0.7295664535204521,0.94,1.0,1.0,10/59,12.14%,DPM1;SELENOK;PIGP;ZDHHC8;ZDHHC13;MPPE1;ZDHHC20;PIGB;PGAP3;GPLD1
prerank,cellular amino acid catabolic process (GO:0009063),0.18356559773637218,0.7294776101510814,0.9617977528089887,1.0,1.0,24/87,21.70%,OTC;QDPR;BCKDK;ASPA;HMGCLL1;HAAO;AMT;MCCC2;SDSL;HMGCL;GLS2;GLS;GLUD1;CARNS1;TDO2;SARDH;GAD1;DDO;BCAT2;DLST;SLC25A21;ACAT1;DDAH1;GSTZ1
prerank,nuclear transport (GO:0051169),-0.268223332937995,-0.7293825326769,0.82421875,0.9556937509410214,1.0,2/16,6.96%,RSRC1;NUP98
prerank,regulation of exit from mitosis (GO:0007096),0.20710770355430183,0.7290537871580652,0.8949771689497716,1.0,1.0,3/38,5.70%,ANAPC2;PHB2;ANLN
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2090487278701146,0.7290030391242263,0.8928571428571429,1.0,1.0,12/40,24.39%,DDX11;CENPS;DONSON;TRAIP;ATR;ETAA1;PCNA;GEN1;CDK9;FBH1;RTEL1;TIPIN
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.2891768575959568,-0.7288124601355702,0.8249566724436742,0.9559459559582923,1.0,8/13,37.00%,LRRK2;HGF;TXN;NFE2L2;MET;PYCR1;PARK7;PDE8A
prerank,negative regulation of centrosome duplication (GO:0010826),-0.3007610479591115,-0.7286451716282509,0.8052434456928839,0.9557471574439604,1.0,1/11,3.07%,KAT2B
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.1913246301852134,-0.7279820568088813,0.9342806394316163,0.9561046415031896,1.0,17/72,23.23%,RBX1;MRE11;ERCC2;DICER1;XRN2;POLD3;OGG1;RPA3;DNA2;RPA1;PDE12;ERCC3;EDC3;RPA2;DCP1A;RFC4;RFC1
prerank,regulation of protein sumoylation (GO:0033233),-0.26745256788517335,-0.7276539868292001,0.8436363636363636,0.9560592007841384,1.0,5/17,19.68%,ZMIZ1;UBA2;HDAC4;CTNNB1;PIAS4
prerank,fatty acid catabolic process (GO:0009062),-0.19305768012147398,-0.7275538371854805,0.9399656946826758,0.955791530687217,1.0,13/67,20.49%,ABHD2;HADHB;ABCD3;BDH2;PPARD;ACADL;SLC27A4;ACAD11;ACADVL;ACOX1;PCCA;LPIN2;PCCB
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.24910716928466323,-0.7266129492615485,0.8461538461538461,0.9565041441671247,1.0,9/20,35.33%,NKTR;PPIG;FKBP5;PPIF;PPIH;CWC27;PPIE;PPIC;FKBP1B
prerank,sulfur compound catabolic process (GO:0044273),0.21743587874842285,0.7261663388513251,0.8653421633554084,1.0,1.0,6/38,10.65%,GADL1;DPEP1;NCAN;FMOD;PRELP;HEXB
prerank,negative regulation of B cell activation (GO:0050869),-0.2507225069684125,-0.7261621792249779,0.8614800759013282,0.9566121877337224,1.0,4/21,14.90%,LYN;ATM;RC3H1;TNFAIP3
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.2537413713919502,-0.72577538266575,0.8478664192949907,0.9566750181302259,1.0,8/20,30.50%,PSMG2;PTGES3;PFDN6;HSP90AA1;NDUFAF1;PSMG1;CCT2;PSMG3
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.2697930305660612,-0.7249388526046218,0.8674911660777385,0.9572132322101028,1.0,5/17,18.92%,WASF2;FCHSD2;NCKAP1;GMFB;WASF1
prerank,protein secretion (GO:0009306),-0.20057348594096694,-0.724870472490276,0.9320214669051878,0.9569021036444362,1.0,9/56,12.56%,CAMK2G;TANGO6;STEAP3;MON1A;COPG1;PCSK5;TVP23A;RAB8B;SNX19
prerank,triglyceride catabolic process (GO:0019433),-0.2520896133736097,-0.7245219577039752,0.8647166361974405,0.9569155249268165,1.0,6/19,40.17%,LPL;PNPLA2;FABP3;LIPH;FABP4;FABP12
prerank,establishment of mitotic spindle localization (GO:0040001),-0.23104713801719318,-0.7242514083407116,0.8884892086330936,0.9568269218562229,1.0,6/28,22.31%,ITGB1;DCTN1;PAFAH1B1;FBXW11;NDEL1;MISP
prerank,regulation of cell cycle phase transition (GO:1901987),0.17861034735830125,0.7241584673410927,0.9649122807017544,1.0,1.0,19/91,17.13%,ANAPC2;PSMC5;ATP2B4;PSMD10;DDB1;PSMD14;NEK10;NEK11;PSMB7;PSMA4;CDC26;PSMD1;TAF1;PSMF1;PSMB8;CDC27;PSMD7;PSMB5;PSMD2
prerank,negative regulation of cell division (GO:0051782),-0.2946847518440874,-0.7239403555516015,0.825136612021858,0.9567917061499118,1.0,3/11,24.41%,TXNIP;BLM;E2F7
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.2273656019953123,-0.7237923430790737,0.872822299651568,0.956571285058234,1.0,7/30,19.32%,CAV1;PRKCD;PARP14;SH3BP5L;HYAL2;PPP2CA;PTPRC
prerank,response to muramyl dipeptide (GO:0032495),-0.2886736121243458,-0.7230675720054233,0.8347978910369068,0.9570006503326401,1.0,5/12,25.08%,NOD1;ARHGEF2;CHMP5;NOD2;ERBIN
prerank,renal water homeostasis (GO:0003091),0.23860366300800984,0.7229238904618056,0.8603104212860311,1.0,1.0,5/23,14.39%,ADCY8;AQP4;ADCY7;PRKAR1B;ADCY3
prerank,dermatan sulfate metabolic process (GO:0030205),-0.28303461651440187,-0.7226050660792013,0.8348457350272233,0.9571049950707843,1.0,3/13,10.57%,DSE;CSPG4;BGN
prerank,natural killer cell mediated immunity (GO:0002228),-0.27162975295693675,-0.7217493895429493,0.7956600361663653,0.957626298930265,1.0,9/15,53.23%,CEBPG;ARL8B;RAET1E;TUBB4B;SLAMF7;KLRD1;KLRK1;KIF5B;KLRC2
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.29053020854771067,-0.7217284317496002,0.8524305555555556,0.9568743066698642,1.0,4/12,16.38%,SPPL3;STIMATE;LMCD1;IGF1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.29053020854771067,-0.7217284317496002,0.8524305555555556,0.9568743066698642,1.0,4/12,16.38%,SPPL3;STIMATE;LMCD1;IGF1
prerank,regulation of mitochondrial translation (GO:0070129),-0.24657722106335192,-0.7206982768179543,0.8420138888888888,0.957631468227859,1.0,10/21,40.77%,RPUSD4;MRPS27;MPV17L2;UQCC2;MTG2;TSFM;ALKBH1;NSUN3;RCC1L;TRMT10C
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.26193423935658866,0.7206649687166531,0.8202247191011236,1.0,1.0,3/14,14.71%,OXSR1;CCL5;CCL7
prerank,meiosis I (GO:0007127),-0.2432578329613025,-0.7204538267711647,0.8798586572438163,0.9575078139572102,1.0,9/23,32.33%,ZSCAN21;FOXJ3;BCL2L11;HSF2BP;TDRD9;DDX4;MYBL1;FOXJ2;MEIOB
prerank,histone H4-K16 acetylation (GO:0043984),-0.2551412874589603,-0.7199329221391214,0.8436363636363636,0.9576973114509618,1.0,6/19,23.01%,KANSL3;PHF20;HCFC1;JADE2;OGT;WDR5
prerank,carbohydrate catabolic process (GO:0016052),0.2076817242203636,0.7196807444739914,0.8891566265060241,1.0,1.0,4/38,10.95%,GCK;TPI1;PKM;ENO2
prerank,tRNA 5'-end processing (GO:0099116),0.26112890060902877,0.7187513884456294,0.8446808510638298,1.0,1.0,15/15,73.91%,RPP25L;PRORP;POP7;POP5;RPP21;POP1;HSD17B10;RPP38;RPP25;RPP14;TRMT10C;RPP40;SSB;POP4;RPP30
prerank,hexose transmembrane transport (GO:0008645),-0.24828941861998982,-0.7186829298055404,0.8660869565217392,0.9586166411104237,1.0,3/21,13.25%,SLC2A1;PPARD;SLC2A9
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.2933721962596131,-0.7186152102273201,0.8242990654205608,0.9583005245147451,1.0,4/11,18.37%,UQCR11;UQCRFS1;UQCRC1;UQCC3
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.28934223350531457,0.7183631019910518,0.8278867102396514,1.0,1.0,1/11,3.11%,CACNA2D1
prerank,positive regulation of transporter activity (GO:0032411),-0.27866892606251575,-0.7180441784331398,0.8374558303886925,0.9585131659380167,1.0,2/13,7.87%,RXRA;TRPC6
prerank,DNA integrity checkpoint signaling (GO:0031570),0.21104167408202232,0.7173618650344111,0.9095022624434389,1.0,1.0,4/36,5.71%,RHNO1;CDC45;USP28;DONSON
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.20871400017346017,-0.7155202216981816,0.921602787456446,0.9607872978653879,1.0,20/45,32.99%,GCNT2;APP;LARP1;FOXO3;PUM1;ZC3H7B;RPL10;RC3H1;RBM4B;RBM3;METTL16;MTPN;PARP9;NANOS1;TDRD7;ZC3H7A;METTL18;ATXN2;EIF2B4;PUM2
prerank,granulocyte chemotaxis (GO:0071621),0.19461749451487445,0.7151460063348216,0.9413092550790068,1.0,1.0,8/55,14.71%,PDE4B;CXADR;PF4;CCL13;CCL5;CCL2;PPIA;CCL7
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.27249411327963924,-0.714935648071104,0.8327137546468402,0.9610126579688049,1.0,1/14,2.75%,THBS1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.27936461335009377,0.7148752376558459,0.838074398249453,1.0,1.0,4/12,18.92%,DOCK10;GPR183;FCGR2B;POU2AF1
prerank,cellular response to fatty acid (GO:0071398),-0.29244575660036976,-0.7144353764627988,0.8429906542056075,0.9611555183222078,1.0,6/12,32.40%,IRS1;LPL;DGAT2;PID1;PDK4;PDK3
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.26701749434444183,0.714097873146498,0.8414376321353065,1.0,1.0,6/13,27.38%,PCID2;CDK5RAP2;ANAPC15;GEN1;MAD2L1;NDC80
prerank,spliceosomal complex assembly (GO:0000245),0.20033759105144872,0.7133545606580208,0.9314516129032258,1.0,1.0,8/46,13.59%,CELF5;CELF4;CELF2;CELF6;SRPK1;DDX1;SNRPD1;SNRPD2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.261440871789157,0.713278443933447,0.8523489932885906,1.0,1.0,5/16,19.56%,CELF4;SF3B4;DAZAP1;PRDX6;RBMX
prerank,protein K11-linked ubiquitination (GO:0070979),-0.23381899892511487,-0.7128700147124757,0.8937282229965157,0.9624198999672624,1.0,15/27,36.49%,UBE2D3;CDC16;UBE2E2;UBE2L3;RNF4;FZR1;ANAPC7;ANAPC11;UBE2H;ANAPC10;ANAPC5;ANAPC13;UBE2A;UBE2T;UBE2C
prerank,response to unfolded protein (GO:0006986),0.19982763161395622,0.7127697795251836,0.9451073985680191,1.0,1.0,6/48,7.99%,PACRG;HSPA4L;DNAJB4;HSPA9;HSF1;HSPA1L
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.2437111249463323,-0.712060487304468,0.8810408921933085,0.9628376170594855,1.0,5/22,18.21%,RBX1;ERCC2;XPC;ERCC3;CETN2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.24935387031596673,0.7120346190231336,0.8672768878718535,1.0,1.0,3/18,12.14%,BLK;C3AR1;GPLD1
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.2432535260437155,-0.7114536779974052,0.8729874776386404,0.9630854226190193,1.0,6/24,16.68%,MIEF1;TCAF1;MTCL1;MIEF2;CHP1;FYN
prerank,regulation of B cell differentiation (GO:0045577),-0.2566192825938739,-0.7110317172303465,0.8479427549194991,0.9631635224329447,1.0,5/17,36.92%,PPP2R3C;ZFP36L1;IKZF3;MMP14;SYK
prerank,protein methylation (GO:0006479),-0.21305677026517605,-0.711016413271752,0.9225225225225225,0.9627892130830025,1.0,8/40,18.02%,NSD1;NSD3;SETD3;EHMT1;GSPT1;FAM98A;N6AMT1;CARM1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.26407891217338597,-0.7106145781601956,0.8452173913043478,0.9628134792684981,1.0,2/16,6.99%,CAV1;PARP14
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.2670833374417349,-0.7099242667829132,0.8620689655172413,0.9631265629912638,1.0,4/14,21.18%,SRSF12;SFSWAP;RNPS1;SRSF10
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.23955508924062147,-0.7098792578803305,0.8732876712328768,0.9627855419734951,1.0,7/21,31.26%,TTC23;SMO;KIF7;TUBD1;TEDC2;ARMC9;SHH
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.25503612741896725,-0.7095024623561019,0.8858695652173914,0.9627790231819406,1.0,3/18,6.39%,SARNP;THOC2;IWS1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3018291872916511,-0.7094669197261385,0.8345724907063197,0.9624307306319314,1.0,5/10,44.43%,PDCD4;AIDA;DUSP19;HIPK3;GSTP1
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.20220541086076133,-0.7084773059677754,0.9377224199288257,0.9630825446666023,1.0,16/50,26.87%,PSMA2;PSME2;PSMB4;AZIN1;PSMC2;PSMB2;PSMB1;PSMA8;OAZ2;PSME1;NQO1;PSMD4;PSMA7;PSMD5;PSMB10;PSMA3
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.20632301331228545,-0.7076475688802529,0.9449378330373002,0.9635351781399473,1.0,15/45,31.57%,APP;CASP8;JAK2;LPL;PANX1;TRIM16;GBP5;CCL19;NOD2;CASP1;FZD5;LGALS9;NLRC4;STAT3;TLR6
prerank,lipoprotein localization (GO:0044872),-0.29180123194111385,-0.7062434746125404,0.8464351005484461,0.9645550269579171,1.0,3/11,26.11%,ZDHHC3;PPARG;LRP1
prerank,regulation of histone methylation (GO:0031060),-0.27638347582658296,-0.7062352857275349,0.8676207513416816,0.9641738388316284,1.0,1/13,1.14%,NSD1
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.25114261568180685,-0.7060839456128261,0.866785079928952,0.9639376783855218,1.0,5/18,17.16%,LDLRAP1;PSEN2;ADAM10;PSEN1;APH1A
prerank,triglyceride homeostasis (GO:0070328),-0.23604083188814518,-0.7053345614280964,0.8957597173144877,0.9642696254420651,1.0,15/26,48.36%,SCARB1;LPL;C1QTNF3;DGAT2;PNPLA8;RORA;IL18;SIRT1;APOC4;PLA2G12B;NR1H3;HNF4A;ACSM2A;ANGPTL8;APOA1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.2598032941373324,-0.7050977310220792,0.889763779527559,0.964116393644705,1.0,8/17,33.13%,DMAC2L;ATP5F1E;ATP5F1C;ATP5MF;ATP5PO;STOML2;ATP5F1D;ATP5MC2
prerank,DNA geometric change (GO:0032392),-0.23855616105112792,-0.7044195394225511,0.8848368522072937,0.9644148026066024,1.0,8/24,24.95%,MRE11;MCM9;DNA2;ANXA1;WRN;BLM;HMGB1;DHX9
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.2776158468705019,-0.7042327922342791,0.8405797101449275,0.9642126216075904,1.0,4/13,15.65%,ASPH;CASP8;PERP;LGMN
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.27172839027510226,0.7023025099468964,0.8561946902654868,1.0,1.0,2/13,11.60%,CHST2;EXTL2
prerank,central nervous system neuron axonogenesis (GO:0021955),0.2764792296956279,0.7012901483172744,0.8571428571428571,1.0,1.0,4/12,17.06%,EPHB1;SPTBN4;B4GALT6;HSP90AB1
prerank,glycerol metabolic process (GO:0006071),0.28455940509913147,0.7011831324230037,0.8393665158371041,1.0,1.0,4/10,21.14%,TPI1;GK;PGP;ANGPTL3
prerank,iron-sulfur cluster assembly (GO:0016226),0.22678127931056585,0.7010617418239307,0.9217391304347826,1.0,1.0,9/24,23.75%,HSPA9;ISCA2;NFU1;CIAO3;NUBP2;NUBP1;NFS1;CIAPIN1;LYRM4
prerank,dendritic cell differentiation (GO:0097028),-0.24229238817563825,-0.7006223025935543,0.8658088235294118,0.9672773973453842,1.0,3/22,5.73%,LYN;TGFBR2;GAS6
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.226115111338269,-0.7001340214967355,0.9001814882032668,0.9673900149424477,1.0,11/30,27.88%,DNAJC7;GAK;ERO1A;PTGES3;UGGT1;DNAJB12;HSPA14;HSPA13;HSPA1B;CCT2;SDF2L1
prerank,icosanoid biosynthetic process (GO:0046456),0.29110288875489765,0.699473212826159,0.8512035010940919,1.0,1.0,1/10,2.26%,FADS1
prerank,negative regulation by host of viral transcription (GO:0043922),-0.27866881299179885,-0.699391931567871,0.8759541984732825,0.9676794941513257,1.0,3/12,17.32%,HDAC1;JUN;TFAP4
prerank,positive regulation of chromosome organization (GO:2001252),0.2621944615898062,0.6990667310110011,0.8620689655172413,1.0,1.0,4/15,17.25%,DDX11;GNL3;RAD21;DHX36
prerank,regulation of biosynthetic process (GO:0009889),0.2781369656644278,0.6979915975355541,0.8498845265588915,1.0,1.0,11/11,72.21%,SPHK2;ALOX5;SNCA;PCK1;UCP1;PIKFYVE;CCN6;GSTP1;THRSP;MID1IP1;SLC25A33
prerank,glutathione metabolic process (GO:0006749),0.20400992693159312,0.6979844154962572,0.928921568627451,1.0,1.0,4/38,8.04%,NAT8;GGCT;GLRX2;DPEP1
prerank,positive regulation of interleukin-13 production (GO:0032736),0.2850656830704493,0.6979170686452763,0.8401826484018264,1.0,1.0,2/10,10.14%,SPHK2;PRKCZ
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.23874150199076827,-0.6951073157006501,0.8922800718132855,0.9713029735969109,1.0,2/22,3.85%,SLC7A5;IL15
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.2934115170004825,-0.6949523885998283,0.868231046931408,0.9710581852582818,1.0,1/10,5.52%,ELOVL5
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.19941342626176006,0.6945370959093612,0.9429223744292238,1.0,1.0,5/42,10.09%,SYCP1;WRNIP1;POLD4;PCLAF;POLA1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.2721427952369311,-0.6940514649917771,0.8589511754068716,0.9715307371112295,1.0,2/12,9.84%,PPARA;AKT1
prerank,regulation of establishment of protein localization (GO:0070201),0.2690226998569453,0.6933644508307781,0.8876651982378855,1.0,1.0,3/13,12.83%,PTP4A3;CORO2B;CEP135
prerank,cellular response to interleukin-2 (GO:0071352),-0.2816321902266191,-0.6933112058163063,0.8827708703374778,0.971426824138458,1.0,4/11,29.51%,JAK1;PTK2B;IL2RA;IL2RG
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.2816321902266191,-0.6933112058163063,0.8827708703374778,0.971426824138458,1.0,4/11,29.51%,JAK1;PTK2B;IL2RA;IL2RG
prerank,regulation of coagulation (GO:0050818),-0.2836840591609093,-0.6933040398886345,0.860036832412523,0.9710419698458473,1.0,1/11,1.62%,CAV1
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.1904142685362944,-0.6923820712047913,0.9477351916376306,0.9714954659420588,1.0,11/52,21.80%,DGLUCY;SLC25A32;OGDH;IDH1;MTHFD1;ALDH18A1;HOGA1;MTHFD1L;ALDH1L1;GCLC;MTRR
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.21483702136000396,0.6922909868299069,0.9157894736842105,1.0,1.0,4/31,13.29%,BLK;VTCN1;SDC4;CD86
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.27074457011305125,-0.6921023839394121,0.86996336996337,0.9713548843428217,1.0,2/14,7.48%,HNRNPA0;MAPKAPK2
prerank,cellular response to pH (GO:0071467),0.2534191837599909,0.6919348072456921,0.8808988764044944,1.0,1.0,4/17,15.20%,IMPACT;GPLD1;ASIC1;GPR68
prerank,regulation of protein localization to centrosome (GO:1904779),-0.2905634572608827,-0.6908375743316953,0.874326750448833,0.9720624588308063,1.0,2/10,6.45%,GSK3B;CEP250
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.2830830761898569,-0.6903955982916583,0.8604651162790697,0.9720797237847132,1.0,4/11,25.72%,NOVA2;RASA1;PCBP1;IGF2BP2
prerank,calcium import into the mitochondrion (GO:0036444),0.2803950586415183,0.6901132841779593,0.8634361233480177,1.0,1.0,1/10,1.91%,SLC25A23
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.1830561298963412,-0.689733492491315,0.9633507853403142,0.9722888891134481,1.0,23/68,32.20%,MNAT1;ERCC2;CPSF7;TAF1B;MAZ;LSM11;TAF1C;SNRPE;ERCC3;CAVIN1;LSM10;FIP1L1;UBTF;TAF1D;POLR1E;POLR2L;POLR2H;GTF2H3;CCNH;POLR3K;MTERF2;POLR1H;SMN1
prerank,myeloid dendritic cell activation (GO:0001773),0.26454724550248077,0.6896638923916549,0.851063829787234,1.0,1.0,2/12,11.00%,CAMK4;BATF
prerank,DNA dealkylation (GO:0035510),-0.283911975660256,-0.6887114668519673,0.8576642335766423,0.9724165411845496,1.0,2/10,7.77%,FTO;ASCC1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.283911975660256,-0.6887114668519673,0.8576642335766423,0.9724165411845496,1.0,2/10,7.77%,FTO;ASCC1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.22958953294953943,0.6883427371532839,0.9118329466357309,1.0,1.0,3/23,7.87%,OTC;SLC9A7;SLC12A5
prerank,sphingolipid catabolic process (GO:0030149),0.2561009918945828,0.6882547657344386,0.8663697104677061,1.0,1.0,3/15,8.22%,ENPP2;SPHK1;ACER1
prerank,membrane lipid metabolic process (GO:0006643),-0.23369622731575995,-0.6881803457323489,0.8853046594982079,0.9725056460203739,1.0,10/22,32.41%,ST3GAL6;B4GALT4;AGK;SPTLC1;SERINC1;TEX2;CYP1B1;CERKL;MGST2;ALOXE3
prerank,homocysteine metabolic process (GO:0050667),-0.28094471556280565,-0.6874106933152359,0.8558052434456929,0.9728101124849903,1.0,7/11,41.18%,NOX4;CTH;MTRR;MPST;BLMH;CBS;TST
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.2044141742297169,-0.6868365458671071,0.9329710144927537,0.9729131771664156,1.0,4/37,11.81%,ENTPD1;ENTPD6;RNASE3;XRN2
prerank,negative regulation of inclusion body assembly (GO:0090084),0.28075045369604784,0.6864060737035644,0.8322440087145969,1.0,1.0,4/10,20.34%,SORL1;DNAJB2;DNAJB1;DNAJA4
prerank,autophagosome maturation (GO:0097352),-0.2099876989974545,-0.6860155084080388,0.9262589928057554,0.9732486417843107,1.0,4/32,10.83%,LIX1L;MAP1LC3B;TECPR1;GABARAP
prerank,defense response to Gram-positive bacterium (GO:0050830),0.2026269310649246,0.6855467964745017,0.9471264367816092,1.0,1.0,6/40,11.74%,RNASE6;CHGA;ANG;IL12A;MBL2;HMGB2
prerank,positive regulation of macrophage differentiation (GO:0045651),0.2662970313243642,0.685207272011134,0.86810551558753,1.0,1.0,2/11,7.79%,HSF1;PF4
prerank,tRNA 5'-leader removal (GO:0001682),0.26109611400590116,0.6845772945271661,0.8765957446808511,1.0,1.0,13/13,73.91%,RPP25L;PRORP;POP7;POP5;RPP21;POP1;RPP38;RPP25;RPP14;RPP40;SSB;POP4;RPP30
prerank,mRNA modification (GO:0016556),-0.23602589104437693,-0.6841292643096415,0.9014598540145985,0.9745301050898068,1.0,13/22,44.40%,CBLL1;METTL14;WTAP;TRUB1;METTL16;RPUSD2;TRMT61A;PCIF1;PUS7;TRMT10C;VIRMA;DKC1;NSUN2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.25846587758446743,-0.6839999251555406,0.8697247706422019,0.9742558288452239,1.0,4/15,17.56%,SAMHD1;STAT2;USP18;NLRC5
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.2839324545263194,0.6838115437566072,0.8552338530066815,1.0,1.0,4/10,21.74%,TSKU;WHRN;PLS1;PDZD7
prerank,regulation of lamellipodium organization (GO:1902743),0.26009699541555537,0.6837372804505332,0.8782608695652174,1.0,1.0,2/14,7.85%,PDPN;CARMIL1
prerank,cellular response to misfolded protein (GO:0071218),-0.23975340107791443,-0.6830928333014886,0.8789473684210526,0.9746434781665991,1.0,11/20,43.33%,CUL3;ATXN3;UGGT1;DNAJB12;KLHL15;RNF185;VCP;RNF5;POMT2;RNF126;DNAJB14
prerank,RNA polyadenylation (GO:0043631),-0.22554266086586633,-0.6823778867436358,0.9236234458259325,0.9744781457686242,1.0,8/26,27.32%,TENT4B;APP;CDC73;TENT2;FIP1L1;AHCYL1;LEO1;PABPC1
prerank,mRNA polyadenylation (GO:0006378),-0.22554266086586633,-0.6823778867436358,0.9236234458259325,0.9744781457686242,1.0,8/26,27.32%,TENT4B;APP;CDC73;TENT2;FIP1L1;AHCYL1;LEO1;PABPC1
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.26284938923837403,-0.6811817524774715,0.8872180451127819,0.9750860565952303,1.0,4/14,18.14%,MSN;EZR;RHOA;RAP2A
prerank,vitamin D metabolic process (GO:0042359),0.2590585815908708,0.6810879381321218,0.8769574944071589,1.0,1.0,3/13,16.35%,CYP24A1;GC;CYP1A1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.288121983934733,-0.6803822870923595,0.8578947368421053,0.9753823497982848,1.0,4/10,30.86%,CEACAM1;PTPRC;LGALS9;LILRB1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.2432743378766918,-0.6801317669995657,0.8871252204585538,0.9752194639346257,1.0,7/19,32.19%,DDIT4;TP53;HIPK1;PHLDA3;TMEM109;CDIP1;RPS27L
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.24957247424990492,-0.679896622661391,0.8706293706293706,0.9750138087699509,1.0,16/18,49.10%,BNIP3;THEM4;PPIF;ALKBH7;PMAIP1;NAIF1;SPG7;SLC25A5;HEBP2;SLC25A31;BAK1;MUL1;BCL2L1;BAD;TMEM102;CAMK2A
prerank,ceramide catabolic process (GO:0046514),-0.264107127381944,-0.6794210830195164,0.8909426987060998,0.9750252467087926,1.0,5/14,27.88%,ACER2;ACER3;ASAH1;GLA;HEXA
prerank,development of primary male sexual characteristics (GO:0046546),-0.20753454402347957,-0.6785423166160092,0.9354275741710296,0.975371018823183,1.0,9/34,25.40%,KITLG;TGFB2;MAMLD1;NCOA4;SIX4;LHFPL2;COL9A3;BIK;WNT2B
prerank,ketone body metabolic process (GO:1902224),-0.29083293220751716,-0.6783593323421736,0.8594890510948905,0.9751358068220477,1.0,4/10,24.63%,BDH2;HMGCS2;OXCT1;ACSS3
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.17106914667989204,-0.6768225510466301,0.9833333333333333,0.9759438313860256,1.0,24/94,23.44%,YWHAE;CEP57;CEP250;CEP78;HAUS8;DCTN1;DCTN3;CSNK1D;PAFAH1B1;HAUS6;CEP41;ALMS1;RAB11A;PLK4;PCM1;CETN2;CNTRL;CEP152;ODF2;HSP90AA1;PCNT;NPHP1;CEP131;AKAP9
prerank,receptor recycling (GO:0001881),0.27812091311175785,0.676724768212923,0.8863157894736842,1.0,1.0,3/10,18.60%,SORL1;PHETA1;NSG1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.2495785451433346,0.6766942032652218,0.8704545454545455,1.0,1.0,5/16,23.17%,DCPS;PSIP1;SNRPC;NCBP2;WBP11
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.17521404466645413,-0.6765567562421562,0.9880341880341881,0.9757594514938314,1.0,30/84,33.28%,RB1;PSMA2;CUL3;PSME2;PSMB4;CDC16;ANAPC16;PSMC2;PSMB2;PSMB1;PSMA8;PSME1;BUB1B;ECRG4;PSMD4;BUB3;PSMA7;FZR1;PSMD5;ANAPC7;PSMB10;PSMA3;FBXO31;ANAPC11;ANAPC10;ANAPC5;PSMD13;PLK1;PSMB6;AURKA
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.2602389393280329,0.6757279905724103,0.8850574712643678,1.0,1.0,2/13,9.92%,CD177;SPHK2
prerank,hexose metabolic process (GO:0019318),-0.2027772421697611,-0.6751310850258798,0.9385171790235082,0.9765268140258233,1.0,12/39,26.52%,CHST15;HECTD4;PPARD;GALK2;ALDOC;GALK1;BRAT1;FPGT;FUOM;GALM;PMM2;SLC37A4
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.2244575188765602,-0.6751030557703953,0.9116541353383458,0.9761576415803366,1.0,2/24,4.87%,PLA2G4A;LPCAT1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.2575500413777927,0.6750198472422343,0.8833693304535637,1.0,1.0,1/14,4.83%,ATP1B1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.22469888626222334,-0.6748886140646169,0.9168207024029574,0.975932645408559,1.0,6/23,25.79%,PLA2G4A;MBOAT1;PLA2G12A;LPCAT3;PNPLA8;PLA2G4F
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.1709414766763767,-0.6748784956485678,0.9783001808318263,0.9755589707163962,1.0,27/87,28.33%,COX16;COX18;SAMM50;NDUFV3;ACAD9;SCO1;NDUFB2;NDUFB11;UQCRFS1;COX17;DMAC2;NDUFS2;UQCC3;NDUFA7;NDUFV1;UQCC2;COA8;TMEM126B;NDUFC2;NDUFV2;NDUFAF1;NDUFB3;IMMP2L;SDHAF4;NDUFB4;SLC25A33;NDUFS5
prerank,lipid catabolic process (GO:0016042),-0.24094261014774568,-0.6747617328868938,0.8992805755395683,0.9752715520607091,1.0,3/18,14.81%,ACADL;LPL;LIPE
prerank,activin receptor signaling pathway (GO:0032924),-0.2556000295315777,-0.6736752017344846,0.9057591623036649,0.9757456418068775,1.0,7/15,40.23%,SMAD2;ACVR2A;ACVR2B;TGFBR1;SMAD3;INHBB;ACVR1
prerank,regulation of T cell chemotaxis (GO:0010819),0.2628418110809695,0.6730771919156976,0.8972602739726028,1.0,1.0,2/11,12.58%,OXSR1;CCL5
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.2660869671073608,-0.6730087329374225,0.8835125448028673,0.9758963798810832,1.0,6/12,33.47%,RNF168;NELFB;HNRNPU;LARP7;NELFA;NELFCD
prerank,stabilization of membrane potential (GO:0030322),0.24068253017687347,0.6706399219058273,0.8826185101580135,1.0,1.0,5/16,23.50%,KCNK12;KCNK10;KCNK9;KCNK4;KCNN4
prerank,positive regulation of telomere capping (GO:1904355),-0.24627909288302594,-0.6705670774973118,0.8856624319419237,0.9773840895592181,1.0,3/17,13.71%,NEK7;MAPK1;PNKP
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.2570635883185538,0.6700489928615686,0.9,1.0,1.0,3/13,14.64%,ISCA2;CISD3;NFU1
prerank,RNA interference (GO:0016246),-0.2410538026199438,-0.6695727999382046,0.9090909090909091,0.9777564046471187,1.0,9/17,34.66%,CELF1;DICER1;AGO2;DROSHA;TERT;DHX9;TSN;TARBP2;MRPL44
prerank,chemokine-mediated signaling pathway (GO:0070098),0.19274484922044532,0.6693207385864276,0.9586206896551724,1.0,1.0,11/42,22.66%,OXSR1;PF4;CCL13;CCL5;THPO;CCL2;CCL7;CX3CL1;CCL14;CIB1;STK39
prerank,regulation of protein processing (GO:0070613),0.227631730271106,0.668705466596771,0.9170403587443946,1.0,1.0,2/21,3.86%,TMEM59;CLN3
prerank,P-body assembly (GO:0033962),-0.2667126024766693,-0.6679823297407831,0.8774774774774775,0.9785583859037983,1.0,4/12,21.53%,LIMD1;RC3H1;EDC3;LSM3
prerank,regulation of ERAD pathway (GO:1904292),0.26324103534953247,0.6676991452568359,0.8931818181818182,1.0,1.0,2/11,7.01%,TMEM259;USP25
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.19567742733424573,-0.6672173013856021,0.9429530201342282,0.9787534146369529,1.0,18/40,36.42%,LRRK2;ABL1;ARL6IP5;AKT1;SOD1;STOML2;RNF122;SLC25A33;PID1;STOX1;PYCR1;PMAIP1;PIP5KL1;HEBP2;PARK7;VCP;AKT2;ATP5IF1
prerank,negative regulation of protein secretion (GO:0050709),-0.20160258839249245,-0.6668242178318455,0.9525483304042179,0.9786670558828153,1.0,15/38,32.22%,CD200;IRS1;RAB11FIP3;RHBDF2;DPH3;CCN3;RAB11FIP1;RAB11FIP5;SERGEF;F2R;HMGCR;MIDN;RSAD2;RHBDF1;KCNB1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.25261191210271006,-0.6666571871844262,0.89568345323741,0.9784148975528585,1.0,5/14,20.71%,RTRAF;TSEN15;TSEN34;TRPT1;RTCB
prerank,ovarian follicle development (GO:0001541),0.2560918456625184,0.6660873125814674,0.9,1.0,1.0,3/13,13.54%,ANG;VEGFA;KIT
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.21544786400558089,-0.6657830542009399,0.9285714285714286,0.9786718656767115,1.0,8/25,30.70%,SLC7A5;CD55;PLCG2;NOD2;FZD5;MAP3K7;TRIM6;TNFRSF14
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.20416433434557732,-0.6657214922721143,0.9372759856630825,0.9783382871917012,1.0,6/33,18.02%,CBFB;ESR1;UFM1;H3-3A;HDAC6;CARM1
prerank,protein trimerization (GO:0070206),-0.2515572672013337,-0.6640963446546383,0.8917431192660551,0.9788031461272848,1.0,7/14,31.68%,SCARA5;SLC1A5;MIF;CLYBL;DISP1;STEAP4;ALOX5AP
prerank,protein homotrimerization (GO:0070207),-0.2515572672013337,-0.6640963446546383,0.8917431192660551,0.9788031461272848,1.0,7/14,31.68%,SCARA5;SLC1A5;MIF;CLYBL;DISP1;STEAP4;ALOX5AP
prerank,dendritic cell chemotaxis (GO:0002407),0.24664821506861617,0.6640778872040436,0.9094922737306843,1.0,1.0,6/14,25.08%,CCR6;CCL5;GPR183;CXCR4;TRPM2;CCR5
prerank,B cell mediated immunity (GO:0019724),0.27309816721064517,0.6640625764315331,0.8832951945080092,1.0,1.0,10/10,72.71%,MSH2;FCGR2B;CD70;CD27;CD19;SLA2;CARD9;TLR8;CD74;FCER1G
prerank,microtubule polymerization (GO:0046785),-0.2068558916832426,-0.6637731537647289,0.9337979094076655,0.9786479541554485,1.0,7/28,18.72%,RANBP9;SLAIN2;CSNK1D;TUBGCP4;TUBGCP5;TRPV4;NDEL1
prerank,protein depolymerization (GO:0051261),-0.20915623289028534,-0.6632600543133217,0.9433628318584071,0.9786433628247363,1.0,14/27,40.53%,MICAL2;CFL2;CFL1;DSTN;KIF18B;KIF14;MICAL1;STMN1;NCKAP5L;CKAP5;TWF2;KIF2C;VIL1;KATNB1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.2670714072396633,0.6620403051235129,0.888641425389755,1.0,1.0,2/11,9.47%,ITM2C;ABCA2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.2453863317293069,-0.6618115597021015,0.9078014184397163,0.9792959237590972,1.0,9/16,38.67%,ATM;TERF2;SMG6;PINX1;NAF1;TNKS2;TNKS;SLX4;ERCC4
prerank,response to light stimulus (GO:0009416),-0.1818393690711638,-0.6610221295541379,0.9626334519572953,0.9795048833001075,1.0,21/55,34.19%,MAP4K3;UBE4B;ERCC2;REV1;MAPK8;ERCC3;ERCC8;USP1;ERCC6;DTL;CRY2;GPR52;TYR;TRIM32;USF1;FECH;UBE2A;RRH;AANAT;OPN1MW3;OPN1MW
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.24274222927924644,-0.6599823065442103,0.8998302207130731,0.9798440067101295,1.0,7/17,29.89%,FGF1;PRKAA1;ERLIN2;SOD1;LPCAT3;RAN;MBTPS1
prerank,protein palmitoylation (GO:0018345),0.20467686273647745,0.6599393931082509,0.9710467706013363,1.0,1.0,6/30,15.71%,SELENOK;ZDHHC8;ZDHHC13;ZDHHC20;ZDHHC24;ZDHHC7
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.22246289524458052,-0.6590132302292031,0.9163636363636364,0.9797934891105283,1.0,2/22,4.27%,ZDHHC6;ZDHHC3
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.22246289524458052,-0.6590132302292031,0.9163636363636364,0.9797934891105283,1.0,2/22,4.27%,ZDHHC6;ZDHHC3
prerank,regulation of histone modification (GO:0031056),-0.26244299629984114,-0.6582034184752374,0.9047619047619048,0.9800418262200505,1.0,4/13,22.61%,SETD5;HPF1;IGF2;MYOCD
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.23869725769056585,0.657615437832481,0.9038031319910514,1.0,1.0,2/16,11.48%,CENPS;MUS81
prerank,microtubule bundle formation (GO:0001578),0.1895682807005753,0.6573298735306007,0.9402298850574713,1.0,1.0,10/42,18.59%,CFAP74;MAP1S;DCX;TPPP3;TPPP;FOXJ1;GAS8;NUMA1;AAAS;CDK5RAP2
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.25422452216461106,0.6559397837616899,0.9145299145299145,1.0,1.0,3/12,17.75%,NAE1;ORC1;CHEK2
prerank,regulation of mRNA metabolic process (GO:1903311),-0.268126702679328,-0.6559019802789792,0.8948339483394834,0.9812721277702872,1.0,5/11,27.71%,IWS1;SRPK2;CDK11B;DHX9;SLTM
prerank,regulation of neuroinflammatory response (GO:0150077),-0.2389840969383266,-0.6558380027121691,0.9192100538599641,0.9809331183579788,1.0,2/19,5.58%,CD200;TNFRSF1B
prerank,folic acid metabolic process (GO:0046655),0.22878180563106087,0.6556054072254022,0.9209302325581395,1.0,1.0,3/18,9.28%,SLC46A1;SLC19A1;ALDH1L2
prerank,microtubule depolymerization (GO:0007019),0.2369230769230768,0.6550111382158066,0.9223529411764706,1.0,1.0,17/17,76.33%,STMN2;STMN4;STMN3;NCKAP5;KIF18A;KIF2A;KIF24;STMND1;KATNB1;KIF2C;CKAP5;KIF19;NCKAP5L;STMN1;CCSAP;KIF14;KIF18B
prerank,mitotic DNA replication (GO:1902969),-0.2783414622954222,-0.6549653351679955,0.8893058161350844,0.9811583000134017,1.0,5/10,24.65%,MCM4;GINS3;GINS1;MCM3;LIG1
prerank,positive regulation of establishment of protein localization (GO:1904951),0.23548892719532094,0.654808167079936,0.9372197309417041,1.0,1.0,4/18,13.38%,PTP4A3;CORO2B;CEP135;WRAP53
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.23407304165844575,-0.6545472420699928,0.9181184668989547,0.9810481699029943,1.0,12/18,43.01%,MECP2;RAB11A;CCND1;CDC25A;BRD4;DTL;STOX1;CDK4;FBXO5;CCNB1;CDC25C;RAD51C
prerank,regulation of cellular metabolic process (GO:0031323),-0.18819579443669593,-0.6536812669724875,0.9758620689655172,0.981247245908038,1.0,19/45,37.79%,PANK2;PPARA;ACACB;FLOT1;AGPAT1;MKLN1;KIF16B;CYP1B1;VPS35;RNF34;PID1;PDK4;PDK3;FASN;TBC1D16;PM20D2;PARL;FOXM1;GNB3
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.21242639246712622,-0.6528945059874874,0.9326241134751773,0.9813710311677754,1.0,3/26,10.77%,APP;CBL;NCK2
prerank,regulation of histone deacetylation (GO:0031063),0.25004467623844884,0.6526662881738942,0.9175946547884187,1.0,1.0,2/13,9.92%,PRMT6;SPHK2
prerank,positive regulation of cellular respiration (GO:1901857),-0.27241640931232325,-0.6523085323678173,0.9052823315118397,0.9813658960255099,1.0,6/11,40.16%,IFNAR1;IL10RB;IFNLR1;PARK7;VCP;IL4
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.2824942565588289,-0.6521931201362787,0.9083191850594228,0.9810554877053357,1.0,7/10,37.00%,LRRK2;TXN;NFE2L2;RIPK1;PYCR1;PARK7;PDE8A
prerank,coenzyme A biosynthetic process (GO:0015937),-0.27054482155137083,-0.6513228691476587,0.8957952468007313,0.9804753314453524,1.0,1/11,3.56%,PANK2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.27054482155137083,-0.6513228691476587,0.8957952468007313,0.9804753314453524,1.0,1/11,3.56%,PANK2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.27054482155137083,-0.6513228691476587,0.8957952468007313,0.9804753314453524,1.0,1/11,3.56%,PANK2
prerank,negative regulation of cholesterol transport (GO:0032375),-0.27414290490910215,-0.6510636762427537,0.8993055555555556,0.9802590816553045,1.0,1/10,5.38%,NFKB1
prerank,nucleosome assembly (GO:0006334),-0.20213798479003522,-0.6510370732996947,0.9498207885304659,0.9798926445065761,1.0,4/31,14.82%,KAT6B;BRD2;SPTY2D1;H3-3A
prerank,snRNA metabolic process (GO:0016073),-0.23333584747144107,-0.6492388071525248,0.9119850187265918,0.9806901820287742,1.0,6/17,29.96%,INTS8;INTS3;INTS9;INTS7;INTS5;INTS12
prerank,negative regulation of mRNA processing (GO:0050686),-0.24014329267209045,-0.6482364058490727,0.9310344827586207,0.9809595265269918,1.0,4/15,21.18%,SRSF12;SFSWAP;RNPS1;SRSF10
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.2384401998835628,0.6480679564179177,0.9113636363636364,1.0,1.0,4/15,17.75%,NEK11;MUS81;RAD9B;CHEK2
prerank,signal peptide processing (GO:0006465),-0.2647661054536519,-0.6479241465033664,0.9156193895870736,0.9807939808349511,1.0,4/11,25.87%,SPPL3;PCSK5;CLN5;SEC11A
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.21766392276740026,-0.6451805375656282,0.9321100917431193,0.9822273864499391,1.0,9/25,27.88%,DNAJC7;GAK;ERO1A;PTGES3;DNAJB12;HSPA14;HSPA13;HSPA1B;SDF2L1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.2617795147362967,-0.6450087905142261,0.9215686274509803,0.9819490523756379,1.0,4/11,34.54%,LRP6;CTNNB1;FZD1;NR4A2
prerank,positive regulation of histone methylation (GO:0031062),-0.21726206922208913,-0.6447750100367652,0.9299242424242424,0.9817006388669944,1.0,8/24,30.94%,SMAD4;DNMT1;CTNNB1;BRCA1;OGT;WDR5;PHF19;DNMT3B
prerank,t-circle formation (GO:0090656),-0.2698755948319984,-0.6444028734371302,0.9128919860627178,0.980782991316732,1.0,4/10,27.65%,DNA2;WRN;BLM;EXO1
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.2698755948319984,-0.6444028734371302,0.9128919860627178,0.980782991316732,1.0,4/10,27.65%,DNA2;WRN;BLM;EXO1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.2698755948319984,-0.6444028734371302,0.9128919860627178,0.980782991316732,1.0,4/10,27.65%,DNA2;WRN;BLM;EXO1
prerank,retinal metabolic process (GO:0042574),0.2506012307996177,0.6435241797237108,0.9127358490566038,1.0,1.0,1/12,2.73%,AKR1C1
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.22801606800206262,-0.6418762214150868,0.9442446043165468,0.9819698659425892,1.0,7/19,29.63%,SLC25A32;MTHFD1;MTHFD1L;ALDH1L1;MTRR;GGH;SHMT1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.20962024770375415,0.640926627536985,0.9507829977628636,1.0,1.0,6/23,18.77%,IL12A;RASGRP1;CD226;SLAMF6;ARRB2;CADM1
prerank,stress granule assembly (GO:0034063),0.21623049379479248,0.6404091066202842,0.9268867924528302,1.0,1.0,2/20,8.42%,BICD1;MAPT
prerank,gonad development (GO:0008406),0.18431769977763623,0.6386572018823558,0.9782082324455206,1.0,1.0,11/41,20.74%,ADAM29;WT1;GATA6;KIT;WNT4;MKKS;MSH2;SOX9;NUP107;ADAM21;IRX5
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.23592056244781806,-0.6378354568463767,0.9379699248120301,0.9840135845893643,1.0,3/16,16.00%,SHLD1;CGAS;MAD2L2
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.23509871977814278,0.637554994786209,0.9100877192982456,1.0,1.0,3/15,15.09%,DHX33;USP50;EIF2AK2
prerank,male gonad development (GO:0008584),-0.195221201346396,-0.637469365627109,0.9755244755244755,0.9838415047420626,1.0,4/34,11.06%,KITLG;TGFB2;MAMLD1;NCOA4
prerank,regulation of macrophage differentiation (GO:0045649),0.23247056301638136,0.6368639336386855,0.9323671497584541,1.0,1.0,2/15,7.79%,HSF1;PF4
prerank,pancreas development (GO:0031016),0.24959433154083635,0.6364998949329308,0.9118329466357309,1.0,1.0,2/12,8.25%,PROX1;DNAAF1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.19006224865700413,0.636306509348693,0.9601769911504425,1.0,1.0,4/32,9.94%,RNASE6;ANG;PF4;CCL13
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.27119668072023456,-0.6358264337573849,0.9057591623036649,0.9844042157222211,1.0,1/10,5.37%,GFPT2
prerank,cellular response to sterol (GO:0036315),-0.2464584330969329,-0.6354812585378526,0.9309090909090909,0.9842138572470867,1.0,3/13,12.41%,SMO;LRP6;INSIG2
prerank,T cell activation involved in immune response (GO:0002286),-0.2577164282412192,-0.635075005121503,0.9061371841155235,0.9840596600978225,1.0,7/12,37.42%,ICAM1;LCP1;EIF2AK4;FCER1G;LILRB1;CD74;MDK
prerank,phospholipid homeostasis (GO:0055091),0.2503633262621132,0.6343460066252903,0.9311926605504587,1.0,1.0,4/11,22.89%,RCN3;TLCD2;ANGPTL3;ABCG1
prerank,positive regulation of immune response (GO:0050778),-0.17033127561459693,-0.6339585198394329,0.9863713798977853,0.9843370862757582,1.0,17/64,29.07%,IL15;IL6ST;NMI;TGFB2;AKIRIN2;PLSCR1;POLR3F;IFI35;GBP5;NOD2;PTPRC;ITGAM;DHX9;EIF2AK4;LGALS9;RIOK3;RSAD2
prerank,epithelial cell development (GO:0002064),0.2172179818670432,0.6321422727218893,0.9454148471615721,1.0,1.0,1/20,1.29%,WNT7B
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.23303034930379465,-0.6317290612902723,0.9294755877034359,0.985202887091786,1.0,4/16,24.85%,SCARB1;MFSD2A;DAGLB;PNPLA2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.1951941356760157,0.630283452879629,0.9503386004514672,1.0,1.0,12/29,23.84%,TERF1;ANKRD28;WRAP53;PPIA;CDK2;ACD;HSP90AB1;TERF2IP;TELO2;NOP10;SHQ1;RTEL1
prerank,reticulophagy (GO:0061709),-0.2545122092950761,-0.6302632969674866,0.9087591240875912,0.9856294562316301,1.0,4/12,26.64%,UFM1;ULK2;ATG2A;ATG2B
prerank,regulation of transport (GO:0051049),-0.19148956559864255,-0.6299823904920008,0.9705882352941176,0.9853936750441299,1.0,6/36,16.66%,LRRK2;SCFD1;ARL6IP5;ACTB;ICA1;RAB11A
prerank,protein O-linked mannosylation (GO:0035269),-0.2272371102598933,-0.6298301361164435,0.9459459459459459,0.9851029293633132,1.0,2/18,3.65%,TMTC1;TMTC2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.2188472775935753,-0.6297324537137733,0.9294532627865961,0.9847774629043194,1.0,3/20,16.38%,RB1;FOXC1;IGF1
prerank,RNA methylation (GO:0001510),0.167342676068691,0.629444140662251,0.9840909090909091,1.0,1.0,17/60,23.09%,MTERF4;TRMT6;GTPBP3;TRMT13;TRMT10A;BUD23;ZC3H13;TFB1M;DIMT1;FTSJ1;METTL8;NSUN6;CMTR1;METTL2A;METTL2B;TRMT5;THUMPD3
prerank,neural tube development (GO:0021915),-0.2372767780845118,-0.6289838955222228,0.9311594202898551,0.9847927142360218,1.0,1/15,1.73%,PKD2
prerank,proteoglycan metabolic process (GO:0006029),-0.20434374659298593,-0.6281701394568919,0.9468864468864469,0.9848359871075959,1.0,11/26,35.56%,BMPR2;CSGALNACT1;CHST11;IGF1;HPSE;CSGALNACT2;XYLT1;SULF1;CHST14;CHST13;CNMD
prerank,regulation of tissue remodeling (GO:0034103),-0.22539943820827585,-0.6279333086168929,0.9500924214417745,0.9845862193599201,1.0,3/18,12.66%,IL15;FLT4;CEACAM1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.18620196305402703,-0.6274596542951768,0.9837251356238698,0.9844619599452915,1.0,12/39,32.46%,RPS14;RPSA;RPS16;RPS27;UTP4;RPS7;RPS15;RPS17;EMG1;RIOK3;RPS27L;SRFBP1
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.2504447433868558,-0.6269005187010407,0.9132007233273056,0.9843775871790714,1.0,3/13,15.49%,RIC3;STX3;ABCA7
prerank,T cell proliferation (GO:0042098),0.24254847649999436,0.6268410137903334,0.9269911504424779,1.0,1.0,4/13,18.77%,TNFSF18;RASGRP1;DOCK8;CADM1
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.26134083740527386,-0.6263097169922136,0.9026548672566371,0.9843271622356854,1.0,9/11,51.45%,TP53;PTGIS;FAP;DLC1;CIDEA;DFFA;BCL2L1;SIRT2;ZC3H12A
prerank,necroptotic process (GO:0070266),-0.23456104436368141,-0.6251909883715985,0.915129151291513,0.9845624591094769,1.0,12/16,49.60%,TRPM7;RIPK1;IPMK;TICAM1;CD14;MLKL;TLR4;TICAM2;TLR3;ITPK1;RIPK3;LY96
prerank,regulation of neurogenesis (GO:0050767),-0.17523476554161155,-0.6247795121891354,0.9873873873873874,0.9844006185827774,1.0,11/55,20.39%,HES1;SPEN;TGM2;YAP1;NOTCH1;NUMB;CTNNB1;HEY1;HEY2;PCM1;LIG4
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.20637773812363783,0.6226253763897645,0.9536423841059603,1.0,1.0,6/23,16.96%,LMAN1;SURF4;SELENOS;TMED9;SEL1L;AUP1
prerank,cellular response to chemokine (GO:1990869),-0.17896458776327445,-0.6221636987227814,0.9845360824742269,0.9854302924653883,1.0,13/46,30.62%,LRCH1;CCL25;SLC12A2;RHOA;ACKR3;FOXC1;CCL19;CXCL12;PTK2B;CXCL10;DUSP1;WNK1;GPR75
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.23619231004589053,-0.6208197120581248,0.9428044280442804,0.9857315725632607,1.0,8/14,40.43%,IRS1;AKT1;PTPN2;ARPP19;PMAIP1;AKT2;NNMT;SIRT1
prerank,response to sterol (GO:0036314),-0.25348172546313064,-0.6203065102681955,0.9263157894736842,0.9856253409967886,1.0,6/11,30.81%,TGFBR2;SMAD2;PMVK;TGFBR1;RORC;TGFB1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.21000564138497935,0.6201917830681587,0.9401709401709402,1.0,1.0,8/22,23.70%,VPS37D;TSG101;UBAP1;MVB12B;VPS4B;UBAP1L;PTPN23;VPS28
prerank,alpha-amino acid catabolic process (GO:1901606),0.19677827624713165,0.6193612624148873,0.9577167019027484,1.0,1.0,8/29,23.59%,OTC;HAAO;TDO2;SARDH;DDO;ACAT1;GSTZ1;ALDH4A1
prerank,pyruvate metabolic process (GO:0006090),-0.17673783696485704,-0.6189173824488422,0.982363315696649,0.9859733461960161,1.0,6/52,12.06%,BSG;SRR;DLD;SLC16A1;ALDOC;PDHB
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.22652749895872976,-0.6172228101010757,0.9330985915492958,0.9864381290750773,1.0,9/17,40.89%,SLC7A5;RARA;LGALS9;FCER1G;CEBPB;NLRP3;SYK;GATA3;CD28
prerank,positive regulation of protein sumoylation (GO:0033235),-0.26304094383407717,-0.6169791925330127,0.9420560747663551,0.9861731366528889,1.0,4/10,24.70%,UBA2;HDAC4;PIAS4;SAE1
prerank,long-chain fatty acid transport (GO:0015909),-0.19390904181366786,-0.615652958095695,0.9708029197080292,0.9864529987989955,1.0,18/30,42.75%,ABCD3;MFSD2A;ACACB;CPT1A;SLC27A4;ACSL1;PPARG;SPX;FABP3;SLC27A6;CPT2;MID1IP1;FABP4;PRKAG2;THRSP;SLC25A20;SLC27A2;ABCD1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.21531793305025346,0.6154862871986392,0.9633251833740831,1.0,1.0,3/16,15.02%,IL12A;IL12RB1;IL23A
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.24084797136947386,-0.6141416481409427,0.926873857404022,0.9868324355343829,1.0,1/13,1.34%,NOS3
prerank,UV-damage excision repair (GO:0070914),0.23854917525020122,0.6094067010153316,0.9461358313817331,1.0,1.0,2/12,10.09%,DDB1;POLA1
prerank,negative regulation of viral life cycle (GO:1903901),-0.23464395882750266,-0.6084636311430054,0.9593345656192237,0.9891005011548069,1.0,2/15,11.64%,LY6E;IFITM3
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.1934774305545942,-0.6081179179860209,0.9587242026266416,0.9888783954234505,1.0,7/29,25.79%,PLA2G4A;LPCAT1;TMEM86B;PLA2G12A;LPCAT3;PNPLA8;PLA2G4F
prerank,telomere maintenance via telomerase (GO:0007004),-0.1917974459850837,-0.6079493021505726,0.9622980251346499,0.9885743751344163,1.0,9/28,24.82%,MRE11;PPP6R3;RPA1;PTGES3;TERF2;TERT;HSP90AA1;RFC1;PINX1
prerank,regulation of superoxide anion generation (GO:0032928),0.22668976608546448,0.6066982622916277,0.944578313253012,1.0,1.0,2/14,8.42%,CD177;MAPT
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.2563543260795973,-0.6055334554986159,0.9295238095238095,0.9892708611443339,1.0,4/10,29.48%,RPUSD4;NAF1;RPUSD2;GAR1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.20375847769484767,-0.6046589397949709,0.9725085910652921,0.9892998944435886,1.0,5/24,23.05%,LRRK2;AQP11;HERPUD1;LPCAT3;TXNDC12
prerank,regulation of chromosome organization (GO:0033044),-0.20482117847175957,-0.6045954408475255,0.9669117647058824,0.9889506746241286,1.0,9/22,33.70%,RB1;WAPL;TERF2;LIG4;SMG6;HNRNPD;SMG1;HDAC8;PIF1
prerank,triglyceride metabolic process (GO:0006641),0.1696727949637847,0.6045675915034097,0.9867256637168141,1.0,1.0,7/48,16.51%,LPIN1;GK;LIPC;MOGAT1;APOE;APOC1;SEL1L
prerank,cellular biogenic amine metabolic process (GO:0006576),0.2350979796568411,0.603884438624474,0.9225352112676056,1.0,1.0,2/12,8.27%,TRH;SLC29A4
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.24826580095243225,0.6034136977563165,0.9429824561403509,1.0,1.0,5/10,28.05%,VEGFA;FZD3;CX3CL1;CX3CR1;KDM1A
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.23331844685069952,0.6022984232728553,0.9285714285714286,1.0,1.0,1/12,3.75%,GGCT
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.22411009084739508,0.602270280726106,0.9385964912280702,1.0,1.0,14/15,64.25%,SELENOS;SEL1L;AUP1;NPLOC4;DERL2;SYVN1;UFD1;TMEM129;FAF2;DERL1;HSP90B1;SEC61B;VCP;OS9
prerank,regulation of nervous system development (GO:0051960),0.17674754385234584,0.6018577591671679,0.9790697674418605,1.0,1.0,2/37,5.85%,TENM4;PTPRZ1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.22884929262142345,0.6005227706794198,0.9336283185840708,1.0,1.0,3/14,12.46%,CD81;CARD11;CD226
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.21274699077595316,0.6001610834686946,0.9493392070484582,1.0,1.0,7/17,28.30%,LIPC;PCSK6;APOC1;ANGPTL3;NR1H2;SORT1;HDAC9
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.23129157303330317,-0.5994778445438312,0.9498269896193772,0.9907131489612289,1.0,5/14,30.42%,FOXO3;MRPL12;FASTKD5;SLC25A33;MTERF2
prerank,positive regulation of protein depolymerization (GO:1901881),0.23996828412345364,0.5994371119941451,0.9313304721030042,1.0,1.0,2/11,9.80%,PLEK;STMN2
prerank,regulation of microtubule-based movement (GO:0060632),0.23932045433108462,0.5990910783442029,0.9331896551724138,1.0,1.0,2/11,8.66%,MAP2;NEFH
prerank,monosaccharide transmembrane transport (GO:0015749),0.21977651211679874,0.5978921580181681,0.9456264775413712,1.0,1.0,2/16,9.94%,SLC2A10;SLC2A8
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.20240698569375193,-0.5965385749378539,0.9726775956284153,0.9915423431106077,1.0,6/23,24.47%,RBX1;XPC;CETN2;COPS7A;COPS8;COPS4
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.19640935220331823,0.5962122523869368,0.9619952494061758,1.0,1.0,4/23,12.58%,H1-0;MUS81;HMGB2;REXO4
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.2535629059015508,-0.5954573065977946,0.9397810218978102,0.9916114098369372,1.0,5/10,29.46%,ACER2;SERPINE1;CYP1B1;SNAI2;WNK1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.22329801665114823,0.5949251670883359,0.9368191721132898,1.0,1.0,3/14,19.45%,RASGRP1;IL23A;CD84
prerank,heterocycle biosynthetic process (GO:0018130),0.22131690685951502,0.5920549195710828,0.9551282051282052,1.0,1.0,5/14,22.45%,PYCR2;ALOX5;NOXRED1;NFS1;LIAS
prerank,organelle disassembly (GO:1903008),0.18210418023466712,0.5919299462028431,0.9930555555555556,1.0,1.0,6/33,17.26%,VRK1;ZFAND1;UBA5;GOLGA2;UFL1;RETREG1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.22555145019882603,0.5903750256113093,0.9468822170900693,1.0,1.0,1/13,2.30%,UBE2J1
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.2100708889634894,-0.590042706415426,0.9547101449275363,0.9930392401976164,1.0,6/19,25.93%,POLR2G;TERF2;ATRX;POLR2C;POLR2L;POLR2H
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.2100708889634894,-0.590042706415426,0.9547101449275363,0.9930392401976164,1.0,6/19,25.93%,POLR2G;TERF2;ATRX;POLR2C;POLR2L;POLR2H
prerank,regulation of telomere maintenance (GO:0032204),-0.19093884557494567,-0.5891490520476588,0.9729241877256317,0.993012218607758,1.0,11/26,33.70%,MRE11;PPP1R10;TERF2;USP7;ATRX;SMG6;HNRNPD;SMG1;RAD50;HDAC8;PIF1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.21260728561192044,0.588838614582797,0.9593679458239278,1.0,1.0,6/17,25.16%,SELENOS;SEL1L;AUP1;HM13;NPLOC4;DERL2
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.20763505492009604,-0.5880109105909641,0.9664310954063604,0.9930752632760304,1.0,4/19,21.05%,RIC3;CHRNB1;NQO1;CHRNA4
prerank,inner ear morphogenesis (GO:0042472),-0.20099444771388464,-0.5879182607902698,0.9782608695652174,0.9927319931875843,1.0,2/22,5.59%,TBX1;SIX1
prerank,lipoprotein transport (GO:0042953),0.24855084499088353,0.5867971988035046,0.9244060475161987,1.0,1.0,4/10,26.23%,PRKCB;VMP1;UNC119;CD36
prerank,phosphate ion transmembrane transport (GO:0035435),-0.2320862462404904,-0.5854074385173716,0.9704861111111112,0.9932284442175228,1.0,5/12,31.13%,SLC25A11;SLC20A2;SLC37A4;SLC20A1;SLC25A10
prerank,chromatin assembly or disassembly (GO:0006333),0.23208687386436827,0.5852767667707639,0.9464285714285714,1.0,1.0,1/11,5.61%,M1AP
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.19787941111313406,-0.5828126821363284,0.956369982547993,0.9937692439352132,1.0,9/22,30.26%,PPM1F;PPM1B;PPP2CB;PPM1D;DUSP16;PPP2CA;PPP1CA;DUSP1;DUSP6
prerank,endocrine system development (GO:0035270),-0.20115178432682704,-0.5826546709594153,0.9803571428571428,0.9934421397679594,1.0,6/21,28.59%,TBX1;SIX1;WNT11;NF1;STRA6;TGFBR1
prerank,carboxylic acid catabolic process (GO:0046395),0.22494033174025563,0.5816066786263401,0.9483870967741935,1.0,1.0,3/12,20.47%,BCKDK;NPL;GNPDA1
prerank,Golgi inheritance (GO:0048313),-0.2384730431213312,-0.5814112264504098,0.9414990859232175,0.9935010134921384,1.0,5/11,33.57%,YWHAZ;VCPIP1;PLK3;STX5;PDCD10
prerank,protein mannosylation (GO:0035268),-0.19775423632401395,-0.5813005990561515,0.978494623655914,0.9931548366715958,1.0,2/22,3.65%,TMTC1;TMTC2
prerank,protein localization to kinetochore (GO:0034501),0.21666248116524364,0.5796994236720036,0.9659863945578231,1.0,1.0,14/14,78.35%,RCC2;CDK1;IK;ZWILCH;ZW10;KNL1;CHAMP1;AURKB;CENPT;MIS12;SPDL1;MTBP;TTK;BUB3
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.22905430214052266,0.5787817080384005,0.9594017094017094,1.0,1.0,3/11,16.74%,P2RX3;P2RX5;CDH13
prerank,epithelial cell morphogenesis (GO:0003382),0.20679933125833766,0.5764677306676033,0.9672489082969432,1.0,1.0,1/17,2.77%,STC1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.23024572253523712,-0.5741164739492933,0.957968476357268,0.9952064773434551,1.0,3/12,20.88%,RBP4;NOD2;STRAP
prerank,coenzyme A metabolic process (GO:0015936),0.20828495116800122,0.5735812621881659,0.9669603524229075,1.0,1.0,6/14,25.86%,ACLY;ACOT7;ACAT1;CROT;DCAKD;COASY
prerank,glycine metabolic process (GO:0006544),-0.2244642654643483,-0.5703649977099142,0.9578947368421052,0.9959944235161773,1.0,1/12,3.50%,DLD
prerank,oogenesis (GO:0048477),0.21188266859157412,0.5689600215177144,0.9772727272727273,1.0,1.0,1/15,3.69%,FMN2
prerank,negative regulation of T cell proliferation (GO:0042130),0.18245643603624265,0.5687339680596446,0.985200845665962,1.0,1.0,27/28,73.00%,VTCN1;SDC4;CD86;PRNP;IL4I1;TNFRSF21;PRKAR1A;SCRIB;PLA2G2F;DLG5;VSIG4;IL10;BTN2A2;PLA2G2D;CD80;GLMN;SPN;FOXP3;PDCD1LG2;CRTAM;ARG1;GPNMB;CD274;CEBPB;LILRB1;TNFRSF14;LGALS9
prerank,regulation of small molecule metabolic process (GO:0062012),-0.18244299735720163,-0.5685024390063617,0.9773123909249564,0.9961657391180393,1.0,4/28,13.89%,PANK2;PPARA;ACADL;ACADVL
prerank,regulation of DNA metabolic process (GO:0051052),0.1622074340029453,0.5682949980150249,0.9951100244498777,1.0,1.0,11/44,22.34%,WRNIP1;XRCC5;PDGFA;SMG5;SIRT7;UPF1;KAT7;WDR70;WDR18;TERF2IP;CDK9
prerank,regulation of interleukin-17 production (GO:0032660),-0.1783478159623912,-0.5675093301596206,0.9818511796733213,0.9960838178502937,1.0,2/31,3.85%,SLC7A5;IL15
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.2391720175263928,-0.5660809220292689,0.9699115044247788,0.996151729210484,1.0,6/11,32.94%,CASP8;RIPK1;TICAM1;RFTN1;TNIP2;SCARA3
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.22167039234032582,0.5659796759185114,0.9573991031390134,1.0,1.0,4/12,19.62%,LDLR;CLU;APOE;PFDN4
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.22091716062551303,-0.5649095413791124,0.9523809523809523,0.9961328617969749,1.0,1/13,5.60%,CBL
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.23350643737581978,0.5648310231028616,0.9482352941176471,1.0,1.0,3/10,19.56%,SOCS3;INPP5F;PPP2R1A
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.2341023183883222,-0.5647989210048353,0.9576719576719577,0.9957841839450807,1.0,4/11,24.39%,ADM;SAG;ARRB1;GRK3
prerank,lymphocyte migration (GO:0072676),-0.17808049366778517,-0.5642458049645831,0.990990990990991,0.9955645526730291,1.0,3/32,9.20%,CCL25;MSN;S1PR1
prerank,carnitine shuttle (GO:0006853),0.2222303893169626,0.5615495130544639,0.9701149425287356,1.0,1.0,2/11,9.05%,ACACA;CPT1B
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.1973142035018084,0.5598286070170911,0.9735576923076923,1.0,1.0,10/19,29.21%,ATP13A2;HTRA2;HTT;VDAC1;FBXO7;USP36;DNM1L;SREBF1;PINK1;SREBF2
prerank,positive regulation of bone resorption (GO:0045780),0.22327537505492437,0.5597102000377943,0.9558498896247241,1.0,1.0,11/11,77.69%,SPP1;ADAM8;DEF8;ATP6AP1;PRKCA;TNFRSF11A;DCSTAMP;TNFSF11;SYK;MC4R;PLEKHM1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.2149359182010395,-0.5593074313941434,0.9683426443202979,0.99661692428856,1.0,2/14,9.00%,SEMA7A;PLCG2
prerank,regulation of fatty acid oxidation (GO:0046320),-0.20807084083163221,-0.5586510772964968,0.9653979238754326,0.9964242346243993,1.0,3/16,13.89%,PPARA;ACADL;ACADVL
prerank,rRNA methylation (GO:0031167),0.19010582473322737,0.5586190929954681,0.9844097995545658,1.0,1.0,4/22,13.07%,MTERF4;BUD23;TFB1M;DIMT1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.23170747586439203,-0.5571305459724857,0.9710669077757685,0.9964686495066691,1.0,2/11,16.25%,JAK2;TAF7
prerank,cochlea morphogenesis (GO:0090103),-0.23709764271266925,-0.5570863245671966,0.9464944649446494,0.9961040707162168,1.0,1/10,3.63%,TBX1
prerank,establishment of spindle localization (GO:0051293),-0.21561911909019685,-0.5569278766742353,0.9612676056338029,0.9957760103988256,1.0,6/14,39.73%,MAP4;CFL1;TLE6;ESPL1;NLRP5;ZBED3
prerank,actin-myosin filament sliding (GO:0033275),-0.1660250654687373,-0.5559397836810942,0.9945553539019963,0.995288187038645,1.0,13/38,36.60%,TPM3;TPM1;MYL6;TNNI1;TNNT3;ACTN2;TTN;TPM2;MYBPC2;TCAP;MYL3;ACTA1;MYH6
prerank,muscle filament sliding (GO:0030049),-0.1660250654687373,-0.5559397836810942,0.9945553539019963,0.995288187038645,1.0,13/38,36.60%,TPM3;TPM1;MYL6;TNNI1;TNNT3;ACTN2;TTN;TPM2;MYBPC2;TCAP;MYL3;ACTA1;MYH6
prerank,nucleotide biosynthetic process (GO:0009165),-0.198376539972666,-0.5531968650017872,0.9850746268656716,0.9956741967780451,1.0,7/18,35.84%,MTHFD1;HPRT1;PRPS2;PNP;GART;ME1;NMNAT3
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.1965923809420788,-0.5524518070850242,0.9791304347826087,0.995484788552625,1.0,5/20,20.96%,LDLRAP1;ACADL;ACADVL;FMO5;LPCAT3
prerank,tetrahydrofolate metabolic process (GO:0046653),0.2228110932577152,0.552212818244879,0.9671361502347418,1.0,1.0,1/10,5.28%,TYMS
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.2292776432919176,-0.5516511794651554,0.9642857142857143,0.9953099930676318,1.0,5/11,37.65%,SLC19A2;SLC19A3;DCK;SLC25A19;THTPA
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.23076486457680673,-0.551320148689154,0.9689655172413794,0.9950162459381844,1.0,3/10,28.54%,TAF7;BRCA1;SET
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.20093473169639936,-0.550745901745897,0.9771863117870723,0.9947786263035863,1.0,5/17,29.29%,AFG1L;COX10;COX6C;COX5A;COX4I2
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.19250924225466565,-0.5475830320686578,0.9634551495016611,0.9952228725150579,1.0,4/18,26.06%,ABL1;PRKDC;PRDM1;ZFP36L1
prerank,mitochondrial transcription (GO:0006390),-0.23153337794437504,-0.5461290574989495,0.971830985915493,0.9952150655746859,1.0,4/10,30.42%,FOXO3;MRPL12;SLC25A33;MTERF2
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.2147130224760633,0.5459548391740483,0.9572649572649573,1.0,1.0,2/12,15.02%,RASGRP1;IL23A
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.194150092342004,0.5440139323243933,0.9636363636363636,1.0,1.0,1/16,2.91%,TMEM161A
prerank,negative regulation of phagocytosis (GO:0050765),0.1925054744345518,0.5434211072414893,0.9815668202764977,1.0,1.0,4/17,17.74%,SYT11;CD47;SIRPA;FCGR2B
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.2153029359597251,-0.5423608942424729,0.9750445632798574,0.9957478680570162,1.0,4/13,32.09%,IRAK1;IRAK2;PIK3AP1;TNIP2
prerank,positive regulation of leukocyte migration (GO:0002687),-0.1767736054970432,-0.5417122593382111,0.9869888475836431,0.9955189929806999,1.0,3/27,11.69%,ICAM1;IL6R;EDN3
prerank,protein polyglutamylation (GO:0018095),0.21879303952048046,0.5413321346239971,0.9560185185185185,1.0,1.0,5/11,26.93%,TPGS1;TTLL5;CFAP20;TTLL11;TTLL2
prerank,anterograde synaptic vesicle transport (GO:0048490),0.20177590226331218,0.5390998359408458,0.9862385321100917,1.0,1.0,3/15,15.41%,AP3S2;AP3M2;SNAPIN
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.20177590226331218,0.5390998359408458,0.9862385321100917,1.0,1.0,3/15,15.41%,AP3S2;AP3M2;SNAPIN
prerank,negative regulation of DNA recombination (GO:0045910),0.15376785158598788,0.5373308539425766,0.9954337899543378,1.0,1.0,15/43,25.96%,SHLD3;TERF1;H1-0;POLR2D;FANCB;ACD;MSH2;TERF2IP;FBH1;RTEL1;UBQLN4;POLR2J;POLR2K;ZRANB3;POLQ
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.20935417735044218,-0.5365672471504563,0.9639468690702088,0.9962643732026323,1.0,2/13,10.57%,CSPG4;BGN
prerank,regulation of activated T cell proliferation (GO:0046006),-0.1689379538688119,-0.5360830720116719,0.987719298245614,0.9959984507429063,1.0,19/30,49.57%,ICOSLG;RC3H1;IGF1;RPS3;IGF2;HMGB1;LGALS9;IL27RA;CD274;IL18;CRTAM;PDCD1LG2;TNFSF9;FOXP3;IL23R;AGER;IL12B;IL2;RIPK3
prerank,ATP transport (GO:0015867),0.22497945787126697,0.5348403115558632,0.9804772234273319,1.0,1.0,2/10,15.25%,SLC25A4;CD47
prerank,negative regulation of cation channel activity (GO:2001258),-0.1772391971687134,-0.5342351275653325,0.9833333333333333,0.9960408353519332,1.0,2/26,10.36%,PKD2;GSTM2
prerank,regulation of transposition (GO:0010528),-0.21206419429459256,-0.5306337098991963,0.9781021897810219,0.9963906972559344,1.0,6/13,40.03%,UBR2;TDRD9;DDX4;MYBL1;PIWIL4;SPOCD1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.20945754696490287,-0.5291688592025486,0.9779816513761468,0.9963209914460192,1.0,4/13,22.63%,SEC16B;BCAP31;EDEM2;SAR1A
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.21123234609429473,0.5275598070910387,0.9725158562367865,1.0,1.0,2/11,13.38%,TERF1;WRAP53
prerank,N-terminal protein amino acid modification (GO:0031365),-0.20594599777619463,-0.5273508754184079,0.9844961240310077,0.9963099129652822,1.0,2/14,10.04%,NAA16;NAA15
prerank,protein deneddylation (GO:0000338),-0.2219142565015274,-0.526544656062889,0.9735449735449735,0.996098228108589,1.0,4/10,30.55%,COPS7A;COPS8;COPS4;COPS5
prerank,acylglycerol homeostasis (GO:0055090),-0.1876277531464925,-0.5259613820368728,0.9839857651245552,0.995839686552517,1.0,12/20,48.36%,SCARB1;LPL;PNPLA8;RORA;IL18;APOC4;PLA2G12B;NR1H3;HNF4A;ACSM2A;ANGPTL8;APOA1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.20450097812332504,-0.5250518023459434,0.9817850637522769,0.9956384096532619,1.0,7/14,39.88%,RARA;ANXA1;CCL19;NFKBID;NLRP3;IL18;MYB
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.15667058597751468,-0.5235058018326978,1.0,0.9955494633408968,1.0,18/37,45.32%,PPARA;PDCD4;IL17RA;GBP5;NOD2;TREM2;MAPK14;STAT3;TICAM1;TLR6;NOS2;HIF1A;APPL2;ABCD1;CARD9;TLR4;TNF;IL6
prerank,hexose biosynthetic process (GO:0019319),-0.15303587870647234,-0.517193100550843,0.9930915371329879,0.9963298827298532,1.0,5/42,14.04%,CHST15;RBP4;SLC25A11;ALDOC;ATF4
prerank,superoxide anion generation (GO:0042554),0.199585377157798,0.5168952401730232,0.9810874704491725,1.0,1.0,2/13,11.54%,ALOX12;NOX3
prerank,protein localization to phagophore assembly site (GO:0034497),-0.2086486623255394,-0.514816292493132,0.97632058287796,0.9963557117043534,1.0,5/11,34.25%,WIPI1;WDR45B;ATG9A;PACS2;WIPI2
prerank,gluconeogenesis (GO:0006094),0.14467627759239562,0.5123316500011335,1.0,1.0,1.0,2/39,5.09%,SLC25A13;TPI1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.19759572390827895,0.5108702543997532,0.9903147699757869,1.0,1.0,3/13,18.00%,BMF;VDAC2;RHOT1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.17970028142142808,0.5092820425909615,0.9748283752860412,1.0,1.0,3/18,15.69%,CHGA;ADRA2A;BMP8A
prerank,intracellular sterol transport (GO:0032366),-0.20088257205117271,-0.5081839319287207,0.9837837837837838,0.9970322862173178,1.0,3/13,20.56%,STARD4;STAR;OSBPL2
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.16906672095654363,0.507740475625115,0.9886104783599089,1.0,1.0,4/22,19.02%,IL12A;IL12RB1;IL23A;ZBTB1
prerank,kinetochore organization (GO:0051383),-0.19950846856220836,-0.5070466342849714,0.978494623655914,0.9968204083963602,1.0,6/13,39.77%,POGZ;CENPE;CENPH;NUF2;MIS12;CENPT
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.1999771202235929,-0.5063618881762869,0.9827586206896551,0.9965421790556662,1.0,5/13,32.76%,AQP11;LPCAT3;EIF2AK3;USP19;MANF
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.1811796611400501,0.5056432180347992,0.986046511627907,1.0,1.0,7/16,29.33%,PIGP;PIGB;PIGQ;DPM2;PIGA;PIGM;PIGC
prerank,cGMP biosynthetic process (GO:0006182),-0.21821460575802903,-0.504336755944936,0.980072463768116,0.9964636165565299,1.0,3/10,24.28%,NPR1;GUCY1A1;GUCY2C
prerank,tryptophan catabolic process (GO:0006569),0.20500910175130263,0.5033738296405664,0.9748283752860412,1.0,1.0,11/11,79.51%,HAAO;TDO2;IL4I1;AFMID;ACMSD;IDO1;IDO2;AADAT;KYAT1;KYNU;KMO
prerank,maintenance of protein localization in organelle (GO:0072595),-0.17911754219487225,-0.5021527931749055,0.9927140255009107,0.9963961102315666,1.0,8/19,37.85%,AKT1;TAF8;TAF3;ARL2;HNRNPU;MORC3;TOPORS;ARL2BP
prerank,female gonad development (GO:0008585),-0.17781072022168956,-0.5005217720803039,0.9946902654867257,0.9962330633583986,1.0,8/19,33.43%,EIF2B2;SOD1;NR2F2;FOXL2;COL9A3;CEBPB;EIF2B4;EIF2B5
prerank,tryptophan metabolic process (GO:0006568),0.20500910175130255,0.5000565199770788,0.9819819819819819,1.0,1.0,11/11,79.51%,HAAO;TDO2;IL4I1;ACMSD;IDO1;ATP7A;IDO2;AADAT;KYAT1;KYNU;KMO
prerank,indolalkylamine catabolic process (GO:0046218),0.20499623399447647,0.49444573702878797,0.9709821428571429,1.0,1.0,10/10,79.51%,HAAO;TDO2;IL4I1;ACMSD;IDO1;IDO2;AADAT;KYAT1;KYNU;KMO
prerank,DNA modification (GO:0006304),0.16111760651681073,0.48851273612556634,0.9934497816593887,1.0,1.0,2/22,6.89%,TERF1;UNG
prerank,RNA modification (GO:0009451),0.1332340241144664,0.48439236488769033,1.0,1.0,1.0,13/54,22.42%,QTRT2;TRMT6;TFB1M;TSR3;FTSJ1;AARS2;ANKRD16;QTRT1;TRIT1;NSUN6;ADAT2;THUMPD1;NOP10
prerank,rRNA transcription (GO:0009303),-0.17963763043472275,-0.48098171751391633,0.9964726631393298,0.9981370016053568,1.0,5/17,25.09%,TAF1B;BRF1;CAVIN1;GTF3C4;POLR1E
prerank,aggrephagy (GO:0035973),0.14810632376974106,0.4793164407661589,0.9953917050691244,1.0,1.0,7/27,21.97%,DYNC1I1;DYNC1LI2;VIM;UBB;DYNC1I2;ACBD5;SQSTM1
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.1882971899779209,-0.47852269359259836,0.9912126537785588,0.9980183178176989,1.0,2/13,13.29%,GAS6;AP1G1
prerank,microglial cell activation (GO:0001774),0.16169318304790323,0.4777821499783992,0.9908466819221968,1.0,1.0,7/21,26.02%,GRN;MAPT;CLU;CX3CL1;SNCA;CX3CR1;TYROBP
prerank,protein import into peroxisome membrane (GO:0045046),-0.1641512059327066,-0.4775927987541937,0.9963768115942029,0.9977388331326685,1.0,7/22,33.89%,ABCD3;RAB8B;PEX14;PEX3;PEX11B;PEX19;PEX26
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.18792107423161486,0.469453582580959,0.9885057471264368,1.0,1.0,3/11,21.50%,UGGT2;AUP1;TOR1A
prerank,positive regulation of protein maturation (GO:1903319),0.19063461176322904,0.4675282957444009,0.9911699779249448,1.0,1.0,11/11,80.95%,NKD2;ADAM8;ASTL;TNP2;ANGPTL8;TFR2;CCBE1;BAG2;NLRC4;RHBDD1;SOX4
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.17212709784121882,-0.4670262679949884,0.9981785063752276,0.9983176342306829,1.0,8/16,42.84%,RC3H1;MOV10;RBM24;ZFP36L1;ZC3H12D;TRIM71;DND1;PLEKHN1
prerank,regulation of B cell activation (GO:0050864),0.14908588301815673,0.46347624441772733,0.9977728285077951,1.0,1.0,25/25,85.11%,SAMSN1;FOXJ1;FCGR2B;IL4I1;MZB1;IGLL1;TNFSF4;TLR9;ZFP36L2;SH3KBP1;LAPTM5;IL10;CD19;SLAMF8;IL6;CD22;IL4;AHR;THEMIS2;IKZF3;TNIP2;BANK1;ZFP36L1;NOD2;TNFAIP3
prerank,positive regulation of interleukin-10 production (GO:0032733),0.14157704068180493,0.4598313039252752,1.0,1.0,1.0,4/30,15.02%,INAVA;PRKCZ;LILRA5;IL23A
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.16866346430177012,-0.45290469353410645,0.99644128113879,0.9990224222556439,1.0,10/16,50.08%,VSIR;LILRB1;TRIB2;CD274;PDCD1LG2;FOXP3;IL23R;AGER;IL12B;DLL1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.1679223322199407,0.44022121156846356,0.9952380952380953,1.0,1.0,2/15,11.60%,CHST2;EXTL2
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.16145469011685654,-0.43907874244507406,0.9911190053285968,0.9994705966047823,1.0,5/18,24.66%,ICOSLG;IGF1;RPS3;IGF2;HMGB1
prerank,regulation of interleukin-10 production (GO:0032653),-0.12729568790170162,-0.4364991943263224,1.0,0.9992229257391089,1.0,25/44,50.08%,CD34;PLCG2;VSIR;NOD2;HMGB1;LGALS9;LILRB1;STAT3;TSLP;TRIB2;CD274;SYK;PDCD1LG2;IL4;CD28;TLR4;IL6;FOXP3;IRF4;IL23R;AGER;F2RL1;IL12B;XCL1;DLL1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.1788851613864461,0.4343204102600703,0.997920997920998,1.0,1.0,1/10,9.73%,IL12A
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.16648710054997362,0.43419734965401596,0.9955156950672646,0.9992618660179535,1.0,1/13,6.89%,UNG
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.16557831801820708,0.41952970126994377,0.9977628635346756,0.9989294954118222,1.0,2/12,13.38%,GNL3;WRAP53
prerank,regulation of stem cell population maintenance (GO:2000036),-0.1464453617266153,-0.41074843954253026,0.9981981981981982,0.9998460502078902,1.0,4/18,27.04%,TAF5L;PTN;CNOT2;CNOT1
prerank,smoothened signaling pathway (GO:0007224),-0.12196330902113194,-0.3859468319053995,1.0,0.9999823589807698,1.0,5/32,20.33%,SMO;GLI3;HIPK1;TMEM17;PKD2L1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.15523301913530868,-0.37618773289075774,0.9981549815498155,0.9997281083147905,1.0,4/11,36.28%,ATF4;NONO;PARK7;HIF1A
